1	1	PDF	pdf	NN	3	compound	0	3	_	_	_	_	_
1	2	printable	printable	JJ	3	amod	4	13	_	_	_	_	_
1	3	version	version	NN	19	dep	14	21	_	_	_	_	_
1	4	of	of	IN	7	case	22	24	_	_	_	_	_
1	5	4.5	4.5	CD	7	nummod	25	28	_	_	_	_	_
1	6	Hepatitis	Hepatitis	NNP	7	compound	29	38	_	_	_	_	_
1	7	B	b	NN	3	nmod	39	40	_	_	_	_	_
1	8	of	of	IN	11	case	41	43	_	_	_	_	_
1	9	the	the	DT	11	det	44	47	_	_	_	_	_
1	10	10th	10th	JJ	11	amod	48	52	_	_	_	_	_
1	11	edition	edition	NN	7	nmod	53	60	_	_	_	_	_
1	12	of	of	IN	16	case	61	63	_	_	_	_	_
1	13	the	the	DT	16	det	64	67	_	_	_	_	_
1	14	Handbook	Handbook	NNP	16	compound	68	76	_	_	_	_	_
1	15	(	(	CD	16	nummod	77	78	_	_	_	_	_
1	16	PDF	pdf	NN	11	nmod	78	81	_	_	_	_	_
1	17	530	530	CD	18	nummod	82	85	_	_	_	_	_
1	18	KB	kb	NN	19	dep	86	88	_	_	_	_	_
1	19	)	)	CD	24	dep	88	89	_	_	_	_	_
1	20	This	this	DT	21	det	90	94	_	_	_	_	_
1	21	chapter	chapter	NN	19	dep	95	102	_	_	_	_	_
1	22	has	have	VBZ	24	aux	103	106	_	_	_	_	_
1	23	been	be	VBN	24	auxpass	107	111	_	_	_	_	_
1	24	amended	amend	VBN	0	ROOT	112	119	_	_	_	_	_
1	25	on	on	IN	26	case	120	122	_	_	_	_	_
1	26	July	July	NNP	24	nmod	123	127	_	_	_	_	_
1	27	2016	2016	CD	26	nummod	128	132	_	_	_	_	_
1	28	.	.	.	24	punct	132	133	_	_	_	_	_

2	1	4.5.1	4.5.1	CD	5	nummod	134	139	_	_	_	_	_
2	2	Virology	Virology	NNP	5	compound	140	148	_	_	_	_	_
2	3	Hepatitis	Hepatitis	NNP	5	compound	149	158	B-event-212467	_	_	_	_
2	4	B	b	NN	5	compound	159	160	I-event-212467	_	_	_	_
2	5	virus	virus	NN	9	nsubj	161	166	B-event-212468	_	_	_	_
2	6	(	(	CD	8	nummod	167	168	_	_	_	_	_
2	7	HBV	hbv	NN	8	compound	168	171	_	_	_	_	_
2	8	)	)	NN	5	dep	171	172	_	_	_	_	_
2	9	contains	contain	VBZ	0	ROOT	173	181	_	_	_	_	_
2	10	circular	circular	JJ	13	amod	182	190	_	_	_	_	_
2	11	,	,	,	13	punct	190	191	_	_	_	_	_
2	12	partially	partially	RB	13	advmod	192	201	_	_	_	_	_
2	13	double-stranded	double-stranded	JJ	14	amod	202	217	_	_	_	_	_
2	14	DNA	dna	NN	9	dobj	218	221	_	_	_	_	_
2	15	.	.	.	9	punct	221	222	_	_	_	_	_

3	1	The	the	DT	3	det	223	226	_	_	_	_	_
3	2	outer	outer	JJ	3	amod	227	232	_	_	_	_	_
3	3	surface	surface	NN	8	nsubj	233	240	_	_	_	_	_
3	4	of	of	IN	6	case	241	243	_	_	_	_	_
3	5	the	the	DT	6	det	244	247	_	_	_	_	_
3	6	virus	virus	NN	3	nmod	248	253	_	_	_	_	_
3	7	is	be	VBZ	8	cop	254	256	_	_	_	_	_
3	8	glycolipid	glycolipid	NN	0	ROOT	257	267	_	_	_	_	_
3	9	,	,	,	8	punct	267	268	_	_	_	_	_
3	10	which	which	WDT	11	nsubj	269	274	_	_	_	_	_
3	11	contains	contain	VBZ	8	acl:relcl	275	283	_	_	_	_	_
3	12	the	the	DT	15	det	284	287	_	_	_	_	_
3	13	hepatitis	hepatitis	NN	15	compound	288	297	_	_	_	_	_
3	14	B	b	NN	15	compound	298	299	_	_	_	_	_
3	15	surface	surface	NN	11	dobj	300	307	_	_	_	_	_
3	16	antigen	antigen	NN	19	compound	308	315	_	_	_	_	_
3	17	(	(	CD	19	nummod	316	317	_	_	_	_	_
3	18	HBsAg	hbsag	NN	19	compound	317	322	_	_	_	_	_
3	19	)	)	NN	15	dep	322	323	_	_	_	_	_
3	20	.	.	.	8	punct	323	324	_	_	_	_	_

4	1	Other	other	JJ	4	amod	325	330	_	_	_	_	_
4	2	important	important	JJ	4	amod	331	340	_	_	_	_	_
4	3	antigenic	antigenic	JJ	4	amod	341	350	_	_	_	_	_
4	4	components	component	NNS	13	nsubj	351	361	_	_	_	_	_
4	5	are	be	VBP	13	cop	362	365	_	_	_	_	_
4	6	the	the	DT	13	det	366	369	_	_	_	_	_
4	7	hepatitis	hepatitis	NN	13	compound	370	379	_	_	_	_	_
4	8	B	b	NN	13	compound	380	381	_	_	_	_	_
4	9	core	core	NN	13	compound	382	386	_	_	_	_	_
4	10	antigen	antigen	NN	13	compound	387	394	_	_	_	_	_
4	11	(	(	CD	13	nummod	395	396	_	_	_	_	_
4	12	HBcAg	hbcag	NN	13	compound	396	401	_	_	_	_	_
4	13	)	)	NN	0	ROOT	401	402	_	_	_	_	_
4	14	and	and	CC	13	cc	403	406	_	_	_	_	_
4	15	hepatitis	hepatitis	NN	16	compound	407	416	_	_	_	_	_
4	16	B	b	NN	13	conj	417	418	_	_	_	_	_
4	17	e	e	SYM	18	dep	419	420	_	_	_	_	_
4	18	antigen	antigen	NN	21	dep	421	428	_	_	_	_	_
4	19	(	(	CD	18	nummod	429	430	_	_	_	_	_
4	20	HBeAg	hbeag	NN	21	compound	430	435	_	_	_	_	_
4	21	)	)	NN	13	dep	435	436	_	_	_	_	_
4	22	.	.	.	13	punct	436	437	_	_	_	_	_

5	1	HBcAg	hbcag	NN	4	nsubj	438	443	_	_	_	_	_
5	2	is	be	VBZ	4	cop	444	446	_	_	_	_	_
5	3	not	not	RB	4	neg	447	450	_	_	_	_	_
5	4	detectable	detectable	JJ	0	ROOT	451	461	B-event-211398	_	_	_	_
5	5	in	in	IN	6	case	462	464	_	_	_	_	_
5	6	serum	serum	NN	4	nmod	465	470	_	_	_	_	_
5	7	,	,	,	4	punct	470	471	_	_	_	_	_
5	8	but	but	CC	4	cc	472	475	_	_	_	_	_
5	9	can	can	MD	11	aux	476	479	_	_	_	_	_
5	10	be	be	VB	11	auxpass	480	482	_	_	_	_	_
5	11	detected	detect	VBN	4	conj	483	491	B-event-211399	_	_	_	_
5	12	in	in	IN	14	case	492	494	_	_	_	_	_
5	13	liver	liver	NN	14	compound	495	500	_	_	_	_	_
5	14	tissue	tissue	NN	11	nmod	501	507	_	_	_	_	_
5	15	in	in	IN	16	case	508	510	_	_	_	_	_
5	16	persons	person	NNS	11	nmod	511	518	_	_	_	_	_
5	17	with	with	IN	23	case	519	523	_	_	_	_	_
5	18	acute	acute	JJ	23	amod	524	529	_	_	_	_	_
5	19	or	or	CC	18	cc	530	532	_	_	_	_	_
5	20	chronic	chronic	JJ	21	amod	533	540	_	_	_	_	_
5	21	hepatitis	hepatitis	NN	18	conj	541	550	B-event-211400	_	_	_	_
5	22	B	b	NN	23	compound	551	552	I-event-211400	_	_	_	_
5	23	infection	infection	NN	16	nmod	553	562	B-event-211401	_	_	_	_
5	24	.	.	.	4	punct	562	563	_	_	_	_	_

6	1	HBeAg	hbeag	NN	19	nsubj	564	569	_	_	_	_	_
6	2	,	,	,	1	punct	569	570	_	_	_	_	_
6	3	and	and	CC	1	cc	571	574	_	_	_	_	_
6	4	antibodies	antibody	NNS	1	conj	575	585	_	_	_	_	_
6	5	against	against	IN	6	case	586	593	_	_	_	_	_
6	6	HBeAg	hbeag	NN	4	nmod	594	599	_	_	_	_	_
6	7	(	(	CD	9	nummod	600	601	_	_	_	_	_
6	8	anti-HBe	anti-hbe	JJ	9	amod	601	609	_	_	_	_	_
6	9	)	)	NN	6	dep	609	610	_	_	_	_	_
6	10	or	or	CC	6	cc	611	613	_	_	_	_	_
6	11	the	the	DT	12	det	614	617	_	_	_	_	_
6	12	HBcAg	hbcag	NN	6	conj	618	623	_	_	_	_	_
6	13	(	(	CD	15	nummod	624	625	_	_	_	_	_
6	14	anti-HBc	anti-hbc	JJ	15	amod	625	633	_	_	_	_	_
6	15	)	)	NN	12	dep	633	634	_	_	_	_	_
6	16	,	,	,	1	punct	634	635	_	_	_	_	_
6	17	are	be	VBP	19	cop	636	639	_	_	_	_	_
6	18	serological	serological	JJ	19	amod	640	651	_	_	_	_	_
6	19	markers	marker	NNS	0	ROOT	652	659	_	_	_	_	_
6	20	of	of	IN	22	case	660	662	_	_	_	_	_
6	21	HBV	hbv	NN	22	compound	663	666	B-event-211402	_	_	_	_
6	22	infection	infection	NN	19	nmod	667	676	B-event-211403	_	_	_	_
6	23	.	.	.	19	punct	676	677	_	_	_	_	_

7	1	Antibodies	antibody	NNS	7	nsubj	678	688	_	_	_	_	_
7	2	against	against	IN	6	case	689	696	_	_	_	_	_
7	3	HBsAg	hbsag	NN	5	nmod:npmod	697	702	_	_	_	_	_
7	4	(	(	CD	3	nummod	703	704	_	_	_	_	_
7	5	anti-HBs	anti-hbs	JJ	6	amod	704	712	_	_	_	_	_
7	6	)	)	NN	1	nmod	712	713	_	_	_	_	_
7	7	indicate	indicate	VBP	0	ROOT	714	722	_	_	_	_	_
7	8	immunity	immunity	NN	7	dobj	723	731	B-event-211404	_	_	_	_
7	9	,	,	,	8	punct	731	732	_	_	_	_	_
7	10	which	which	WDT	12	nsubj	733	738	_	_	_	_	_
7	11	may	may	MD	12	aux	739	742	_	_	_	_	_
7	12	result	result	VB	8	acl:relcl	743	749	_	_	_	_	_
7	13	from	from	IN	16	case	750	754	_	_	_	_	_
7	14	either	either	CC	16	cc:preconj	755	761	_	_	_	_	_
7	15	natural	natural	JJ	16	amod	762	769	_	_	_	_	_
7	16	infection	infection	NN	12	nmod	770	779	B-event-211405	_	_	_	_
7	17	or	or	CC	16	cc	780	782	_	_	_	_	_
7	18	immunisation	immunisation	NN	19	compound	783	795	B-event-211406	_	_	_	_
7	19	(	(	NN	16	conj	796	797	_	_	_	_	_
7	20	in	in	IN	22	case	797	799	_	_	_	_	_
7	21	which	which	WDT	22	det	800	805	_	_	_	_	_
7	22	case	case	NN	28	nmod	806	810	_	_	_	_	_
7	23	there	there	EX	28	expl	811	816	_	_	_	_	_
7	24	would	would	MD	28	aux	817	822	_	_	_	_	_
7	25	not	not	RB	28	neg	823	826	_	_	_	_	_
7	26	be	be	VB	28	cop	827	829	_	_	_	_	_
7	27	any	any	DT	28	det	830	833	_	_	_	_	_
7	28	markers	marker	NNS	12	ccomp	834	841	_	_	_	_	_
7	29	of	of	IN	32	case	842	844	_	_	_	_	_
7	30	HBV	hbv	NN	32	compound	845	848	B-event-211407	_	_	_	_
7	31	infection	infection	NN	32	compound	849	858	B-event-211408	_	_	_	_
7	32	)	)	NN	28	nmod	858	859	_	_	_	_	_
7	33	.	.	.	7	punct	859	860	_	_	_	_	_

8	1	Persistence	persistence	NN	4	nsubj	861	872	_	_	_	_	_
8	2	of	of	IN	3	case	873	875	_	_	_	_	_
8	3	HBsAg	hbsag	NN	1	nmod	876	881	_	_	_	_	_
8	4	denotes	denote	VBZ	0	ROOT	882	889	_	_	_	_	_
8	5	infectivity	infectivity	NN	4	dobj	890	901	B-event-211409	_	_	_	_
8	6	,	,	,	5	punct	901	902	_	_	_	_	_
8	7	which	which	WDT	9	nsubj	903	908	_	_	_	_	_
8	8	is	be	VBZ	9	cop	909	911	_	_	_	_	_
8	9	greater	greater	JJR	5	acl:relcl	912	919	_	_	_	_	_
8	10	if	if	IN	19	mark	920	922	_	_	_	_	_
8	11	HBeAg	hbeag	NN	19	nsubj	923	928	_	_	_	_	_
8	12	and/or	and/or	CC	11	cc	929	935	_	_	_	_	_
8	13	HBV	hbv	NN	14	compound	936	939	_	_	_	_	_
8	14	DNA	dna	NN	11	conj	940	943	_	_	_	_	_
8	15	are	be	VBP	19	cop	944	947	_	_	_	_	_
8	16	also	also	RB	19	advmod	948	952	_	_	_	_	_
8	17	positive	positive	JJ	19	amod	953	961	_	_	_	_	_
8	18	.1	.1	NN	19	compound	961	963	_	_	_	_	_
8	19	Occult	occult	NN	62	advcl	964	970	_	_	_	_	_
8	20	hepatitis	hepatitis	NN	22	compound	971	980	B-event-211410	_	_	_	_
8	21	B	b	NN	22	compound	981	982	I-event-211410	_	_	_	_
8	22	infection	infection	NN	24	nsubjpass	983	992	B-event-211411	_	_	_	_
8	23	is	be	VBZ	24	auxpass	993	995	_	_	_	_	_
8	24	characterised	characterise	VBN	19	acl:relcl	996	1009	_	_	_	_	_
8	25	by	by	IN	27	case	1010	1012	_	_	_	_	_
8	26	the	the	DT	27	det	1013	1016	_	_	_	_	_
8	27	presence	presence	NN	24	nmod	1017	1025	_	_	_	_	_
8	28	of	of	IN	30	case	1026	1028	_	_	_	_	_
8	29	HBV	hbv	NN	30	compound	1029	1032	_	_	_	_	_
8	30	DNA	dna	NN	27	nmod	1033	1036	_	_	_	_	_
8	31	in	in	IN	34	case	1037	1039	_	_	_	_	_
8	32	the	the	DT	34	det	1040	1043	_	_	_	_	_
8	33	liver	liver	NN	34	compound	1044	1049	_	_	_	_	_
8	34	(	(	NN	30	nmod	1050	1051	_	_	_	_	_
8	35	with	with	IN	40	case	1051	1055	_	_	_	_	_
8	36	or	or	CC	35	cc	1056	1058	_	_	_	_	_
8	37	without	without	IN	35	conj	1059	1066	_	_	_	_	_
8	38	detectable	detectable	JJ	40	amod	1067	1077	B-event-211412	_	_	_	_
8	39	HBV	hbv	NN	40	compound	1078	1081	_	_	_	_	_
8	40	DNA	dna	NN	24	nmod	1082	1085	_	_	_	_	_
8	41	in	in	IN	44	case	1086	1088	_	_	_	_	_
8	42	the	the	DT	44	det	1089	1092	_	_	_	_	_
8	43	serum	serum	NN	44	compound	1093	1098	_	_	_	_	_
8	44	)	)	NN	40	nmod	1098	1099	_	_	_	_	_
8	45	and	and	CC	40	cc	1100	1103	_	_	_	_	_
8	46	negative	negative	JJ	48	amod	1104	1112	_	_	_	_	_
8	47	HBsAg	hbsag	NN	48	compound	1113	1118	_	_	_	_	_
8	48	.2	.2	NN	40	conj	1118	1120	_	_	_	_	_
8	49	4.5.2	4.5.2	CD	51	nummod	1122	1127	_	_	_	_	_
8	50	Clinical	clinical	JJ	51	amod	1128	1136	_	_	_	_	_
8	51	features	feature	NNS	48	dep	1137	1145	_	_	_	_	_
8	52	In	in	IN	57	case	1146	1148	_	_	_	_	_
8	53	approximately	approximately	RB	56	advmod	1149	1162	_	_	_	_	_
8	54	30	30	CD	56	compound	1163	1165	_	_	_	_	_
8	55	to	to	TO	56	dep	1166	1168	_	_	_	_	_
8	56	50	50	CD	57	nummod	1169	1171	_	_	_	_	_
8	57	%	%	NN	62	nmod	1171	1172	_	_	_	_	_
8	58	of	of	IN	59	case	1173	1175	_	_	_	_	_
8	59	adults	adult	NNS	57	nmod	1176	1182	_	_	_	_	_
8	60	,	,	,	62	punct	1182	1183	_	_	_	_	_
8	61	infection	infection	NN	62	nsubj	1184	1193	B-event-211413	_	_	_	_
8	62	causes	cause	VBZ	9	ccomp	1194	1200	_	_	_	_	_
8	63	symptomatic	symptomatic	JJ	64	amod	1201	1212	B-event-212469	_	_	_	_
8	64	acute	acute	JJ	65	amod	1213	1218	_	_	_	_	_
8	65	hepatitis	hepatitis	NN	62	dobj	1219	1228	B-event-211414	_	_	_	_
8	66	,	,	,	62	punct	1228	1229	_	_	_	_	_
8	67	but	but	CC	62	cc	1230	1233	_	_	_	_	_
8	68	in	in	IN	69	case	1234	1236	_	_	_	_	_
8	69	neonates	neonate	NNS	96	nmod	1237	1245	_	_	_	_	_
8	70	and	and	CC	69	cc	1246	1249	_	_	_	_	_
8	71	young	young	JJ	72	amod	1250	1255	_	_	_	_	_
8	72	children	child	NNS	69	conj	1256	1264	_	_	_	_	_
8	73	,	,	,	96	punct	1264	1265	_	_	_	_	_
8	74	particularly	particularly	RB	86	advmod	1266	1278	_	_	_	_	_
8	75	those	those	DT	76	det	1279	1284	_	_	_	_	_
8	76	<	<	JJR	86	nsubj	1285	1286	_	_	_	_	_
8	77	1	1	CD	76	nummod	1286	1287	_	_	_	_	_
8	78	year	year	NN	76	nmod:tmod	1288	1292	_	_	_	_	_
8	79	of	of	IN	80	case	1293	1295	_	_	_	_	_
8	80	age	age	NN	76	nmod	1296	1299	_	_	_	_	_
8	81	,	,	,	80	punct	1299	1300	_	_	_	_	_
8	82	initial	initial	JJ	83	amod	1301	1308	_	_	_	_	_
8	83	infection	infection	NN	80	appos	1309	1318	B-event-211415	_	_	_	_
8	84	is	be	VBZ	86	cop	1319	1321	_	_	_	_	_
8	85	usually	usually	RB	86	advmod	1322	1329	_	_	_	_	_
8	86	asymptomatic	asymptomatic	JJ	96	advcl	1330	1342	B-event-211416	_	_	_	_
8	87	.3,4	.3,4	CD	86	nmod:tmod	1342	1346	_	_	_	_	_
8	88	The	the	DT	90	det	1347	1350	_	_	_	_	_
8	89	incubation	incubation	NN	90	compound	1351	1361	B-event-211417	_	_	_	_
8	90	period	period	NN	96	nsubj	1362	1368	_	_	_	_	_
8	91	is	be	VBZ	96	cop	1369	1371	_	_	_	_	_
8	92	usually	usually	RB	96	advmod	1372	1379	_	_	_	_	_
8	93	45	45	CD	95	compound	1380	1382	_	_	_	_	_
8	94	to	to	TO	95	dep	1383	1385	_	_	_	_	_
8	95	180	180	CD	96	nummod	1386	1389	_	_	_	_	_
8	96	days	day	NNS	62	conj	1390	1394	_	_	_	_	_
8	97	and	and	CC	62	cc	1395	1398	_	_	_	_	_
8	98	the	the	DT	99	det	1399	1402	_	_	_	_	_
8	99	period	period	NN	102	nsubj	1403	1409	_	_	_	_	_
8	100	of	of	IN	101	case	1410	1412	_	_	_	_	_
8	101	communicability	communicability	NN	99	nmod	1413	1428	B-event-211418	_	_	_	_
8	102	extends	extend	VBZ	62	conj	1429	1436	_	_	_	_	_
8	103	from	from	IN	105	case	1437	1441	_	_	_	_	_
8	104	several	several	JJ	105	amod	1442	1449	_	_	_	_	_
8	105	weeks	week	NNS	102	nmod	1450	1455	_	_	_	_	_
8	106	before	before	IN	108	case	1456	1462	_	_	_	_	_
8	107	the	the	DT	108	det	1463	1466	_	_	_	_	_
8	108	onset	onset	NN	9	nmod	1467	1472	_	_	_	_	_
8	109	of	of	IN	111	case	1473	1475	_	_	_	_	_
8	110	acute	acute	JJ	111	amod	1476	1481	_	_	_	_	_
8	111	illness	illness	NN	108	nmod	1482	1489	B-event-211419	_	_	_	_
8	112	usually	usually	RB	115	advmod	1490	1497	_	_	_	_	_
8	113	to	to	TO	115	case	1498	1500	_	_	_	_	_
8	114	the	the	DT	115	det	1501	1504	_	_	_	_	_
8	115	end	end	NN	9	nmod	1505	1508	_	_	_	_	_
8	116	of	of	IN	118	case	1509	1511	_	_	_	_	_
8	117	the	the	DT	118	det	1512	1515	_	_	_	_	_
8	118	period	period	NN	115	nmod	1516	1522	_	_	_	_	_
8	119	of	of	IN	121	case	1523	1525	_	_	_	_	_
8	120	acute	acute	JJ	121	amod	1526	1531	_	_	_	_	_
8	121	illness	illness	NN	118	nmod	1532	1539	B-event-211420	_	_	_	_
8	122	.	.	.	4	punct	1539	1540	_	_	_	_	_

9	1	Acute	acute	JJ	2	amod	1541	1546	_	_	_	_	_
9	2	illness	illness	NN	5	nsubj	1547	1554	B-event-211421	_	_	_	_
9	3	is	be	VBZ	5	cop	1555	1557	_	_	_	_	_
9	4	clinically	clinically	RB	5	advmod	1558	1568	_	_	_	_	_
9	5	indistinguishable	indistinguishable	JJ	0	ROOT	1569	1586	_	_	_	_	_
9	6	from	from	IN	8	case	1587	1591	_	_	_	_	_
9	7	other	other	JJ	8	amod	1592	1597	_	_	_	_	_
9	8	forms	form	NNS	5	nmod	1598	1603	_	_	_	_	_
9	9	of	of	IN	10	case	1604	1606	_	_	_	_	_
9	10	hepatitis	hepatitis	NN	8	nmod	1607	1616	B-event-211422	_	_	_	_
9	11	,	,	,	5	punct	1616	1617	_	_	_	_	_
9	12	and	and	CC	5	cc	1618	1621	_	_	_	_	_
9	13	symptoms	symptom	NNS	14	nsubj	1622	1630	B-event-211423	_	_	_	_
9	14	include	include	VBP	5	conj	1631	1638	_	_	_	_	_
9	15	fever	fever	NN	14	dobj	1639	1644	B-event-211424	_	_	_	_
9	16	,	,	,	15	punct	1644	1645	_	_	_	_	_
9	17	jaundice	jaundice	NN	15	conj	1646	1654	B-event-211425	_	_	_	_
9	18	,	,	,	15	punct	1654	1655	_	_	_	_	_
9	19	malaise	malaise	NN	15	conj	1656	1663	B-event-211426	_	_	_	_
9	20	,	,	,	15	punct	1663	1664	_	_	_	_	_
9	21	anorexia	anorexia	NN	15	conj	1665	1673	B-event-211427	_	_	_	_
9	22	,	,	,	15	punct	1673	1674	_	_	_	_	_
9	23	nausea	nausea	NN	15	conj	1675	1681	B-event-211428	_	_	_	_
9	24	and	and	CC	15	cc	1682	1685	_	_	_	_	_
9	25	vomiting	vomiting	NN	15	conj	1686	1694	B-event-211429	_	_	_	_
9	26	,	,	,	15	punct	1694	1695	_	_	_	_	_
9	27	abdominal	abdominal	JJ	29	amod	1696	1705	_	_	_	_	_
9	28	pain	pain	NN	29	compound	1706	1710	B-event-211430	_	_	_	_
9	29	(	(	NN	15	conj	1711	1712	_	_	_	_	_
9	30	especially	especially	RB	36	advmod	1712	1722	_	_	_	_	_
9	31	in	in	IN	36	case	1723	1725	_	_	_	_	_
9	32	the	the	DT	36	det	1726	1729	_	_	_	_	_
9	33	right	right	JJ	36	amod	1730	1735	_	_	_	_	_
9	34	upper	upper	JJ	36	amod	1736	1741	_	_	_	_	_
9	35	quadrant	quadrant	JJ	36	amod	1742	1750	_	_	_	_	_
9	36	)	)	NN	29	nmod	1750	1751	_	_	_	_	_
9	37	,	,	,	36	punct	1751	1752	_	_	_	_	_
9	38	myalgia	myalgia	NN	36	conj	1753	1760	B-event-211431	_	_	_	_
9	39	,	,	,	36	punct	1760	1761	_	_	_	_	_
9	40	and	and	CC	36	cc	1762	1765	_	_	_	_	_
9	41	the	the	DT	42	det	1766	1769	_	_	_	_	_
9	42	passage	passage	NN	36	conj	1770	1777	B-event-211432	_	_	_	_
9	43	of	of	IN	45	case	1778	1780	_	_	_	_	_
9	44	dark-coloured	dark-coloured	JJ	45	amod	1781	1794	_	_	_	_	_
9	45	urine	urine	NN	42	nmod	1795	1800	_	_	_	_	_
9	46	and	and	CC	15	cc	1801	1804	_	_	_	_	_
9	47	light-coloured	light-coloured	JJ	48	amod	1805	1819	_	_	_	_	_
9	48	stools	stool	NNS	15	conj	1820	1826	_	_	_	_	_
9	49	.	.	.	5	punct	1826	1827	_	_	_	_	_

10	1	Jaundice	Jaundice	NNP	4	nsubjpass	1828	1836	B-event-211433	_	_	_	_
10	2	may	may	MD	4	aux	1837	1840	_	_	_	_	_
10	3	be	be	VB	4	auxpass	1841	1843	_	_	_	_	_
10	4	preceded	precede	VBN	0	ROOT	1844	1852	_	_	_	_	_
10	5	by	by	IN	9	case	1853	1855	_	_	_	_	_
10	6	an	a	DT	9	det	1856	1858	_	_	_	_	_
10	7	acute	acute	JJ	8	amod	1859	1864	_	_	_	_	_
10	8	febrile	febrile	JJ	9	amod	1865	1872	_	_	_	_	_
10	9	illness	illness	NN	4	nmod	1873	1880	B-event-211434	_	_	_	_
10	10	with	with	IN	11	case	1881	1885	_	_	_	_	_
10	11	arthralgia	arthralgia	NN	9	nmod	1886	1896	B-event-211435	_	_	_	_
10	12	or	or	CC	11	cc	1897	1899	_	_	_	_	_
10	13	arthritis	arthritis	NN	11	conj	1900	1909	B-event-211436	_	_	_	_
10	14	and	and	CC	9	cc	1910	1913	_	_	_	_	_
10	15	rash	rash	NN	9	conj	1914	1918	B-event-211437	_	_	_	_
10	16	,	,	,	15	punct	1918	1919	_	_	_	_	_
10	17	most	most	JJS	18	dep	1920	1924	_	_	_	_	_
10	18	typical	typical	JJ	15	amod	1925	1932	_	_	_	_	_
10	19	of	of	IN	21	case	1933	1935	_	_	_	_	_
10	20	hepatitis	hepatitis	NN	21	compound	1936	1945	B-event-211438	_	_	_	_
10	21	B	b	NN	15	nmod	1946	1947	I-event-211438	_	_	_	_
10	22	.	.	.	4	punct	1947	1948	_	_	_	_	_

11	1	During	during	IN	2	case	1949	1955	_	_	_	_	_
11	2	recovery	recovery	NN	8	nmod	1956	1964	B-event-211439	_	_	_	_
11	3	,	,	,	8	punct	1964	1965	_	_	_	_	_
11	4	malaise	malaise	NN	8	nsubj	1966	1973	B-event-211440	_	_	_	_
11	5	and	and	CC	4	cc	1974	1977	_	_	_	_	_
11	6	fatigue	fatigue	NN	4	conj	1978	1985	B-event-211441	_	_	_	_
11	7	may	may	MD	8	aux	1986	1989	_	_	_	_	_
11	8	persist	persist	VB	0	ROOT	1990	1997	_	_	_	_	_
11	9	for	for	IN	11	case	1998	2001	_	_	_	_	_
11	10	many	many	JJ	11	amod	2002	2006	_	_	_	_	_
11	11	weeks	week	NNS	8	nmod	2007	2012	_	_	_	_	_
11	12	.	.	.	8	punct	2012	2013	_	_	_	_	_

12	1	Fulminant	fulminant	JJ	2	amod	2014	2023	_	_	_	_	_
12	2	hepatitis	hepatitis	NN	3	nsubj	2024	2033	B-event-211442	_	_	_	_
12	3	occurs	occur	VBZ	52	dep	2034	2040	_	_	_	_	_
12	4	in	in	IN	12	case	2041	2043	_	_	_	_	_
12	5	up	up	RB	12	advmod	2044	2046	_	_	_	_	_
12	6	to	to	TO	8	case	2047	2049	_	_	_	_	_
12	7	1	1	CD	8	nummod	2050	2051	_	_	_	_	_
12	8	%	%	NN	5	nmod	2051	2052	_	_	_	_	_
12	9	of	of	IN	11	case	2053	2055	_	_	_	_	_
12	10	acute	acute	JJ	11	amod	2056	2061	_	_	_	_	_
12	11	cases	case	NNS	8	nmod	2062	2067	_	_	_	_	_
12	12	.1,5	.1,5	CD	3	nmod	2067	2071	_	_	_	_	_
12	13	Following	follow	VBG	15	case	2072	2081	_	_	_	_	_
12	14	acute	acute	JJ	15	amod	2082	2087	_	_	_	_	_
12	15	infection	infection	NN	12	nmod	2088	2097	B-event-211443	_	_	_	_
12	16	,	,	,	12	punct	2097	2098	_	_	_	_	_
12	17	approximately	approximately	RB	20	advmod	2099	2112	_	_	_	_	_
12	18	1	1	CD	20	compound	2113	2114	_	_	_	_	_
12	19	to	to	TO	20	dep	2115	2117	_	_	_	_	_
12	20	10	10	CD	21	nummod	2118	2120	_	_	_	_	_
12	21	%	%	NN	12	appos	2120	2121	_	_	_	_	_
12	22	of	of	IN	23	case	2122	2124	_	_	_	_	_
12	23	persons	person	NNS	21	nmod	2125	2132	_	_	_	_	_
12	24	infected	infect	VBN	23	dep	2133	2141	B-event-211444	_	_	_	_
12	25	in	in	IN	26	case	2142	2144	_	_	_	_	_
12	26	adulthood	adulthood	NN	24	nmod	2145	2154	_	_	_	_	_
12	27	,4,6	,4,6	CD	26	nummod	2154	2158	_	_	_	_	_
12	28	but	but	CC	24	cc	2159	2162	_	_	_	_	_
12	29	up	up	RB	35	advmod	2163	2165	_	_	_	_	_
12	30	to	to	TO	32	case	2166	2168	_	_	_	_	_
12	31	90	90	CD	32	nummod	2169	2171	_	_	_	_	_
12	32	%	%	NN	29	nmod	2171	2172	_	_	_	_	_
12	33	of	of	IN	34	case	2173	2175	_	_	_	_	_
12	34	those	those	DT	32	nmod	2176	2181	_	_	_	_	_
12	35	infected	infect	VBN	24	conj	2182	2190	B-event-211445	_	_	_	_
12	36	in	in	IN	38	case	2191	2193	_	_	_	_	_
12	37	early	early	JJ	38	amod	2194	2199	_	_	_	_	_
12	38	infancy	infancy	NN	35	nmod	2200	2207	_	_	_	_	_
12	39	,6	,6	CD	38	nummod	2207	2209	_	_	_	_	_
12	40	become	become	VBN	38	acl	2210	2216	_	_	_	_	_
12	41	chronically	chronically	RB	42	advmod	2217	2228	_	_	_	_	_
12	42	infected	infect	VBN	40	xcomp	2229	2237	B-event-211446	_	_	_	_
12	43	with	with	IN	46	case	2238	2242	_	_	_	_	_
12	44	hepatitis	hepatitis	NNP	46	compound	2243	2252	B-event-211447	_	_	_	_
12	45	B.	B.	NNP	46	compound	2253	2255	I-event-211447	_	_	_	_
12	46	Persons	Persons	NNPS	42	nmod	2256	2263	_	_	_	_	_
12	47	chronically	chronically	RB	46	advmod	2264	2275	_	_	_	_	_
12	48	infected	infect	VBN	12	acl	2276	2284	B-event-211448	_	_	_	_
12	49	with	with	IN	50	case	2285	2289	_	_	_	_	_
12	50	HBV	hbv	NN	48	nmod	2290	2293	B-event-211449	_	_	_	_
12	51	are	be	VBP	52	auxpass	2294	2297	_	_	_	_	_
12	52	identified	identify	VBN	0	ROOT	2298	2308	_	_	_	_	_
12	53	by	by	IN	56	case	2309	2311	_	_	_	_	_
12	54	the	the	DT	56	det	2312	2315	_	_	_	_	_
12	55	long-term	long-term	JJ	56	amod	2316	2325	_	_	_	_	_
12	56	presence	presence	NN	52	nmod	2326	2334	_	_	_	_	_
12	57	(	(	RB	58	advmod	2335	2336	_	_	_	_	_
12	58	longer	longer	JJR	56	amod	2336	2342	_	_	_	_	_
12	59	than	than	IN	61	case	2343	2347	_	_	_	_	_
12	60	6	6	CD	61	nummod	2348	2349	_	_	_	_	_
12	61	months	month	NNS	52	nmod	2350	2356	_	_	_	_	_
12	62	)	)	CD	52	nsubjpass	2356	2357	_	_	_	_	_
12	63	of	of	IN	64	mark	2358	2360	_	_	_	_	_
12	64	circulating	circulate	VBG	62	acl	2361	2372	B-event-211450	_	_	_	_
12	65	HBsAg	hbsag	NN	64	dobj	2373	2378	_	_	_	_	_
12	66	.1,5	.1,5	CD	65	nummod	2378	2382	_	_	_	_	_
12	67	Those	those	DT	72	nsubj	2383	2388	_	_	_	_	_
12	68	with	with	IN	70	case	2389	2393	_	_	_	_	_
12	69	occult	occult	NN	70	compound	2394	2400	_	_	_	_	_
12	70	infection	infection	NN	67	nmod	2401	2410	B-event-211451	_	_	_	_
12	71	may	may	MD	72	aux	2411	2414	_	_	_	_	_
12	72	reactivate	reactivate	VB	65	acl:relcl	2415	2425	B-event-211452	_	_	_	_
12	73	HBV	hbv	NN	74	compound	2426	2429	B-event-211453	_	_	_	_
12	74	infection	infection	NN	72	dobj	2430	2439	B-event-211454	_	_	_	_
12	75	if	if	IN	77	mark	2440	2442	_	_	_	_	_
12	76	they	they	PRP	77	nsubj	2443	2447	_	_	_	_	_
12	77	become	become	VBP	72	advcl	2448	2454	_	_	_	_	_
12	78	immunocompromised	immunocompromised	JJ	77	xcomp	2455	2472	B-event-211455	_	_	_	_
12	79	.	.	.	52	punct	2472	2473	_	_	_	_	_

13	1	Persons	person	NNS	7	nsubj	2474	2481	_	_	_	_	_
13	2	with	with	IN	5	case	2482	2486	_	_	_	_	_
13	3	chronic	chronic	JJ	5	amod	2487	2494	_	_	_	_	_
13	4	HBV	hbv	NN	5	compound	2495	2498	B-event-211456	_	_	_	_
13	5	infection	infection	NN	1	nmod	2499	2508	B-event-211457	_	_	_	_
13	6	are	be	VBP	7	cop	2509	2512	_	_	_	_	_
13	7	capable	capable	JJ	0	ROOT	2513	2520	_	_	_	_	_
13	8	of	of	IN	9	mark	2521	2523	_	_	_	_	_
13	9	transmitting	transmit	VBG	7	advcl	2524	2536	B-event-211458	_	_	_	_
13	10	the	the	DT	11	det	2537	2540	_	_	_	_	_
13	11	disease	disease	NN	9	dobj	2541	2548	B-event-211459	_	_	_	_
13	12	,	,	,	11	punct	2548	2549	_	_	_	_	_
13	13	including	include	VBG	16	case	2550	2559	_	_	_	_	_
13	14	mother-to-child	mother-to-child	JJ	16	amod	2560	2575	_	_	_	_	_
13	15	peripartum	peripartum	NN	16	compound	2576	2586	_	_	_	_	_
13	16	transmission	transmission	NN	11	nmod	2587	2599	B-event-211460	_	_	_	_
13	17	,	,	,	16	punct	2599	2600	_	_	_	_	_
13	18	though	though	IN	21	mark	2601	2607	_	_	_	_	_
13	19	they	they	PRP	21	nsubj	2608	2612	_	_	_	_	_
13	20	often	often	RB	21	advmod	2613	2618	_	_	_	_	_
13	21	remain	remain	VBP	16	acl:relcl	2619	2625	_	_	_	_	_
13	22	asymptomatic	asymptomatic	JJ	21	xcomp	2626	2638	B-event-211461	_	_	_	_
13	23	and	and	CC	21	cc	2639	2642	_	_	_	_	_
13	24	may	may	MD	27	aux	2643	2646	_	_	_	_	_
13	25	not	not	RB	27	neg	2647	2650	_	_	_	_	_
13	26	be	be	VB	27	cop	2651	2653	_	_	_	_	_
13	27	aware	aware	JJ	21	conj	2654	2659	_	_	_	_	_
13	28	that	that	IN	31	mark	2660	2664	_	_	_	_	_
13	29	they	they	PRP	31	nsubj	2665	2669	_	_	_	_	_
13	30	are	be	VBP	31	cop	2670	2673	_	_	_	_	_
13	31	infected	infected	JJ	27	ccomp	2674	2682	B-event-211462	_	_	_	_
13	32	.	.	.	7	punct	2682	2683	_	_	_	_	_

14	1	Most	most	JJS	10	nsubj	2684	2688	_	_	_	_	_
14	2	of	of	IN	5	case	2689	2691	_	_	_	_	_
14	3	the	the	DT	5	det	2692	2695	_	_	_	_	_
14	4	serious	serious	JJ	5	amod	2696	2703	_	_	_	_	_
14	5	complications	complication	NNS	1	nmod	2704	2717	B-event-211463	_	_	_	_
14	6	associated	associate	VBN	5	acl	2718	2728	_	_	_	_	_
14	7	with	with	IN	9	case	2729	2733	_	_	_	_	_
14	8	hepatitis	hepatitis	NN	9	compound	2734	2743	B-event-211464	_	_	_	_
14	9	B	b	NN	6	nmod	2744	2745	I-event-211464	_	_	_	_
14	10	occur	occur	VBP	0	ROOT	2746	2751	_	_	_	_	_
14	11	in	in	IN	13	case	2752	2754	_	_	_	_	_
14	12	the	the	DT	13	det	2755	2758	_	_	_	_	_
14	13	context	context	NN	10	nmod	2759	2766	_	_	_	_	_
14	14	of	of	IN	17	case	2767	2769	_	_	_	_	_
14	15	chronic	chronic	JJ	17	amod	2770	2777	_	_	_	_	_
14	16	HBV	hbv	NN	17	compound	2778	2781	B-event-211465	_	_	_	_
14	17	infection	infection	NN	13	nmod	2782	2791	B-event-211466	_	_	_	_
14	18	,	,	,	17	punct	2791	2792	_	_	_	_	_
14	19	which	which	WDT	21	nsubjpass	2793	2798	_	_	_	_	_
14	20	is	be	VBZ	21	auxpass	2799	2801	_	_	_	_	_
14	21	associated	associate	VBN	17	acl:relcl	2802	2812	_	_	_	_	_
14	22	in	in	IN	26	case	2813	2815	_	_	_	_	_
14	23	up	up	RB	25	advmod	2816	2818	_	_	_	_	_
14	24	to	to	TO	25	dep	2819	2821	_	_	_	_	_
14	25	25	25	CD	26	nummod	2822	2824	_	_	_	_	_
14	26	%	%	NN	21	nmod	2824	2825	_	_	_	_	_
14	27	of	of	IN	28	case	2826	2828	_	_	_	_	_
14	28	cases	case	NNS	26	nmod	2829	2834	_	_	_	_	_
14	29	with	with	IN	31	case	2835	2839	_	_	_	_	_
14	30	premature	premature	JJ	31	amod	2840	2849	_	_	_	_	_
14	31	mortality	mortality	NN	21	nmod	2850	2859	B-event-211467	_	_	_	_
14	32	due	due	JJ	31	amod	2860	2863	_	_	_	_	_
14	33	to	to	TO	34	case	2864	2866	_	_	_	_	_
14	34	cirrhosis	cirrhosis	NN	32	nmod	2867	2876	B-event-211468	_	_	_	_
14	35	and/or	and/or	CC	21	cc	2877	2883	_	_	_	_	_
14	36	hepatocellular	hepatocellular	JJ	21	conj	2884	2898	_	_	_	_	_
14	37	carcinoma	carcinoma	NN	47	nsubj	2899	2908	B-event-211469	_	_	_	_
14	38	.1	.1	NN	40	compound	2908	2910	_	_	_	_	_
14	39	4.5.3	4.5.3	CD	40	nummod	2911	2916	_	_	_	_	_
14	40	Epidemiology	Epidemiology	NNP	37	dep	2917	2929	_	_	_	_	_
14	41	The	the	DT	42	det	2930	2933	_	_	_	_	_
14	42	prevalence	prevalence	NN	37	dep	2934	2944	_	_	_	_	_
14	43	of	of	IN	46	case	2945	2947	_	_	_	_	_
14	44	chronic	chronic	JJ	46	amod	2948	2955	_	_	_	_	_
14	45	HBV	hbv	NN	46	compound	2956	2959	B-event-211470	_	_	_	_
14	46	infection	infection	NN	42	nmod	2960	2969	B-event-211471	_	_	_	_
14	47	differs	differ	VBZ	36	ccomp	2970	2977	_	_	_	_	_
14	48	in	in	IN	50	case	2978	2980	_	_	_	_	_
14	49	different	different	JJ	50	amod	2981	2990	_	_	_	_	_
14	50	parts	part	NNS	47	nmod	2991	2996	_	_	_	_	_
14	51	of	of	IN	53	case	2997	2999	_	_	_	_	_
14	52	the	the	DT	53	det	3000	3003	_	_	_	_	_
14	53	world	world	NN	50	nmod	3004	3009	_	_	_	_	_
14	54	,	,	,	47	punct	3009	3010	_	_	_	_	_
14	55	and	and	CC	47	cc	3011	3014	_	_	_	_	_
14	56	may	may	MD	59	aux	3015	3018	_	_	_	_	_
14	57	be	be	VB	59	cop	3019	3021	_	_	_	_	_
14	58	quite	quite	RB	59	advmod	3022	3027	_	_	_	_	_
14	59	variable	variable	JJ	47	conj	3028	3036	_	_	_	_	_
14	60	within	within	IN	61	case	3037	3043	_	_	_	_	_
14	61	countries	country	NNS	36	nmod	3044	3053	_	_	_	_	_
14	62	.	.	.	10	punct	3053	3054	_	_	_	_	_

15	1	The	the	DT	2	det	3055	3058	_	_	_	_	_
15	2	prevalence	prevalence	NN	7	nsubj	3059	3069	_	_	_	_	_
15	3	of	of	IN	6	case	3070	3072	_	_	_	_	_
15	4	chronic	chronic	JJ	6	amod	3073	3080	_	_	_	_	_
15	5	HBV	hbv	NN	6	compound	3081	3084	B-event-211472	_	_	_	_
15	6	infection	infection	NN	2	nmod	3085	3094	B-event-211473	_	_	_	_
15	7	varies	vary	VBZ	0	ROOT	3095	3101	_	_	_	_	_
15	8	from	from	IN	12	case	3102	3106	_	_	_	_	_
15	9	less	less	JJR	11	advmod	3107	3111	_	_	_	_	_
15	10	than	than	IN	9	mwe	3112	3116	_	_	_	_	_
15	11	0.5	0.5	CD	12	nummod	3117	3120	_	_	_	_	_
15	12	%	%	NN	7	nmod	3120	3121	_	_	_	_	_
15	13	among	among	IN	14	case	3122	3127	_	_	_	_	_
15	14	Caucasians	Caucasians	NNPS	12	nmod	3128	3138	_	_	_	_	_
15	15	in	in	IN	21	case	3139	3141	_	_	_	_	_
15	16	the	the	DT	21	det	3142	3145	_	_	_	_	_
15	17	United	United	NNP	21	compound	3146	3152	_	_	_	_	_
15	18	States	States	NNPS	21	compound	3153	3159	_	_	_	_	_
15	19	,	,	,	21	punct	3159	3160	_	_	_	_	_
15	20	northern	northern	JJ	21	amod	3161	3169	_	_	_	_	_
15	21	Europe	Europe	NNP	7	nmod	3170	3176	_	_	_	_	_
15	22	and	and	CC	21	cc	3177	3180	_	_	_	_	_
15	23	Australia	Australia	NNP	21	conj	3181	3190	_	_	_	_	_
15	24	,	,	,	21	punct	3190	3191	_	_	_	_	_
15	25	1	1	CD	27	compound	3192	3193	_	_	_	_	_
15	26	to	to	TO	27	dep	3194	3196	_	_	_	_	_
15	27	5	5	CD	28	nummod	3197	3198	_	_	_	_	_
15	28	%	%	NN	21	appos	3198	3199	_	_	_	_	_
15	29	in	in	IN	32	case	3200	3202	_	_	_	_	_
15	30	the	the	DT	32	det	3203	3206	_	_	_	_	_
15	31	Mediterranean	mediterranean	JJ	32	amod	3207	3220	_	_	_	_	_
15	32	countries	country	NNS	28	nmod	3221	3230	_	_	_	_	_
15	33	,	,	,	32	punct	3230	3231	_	_	_	_	_
15	34	parts	part	NNS	32	appos	3232	3237	_	_	_	_	_
15	35	of	of	IN	44	case	3238	3240	_	_	_	_	_
15	36	eastern	eastern	JJ	44	amod	3241	3248	_	_	_	_	_
15	37	Europe	Europe	NNP	44	compound	3249	3255	_	_	_	_	_
15	38	,	,	,	37	punct	3255	3256	_	_	_	_	_
15	39	Africa	Africa	NNP	37	conj	3257	3263	_	_	_	_	_
15	40	,	,	,	37	punct	3263	3264	_	_	_	_	_
15	41	Central	Central	NNP	37	conj	3265	3272	_	_	_	_	_
15	42	and	and	CC	37	cc	3273	3276	_	_	_	_	_
15	43	South	South	NNP	37	conj	3277	3282	_	_	_	_	_
15	44	America	America	NNP	34	nmod	3283	3290	_	_	_	_	_
15	45	,	,	,	32	punct	3290	3291	_	_	_	_	_
15	46	up	up	RB	32	advmod	3292	3294	_	_	_	_	_
15	47	to	to	TO	51	case	3295	3297	_	_	_	_	_
15	48	greater	greater	JJR	50	advmod	3298	3305	_	_	_	_	_
15	49	than	than	IN	50	advmod	3306	3310	_	_	_	_	_
15	50	10	10	CD	51	nummod	3311	3313	_	_	_	_	_
15	51	%	%	NN	46	nmod	3313	3314	_	_	_	_	_
15	52	in	in	IN	60	case	3315	3317	_	_	_	_	_
15	53	many	many	JJ	60	amod	3318	3322	_	_	_	_	_
15	54	sub-Saharan	sub-saharan	JJ	60	amod	3323	3334	_	_	_	_	_
15	55	African	African	NNP	60	compound	3335	3342	_	_	_	_	_
15	56	,	,	,	55	punct	3342	3343	_	_	_	_	_
15	57	East	East	NNP	55	conj	3344	3348	_	_	_	_	_
15	58	and	and	CC	55	cc	3349	3352	_	_	_	_	_
15	59	Southeast	Southeast	NNP	55	conj	3353	3362	_	_	_	_	_
15	60	Asian	Asian	NNP	32	nmod	3363	3368	_	_	_	_	_
15	61	and	and	CC	7	cc	3369	3372	_	_	_	_	_
15	62	Pacific	Pacific	NNP	64	compound	3373	3380	_	_	_	_	_
15	63	island	island	NN	64	compound	3381	3387	_	_	_	_	_
15	64	populations.7-10	populations.7-10	NN	7	conj	3388	3404	_	_	_	_	_
15	65	In	in	IN	66	case	3405	3407	_	_	_	_	_
15	66	regions	region	NNS	64	dep	3408	3415	_	_	_	_	_
15	67	of	of	IN	71	case	3416	3418	_	_	_	_	_
15	68	moderate	moderate	JJ	70	amod	3419	3427	_	_	_	_	_
15	69	to	to	TO	70	dep	3428	3430	_	_	_	_	_
15	70	high	high	JJ	71	amod	3431	3435	_	_	_	_	_
15	71	prevalence	prevalence	NN	66	nmod	3436	3446	_	_	_	_	_
15	72	of	of	IN	73	case	3447	3449	_	_	_	_	_
15	73	HBsAg	hbsag	NN	71	nmod	3450	3455	_	_	_	_	_
15	74	(	(	CD	73	nummod	3456	3457	_	_	_	_	_
15	75	where	where	WRB	84	advmod	3457	3462	_	_	_	_	_
15	76	≥	≥	NN	84	nsubj	3463	3464	_	_	_	_	_
15	77	2	2	CD	78	compound	3464	3465	_	_	_	_	_
15	78	%	%	NN	76	amod	3465	3466	_	_	_	_	_
15	79	of	of	IN	81	case	3467	3469	_	_	_	_	_
15	80	the	the	DT	81	det	3470	3473	_	_	_	_	_
15	81	population	population	NN	76	nmod	3474	3484	_	_	_	_	_
15	82	is	be	VBZ	84	cop	3485	3487	_	_	_	_	_
15	83	HBsAg-positive	hbsag-positive	JJ	84	amod	3488	3502	_	_	_	_	_
15	84	)	)	NN	7	advcl	3502	3503	_	_	_	_	_
15	85	,	,	,	84	punct	3503	3504	_	_	_	_	_
15	86	infections	infection	NNS	84	appos	3505	3515	B-event-211474	_	_	_	_
15	87	are	be	VBP	89	auxpass	3516	3519	_	_	_	_	_
15	88	mainly	mainly	RB	89	advmod	3520	3526	_	_	_	_	_
15	89	acquired	acquire	VBN	86	acl:relcl	3527	3535	B-event-211475	_	_	_	_
15	90	perinatally	perinatally	RB	89	advmod	3536	3547	_	_	_	_	_
15	91	or	or	CC	84	cc	3548	3550	_	_	_	_	_
15	92	in	in	RB	94	advmod	3551	3553	_	_	_	_	_
15	93	early	early	JJ	94	amod	3554	3559	_	_	_	_	_
15	94	childhood	childhood	NN	84	conj	3560	3569	_	_	_	_	_
15	95	.1	.1	CD	97	nummod	3569	3571	_	_	_	_	_
15	96	Chronic	chronic	JJ	97	amod	3573	3580	_	_	_	_	_
15	97	infection	infection	NN	94	dep	3581	3590	B-event-211476	_	_	_	_
15	98	and	and	CC	7	cc	3591	3594	_	_	_	_	_
15	99	its	its	PRP$	100	nmod:poss	3595	3598	_	_	_	_	_
15	100	sequelae	sequelae	NN	108	nsubj	3599	3607	_	_	_	_	_
15	101	,	,	,	100	punct	3607	3608	_	_	_	_	_
15	102	including	include	VBG	103	case	3609	3618	_	_	_	_	_
15	103	cirrhosis	cirrhosis	NN	100	nmod	3619	3628	B-event-211477	_	_	_	_
15	104	and	and	CC	103	cc	3629	3632	_	_	_	_	_
15	105	hepatocellular	hepatocellular	JJ	106	amod	3633	3647	_	_	_	_	_
15	106	carcinoma	carcinoma	NN	103	conj	3648	3657	B-event-211478	_	_	_	_
15	107	,	,	,	100	punct	3657	3658	_	_	_	_	_
15	108	contribute	contribute	VBP	7	conj	3659	3669	_	_	_	_	_
15	109	to	to	TO	111	case	3670	3672	_	_	_	_	_
15	110	the	the	DT	111	det	3673	3676	_	_	_	_	_
15	111	majority	majority	NN	108	nmod	3677	3685	_	_	_	_	_
15	112	of	of	IN	115	case	3686	3688	_	_	_	_	_
15	113	HBV	hbv	NN	115	compound	3689	3692	B-event-211479	_	_	_	_
15	114	disease	disease	NN	115	compound	3693	3700	B-event-211480	_	_	_	_
15	115	burden	burden	NN	111	nmod	3701	3707	_	_	_	_	_
15	116	in	in	IN	117	case	3708	3710	_	_	_	_	_
15	117	Australia	Australia	NNP	115	nmod	3711	3720	_	_	_	_	_
15	118	.	.	.	7	punct	3720	3721	_	_	_	_	_

16	1	In	in	IN	3	case	3722	3724	_	_	_	_	_
16	2	recent	recent	JJ	3	amod	3725	3731	_	_	_	_	_
16	3	decades	decade	NNS	12	nmod	3732	3739	_	_	_	_	_
16	4	,	,	,	12	punct	3739	3740	_	_	_	_	_
16	5	the	the	DT	6	det	3741	3744	_	_	_	_	_
16	6	burden	burden	NN	12	nsubj	3745	3751	_	_	_	_	_
16	7	from	from	IN	9	case	3752	3756	_	_	_	_	_
16	8	such	such	JJ	9	amod	3757	3761	_	_	_	_	_
16	9	disease	disease	NN	6	nmod	3762	3769	B-event-211481	_	_	_	_
16	10	has	have	VBZ	12	aux	3770	3773	_	_	_	_	_
16	11	been	be	VBN	12	aux	3774	3778	_	_	_	_	_
16	12	increasing	increase	VBG	0	ROOT	3779	3789	B-event-211482	_	_	_	_
16	13	,	,	,	12	punct	3789	3790	_	_	_	_	_
16	14	concurrent	concurrent	JJ	42	amod	3791	3801	_	_	_	_	_
16	15	with	with	IN	18	case	3802	3806	_	_	_	_	_
16	16	the	the	DT	18	det	3807	3810	_	_	_	_	_
16	17	increasing	increase	VBG	18	amod	3811	3821	B-event-211483	_	_	_	_
16	18	number	number	NN	14	nmod	3822	3828	_	_	_	_	_
16	19	of	of	IN	20	case	3829	3831	_	_	_	_	_
16	20	immigrants	immigrant	NNS	18	nmod	3832	3842	B-event-212470	_	_	_	_
16	21	from	from	IN	22	case	3843	3847	_	_	_	_	_
16	22	regions	region	NNS	20	nmod	3848	3855	_	_	_	_	_
16	23	of	of	IN	25	case	3856	3858	_	_	_	_	_
16	24	high	high	JJ	25	amod	3859	3863	_	_	_	_	_
16	25	HBV	hbv	NN	22	nmod	3864	3867	B-event-211484	_	_	_	_
16	26	prevalence	prevalence	NN	28	compound	3868	3878	_	_	_	_	_
16	27	.11	.11	CD	28	nummod	3878	3881	_	_	_	_	_
16	28	Aboriginal	Aboriginal	NNP	25	dep	3882	3892	_	_	_	_	_
16	29	and	and	CC	25	cc	3893	3896	_	_	_	_	_
16	30	Torres	Torres	NNP	32	compound	3897	3903	_	_	_	_	_
16	31	Strait	Strait	NNP	32	compound	3904	3910	_	_	_	_	_
16	32	Islander	Islander	NNP	25	conj	3911	3919	_	_	_	_	_
16	33	people	people	NNS	32	dep	3920	3926	_	_	_	_	_
16	34	,	,	,	18	punct	3926	3927	_	_	_	_	_
16	35	and	and	CC	18	cc	3928	3931	_	_	_	_	_
16	36	migrants	migrant	NNS	18	conj	3932	3940	_	_	_	_	_
16	37	born	bear	VBN	36	acl	3941	3945	_	_	_	_	_
16	38	in	in	IN	39	case	3946	3948	_	_	_	_	_
16	39	Asia	Asia	NNP	37	nmod	3949	3953	_	_	_	_	_
16	40	and	and	CC	39	cc	3954	3957	_	_	_	_	_
16	41	Pacific	Pacific	NNP	39	conj	3958	3965	_	_	_	_	_
16	42	islands	island	NNS	53	nsubj	3966	3973	_	_	_	_	_
16	43	,	,	,	42	punct	3973	3974	_	_	_	_	_
16	44	North	North	NNP	45	compound	3975	3980	_	_	_	_	_
16	45	Africa	Africa	NNP	42	appos	3981	3987	_	_	_	_	_
16	46	,	,	,	45	punct	3987	3988	_	_	_	_	_
16	47	Middle	Middle	NNP	48	compound	3989	3995	_	_	_	_	_
16	48	Eastern	Eastern	NNP	45	conj	3996	4003	_	_	_	_	_
16	49	and	and	CC	45	cc	4004	4007	_	_	_	_	_
16	50	Mediterranean	mediterranean	JJ	51	amod	4008	4021	_	_	_	_	_
16	51	countries	country	NNS	45	conj	4022	4031	_	_	_	_	_
16	52	,	,	,	42	punct	4031	4032	_	_	_	_	_
16	53	have	have	VBP	12	conj	4033	4037	_	_	_	_	_
16	54	a	a	DT	57	det	4038	4039	_	_	_	_	_
16	55	significantly	significantly	RB	57	advmod	4040	4053	_	_	_	_	_
16	56	increased	increase	VBN	57	amod	4054	4063	_	_	_	_	_
16	57	prevalence	prevalence	NN	53	dobj	4064	4074	_	_	_	_	_
16	58	of	of	IN	61	case	4075	4077	_	_	_	_	_
16	59	chronic	chronic	JJ	61	amod	4078	4085	_	_	_	_	_
16	60	HBV	hbv	NN	61	compound	4086	4089	B-event-211485	_	_	_	_
16	61	infection	infection	NN	57	nmod	4090	4099	B-event-211486	_	_	_	_
16	62	compared	compare	VBN	65	case	4100	4108	_	_	_	_	_
16	63	with	with	IN	65	case	4109	4113	_	_	_	_	_
16	64	the	the	DT	65	det	4114	4117	_	_	_	_	_
16	65	rest	rest	NN	61	nmod	4118	4122	_	_	_	_	_
16	66	of	of	IN	72	case	4123	4125	_	_	_	_	_
16	67	the	the	DT	72	det	4126	4129	_	_	_	_	_
16	68	Australian-born	australian-born	JJ	72	amod	4130	4145	_	_	_	_	_
16	69	population	population	NN	72	compound	4146	4156	_	_	_	_	_
16	70	.12,13	.12,13	CD	72	nummod	4156	4162	_	_	_	_	_
16	71	First-generation	first-generation	NN	72	compound	4163	4179	_	_	_	_	_
16	72	immigrants	immigrant	NNS	65	nmod	4180	4190	B-event-212471	_	_	_	_
16	73	of	of	IN	74	case	4191	4193	_	_	_	_	_
16	74	culturally	culturally	RB	65	acl	4194	4204	_	_	_	_	_
16	75	and	and	CC	12	cc	4205	4208	_	_	_	_	_
16	76	linguistically	linguistically	RB	77	advmod	4209	4223	_	_	_	_	_
16	77	diverse	diverse	JJ	78	amod	4224	4231	_	_	_	_	_
16	78	background	background	NN	91	nsubj	4232	4242	_	_	_	_	_
16	79	,	,	,	78	punct	4242	4243	_	_	_	_	_
16	80	who	who	WP	84	nsubj	4244	4247	_	_	_	_	_
16	81	are	be	VBP	84	cop	4248	4251	_	_	_	_	_
16	82	mostly	mostly	RB	84	advmod	4252	4258	_	_	_	_	_
16	83	from	from	IN	84	case	4259	4263	_	_	_	_	_
16	84	countries	country	NNS	78	acl:relcl	4264	4273	_	_	_	_	_
16	85	of	of	IN	88	case	4274	4276	_	_	_	_	_
16	86	high	high	JJ	88	amod	4277	4281	_	_	_	_	_
16	87	HBV	hbv	NN	88	compound	4282	4285	B-event-211487	_	_	_	_
16	88	endemicity	endemicity	NN	84	nmod	4286	4296	_	_	_	_	_
16	89	,	,	,	78	punct	4296	4297	_	_	_	_	_
16	90	usually	usually	RB	91	advmod	4298	4305	_	_	_	_	_
16	91	retain	retain	VBP	12	conj	4306	4312	B-event-211490	_	_	_	_
16	92	the	the	DT	93	det	4313	4316	_	_	_	_	_
16	93	prevalence	prevalence	NN	91	dobj	4317	4327	_	_	_	_	_
16	94	of	of	IN	97	case	4328	4330	_	_	_	_	_
16	95	chronic	chronic	JJ	97	amod	4331	4338	_	_	_	_	_
16	96	HBV	hbv	NN	97	compound	4339	4342	B-event-211488	_	_	_	_
16	97	infection	infection	NN	93	nmod	4343	4352	B-event-211489	_	_	_	_
16	98	of	of	IN	100	case	4353	4355	_	_	_	_	_
16	99	their	they	PRP$	100	nmod:poss	4356	4361	_	_	_	_	_
16	100	country	country	NN	97	nmod	4362	4369	_	_	_	_	_
16	101	of	of	IN	102	case	4370	4372	_	_	_	_	_
16	102	origin	origin	NN	100	nmod	4373	4379	_	_	_	_	_
16	103	.	.	.	12	punct	4379	4380	_	_	_	_	_

17	1	Other	other	JJ	3	amod	4381	4386	_	_	_	_	_
17	2	population	population	NN	3	compound	4387	4397	_	_	_	_	_
17	3	groups	group	NNS	13	nsubj	4398	4404	_	_	_	_	_
17	4	with	with	IN	7	case	4405	4409	_	_	_	_	_
17	5	an	a	DT	7	det	4410	4412	_	_	_	_	_
17	6	increased	increase	VBN	7	amod	4413	4422	_	_	_	_	_
17	7	prevalence	prevalence	NN	3	nmod	4423	4433	_	_	_	_	_
17	8	of	of	IN	9	case	4434	4436	_	_	_	_	_
17	9	markers	marker	NNS	7	nmod	4437	4444	_	_	_	_	_
17	10	of	of	IN	12	case	4445	4447	_	_	_	_	_
17	11	HBV	hbv	NN	12	compound	4448	4451	B-event-211491	_	_	_	_
17	12	infection	infection	NN	9	nmod	4452	4461	B-event-211492	_	_	_	_
17	13	include	include	VBP	0	ROOT	4462	4469	_	_	_	_	_
17	14	patients	patient	NNS	13	dobj	4470	4478	_	_	_	_	_
17	15	with	with	IN	17	case	4479	4483	_	_	_	_	_
17	16	HIV	hiv	NN	17	compound	4484	4487	B-event-211493	_	_	_	_
17	17	infection	infection	NN	13	nmod	4488	4497	B-event-211494	_	_	_	_
17	18	,	,	,	17	punct	4497	4498	_	_	_	_	_
17	19	persons	person	NNS	17	appos	4499	4506	_	_	_	_	_
17	20	who	who	WP	21	nsubj	4507	4510	_	_	_	_	_
17	21	used	use	VBD	19	acl:relcl	4511	4515	_	_	_	_	_
17	22	injected	inject	VBN	21	dep	4516	4524	B-event-211495	_	_	_	_
17	23	drugs	drug	NNS	22	dobj	4525	4530	_	_	_	_	_
17	24	between	between	IN	25	case	4531	4538	_	_	_	_	_
17	25	1980	1980	CD	23	nmod	4539	4543	_	_	_	_	_
17	26	and	and	CC	25	cc	4544	4547	_	_	_	_	_
17	27	1990	1990	CD	25	conj	4548	4552	_	_	_	_	_
17	28	,	,	,	13	punct	4552	4553	_	_	_	_	_
17	29	and	and	CC	13	cc	4554	4557	_	_	_	_	_
17	30	household	household	NN	31	compound	4558	4567	_	_	_	_	_
17	31	contacts	contact	NNS	34	nsubj	4568	4576	_	_	_	_	_
17	32	of	of	IN	33	case	4577	4579	_	_	_	_	_
17	33	someone	someone	NN	31	nmod	4580	4587	_	_	_	_	_
17	34	diagnosed	diagnose	VBD	13	conj	4588	4597	B-event-211496	_	_	_	_
17	35	with	with	IN	36	case	4598	4602	_	_	_	_	_
17	36	hepatitis	hepatitis	NN	34	nmod	4603	4612	B-event-211497	_	_	_	_
17	37	between	between	IN	38	case	4613	4620	_	_	_	_	_
17	38	1980	1980	CD	36	nmod	4621	4625	_	_	_	_	_
17	39	and	and	CC	13	cc	4626	4629	_	_	_	_	_
17	40	1990.13	1990.13	CD	41	nummod	4630	4637	_	_	_	_	_
17	41	Notification	notification	NN	46	nsubj	4638	4650	_	_	_	_	_
17	42	of	of	IN	45	case	4651	4653	_	_	_	_	_
17	43	chronic	chronic	JJ	45	amod	4654	4661	_	_	_	_	_
17	44	HBV	hbv	NN	45	compound	4662	4665	B-event-211498	_	_	_	_
17	45	infection	infection	NN	41	nmod	4666	4675	B-event-211499	_	_	_	_
17	46	depends	depend	VBZ	13	conj	4676	4683	_	_	_	_	_
17	47	on	on	IN	48	case	4684	4686	_	_	_	_	_
17	48	levels	level	NNS	46	nmod	4687	4693	_	_	_	_	_
17	49	of	of	IN	52	case	4694	4696	_	_	_	_	_
17	50	hepatitis	hepatitis	NN	52	compound	4697	4706	B-event-211500	_	_	_	_
17	51	B	b	NN	52	compound	4707	4708	I-event-211500	_	_	_	_
17	52	testing	testing	NN	48	nmod	4709	4716	B-event-211501	_	_	_	_
17	53	and	and	CC	52	cc	4717	4720	_	_	_	_	_
17	54	reporting	reporting	NN	52	conj	4721	4730	B-event-211502	_	_	_	_
17	55	,	,	,	13	punct	4730	4731	_	_	_	_	_
17	56	and	and	CC	13	cc	4732	4735	_	_	_	_	_
17	57	a	a	DT	59	det	4736	4737	_	_	_	_	_
17	58	substantial	substantial	JJ	59	amod	4738	4749	_	_	_	_	_
17	59	proportion	proportion	NN	66	nsubj	4750	4760	_	_	_	_	_
17	60	of	of	IN	61	case	4761	4763	_	_	_	_	_
17	61	persons	person	NNS	59	nmod	4764	4771	_	_	_	_	_
17	62	with	with	IN	65	case	4772	4776	_	_	_	_	_
17	63	chronic	chronic	JJ	65	amod	4777	4784	_	_	_	_	_
17	64	HBV	hbv	NN	65	compound	4785	4788	B-event-211503	_	_	_	_
17	65	infection	infection	NN	61	nmod	4789	4798	B-event-211504	_	_	_	_
17	66	remain	remain	VBP	13	conj	4799	4805	_	_	_	_	_
17	67	undiagnosed	undiagnosed	JJ	66	xcomp	4806	4817	B-event-211505	_	_	_	_
17	68	.	.	.	13	punct	4817	4818	_	_	_	_	_

18	1	It	it	PRP	4	nsubjpass	4819	4821	_	_	_	_	_
18	2	has	have	VBZ	4	aux	4822	4825	_	_	_	_	_
18	3	been	be	VBN	4	auxpass	4826	4830	_	_	_	_	_
18	4	estimated	estimate	VBN	78	dep	4831	4840	B-event-211506	_	_	_	_
18	5	by	by	IN	7	case	4841	4843	_	_	_	_	_
18	6	mathematical	mathematical	JJ	7	amod	4844	4856	_	_	_	_	_
18	7	modelling	modelling	NN	4	nmod	4857	4866	_	_	_	_	_
18	8	that	that	IN	18	nsubj	4867	4871	_	_	_	_	_
18	9	,	,	,	18	punct	4871	4872	_	_	_	_	_
18	10	in	in	IN	11	case	4873	4875	_	_	_	_	_
18	11	2010	2010	CD	18	nmod	4876	4880	_	_	_	_	_
18	12	,	,	,	18	punct	4880	4881	_	_	_	_	_
18	13	about	about	IN	16	case	4882	4887	_	_	_	_	_
18	14	170	170	CD	15	compound	4888	4891	_	_	_	_	_
18	15	000	000	CD	16	nummod	4892	4895	_	_	_	_	_
18	16	people	people	NNS	18	nmod	4896	4902	_	_	_	_	_
18	17	were	be	VBD	18	aux	4903	4907	_	_	_	_	_
18	18	living	live	VBG	7	acl:relcl	4908	4914	_	_	_	_	_
18	19	with	with	IN	21	case	4915	4919	_	_	_	_	_
18	20	HBV	hbv	NN	21	compound	4920	4923	B-event-211507	_	_	_	_
18	21	infection	infection	NN	18	nmod	4924	4933	B-event-211508	_	_	_	_
18	22	in	in	IN	23	case	4934	4936	_	_	_	_	_
18	23	Australia	Australia	NNP	21	nmod	4937	4946	_	_	_	_	_
18	24	,	,	,	18	punct	4946	4947	_	_	_	_	_
18	25	with	with	IN	28	case	4948	4952	_	_	_	_	_
18	26	about	about	IN	28	case	4953	4958	_	_	_	_	_
18	27	335	335	CD	28	nummod	4959	4962	_	_	_	_	_
18	28	deaths	death	NNS	18	nmod	4963	4969	B-event-212473	_	_	_	_
18	29	due	due	JJ	39	amod	4970	4973	_	_	_	_	_
18	30	to	to	TO	32	case	4974	4976	_	_	_	_	_
18	31	HBV	hbv	NN	32	compound	4977	4980	B-event-211509	_	_	_	_
18	32	infection	infection	NN	29	nmod	4981	4990	B-event-211510	_	_	_	_
18	33	in	in	IN	35	case	4991	4993	_	_	_	_	_
18	34	that	that	DT	35	det	4994	4998	_	_	_	_	_
18	35	year	year	NN	32	nmod	4999	5003	_	_	_	_	_
18	36	.14	.14	CD	29	nmod:tmod	5003	5006	_	_	_	_	_
18	37	Newly	newly	RB	38	advmod	5007	5012	_	_	_	_	_
18	38	acquired	acquire	VBN	39	amod	5013	5021	B-event-212472	_	_	_	_
18	39	cases	case	NNS	46	nsubj	5022	5027	_	_	_	_	_
18	40	of	of	IN	42	case	5028	5030	_	_	_	_	_
18	41	HBV	hbv	NN	42	compound	5031	5034	B-event-211511	_	_	_	_
18	42	infection	infection	NN	39	nmod	5035	5044	B-event-211512	_	_	_	_
18	43	in	in	IN	44	case	5045	5047	_	_	_	_	_
18	44	Australia	Australia	NNP	39	nmod	5048	5057	_	_	_	_	_
18	45	mostly	mostly	RB	46	advmod	5058	5064	_	_	_	_	_
18	46	occur	occur	VBP	28	acl:relcl	5065	5070	_	_	_	_	_
18	47	in	in	IN	49	case	5071	5073	_	_	_	_	_
18	48	young	young	JJ	49	amod	5074	5079	_	_	_	_	_
18	49	adults	adult	NNS	46	nmod	5080	5086	_	_	_	_	_
18	50	,	,	,	46	punct	5086	5087	_	_	_	_	_
18	51	through	through	IN	52	mark	5088	5095	_	_	_	_	_
18	52	injecting	inject	VBG	46	advcl	5096	5105	B-event-211513	_	_	_	_
18	53	drug	drug	NN	54	compound	5106	5110	_	_	_	_	_
18	54	use	use	NN	52	dobj	5111	5114	_	_	_	_	_
18	55	,	,	,	54	punct	5114	5115	_	_	_	_	_
18	56	skin	skin	NN	58	compound	5116	5120	_	_	_	_	_
18	57	penetration	penetration	NN	58	compound	5121	5132	B-event-211514	_	_	_	_
18	58	procedures	procedure	NNS	54	conj	5133	5143	_	_	_	_	_
18	59	or	or	CC	54	cc	5144	5146	_	_	_	_	_
18	60	sexual	sexual	JJ	61	amod	5147	5153	B-event-211515	_	_	_	_
18	61	contact	contact	NN	54	conj	5154	5161	B-event-211516	_	_	_	_
18	62	.15	.15	CD	61	nummod	5161	5164	_	_	_	_	_
18	63	Between	between	IN	64	case	5165	5172	_	_	_	_	_
18	64	2006	2006	CD	52	nmod	5173	5177	_	_	_	_	_
18	65	and	and	CC	64	cc	5178	5181	_	_	_	_	_
18	66	2010	2010	CD	64	conj	5182	5186	_	_	_	_	_
18	67	,	,	,	18	punct	5186	5187	_	_	_	_	_
18	68	the	the	DT	70	det	5188	5191	_	_	_	_	_
18	69	notification	notification	NN	70	compound	5192	5204	_	_	_	_	_
18	70	rate	rate	NN	18	dobj	5205	5209	_	_	_	_	_
18	71	of	of	IN	74	case	5210	5212	_	_	_	_	_
18	72	newly	newly	RB	73	advmod	5213	5218	_	_	_	_	_
18	73	acquired	acquire	VBN	74	amod	5219	5227	B-event-211517	_	_	_	_
18	74	hepatitis	hepatitis	NN	70	nmod	5228	5237	B-event-211518	_	_	_	_
18	75	B	b	NN	78	nsubj	5238	5239	I-event-211518	_	_	_	_
18	76	in	in	IN	77	case	5240	5242	_	_	_	_	_
18	77	Australia	Australia	NNP	75	nmod	5243	5252	_	_	_	_	_
18	78	ranged	range	VBD	0	ROOT	5253	5259	_	_	_	_	_
18	79	from	from	IN	82	case	5260	5264	_	_	_	_	_
18	80	1.0	1.0	CD	82	compound	5265	5268	_	_	_	_	_
18	81	to	to	TO	82	dep	5269	5271	_	_	_	_	_
18	82	1.4	1.4	CD	78	nmod	5272	5275	_	_	_	_	_
18	83	per	per	IN	86	case	5276	5279	_	_	_	_	_
18	84	100	100	CD	85	compound	5280	5283	_	_	_	_	_
18	85	000	000	CD	86	nummod	5284	5287	_	_	_	_	_
18	86	population	population	NN	82	nmod	5288	5298	_	_	_	_	_
18	87	.	.	.	78	punct	5298	5299	_	_	_	_	_

19	1	Since	since	IN	2	case	5300	5305	_	_	_	_	_
19	2	2001	2001	CD	13	nmod	5306	5310	_	_	_	_	_
19	3	,	,	,	13	punct	5310	5311	_	_	_	_	_
19	4	the	the	DT	5	det	5312	5315	_	_	_	_	_
19	5	rate	rate	NN	13	nsubj	5316	5320	_	_	_	_	_
19	6	of	of	IN	7	case	5321	5323	_	_	_	_	_
19	7	diagnosis	diagnosis	NN	5	nmod	5324	5333	B-event-211519	_	_	_	_
19	8	of	of	IN	11	case	5334	5336	_	_	_	_	_
19	9	newly	newly	RB	10	advmod	5337	5342	_	_	_	_	_
19	10	acquired	acquire	VBN	11	amod	5343	5351	B-event-211520	_	_	_	_
19	11	infections	infection	NNS	7	nmod	5352	5362	B-event-211521	_	_	_	_
19	12	has	have	VBZ	13	aux	5363	5366	_	_	_	_	_
19	13	declined	decline	VBN	40	ccomp	5367	5375	B-event-211522	_	_	_	_
19	14	substantially	substantially	RB	13	advmod	5376	5389	_	_	_	_	_
19	15	among	among	IN	16	case	5390	5395	_	_	_	_	_
19	16	people	people	NNS	13	nmod	5396	5402	_	_	_	_	_
19	17	aged	aged	JJ	16	amod	5403	5407	_	_	_	_	_
19	18	15	15	CD	19	compound	5408	5410	_	_	_	_	_
19	19	–	–	CD	17	nmod	5410	5411	_	_	_	_	_
19	20	29	29	CD	21	nummod	5411	5413	_	_	_	_	_
19	21	years	year	NNS	19	dep	5414	5419	_	_	_	_	_
19	22	and	and	CC	13	cc	5420	5423	_	_	_	_	_
19	23	has	have	VBZ	24	aux	5424	5427	_	_	_	_	_
19	24	remained	remain	VBN	13	conj	5428	5436	_	_	_	_	_
19	25	relatively	relatively	RB	26	advmod	5437	5447	_	_	_	_	_
19	26	stable	stable	JJ	30	amod	5448	5454	B-event-212474	_	_	_	_
19	27	among	among	IN	28	case	5455	5460	_	_	_	_	_
19	28	people	people	NNS	26	nmod	5461	5467	_	_	_	_	_
19	29	aged	aged	JJ	30	amod	5468	5472	_	_	_	_	_
19	30	≥	≥	NN	24	xcomp	5473	5474	_	_	_	_	_
19	31	30	30	CD	32	nummod	5474	5476	_	_	_	_	_
19	32	years.14-16	years.14-16	NN	24	nmod:tmod	5477	5488	_	_	_	_	_
19	33	However	however	RB	32	advmod	5489	5496	_	_	_	_	_
19	34	,	,	,	40	punct	5496	5497	_	_	_	_	_
19	35	some	some	DT	38	det	5498	5502	_	_	_	_	_
19	36	new	new	JJ	38	amod	5503	5506	_	_	_	_	_
19	37	HBV	hbv	NN	38	compound	5507	5510	B-event-211523	_	_	_	_
19	38	infections	infection	NNS	40	nsubj	5511	5521	B-event-211524	_	_	_	_
19	39	are	be	VBP	40	cop	5522	5525	_	_	_	_	_
19	40	asymptomatic	asymptomatic	JJ	0	ROOT	5526	5538	B-event-211525	_	_	_	_
19	41	and	and	CC	40	cc	5539	5542	_	_	_	_	_
19	42	may	may	MD	43	aux	5543	5546	_	_	_	_	_
19	43	go	go	VB	40	conj	5547	5549	_	_	_	_	_
19	44	undetected	undetected	JJ	43	xcomp	5550	5560	B-event-211526	_	_	_	_
19	45	.	.	.	40	punct	5560	5561	_	_	_	_	_

20	1	Similar	similar	JJ	27	nsubjpass	5563	5570	_	_	_	_	_
20	2	to	to	TO	4	case	5571	5573	_	_	_	_	_
20	3	chronic	chronic	JJ	4	amod	5574	5581	_	_	_	_	_
20	4	infection	infection	NN	1	nmod	5582	5591	B-event-211527	_	_	_	_
20	5	,	,	,	4	punct	5591	5592	_	_	_	_	_
20	6	higher	higher	JJR	7	amod	5593	5599	_	_	_	_	_
20	7	rates	rate	NNS	4	appos	5600	5605	_	_	_	_	_
20	8	of	of	IN	9	case	5606	5608	_	_	_	_	_
20	9	notified	notify	VBN	7	acl	5609	5617	_	_	_	_	_
20	10	cases	case	NNS	9	dobj	5618	5623	_	_	_	_	_
20	11	of	of	IN	14	case	5624	5626	_	_	_	_	_
20	12	newly	newly	RB	13	advmod	5627	5632	_	_	_	_	_
20	13	acquired	acquire	VBN	14	amod	5633	5641	B-event-211528	_	_	_	_
20	14	hepatitis	hepatitis	NN	10	nmod	5642	5651	B-event-211529	_	_	_	_
20	15	B	b	NN	10	dep	5652	5653	I-event-211529	_	_	_	_
20	16	,	,	,	9	punct	5653	5654	_	_	_	_	_
20	17	or	or	CC	9	cc	5655	5657	_	_	_	_	_
20	18	hospitalisation	hospitalisation	NN	19	nmod:npmod	5658	5673	B-event-211530	_	_	_	_
20	19	due	due	JJ	9	conj	5674	5677	_	_	_	_	_
20	20	to	to	TO	23	case	5678	5680	_	_	_	_	_
20	21	acute	acute	JJ	23	amod	5681	5686	_	_	_	_	_
20	22	hepatitis	hepatitis	NN	23	compound	5687	5696	B-event-211531	_	_	_	_
20	23	B	b	NN	19	nmod	5697	5698	I-event-211531	_	_	_	_
20	24	,	,	,	9	punct	5698	5699	_	_	_	_	_
20	25	have	have	VBP	27	aux	5700	5704	_	_	_	_	_
20	26	been	be	VBN	27	auxpass	5705	5709	_	_	_	_	_
20	27	reported	report	VBN	0	ROOT	5710	5718	B-event-211532	_	_	_	_
20	28	among	among	IN	34	case	5719	5724	_	_	_	_	_
20	29	Aboriginal	Aboriginal	NNP	34	compound	5725	5735	_	_	_	_	_
20	30	and	and	CC	29	cc	5736	5739	_	_	_	_	_
20	31	Torres	Torres	NNP	29	conj	5740	5746	_	_	_	_	_
20	32	Strait	Strait	NNP	34	compound	5747	5753	_	_	_	_	_
20	33	Islander	Islander	NNP	34	compound	5754	5762	_	_	_	_	_
20	34	people	people	NNS	27	nmod	5763	5769	_	_	_	_	_
20	35	compared	compare	VBN	40	case	5770	5778	_	_	_	_	_
20	36	with	with	IN	40	case	5779	5783	_	_	_	_	_
20	37	the	the	DT	40	det	5784	5787	_	_	_	_	_
20	38	general	general	JJ	40	amod	5788	5795	_	_	_	_	_
20	39	Australian	australian	JJ	40	amod	5796	5806	_	_	_	_	_
20	40	population	population	NN	27	advcl	5807	5817	_	_	_	_	_
20	41	.17,18	.17,18	CD	52	nsubj	5817	5823	_	_	_	_	_
20	42	In	in	IN	48	case	5824	5826	_	_	_	_	_
20	43	one	one	CD	48	nummod	5827	5830	_	_	B-source-25376	_	_
20	44	United	United	NNP	46	compound	5831	5837	_	_	I-source-25376	_	_
20	45	States	States	NNPS	46	compound	5838	5844	_	_	I-source-25376	_	_
20	46	study	study	NN	48	compound	5845	5850	_	_	I-source-25376	_	_
20	47	,	,	,	48	punct	5850	5851	_	_	_	_	_
20	48	adults	adult	NNS	41	nmod	5852	5858	_	B-content-25377:25376-Source	_	_	_
20	49	with	with	IN	51	case	5859	5863	_	I-content-25377	_	_	_
20	50	diabetes	diabetes	NN	51	compound	5864	5872	B-event-211533	I-content-25377	_	_	_
20	51	mellitus	mellitus	NN	48	nmod	5873	5881	I-event-211533	I-content-25377	_	_	_
20	52	had	have	VBD	40	acl:relcl	5882	5885	_	I-content-25377	_	_	_
20	53	a	a	DT	55	det	5886	5887	_	I-content-25377	_	_	_
20	54	greater	greater	JJR	55	amod	5888	5895	_	I-content-25377	_	_	_
20	55	chance	chance	NN	52	dobj	5896	5902	_	I-content-25377	_	_	_
20	56	of	of	IN	57	mark	5903	5905	_	I-content-25377	_	_	_
20	57	developing	develop	VBG	55	acl	5906	5916	B-event-211534	I-content-25377	_	_	_
20	58	acute	acute	JJ	61	amod	5917	5922	_	I-content-25377	_	_	_
20	59	hepatitis	hepatitis	NN	61	compound	5923	5932	B-event-211535	I-content-25377	_	_	_
20	60	B	b	NN	61	compound	5933	5934	I-event-211535	I-content-25377	_	_	_
20	61	disease	disease	NN	57	dobj	5935	5942	B-event-211536	I-content-25377	_	_	_
20	62	than	than	IN	65	case	5943	5947	_	I-content-25377	_	_	_
20	63	the	the	DT	65	det	5948	5951	_	I-content-25377	_	_	_
20	64	general	general	JJ	65	amod	5952	5959	_	I-content-25377	_	_	_
20	65	population	population	NN	57	nmod	5960	5970	_	I-content-25377	_	_	_
20	66	;	;	:	27	punct	5970	5971	_	_	_	_	_
20	67	19	19	CD	68	nmod:npmod	5971	5973	_	_	_	_	_
20	68	however	however	RB	71	advmod	5974	5981	_	_	_	_	_
20	69	,	,	,	71	punct	5981	5982	_	_	_	_	_
20	70	there	there	EX	71	expl	5983	5988	_	_	_	_	_
20	71	are	be	VBP	27	parataxis	5989	5992	_	_	_	_	_
20	72	no	no	DT	75	neg	5993	5995	_	_	_	_	_
20	73	published	publish	VBN	75	amod	5996	6005	B-event-211537	_	_	_	_
20	74	Australian	australian	JJ	75	amod	6006	6016	_	_	_	_	_
20	75	studies	study	NNS	71	nsubj	6017	6024	B-event-211538	_	_	_	_
20	76	examining	examine	VBG	75	acl	6025	6034	_	_	_	_	_
20	77	this	this	DT	76	dobj	6035	6039	_	_	_	_	_
20	78	.	.	.	27	punct	6039	6040	_	_	_	_	_

21	1	Transmission	Transmission	NNP	5	nsubj	6041	6053	B-event-211539	_	_	_	_
21	2	of	of	IN	3	case	6054	6056	_	_	_	_	_
21	3	HBV	hbv	NN	1	nmod	6057	6060	B-event-211540	_	_	_	_
21	4	may	may	MD	5	aux	6061	6064	_	_	_	_	_
21	5	result	result	VB	0	ROOT	6065	6071	_	_	_	_	_
21	6	from	from	IN	7	case	6072	6076	_	_	_	_	_
21	7	inoculation	inoculation	NN	5	nmod	6077	6088	B-event-211541	_	_	_	_
21	8	through	through	IN	24	case	6089	6096	_	_	_	_	_
21	9	broken	break	VBN	24	csubj	6097	6103	B-event-211542	_	_	_	_
21	10	or	or	CC	9	cc	6104	6106	_	_	_	_	_
21	11	penetrated	penetrate	VBN	9	conj	6107	6117	B-event-211543	_	_	_	_
21	12	skin	skin	NN	9	dobj	6118	6122	_	_	_	_	_
21	13	,	,	,	9	punct	6122	6123	_	_	_	_	_
21	14	or	or	CC	9	cc	6124	6126	_	_	_	_	_
21	15	by	by	IN	17	case	6127	6129	_	_	_	_	_
21	16	mucosal	mucosal	JJ	17	amod	6130	6137	_	_	_	_	_
21	17	contact	contact	NN	9	conj	6138	6145	B-event-211544	_	_	_	_
21	18	with	with	IN	23	case	6146	6150	_	_	_	_	_
21	19	blood	blood	NN	23	compound	6151	6156	_	_	_	_	_
21	20	or	or	CC	19	cc	6157	6159	_	_	_	_	_
21	21	other	other	JJ	19	conj	6160	6165	_	_	_	_	_
21	22	body	body	NN	23	compound	6166	6170	_	_	_	_	_
21	23	fluids	fluid	NNS	17	nmod	6171	6177	_	_	_	_	_
21	24	(	(	VBP	5	nmod	6178	6179	_	_	_	_	_
21	25	mainly	mainly	RB	27	advmod	6179	6185	_	_	_	_	_
21	26	vaginal	vaginal	JJ	27	amod	6186	6193	_	_	_	_	_
21	27	fluids	fluid	NNS	24	dobj	6194	6200	_	_	_	_	_
21	28	and	and	CC	24	cc	6201	6204	_	_	_	_	_
21	29	semen	semen	NN	24	conj	6205	6210	_	_	_	_	_
21	30	)	)	CD	29	nummod	6210	6211	_	_	_	_	_
21	31	from	from	IN	34	case	6212	6216	_	_	_	_	_
21	32	an	a	DT	34	det	6217	6219	_	_	_	_	_
21	33	infectious	infectious	JJ	34	amod	6220	6230	B-event-211545	_	_	_	_
21	34	person	person	NN	29	nmod	6231	6237	_	_	_	_	_
21	35	.	.	.	5	punct	6237	6238	_	_	_	_	_

22	1	There	there	EX	2	expl	6239	6244	_	_	_	_	_
22	2	are	be	VBP	0	ROOT	6245	6248	_	_	_	_	_
22	3	four	four	CD	5	nummod	6249	6253	_	_	_	_	_
22	4	major	major	JJ	5	amod	6254	6259	_	_	_	_	_
22	5	routes	route	NNS	2	nsubj	6260	6266	_	_	_	_	_
22	6	of	of	IN	8	case	6267	6269	_	_	_	_	_
22	7	HBV	hbv	NN	8	compound	6270	6273	B-event-211546	_	_	_	_
22	8	transmission	transmission	NN	5	nmod	6274	6286	B-event-211547	_	_	_	_
22	9	:	:	:	2	punct	6286	6287	_	_	_	_	_
22	10	In	in	IN	11	case	6288	6290	_	_	_	_	_
22	11	Australia	Australia	NNP	69	nmod	6291	6300	_	_	_	_	_
22	12	,	,	,	69	punct	6300	6301	_	_	_	_	_
22	13	screening	screening	NN	69	nsubj	6302	6311	B-event-211548	_	_	_	_
22	14	of	of	IN	18	case	6312	6314	_	_	_	_	_
22	15	blood	blood	NN	18	compound	6315	6320	_	_	_	_	_
22	16	and	and	CC	15	cc	6321	6324	_	_	_	_	_
22	17	organ	organ	NN	15	conj	6325	6330	_	_	_	_	_
22	18	donors	donor	NNS	13	nmod	6331	6337	_	_	_	_	_
22	19	using	use	VBG	18	acl	6338	6343	_	_	_	_	_
22	20	serological	serological	JJ	31	nsubj	6344	6355	_	_	_	_	_
22	21	,	,	,	20	punct	6355	6356	_	_	_	_	_
22	22	and	and	CC	20	cc	6357	6360	_	_	_	_	_
22	23	subsequently	subsequently	RB	27	advmod	6361	6373	_	_	_	_	_
22	24	nucleic	nucleic	JJ	27	amod	6374	6381	_	_	_	_	_
22	25	acid	acid	NN	27	compound	6382	6386	_	_	_	_	_
22	26	amplification	amplification	NN	27	compound	6387	6400	_	_	_	_	_
22	27	testing	testing	NN	20	conj	6401	6408	B-event-211549	_	_	_	_
22	28	,	,	,	20	punct	6408	6409	_	_	_	_	_
22	29	has	have	VBZ	31	aux	6410	6413	_	_	_	_	_
22	30	virtually	virtually	RB	31	advmod	6414	6423	_	_	_	_	_
22	31	eliminated	eliminate	VBN	19	ccomp	6424	6434	B-event-211550	_	_	_	_
22	32	the	the	DT	33	det	6435	6438	_	_	_	_	_
22	33	risk	risk	NN	31	dobj	6439	6443	B-event-211551	_	_	_	_
22	34	of	of	IN	35	case	6444	6446	_	_	_	_	_
22	35	transmission	transmission	NN	33	nmod	6447	6459	B-event-211552	_	_	_	_
22	36	of	of	IN	38	case	6460	6462	_	_	_	_	_
22	37	hepatitis	hepatitis	NN	38	compound	6463	6472	B-event-211553	_	_	_	_
22	38	B	b	NN	35	nmod	6473	6474	I-event-211553	_	_	_	_
22	39	through	through	IN	41	case	6475	6482	_	_	_	_	_
22	40	blood	blood	NN	41	compound	6483	6488	_	_	_	_	_
22	41	transfusion	transfusion	NN	31	nmod	6489	6500	B-event-211554	_	_	_	_
22	42	and	and	CC	41	cc	6501	6504	_	_	_	_	_
22	43	organ	organ	NN	44	compound	6505	6510	_	_	_	_	_
22	44	transplants	transplant	NNS	41	conj	6511	6522	B-event-211555	_	_	_	_
22	45	.20,21	.20,21	CD	46	nummod	6522	6528	_	_	_	_	_
22	46	Saliva	saliva	NNS	48	nsubj	6529	6535	_	_	_	_	_
22	47	may	may	MD	48	aux	6536	6539	_	_	_	_	_
22	48	contain	contain	VB	41	acl:relcl	6540	6547	_	_	_	_	_
22	49	levels	level	NNS	48	dobj	6548	6554	_	_	_	_	_
22	50	of	of	IN	51	case	6555	6557	_	_	_	_	_
22	51	virus	virus	NN	49	nmod	6558	6563	B-event-211556	_	_	_	_
22	52	that	that	WDT	54	nsubj	6564	6568	_	_	_	_	_
22	53	are	be	VBP	54	cop	6569	6572	_	_	_	_	_
22	54	likely	likely	JJ	49	acl:relcl	6573	6579	_	_	_	_	_
22	55	to	to	TO	57	mark	6580	6582	_	_	_	_	_
22	56	be	be	VB	57	cop	6583	6585	_	_	_	_	_
22	57	infective	infective	JJ	54	xcomp	6586	6595	B-event-211557	_	_	_	_
22	58	only	only	RB	31	cc	6596	6600	_	_	_	_	_
22	59	if	if	IN	58	dep	6601	6603	_	_	_	_	_
22	60	inoculated	inoculate	VBN	31	conj	6604	6614	B-event-211558	_	_	_	_
22	61	directly	directly	RB	60	advmod	6615	6623	_	_	_	_	_
22	62	into	into	IN	63	case	6624	6628	_	_	_	_	_
22	63	tissue	tissue	NN	60	nmod	6629	6635	_	_	_	_	_
22	64	(	(	CD	65	compound	6636	6637	_	_	_	_	_
22	65	ocular	ocular	JJ	31	dobj	6637	6643	_	_	_	_	_
22	66	or	or	CC	65	cc	6644	6646	_	_	_	_	_
22	67	mucous	mucous	JJ	68	amod	6647	6653	_	_	_	_	_
22	68	membranes	membrane	NNS	65	conj	6654	6663	_	_	_	_	_
22	69	)	)	VBP	2	parataxis	6663	6664	_	_	_	_	_
22	70	.	.	.	2	punct	6664	6665	_	_	_	_	_

23	1	The	the	DT	2	det	6666	6669	_	_	_	_	_
23	2	risk	risk	NN	40	nsubj	6670	6674	B-event-211559	_	_	_	_
23	3	of	of	IN	4	case	6675	6677	_	_	_	_	_
23	4	transmission	transmission	NN	2	nmod	6678	6690	B-event-211560	_	_	_	_
23	5	by	by	IN	7	case	6691	6693	_	_	_	_	_
23	6	inadvertent	inadvertent	JJ	7	amod	6694	6705	_	_	_	_	_
23	7	inoculation	inoculation	NN	4	nmod	6706	6717	B-event-211561	_	_	_	_
23	8	by	by	IN	10	case	6718	6720	_	_	_	_	_
23	9	other	other	JJ	10	amod	6721	6726	_	_	_	_	_
23	10	means	means	NNS	7	nmod	6727	6732	_	_	_	_	_
23	11	,	,	,	10	punct	6732	6733	_	_	_	_	_
23	12	such	such	JJ	15	case	6734	6738	_	_	_	_	_
23	13	as	as	IN	12	mwe	6739	6741	_	_	_	_	_
23	14	by	by	IN	15	case	6742	6744	_	_	_	_	_
23	15	toothbrush	toothbrush	NN	10	nmod	6745	6755	_	_	_	_	_
23	16	,	,	,	10	punct	6755	6756	_	_	_	_	_
23	17	razor	razor	NN	18	dep	6757	6762	_	_	_	_	_
23	18	etc.	etc.	NN	10	amod	6763	6767	_	_	_	_	_
23	19	,	,	,	7	punct	6767	6768	_	_	_	_	_
23	20	or	or	CC	7	cc	6769	6771	_	_	_	_	_
23	21	through	through	IN	24	case	6772	6779	_	_	_	_	_
23	22	close	close	JJ	24	amod	6780	6785	_	_	_	_	_
23	23	personal	personal	JJ	24	amod	6786	6794	_	_	_	_	_
23	24	contact	contact	NN	7	conj	6795	6802	B-event-211562	_	_	_	_
23	25	in	in	IN	26	case	6803	6805	_	_	_	_	_
23	26	households	household	NNS	24	nmod	6806	6816	_	_	_	_	_
23	27	in	in	IN	28	case	6817	6819	_	_	_	_	_
23	28	which	which	WDT	34	nmod	6820	6825	_	_	_	_	_
23	29	one	one	CD	33	nummod	6826	6829	_	_	_	_	_
23	30	or	or	CC	29	cc	6830	6832	_	_	_	_	_
23	31	more	more	JJR	29	conj	6833	6837	_	_	_	_	_
23	32	infected	infected	JJ	33	amod	6838	6846	B-event-211563	_	_	_	_
23	33	persons	person	NNS	34	nsubj	6847	6854	_	_	_	_	_
23	34	reside	reside	VBP	26	acl:relcl	6855	6861	_	_	_	_	_
23	35	,	,	,	40	punct	6861	6862	_	_	_	_	_
23	36	is	be	VBZ	40	cop	6863	6865	_	_	_	_	_
23	37	low	low	JJ	40	dep	6866	6869	_	_	_	_	_
23	38	but	but	CC	40	cc	6870	6873	_	_	_	_	_
23	39	not	not	RB	40	conj	6874	6877	_	_	_	_	_
23	40	negligible.22-29	negligible.22-29	JJ	0	ROOT	6878	6894	_	_	_	_	_
23	41	The	the	DT	42	det	6895	6898	_	_	_	_	_
23	42	strategy	strategy	NN	52	nsubj	6899	6907	_	_	_	_	_
23	43	for	for	IN	44	case	6908	6911	_	_	_	_	_
23	44	prevention	prevention	NN	42	nmod	6912	6922	B-event-211564	_	_	_	_
23	45	of	of	IN	47	case	6923	6925	_	_	_	_	_
23	46	hepatitis	hepatitis	NN	47	compound	6926	6935	B-event-211565	_	_	_	_
23	47	B	b	NN	44	nmod	6936	6937	I-event-211565	_	_	_	_
23	48	through	through	IN	49	case	6938	6945	_	_	_	_	_
23	49	immunisation	immunisation	NN	47	nmod	6946	6958	B-event-211566	_	_	_	_
23	50	in	in	IN	51	case	6959	6961	_	_	_	_	_
23	51	Australia	Australia	NNP	49	nmod	6962	6971	_	_	_	_	_
23	52	commenced	commence	VBD	40	ccomp	6972	6981	_	_	_	_	_
23	53	in	in	IN	56	case	6982	6984	_	_	_	_	_
23	54	the	the	DT	56	det	6985	6988	_	_	_	_	_
23	55	early	early	JJ	56	amod	6989	6994	_	_	_	_	_
23	56	1980s	1980s	CD	52	nmod	6995	7000	_	_	_	_	_
23	57	,	,	,	52	punct	7000	7001	_	_	_	_	_
23	58	with	with	IN	60	case	7002	7006	_	_	_	_	_
23	59	vaccination	vaccination	NN	60	compound	7007	7018	B-event-211567	_	_	_	_
23	60	programs	program	NNS	52	nmod	7019	7027	B-event-211568	_	_	_	_
23	61	targeting	target	VBG	60	acl	7028	7037	_	_	_	_	_
23	62	individuals	individual	NNS	61	dobj	7038	7049	_	_	_	_	_
23	63	with	with	IN	65	case	7050	7054	_	_	_	_	_
23	64	increased	increase	VBN	65	amod	7055	7064	B-event-211569	_	_	_	_
23	65	risk	risk	NN	61	nmod	7065	7069	B-event-211570	_	_	_	_
23	66	of	of	IN	68	case	7070	7072	_	_	_	_	_
23	67	HBV	hbv	NN	68	compound	7073	7076	B-event-211571	_	_	_	_
23	68	exposure	exposure	NN	65	nmod	7077	7085	B-event-211572	_	_	_	_
23	69	,	,	,	65	punct	7085	7086	_	_	_	_	_
23	70	including	include	VBG	71	case	7087	7096	_	_	_	_	_
23	71	infants	infant	NNS	65	nmod	7097	7104	_	_	_	_	_
23	72	at	at	IN	74	case	7105	7107	_	_	_	_	_
23	73	particular	particular	JJ	74	amod	7108	7118	_	_	_	_	_
23	74	risk	risk	NN	71	nmod	7119	7123	B-event-211573	_	_	_	_
23	75	of	of	IN	76	case	7124	7126	_	_	_	_	_
23	76	infection	infection	NN	74	nmod	7127	7136	B-event-211574	_	_	_	_
23	77	at	at	IN	78	case	7137	7139	_	_	_	_	_
23	78	birth	birth	NN	65	nmod	7140	7145	B-event-211575	_	_	_	_
23	79	.	.	.	40	punct	7145	7146	_	_	_	_	_

24	1	Universal	Universal	NNP	3	compound	7147	7156	_	_	_	_	_
24	2	infant	infant	NN	3	compound	7157	7163	_	_	_	_	_
24	3	vaccination	vaccination	NN	4	nsubj	7164	7175	B-event-211576	_	_	_	_
24	4	commenced	commence	VBD	0	ROOT	7176	7185	_	_	_	_	_
24	5	in	in	IN	8	case	7186	7188	_	_	_	_	_
24	6	the	the	DT	8	det	7189	7192	_	_	_	_	_
24	7	Northern	northern	JJ	8	amod	7193	7201	_	_	_	_	_
24	8	Territory	territory	NN	4	nmod	7202	7211	_	_	_	_	_
24	9	in	in	IN	10	case	7212	7214	_	_	_	_	_
24	10	1990	1990	CD	4	nmod	7215	7219	_	_	_	_	_
24	11	.	.	.	4	punct	7219	7220	_	_	_	_	_

25	1	A	a	DT	6	det	7221	7222	_	I-content-25282	_	_	_
25	2	universal	universal	JJ	6	amod	7223	7232	_	I-content-25282	_	_	_
25	3	hepatitis	hepatitis	NN	6	compound	7233	7242	_	I-content-25282	_	_	_
25	4	B	b	NN	6	compound	7243	7244	_	I-content-25282	_	_	_
25	5	vaccination	vaccination	NN	6	compound	7245	7256	B-event-211577	I-content-25282	_	_	_
25	6	program	program	NN	8	nsubjpass	7257	7264	B-event-211578	I-content-25282	_	_	_
25	7	was	be	VBD	8	auxpass	7265	7268	_	_	_	_	_
25	8	recommended	recommend	VBN	0	ROOT	7269	7280	_	_	_	B-cue-25283	_
25	9	for	for	IN	10	case	7281	7284	_	_	_	_	_
25	10	infants	infant	NNS	8	nmod	7285	7292	_	_	_	_	_
25	11	and	and	CC	10	cc	7293	7296	_	_	_	_	_
25	12	adolescents	adolescent	NNS	10	conj	7297	7308	_	_	_	_	_
25	13	in	in	IN	14	case	7309	7311	_	_	_	_	_
25	14	1996	1996	CD	8	nmod	7312	7316	_	_	_	_	_
25	15	.	.	.	8	punct	7316	7317	_	_	_	_	_

26	1	The	the	DT	3	det	7318	7321	_	_	_	_	_
26	2	adolescent	adolescent	JJ	3	amod	7322	7332	_	_	_	_	_
26	3	program	program	NN	26	nsubj	7333	7340	B-event-211579	_	_	_	_
26	4	commenced	commence	VBN	3	acl	7341	7350	_	_	_	_	_
26	5	in	in	IN	7	case	7351	7353	_	_	_	_	_
26	6	some	some	DT	7	det	7354	7358	_	_	_	_	_
26	7	states	state	NNS	4	nmod	7359	7365	_	_	_	_	_
26	8	and	and	CC	7	cc	7366	7369	_	_	_	_	_
26	9	territories	territory	NNS	7	conj	7370	7381	_	_	_	_	_
26	10	in	in	IN	11	case	7382	7384	_	_	_	_	_
26	11	1997	1997	CD	7	nmod	7385	7389	_	_	_	_	_
26	12	and	and	CC	11	cc	7390	7393	_	_	_	_	_
26	13	the	the	DT	16	det	7394	7397	_	_	_	_	_
26	14	universal	universal	JJ	16	amod	7398	7407	_	_	_	_	_
26	15	infant	infant	NN	16	compound	7408	7414	_	_	_	_	_
26	16	program	program	NN	11	conj	7415	7422	B-event-211580	_	_	_	_
26	17	,	,	,	3	punct	7422	7423	_	_	_	_	_
26	18	which	which	WDT	19	nsubj	7424	7429	_	_	_	_	_
26	19	includes	include	VBZ	3	acl:relcl	7430	7438	_	_	_	_	_
26	20	a	a	DT	21	det	7439	7440	_	_	_	_	_
26	21	dose	dose	NN	19	dobj	7441	7445	B-event-211581	_	_	_	_
26	22	given	give	VBN	24	case	7446	7451	_	_	_	_	_
26	23	at	at	IN	24	case	7452	7454	_	_	_	_	_
26	24	birth	birth	NN	19	advcl	7455	7460	_	_	_	_	_
26	25	,	,	,	3	punct	7460	7461	_	_	_	_	_
26	26	began	begin	VBD	0	ROOT	7462	7467	_	_	_	_	_
26	27	nationally	nationally	RB	26	advmod	7468	7478	_	_	_	_	_
26	28	in	in	IN	29	case	7479	7481	_	_	_	_	_
26	29	2000	2000	CD	26	nmod	7482	7486	_	_	_	_	_
26	30	.	.	.	26	punct	7486	7487	_	_	_	_	_

27	1	The	the	DT	3	det	7488	7491	_	_	_	_	_
27	2	adolescent	adolescent	JJ	3	amod	7492	7502	_	_	_	_	_
27	3	program	program	NN	5	nsubj	7503	7510	B-event-211582	_	_	_	_
27	4	will	will	MD	5	aux	7511	7515	_	_	_	_	_
27	5	continue	continue	VB	0	ROOT	7516	7524	_	_	_	_	_
27	6	until	until	IN	16	mark	7525	7530	_	_	_	_	_
27	7	those	those	DT	16	nsubj	7531	7536	_	_	_	_	_
27	8	immunised	immunise	VBN	7	acl	7537	7546	B-event-211583	_	_	_	_
27	9	for	for	IN	11	case	7547	7550	_	_	_	_	_
27	10	hepatitis	hepatitis	NN	11	compound	7551	7560	B-event-211584	_	_	_	_
27	11	B	b	NN	8	nmod	7561	7562	I-event-211584	_	_	_	_
27	12	in	in	IN	15	case	7563	7565	_	_	_	_	_
27	13	the	the	DT	15	det	7566	7569	_	_	_	_	_
27	14	infant	infant	NN	15	compound	7570	7576	_	_	_	_	_
27	15	program	program	NN	11	nmod	7577	7584	B-event-211585	_	_	_	_
27	16	reach	reach	VBP	5	advcl	7585	7590	_	_	_	_	_
27	17	adolescence	adolescence	NN	16	dobj	7591	7602	_	_	_	_	_
27	18	.	.	.	5	punct	7602	7603	_	_	_	_	_

28	1	4.5.4	4.5.4	CD	2	nummod	7604	7609	_	_	_	_	_
28	2	Vaccines	vaccine	NNS	7	nsubjpass	7610	7618	_	_	_	_	_
28	3	Hepatitis	Hepatitis	NNP	5	compound	7619	7628	_	_	_	_	_
28	4	B	B	NNP	5	compound	7629	7630	_	_	_	_	_
28	5	vaccines	vaccine	NNS	2	dep	7631	7639	_	_	_	_	_
28	6	are	be	VBP	7	auxpass	7640	7643	_	_	_	_	_
28	7	prepared	prepare	VBN	0	ROOT	7644	7652	B-event-211586	_	_	_	_
28	8	using	use	VBG	7	xcomp	7653	7658	_	_	_	_	_
28	9	recombinant	recombinant	JJ	10	amod	7659	7670	B-event-211587	_	_	_	_
28	10	technology	technology	NN	8	dobj	7671	7681	_	_	_	_	_
28	11	.	.	.	7	punct	7681	7682	_	_	_	_	_

29	1	After	after	IN	2	case	7683	7688	_	_	_	_	_
29	2	purification	purification	NN	8	nmod	7689	7701	B-event-211588	_	_	_	_
29	3	,	,	,	8	punct	7701	7702	_	_	_	_	_
29	4	the	the	DT	6	det	7703	7706	_	_	_	_	_
29	5	HBsAg	hbsag	NN	6	compound	7707	7712	_	_	_	_	_
29	6	protein	protein	NN	8	nsubjpass	7713	7720	_	_	_	_	_
29	7	is	be	VBZ	8	auxpass	7721	7723	_	_	_	_	_
29	8	adsorbed	adsorb	VBN	0	ROOT	7724	7732	B-event-211589	_	_	_	_
29	9	onto	onto	IN	12	case	7733	7737	_	_	_	_	_
29	10	elemental	elemental	JJ	12	amod	7738	7747	_	_	_	_	_
29	11	aluminium	aluminium	NN	12	compound	7748	7757	_	_	_	_	_
29	12	(	(	NN	8	nmod	7758	7759	_	_	_	_	_
29	13	as	as	IN	14	case	7759	7761	_	_	_	_	_
29	14	hydroxide	hydroxide	NN	8	nmod	7762	7771	_	_	_	_	_
29	15	and/or	and/or	CC	14	cc	7772	7778	_	_	_	_	_
29	16	phosphate	phosphate	NN	17	compound	7779	7788	_	_	_	_	_
29	17	)	)	NN	14	conj	7788	7789	_	_	_	_	_
29	18	.	.	.	8	punct	7789	7790	_	_	_	_	_

30	1	Hepatitis	Hepatitis	NNP	3	compound	7791	7800	_	_	_	_	_
30	2	B	B	NNP	3	compound	7801	7802	_	_	_	_	_
30	3	vaccines	vaccine	NNS	5	nsubj	7803	7811	_	_	_	_	_
30	4	may	may	MD	5	aux	7812	7815	_	_	_	_	_
30	5	contain	contain	VB	0	ROOT	7816	7823	_	_	_	_	_
30	6	up	up	RP	5	compound:prt	7824	7826	_	_	_	_	_
30	7	to	to	TO	9	case	7827	7829	_	_	_	_	_
30	8	1	1	CD	9	nummod	7830	7831	_	_	_	_	_
30	9	%	%	NN	5	nmod	7831	7832	_	_	_	_	_
30	10	yeast	yeast	NN	11	compound	7833	7838	_	_	_	_	_
30	11	proteins	protein	NNS	12	nsubj	7839	7847	_	_	_	_	_
30	12	(	(	VBP	9	acl:relcl	7848	7849	_	_	_	_	_
30	13	but	but	CC	17	case	7849	7852	_	_	_	_	_
30	14	no	no	DT	17	neg	7853	7855	_	_	_	_	_
30	15	yeast	yeast	NN	17	compound	7856	7861	_	_	_	_	_
30	16	DNA	dna	NN	17	compound	7862	7865	_	_	_	_	_
30	17	)	)	NN	12	nmod	7865	7866	_	_	_	_	_
30	18	.	.	.	5	punct	7866	7867	_	_	_	_	_

31	1	The	the	DT	2	det	7869	7872	_	_	_	_	_
31	2	Engerix-B	Engerix-B	NNP	9	nsubjpass	7873	7882	_	_	_	_	_
31	3	and	and	CC	2	cc	7883	7886	_	_	_	_	_
31	4	the	the	DT	5	det	7887	7890	_	_	_	_	_
31	5	H-B-Vax	h-b-vax	NN	2	conj	7891	7898	_	_	_	_	_
31	6	II	ii	CD	7	nummod	7899	7901	_	_	_	_	_
31	7	vaccines	vaccine	NNS	5	dep	7902	7910	_	_	_	_	_
31	8	are	be	VBP	9	auxpass	7911	7914	_	_	_	_	_
31	9	manufactured	manufacture	VBN	0	ROOT	7915	7927	B-event-211590	_	_	_	_
31	10	by	by	IN	12	case	7928	7930	_	_	_	_	_
31	11	different	different	JJ	12	amod	7931	7940	_	_	_	_	_
31	12	processes	process	NNS	9	nmod	7941	7950	B-event-211591	_	_	_	_
31	13	,	,	,	9	punct	7950	7951	_	_	_	_	_
31	14	and	and	CC	9	cc	7952	7955	_	_	_	_	_
31	15	the	the	DT	17	det	7956	7959	_	_	_	_	_
31	16	HBsAg	hbsag	NN	17	compound	7960	7965	_	_	_	_	_
31	17	content	content	NN	28	nsubj	7966	7973	_	_	_	_	_
31	18	of	of	IN	22	case	7974	7976	_	_	_	_	_
31	19	‘	‘	CD	22	nummod	7977	7978	_	_	_	_	_
31	20	equivalent	equivalent	JJ	22	amod	7978	7988	_	_	_	_	_
31	21	’	’	NN	22	compound	7988	7989	_	_	_	_	_
31	22	doses	dose	NNS	17	nmod	7990	7995	_	_	_	_	_
31	23	of	of	IN	26	case	7996	7998	_	_	_	_	_
31	24	these	these	DT	26	det	7999	8004	_	_	_	_	_
31	25	two	two	CD	26	nummod	8005	8008	_	_	_	_	_
31	26	vaccines	vaccine	NNS	22	nmod	8009	8017	_	_	_	_	_
31	27	is	be	VBZ	28	cop	8018	8020	_	_	_	_	_
31	28	different	different	JJ	9	conj	8021	8030	_	_	_	_	_
31	29	.	.	.	9	punct	8030	8031	_	_	_	_	_

32	1	the	the	DT	3	det	8033	8036	_	_	_	_	_
32	2	HBsAg	hbsag	NN	3	compound	8037	8042	_	_	_	_	_
32	3	content	content	NN	14	nsubj	8043	8050	_	_	_	_	_
32	4	of	of	IN	7	case	8051	8053	_	_	_	_	_
32	5	the	the	DT	7	det	8054	8057	_	_	_	_	_
32	6	paediatric	paediatric	JJ	7	amod	8058	8068	_	_	_	_	_
32	7	formulations	formulation	NNS	3	nmod	8069	8081	_	_	_	_	_
32	8	of	of	IN	11	case	8082	8084	_	_	_	_	_
32	9	these	these	DT	11	det	8085	8090	_	_	_	_	_
32	10	two	two	CD	11	nummod	8091	8094	_	_	_	_	_
32	11	vaccines	vaccine	NNS	7	nmod	8095	8103	_	_	_	_	_
32	12	is	be	VBZ	14	cop	8104	8106	_	_	_	_	_
32	13	half	half	PDT	14	det:predet	8107	8111	_	_	_	_	_
32	14	that	that	DT	0	ROOT	8112	8116	_	_	_	_	_
32	15	of	of	IN	21	case	8117	8119	_	_	_	_	_
32	16	the	the	DT	18	det	8120	8123	_	_	_	_	_
32	17	corresponding	corresponding	JJ	18	amod	8124	8137	_	_	_	_	_
32	18	manufacturer	manufacturer	NN	21	nmod:poss	8138	8150	B-event-211592	_	_	_	_
32	19	's	's	POS	18	case	8150	8152	_	_	_	_	_
32	20	adult	adult	JJ	21	amod	8153	8158	_	_	_	_	_
32	21	formulation	formulation	NN	14	nmod	8159	8170	_	_	_	_	_
32	22	.	.	.	14	punct	8170	8171	_	_	_	_	_

33	1	Studies	study	NNS	8	nsubjpass	8172	8179	B-event-211593	_	_	_	_
33	2	of	of	IN	5	case	8180	8182	_	_	_	_	_
33	3	hepatitis	hepatitis	NN	5	compound	8183	8192	_	_	_	_	_
33	4	B	b	NN	5	compound	8193	8194	_	_	_	_	_
33	5	vaccines	vaccine	NNS	1	nmod	8195	8203	_	_	_	_	_
33	6	have	have	VBP	8	aux	8204	8208	_	_	_	_	_
33	7	been	be	VBN	8	auxpass	8209	8213	_	_	_	_	_
33	8	conducted	conduct	VBN	0	ROOT	8214	8223	_	_	_	_	_
33	9	using	use	VBG	8	xcomp	8224	8229	_	_	_	_	_
33	10	different	different	JJ	11	amod	8230	8239	_	_	_	_	_
33	11	schedules	schedule	NNS	9	dobj	8240	8249	_	_	_	_	_
33	12	and	and	CC	11	cc	8250	8253	_	_	_	_	_
33	13	intervals	interval	NNS	11	conj	8254	8263	_	_	_	_	_
33	14	for	for	IN	17	case	8264	8267	_	_	_	_	_
33	15	different	different	JJ	17	amod	8268	8277	_	_	_	_	_
33	16	age	age	NN	17	compound	8278	8281	_	_	_	_	_
33	17	groups	group	NNS	9	nmod	8282	8288	_	_	_	_	_
33	18	.	.	.	8	punct	8288	8289	_	_	_	_	_

34	1	Acceptable	acceptable	JJ	2	amod	8290	8300	_	_	_	_	_
34	2	schedules	schedule	NNS	4	nsubjpass	8301	8310	_	_	_	_	_
34	3	are	be	VBP	4	auxpass	8311	8314	_	_	_	_	_
34	4	shown	show	VBN	0	ROOT	8315	8320	_	_	_	_	_
34	5	in	in	IN	6	case	8321	8323	_	_	_	_	_
34	6	Table	Table	NNP	4	nmod	8324	8329	_	_	_	_	_
34	7	4.5.1	4.5.1	CD	6	nummod	8330	8335	_	_	_	_	_
34	8	and	and	CC	4	cc	8336	8339	_	_	_	_	_
34	9	are	be	VBP	10	auxpass	8340	8343	_	_	_	_	_
34	10	described	describe	VBN	4	conj	8344	8353	_	_	_	_	_
34	11	below	below	IN	10	nmod	8354	8359	_	_	_	_	_
34	12	.	.	.	4	punct	8359	8360	_	_	_	_	_

35	1	The	the	DT	4	det	8361	8364	_	_	_	_	_
35	2	standard	standard	JJ	4	amod	8365	8373	_	_	_	_	_
35	3	3-dose	3-dose	JJ	4	amod	8374	8380	_	_	_	_	_
35	4	schedule	schedule	NN	35	nsubj	8381	8389	_	_	_	_	_
35	5	and	and	CC	4	cc	8390	8393	_	_	_	_	_
35	6	variations	variation	NNS	7	compound	8394	8404	_	_	_	_	_
35	7	Neonates	neonate	NNS	4	conj	8405	8413	_	_	_	_	_
35	8	,	,	,	7	punct	8413	8414	_	_	_	_	_
35	9	children	child	NNS	7	conj	8415	8423	_	_	_	_	_
35	10	and	and	CC	7	cc	8424	8427	_	_	_	_	_
35	11	young	young	JJ	12	amod	8428	8433	_	_	_	_	_
35	12	adults	adult	NNS	7	conj	8434	8440	_	_	_	_	_
35	13	aged	aged	JJ	12	amod	8441	8445	_	_	_	_	_
35	14	<	<	JJR	13	dep	8446	8447	_	_	_	_	_
35	15	20	20	CD	16	nummod	8447	8449	_	_	_	_	_
35	16	years	year	NNS	12	nmod:tmod	8450	8455	_	_	_	_	_
35	17	The	the	DT	21	det	8456	8459	_	_	_	_	_
35	18	recommended	recommend	VBN	21	amod	8460	8471	B-event-211594	_	_	_	_
35	19	Australian	australian	JJ	21	amod	8472	8482	_	_	_	_	_
35	20	infant	infant	NN	21	compound	8483	8489	_	_	_	_	_
35	21	schedule	schedule	NN	22	nsubj	8490	8498	_	_	_	_	_
35	22	consists	consist	VBZ	35	parataxis	8499	8507	_	_	_	_	_
35	23	of	of	IN	25	case	8508	8510	_	_	_	_	_
35	24	a	a	DT	25	det	8511	8512	_	_	_	_	_
35	25	dose	dose	NN	22	nmod	8513	8517	_	_	_	_	_
35	26	of	of	IN	30	case	8518	8520	_	_	_	_	_
35	27	monovalent	monovalent	JJ	30	amod	8521	8531	_	_	_	_	_
35	28	hepatitis	hepatitis	NN	30	compound	8532	8541	_	_	_	_	_
35	29	B	b	NN	30	compound	8542	8543	_	_	_	_	_
35	30	vaccine	vaccine	NN	25	nmod	8544	8551	B-event-211595	_	_	_	_
35	31	given	give	VBN	33	case	8552	8557	_	_	_	_	_
35	32	at	at	IN	33	case	8558	8560	_	_	_	_	_
35	33	birth	birth	NN	22	advcl	8561	8566	_	_	_	_	_
35	34	,	,	,	22	punct	8566	8567	_	_	_	_	_
35	35	followed	follow	VBN	0	ROOT	8568	8576	_	_	_	_	_
35	36	by	by	IN	38	case	8577	8579	_	_	_	_	_
35	37	3	3	CD	38	nummod	8580	8581	_	_	_	_	_
35	38	doses	dose	NNS	35	nmod	8582	8587	_	_	_	_	_
35	39	of	of	IN	44	case	8588	8590	_	_	_	_	_
35	40	a	a	DT	44	det	8591	8592	_	_	_	_	_
35	41	hepatitis	hepatitis	NN	44	compound	8593	8602	_	_	_	_	_
35	42	B-containing	b-containing	JJ	44	amod	8603	8615	_	_	_	_	_
35	43	combination	combination	NN	44	compound	8616	8627	_	_	_	_	_
35	44	vaccine	vaccine	NN	38	nmod	8628	8635	B-event-211596	_	_	_	_
35	45	,	,	,	35	punct	8635	8636	_	_	_	_	_
35	46	given	give	VBN	48	case	8637	8642	_	_	_	_	_
35	47	at	at	IN	48	case	8643	8645	_	_	_	_	_
35	48	2	2	CD	35	advcl	8646	8647	_	_	_	_	_
35	49	,	,	,	35	punct	8647	8648	_	_	_	_	_
35	50	4	4	CD	53	compound	8649	8650	_	_	_	_	_
35	51	and	and	CC	50	cc	8651	8654	_	_	_	_	_
35	52	6	6	CD	50	conj	8655	8656	_	_	_	_	_
35	53	months	month	NNS	57	nsubj	8657	8663	_	_	_	_	_
35	54	of	of	IN	55	case	8664	8666	_	_	_	_	_
35	55	age	age	NN	53	nmod	8667	8670	_	_	_	_	_
35	56	(	(	CD	55	nummod	8671	8672	_	_	_	_	_
35	57	refer	refer	VBP	35	conj	8672	8677	_	_	_	_	_
35	58	to	to	TO	59	mark	8678	8680	_	_	_	_	_
35	59	‘	‘	VB	57	xcomp	8681	8682	_	_	_	_	_
35	60	Infants	infant	NNS	59	dobj	8682	8689	_	_	_	_	_
35	61	and	and	CC	35	cc	8690	8693	_	_	_	_	_
35	62	young	young	JJ	63	amod	8694	8699	_	_	_	_	_
35	63	children	child	NNS	64	nsubj	8700	8708	_	_	_	_	_
35	64	’	’	VBP	35	conj	8708	8709	_	_	_	_	_
35	65	inï	inï	NN	64	dobj	8710	8713	_	_	_	_	_
35	66	¿	¿	CD	67	compound	8713	8714	_	_	_	_	_
35	67	½	½	CD	65	dep	8714	8715	_	_	_	_	_
35	68	4.5.7	4.5.7	CD	69	nummod	8715	8720	_	_	_	_	_
35	69	ï	ï	NN	74	dep	8720	8721	_	_	_	_	_
35	70	¿	¿	CD	71	nummod	8721	8722	_	_	_	_	_
35	71	½	½	CD	69	dep	8722	8723	_	_	_	_	_
35	72	Recommendationsï	Recommendationsï	NNP	74	dep	8723	8739	_	_	_	_	_
35	73	¿	¿	CD	74	compound	8739	8740	_	_	_	_	_
35	74	½	½	CD	65	dep	8740	8741	_	_	_	_	_
35	75	below	below	IN	76	case	8741	8746	_	_	_	_	_
35	76	)	)	CD	74	nmod	8746	8747	_	_	_	_	_
35	77	.	.	.	35	punct	8747	8748	_	_	_	_	_

36	1	If	if	IN	6	mark	8749	8751	_	_	_	_	B-claim-10404
36	2	an	a	DT	3	det	8752	8754	_	_	_	_	I-claim-10404
36	3	infant	infant	NN	6	nsubj	8755	8761	_	_	_	_	I-claim-10404
36	4	did	do	VBD	6	aux	8762	8765	_	_	_	_	I-claim-10404
36	5	not	not	RB	6	neg	8766	8769	_	_	_	_	I-claim-10404
36	6	receive	receive	VB	24	advcl	8770	8777	_	_	_	_	I-claim-10404
36	7	the	the	DT	9	det	8778	8781	_	_	_	_	I-claim-10404
36	8	birth	birth	NN	9	compound	8782	8787	_	_	_	_	I-claim-10404
36	9	dose	dose	NN	6	dobj	8788	8792	B-event-211597	_	_	_	I-claim-10404
36	10	within	within	IN	14	case	8793	8799	_	_	_	_	I-claim-10404
36	11	the	the	DT	14	det	8800	8803	_	_	_	_	I-claim-10404
36	12	1st	1st	JJ	14	amod	8804	8807	_	_	_	_	I-claim-10404
36	13	7	7	CD	14	nummod	8808	8809	_	_	_	_	I-claim-10404
36	14	days	day	NNS	6	nmod	8810	8814	_	_	_	_	I-claim-10404
36	15	of	of	IN	16	case	8815	8817	_	_	_	_	I-claim-10404
36	16	life	life	NN	14	nmod	8818	8822	_	_	_	_	I-claim-10404
36	17	,	,	,	24	punct	8822	8823	_	_	_	_	I-claim-10404
36	18	catch-up	catch-up	NN	24	nsubj	8824	8832	B-event-211598	_	_	_	I-claim-10404
36	19	of	of	IN	21	case	8833	8835	_	_	_	_	I-claim-10404
36	20	that	that	DT	21	det	8836	8840	_	_	_	_	I-claim-10404
36	21	dose	dose	NN	18	nmod	8841	8845	_	_	_	_	I-claim-10404
36	22	is	be	VBZ	24	cop	8846	8848	_	_	_	_	I-claim-10404
36	23	not	not	RB	24	neg	8849	8852	_	_	_	_	I-claim-10404
36	24	necessary	necessary	JJ	0	ROOT	8853	8862	_	_	_	_	I-claim-10404
36	25	.	.	.	24	punct	8862	8863	_	_	_	_	_

37	1	Such	such	JJ	2	amod	8864	8868	_	_	_	_	B-claim-10405
37	2	infants	infant	NNS	5	nsubj	8869	8876	_	_	_	_	I-claim-10405
37	3	then	then	RB	5	advmod	8877	8881	_	_	_	_	I-claim-10405
37	4	only	only	RB	5	advmod	8882	8886	_	_	_	_	I-claim-10405
37	5	require	require	VB	0	ROOT	8888	8895	_	_	_	_	I-claim-10405
37	6	3	3	CD	7	nummod	8896	8897	_	_	_	_	I-claim-10405
37	7	doses	dose	NNS	5	dobj	8898	8903	_	_	_	_	I-claim-10405
37	8	of	of	IN	12	case	8904	8906	_	_	_	_	I-claim-10405
37	9	a	a	DT	12	det	8907	8908	_	_	_	_	I-claim-10405
37	10	hepatitis	hepatitis	NN	12	compound	8909	8918	_	_	_	_	I-claim-10405
37	11	B-containing	b-containing	JJ	12	amod	8919	8931	_	_	_	_	I-claim-10405
37	12	vaccine	vaccine	NN	7	nmod	8932	8939	B-event-211599	_	_	_	I-claim-10405
37	13	,	,	,	5	punct	8939	8940	_	_	_	_	I-claim-10405
37	14	given	give	VBN	16	case	8941	8946	_	_	_	_	I-claim-10405
37	15	at	at	IN	16	case	8947	8949	_	_	_	_	I-claim-10405
37	16	2	2	CD	5	advcl	8950	8951	_	_	_	_	I-claim-10405
37	17	,	,	,	16	punct	8951	8952	_	_	_	_	I-claim-10405
37	18	4	4	CD	21	compound	8953	8954	_	_	_	_	I-claim-10405
37	19	and	and	CC	18	cc	8955	8958	_	_	_	_	I-claim-10405
37	20	6	6	CD	18	conj	8959	8960	_	_	_	_	I-claim-10405
37	21	months	month	NNS	16	appos	8961	8967	_	_	_	_	I-claim-10405
37	22	of	of	IN	23	case	8968	8970	_	_	_	_	I-claim-10405
37	23	age	age	NN	21	nmod	8971	8974	_	_	_	_	I-claim-10405
37	24	.	.	.	5	punct	8974	8975	_	_	_	_	_

38	1	A	a	DT	3	det	8976	8977	_	B-content-25284:25285-Cue	_	_	B-claim-10406
38	2	3-dose	3-dose	JJ	3	amod	8978	8984	_	I-content-25284	_	_	I-claim-10406
38	3	schedule	schedule	NN	20	nsubjpass	8985	8993	_	I-content-25284	_	_	I-claim-10406
38	4	at	at	IN	5	case	8994	8996	_	I-content-25284	_	_	I-claim-10406
38	5	birth	birth	NN	3	nmod	8997	9002	_	I-content-25284	_	_	I-claim-10406
38	6	,	,	,	5	punct	9002	9003	_	I-content-25284	_	_	I-claim-10406
38	7	1	1	CD	8	nummod	9004	9005	_	I-content-25284	_	_	I-claim-10406
38	8	–	–	NN	5	conj	9005	9006	_	I-content-25284	_	_	I-claim-10406
38	9	2	2	CD	10	nummod	9006	9007	_	I-content-25284	_	_	I-claim-10406
38	10	months	month	NNS	8	nmod:tmod	9008	9014	_	I-content-25284	_	_	I-claim-10406
38	11	and	and	CC	5	cc	9015	9018	_	I-content-25284	_	_	I-claim-10406
38	12	6	6	CD	13	nummod	9019	9020	_	I-content-25284	_	_	I-claim-10406
38	13	–	–	NN	5	conj	9020	9021	_	I-content-25284	_	_	I-claim-10406
38	14	18	18	CD	15	nummod	9021	9023	_	I-content-25284	_	_	I-claim-10406
38	15	months	month	NNS	13	nmod:tmod	9024	9030	_	I-content-25284	_	_	I-claim-10406
38	16	of	of	IN	17	case	9031	9033	_	I-content-25284	_	_	I-claim-10406
38	17	age	age	NN	13	nmod	9034	9037	_	I-content-25284	_	_	I-claim-10406
38	18	has	have	VBZ	20	aux	9038	9041	_	_	_	_	I-claim-10406
38	19	been	be	VBN	20	auxpass	9042	9046	_	_	_	_	I-claim-10406
38	20	shown	show	VBN	0	ROOT	9048	9053	_	_	_	B-cue-25285	I-claim-10406
38	21	to	to	TO	23	mark	9054	9056	_	D-content-25284	_	_	I-claim-10406
38	22	be	be	VB	23	cop	9057	9059	_	I-content-25284	_	_	I-claim-10406
38	23	equally	equally	RB	20	xcomp	9060	9067	_	I-content-25284	_	_	I-claim-10406
38	24	as	as	IN	25	case	9068	9070	_	I-content-25284	_	_	I-claim-10406
38	25	immunogenic	immunogenic	JJ	23	advcl	9071	9082	_	I-content-25284	_	_	I-claim-10406
38	26	as	as	IN	30	case	9083	9085	_	I-content-25284	_	_	I-claim-10406
38	27	the	the	DT	30	det	9086	9089	_	I-content-25284	_	_	I-claim-10406
38	28	recommended	recommend	VBN	30	amod	9090	9101	B-event-211600	I-content-25284	_	_	I-claim-10406
38	29	Australian	australian	JJ	30	amod	9102	9112	_	I-content-25284	_	_	I-claim-10406
38	30	schedule	schedule	NN	23	nmod	9113	9121	_	I-content-25284	_	_	I-claim-10406
38	31	above	above	IN	30	acl	9122	9127	_	I-content-25284	_	_	I-claim-10406
38	32	;	;	:	20	punct	9127	9128	_	_	_	_	I-claim-10406
38	33	such	such	JJ	34	amod	9129	9133	_	_	_	_	I-claim-10406
38	34	schedules	schedule	NNS	37	nsubjpass	9134	9143	B-event-211601	_	_	_	I-claim-10406
38	35	are	be	VBP	37	auxpass	9144	9147	_	_	_	_	I-claim-10406
38	36	often	often	RB	37	advmod	9148	9153	_	_	_	_	I-claim-10406
38	37	used	use	VBN	20	parataxis	9154	9158	_	_	_	_	I-claim-10406
38	38	overseas.30-32	overseas.30-32	JJ	39	amod	9159	9173	_	_	_	_	I-claim-10406 B-claim-10407 I-claim-10407
38	39	Children	child	NNS	37	dobj	9174	9182	_	_	_	_	I-claim-10407
38	40	born	bear	VBN	39	acl	9183	9187	_	_	_	_	I-claim-10407
38	41	overseas	overseas	RB	40	advmod	9188	9196	_	_	_	_	I-claim-10407
38	42	who	who	WP	44	nsubj	9197	9200	_	_	_	_	I-claim-10407
38	43	have	have	VBP	44	aux	9201	9205	_	_	_	_	I-claim-10407
38	44	received	receive	VBN	39	acl:relcl	9206	9214	_	_	_	_	I-claim-10407
38	45	hepatitis	hepatitis	NN	47	compound	9215	9224	_	_	_	_	I-claim-10407
38	46	B	b	NN	47	compound	9225	9226	_	_	_	_	I-claim-10407
38	47	vaccine	vaccine	NN	56	nsubjpass	9227	9234	B-event-211602	_	_	_	I-claim-10407
38	48	in	in	IN	52	case	9235	9237	_	_	_	_	I-claim-10407
38	49	such	such	JJ	52	amod	9238	9242	_	_	_	_	I-claim-10407
38	50	a	a	DT	52	det	9243	9244	_	_	_	_	I-claim-10407
38	51	3-dose	3-dose	JJ	52	amod	9245	9251	_	_	_	_	I-claim-10407
38	52	schedule	schedule	NN	47	nmod	9252	9260	_	_	_	_	I-claim-10407
38	53	can	can	MD	56	aux	9261	9264	_	_	_	_	I-claim-10407
38	54	also	also	RB	56	advmod	9265	9269	_	_	_	_	I-claim-10407
38	55	be	be	VB	56	auxpass	9270	9272	_	_	_	_	I-claim-10407
38	56	considered	consider	VBN	44	ccomp	9273	9283	B-event-211603	_	_	_	I-claim-10407
38	57	to	to	TO	59	mark	9284	9286	_	_	_	_	I-claim-10407
38	58	have	have	VB	59	aux	9287	9291	_	_	_	_	I-claim-10407
38	59	completed	complete	VBN	56	xcomp	9292	9301	B-event-211604	_	_	_	I-claim-10407
38	60	the	the	DT	63	det	9302	9305	_	_	_	_	I-claim-10407
38	61	primary	primary	JJ	63	amod	9306	9313	_	_	_	_	I-claim-10407
38	62	vaccination	vaccination	NN	63	compound	9314	9325	_	_	_	_	I-claim-10407
38	63	course	course	NN	59	dobj	9326	9332	_	_	_	_	I-claim-10407
38	64	.	.	.	20	punct	9332	9333	_	_	_	_	_

39	1	For	for	IN	2	case	9334	9337	_	_	_	_	B-claim-10408
39	2	infants	infant	NNS	17	nmod	9338	9345	_	_	_	_	I-claim-10408
39	3	,	,	,	17	punct	9345	9346	_	_	_	_	I-claim-10408
39	4	the	the	DT	6	det	9347	9350	_	_	_	_	I-claim-10408
39	5	final	final	JJ	6	amod	9351	9356	_	_	_	_	I-claim-10408
39	6	dose	dose	NN	17	nsubjpass	9357	9361	_	_	_	_	I-claim-10408
39	7	of	of	IN	13	case	9362	9364	_	_	_	_	I-claim-10408
39	8	the	the	DT	13	det	9365	9368	_	_	_	_	I-claim-10408
39	9	primary	primary	JJ	13	amod	9369	9376	_	_	_	_	I-claim-10408
39	10	hepatitis	hepatitis	NN	13	compound	9377	9386	_	_	_	_	I-claim-10408
39	11	B	b	NN	13	compound	9387	9388	_	_	_	_	I-claim-10408
39	12	vaccine	vaccine	NN	13	compound	9389	9396	B-event-211605	_	_	_	I-claim-10408
39	13	course	course	NN	6	nmod	9397	9403	_	_	_	_	I-claim-10408
39	14	should	should	MD	17	aux	9404	9410	_	_	_	_	I-claim-10408
39	15	preferably	preferably	RB	17	advmod	9411	9421	_	_	_	_	I-claim-10408
39	16	be	be	VB	17	auxpass	9422	9424	_	_	_	_	I-claim-10408
39	17	administered	administer	VBN	0	ROOT	9426	9438	B-event-211606	_	_	_	I-claim-10408
39	18	at	at	IN	21	case	9439	9441	_	_	_	_	I-claim-10408
39	19	≥	≥	CD	20	compound	9442	9443	_	_	_	_	I-claim-10408
39	20	24	24	CD	21	nummod	9443	9445	_	_	_	_	I-claim-10408
39	21	weeks	week	NNS	17	nmod	9446	9451	_	_	_	_	I-claim-10408
39	22	of	of	IN	23	case	9452	9454	_	_	_	_	I-claim-10408
39	23	age	age	NN	21	nmod	9455	9458	_	_	_	_	I-claim-10408
39	24	.	.	.	17	punct	9458	9459	_	_	_	_	_

40	1	However	however	RB	29	advmod	9460	9467	_	_	_	_	B-claim-10409
40	2	,	,	,	29	punct	9467	9468	_	_	_	_	I-claim-10409
40	3	if	if	IN	8	mark	9469	9471	_	_	_	_	I-claim-10409
40	4	the	the	DT	6	det	9472	9475	_	_	_	_	I-claim-10409
40	5	final	final	JJ	6	amod	9476	9481	_	_	_	_	I-claim-10409
40	6	dose	dose	NN	8	nsubjpass	9482	9486	B-event-211607	_	_	_	I-claim-10409
40	7	is	be	VBZ	8	auxpass	9487	9489	_	_	_	_	I-claim-10409
40	8	given	give	VBN	29	dep	9490	9495	_	_	_	_	I-claim-10409
40	9	at	at	IN	10	case	9496	9498	_	_	_	_	I-claim-10409
40	10	<	<	JJR	8	nmod	9499	9500	_	_	_	_	I-claim-10409
40	11	24	24	CD	12	nummod	9500	9502	_	_	_	_	I-claim-10409
40	12	weeks	week	NNS	10	nmod:tmod	9503	9508	_	_	_	_	I-claim-10409
40	13	but	but	CC	8	cc	9509	9512	_	_	_	_	I-claim-10409
40	14	≥	≥	CD	15	compound	9513	9514	_	_	_	_	I-claim-10409
40	15	16	16	CD	16	nummod	9514	9516	_	_	_	_	I-claim-10409
40	16	weeks	week	NNS	23	nsubj	9517	9522	_	_	_	_	I-claim-10409
40	17	of	of	IN	18	case	9523	9525	_	_	_	_	I-claim-10409
40	18	age	age	NN	16	nmod	9526	9529	_	_	_	_	I-claim-10409
40	19	,	,	,	23	punct	9529	9530	_	_	_	_	I-claim-10409
40	20	it	it	PRP	23	nsubj	9531	9533	_	_	_	_	I-claim-10409
40	21	is	be	VBZ	23	cop	9534	9536	_	_	_	_	I-claim-10409
40	22	not	not	RB	23	neg	9537	9540	_	_	_	_	I-claim-10409
40	23	necessary	necessary	JJ	8	conj	9541	9550	_	_	_	_	I-claim-10409
40	24	to	to	TO	25	mark	9551	9553	_	_	_	_	I-claim-10409
40	25	repeat	repeat	VB	23	xcomp	9554	9560	B-event-211608	_	_	_	I-claim-10409
40	26	the	the	DT	27	det	9561	9564	_	_	_	_	I-claim-10409
40	27	dose	dose	NN	25	dobj	9565	9569	B-event-211609	_	_	_	I-claim-10409
40	28	,	,	,	29	punct	9569	9570	_	_	_	_	I-claim-10409
40	29	provided	provide	VBD	0	ROOT	9571	9579	_	_	_	_	I-claim-10409
40	30	the	the	DT	32	det	9581	9584	_	_	_	_	I-claim-10409
40	31	minimum	minimum	JJ	32	amod	9585	9592	_	_	_	_	I-claim-10409
40	32	intervals	interval	NNS	29	dobj	9593	9602	_	_	_	_	I-claim-10409
40	33	between	between	IN	34	case	9603	9610	_	_	_	_	I-claim-10409
40	34	doses	dose	NNS	32	nmod	9611	9616	_	_	_	_	I-claim-10409
40	35	in	in	IN	36	case	9617	9619	_	_	_	_	I-claim-10409
40	36	Table	Table	NNP	34	nmod	9620	9625	_	_	_	_	I-claim-10409
40	37	2.1.7	2.1.7	CD	38	compound	9626	9631	_	_	_	_	I-claim-10409
40	38	(	(	CD	42	dep	9632	9633	_	_	_	_	I-claim-10409
40	39	in	in	IN	41	case	9633	9635	_	_	_	_	I-claim-10409
40	40	2.1.5	2.1.5	CD	41	nummod	9636	9641	_	_	_	_	I-claim-10409
40	41	ï	ï	NN	38	nmod	9641	9642	_	_	_	_	I-claim-10409
40	42	¿	¿	CD	32	dep	9642	9643	_	_	_	_	I-claim-10409
40	43	½	½	CD	44	nummod	9643	9644	_	_	_	_	I-claim-10409
40	44	Catch-up	catch-up	NN	42	dep	9644	9652	_	_	_	_	I-claim-10409
40	45	.	.	.	42	punct	9652	9653	_	_	_	_	I-claim-10409
40	46	)	)	SYM	32	dep	9653	9654	_	_	_	_	I-claim-10409

41	1	have	have	VB	3	aux	9655	9659	_	_	_	_	I-claim-10409
41	2	been	be	VBN	3	auxpass	9660	9664	_	_	_	_	I-claim-10409
41	3	met	meet	VBN	0	ROOT	9665	9668	_	_	_	_	I-claim-10409
41	4	.	.	.	3	punct	9668	9669	_	_	_	_	_

42	1	For	for	IN	3	case	9670	9673	_	_	_	_	_
42	2	older	older	JJR	3	amod	9674	9679	_	_	_	_	_
42	3	children	child	NNS	41	nmod	9680	9688	_	_	_	_	_
42	4	and	and	CC	3	cc	9689	9692	_	_	_	_	_
42	5	young	young	JJ	6	amod	9693	9698	_	_	_	_	_
42	6	adults	adult	NNS	3	conj	9699	9705	_	_	_	_	_
42	7	aged	aged	JJ	6	amod	9706	9710	_	_	_	_	_
42	8	<	<	JJR	7	dep	9711	9712	_	_	_	_	_
42	9	20	20	CD	10	nummod	9712	9714	_	_	_	_	_
42	10	years	year	NNS	7	nmod:tmod	9715	9720	_	_	_	_	_
42	11	(	(	RB	6	advmod	9721	9722	_	_	_	_	_
42	12	who	who	WP	15	nsubj	9722	9725	_	_	_	_	_
42	13	have	have	VBP	15	aux	9726	9730	_	_	_	_	_
42	14	not	not	RB	15	neg	9731	9734	_	_	_	_	_
42	15	received	receive	VBN	6	acl:relcl	9735	9743	_	_	_	_	_
42	16	hepatitis	hepatitis	NN	18	compound	9744	9753	_	_	_	_	_
42	17	B	b	NN	18	compound	9754	9755	_	_	_	_	_
42	18	vaccination	vaccination	NN	15	dobj	9756	9767	B-event-211610	_	_	_	_
42	19	earlier	earlier	RBR	15	advmod	9768	9775	_	_	_	_	_
42	20	in	in	IN	21	case	9776	9778	_	_	_	_	_
42	21	life	life	NN	19	nmod	9779	9783	_	_	_	_	_
42	22	)	)	CD	21	nummod	9783	9784	_	_	_	_	_
42	23	a	a	DT	25	det	9785	9786	_	_	_	_	_
42	24	3-dose	3-dose	JJ	25	amod	9787	9793	_	_	_	_	_
42	25	schedule	schedule	NN	41	nsubjpass	9794	9802	_	_	_	_	_
42	26	of	of	IN	33	case	9803	9805	_	_	_	_	_
42	27	the	the	DT	33	det	9806	9809	_	_	_	_	_
42	28	paediatric	paediatric	JJ	33	amod	9810	9820	_	_	_	_	_
42	29	formulation	formulation	NN	33	compound	9821	9832	_	_	_	_	_
42	30	(	(	NN	33	compound	9833	9834	_	_	_	_	_
42	31	0.5	0.5	CD	33	nummod	9834	9837	_	_	_	_	_
42	32	mL	ml	NN	33	compound	9838	9840	_	_	_	_	_
42	33	)	)	NN	25	nmod	9840	9841	_	_	_	_	_
42	34	of	of	IN	38	case	9842	9844	_	_	_	_	_
42	35	monovalent	monovalent	JJ	38	amod	9845	9855	_	_	_	_	_
42	36	hepatitis	hepatitis	NN	38	compound	9856	9865	_	_	_	_	_
42	37	B	b	NN	38	compound	9866	9867	_	_	_	_	_
42	38	vaccine	vaccine	NN	33	nmod	9868	9875	B-event-211611	_	_	_	_
42	39	can	can	MD	41	aux	9876	9879	_	_	_	_	_
42	40	be	be	VB	41	auxpass	9880	9882	_	_	_	_	_
42	41	used	use	VBN	0	ROOT	9883	9887	_	_	_	_	_
42	42	(	(	NN	41	dobj	9888	9889	_	_	_	_	_
42	43	at	at	IN	44	case	9889	9891	_	_	_	_	_
42	44	times	time	NNS	42	nmod	9892	9897	_	_	_	_	_
42	45	0	0	CD	44	nummod	9898	9899	_	_	_	_	_
42	46	,	,	,	44	punct	9899	9900	_	_	_	_	_
42	47	1	1	CD	50	compound	9901	9902	_	_	_	_	_
42	48	and	and	CC	47	cc	9903	9906	_	_	_	_	_
42	49	6	6	CD	47	conj	9907	9908	_	_	_	_	_
42	50	months	month	NNS	44	appos	9909	9915	_	_	_	_	_
42	51	)	)	RB	41	advmod	9915	9916	_	_	_	_	_
42	52	,	,	,	41	punct	9916	9917	_	_	_	_	_
42	53	as	as	IN	55	case	9918	9920	_	_	_	_	_
42	54	per	per	IN	55	case	9921	9924	_	_	_	_	_
42	55	Table	Table	NNP	41	nmod	9925	9930	_	_	_	_	_
42	56	4.5.1	4.5.1	CD	55	nummod	9931	9936	_	_	_	_	_
42	57	.	.	.	41	punct	9936	9937	_	_	_	_	_

43	1	Immunogenicity	immunogenicity	NN	2	compound	9938	9952	_	_	B-source-25286	_	_
43	2	studies	study	NNS	3	nsubj	9953	9960	B-event-211612	_	I-source-25286	_	_
43	3	suggest	suggest	VBP	0	ROOT	9961	9968	_	_	_	B-cue-25287	_
43	4	there	there	EX	8	expl	9969	9974	_	B-content-25288:25287-Cue_25286-Source	_	_	_
43	5	can	can	MD	8	aux	9975	9978	_	I-content-25288	_	_	_
43	6	be	be	VB	8	cop	9979	9981	_	I-content-25288	_	_	_
43	7	some	some	DT	8	det	9982	9986	_	I-content-25288	_	_	_
43	8	flexibility	flexibility	NN	3	ccomp	9987	9998	_	I-content-25288	_	_	_
43	9	of	of	IN	13	case	9999	10001	_	I-content-25288	_	_	_
43	10	the	the	DT	13	det	10002	10005	_	I-content-25288	_	_	_
43	11	vaccination	vaccination	NN	13	compound	10006	10017	B-event-211613	I-content-25288	_	_	_
43	12	schedule	schedule	NN	13	compound	10018	10026	_	I-content-25288	_	_	_
43	13	intervals	interval	NNS	8	nmod	10027	10036	_	I-content-25288	_	_	_
43	14	for	for	IN	18	case	10037	10040	_	I-content-25288	_	_	_
43	15	monovalent	monovalent	JJ	18	amod	10042	10052	_	I-content-25288	_	_	_
43	16	hepatitis	hepatitis	NN	18	compound	10053	10062	_	I-content-25288	_	_	_
43	17	B	b	NN	18	compound	10063	10064	_	I-content-25288	_	_	_
43	18	vaccines	vaccine	NNS	13	nmod	10065	10073	_	I-content-25288	_	_	_
43	19	.	.	.	3	punct	10073	10074	_	_	_	_	_

44	1	The	the	DT	2	det	10075	10078	_	_	_	_	_
44	2	use	use	NN	11	nsubj	10079	10082	_	_	_	_	_
44	3	of	of	IN	6	case	10083	10085	_	_	_	_	_
44	4	longer	longer	JJR	6	amod	10086	10092	_	_	_	_	_
44	5	time	time	NN	6	compound	10093	10097	_	_	_	_	_
44	6	intervals	interval	NNS	2	nmod	10098	10107	_	_	_	_	_
44	7	between	between	IN	8	case	10109	10116	_	_	_	_	_
44	8	doses	dose	NNS	6	nmod	10117	10122	B-event-211614	_	_	_	_
44	9	does	do	VBZ	11	aux	10123	10127	_	_	_	_	_
44	10	not	not	RB	11	neg	10128	10131	_	_	_	_	_
44	11	impair	impair	VB	0	ROOT	10132	10138	B-event-211615	_	_	_	_
44	12	the	the	DT	13	det	10139	10142	_	_	_	_	_
44	13	immunogenicity	immunogenicity	NN	11	dobj	10143	10157	_	_	_	_	_
44	14	of	of	IN	17	case	10158	10160	_	_	_	_	_
44	15	hepatitis	hepatitis	NN	17	compound	10161	10170	_	_	_	_	_
44	16	B	b	NN	17	compound	10171	10172	_	_	_	_	_
44	17	vaccine	vaccine	NN	13	nmod	10173	10180	B-event-211616	_	_	_	_
44	18	.33,34	.33,34	CD	35	nsubj	10180	10186	_	_	_	_	_
44	19	The	the	DT	20	det	10187	10190	_	_	_	_	_
44	20	minimum	minimum	NN	21	nmod:npmod	10191	10198	_	_	_	_	_
44	21	interval	interval	JJ	18	amod	10199	10207	_	_	_	_	_
44	22	between	between	IN	27	case	10208	10215	_	_	_	_	_
44	23	the	the	DT	27	det	10216	10219	_	_	_	_	_
44	24	1st	1st	JJ	27	amod	10220	10223	_	_	_	_	_
44	25	and	and	CC	24	cc	10224	10227	_	_	_	_	_
44	26	3rd	3rd	JJ	24	conj	10228	10231	_	_	_	_	_
44	27	doses	dose	NNS	18	nmod	10232	10237	B-event-212475	_	_	_	_
44	28	of	of	IN	32	case	10238	10240	_	_	_	_	_
44	29	a	a	DT	32	det	10241	10242	_	_	_	_	_
44	30	3-dose	3-dose	JJ	32	amod	10243	10249	_	_	_	_	_
44	31	primary	primary	JJ	32	amod	10250	10257	_	_	_	_	_
44	32	schedule	schedule	NN	27	nmod	10258	10266	_	_	_	_	_
44	33	is	be	VBZ	35	cop	10267	10269	_	_	_	_	_
44	34	4	4	CD	35	nummod	10270	10271	_	_	_	_	_
44	35	months	month	NNS	17	acl:relcl	10272	10278	_	_	_	_	_
44	36	.	.	.	11	punct	10278	10279	_	_	_	_	_

45	1	This	this	DT	2	nsubj	10280	10284	_	_	_	_	_
45	2	means	mean	VBZ	31	dep	10285	10290	_	_	_	_	_
45	3	that	that	IN	27	mark	10291	10295	_	_	_	_	_
45	4	a	a	DT	7	det	10296	10297	_	_	_	_	_
45	5	shortened	shorten	VBN	7	amod	10298	10307	B-event-212476	_	_	_	_
45	6	3-dose	3-dose	NN	7	compound	10308	10314	B-event-211617	_	_	_	_
45	7	schedule	schedule	NN	27	nsubj	10315	10323	_	_	_	_	_
45	8	provided	provide	VBN	7	acl	10324	10332	_	_	_	_	_
45	9	at	at	IN	11	case	10333	10335	_	_	_	_	_
45	10	either	either	CC	11	cc:preconj	10336	10342	_	_	_	_	_
45	11	0	0	CD	8	nmod	10343	10344	_	_	_	_	_
45	12	,	,	,	11	punct	10344	10345	_	_	_	_	_
45	13	1	1	CD	11	conj	10346	10347	_	_	_	_	_
45	14	,	,	,	11	punct	10347	10348	_	_	_	_	_
45	15	4	4	CD	16	nummod	10349	10350	_	_	_	_	_
45	16	months	month	NNS	11	conj	10351	10357	_	_	_	_	_
45	17	or	or	CC	11	cc	10358	10360	_	_	_	_	_
45	18	0	0	CD	11	conj	10361	10362	_	_	_	_	_
45	19	,	,	,	18	punct	10362	10363	_	_	_	_	_
45	20	2	2	CD	18	amod	10364	10365	_	_	_	_	_
45	21	,	,	,	18	punct	10365	10366	_	_	_	_	_
45	22	4	4	CD	23	nummod	10367	10368	_	_	_	_	_
45	23	months	month	NNS	11	nmod:tmod	10369	10375	_	_	_	_	_
45	24	is	be	VBZ	27	cop	10376	10378	_	_	_	_	_
45	25	acceptable	acceptable	JJ	27	amod	10379	10389	_	_	_	_	_
45	26	.35	.35	CD	25	nmod:tmod	10389	10392	_	_	_	_	_
45	27	More	more	JJR	2	ccomp	10393	10397	_	B-content-25289:25290-Cue	_	_	_
45	28	compressed	compress	VBN	27	acl	10398	10408	B-event-211619	I-content-25289	_	_	_
45	29	3-dose	3-dose	JJ	30	amod	10409	10415	_	I-content-25289	_	_	_
45	30	schedules	schedule	NNS	28	dobj	10416	10425	_	I-content-25289	_	_	_
45	31	(	(	VBP	0	ROOT	10426	10427	_	_	_	_	_
45	32	e.g.	e.g.	FW	31	dobj	10427	10431	_	_	_	_	_
45	33	0	0	CD	31	nsubj	10432	10433	_	_	_	_	_
45	34	,	,	,	33	punct	10433	10434	_	_	_	_	_
45	35	1	1	CD	33	appos	10435	10436	_	_	_	_	_
45	36	,	,	,	35	punct	10436	10437	_	_	_	_	_
45	37	3	3	CD	38	nummod	10438	10439	_	_	_	_	_
45	38	months	month	NNS	35	appos	10440	10446	_	_	_	_	_
45	39	)	)	CD	42	nsubjpass	10446	10447	_	_	_	_	_
45	40	are	be	VBP	42	auxpass	10448	10451	_	_	_	_	_
45	41	not	not	RB	42	neg	10452	10455	_	_	_	_	_
45	42	recommended	recommend	VBN	38	acl:relcl	10456	10467	_	_	_	B-cue-25290	_
45	43	.	.	.	31	punct	10467	10468	_	_	_	_	_

46	1	Such	such	JJ	0	ROOT	10469	10473	_	_	_	_	_
46	2	compressed	compress	VBN	1	acl	10474	10484	B-event-211618	_	_	_	_
46	3	schedules	schedule	NNS	5	nsubjpass	10485	10494	_	_	_	_	_
46	4	are	be	VBP	5	auxpass	10495	10498	_	_	_	_	_
46	5	associated	associate	VBN	25	dep	10499	10509	_	_	_	_	_
46	6	with	with	IN	9	case	10510	10514	_	_	_	_	_
46	7	lower	lower	JJR	9	amod	10515	10520	_	_	_	_	_
46	8	peak	peak	NN	9	compound	10521	10525	_	_	_	_	_
46	9	levels	level	NNS	5	nmod	10526	10532	_	_	_	_	_
46	10	of	of	IN	12	case	10533	10535	_	_	_	_	_
46	11	anti-HBs	anti-hbs	JJ	12	amod	10536	10544	_	_	_	_	_
46	12	antibody	antibody	NN	9	nmod	10545	10553	_	_	_	_	_
46	13	,36,37	,36,37	CD	5	dobj	10553	10559	_	_	_	_	_
46	14	and	and	CC	13	cc	10560	10563	_	_	_	_	_
46	15	hence	hence	RB	13	advmod	10564	10569	_	_	_	_	_
46	16	likely	likely	JJ	18	amod	10570	10576	_	_	_	_	_
46	17	shorter	shorter	JJR	16	dep	10577	10584	_	_	_	_	_
46	18	duration	duration	NN	13	dep	10585	10593	_	_	_	_	_
46	19	of	of	IN	22	case	10594	10596	_	_	_	_	_
46	20	antibody	antibody	NN	22	compound	10597	10605	_	_	_	_	_
46	21	persistence	persistence	NN	22	compound	10606	10617	_	_	_	_	_
46	22	(	(	NN	18	nmod	10618	10619	_	_	_	_	_
46	23	at	at	IN	24	case	10619	10621	_	_	_	_	_
46	24	levels	level	NNS	22	nmod	10622	10628	_	_	_	_	_
46	25	≥	≥	VBP	2	dep	10629	10630	_	_	_	_	_
46	26	10	10	CD	27	nummod	10630	10632	_	_	_	_	_
46	27	mIU/mL	miu/ml	NN	25	dobj	10633	10639	_	_	_	_	_
46	28	)	)	CD	29	compound	10639	10640	_	_	_	_	_
46	29	,38	,38	CD	27	dep	10640	10643	_	_	_	_	_
46	30	although	although	IN	37	mark	10644	10652	_	_	_	_	_
46	31	the	the	DT	33	det	10653	10656	_	_	_	_	_
46	32	clinical	clinical	JJ	33	amod	10657	10665	_	_	_	_	_
46	33	significance	significance	NN	37	nsubj	10666	10678	_	_	_	_	_
46	34	of	of	IN	35	case	10679	10681	_	_	_	_	_
46	35	this	this	DT	33	nmod	10682	10686	_	_	_	_	_
46	36	is	be	VBZ	37	cop	10687	10689	_	_	_	_	_
46	37	uncertain	uncertain	JJ	27	dep	10690	10699	_	_	_	_	_
46	38	.39	.39	CD	39	compound	10699	10702	_	_	_	_	_
46	39	(	(	CD	40	nummod	10703	10704	_	_	_	_	_
46	40	Refer	refer	NN	37	dep	10704	10709	_	_	_	_	_
46	41	also	also	RB	37	advmod	10710	10714	_	_	_	_	_
46	42	to	to	TO	44	case	10715	10717	_	_	_	_	_
46	43	‘	‘	CD	44	nummod	10718	10719	_	_	_	_	_
46	44	Adults	adult	NNS	37	nmod	10719	10725	_	_	_	_	_
46	45	aged	aged	JJ	44	amod	10726	10730	_	_	_	_	_
46	46	≥	≥	RB	44	advmod	10731	10732	_	_	_	_	_
46	47	20	20	CD	48	nummod	10732	10734	_	_	_	_	_
46	48	years	year	NNS	25	nsubj	10735	10740	_	_	_	_	_
46	49	’	’	RB	48	advmod	10740	10741	_	_	_	_	_
46	50	below	below	IN	25	nmod	10742	10747	_	_	_	_	_
46	51	.	.	.	25	punct	10747	10748	_	_	_	_	_
46	52	)	)	SYM	1	dep	10748	10749	_	_	_	_	_

47	1	Adults	adult	NNS	34	nsubj	10750	10756	_	_	_	_	_
47	2	aged	aged	JJ	1	amod	10757	10761	_	_	_	_	_
47	3	≥	≥	RB	2	advmod	10762	10763	_	_	_	_	_
47	4	20	20	CD	5	nummod	10763	10765	_	_	_	_	_
47	5	years	year	NNS	20	dep	10766	10771	_	_	_	_	_
47	6	For	for	IN	20	mark	10772	10775	_	_	_	_	_
47	7	adults	adult	NNS	20	nsubjpass	10776	10782	_	_	_	_	_
47	8	,	,	,	7	punct	10782	10783	_	_	_	_	_
47	9	monovalent	monovalent	JJ	12	amod	10784	10794	_	_	_	_	_
47	10	hepatitis	hepatitis	NN	12	compound	10795	10804	_	_	_	_	_
47	11	B	b	NN	12	compound	10805	10806	_	_	_	_	_
47	12	vaccine	vaccine	NN	7	appos	10807	10814	B-event-211620	_	_	_	_
47	13	adult	adult	JJ	18	amod	10815	10820	_	_	_	_	_
47	14	formulation	formulation	NN	18	compound	10821	10832	_	_	_	_	_
47	15	(	(	NN	18	compound	10833	10834	_	_	_	_	_
47	16	1.0	1.0	CD	18	nummod	10834	10837	_	_	_	_	_
47	17	mL	ml	NN	18	compound	10838	10840	_	_	_	_	_
47	18	)	)	NN	12	dep	10840	10841	_	_	_	_	_
47	19	is	be	VBZ	20	auxpass	10842	10844	_	_	_	_	_
47	20	given	give	VBN	2	ccomp	10845	10850	_	_	_	_	_
47	21	in	in	IN	24	case	10851	10853	_	_	_	_	_
47	22	a	a	DT	24	det	10854	10855	_	_	_	_	_
47	23	3-dose	3-dose	JJ	24	amod	10856	10862	_	_	_	_	_
47	24	schedule	schedule	NN	20	nmod	10863	10871	_	_	_	_	_
47	25	at	at	IN	26	case	10872	10874	_	_	_	_	_
47	26	times	time	NNS	20	nmod	10875	10880	_	_	_	_	_
47	27	0	0	CD	26	nummod	10881	10882	_	_	_	_	_
47	28	,	,	,	26	punct	10882	10883	_	_	_	_	_
47	29	1	1	CD	32	compound	10884	10885	_	_	_	_	_
47	30	and	and	CC	29	cc	10886	10889	_	_	_	_	_
47	31	6	6	CD	29	conj	10890	10891	_	_	_	_	_
47	32	months	month	NNS	26	appos	10892	10898	_	_	_	_	_
47	33	(	(	RB	34	advmod	10899	10900	_	_	_	_	_
47	34	refer	refer	VBP	0	ROOT	10900	10905	_	_	_	_	_
47	35	to	to	TO	36	case	10906	10908	_	_	_	_	_
47	36	Table	Table	NNP	34	nmod	10909	10914	_	_	_	_	_
47	37	4.5.1	4.5.1	CD	38	compound	10915	10920	_	_	_	_	_
47	38	)	)	CD	36	nummod	10920	10921	_	_	_	_	_
47	39	.	.	.	34	punct	10921	10922	_	_	_	_	_

48	1	There	there	EX	2	expl	10923	10928	_	_	_	_	_
48	2	is	be	VBZ	0	ROOT	10929	10931	_	_	_	_	_
48	3	some	some	DT	4	det	10932	10936	_	_	_	_	_
48	4	flexibility	flexibility	NN	2	nsubj	10937	10948	_	_	_	_	_
48	5	regarding	regard	VBG	7	case	10949	10958	_	_	_	_	_
48	6	the	the	DT	7	det	10959	10962	_	_	_	_	_
48	7	interval	interval	NN	4	nmod	10963	10971	_	_	_	_	_
48	8	between	between	IN	10	case	10972	10979	_	_	_	_	_
48	9	the	the	DT	10	det	10980	10983	_	_	_	_	_
48	10	doses	dose	NNS	7	nmod	10984	10989	_	_	_	_	_
48	11	.	.	.	2	punct	10989	10990	_	_	_	_	_

49	1	The	the	DT	2	det	10991	10994	_	_	_	_	_
49	2	proportion	proportion	NN	28	nsubj	10995	11005	_	_	_	_	_
49	3	of	of	IN	5	case	11006	11008	_	_	_	_	_
49	4	vaccine	vaccine	NN	5	compound	11009	11016	B-event-211621	_	_	_	_
49	5	recipients	recipient	NNS	2	nmod	11017	11027	B-event-212477	_	_	_	_
49	6	attaining	attain	VBG	5	acl	11028	11037	_	_	_	_	_
49	7	a	a	DT	16	det	11038	11039	_	_	_	_	_
49	8	seroprotective	seroprotective	JJ	16	amod	11040	11054	_	_	_	_	_
49	9	anti-HBs	anti-hbs	JJ	16	amod	11055	11063	_	_	_	_	_
49	10	antibody	antibody	NN	16	compound	11064	11072	_	_	_	_	_
49	11	level	level	NN	16	compound	11073	11078	_	_	_	_	_
49	12	(	(	CD	16	nummod	11079	11080	_	_	_	_	_
49	13	≥	≥	CD	16	nummod	11080	11081	_	_	_	_	_
49	14	10	10	CD	16	nummod	11081	11083	_	_	_	_	_
49	15	mIU/mL	miu/ml	NN	16	compound	11084	11090	_	_	_	_	_
49	16	)	)	NN	6	dobj	11090	11091	_	_	_	_	_
49	17	,	,	,	2	punct	11091	11092	_	_	_	_	_
49	18	generally	generally	RB	19	advmod	11093	11102	_	_	_	_	_
49	19	measured	measure	VBN	2	acl	11103	11111	B-event-211622	_	_	_	_
49	20	1	1	CD	21	nummod	11112	11113	_	_	_	_	_
49	21	–	–	NN	19	dobj	11113	11114	_	_	_	_	_
49	22	2	2	CD	23	nummod	11114	11115	_	_	_	_	_
49	23	months	month	NNS	19	nmod	11116	11122	_	_	_	_	_
49	24	after	after	IN	23	case	11123	11128	_	_	_	_	_
49	25	vaccination	vaccination	NN	23	dep	11129	11140	B-event-211623	_	_	_	_
49	26	,	,	,	2	punct	11140	11141	_	_	_	_	_
49	27	is	be	VBZ	28	cop	11142	11144	_	_	_	_	_
49	28	comparable	comparable	JJ	0	ROOT	11145	11155	_	_	_	_	_
49	29	between	between	IN	30	case	11156	11163	_	_	_	_	_
49	30	adults	adult	NNS	28	nmod	11164	11170	_	_	_	_	_
49	31	who	who	WP	32	nsubj	11171	11174	_	_	_	_	_
49	32	received	receive	VBD	30	acl:relcl	11175	11183	_	_	_	_	_
49	33	their	they	PRP$	35	nmod:poss	11184	11189	_	_	_	_	_
49	34	3rd	3rd	JJ	35	amod	11190	11193	_	_	_	_	_
49	35	dose	dose	NN	32	dobj	11194	11198	B-event-211624	_	_	_	_
49	36	at	at	IN	38	case	11199	11201	_	_	_	_	_
49	37	4	4	CD	38	compound	11202	11203	_	_	_	_	_
49	38	–	–	CD	32	nmod	11203	11204	_	_	_	_	_
49	39	6	6	CD	40	nummod	11204	11205	_	_	_	_	_
49	40	months	month	NNS	32	nmod:tmod	11206	11212	_	_	_	_	_
49	41	after	after	IN	78	mark	11213	11218	_	_	_	_	_
49	42	the	the	DT	44	det	11219	11222	_	_	_	_	_
49	43	1st	1st	JJ	44	amod	11223	11226	_	_	_	_	_
49	44	dose	dose	NN	78	nsubj	11227	11231	B-event-211625	_	_	_	_
49	45	and	and	CC	44	cc	11232	11235	_	_	_	_	_
49	46	those	those	DT	44	conj	11236	11241	_	_	_	_	_
49	47	who	who	WP	48	nsubj	11242	11245	_	_	_	_	_
49	48	received	receive	VBD	46	acl:relcl	11246	11254	_	_	_	_	_
49	49	their	they	PRP$	51	nmod:poss	11255	11260	_	_	_	_	_
49	50	3rd	3rd	JJ	51	amod	11261	11264	_	_	_	_	_
49	51	dose	dose	NN	48	dobj	11265	11269	B-event-211626	_	_	_	_
49	52	6	6	CD	53	nummod	11270	11271	_	_	_	_	_
49	53	months	month	NNS	48	nmod:tmod	11272	11278	_	_	_	_	_
49	54	or	or	CC	55	cc	11279	11281	_	_	_	_	_
49	55	more	more	JJR	53	nummod	11282	11286	_	_	_	_	_
49	56	after	after	IN	70	mark	11287	11292	_	_	_	_	_
49	57	the	the	DT	59	det	11293	11296	_	_	_	_	_
49	58	1st	1st	JJ	59	amod	11297	11300	_	_	_	_	_
49	59	dose	dose	NN	70	nsubj	11301	11305	B-event-211627	_	_	_	_
49	60	.40	.40	CD	59	nummod	11305	11308	_	_	_	_	_
49	61	Increasing	increase	VBG	59	acl	11309	11319	_	_	_	_	_
49	62	the	the	DT	63	det	11320	11323	_	_	_	_	_
49	63	interval	interval	NN	61	dobj	11324	11332	_	_	_	_	_
49	64	between	between	IN	69	case	11333	11340	_	_	_	_	_
49	65	the	the	DT	69	det	11341	11344	_	_	_	_	_
49	66	1st	1st	JJ	69	amod	11345	11348	_	_	_	_	_
49	67	and	and	CC	66	cc	11349	11352	_	_	_	_	_
49	68	2nd	2nd	JJ	66	conj	11353	11356	_	_	_	_	_
49	69	doses	dose	NNS	63	nmod	11357	11362	B-event-211629	_	_	_	_
49	70	has	have	VBZ	48	advcl	11363	11366	_	_	_	_	_
49	71	little	little	JJ	72	amod	11367	11373	_	_	_	_	_
49	72	effect	effect	NN	70	dobj	11374	11380	_	_	_	_	_
49	73	on	on	IN	77	case	11381	11383	_	_	_	_	_
49	74	the	the	DT	77	det	11384	11387	_	_	_	_	_
49	75	final	final	JJ	77	amod	11388	11393	_	_	_	_	_
49	76	antibody	antibody	NN	77	compound	11394	11402	_	_	_	_	_
49	77	level	level	NN	72	nmod	11403	11408	_	_	_	_	_
49	78	attained	attain	VBD	32	advcl	11409	11417	B-event-211628	_	_	_	_
49	79	,	,	,	28	punct	11417	11418	_	_	_	_	_
49	80	but	but	CC	28	cc	11419	11422	_	_	_	_	_
49	81	a	a	DT	83	det	11423	11424	_	_	_	_	_
49	82	longer	longer	RBR	83	advmod	11425	11431	_	_	_	_	_
49	83	interval	interval	JJ	91	nsubjpass	11432	11440	_	_	_	_	_
49	84	between	between	IN	89	case	11441	11448	_	_	_	_	_
49	85	the	the	DT	89	det	11449	11452	_	_	_	_	_
49	86	2nd	2nd	JJ	89	amod	11453	11456	_	_	_	_	_
49	87	and	and	CC	86	cc	11457	11460	_	_	_	_	_
49	88	3rd	3rd	JJ	86	conj	11461	11464	_	_	_	_	_
49	89	doses	dose	NNS	83	nmod	11465	11470	B-event-211630	_	_	_	_
49	90	is	be	VBZ	91	auxpass	11471	11473	_	_	_	_	_
49	91	associated	associate	VBN	28	conj	11474	11484	_	_	_	_	_
49	92	with	with	IN	97	case	11485	11489	_	_	_	_	_
49	93	a	a	DT	97	det	11490	11491	_	_	_	_	_
49	94	higher	higher	JJR	97	amod	11492	11498	_	_	_	_	_
49	95	final	final	JJ	97	amod	11499	11504	_	_	_	_	_
49	96	antibody	antibody	NN	97	compound	11505	11513	_	_	_	_	_
49	97	level	level	NN	91	nmod	11514	11519	_	_	_	_	_
49	98	.37	.37	CD	97	dep	11519	11522	_	_	_	_	_
49	99	,	,	,	97	punct	11522	11523	_	_	_	_	_
49	100	41	41	CD	97	appos	11524	11526	_	_	_	_	_
49	101	,	,	,	100	punct	11526	11527	_	_	_	_	_
49	102	42	42	CD	100	amod	11528	11530	_	_	_	_	_
49	103	However	however	RB	91	advmod	11531	11538	_	_	_	_	_
49	104	,	,	,	91	punct	11538	11539	_	_	_	_	_
49	105	for	for	IN	106	case	11540	11543	_	_	_	_	_
49	106	those	those	DT	91	nmod	11544	11549	_	_	_	_	_
49	107	who	who	WP	110	nsubjpass	11550	11553	_	_	_	_	_
49	108	may	may	MD	110	aux	11554	11557	_	_	_	_	_
49	109	be	be	VB	110	auxpass	11558	11560	_	_	_	_	_
49	110	exposed	expose	VBN	106	acl:relcl	11561	11568	B-event-211631	_	_	_	_
49	111	to	to	TO	113	case	11569	11571	_	_	_	_	_
49	112	hepatitis	hepatitis	NN	113	compound	11572	11581	B-event-211632	_	_	_	_
49	113	B	b	NN	110	nmod	11582	11583	I-event-211632	_	_	_	_
49	114	,	,	,	91	punct	11583	11584	_	_	_	_	_
49	115	delaying	delay	VBG	91	xcomp	11585	11593	B-event-211633	_	_	_	_
49	116	the	the	DT	118	det	11594	11597	_	_	_	_	_
49	117	3rd	3rd	JJ	118	amod	11598	11601	_	_	_	_	_
49	118	dose	dose	NN	120	nsubj	11602	11606	B-event-211634	_	_	_	_
49	119	may	may	MD	120	aux	11607	11610	_	_	_	_	_
49	120	increase	increase	VB	115	ccomp	11611	11619	B-event-211635	_	_	_	_
49	121	the	the	DT	122	det	11620	11623	_	_	_	_	_
49	122	risk	risk	NN	120	dobj	11624	11628	B-event-211636	_	_	_	_
49	123	of	of	IN	124	mark	11629	11631	_	_	_	_	_
49	124	acquiring	acquire	VBG	122	acl	11632	11641	B-event-211637	_	_	_	_
49	125	HBV	hbv	NN	126	compound	11642	11645	B-event-211638	_	_	_	_
49	126	infection	infection	NN	124	dobj	11646	11655	B-event-211639	_	_	_	_
49	127	.	.	.	28	punct	11655	11656	_	_	_	_	_

50	1	For	for	IN	5	case	11657	11660	_	_	_	_	_
50	2	a	a	DT	5	det	11661	11662	_	_	_	_	_
50	3	shortened	shorten	VBN	5	amod	11663	11672	B-event-211640	_	_	_	_
50	4	3-dose	3-dose	NN	5	compound	11673	11679	_	_	_	_	_
50	5	schedule	schedule	NN	27	nmod	11680	11688	_	_	_	_	_
50	6	to	to	TO	7	mark	11689	11691	_	_	_	_	_
50	7	attain	attain	VB	5	acl	11692	11698	B-event-211641	_	_	_	_
50	8	comparable	comparable	JJ	10	amod	11699	11709	_	_	_	_	_
50	9	antibody	antibody	NN	10	compound	11710	11718	_	_	_	_	_
50	10	levels	level	NNS	7	dobj	11719	11725	_	_	_	_	_
50	11	to	to	TO	15	case	11726	11728	_	_	_	_	_
50	12	the	the	DT	15	det	11729	11732	_	_	_	_	_
50	13	standard	standard	JJ	15	amod	11733	11741	_	_	_	_	_
50	14	3-dose	3-dose	JJ	15	amod	11742	11748	_	_	_	_	_
50	15	schedule	schedule	NN	7	nmod	11749	11757	_	_	_	_	_
50	16	,	,	,	15	punct	11757	11758	_	_	_	_	_
50	17	all	all	DT	18	advmod	11759	11762	_	_	_	_	_
50	18	three	three	CD	15	appos	11763	11768	_	_	_	_	_
50	19	of	of	IN	22	case	11769	11771	_	_	_	_	_
50	20	the	the	DT	22	det	11772	11775	_	_	_	_	_
50	21	following	follow	VBG	22	amod	11776	11785	_	_	_	_	_
50	22	minimum	minimum	NN	18	nmod	11786	11793	_	_	_	_	_
50	23	interval	interval	JJ	24	amod	11794	11802	_	_	_	_	_
50	24	requirements	requirement	NNS	27	nsubjpass	11803	11815	_	_	_	_	_
50	25	must	must	MD	27	aux	11816	11820	_	_	_	_	_
50	26	be	be	VB	27	auxpass	11821	11823	_	_	_	_	_
50	27	satisfied	satisfy	VBN	0	ROOT	11824	11833	_	_	_	_	_
50	28	:	:	:	27	punct	11833	11834	_	_	_	_	_
50	29	That	that	DT	30	nsubj	11836	11840	_	_	_	_	_
50	30	is	be	VBZ	27	parataxis	11841	11843	_	_	_	_	_
50	31	,	,	,	30	punct	11843	11844	_	_	_	_	_
50	32	either	either	CC	34	cc:preconj	11845	11851	_	_	_	_	_
50	33	a	a	DT	34	det	11852	11853	_	_	_	_	_
50	34	0	0	CD	54	nsubj	11854	11855	_	_	_	_	_
50	35	,	,	,	34	punct	11855	11856	_	_	_	_	_
50	36	1	1	CD	34	conj	11857	11858	_	_	_	_	_
50	37	,	,	,	34	punct	11858	11859	_	_	_	_	_
50	38	4	4	CD	39	nummod	11860	11861	_	_	_	_	_
50	39	month	month	NN	34	conj	11862	11867	_	_	_	_	_
50	40	or	or	CC	34	cc	11868	11870	_	_	_	_	_
50	41	a	a	DT	42	det	11871	11872	_	_	_	_	_
50	42	0	0	CD	34	conj	11873	11874	_	_	_	_	_
50	43	,	,	,	34	punct	11874	11875	_	_	_	_	_
50	44	2	2	CD	34	conj	11876	11877	_	_	_	_	_
50	45	,	,	,	34	punct	11877	11878	_	_	_	_	_
50	46	4	4	CD	47	nummod	11879	11880	_	_	_	_	_
50	47	month	month	NN	34	conj	11881	11886	_	_	_	_	_
50	48	interval	interval	NN	49	compound	11887	11895	_	_	_	_	_
50	49	schedule	schedule	NN	47	dep	11896	11904	_	_	_	_	_
50	50	is	be	VBZ	54	cop	11905	11907	_	_	_	_	_
50	51	an	a	DT	54	det	11908	11910	_	_	_	_	_
50	52	acceptable	acceptable	JJ	54	amod	11911	11921	_	_	_	_	_
50	53	3-dose	3-dose	JJ	54	amod	11922	11928	_	_	_	_	_
50	54	schedule	schedule	NN	30	ccomp	11929	11937	_	_	_	_	_
50	55	for	for	IN	56	case	11938	11941	_	_	_	_	_
50	56	adults	adult	NNS	54	nmod	11942	11948	_	_	_	_	_
50	57	.43	.43	CD	56	nummod	11948	11951	_	_	_	_	_
50	58	The	the	DT	60	det	11952	11955	_	_	_	_	B-claim-10410
50	59	minimum	minimum	NN	60	compound	11956	11963	_	_	_	_	I-claim-10410
50	60	intervals	interval	NNS	65	nsubjpass	11964	11973	_	_	_	_	I-claim-10410
50	61	outlined	outline	VBN	60	acl	11974	11982	_	_	_	_	I-claim-10410
50	62	above	above	IN	61	nmod	11983	11988	_	_	_	_	I-claim-10410
50	63	should	should	MD	65	aux	11989	11995	_	_	_	_	I-claim-10410
50	64	be	be	VB	65	auxpass	11996	11998	_	_	_	_	I-claim-10410
50	65	met	meet	VBN	56	acl:relcl	11999	12002	_	_	_	_	I-claim-10410
50	66	where	where	WRB	67	advmod	12003	12008	_	_	_	_	I-claim-10410
50	67	possible	possible	JJ	65	advcl	12009	12017	_	_	_	_	I-claim-10410
50	68	.	.	.	27	punct	12017	12018	_	_	_	_	_

51	1	More	more	RBR	2	advmod	12019	12023	_	B-content-25291:25292-Cue	_	_	_
51	2	compressed	compress	VBN	4	amod	12024	12034	B-event-211642	I-content-25291	_	_	_
51	3	3-dose	3-dose	JJ	4	amod	12035	12041	_	I-content-25291	_	_	_
51	4	schedules	schedule	NNS	5	nsubj	12042	12051	_	I-content-25291	_	_	_
51	5	(	(	VBP	0	ROOT	12052	12053	_	_	_	_	_
51	6	e.g.	e.g.	FW	5	dobj	12053	12057	_	_	_	_	_
51	7	0	0	CD	12	nummod	12058	12059	_	_	_	_	_
51	8	,	,	,	12	punct	12059	12060	_	_	_	_	_
51	9	1	1	CD	12	nummod	12061	12062	_	_	_	_	_
51	10	,	,	,	12	punct	12062	12063	_	_	_	_	_
51	11	3	3	CD	12	nummod	12064	12065	_	_	_	_	_
51	12	months	month	NNS	16	nsubjpass	12066	12072	_	_	_	_	_
51	13	)	)	CD	12	dep	12072	12073	_	_	_	_	_
51	14	are	be	VBP	16	auxpass	12074	12077	_	_	_	_	_
51	15	not	not	RB	16	neg	12078	12081	_	_	_	_	_
51	16	recommended	recommend	VBN	6	acl:relcl	12082	12093	_	_	_	B-cue-25292	_
51	17	.	.	.	5	punct	12093	12094	_	_	_	_	_

52	1	If	if	IN	16	mark	12095	12097	_	_	_	_	_
52	2	a	a	DT	5	det	12098	12099	_	_	_	_	_
52	3	compressed	compress	VBN	5	amod	12100	12110	B-event-211643	_	_	_	_
52	4	3-dose	3-dose	NN	5	compound	12111	12117	B-event-211644	_	_	_	_
52	5	schedule	schedule	NN	16	nsubjpass	12118	12126	_	_	_	_	_
52	6	that	that	WDT	9	nsubj	12127	12131	_	_	_	_	_
52	7	does	do	VBZ	9	aux	12132	12136	_	_	_	_	_
52	8	not	not	RB	9	neg	12137	12140	_	_	_	_	_
52	9	meet	meet	VB	5	acl:relcl	12141	12145	_	_	_	_	_
52	10	these	these	DT	12	det	12146	12151	_	_	_	_	_
52	11	minimum	minimum	JJ	12	amod	12152	12159	_	_	_	_	_
52	12	intervals	interval	NNS	9	dobj	12160	12169	_	_	_	_	_
52	13	has	have	VBZ	16	aux	12170	12173	_	_	_	_	_
52	14	already	already	RB	16	advmod	12174	12181	_	_	_	_	_
52	15	been	be	VBN	16	auxpass	12182	12186	_	_	_	_	_
52	16	administered	administer	VBN	22	advcl	12187	12199	B-event-211645	_	_	_	_
52	17	,	,	,	22	punct	12199	12200	_	_	_	_	_
52	18	it	it	PRP	22	nsubj	12201	12203	_	_	_	_	_
52	19	may	may	MD	22	aux	12204	12207	_	_	_	_	_
52	20	not	not	RB	22	neg	12208	12211	_	_	_	_	_
52	21	be	be	VB	22	cop	12212	12214	_	_	_	_	_
52	22	necessary	necessary	JJ	0	ROOT	12215	12224	_	_	_	_	_
52	23	to	to	TO	24	mark	12225	12227	_	_	_	_	_
52	24	repeat	repeat	VB	22	xcomp	12228	12234	B-event-211646	_	_	_	_
52	25	a	a	DT	26	det	12235	12236	_	_	_	_	_
52	26	dose	dose	NN	24	dobj	12237	12241	B-event-211647	_	_	_	_
52	27	.	.	.	22	punct	12241	12242	_	_	_	_	_

53	1	Although	although	IN	5	mark	12243	12251	_	_	_	_	_
53	2	compressed	compress	VBN	3	amod	12252	12262	B-event-211648	_	_	_	_
53	3	schedules	schedule	NNS	5	nsubjpass	12263	12272	_	_	_	_	_
53	4	are	be	VBP	5	auxpass	12273	12276	_	_	_	_	_
53	5	associated	associate	VBN	19	csubj	12277	12287	_	_	_	_	_
53	6	with	with	IN	10	case	12288	12292	_	_	_	_	_
53	7	lower	lower	JJR	10	amod	12293	12298	_	_	_	_	_
53	8	peak	peak	JJ	10	amod	12299	12303	_	_	_	_	_
53	9	antibody	antibody	NN	10	compound	12304	12312	_	_	_	_	_
53	10	levels41	levels41	NN	5	nmod	12313	12321	_	_	_	_	_
53	11	and	and	CC	10	cc	12322	12325	_	_	_	_	_
53	12	hence	hence	RB	15	advmod	12326	12331	_	_	_	_	_
53	13	likely	likely	JJ	15	amod	12332	12338	_	_	_	_	_
53	14	shorter	shorter	JJR	15	amod	12339	12346	_	_	_	_	_
53	15	duration	duration	NN	10	conj	12347	12355	_	_	_	_	_
53	16	of	of	IN	18	case	12356	12358	_	_	_	_	_
53	17	antibody	antibody	NN	18	compound	12359	12367	_	_	_	_	_
53	18	levels	level	NNS	15	nmod	12368	12374	_	_	_	_	_
53	19	≥	≥	VBP	0	ROOT	12375	12376	_	_	_	_	_
53	20	10	10	CD	21	nummod	12376	12378	_	_	_	_	_
53	21	mIU/mL	miu/ml	NN	28	nsubj	12379	12385	_	_	_	_	_
53	22	,38	,38	CD	21	dep	12385	12388	_	_	_	_	_
53	23	the	the	DT	24	det	12389	12392	_	_	_	_	_
53	24	significance	significance	NN	21	dep	12393	12405	_	_	_	_	_
53	25	of	of	IN	26	case	12406	12408	_	_	_	_	_
53	26	this	this	DT	24	nmod	12409	12413	_	_	_	_	_
53	27	is	be	VBZ	28	cop	12414	12416	_	_	_	_	_
53	28	unclear	unclear	JJ	19	ccomp	12417	12424	_	_	_	_	_
53	29	.	.	.	19	punct	12424	12425	_	_	_	_	_

54	1	The	the	DT	2	det	12426	12429	_	_	_	_	B-claim-10411
54	2	majority	majority	NN	12	nsubjpass	12430	12438	_	_	_	_	I-claim-10411
54	3	of	of	IN	4	case	12439	12441	_	_	_	_	I-claim-10411
54	4	individuals	individual	NNS	2	nmod	12442	12453	_	_	_	_	I-claim-10411
54	5	in	in	IN	6	case	12454	12456	_	_	_	_	I-claim-10411
54	6	whom	whom	WP	8	nmod	12457	12461	_	_	_	_	I-claim-10411
54	7	anti-HBs	anti-hbs	JJ	8	nsubj	12462	12470	_	_	_	_	I-claim-10411
54	8	becomes	become	VBZ	4	acl:relcl	12471	12478	_	_	_	_	I-claim-10411
54	9	undetectable	undetectable	JJ	8	xcomp	12479	12491	B-event-211649	_	_	_	I-claim-10411
54	10	have	have	VBP	12	aux	12492	12496	_	_	_	_	I-claim-10411
54	11	been	be	VBN	12	auxpass	12497	12501	_	_	_	_	I-claim-10411
54	12	shown	show	VBN	0	ROOT	12502	12507	B-event-211650	_	_	_	I-claim-10411
54	13	to	to	TO	14	mark	12508	12510	_	_	_	_	I-claim-10411
54	14	mount	mount	VB	12	xcomp	12511	12516	_	_	_	_	I-claim-10411
54	15	an	a	DT	17	det	12517	12519	_	_	_	_	I-claim-10411
54	16	anamnestic	anamnestic	JJ	17	amod	12520	12530	_	_	_	_	I-claim-10411
54	17	response	response	NN	14	dobj	12531	12539	B-event-211651	_	_	_	I-claim-10411
54	18	to	to	TO	22	case	12540	12542	_	_	_	_	I-claim-10411
54	19	an	a	DT	22	det	12543	12545	_	_	_	_	I-claim-10411
54	20	additional	additional	JJ	22	amod	12546	12556	_	_	_	_	I-claim-10411
54	21	vaccine	vaccine	NN	22	compound	12557	12564	_	_	_	_	I-claim-10411
54	22	dose	dose	NN	14	nmod	12565	12569	B-event-211652	_	_	_	I-claim-10411
54	23	,	,	,	22	punct	12569	12570	_	_	_	_	I-claim-10411
54	24	which	which	WDT	25	nsubj	12571	12576	_	_	_	_	I-claim-10411
54	25	indicates	indicate	VBZ	22	acl:relcl	12577	12586	_	_	_	_	I-claim-10411
54	26	they	they	PRP	28	nsubj	12587	12591	_	_	_	_	I-claim-10411
54	27	are	be	VBP	28	cop	12592	12595	_	_	_	_	I-claim-10411
54	28	likely	likely	JJ	25	ccomp	12596	12602	_	_	_	_	I-claim-10411
54	29	to	to	TO	31	mark	12603	12605	_	_	_	_	I-claim-10411
54	30	be	be	VB	31	auxpass	12606	12608	_	_	_	_	I-claim-10411
54	31	protected	protect	VBN	28	xcomp	12609	12618	B-event-211653	_	_	_	I-claim-10411
54	32	if	if	IN	61	mark	12619	12621	_	_	_	_	I-claim-10411
54	33	exposed	expose	VBN	61	csubj	12622	12629	B-event-211654	_	_	_	I-claim-10411
54	34	to	to	TO	36	case	12630	12632	_	_	_	_	I-claim-10411
54	35	hepatitis	hepatitis	NN	36	compound	12633	12642	B-event-211655	_	_	_	I-claim-10411
54	36	B	b	NN	33	nmod	12643	12644	I-event-211655	_	_	_	I-claim-10411
54	37	virus	virus	NN	39	nsubj	12645	12650	B-event-211656	_	_	_	I-claim-10411
54	38	.39	.39	CD	37	nummod	12650	12653	_	_	_	_	_
54	39	Note	note	NN	36	acl:relcl	12654	12658	_	_	_	_	_
54	40	that	that	IN	51	mark	12659	12663	_	_	_	_	_
54	41	the	the	DT	42	det	12664	12667	_	_	_	_	_
54	42	interval	interval	NN	51	nsubjpass	12668	12676	_	_	_	_	_
54	43	between	between	IN	48	case	12677	12684	_	_	_	_	_
54	44	the	the	DT	48	det	12685	12688	_	_	_	_	_
54	45	1st	1st	JJ	48	amod	12689	12692	_	_	_	_	_
54	46	and	and	CC	45	cc	12693	12696	_	_	_	_	_
54	47	3rd	3rd	JJ	45	conj	12697	12700	_	_	_	_	_
54	48	doses	dose	NNS	42	nmod	12701	12706	B-event-211657	_	_	_	_
54	49	has	have	VBZ	51	aux	12707	12710	_	_	_	_	_
54	50	been	be	VBN	51	auxpass	12711	12715	_	_	_	_	_
54	51	shortened	shorten	VBN	39	ccomp	12716	12725	B-event-211658	_	_	_	_
54	52	to	to	TO	56	case	12726	12728	_	_	_	_	_
54	53	less	less	JJR	55	advmod	12729	12733	_	_	_	_	_
54	54	than	than	IN	53	mwe	12734	12738	_	_	_	_	_
54	55	4	4	CD	56	nummod	12739	12740	_	_	_	_	_
54	56	months	month	NNS	51	nmod	12741	12747	_	_	_	_	_
54	57	in	in	IN	58	case	12748	12750	_	_	_	_	_
54	58	studies	study	NNS	51	nmod	12751	12758	B-event-211659	_	_	_	_
54	59	of	of	IN	60	case	12759	12761	_	_	_	_	_
54	60	4-dose	4-dose	NN	58	nmod	12762	12768	_	_	_	_	_
54	61	accelerated	accelerate	VBD	31	advcl	12769	12780	B-event-211660	_	_	_	_
54	62	schedules	schedule	NNS	61	dobj	12781	12790	_	_	_	_	_
54	63	,	,	,	61	punct	12790	12791	_	_	_	_	_
54	64	with	with	IN	66	case	12792	12796	_	_	_	_	_
54	65	the	the	DT	66	det	12797	12800	_	_	_	_	_
54	66	aim	aim	NN	61	nmod	12801	12804	_	_	_	_	_
54	67	to	to	TO	68	mark	12805	12807	_	_	_	_	_
54	68	achieve	achieve	VB	66	acl	12808	12815	B-event-211661	_	_	_	_
54	69	a	a	DT	73	det	12816	12817	_	_	_	_	_
54	70	higher	higher	JJR	73	amod	12818	12824	_	_	_	_	_
54	71	seroprotective	seroprotective	JJ	73	amod	12825	12839	_	_	_	_	_
54	72	antibody	antibody	NN	73	compound	12840	12848	_	_	_	_	_
54	73	level	level	NN	68	dobj	12849	12854	_	_	_	_	_
54	74	sooner	sooner	RBR	68	advmod	12855	12861	_	_	_	_	_
54	75	.	.	.	12	punct	12861	12862	_	_	_	_	_

55	1	However	however	RB	36	advmod	12863	12870	_	_	_	_	_
55	2	,	,	,	36	punct	12870	12871	_	_	_	_	_
55	3	as	as	IN	8	mark	12872	12874	_	_	_	_	_
55	4	antibody	antibody	NN	5	compound	12875	12883	_	_	_	_	_
55	5	levels	level	NNS	8	nsubj	12884	12890	_	_	_	_	_
55	6	are	be	VBP	8	cop	12891	12894	_	_	_	_	_
55	7	substantially	substantially	RB	8	advmod	12895	12908	_	_	_	_	_
55	8	lower	lower	JJR	36	advcl	12909	12914	_	_	_	_	_
55	9	after	after	IN	11	mark	12915	12920	_	_	_	_	_
55	10	3	3	CD	11	nsubj	12921	12922	_	_	_	_	_
55	11	accelerated	accelerate	VBD	8	ccomp	12923	12934	B-event-211662	_	_	_	_
55	12	doses	dose	NNS	11	dobj	12935	12940	_	_	_	_	_
55	13	than	than	IN	24	mark	12941	12945	_	_	_	_	_
55	14	after	after	IN	18	case	12946	12951	_	_	_	_	_
55	15	the	the	DT	18	det	12952	12955	_	_	_	_	_
55	16	standard	standard	JJ	18	amod	12956	12964	_	_	_	_	_
55	17	3-dose	3-dose	JJ	18	amod	12965	12971	_	_	_	_	_
55	18	schedule	schedule	NN	24	nmod	12972	12980	_	_	_	_	_
55	19	,42	,42	CD	24	nsubjpass	12980	12983	_	_	_	_	_
55	20	a	a	DT	22	det	12984	12985	_	_	_	_	_
55	21	4th	4th	JJ	22	amod	12986	12989	_	_	_	_	_
55	22	dose	dose	NN	19	dep	12990	12994	_	_	_	_	_
55	23	is	be	VBZ	24	auxpass	12995	12997	_	_	_	_	_
55	24	required	require	VBN	11	advcl	12998	13006	_	_	_	_	_
55	25	to	to	TO	26	mark	13007	13009	_	_	_	_	_
55	26	achieve	achieve	VB	24	xcomp	13010	13017	B-event-211663	_	_	_	_
55	27	comparable	comparable	JJ	29	amod	13018	13028	_	_	_	_	_
55	28	antibody	antibody	NN	29	compound	13029	13037	_	_	_	_	_
55	29	levels	level	NNS	26	dobj	13038	13044	_	_	_	_	_
55	30	to	to	TO	33	case	13045	13047	_	_	_	_	_
55	31	the	the	DT	33	det	13048	13051	_	_	_	_	_
55	32	standard	standard	JJ	33	amod	13052	13060	_	_	_	_	_
55	33	3-dose	3-dose	NN	26	nmod	13061	13067	_	_	_	_	_
55	34	schedule	schedule	NN	36	nsubj	13068	13076	_	_	_	_	_
55	35	(	(	CD	34	nummod	13077	13078	_	_	_	_	_
55	36	refer	refer	VBP	0	ROOT	13078	13083	_	_	_	_	_
55	37	to	to	TO	38	mark	13084	13086	_	_	_	_	_
55	38	‘	‘	VB	36	xcomp	13087	13088	_	_	_	_	_
55	39	Accelerated	Accelerated	NNP	40	compound	13088	13099	_	_	_	_	_
55	40	schedules	schedule	NNS	38	dobj	13100	13109	_	_	_	_	_
55	41	’	’	RB	38	advmod	13109	13110	_	_	_	_	_
55	42	below	below	IN	43	case	13111	13116	_	_	_	_	_
55	43	)	)	NN	38	nmod	13116	13117	_	_	_	_	_
55	44	.	.	.	36	punct	13117	13118	_	_	_	_	_

56	1	The	the	DT	4	det	13119	13122	_	_	_	_	_
56	2	standard	standard	JJ	4	amod	13123	13131	_	_	_	_	_
56	3	3-dose	3-dose	JJ	4	amod	13132	13138	_	_	_	_	_
56	4	schedule	schedule	NN	5	nsubj	13139	13147	_	_	_	_	_
56	5	induces	induce	VBZ	0	ROOT	13148	13155	_	_	_	_	_
56	6	protective	protective	JJ	7	amod	13156	13166	B-event-211664	_	_	_	_
56	7	levels	level	NNS	5	dobj	13167	13173	_	_	_	_	_
56	8	of	of	IN	9	mark	13174	13176	_	_	_	_	_
56	9	neutralising	neutralise	VBG	7	acl	13177	13189	B-event-211665	_	_	_	_
56	10	antibody	antibody	NN	9	dobj	13190	13198	_	_	_	_	_
56	11	against	against	IN	14	case	13199	13206	_	_	_	_	_
56	12	hepatitis	hepatitis	NN	14	compound	13207	13216	B-event-211666	_	_	_	_
56	13	B	b	NN	14	compound	13217	13218	I-event-211666	_	_	_	_
56	14	virus	virus	NN	9	nmod	13219	13224	B-event-211667	_	_	_	_
56	15	in	in	IN	19	case	13225	13227	_	_	_	_	_
56	16	more	more	JJR	18	advmod	13228	13232	_	_	_	_	_
56	17	than	than	IN	16	mwe	13233	13237	_	_	_	_	_
56	18	90	90	CD	19	nummod	13238	13240	_	_	_	_	_
56	19	%	%	NN	14	nmod	13240	13241	_	_	_	_	_
56	20	of	of	IN	21	case	13242	13244	_	_	_	_	_
56	21	adults	adult	NNS	19	nmod	13245	13251	_	_	_	_	_
56	22	.	.	.	5	punct	13251	13252	_	_	_	_	_

57	1	The	the	DT	2	det	13253	13256	_	_	_	_	_
57	2	frequency	frequency	NN	5	nsubj	13257	13266	_	_	_	_	_
57	3	of	of	IN	4	case	13267	13269	_	_	_	_	_
57	4	seroconversion	seroconversion	NN	2	nmod	13270	13284	B-event-211668	_	_	_	_
57	5	increases	increase	VBZ	0	ROOT	13285	13294	_	_	_	_	_
57	6	progressively	progressively	RB	5	advmod	13295	13308	_	_	_	_	_
57	7	from	from	IN	10	case	13309	13313	_	_	_	_	_
57	8	approximately	approximately	RB	9	advmod	13314	13327	_	_	_	_	_
57	9	35	35	CD	10	nummod	13328	13330	_	_	_	_	_
57	10	%	%	NN	5	nmod	13330	13331	_	_	_	_	_
57	11	after	after	IN	14	case	13332	13337	_	_	_	_	_
57	12	the	the	DT	14	det	13338	13341	_	_	_	_	_
57	13	1st	1st	JJ	14	amod	13342	13345	_	_	_	_	_
57	14	dose	dose	NN	10	nmod	13346	13350	B-event-212478	_	_	_	_
57	15	to	to	TO	19	case	13351	13353	_	_	_	_	_
57	16	more	more	JJR	18	advmod	13354	13358	_	_	_	_	_
57	17	than	than	IN	16	mwe	13359	13363	_	_	_	_	_
57	18	90	90	CD	19	nummod	13364	13366	_	_	_	_	_
57	19	%	%	NN	5	nmod	13366	13367	_	_	_	_	_
57	20	after	after	IN	23	case	13368	13373	_	_	_	_	_
57	21	the	the	DT	23	det	13374	13377	_	_	_	_	_
57	22	3rd	3rd	JJ	23	amod	13378	13381	_	_	_	_	_
57	23	dose	dose	NN	19	nmod	13382	13386	B-event-212479	_	_	_	_
57	24	.	.	.	5	punct	13386	13387	_	_	_	_	_

58	1	There	there	EX	2	expl	13388	13393	_	_	_	_	_
58	2	is	be	VBZ	0	ROOT	13394	13396	_	_	_	_	_
58	3	evidence	evidence	NN	2	nsubj	13397	13405	_	_	_	_	_
58	4	of	of	IN	5	case	13406	13408	_	_	_	_	_
58	5	immunity	immunity	NN	3	nmod	13409	13417	B-event-211669	_	_	_	_
58	6	in	in	IN	9	case	13418	13420	_	_	_	_	_
58	7	most	most	JJS	9	amod	13421	13425	_	_	_	_	_
58	8	vaccine	vaccine	NN	9	compound	13426	13433	B-event-211670	_	_	_	_
58	9	recipients	recipient	NNS	5	nmod	13434	13444	B-event-212480	_	_	_	_
58	10	after	after	IN	11	case	13445	13450	_	_	_	_	_
58	11	administration	administration	NN	2	nmod	13451	13465	B-event-211671	_	_	_	_
58	12	of	of	IN	14	case	13466	13468	_	_	_	_	_
58	13	2	2	CD	14	nummod	13469	13470	_	_	_	_	_
58	14	doses	dose	NNS	11	nmod	13471	13476	B-event-211672	_	_	_	_
58	15	of	of	IN	18	case	13477	13479	_	_	_	_	_
58	16	a	a	DT	18	det	13480	13481	_	_	_	_	_
58	17	3-dose	3-dose	JJ	18	amod	13482	13488	_	_	_	_	_
58	18	schedule	schedule	NN	14	nmod	13489	13497	_	_	_	_	_
58	19	.	.	.	2	punct	13497	13498	_	_	_	_	_

59	1	However	however	RB	7	advmod	13499	13506	_	_	_	_	_
59	2	,	,	,	7	punct	13506	13507	_	_	_	_	_
59	3	the	the	DT	5	det	13508	13511	_	_	_	_	_
59	4	3rd	3rd	JJ	5	amod	13512	13515	_	_	_	_	_
59	5	dose	dose	NN	7	nsubj	13516	13520	B-event-211673	_	_	_	_
59	6	is	be	VBZ	7	cop	13521	13523	_	_	_	_	_
59	7	necessary	necessary	JJ	0	ROOT	13524	13533	_	_	_	_	_
59	8	to	to	TO	9	mark	13534	13536	_	_	_	_	_
59	9	increase	increase	VB	7	dep	13537	13545	B-event-211674	_	_	_	_
59	10	the	the	DT	11	det	13546	13549	_	_	_	_	_
59	11	percentage	percentage	NN	9	dobj	13550	13560	_	_	_	_	_
59	12	of	of	IN	13	case	13561	13563	_	_	_	_	_
59	13	responders	responder	NNS	11	nmod	13564	13574	_	_	_	_	_
59	14	and	and	CC	9	cc	13575	13578	_	_	_	_	_
59	15	to	to	TO	16	mark	13579	13581	_	_	_	_	_
59	16	provide	provide	VB	9	conj	13582	13589	_	_	_	_	_
59	17	long-term	long-term	JJ	18	amod	13590	13599	_	_	_	_	_
59	18	protection	protection	NN	16	dobj	13600	13610	B-event-211675	_	_	_	_
59	19	.	.	.	7	punct	13610	13611	_	_	_	_	_

60	1	Alternative	alternative	JJ	3	amod	13612	13623	_	_	_	_	_
60	2	2-dose	2-dose	JJ	3	amod	13624	13630	_	_	_	_	_
60	3	schedule	schedule	NN	9	nsubj	13631	13639	_	_	_	_	_
60	4	for	for	IN	5	case	13640	13643	_	_	_	_	_
60	5	adolescents	adolescent	NNS	3	nmod	13644	13655	_	_	_	_	_
60	6	Several	several	JJ	7	amod	13656	13663	_	_	B-source-25293	_	_
60	7	studies	study	NNS	5	dep	13664	13671	_	_	I-source-25293	_	_
60	8	have	have	VBP	9	aux	13672	13676	_	_	_	_	_
60	9	demonstrated	demonstrate	VBN	0	ROOT	13677	13689	_	_	_	B-cue-25294	_
60	10	that	that	IN	63	mark	13690	13694	_	B-content-25295:25294-Cue_25293-Source	_	_	_
60	11	adolescents	adolescent	NNS	63	nsubj	13695	13706	_	I-content-25295	_	_	_
60	12	11	11	CD	11	nummod	13707	13709	_	I-content-25295	_	_	_
60	13	–	–	CD	14	compound	13709	13710	_	I-content-25295	_	_	_
60	14	15	15	CD	15	nummod	13710	13712	_	I-content-25295	_	_	_
60	15	years	year	NNS	11	nmod	13713	13718	_	I-content-25295	_	_	_
60	16	of	of	IN	15	case	13719	13721	_	I-content-25295	_	_	_
60	17	age	age	NN	15	dep	13722	13725	_	I-content-25295	_	_	_
60	18	who	who	WP	19	nsubj	13726	13729	_	I-content-25295	_	_	_
60	19	receive	receive	VBP	11	acl:relcl	13730	13737	_	I-content-25295	_	_	_
60	20	2	2	CD	21	nummod	13738	13739	_	I-content-25295	_	_	_
60	21	doses	dose	NNS	19	dobj	13740	13745	_	I-content-25295	_	_	_
60	22	of	of	IN	24	case	13746	13748	_	I-content-25295	_	_	_
60	23	adult	adult	JJ	24	amod	13749	13754	_	I-content-25295	_	_	_
60	24	formulation	formulation	NN	21	nmod	13755	13766	_	I-content-25295	_	_	_
60	25	monovalent	monovalent	JJ	28	amod	13767	13777	_	I-content-25295	_	_	_
60	26	hepatitis	hepatitis	NN	28	compound	13778	13787	_	I-content-25295	_	_	_
60	27	B	b	NN	28	compound	13788	13789	_	I-content-25295	_	_	_
60	28	vaccine	vaccine	NN	34	nsubj	13790	13797	B-event-211676	I-content-25295	_	_	_
60	29	4	4	CD	31	compound	13798	13799	_	I-content-25295	_	_	_
60	30	to	to	TO	31	dep	13800	13802	_	I-content-25295	_	_	_
60	31	6	6	CD	32	nummod	13803	13804	_	I-content-25295	_	_	_
60	32	months	month	NNS	33	nmod:npmod	13805	13811	_	I-content-25295	_	_	_
60	33	apart	apart	RB	34	advmod	13812	13817	_	I-content-25295	_	_	_
60	34	develop	develop	VBP	21	acl:relcl	13818	13825	B-event-211677	I-content-25295	_	_	_
60	35	similar	similar	JJ	38	amod	13826	13833	_	I-content-25295	_	_	_
60	36	protective	protective	JJ	38	amod	13834	13844	B-event-211678	I-content-25295	_	_	_
60	37	antibody	antibody	NN	38	compound	13845	13853	_	I-content-25295	_	_	_
60	38	levels	level	NNS	34	dobj	13854	13860	_	I-content-25295	_	_	_
60	39	to	to	TO	40	case	13861	13863	_	I-content-25295	_	_	_
60	40	those	those	DT	34	nmod	13864	13869	_	I-content-25295	_	_	_
60	41	vaccinated	vaccinate	VBN	40	acl	13870	13880	B-event-211679	I-content-25295	_	_	_
60	42	using	use	VBG	41	xcomp	13881	13886	_	I-content-25295	_	_	_
60	43	paediatric	paediatric	JJ	44	amod	13887	13897	_	I-content-25295	_	_	_
60	44	formulations	formulation	NNS	42	dobj	13898	13910	_	I-content-25295	_	_	_
60	45	in	in	IN	49	case	13911	13913	_	I-content-25295	_	_	_
60	46	the	the	DT	49	det	13914	13917	_	I-content-25295	_	_	_
60	47	standard	standard	JJ	49	amod	13918	13926	_	I-content-25295	_	_	_
60	48	3-dose	3-dose	JJ	49	amod	13927	13933	_	I-content-25295	_	_	_
60	49	schedule.44-46	schedule.44-46	NN	42	nmod	13934	13948	_	I-content-25295	_	_	_
60	50	Using	use	VBG	49	acl	13949	13954	_	_	_	_	_
60	51	a	a	DT	53	det	13955	13956	_	_	_	_	_
60	52	2-dose	2-dose	JJ	53	amod	13957	13963	B-event-211681	_	_	_	_
60	53	schedule	schedule	NN	50	dobj	13964	13972	_	_	_	_	_
60	54	for	for	IN	61	case	13973	13976	_	_	_	_	_
60	55	the	the	DT	61	det	13977	13980	_	_	_	_	_
60	56	11	11	CD	57	compound	13981	13983	_	_	_	_	_
60	57	–	–	CD	61	amod	13983	13984	_	_	_	_	_
60	58	15	15	CD	59	nummod	13984	13986	_	_	_	_	_
60	59	years	year	NNS	57	nmod:tmod	13987	13992	_	_	_	_	_
60	60	age	age	NN	61	compound	13993	13996	_	_	_	_	_
60	61	group	group	NN	53	nmod	13997	14002	_	_	_	_	_
60	62	may	may	MD	63	aux	14003	14006	_	_	_	_	_
60	63	improve	improve	VB	9	ccomp	14007	14014	B-event-211680	_	_	_	_
60	64	compliance	compliance	NN	63	dobj	14015	14025	B-event-211682	_	_	_	_
60	65	and	and	CC	63	cc	14026	14029	_	_	_	_	_
60	66	will	will	MD	67	aux	14030	14034	_	_	_	_	_
60	67	provide	provide	VB	63	conj	14035	14042	_	_	_	_	_
60	68	comparable	comparable	JJ	69	amod	14043	14053	_	_	_	_	_
60	69	immunogenicity	immunogenicity	NN	67	dobj	14054	14068	_	_	_	_	_
60	70	to	to	TO	71	case	14069	14071	_	_	_	_	_
60	71	that	that	DT	67	nmod	14072	14076	_	_	_	_	_
60	72	of	of	IN	76	case	14077	14079	_	_	_	_	_
60	73	a	a	DT	76	det	14080	14081	_	_	_	_	_
60	74	3-dose	3-dose	JJ	76	amod	14082	14088	B-event-211683	_	_	_	_
60	75	paediatric	paediatric	JJ	76	amod	14089	14099	_	_	_	_	_
60	76	schedule	schedule	NN	71	nmod	14100	14108	_	_	_	_	_
60	77	.	.	.	9	punct	14108	14109	_	_	_	_	_

61	1	Adolescents	adolescent	NNS	2	nsubj	14110	14121	_	_	_	_	_
61	2	(	(	VBP	28	dep	14122	14123	_	_	_	_	_
61	3	11	11	CD	6	nummod	14123	14125	_	_	_	_	_
61	4	–	–	CD	6	nummod	14125	14126	_	_	_	_	_
61	5	15	15	CD	6	nummod	14126	14128	_	_	_	_	_
61	6	years	year	NNS	12	nsubjpass	14129	14134	_	_	_	_	_
61	7	of	of	IN	9	case	14135	14137	_	_	_	_	_
61	8	age	age	NN	9	compound	14138	14141	_	_	_	_	_
61	9	)	)	NN	6	nmod	14141	14142	_	_	_	_	_
61	10	can	can	MD	12	aux	14143	14146	_	_	_	_	_
61	11	be	be	VB	12	auxpass	14147	14149	_	_	_	_	_
61	12	vaccinated	vaccinate	VBN	2	ccomp	14150	14160	B-event-211684	_	_	_	_
61	13	with	with	IN	16	case	14161	14165	_	_	_	_	_
61	14	the	the	DT	16	det	14166	14169	_	_	_	_	_
61	15	adult	adult	JJ	16	amod	14170	14175	_	_	_	_	_
61	16	formulation	formulation	NN	12	nmod	14176	14187	_	_	_	_	_
61	17	of	of	IN	19	case	14188	14190	_	_	_	_	_
61	18	either	either	CC	19	cc:preconj	14191	14197	_	_	_	_	_
61	19	H-B-Vax	h-b-vax	NN	16	nmod	14198	14205	_	_	_	_	_
61	20	II	ii	CD	19	nummod	14206	14208	_	_	_	_	_
61	21	or	or	CC	19	cc	14209	14211	_	_	_	_	_
61	22	Engerix-B	Engerix-B	NNP	19	conj	14212	14221	_	_	_	_	_
61	23	in	in	IN	27	case	14222	14224	_	_	_	_	_
61	24	a	a	DT	27	det	14225	14226	_	_	_	_	_
61	25	2-dose	2-dose	JJ	27	amod	14227	14233	_	_	_	_	_
61	26	schedule	schedule	NN	27	compound	14234	14242	_	_	_	_	_
61	27	(	(	NN	12	nmod	14243	14244	_	_	_	_	_
61	28	refer	refer	VBP	0	ROOT	14244	14249	_	_	_	_	_
61	29	to	to	TO	30	case	14250	14252	_	_	_	_	_
61	30	Table	Table	NNP	28	nmod	14253	14258	_	_	_	_	_
61	31	4.5.1	4.5.1	CD	30	nummod	14259	14264	_	_	_	_	_
61	32	)	)	CD	28	nsubj	14264	14265	_	_	_	_	_
61	33	.	.	.	28	punct	14265	14266	_	_	_	_	_

62	1	*	*	SYM	2	dep	14267	14268	_	_	_	_	_
62	2	ï	ï	NN	9	dep	14268	14269	_	_	_	_	_
62	3	¿	¿	CD	2	nummod	14269	14270	_	_	_	_	_
62	4	½	½	NN	9	nsubj	14270	14271	_	_	_	_	_
62	5	For	for	IN	7	case	14271	14274	_	_	_	_	_
62	6	minimum	minimum	JJ	7	amod	14275	14282	_	_	_	_	_
62	7	intervals	interval	NNS	4	nmod	14283	14292	_	_	_	_	_
62	8	,	,	,	4	punct	14292	14293	_	_	_	_	_
62	9	refer	refer	VBP	0	ROOT	14294	14299	_	_	_	_	_
62	10	to	to	TO	11	case	14300	14302	_	_	_	_	_
62	11	text	text	NN	9	nmod	14303	14307	_	_	_	_	_
62	12	above	above	IN	11	case	14308	14313	_	_	_	_	_
62	13	.	.	.	9	punct	14313	14314	_	_	_	_	_

63	1	†	†	NN	12	nmod	14316	14317	_	_	_	_	_
63	2	In	in	IN	1	case	14318	14320	_	_	_	_	_
63	3	these	these	DT	4	det	14321	14326	_	_	_	_	_
63	4	schedules	schedule	NNS	1	dep	14327	14336	_	_	_	_	_
63	5	,	,	,	12	punct	14336	14337	_	_	_	_	_
63	6	the	the	DT	8	det	14338	14341	_	_	_	_	_
63	7	‘	‘	NN	8	compound	14342	14343	_	_	_	_	_
63	8	day	day	NN	12	nsubj	14343	14346	_	_	_	_	_
63	9	0	0	CD	11	nummod	14347	14348	_	_	_	_	_
63	10	’	’	CD	11	nummod	14348	14349	_	_	_	_	_
63	11	dose	dose	NN	8	dep	14350	14354	_	_	_	_	_
63	12	refers	refer	VBZ	0	ROOT	14355	14361	_	_	_	_	_
63	13	to	to	TO	15	case	14362	14364	_	_	_	_	_
63	14	the	the	DT	15	det	14365	14368	_	_	_	_	_
63	15	day	day	NN	12	nmod	14369	14372	_	_	_	_	_
63	16	when	when	WRB	21	advmod	14373	14377	_	_	_	_	_
63	17	the	the	DT	19	det	14378	14381	_	_	_	_	_
63	18	1st	1st	JJ	19	amod	14382	14385	_	_	_	_	_
63	19	dose	dose	NN	21	nsubjpass	14386	14390	B-event-211685	_	_	_	_
63	20	is	be	VBZ	21	auxpass	14391	14393	_	_	_	_	_
63	21	given	give	VBN	15	acl:relcl	14394	14399	_	_	_	_	_
63	22	(	(	CD	21	iobj	14400	14401	_	_	_	_	_
63	23	i.e.	i.e.	FW	21	dobj	14401	14405	_	_	_	_	_
63	24	day	day	NN	21	nmod:tmod	14406	14409	_	_	_	_	_
63	25	0	0	CD	21	dobj	14410	14411	_	_	_	_	_
63	26	of	of	IN	30	case	14412	14414	_	_	_	_	_
63	27	the	the	DT	30	det	14415	14418	_	_	_	_	_
63	28	vaccination	vaccination	NN	30	compound	14419	14430	B-event-211686	_	_	_	_
63	29	course	course	NN	30	compound	14431	14437	_	_	_	_	_
63	30	)	)	NN	21	nmod	14437	14438	_	_	_	_	_
63	31	,	,	,	15	punct	14438	14439	_	_	_	_	_
63	32	not	not	RB	34	neg	14440	14443	_	_	_	_	_
63	33	the	the	DT	34	det	14444	14447	_	_	_	_	_
63	34	age	age	NN	15	appos	14448	14451	_	_	_	_	_
63	35	of	of	IN	37	case	14452	14454	_	_	_	_	_
63	36	the	the	DT	37	det	14455	14458	_	_	_	_	_
63	37	recipient	recipient	JJ	34	nmod	14459	14468	B-event-211687	_	_	_	_
63	38	.	.	.	12	punct	14468	14469	_	_	_	_	_

64	1	For	for	IN	3	case	14470	14473	_	_	_	_	_
64	2	infant	infant	NN	3	compound	14474	14480	_	_	_	_	_
64	3	vaccination	vaccination	NN	17	nmod	14482	14493	B-event-211688	_	_	_	_
64	4	,	,	,	17	punct	14493	14494	_	_	_	_	_
64	5	where	where	WRB	13	advmod	14495	14500	_	_	_	_	_
64	6	the	the	DT	8	det	14501	14504	_	_	_	_	_
64	7	1st	1st	JJ	8	amod	14505	14508	_	_	_	_	_
64	8	dose	dose	NN	13	nsubj	14509	14513	B-event-211689	_	_	_	_
64	9	is	be	VBZ	13	cop	14514	14516	_	_	_	_	_
64	10	a	a	DT	13	det	14517	14518	_	_	_	_	_
64	11	‘	‘	JJ	13	amod	14519	14520	_	_	_	_	_
64	12	birth	birth	NN	13	compound	14520	14525	_	_	_	_	_
64	13	dose	dose	NN	17	advcl	14526	14530	_	_	_	_	_
64	14	’	’	CD	13	nummod	14530	14531	_	_	_	_	_
64	15	it	it	PRP	17	nsubjpass	14532	14534	_	_	_	_	_
64	16	is	be	VBZ	17	auxpass	14535	14537	_	_	_	_	_
64	17	indicated	indicate	VBN	0	ROOT	14538	14547	_	_	_	_	_
64	18	as	as	IN	19	case	14548	14550	_	_	_	_	_
64	19	so	so	RB	17	advcl	14551	14553	_	_	_	_	_
64	20	.	.	.	17	punct	14553	14554	_	_	_	_	_

65	1	‡	‡	FW	4	compound	14556	14557	_	_	_	_	_
65	2	ï	ï	FW	4	compound	14557	14558	_	_	_	_	_
65	3	¿	¿	FW	4	compound	14558	14559	_	_	_	_	_
65	4	½	½	FW	17	nsubjpass	14559	14560	_	_	_	_	_
65	5	The	the	DT	7	det	14560	14563	_	_	_	_	_
65	6	final	final	JJ	7	amod	14564	14569	_	_	_	_	_
65	7	dose	dose	NN	4	dep	14570	14574	B-event-211690	_	_	_	_
65	8	of	of	IN	11	case	14575	14577	_	_	_	_	_
65	9	the	the	DT	11	det	14578	14581	_	_	_	_	_
65	10	primary	primary	JJ	11	amod	14582	14589	_	_	_	_	_
65	11	course	course	NN	4	nmod	14590	14596	_	_	_	_	_
65	12	for	for	IN	13	case	14597	14600	_	_	_	_	_
65	13	infants	infant	NNS	11	nmod	14601	14608	_	_	_	_	_
65	14	should	should	MD	17	aux	14609	14615	_	_	_	_	_
65	15	preferably	preferably	RB	17	advmod	14616	14626	_	_	_	_	_
65	16	be	be	VB	17	auxpass	14627	14629	_	_	_	_	_
65	17	given	give	VBN	0	ROOT	14631	14636	_	_	_	_	_
65	18	at	at	IN	21	case	14637	14639	_	_	_	_	_
65	19	≥	≥	CD	20	compound	14640	14641	_	_	_	_	_
65	20	24	24	CD	21	nummod	14641	14643	_	_	_	_	_
65	21	weeks	week	NNS	17	nmod	14644	14649	_	_	_	_	_
65	22	of	of	IN	23	case	14650	14652	_	_	_	_	_
65	23	age	age	NN	21	nmod	14653	14656	_	_	_	_	_
65	24	;	;	:	17	punct	14657	14658	_	_	_	_	_
65	25	however	however	RB	49	advmod	14659	14666	_	_	_	_	_
65	26	,	,	,	49	punct	14666	14667	_	_	_	_	_
65	27	if	if	IN	43	mark	14668	14670	_	_	_	_	_
65	28	given	give	VBN	30	case	14671	14676	_	_	_	_	_
65	29	at	at	IN	30	case	14677	14679	_	_	_	_	_
65	30	<	<	JJR	43	advcl	14680	14681	_	_	_	_	_
65	31	24	24	CD	32	nummod	14681	14683	_	_	_	_	_
65	32	weeks	week	NNS	30	nmod:tmod	14684	14689	_	_	_	_	_
65	33	but	but	CC	34	case	14690	14693	_	_	_	_	_
65	34	≥	≥	CD	30	nmod	14694	14695	_	_	_	_	_
65	35	16	16	CD	36	nummod	14695	14697	_	_	_	_	_
65	36	weeks	week	NNS	30	nmod:tmod	14698	14703	_	_	_	_	_
65	37	of	of	IN	38	case	14704	14706	_	_	_	_	_
65	38	age	age	NN	30	nmod	14707	14710	_	_	_	_	_
65	39	,	,	,	43	punct	14710	14711	_	_	_	_	_
65	40	it	it	PRP	43	nsubj	14712	14714	_	_	_	_	_
65	41	is	be	VBZ	43	cop	14715	14717	_	_	_	_	_
65	42	not	not	RB	43	neg	14718	14721	_	_	_	_	_
65	43	necessary	necessary	JJ	49	dep	14722	14731	_	_	_	_	_
65	44	to	to	TO	45	mark	14732	14734	_	_	_	_	_
65	45	repeat	repeat	VB	43	xcomp	14735	14741	B-event-211691	_	_	_	_
65	46	the	the	DT	47	det	14742	14745	_	_	_	_	_
65	47	dose	dose	NN	45	dobj	14746	14750	B-event-211692	_	_	_	_
65	48	,	,	,	49	punct	14750	14751	_	_	_	_	_
65	49	provided	provide	VBD	17	parataxis	14752	14760	_	_	_	_	_
65	50	the	the	DT	52	det	14761	14764	_	_	_	_	_
65	51	minimum	minimum	JJ	52	amod	14765	14772	_	_	_	_	_
65	52	intervals	interval	NNS	57	nsubjpass	14773	14782	_	_	_	_	_
65	53	between	between	IN	54	case	14783	14790	_	_	_	_	_
65	54	doses	dose	NNS	52	nmod	14791	14796	_	_	_	_	_
65	55	have	have	VBP	57	aux	14797	14801	_	_	_	_	_
65	56	been	be	VBN	57	auxpass	14802	14806	_	_	_	_	_
65	57	met	meet	VBN	49	ccomp	14807	14810	_	_	_	_	_
65	58	(	(	RB	57	advmod	14811	14812	_	_	_	_	_
65	59	refer	refer	VB	57	ccomp	14812	14817	_	_	_	_	_
65	60	to	to	TO	61	case	14818	14820	_	_	_	_	_
65	61	Table	Table	NNP	59	nmod	14821	14826	_	_	_	_	_
65	62	2.1.7	2.1.7	CD	61	nummod	14827	14832	_	_	_	_	_
65	63	in	in	IN	65	case	14833	14835	_	_	_	_	_
65	64	2.1.5	2.1.5	CD	65	nummod	14836	14841	_	_	_	_	_
65	65	Catch-up	catch-up	NN	59	nmod	14842	14850	_	_	_	_	_
65	66	)	)	CD	65	dep	14850	14851	_	_	_	_	_
65	67	.	.	.	17	punct	14851	14852	_	_	_	_	_

66	1	ï	ï	NN	10	nsubjpass	14854	14855	_	_	_	_	_
66	2	¿	¿	SYM	3	dep	14855	14856	_	_	_	_	_
66	3	½	½	CD	1	acl:relcl	14856	14857	_	_	_	_	_
66	4	The	the	DT	7	det	14858	14861	_	_	_	_	_
66	5	2	2	CD	7	nummod	14862	14863	_	_	_	_	_
66	6	month	month	NN	7	compound	14864	14869	_	_	_	_	_
66	7	dose	dose	NN	1	dep	14870	14874	B-event-211693	_	_	_	_
66	8	can	can	MD	10	aux	14875	14878	_	_	_	_	_
66	9	be	be	VB	10	auxpass	14879	14881	_	_	_	_	_
66	10	given	give	VBN	0	ROOT	14882	14887	_	_	_	_	_
66	11	as	as	RB	12	advmod	14888	14890	_	_	_	_	_
66	12	early	early	RB	10	advmod	14891	14896	_	_	_	_	_
66	13	as	as	IN	15	case	14897	14899	_	_	_	_	_
66	14	6	6	CD	15	nummod	14900	14901	_	_	_	_	_
66	15	weeks	week	NNS	10	nmod	14902	14907	_	_	_	_	_
66	16	of	of	IN	17	case	14909	14911	_	_	_	_	_
66	17	age	age	NN	15	nmod	14912	14915	_	_	_	_	_
66	18	.	.	.	10	punct	14915	14916	_	_	_	_	_

67	1	ï	ï	NN	69	nsubjpass	14919	14920	_	_	_	_	_
67	2	¿	¿	SYM	12	dep	14920	14921	_	_	_	_	_
67	3	½	½	FW	6	compound	14921	14922	_	_	_	_	_
67	4	ï	ï	FW	6	compound	14922	14923	_	_	_	_	_
67	5	¿	¿	FW	6	compound	14923	14924	_	_	_	_	_
67	6	½	½	FW	12	nsubjpass	14924	14925	_	_	_	_	_
67	7	This	this	DT	8	det	14925	14929	_	_	_	_	_
67	8	schedule	schedule	NN	6	dep	14930	14938	_	_	_	_	_
67	9	should	should	MD	12	aux	14939	14945	_	_	_	_	_
67	10	not	not	RB	12	neg	14947	14950	_	_	_	_	_
67	11	be	be	VB	12	auxpass	14951	14953	_	_	_	_	_
67	12	used	use	VBN	69	advcl	14954	14958	_	_	_	_	_
67	13	for	for	IN	14	case	14959	14962	_	_	_	_	_
67	14	those	those	DT	12	nmod	14963	14968	_	_	_	_	_
67	15	who	who	WP	16	nsubj	14969	14972	_	_	_	_	_
67	16	require	require	VBP	14	acl:relcl	14973	14980	_	_	_	_	_
67	17	prompt	prompt	JJ	18	amod	14981	14987	_	_	_	_	_
67	18	protection	protection	NN	16	dobj	14988	14998	B-event-211694	_	_	_	_
67	19	against	against	IN	21	case	14999	15006	_	_	_	_	_
67	20	hepatitis	hepatitis	NN	21	compound	15007	15016	B-event-211695	_	_	_	_
67	21	B	b	NN	16	nmod	15017	15018	I-event-211695	_	_	_	_
67	22	,	,	,	16	punct	15018	15019	_	_	_	_	_
67	23	for	for	IN	24	case	15020	15023	_	_	_	_	_
67	24	example	example	NN	16	nmod	15024	15031	_	_	_	_	_
67	25	,	,	,	16	punct	15031	15032	_	_	_	_	_
67	26	if	if	IN	28	mark	15033	15035	_	_	_	_	_
67	27	there	there	EX	28	expl	15036	15041	_	_	_	_	_
67	28	is	be	VBZ	16	advcl	15042	15044	_	_	_	_	_
67	29	close	close	JJ	30	amod	15045	15050	_	_	_	_	_
67	30	contact	contact	NN	28	nsubj	15051	15058	_	_	_	_	_
67	31	with	with	IN	33	case	15059	15063	_	_	_	_	_
67	32	a	a	DT	33	det	15064	15065	_	_	_	_	_
67	33	person	person	NN	30	nmod	15066	15072	_	_	_	_	_
67	34	known	know	VBN	33	acl	15073	15078	_	_	_	_	_
67	35	to	to	TO	38	mark	15079	15081	_	_	_	_	_
67	36	be	be	VB	38	auxpass	15082	15084	_	_	_	_	_
67	37	chronically	chronically	RB	38	advmod	15085	15096	_	_	_	_	_
67	38	infected	infect	VBN	34	xcomp	15097	15105	B-event-211696	_	_	_	_
67	39	with	with	IN	43	case	15106	15110	_	_	_	_	_
67	40	hepatitis	hepatitis	NNP	43	compound	15111	15120	B-event-211697	_	_	_	_
67	41	B.	B.	NNP	43	compound	15121	15123	I-event-211697	_	_	_	_
67	42	Accelerated	Accelerated	NNP	43	compound	15124	15135	B-event-212481	_	_	_	_
67	43	schedules	schedule	NNS	38	nmod	15136	15145	_	_	_	_	_
67	44	Engerix-B	Engerix-B	NNP	38	nmod	15146	15155	_	_	_	_	_
67	45	(	(	CD	44	nummod	15156	15157	_	_	_	_	_
67	46	monovalent	monovalent	JJ	49	amod	15157	15167	_	_	_	_	_
67	47	hepatitis	hepatitis	NN	49	compound	15168	15177	_	_	_	_	_
67	48	B	b	NN	49	compound	15178	15179	_	_	_	_	_
67	49	vaccine	vaccine	NN	44	dep	15180	15187	_	_	_	_	_
67	50	,	,	,	49	punct	15187	15188	_	_	_	_	_
67	51	paediatric	paediatric	JJ	54	amod	15189	15199	_	_	_	_	_
67	52	and	and	CC	51	cc	15200	15203	_	_	_	_	_
67	53	adult	adult	JJ	51	conj	15204	15209	_	_	_	_	_
67	54	)	)	NN	49	conj	15209	15210	_	_	_	_	_
67	55	and	and	CC	49	cc	15211	15214	_	_	_	_	_
67	56	Twinrix	twinrix	JJ	57	amod	15215	15222	_	_	_	_	_
67	57	(	(	NN	49	conj	15223	15224	_	_	_	_	_
67	58	720/20	720/20	CD	59	compound	15224	15230	_	_	_	_	_
67	59	)	)	CD	63	nummod	15230	15231	_	_	_	_	_
67	60	(	(	NN	63	compound	15232	15233	_	_	_	_	_
67	61	combination	combination	NN	63	compound	15233	15244	_	_	_	_	_
67	62	hepatitis	hepatitis	NN	63	compound	15245	15254	_	_	_	_	_
67	63	A/hepatitis	a/hepatitis	NN	57	dep	15255	15266	_	_	_	_	_
67	64	B	b	NN	66	compound	15267	15268	_	_	_	_	_
67	65	vaccine	vaccine	NN	66	compound	15269	15276	_	_	_	_	_
67	66	)	)	NN	69	nsubjpass	15276	15277	_	_	_	_	_
67	67	are	be	VBP	69	auxpass	15278	15281	_	_	_	_	_
67	68	also	also	RB	69	advmod	15282	15286	_	_	_	_	_
67	69	registered	register	VBN	0	ROOT	15287	15297	B-event-211698	_	_	_	_
67	70	for	for	IN	71	case	15298	15301	_	_	_	_	_
67	71	use	use	NN	69	nmod	15302	15305	_	_	_	_	_
67	72	in	in	IN	74	case	15306	15308	_	_	_	_	_
67	73	accelerated	accelerate	VBN	74	amod	15309	15320	B-event-211699	_	_	_	_
67	74	schedules	schedule	NNS	69	nmod	15321	15330	_	_	_	_	_
67	75	,	,	,	74	punct	15330	15331	_	_	_	_	_
67	76	which	which	WDT	77	nsubj	15332	15337	_	_	_	_	_
67	77	consist	consist	VBP	74	acl:relcl	15338	15345	_	_	_	_	_
67	78	of	of	IN	80	case	15346	15348	_	_	_	_	_
67	79	4	4	CD	80	nummod	15349	15350	_	_	_	_	_
67	80	doses	dose	NNS	77	advmod	15351	15356	_	_	_	_	_
67	81	in	in	IN	83	case	15357	15359	_	_	_	_	_
67	82	total	total	JJ	83	amod	15360	15365	_	_	_	_	_
67	83	(	(	NN	80	nmod	15366	15367	_	_	_	_	_
67	84	refer	refer	VB	77	dep	15367	15372	_	_	_	_	_
67	85	to	to	TO	86	case	15373	15375	_	_	_	_	_
67	86	Table	Table	NNP	84	nmod	15376	15381	_	_	_	_	_
67	87	4.5.2	4.5.2	CD	86	nummod	15382	15387	_	_	_	_	_
67	88	below	below	IN	89	case	15388	15393	_	_	_	_	_
67	89	)	)	CD	84	nmod	15393	15394	_	_	_	_	_
67	90	.	.	.	69	punct	15394	15395	_	_	_	_	_

68	1	Accelerated	accelerate	VBN	3	dep	15396	15407	B-event-211700	_	_	_	_
68	2	schedules	schedule	NNS	3	nsubj	15408	15417	_	_	_	_	_
68	3	result	result	VBP	0	ROOT	15418	15424	_	_	_	_	_
68	4	in	in	IN	11	mark	15425	15427	_	_	_	_	_
68	5	a	a	DT	7	det	15428	15429	_	_	_	_	_
68	6	high	high	JJ	7	amod	15430	15434	_	_	_	_	_
68	7	proportion	proportion	NN	11	nsubj	15435	15445	_	_	_	_	_
68	8	of	of	IN	10	case	15446	15448	_	_	_	_	_
68	9	vaccine	vaccine	NN	10	compound	15449	15456	B-event-211701	_	_	_	_
68	10	recipients	recipient	NNS	7	nmod	15457	15467	B-event-212482	_	_	_	_
68	11	attaining	attain	VBG	3	advcl	15468	15477	_	_	_	_	_
68	12	a	a	DT	21	det	15478	15479	_	_	_	_	_
68	13	seroprotective	seroprotective	JJ	21	amod	15480	15494	_	_	_	_	_
68	14	anti-HBs	anti-hbs	JJ	21	amod	15495	15503	_	_	_	_	_
68	15	antibody	antibody	NN	21	compound	15504	15512	_	_	_	_	_
68	16	level	level	NN	21	compound	15513	15518	_	_	_	_	_
68	17	(	(	CD	21	nummod	15519	15520	_	_	_	_	_
68	18	≥	≥	CD	21	nummod	15520	15521	_	_	_	_	_
68	19	10	10	CD	21	nummod	15521	15523	_	_	_	_	_
68	20	mIU/mL	miu/ml	NN	21	compound	15524	15530	_	_	_	_	_
68	21	)	)	NN	11	dobj	15530	15531	_	_	_	_	_
68	22	in	in	IN	25	case	15532	15534	_	_	_	_	_
68	23	the	the	DT	25	det	15535	15538	_	_	_	_	_
68	24	early	early	JJ	25	amod	15539	15544	_	_	_	_	_
68	25	months	month	NNS	11	nmod	15545	15551	_	_	_	_	_
68	26	following	follow	VBG	27	case	15552	15561	_	_	_	_	_
68	27	commencement	commencement	NN	25	nmod	15562	15574	B-event-211702	_	_	_	_
68	28	of	of	IN	30	case	15575	15577	_	_	_	_	_
68	29	the	the	DT	30	det	15578	15581	_	_	_	_	_
68	30	schedule	schedule	NN	27	nmod	15582	15590	_	_	_	_	_
68	31	.	.	.	3	punct	15590	15591	_	_	_	_	_

69	1	However	however	RB	57	advmod	15592	15599	_	_	_	_	_
69	2	,	,	,	7	punct	15599	15600	_	_	_	_	_
69	3	multiple	multiple	JJ	4	amod	15601	15609	_	_	B-source-25296	_	_
69	4	studies	study	NNS	7	nsubj	15610	15617	B-event-211703	_	I-source-25296	_	_
69	5	have	have	VBP	7	aux	15618	15622	_	_	_	_	_
69	6	consistently	consistently	RB	7	advmod	15623	15635	_	_	_	_	_
69	7	shown	show	VBN	57	parataxis	15636	15641	_	_	_	B-cue-25297	_
69	8	that	that	IN	13	mark	15642	15646	_	B-content-25298:25297-Cue_25296-Source	_	_	_
69	9	antibody	antibody	NN	10	compound	15647	15655	_	I-content-25298	_	_	_
69	10	levels	level	NNS	13	nsubj	15656	15662	_	I-content-25298	_	_	_
69	11	are	be	VBP	13	cop	15663	15666	_	I-content-25298	_	_	_
69	12	substantially	substantially	RB	13	advmod	15667	15680	_	I-content-25298	_	_	_
69	13	lower	lower	JJR	7	ccomp	15681	15686	_	I-content-25298	_	_	_
69	14	at	at	IN	15	case	15687	15689	_	I-content-25298	_	_	_
69	15	month	month	NN	13	nmod	15690	15695	_	I-content-25298	_	_	_
69	16	7	7	CD	15	nummod	15696	15697	_	I-content-25298	_	_	_
69	17	,	,	,	13	punct	15697	15698	_	I-content-25298	_	_	_
69	18	after	after	IN	20	mark	15699	15704	_	I-content-25298	_	_	_
69	19	3	3	CD	20	nsubj	15705	15706	_	I-content-25298	_	_	_
69	20	accelerated	accelerate	VBD	13	advcl	15707	15718	B-event-211704	I-content-25298	_	_	_
69	21	doses	dose	NNS	20	dobj	15719	15724	B-event-211705	I-content-25298	_	_	_
69	22	,	,	,	20	punct	15724	15725	_	I-content-25298	_	_	_
69	23	than	than	IN	36	mark	15726	15730	_	I-content-25298	_	_	_
69	24	after	after	IN	28	case	15731	15736	_	I-content-25298	_	_	_
69	25	the	the	DT	28	det	15737	15740	_	I-content-25298	_	_	_
69	26	standard	standard	JJ	28	amod	15741	15749	_	I-content-25298	_	_	_
69	27	3-dose	3-dose	NN	28	compound	15750	15756	_	I-content-25298	_	_	_
69	28	schedule	schedule	NN	36	nmod	15757	15765	_	I-content-25298	_	_	_
69	29	(	(	CD	30	nummod	15766	15767	_	I-content-25298	_	_	_
69	30	0	0	CD	36	nsubj	15767	15768	_	I-content-25298	_	_	_
69	31	,	,	,	30	punct	15768	15769	_	I-content-25298	_	_	_
69	32	1	1	CD	30	amod	15770	15771	_	I-content-25298	_	_	_
69	33	,	,	,	30	punct	15771	15772	_	I-content-25298	_	_	_
69	34	6	6	CD	35	nummod	15773	15774	_	I-content-25298	_	_	_
69	35	months	month	NNS	30	nmod:tmod	15775	15781	_	I-content-25298	_	_	_
69	36	)	)	VBP	20	advcl	15781	15782	_	I-content-25298	_	_	_
69	37	.42	.42	CD	36	dobj	15782	15785	_	_	_	_	_
69	38	Also	also	RB	36	advmod	15786	15790	_	_	_	_	_
69	39	,	,	,	7	punct	15790	15791	_	_	_	_	_
69	40	some	some	DT	41	det	15792	15796	_	_	B-source-25299	_	_
69	41	studies	study	NNS	57	nsubj	15797	15804	B-event-211706	_	I-source-25299	_	_
69	42	,	,	,	41	punct	15804	15805	_	_	I-source-25299	_	_
69	43	in	in	IN	44	case	15806	15808	_	_	I-source-25299	_	_
69	44	particular	particular	JJ	41	nmod	15809	15819	_	_	I-source-25299	_	_
69	45	among	among	IN	46	case	15820	15825	_	_	I-source-25299	_	_
69	46	persons	person	NNS	44	nmod	15826	15833	_	_	I-source-25299	_	_
69	47	who	who	WP	48	nsubj	15834	15837	_	_	I-source-25299	_	_
69	48	inject	inject	VBP	46	acl:relcl	15838	15844	B-event-211707	_	I-source-25299	_	_
69	49	drugs	drug	NNS	48	dobj	15845	15850	_	_	I-source-25299	_	_
69	50	and/or	and/or	CC	48	cc	15851	15857	_	_	I-source-25299	_	_
69	51	inmates	inmate	NNS	48	conj	15858	15865	_	_	I-source-25299	_	_
69	52	of	of	IN	54	case	15866	15868	_	_	I-source-25299	_	_
69	53	correctional	correctional	JJ	54	amod	15869	15881	_	_	I-source-25299	_	_
69	54	facilities	facility	NNS	51	nmod	15882	15892	_	_	I-source-25299	_	_
69	55	,	,	,	41	punct	15892	15893	_	_	I-source-25299	_	_
69	56	have	have	VBP	57	aux	15894	15898	_	_	_	_	_
69	57	shown	show	VBN	0	ROOT	15899	15904	_	_	_	B-cue-25300	_
69	58	a	a	DT	60	det	15905	15906	_	B-content-25301:25299-Source_25300-Cue	_	_	_
69	59	lower	lower	JJR	60	amod	15907	15912	_	I-content-25301	_	_	_
69	60	proportion	proportion	NN	57	dobj	15913	15923	_	I-content-25301	_	_	_
69	61	of	of	IN	62	case	15924	15926	_	I-content-25301	_	_	_
69	62	subjects	subject	NNS	60	nmod	15927	15935	_	I-content-25301	_	_	_
69	63	attaining	attain	VBG	62	acl	15936	15945	B-event-211708	I-content-25301	_	_	_
69	64	the	the	DT	67	det	15946	15949	_	I-content-25301	_	_	_
69	65	seroprotective	seroprotective	JJ	67	amod	15950	15964	_	I-content-25301	_	_	_
69	66	antibody	antibody	NN	67	compound	15965	15973	_	I-content-25301	_	_	_
69	67	level	level	NN	63	dobj	15974	15979	_	I-content-25301	_	_	_
69	68	after	after	IN	70	case	15980	15985	_	I-content-25301	_	_	_
69	69	3	3	CD	70	nummod	15986	15987	_	I-content-25301	_	_	_
69	70	doses	dose	NNS	63	nmod	15988	15993	B-event-211709	I-content-25301	_	_	_
69	71	of	of	IN	74	case	15994	15996	_	I-content-25301	_	_	_
69	72	an	a	DT	74	det	15997	15999	_	I-content-25301	_	_	_
69	73	accelerated	accelerate	VBN	74	amod	16000	16011	B-event-211710	I-content-25301	_	_	_
69	74	schedule	schedule	NN	70	nmod	16012	16020	_	I-content-25301	_	_	_
69	75	than	than	IN	100	mark	16021	16025	_	I-content-25301	_	_	_
69	76	after	after	IN	80	case	16026	16031	_	I-content-25301	_	_	_
69	77	the	the	DT	80	det	16032	16035	_	I-content-25301	_	_	_
69	78	standard	standard	JJ	80	amod	16036	16044	_	I-content-25301	_	_	_
69	79	3-dose	3-dose	JJ	80	amod	16045	16051	B-event-211711	I-content-25301	_	_	_
69	80	schedule	schedule	NN	100	nmod	16052	16060	_	I-content-25301	_	_	_
69	81	.42,47,48	.42,47,48	CD	80	dep	16060	16069	_	_	_	_	_
69	82	After	after	IN	85	case	16070	16075	_	_	_	_	_
69	83	the	the	DT	85	det	16076	16079	_	_	_	_	_
69	84	4th	4th	JJ	85	amod	16080	16083	_	_	_	_	_
69	85	dose	dose	NN	80	nmod	16084	16088	B-event-211712	_	_	_	_
69	86	of	of	IN	89	case	16089	16091	_	_	_	_	_
69	87	an	a	DT	89	det	16092	16094	_	_	_	_	_
69	88	accelerated	accelerate	VBN	89	amod	16095	16106	B-event-211713	_	_	_	_
69	89	schedule	schedule	NN	85	nmod	16107	16115	_	_	_	_	_
69	90	,	,	,	85	punct	16115	16116	_	_	_	_	_
69	91	administered	administer	VBN	80	acl	16117	16129	B-event-211714	_	_	_	_
69	92	at	at	IN	94	case	16130	16132	_	_	_	_	_
69	93	12	12	CD	94	nummod	16133	16135	_	_	_	_	_
69	94	months	month	NNS	91	nmod	16136	16142	_	_	_	_	_
69	95	,	,	,	100	punct	16142	16143	_	_	_	_	_
69	96	anti-HBs	anti-hbs	JJ	98	amod	16144	16152	_	_	_	_	_
69	97	antibody	antibody	NN	98	compound	16153	16161	_	_	_	_	_
69	98	levels	level	NNS	100	nsubj	16162	16168	_	_	_	_	_
69	99	are	be	VBP	100	cop	16169	16172	_	_	_	_	_
69	100	higher	higher	JJR	57	advcl	16173	16179	_	_	_	_	_
69	101	or	or	CC	100	cc	16180	16182	_	_	_	_	_
69	102	comparable	comparable	JJ	100	conj	16183	16193	_	_	_	_	_
69	103	to	to	TO	104	case	16194	16196	_	_	_	_	_
69	104	those	those	DT	102	nmod	16197	16202	_	_	_	_	_
69	105	after	after	IN	109	case	16203	16208	_	_	_	_	_
69	106	a	a	DT	109	det	16209	16210	_	_	_	_	_
69	107	standard	standard	JJ	109	amod	16211	16219	_	_	_	_	_
69	108	3-dose	3-dose	JJ	109	amod	16220	16226	_	_	_	_	_
69	109	schedule	schedule	NN	104	nmod	16227	16235	_	_	_	_	_
69	110	.	.	.	57	punct	16235	16236	_	_	_	_	_

70	1	Hence	hence	RB	8	advmod	16237	16242	_	_	_	_	_
70	2	,	,	,	8	punct	16242	16243	_	_	_	_	_
70	3	a	a	DT	5	det	16244	16245	_	_	_	_	_
70	4	4th	4th	JJ	5	amod	16246	16249	_	_	_	_	_
70	5	dose	dose	NN	8	nsubjpass	16250	16254	B-event-211715	_	_	_	_
70	6	should	should	MD	8	aux	16255	16261	_	_	_	_	_
70	7	be	be	VB	8	auxpass	16262	16264	_	_	_	_	_
70	8	administered	administer	VBN	0	ROOT	16265	16277	B-event-211716	_	_	_	_
70	9	at	at	IN	11	case	16278	16280	_	_	_	_	_
70	10	12	12	CD	11	nummod	16281	16283	_	_	_	_	_
70	11	months	month	NNS	8	nmod	16284	16290	_	_	_	_	_
70	12	to	to	TO	13	mark	16291	16293	_	_	_	_	_
70	13	complete	complete	VB	8	xcomp	16294	16302	B-event-211717	_	_	_	_
70	14	an	a	DT	16	det	16303	16305	_	_	_	_	_
70	15	accelerated	accelerate	VBN	16	amod	16306	16317	B-event-211718	_	_	_	_
70	16	schedule	schedule	NN	13	dobj	16318	16326	_	_	_	_	_
70	17	.	.	.	8	punct	16326	16327	_	_	_	_	_

71	1	Accelerated	accelerate	VBN	0	ROOT	16328	16339	B-event-211719	_	_	_	B-claim-10412
71	2	schedules	schedule	NNS	1	dobj	16340	16349	_	_	_	_	I-claim-10412
71	3	should	should	MD	6	aux	16350	16356	_	_	_	_	I-claim-10412
71	4	only	only	RB	6	advmod	16357	16361	_	_	_	_	I-claim-10412
71	5	be	be	VB	6	auxpass	16362	16364	_	_	_	_	I-claim-10412
71	6	used	use	VBN	1	auxpass	16365	16369	B-event-211720	_	_	_	I-claim-10412
71	7	for	for	IN	9	case	16370	16373	_	_	_	_	I-claim-10412
71	8	those	those	DT	9	det	16374	16379	_	_	_	_	I-claim-10412
71	9	persons	person	NNS	6	nmod	16380	16387	_	_	_	_	I-claim-10412
71	10	with	with	IN	13	case	16388	16392	_	_	_	_	I-claim-10412
71	11	an	a	DT	13	det	16393	16395	_	_	_	_	I-claim-10412
71	12	imminent	imminent	JJ	13	amod	16396	16404	_	_	_	_	I-claim-10412
71	13	risk	risk	NN	6	nmod	16405	16409	B-event-211721	_	_	_	I-claim-10412
71	14	of	of	IN	15	case	16410	16412	_	_	_	_	I-claim-10412
71	15	exposure	exposure	NN	13	nmod	16413	16421	B-event-211722	_	_	_	I-claim-10412
71	16	,	,	,	13	punct	16421	16422	_	_	_	_	I-claim-10412
71	17	such	such	JJ	19	case	16423	16427	_	_	_	_	I-claim-10412
71	18	as	as	IN	17	mwe	16428	16430	_	_	_	_	I-claim-10412
71	19	those	those	DT	13	nmod	16431	16436	_	_	_	_	I-claim-10412
71	20	intending	intend	VBG	19	acl	16437	16446	_	_	_	_	I-claim-10412
71	21	to	to	TO	22	mark	16447	16449	_	_	_	_	I-claim-10412
71	22	travel	travel	VB	20	xcomp	16450	16456	B-event-211723	_	_	_	I-claim-10412
71	23	to	to	TO	25	case	16457	16459	_	_	_	_	I-claim-10412
71	24	hepatitis	hepatitis	NN	25	compound	16460	16469	B-event-211724	_	_	_	I-claim-10412
71	25	B	b	NN	22	nmod	16470	16471	I-event-211724	_	_	_	I-claim-10412
71	26	endemic	endemic	JJ	27	amod	16472	16479	_	_	_	_	I-claim-10412
71	27	areas	area	NNS	1	nsubjpass	16480	16485	_	_	_	_	I-claim-10412
71	28	with	with	IN	32	case	16486	16490	_	_	_	_	I-claim-10412
71	29	a	a	DT	32	det	16491	16492	_	_	_	_	I-claim-10412
71	30	very	very	RB	31	advmod	16493	16497	_	_	_	_	I-claim-10412
71	31	limited	limited	JJ	32	amod	16498	16505	_	_	_	_	I-claim-10412
71	32	time	time	NN	27	nmod	16506	16510	_	_	_	_	I-claim-10412
71	33	before	before	IN	34	case	16511	16517	_	_	_	_	I-claim-10412
71	34	departure	departure	NN	32	nmod	16518	16527	B-event-211725	_	_	_	I-claim-10412
71	35	.	.	.	1	punct	16527	16528	_	_	_	_	_

72	1	As	as	IN	15	mark	16529	16531	_	_	_	_	_
72	2	higher	higher	JJR	4	amod	16532	16538	_	_	_	_	_
72	3	seroprotective	seroprotective	JJ	4	amod	16539	16553	_	_	_	_	_
72	4	rates	rate	NNS	15	nsubjpass	16554	16559	_	_	_	_	_
72	5	after	after	IN	8	case	16560	16565	_	_	_	_	_
72	6	the	the	DT	8	det	16566	16569	_	_	_	_	_
72	7	3rd	3rd	JJ	8	amod	16570	16573	_	_	_	_	_
72	8	dose	dose	NN	4	nmod	16574	16578	B-event-211726	_	_	_	_
72	9	of	of	IN	13	case	16579	16581	_	_	_	_	_
72	10	an	a	DT	13	det	16582	16584	_	_	_	_	_
72	11	accelerated	accelerate	VBN	13	amod	16585	16596	B-event-211727	_	_	_	_
72	12	4-dose	4-dose	NN	13	compound	16597	16603	_	_	_	_	_
72	13	schedule	schedule	NN	8	nmod	16604	16612	_	_	_	_	_
72	14	are	be	VBP	15	auxpass	16613	16616	_	_	_	_	_
72	15	seen	see	VBN	43	advcl	16617	16621	_	_	_	_	_
72	16	after	after	IN	18	case	16622	16627	_	_	_	_	_
72	17	the	the	DT	18	det	16628	16631	_	_	_	_	_
72	18	0	0	CD	15	nmod	16632	16633	_	_	_	_	_
72	19	,	,	,	18	punct	16633	16634	_	_	_	_	_
72	20	1	1	CD	18	amod	16635	16636	_	_	_	_	_
72	21	,	,	,	18	punct	16636	16637	_	_	_	_	_
72	22	2	2	CD	18	amod	16638	16639	_	_	_	_	_
72	23	,	,	,	18	punct	16639	16640	_	_	_	_	_
72	24	12	12	CD	25	nummod	16641	16643	_	_	_	_	_
72	25	months	month	NNS	18	appos	16644	16650	_	_	_	_	_
72	26	schedule	schedule	NN	25	dep	16651	16659	_	_	_	_	_
72	27	than	than	IN	30	case	16660	16664	_	_	_	_	_
72	28	after	after	IN	30	case	16665	16670	_	_	_	_	_
72	29	the	the	DT	30	det	16671	16674	_	_	_	_	_
72	30	0	0	CD	15	nmod	16675	16676	_	_	_	_	_
72	31	,	,	,	30	punct	16676	16677	_	_	_	_	_
72	32	7	7	CD	30	amod	16678	16679	_	_	_	_	_
72	33	,	,	,	30	punct	16679	16680	_	_	_	_	_
72	34	21	21	CD	35	nummod	16681	16683	_	_	_	_	_
72	35	days	day	NNS	30	appos	16684	16688	_	_	_	_	_
72	36	,	,	,	30	punct	16688	16689	_	_	_	_	_
72	37	12	12	CD	38	nummod	16690	16692	_	_	_	_	_
72	38	months	month	NNS	30	appos	16693	16699	_	_	_	_	_
72	39	schedule	schedule	NN	38	dep	16700	16708	_	_	_	_	_
72	40	,	,	,	43	punct	16708	16709	_	_	_	_	_
72	41	it	it	PRP	43	nsubjpass	16710	16712	_	_	_	_	_
72	42	is	be	VBZ	43	auxpass	16713	16715	_	_	_	_	_
72	43	recommended	recommend	VBN	0	ROOT	16716	16727	_	_	_	B-cue-25302	_
72	44	that	that	IN	50	mark	16728	16732	_	B-content-25303:25302-Cue	_	_	_
72	45	the	the	DT	47	det	16733	16736	_	I-content-25303	_	_	_
72	46	latter	latter	JJ	47	amod	16737	16743	_	I-content-25303	_	_	_
72	47	schedule	schedule	NN	50	nsubjpass	16744	16752	_	I-content-25303	_	_	_
72	48	only	only	RB	50	advmod	16753	16757	_	I-content-25303	_	_	_
72	49	be	be	VB	50	auxpass	16758	16760	_	I-content-25303	_	_	_
72	50	used	use	VBN	43	ccomp	16761	16765	B-event-211728	I-content-25303	_	_	_
72	51	in	in	IN	53	case	16766	16768	_	I-content-25303	_	_	_
72	52	exceptional	exceptional	JJ	53	amod	16769	16780	_	I-content-25303	_	_	_
72	53	circumstances	circumstance	NNS	50	nmod	16781	16794	_	I-content-25303	_	_	_
72	54	.	.	.	43	punct	16794	16795	_	_	_	_	_

73	1	Combination	combination	NN	8	compound	16796	16807	_	_	_	_	_
73	2	hepatitis	hepatitis	NN	8	compound	16808	16817	_	_	_	_	_
73	3	A/hepatitis	a/hepatitis	NN	8	compound	16818	16829	_	_	_	_	_
73	4	B	b	NN	8	compound	16830	16831	_	_	_	_	_
73	5	vaccine	vaccine	NN	8	compound	16832	16839	_	_	_	_	_
73	6	schedules	schedule	NNS	8	dep	16840	16849	_	_	_	_	_
73	7	The	the	DT	8	det	16850	16853	_	_	_	_	_
73	8	schedules	schedule	NNS	16	nsubjpass	16854	16863	_	_	_	_	_
73	9	for	for	IN	14	case	16864	16867	_	_	_	_	_
73	10	combination	combination	NN	14	compound	16868	16879	_	_	_	_	_
73	11	hepatitis	hepatitis	NN	14	compound	16880	16889	_	_	_	_	_
73	12	A/hepatitis	a/hepatitis	NN	14	compound	16890	16901	_	_	_	_	_
73	13	B	b	NN	14	compound	16902	16903	_	_	_	_	_
73	14	vaccines	vaccine	NNS	8	nmod	16904	16912	B-event-211729	_	_	_	_
73	15	are	be	VBP	16	auxpass	16913	16916	_	_	_	_	_
73	16	shown	show	VBN	0	ROOT	16917	16922	_	_	_	_	_
73	17	in	in	IN	18	case	16923	16925	_	_	_	_	_
73	18	Table	Table	NNP	16	nmod	16926	16931	_	_	_	_	_
73	19	4.5.1	4.5.1	CD	20	compound	16932	16937	_	_	_	_	_
73	20	(	(	CD	18	dep	16938	16939	_	_	_	_	_
73	21	and	and	CC	18	cc	16939	16942	_	_	_	_	_
73	22	4.4	4.4	CD	25	nummod	16943	16946	_	_	_	_	_
73	23	Hepatitis	Hepatitis	NNP	25	compound	16947	16956	_	_	_	_	_
73	24	A	A	NNP	25	compound	16957	16958	_	_	_	_	_
73	25	)	)	NN	18	conj	16958	16959	_	_	_	_	_
73	26	.	.	.	16	punct	16959	16960	_	_	_	_	_

74	1	Three-dose	three-dose	JJ	2	amod	16961	16971	B-event-211730	_	_	_	B-claim-10413
74	2	schedules	schedule	NNS	12	nsubj	16972	16981	_	_	_	_	I-claim-10413
74	3	for	for	IN	4	case	16982	16985	_	_	_	_	I-claim-10413
74	4	adults	adult	NNS	2	nmod	16986	16992	_	_	_	_	I-claim-10413
74	5	and	and	CC	4	cc	16993	16996	_	_	_	_	I-claim-10413
74	6	children	child	NNS	4	conj	16997	17005	_	_	_	_	I-claim-10413
74	7	aged	aged	JJ	4	amod	17006	17010	_	_	_	_	I-claim-10413
74	8	<	<	JJR	7	dep	17011	17012	_	_	_	_	I-claim-10413
74	9	16	16	CD	10	nummod	17012	17014	_	_	_	_	I-claim-10413
74	10	years	year	NNS	2	nmod:tmod	17015	17020	_	_	_	_	I-claim-10413
74	11	are	be	VBP	12	cop	17021	17024	_	_	_	_	I-claim-10413
74	12	acceptable	acceptable	JJ	0	ROOT	17025	17035	_	_	_	_	I-claim-10413
74	13	;	;	:	12	punct	17035	17036	_	_	_	_	I-claim-10413
74	14	however	however	RB	35	advmod	17037	17044	_	_	_	_	I-claim-10413
74	15	,	,	,	35	punct	17044	17045	_	_	_	_	I-claim-10413
74	16	a	a	DT	18	det	17046	17047	_	_	_	_	I-claim-10413
74	17	2-dose	2-dose	JJ	18	amod	17048	17054	_	_	_	_	I-claim-10413
74	18	schedule	schedule	NN	35	nsubj	17055	17063	_	_	_	_	I-claim-10413
74	19	in	in	IN	20	case	17064	17066	_	_	_	_	I-claim-10413
74	20	children	child	NNS	18	nmod	17067	17075	_	_	_	_	I-claim-10413
74	21	1	1	CD	22	compound	17076	17077	_	_	_	_	I-claim-10413
74	22	–	–	CD	20	amod	17077	17078	_	_	_	_	I-claim-10413
74	23	15	15	CD	24	nummod	17078	17080	_	_	_	_	I-claim-10413
74	24	years	year	NNS	22	nmod:tmod	17081	17086	_	_	_	_	I-claim-10413
74	25	of	of	IN	26	case	17087	17089	_	_	_	_	I-claim-10413
74	26	age	age	NN	20	nmod	17090	17093	_	_	_	_	I-claim-10413
74	27	,	,	,	20	punct	17093	17094	_	_	_	_	I-claim-10413
74	28	using	use	VBG	20	acl	17095	17100	B-event-211731	_	_	_	I-claim-10413
74	29	Twinrix	Twinrix	NNP	28	dobj	17101	17108	_	_	_	_	I-claim-10413
74	30	(	(	CD	31	compound	17109	17110	_	_	_	_	I-claim-10413
74	31	720/20	720/20	CD	32	nummod	17110	17116	_	_	_	_	I-claim-10413
74	32	)	)	NN	29	dep	17116	17117	_	_	_	_	I-claim-10413
74	33	,	,	,	29	punct	17117	17118	_	_	_	_	I-claim-10413
74	34	also	also	RB	29	advmod	17119	17123	_	_	_	_	I-claim-10413
74	35	results	result	VBZ	12	parataxis	17124	17131	_	_	_	_	I-claim-10413
74	36	in	in	IN	39	case	17132	17134	_	_	_	_	I-claim-10413
74	37	protective	protective	JJ	39	amod	17135	17145	B-event-211732	_	_	_	I-claim-10413
74	38	antibody	antibody	NN	39	compound	17146	17154	_	_	_	_	I-claim-10413
74	39	levels	level	NNS	35	nmod	17155	17161	_	_	_	_	I-claim-10413
74	40	for	for	IN	43	case	17162	17165	_	_	_	_	I-claim-10413
74	41	both	both	DT	43	cc:preconj	17166	17170	_	_	_	_	I-claim-10413
74	42	hepatitis	hepatitis	NN	43	compound	17171	17180	_	_	_	_	I-claim-10413
74	43	A	a	NN	39	nmod	17181	17182	_	_	_	_	I-claim-10413
74	44	and	and	CC	43	cc	17183	17186	_	_	_	_	I-claim-10413
74	45	hepatitis	hepatitis	NN	46	compound	17187	17196	_	_	_	_	I-claim-10413
74	46	B	b	NN	43	conj	17197	17198	_	_	_	_	I-claim-10413
74	47	.	.	.	12	punct	17198	17199	_	_	_	_	_

75	1	An	a	DT	3	det	17200	17202	_	_	_	_	_
75	2	accelerated	accelerate	VBN	3	amod	17203	17214	B-event-211733	_	_	_	_
75	3	schedule	schedule	NN	17	nsubjpass	17215	17223	_	_	_	_	_
75	4	for	for	IN	9	case	17224	17227	_	_	_	_	_
75	5	combination	combination	NN	9	compound	17228	17239	_	_	_	_	_
75	6	hepatitis	hepatitis	NN	9	compound	17240	17249	_	_	_	_	_
75	7	A/hepatitis	a/hepatitis	NN	9	compound	17250	17261	_	_	_	_	_
75	8	B	b	NN	9	compound	17262	17263	_	_	_	_	_
75	9	vaccine	vaccine	NN	3	nmod	17264	17271	_	_	_	_	_
75	10	in	in	IN	13	case	17272	17274	_	_	_	_	_
75	11	those	those	DT	13	det	17275	17280	_	_	_	_	_
75	12	aged	aged	JJ	13	amod	17281	17285	_	_	_	_	_
75	13	≥	≥	NN	9	nmod	17286	17287	_	_	_	_	_
75	14	16	16	CD	15	nummod	17287	17289	_	_	_	_	_
75	15	years	year	NNS	3	nmod:tmod	17290	17295	_	_	_	_	_
75	16	is	be	VBZ	17	auxpass	17296	17298	_	_	_	_	_
75	17	shown	show	VBN	0	ROOT	17299	17304	_	_	_	_	_
75	18	in	in	IN	19	case	17305	17307	_	_	_	_	_
75	19	Table	Table	NNP	17	nmod	17308	17313	_	_	_	_	_
75	20	4.5.2	4.5.2	CD	19	nummod	17314	17319	_	_	_	_	_
75	21	.	.	.	17	punct	17319	17320	_	_	_	_	_

76	1	above	above	RB	0	ROOT	17321	17326	_	_	_	_	_
76	2	.	.	.	1	punct	17326	17327	_	_	_	_	_

77	1	The	the	DT	3	det	17328	17331	_	_	_	_	_
77	2	appropriate	appropriate	JJ	3	amod	17332	17343	_	_	_	_	_
77	3	use	use	NN	8	nsubjpass	17344	17347	_	_	_	_	_
77	4	of	of	IN	6	case	17348	17350	_	_	_	_	_
77	5	accelerated	accelerate	VBN	6	amod	17351	17362	B-event-211734	_	_	_	_
77	6	schedules	schedule	NNS	3	nmod	17363	17372	_	_	_	_	_
77	7	is	be	VBZ	8	auxpass	17373	17375	_	_	_	_	_
77	8	discussed	discuss	VBN	0	ROOT	17376	17385	_	_	_	_	_
77	9	above	above	IN	8	nmod	17386	17391	_	_	_	_	_
77	10	.	.	.	8	punct	17391	17392	_	_	_	_	_

78	1	The	the	DT	2	det	17393	17396	_	B-content-25304:25305-Cue	_	_	_
78	2	use	use	NN	23	nsubjpass	17397	17400	_	I-content-25304	_	_	_
78	3	of	of	IN	6	case	17401	17403	_	I-content-25304	_	_	_
78	4	mixed	mixed	JJ	6	amod	17404	17409	_	I-content-25304	_	_	_
78	5	vaccine	vaccine	NN	6	compound	17410	17417	B-event-211735	I-content-25304	_	_	_
78	6	schedules	schedule	NNS	2	nmod	17418	17427	_	I-content-25304	_	_	_
78	7	using	use	VBG	6	acl	17428	17433	_	I-content-25304	_	_	_
78	8	both	both	CC	14	cc:preconj	17434	17438	_	I-content-25304	_	_	_
78	9	the	the	DT	14	det	17439	17442	_	I-content-25304	_	_	_
78	10	combination	combination	NN	14	compound	17443	17454	_	I-content-25304	_	_	_
78	11	hepatitis	hepatitis	NN	14	compound	17455	17464	_	I-content-25304	_	_	_
78	12	A/hepatitis	a/hepatitis	NN	14	compound	17465	17476	_	I-content-25304	_	_	_
78	13	B	b	NN	14	compound	17477	17478	_	I-content-25304	_	_	_
78	14	vaccine	vaccine	NN	7	dobj	17479	17486	B-event-211736	I-content-25304	_	_	_
78	15	and	and	CC	14	cc	17487	17490	_	I-content-25304	_	_	_
78	16	monovalent	monovalent	JJ	19	amod	17491	17501	_	I-content-25304	_	_	_
78	17	hepatitis	hepatitis	NN	19	compound	17502	17511	_	I-content-25304	_	_	_
78	18	B	b	NN	19	compound	17512	17513	_	I-content-25304	_	_	_
78	19	vaccines	vaccine	NNS	14	conj	17514	17522	B-event-211737	I-content-25304	_	_	_
78	20	is	be	VBZ	23	auxpass	17523	17525	_	_	_	_	_
78	21	not	not	RB	23	neg	17526	17529	_	_	_	_	_
78	22	routinely	routinely	RB	23	advmod	17530	17539	_	_	_	_	_
78	23	recommended	recommend	VBN	0	ROOT	17540	17551	_	_	_	B-cue-25305	_
78	24	.	.	.	23	punct	17551	17552	_	_	_	_	_

79	1	Generally	generally	RB	11	advmod	17553	17562	_	_	_	_	_
79	2	,	,	,	11	punct	17562	17563	_	_	_	_	_
79	3	use	use	NN	11	nsubjpass	17564	17567	_	B-content-25306:25307-Cue	_	_	_
79	4	of	of	IN	7	case	17568	17570	_	I-content-25306	_	_	_
79	5	the	the	DT	7	det	17571	17574	_	I-content-25306	_	_	_
79	6	same	same	JJ	7	amod	17575	17579	_	I-content-25306	_	_	_
79	7	brand	brand	NN	3	nmod	17580	17585	_	I-content-25306	_	_	_
79	8	of	of	IN	9	case	17586	17588	_	I-content-25306	_	_	_
79	9	vaccine	vaccine	NN	7	nmod	17589	17596	B-event-211738	I-content-25306	_	_	_
79	10	is	be	VBZ	11	auxpass	17597	17599	_	_	_	_	_
79	11	recommended	recommend	VBN	0	ROOT	17600	17611	_	_	_	B-cue-25307	_
79	12	.	.	.	11	punct	17611	17612	_	_	_	_	_

80	1	(	(	NN	2	compound	17613	17614	_	_	_	_	_
80	2	Refer	refer	NN	0	ROOT	17614	17619	_	_	_	_	_
80	3	also	also	RB	2	dep	17620	17624	_	_	_	_	_
80	4	to	to	TO	6	case	17625	17627	_	_	_	_	_
80	5	‘	‘	CD	6	nummod	17628	17629	_	_	_	_	_
80	6	Interchangeability	interchangeability	NN	3	nmod	17629	17647	_	_	_	_	_
80	7	of	of	IN	10	case	17648	17650	_	_	_	_	_
80	8	hepatitis	hepatitis	NN	10	compound	17651	17660	_	_	_	_	_
80	9	B	b	NN	10	compound	17661	17662	_	_	_	_	_
80	10	vaccines	vaccine	NNS	6	nmod	17663	17671	_	_	_	_	_
80	11	’	’	VBP	10	acl:relcl	17671	17672	_	_	_	_	_
80	12	in	in	IN	13	case	17673	17675	_	_	_	_	_
80	13	4.5.6	4.5.6	CD	3	advcl	17676	17681	_	_	_	_	_
80	14	Dosage	dosage	NN	13	advmod	17682	17688	_	_	_	_	_
80	15	and	and	CC	14	cc	17689	17692	_	_	_	_	_
80	16	administration	administration	NN	14	conj	17693	17707	_	_	_	_	_
80	17	below	below	IN	14	case	17708	17713	_	_	_	_	_
80	18	.	.	.	13	punct	17713	17714	_	_	_	_	_
80	19	)	)	SYM	2	dep	17714	17715	_	_	_	_	_

81	1	4.5.5	4.5.5	CD	2	nummod	17716	17721	_	_	_	_	_
81	2	Transport	transport	NN	0	ROOT	17722	17731	B-event-212483	_	_	_	_
81	3	,	,	,	2	punct	17731	17732	_	_	_	_	_
81	4	storage	storage	NN	2	appos	17733	17740	B-event-212484	_	_	_	_
81	5	and	and	CC	4	cc	17741	17744	_	_	_	_	_
81	6	handling	handle	VBG	4	conj	17745	17753	B-event-212485	_	_	_	_
81	7	Transport	transport	NN	21	compound	17754	17763	B-event-211739	_	_	_	_
81	8	according	accord	VBG	13	case	17764	17773	_	_	_	_	_
81	9	to	to	TO	8	mwe	17774	17776	_	_	_	_	_
81	10	National	National	NNP	13	compound	17777	17785	_	_	_	_	_
81	11	vaccine	vaccine	NN	13	compound	17786	17793	_	_	_	_	_
81	12	storage	storage	NN	13	compound	17794	17801	_	_	_	_	_
81	13	guidelines	guideline	NNS	21	nmod	17802	17812	_	_	_	_	_
81	14	:	:	:	13	punct	17812	17813	_	_	_	_	_
81	15	Strive	strive	VB	13	dep	17814	17820	_	_	_	_	_
81	16	for	for	IN	18	case	17821	17824	_	_	_	_	_
81	17	5.46	5.46	CD	18	nummod	17825	17829	_	_	_	_	_
81	18	Store	store	NN	15	nmod	17830	17835	_	_	_	_	_
81	19	at	at	IN	20	case	17836	17838	_	_	_	_	_
81	20	+2	+2	CD	18	nmod	17839	17841	_	_	_	_	_
81	21	ï	ï	NN	2	dep	17841	17842	_	_	_	_	_
81	22	¿	¿	CD	24	nummod	17842	17843	_	_	_	_	_
81	23	½	½	NN	24	compound	17843	17844	_	_	_	_	_
81	24	C	c	NN	21	dep	17844	17845	_	_	_	_	_
81	25	to	to	TO	27	case	17846	17848	_	_	_	_	_
81	26	+8	+8	CD	27	nummod	17849	17851	_	_	_	_	_
81	27	ï	ï	NN	24	nmod	17851	17852	_	_	_	_	_
81	28	¿	¿	CD	29	compound	17852	17853	_	_	_	_	_
81	29	½	½	CD	30	nummod	17853	17854	_	_	_	_	_
81	30	C.	C.	NNP	33	nsubj	17854	17856	_	_	_	_	_
81	31	Do	do	VBP	33	aux	17857	17859	_	_	_	_	_
81	32	not	not	RB	33	neg	17860	17863	_	_	_	_	_
81	33	freeze	freeze	VB	27	acl:relcl	17864	17870	_	_	_	_	_
81	34	.	.	.	2	punct	17870	17871	_	_	_	_	_

82	1	Infanrix	Infanrix	NNP	2	compound	17872	17880	_	_	_	_	B-claim-10415
82	2	hexa	hexa	NN	5	nsubjpass	17881	17885	_	_	_	_	I-claim-10415
82	3	must	must	MD	5	aux	17886	17890	_	_	_	_	I-claim-10415
82	4	be	be	VB	5	auxpass	17891	17893	_	_	_	_	I-claim-10415
82	5	reconstituted	reconstitute	VBN	0	ROOT	17894	17907	B-event-211740	_	_	_	I-claim-10415
82	6	by	by	IN	7	mark	17908	17910	_	_	_	_	I-claim-10415
82	7	adding	add	VBG	5	advcl	17911	17917	B-event-211741	_	_	_	I-claim-10415
82	8	the	the	DT	10	det	17918	17921	_	_	_	_	I-claim-10415
82	9	entire	entire	JJ	10	amod	17922	17928	_	_	_	_	I-claim-10415
82	10	contents	contents	NNS	7	dobj	17929	17937	_	_	_	_	I-claim-10415
82	11	of	of	IN	13	case	17938	17940	_	_	_	_	I-claim-10415
82	12	the	the	DT	13	det	17941	17944	_	_	_	_	I-claim-10415
82	13	syringe	syringe	NN	10	nmod	17945	17952	_	_	_	_	I-claim-10415
82	14	to	to	TO	16	case	17953	17955	_	_	_	_	I-claim-10415
82	15	the	the	DT	16	det	17956	17959	_	_	_	_	I-claim-10415
82	16	vial	vial	NN	7	nmod	17960	17964	_	_	_	_	I-claim-10415
82	17	and	and	CC	7	cc	17965	17968	_	_	_	_	I-claim-10415
82	18	shaking	shake	VBG	7	conj	17969	17976	B-event-211742	_	_	_	I-claim-10415
82	19	until	until	IN	24	mark	17977	17982	_	_	_	_	I-claim-10415
82	20	the	the	DT	21	det	17983	17986	_	_	_	_	I-claim-10415
82	21	pellet	pellet	NN	24	nsubjpass	17987	17993	_	_	_	_	I-claim-10415
82	22	is	be	VBZ	24	auxpass	17994	17996	_	_	_	_	I-claim-10415
82	23	completely	completely	RB	24	advmod	17997	18007	_	_	_	_	I-claim-10415
82	24	dissolved	dissolve	VBN	18	advcl	18008	18017	B-event-211743	_	_	_	I-claim-10415
82	25	.	.	.	5	punct	18017	18018	_	_	_	_	_

83	1	Reconstituted	reconstitute	VBN	5	csubjpass	18019	18032	B-event-211744	_	_	_	B-claim-10414
83	2	vaccine	vaccine	NN	1	dobj	18033	18040	B-event-211745	_	_	_	I-claim-10414
83	3	should	should	MD	5	aux	18041	18047	_	_	_	_	I-claim-10414
83	4	be	be	VB	5	auxpass	18048	18050	_	_	_	_	I-claim-10414
83	5	used	use	VBN	0	ROOT	18051	18055	_	_	_	_	I-claim-10414
83	6	as	as	IN	7	case	18056	18058	_	_	_	_	I-claim-10414
83	7	soon	soon	RB	5	advmod	18059	18063	_	_	_	_	I-claim-10414
83	8	as	as	IN	9	case	18064	18066	_	_	_	_	I-claim-10414
83	9	practicable	practicable	JJ	5	advcl	18067	18078	_	_	_	_	I-claim-10414
83	10	.	.	.	5	punct	18078	18079	_	_	_	_	_

84	1	If	if	IN	4	mark	18080	18082	_	_	_	_	_
84	2	storage	storage	NN	4	nsubj	18083	18090	B-event-211746	_	_	_	_
84	3	is	be	VBZ	4	cop	18091	18093	_	_	_	_	_
84	4	necessary	necessary	JJ	6	advcl	18094	18103	_	_	_	_	_
84	5	,	,	,	6	punct	18103	18104	_	_	_	_	_
84	6	hold	hold	VB	0	ROOT	18105	18109	_	_	_	_	_
84	7	at	at	IN	9	case	18110	18112	_	_	_	_	_
84	8	room	room	NN	9	compound	18113	18117	_	_	_	_	_
84	9	temperature	temperature	NN	6	nmod	18118	18129	_	_	_	_	_
84	10	for	for	IN	15	case	18130	18133	_	_	_	_	_
84	11	not	not	RB	14	advmod	18134	18137	_	_	_	_	_
84	12	more	more	JJR	14	advmod	18138	18142	_	_	_	_	_
84	13	than	than	IN	12	mwe	18143	18147	_	_	_	_	_
84	14	8	8	CD	15	nummod	18148	18149	_	_	_	_	_
84	15	hours	hour	NNS	9	nmod	18150	18155	_	_	_	_	_
84	16	.	.	.	6	punct	18155	18156	_	_	_	_	_

85	1	4.5.6	4.5.6	CD	17	nummod	18157	18162	_	_	_	_	_
85	2	Dosage	dosage	NN	17	compound	18163	18169	_	_	_	_	_
85	3	and	and	CC	2	cc	18170	18173	_	_	_	_	_
85	4	administration	administration	NN	2	conj	18174	18188	B-event-211747	_	_	_	_
85	5	The	the	DT	6	det	18189	18192	_	_	_	_	_
85	6	schedules	schedule	NNS	2	dep	18193	18202	_	_	_	_	_
85	7	for	for	IN	10	case	18203	18206	_	_	_	_	_
85	8	hepatitis	hepatitis	NN	10	compound	18207	18216	_	_	_	_	_
85	9	B	b	NN	10	compound	18217	18218	_	_	_	_	_
85	10	vaccines	vaccine	NNS	6	nmod	18219	18227	B-event-211748	_	_	_	_
85	11	and	and	CC	2	cc	18228	18231	_	_	_	_	_
85	12	for	for	IN	16	case	18232	18235	_	_	_	_	_
85	13	combination	combination	NN	16	compound	18236	18247	_	_	_	_	_
85	14	hepatitis	hepatitis	NN	16	compound	18248	18257	_	_	_	_	_
85	15	A/hepatitis	a/hepatitis	NN	16	compound	18258	18269	_	_	_	_	_
85	16	B	b	NN	2	conj	18270	18271	_	_	_	_	_
85	17	vaccines	vaccine	NNS	19	nsubjpass	18272	18280	B-event-211749	_	_	_	_
85	18	are	be	VBP	19	auxpass	18281	18284	_	_	_	_	_
85	19	shown	show	VBN	0	ROOT	18285	18290	_	_	_	_	_
85	20	in	in	IN	21	case	18291	18293	_	_	_	_	_
85	21	Table	Table	NNP	19	nmod	18294	18299	_	_	_	_	_
85	22	4.5.1	4.5.1	CD	21	nummod	18300	18305	_	_	_	_	_
85	23	and	and	CC	21	cc	18306	18309	_	_	_	_	_
85	24	4.5.2	4.5.2	CD	21	conj	18310	18315	_	_	_	_	_
85	25	.	.	.	19	punct	18315	18316	_	_	_	_	_

86	1	For	for	IN	6	case	18317	18320	_	_	_	_	_
86	2	combination	combination	NN	6	compound	18321	18332	_	_	_	_	_
86	3	hepatitis	hepatitis	NN	6	compound	18333	18342	_	_	_	_	_
86	4	A/hepatitis	a/hepatitis	NN	6	compound	18343	18354	_	_	_	_	_
86	5	B	b	NN	6	compound	18355	18356	_	_	_	_	_
86	6	vaccines	vaccine	NNS	8	dep	18357	18365	_	_	_	_	_
86	7	,	,	,	8	punct	18365	18366	_	_	_	_	_
86	8	refer	refer	VBP	0	ROOT	18367	18372	_	_	_	_	_
86	9	also	also	RB	8	advmod	18373	18377	_	_	_	_	_
86	10	to	to	TO	11	case	18378	18380	_	_	_	_	_
86	11	4.4	4.4	CD	8	nmod	18381	18384	_	_	_	_	_
86	12	Hepatitis	Hepatitis	NNP	13	compound	18386	18395	_	_	_	_	_
86	13	A	A	NNP	8	nsubj	18396	18397	_	_	_	_	_
86	14	.	.	.	8	punct	18397	18398	_	_	_	_	_

87	1	The	the	DT	2	det	18399	18402	_	_	_	_	_
87	2	dose	dose	NN	10	dep	18403	18407	_	_	_	_	_
87	3	of	of	IN	4	case	18408	18410	_	_	_	_	_
87	4	Engerix-B	engerix-b	NN	2	nmod	18411	18420	_	_	_	_	_
87	5	and	and	CC	4	cc	18421	18424	_	_	_	_	_
87	6	H-B-Vax	h-b-vax	NN	4	conj	18425	18432	_	_	_	_	_
87	7	II	ii	CD	8	nummod	18433	18435	_	_	_	_	_
87	8	(	(	NN	10	dep	18436	18437	_	_	_	_	_
87	9	paediatric	paediatric	JJ	10	amod	18437	18447	_	_	_	_	_
87	10	formulations	formulation	NNS	20	dep	18448	18460	_	_	_	_	_
87	11	)	)	CD	10	dep	18460	18461	_	_	_	_	_
87	12	and	and	CC	11	cc	18462	18465	_	_	_	_	_
87	13	Twinrix	Twinrix	NNP	14	compound	18466	18473	_	_	_	_	_
87	14	Junior	Junior	NNP	11	conj	18474	18480	_	_	_	_	_
87	15	(	(	CD	16	compound	18481	18482	_	_	_	_	_
87	16	360/10	360/10	CD	17	nummod	18482	18488	_	_	_	_	_
87	17	)	)	NN	20	nsubj	18488	18489	_	_	_	_	_
87	18	is	be	VBZ	20	cop	18490	18492	_	_	_	_	_
87	19	0.5	0.5	CD	20	nummod	18493	18496	_	_	_	_	_
87	20	mL	ml	NN	0	ROOT	18497	18499	_	_	_	_	_
87	21	,	,	,	20	punct	18499	18500	_	_	_	_	_
87	22	to	to	TO	24	mark	18501	18503	_	_	_	_	_
87	23	be	be	VB	24	auxpass	18504	18506	_	_	_	_	_
87	24	given	give	VBN	20	advcl	18507	18512	_	_	_	_	_
87	25	by	by	IN	27	case	18513	18515	_	_	_	_	_
87	26	IM	im	NN	27	compound	18516	18518	_	_	_	_	_
87	27	injection	injection	NN	24	nmod	18519	18528	B-event-211750	_	_	_	_
87	28	.	.	.	20	punct	18528	18529	_	_	_	_	_

88	1	The	the	DT	2	det	18530	18533	_	_	_	_	_
88	2	dose	dose	NN	10	dep	18534	18538	_	_	_	_	_
88	3	of	of	IN	4	case	18539	18541	_	_	_	_	_
88	4	Engerix-B	engerix-b	NN	2	nmod	18542	18551	_	_	_	_	_
88	5	and	and	CC	4	cc	18552	18555	_	_	_	_	_
88	6	H-B-Vax	h-b-vax	NN	4	conj	18556	18563	_	_	_	_	_
88	7	II	ii	CD	8	nummod	18564	18566	_	_	_	_	_
88	8	(	(	NN	10	dep	18567	18568	_	_	_	_	_
88	9	adult	adult	JJ	10	amod	18568	18573	_	_	_	_	_
88	10	formulations	formulation	NNS	19	dep	18574	18586	_	_	_	_	_
88	11	)	)	CD	10	dep	18586	18587	_	_	_	_	_
88	12	and	and	CC	11	cc	18588	18591	_	_	_	_	_
88	13	Twinrix	Twinrix	NNP	11	conj	18592	18599	_	_	_	_	_
88	14	(	(	CD	15	compound	18600	18601	_	_	_	_	_
88	15	720/20	720/20	CD	16	nummod	18601	18607	_	_	_	_	_
88	16	)	)	NN	19	nsubj	18607	18608	_	_	_	_	_
88	17	is	be	VBZ	19	cop	18609	18611	_	_	_	_	_
88	18	1.0	1.0	CD	19	nummod	18612	18615	_	_	_	_	_
88	19	mL	ml	NN	0	ROOT	18616	18618	_	_	_	_	_
88	20	,	,	,	19	punct	18618	18619	_	_	_	_	_
88	21	to	to	TO	23	mark	18620	18622	_	_	_	_	_
88	22	be	be	VB	23	auxpass	18623	18625	_	_	_	_	_
88	23	given	give	VBN	19	advcl	18626	18631	_	_	_	_	_
88	24	by	by	IN	26	case	18632	18634	_	_	_	_	_
88	25	IM	im	NN	26	compound	18635	18637	_	_	_	_	_
88	26	injection	injection	NN	23	nmod	18638	18647	B-event-211751	_	_	_	_
88	27	.	.	.	19	punct	18647	18648	_	_	_	_	_

89	1	The	the	DT	2	det	18650	18653	_	_	_	_	_
89	2	dose	dose	NN	8	nsubj	18654	18658	_	_	_	_	_
89	3	of	of	IN	5	case	18659	18661	_	_	_	_	_
89	4	Infanrix	Infanrix	NNP	5	compound	18662	18670	_	_	_	_	_
89	5	hexa	hexa	NN	2	nmod	18671	18675	_	_	_	_	_
89	6	is	be	VBZ	8	cop	18676	18678	_	_	_	_	_
89	7	0.5	0.5	CD	8	nummod	18679	18682	_	_	_	_	_
89	8	mL	ml	NN	0	ROOT	18683	18685	_	_	_	_	_
89	9	,	,	,	8	punct	18685	18686	_	_	_	_	_
89	10	to	to	TO	12	mark	18687	18689	_	_	_	_	_
89	11	be	be	VB	12	auxpass	18690	18692	_	_	_	_	_
89	12	given	give	VBN	8	advcl	18693	18698	_	_	_	_	_
89	13	by	by	IN	15	case	18699	18701	_	_	_	_	_
89	14	IM	im	NN	15	compound	18702	18704	_	_	_	_	_
89	15	injection	injection	NN	12	nmod	18705	18714	B-event-211752	_	_	_	_
89	16	.	.	.	8	punct	18714	18715	_	_	_	_	_

90	1	Hepatitis	Hepatitis	NNP	2	compound	18716	18725	_	_	_	_	_
90	2	B	B	NNP	12	nsubj	18726	18727	_	_	_	_	_
90	3	and	and	CC	2	cc	18728	18731	_	_	_	_	_
90	4	combination	combination	NN	6	compound	18732	18743	_	_	_	_	_
90	5	hepatitis	hepatitis	NN	6	compound	18744	18753	_	_	_	_	_
90	6	A/hepatitis	a/hepatitis	NN	2	conj	18754	18765	_	_	_	_	_
90	7	B	b	NN	8	compound	18766	18767	_	_	_	_	_
90	8	vaccines	vaccine	NNS	6	dep	18768	18776	B-event-211754	_	_	_	_
90	9	can	can	MD	12	aux	18777	18780	_	_	_	_	_
90	10	generally	generally	RB	12	advmod	18781	18790	_	_	_	_	_
90	11	be	be	VB	12	cop	18791	18793	_	_	_	_	_
90	12	co-administered	co-administered	JJ	0	ROOT	18794	18809	B-event-211753	_	_	_	_
90	13	simultaneously	simultaneously	RB	12	nmod	18810	18824	_	_	_	_	_
90	14	with	with	IN	13	nmod	18825	18829	_	_	_	_	_
90	15	,	,	,	13	punct	18829	18830	_	_	_	_	_
90	16	or	or	CC	13	cc	18831	18833	_	_	_	_	_
90	17	at	at	IN	19	case	18834	18836	_	_	_	_	_
90	18	any	any	DT	19	det	18837	18840	_	_	_	_	_
90	19	time	time	NN	13	conj	18841	18845	_	_	_	_	_
90	20	before	before	IN	21	case	18846	18852	_	_	_	_	_
90	21	or	or	CC	12	advmod	18853	18855	_	_	_	_	_
90	22	after	after	IN	21	case	18856	18861	_	_	_	_	_
90	23	,	,	,	12	punct	18861	18862	_	_	_	_	_
90	24	all	all	DT	26	det	18863	18866	_	_	_	_	_
90	25	other	other	JJ	26	amod	18867	18872	_	_	_	_	_
90	26	vaccines	vaccine	NNS	12	dep	18873	18881	B-event-211755	_	_	_	_
90	27	.	.	.	12	punct	18881	18882	_	_	_	_	_

91	1	Interchangeability	interchangeability	NN	13	nsubjpass	18884	18902	_	_	_	_	_
91	2	of	of	IN	5	case	18903	18905	_	_	_	_	_
91	3	hepatitis	hepatitis	NN	5	compound	18906	18915	_	_	_	_	_
91	4	B	b	NN	5	compound	18916	18917	_	_	_	_	_
91	5	vaccines	vaccine	NNS	1	nmod	18918	18926	_	_	_	_	_
91	6	The	the	DT	7	det	18927	18930	_	_	_	_	_
91	7	Engerix-B	engerix-b	NN	5	dep	18931	18940	_	_	_	_	_
91	8	and	and	CC	5	cc	18941	18944	_	_	_	_	_
91	9	H-B-Vax	h-b-vax	NN	5	conj	18945	18952	_	_	_	_	_
91	10	II	ii	CD	11	nummod	18953	18955	_	_	_	_	_
91	11	vaccines	vaccine	NNS	9	dep	18956	18964	_	_	_	_	_
91	12	are	be	VBP	13	auxpass	18965	18968	_	_	_	_	_
91	13	manufactured	manufacture	VBN	0	ROOT	18969	18981	B-event-211756	_	_	_	_
91	14	by	by	IN	16	case	18982	18984	_	_	_	_	_
91	15	different	different	JJ	16	amod	18985	18994	_	_	_	_	_
91	16	processes	process	NNS	13	nmod	18995	19004	_	_	_	_	_
91	17	,	,	,	13	punct	19004	19005	_	_	_	_	_
91	18	and	and	CC	13	cc	19006	19009	_	_	_	_	_
91	19	the	the	DT	21	det	19010	19013	_	_	_	_	_
91	20	HBsAg	hbsag	NN	21	compound	19014	19019	_	_	_	_	_
91	21	content	content	NN	29	nsubj	19020	19027	_	_	_	_	_
91	22	of	of	IN	27	case	19028	19030	_	_	_	_	_
91	23	an	a	DT	27	det	19031	19033	_	_	_	_	_
91	24	‘	‘	NN	27	compound	19034	19035	_	_	_	_	_
91	25	equivalent	equivalent	JJ	27	amod	19035	19045	_	_	_	_	_
91	26	’	’	NN	27	compound	19045	19046	_	_	_	_	_
91	27	dose	dose	NN	21	nmod	19047	19051	_	_	_	_	_
91	28	is	be	VBZ	29	cop	19052	19054	_	_	_	_	_
91	29	different	different	JJ	13	conj	19055	19064	_	_	_	_	_
91	30	.	.	.	13	punct	19064	19065	_	_	_	_	_

92	1	Although	although	IN	8	mark	19066	19074	_	_	_	_	_
92	2	switching	switching	NN	8	nsubjpass	19075	19084	B-event-211757	B-content-25308:25309-Cue	_	_	_
92	3	of	of	IN	5	case	19085	19087	_	I-content-25308	_	_	_
92	4	vaccine	vaccine	NN	5	compound	19088	19095	_	I-content-25308	_	_	_
92	5	brands	brand	NNS	2	nmod	19096	19102	_	I-content-25308	_	_	_
92	6	is	be	VBZ	8	auxpass	19103	19105	_	_	_	_	_
92	7	not	not	RB	8	neg	19106	19109	_	_	_	_	_
92	8	recommended	recommend	VBN	40	advcl	19110	19121	_	_	_	B-cue-25309	_
92	9	,	,	,	8	punct	19121	19122	_	_	_	_	_
92	10	in	in	IN	11	case	19123	19125	_	_	_	_	_
92	11	cases	case	NNS	8	nmod	19126	19131	_	_	_	_	_
92	12	where	where	WRB	23	advmod	19132	19137	_	_	_	_	_
92	13	the	the	DT	14	det	19138	19141	_	_	_	_	_
92	14	brand	brand	NN	23	nsubjpass	19142	19147	_	_	_	_	_
92	15	of	of	IN	16	case	19148	19150	_	_	_	_	_
92	16	vaccine	vaccine	NN	14	nmod	19151	19158	_	_	_	_	_
92	17	used	use	VBN	16	acl	19159	19163	_	_	_	_	_
92	18	for	for	IN	20	case	19164	19167	_	_	_	_	_
92	19	previous	previous	JJ	20	amod	19168	19176	_	_	_	_	_
92	20	doses	dose	NNS	17	nmod	19177	19182	B-event-211758	_	_	_	_
92	21	is	be	VBZ	23	auxpass	19183	19185	_	_	_	_	_
92	22	not	not	RB	23	neg	19186	19189	_	_	_	_	_
92	23	known	know	VBN	11	acl:relcl	19190	19195	_	_	_	_	_
92	24	,	,	,	40	punct	19195	19196	_	_	_	_	_
92	25	another	another	DT	30	det	19197	19204	_	_	_	_	_
92	26	age-appropriate	age-appropriate	JJ	30	amod	19205	19220	_	_	_	_	_
92	27	‘	‘	NN	30	compound	19221	19222	_	_	_	_	_
92	28	equivalent	equivalent	JJ	30	amod	19222	19232	_	_	_	_	_
92	29	’	’	NN	30	compound	19232	19233	_	_	_	_	_
92	30	dose	dose	NN	40	nsubjpass	19234	19238	B-event-211759	_	_	_	_
92	31	brand	brand	NN	33	nsubj	19239	19244	_	_	_	_	_
92	32	(	(	CD	31	nummod	19245	19246	_	_	_	_	_
92	33	refer	refer	VBP	30	acl:relcl	19246	19251	_	_	_	_	_
92	34	to	to	TO	37	case	19252	19254	_	_	_	_	_
92	35	Table	Table	NNP	37	compound	19255	19260	_	_	_	_	_
92	36	4.5.1	4.5.1	CD	37	nummod	19261	19266	_	_	_	_	_
92	37	)	)	NN	33	nmod	19266	19267	_	_	_	_	_
92	38	may	may	MD	40	aux	19268	19271	_	_	_	_	_
92	39	be	be	VB	40	auxpass	19272	19274	_	_	_	_	_
92	40	used	use	VBN	0	ROOT	19275	19279	_	_	_	_	_
92	41	.	.	.	40	punct	19279	19280	_	_	_	_	_

93	1	For	for	IN	2	case	19281	19284	_	_	_	_	_
93	2	example	example	NN	9	nmod	19285	19292	_	_	_	_	_
93	3	,	,	,	9	punct	19292	19293	_	_	_	_	_
93	4	a	a	DT	5	det	19294	19295	_	_	_	_	_
93	5	study	study	NN	9	nsubj	19296	19301	B-event-211760	_	_	_	_
93	6	in	in	IN	8	case	19302	19304	_	_	_	_	_
93	7	healthy	healthy	JJ	8	amod	19305	19312	_	_	_	_	_
93	8	neonates	neonate	NNS	5	nmod	19313	19321	_	_	_	_	_
93	9	demonstrated	demonstrate	VBD	0	ROOT	19322	19334	B-event-211761	_	_	_	_
93	10	comparable	comparable	JJ	12	amod	19335	19345	_	_	_	_	_
93	11	high	high	JJ	12	amod	19346	19350	_	_	_	_	_
93	12	levels	level	NNS	45	nsubj	19351	19357	_	_	_	_	_
93	13	of	of	IN	14	case	19358	19360	_	_	_	_	_
93	14	immunogenicity	immunogenicity	NN	12	nmod	19361	19375	_	_	_	_	_
93	15	between	between	IN	19	case	19376	19383	_	_	_	_	_
93	16	two	two	CD	19	nummod	19384	19387	_	_	_	_	_
93	17	different	different	JJ	19	amod	19388	19397	_	_	_	_	_
93	18	mixed	mixed	JJ	19	amod	19398	19403	_	_	_	_	_
93	19	regimens	regimen	NNS	14	nmod	19404	19412	_	_	_	_	_
93	20	that	that	WDT	21	nsubj	19413	19417	_	_	_	_	_
93	21	used	use	VBD	19	acl:relcl	19418	19422	_	_	_	_	_
93	22	two	two	CD	26	nummod	19423	19426	_	_	_	_	_
93	23	monovalent	monovalent	JJ	26	amod	19427	19437	_	_	_	_	_
93	24	hepatitis	hepatitis	NN	26	compound	19438	19447	_	_	_	_	_
93	25	B	b	NN	26	compound	19448	19449	_	_	_	_	_
93	26	vaccines	vaccine	NNS	21	dobj	19450	19458	B-event-211762	_	_	_	_
93	27	from	from	IN	29	case	19459	19463	_	_	_	_	_
93	28	different	different	JJ	29	amod	19464	19473	_	_	_	_	_
93	29	manufacturers	manufacturer	NNS	26	nmod	19474	19487	B-event-211763	_	_	_	_
93	30	.50	.50	CD	21	nmod:tmod	19487	19490	_	_	_	_	_
93	31	As	as	IN	33	mark	19491	19493	_	_	_	_	_
93	32	there	there	EX	33	expl	19494	19499	_	_	_	_	_
93	33	is	be	VBZ	21	advcl	19500	19502	_	_	_	_	_
93	34	only	only	RB	36	advmod	19503	19507	_	_	_	_	_
93	35	one	one	CD	36	nummod	19508	19511	_	_	_	_	_
93	36	brand	brand	NN	33	nsubj	19512	19517	_	_	_	_	_
93	37	of	of	IN	42	case	19518	19520	_	_	_	_	_
93	38	combination	combination	NN	42	compound	19521	19532	_	_	_	_	_
93	39	hepatitis	hepatitis	NN	42	compound	19533	19542	_	_	_	_	_
93	40	A/hepatitis	a/hepatitis	NN	42	compound	19543	19554	_	_	_	_	_
93	41	B	b	NN	42	compound	19555	19556	_	_	_	_	_
93	42	vaccine	vaccine	NN	36	nmod	19557	19564	_	_	_	_	_
93	43	,	,	,	42	punct	19564	19565	_	_	_	_	_
93	44	interchangeability	interchangeability	NN	42	appos	19566	19584	_	_	_	_	_
93	45	is	be	VBZ	9	ccomp	19585	19587	_	_	_	_	_
93	46	not	not	RB	45	neg	19588	19591	_	_	_	_	_
93	47	relevant	relevant	JJ	45	xcomp	19592	19600	_	_	_	_	_
93	48	.	.	.	9	punct	19600	19601	_	_	_	_	_

94	1	(	(	NN	2	compound	19602	19603	_	_	_	_	_
94	2	Refer	refer	NN	0	ROOT	19603	19608	_	_	_	_	_
94	3	also	also	RB	2	dep	19609	19613	_	_	_	_	_
94	4	to	to	TO	11	case	19614	19616	_	_	_	_	_
94	5	‘	‘	CD	11	nummod	19617	19618	_	_	_	_	_
94	6	Combination	combination	NN	11	compound	19618	19629	_	_	_	_	_
94	7	hepatitis	hepatitis	NN	11	compound	19630	19639	_	_	_	_	_
94	8	A/hepatitis	a/hepatitis	NN	11	compound	19640	19651	_	_	_	_	_
94	9	B	b	NN	11	compound	19652	19653	_	_	_	_	_
94	10	vaccine	vaccine	NN	11	compound	19654	19661	_	_	_	_	_
94	11	schedules	schedule	NNS	3	nmod	19662	19671	_	_	_	_	_
94	12	’	’	VBP	11	acl:relcl	19671	19672	_	_	_	_	_
94	13	in	in	IN	15	case	19673	19675	_	_	_	_	_
94	14	4.5.4	4.5.4	CD	15	nummod	19676	19681	_	_	_	_	_
94	15	Vaccines	vaccine	NNS	3	advcl	19682	19690	_	_	_	_	_
94	16	above	above	IN	15	advmod	19691	19696	_	_	_	_	_
94	17	.	.	.	15	punct	19696	19697	_	_	_	_	_
94	18	)	)	SYM	2	dep	19697	19698	_	_	_	_	_

95	1	4.5.7	4.5.7	CD	2	nummod	19700	19705	_	_	_	_	_
95	2	Recommendations	recommendation	NNS	18	nsubjpass	19706	19721	B-event-212486	_	_	_	_
95	3	Infants	Infants	NNPS	2	dep	19722	19729	_	_	_	_	_
95	4	and	and	CC	2	cc	19730	19733	_	_	_	_	_
95	5	young	young	JJ	6	amod	19734	19739	_	_	_	_	_
95	6	children	child	NNS	2	conj	19740	19748	_	_	_	_	_
95	7	The	the	DT	12	det	19749	19752	_	_	_	_	_
95	8	recommended	recommend	VBN	12	amod	19753	19764	B-event-211764	_	_	_	_
95	9	hepatitis	hepatitis	NN	12	compound	19765	19774	_	_	_	_	_
95	10	B	b	NN	12	compound	19775	19776	_	_	_	_	_
95	11	vaccine	vaccine	NN	12	compound	19777	19784	_	_	_	_	_
95	12	schedule	schedule	NN	6	nmod	19785	19793	_	_	_	_	_
95	13	for	for	IN	14	case	19794	19797	_	_	_	_	_
95	14	infants	infant	NNS	12	nmod	19798	19805	_	_	_	_	_
95	15	from	from	IN	16	case	19806	19810	_	_	_	_	_
95	16	birth	birth	NN	14	nmod	19811	19816	_	_	_	_	_
95	17	is	be	VBZ	18	auxpass	19817	19819	_	_	_	_	_
95	18	shown	show	VBN	0	ROOT	19820	19825	_	_	_	_	_
95	19	in	in	IN	20	case	19826	19828	_	_	_	_	_
95	20	Table	Table	NNP	18	nmod	19829	19834	_	_	_	_	_
95	21	4.5.1	4.5.1	CD	20	nummod	19835	19840	_	_	_	_	_
95	22	.	.	.	18	punct	19840	19841	_	_	_	_	_

96	1	A	a	DT	3	det	19842	19843	_	B-content-25310:25311-Cue	_	_	_
96	2	birth	birth	NN	3	compound	19844	19849	_	I-content-25310	_	_	_
96	3	dose	dose	NN	12	nsubjpass	19850	19854	_	I-content-25310	_	_	_
96	4	of	of	IN	10	case	19855	19857	_	I-content-25310	_	_	_
96	5	monovalent	monovalent	JJ	6	amod	19858	19868	_	I-content-25310	_	_	_
96	6	paediatric	paediatric	JJ	10	amod	19869	19879	_	I-content-25310	_	_	_
96	7	formulation	formulation	NN	10	compound	19880	19891	_	I-content-25310	_	_	_
96	8	hepatitis	hepatitis	NN	10	compound	19892	19901	_	I-content-25310	_	_	_
96	9	B	b	NN	10	compound	19902	19903	_	I-content-25310	_	_	_
96	10	vaccine	vaccine	NN	3	nmod	19904	19911	B-event-211765	I-content-25310	_	_	_
96	11	is	be	VBZ	12	auxpass	19912	19914	_	_	_	_	_
96	12	recommended	recommend	VBN	0	ROOT	19915	19926	_	_	_	B-cue-25311	_
96	13	for	for	IN	16	case	19927	19930	_	_	_	_	_
96	14	all	all	DT	16	det	19931	19934	_	_	_	_	_
96	15	newborn	newborn	JJ	16	amod	19935	19942	_	_	_	_	_
96	16	infants	infant	NNS	12	nmod	19943	19950	_	_	_	_	_
96	17	.	.	.	12	punct	19950	19951	_	_	_	_	_

97	1	Following	follow	VBG	4	case	19952	19961	_	_	_	_	_
97	2	this	this	DT	4	det	19962	19966	_	_	_	_	_
97	3	birth	birth	NN	4	compound	19967	19972	_	_	_	_	_
97	4	dose	dose	NN	19	nmod	19973	19977	B-event-211766	_	_	_	_
97	5	,	,	,	19	punct	19977	19978	_	_	_	_	_
97	6	3	3	CD	7	nummod	19979	19980	_	_	_	_	_
97	7	doses	dose	NNS	19	nsubjpass	19981	19986	_	_	_	_	_
97	8	of	of	IN	12	case	19987	19989	_	_	_	_	_
97	9	a	a	DT	12	det	19990	19991	_	_	_	_	_
97	10	hepatitis-B-containing	hepatitis-b-containing	JJ	12	amod	19992	20014	_	_	_	_	_
97	11	vaccine	vaccine	NN	12	compound	20015	20022	B-event-211767	_	_	_	_
97	12	(	(	NN	7	nmod	20023	20024	_	_	_	_	_
97	13	usually	usually	RB	14	advmod	20024	20031	_	_	_	_	_
97	14	provided	provide	VBN	12	acl	20032	20040	_	_	_	_	_
97	15	as	as	IN	17	case	20041	20043	_	_	_	_	_
97	16	DTPa-hepB-IPV-Hib	dtpa-hepb-ipv-hib	JJ	17	amod	20044	20061	_	_	_	_	_
97	17	)	)	NN	14	nmod	20061	20062	_	_	_	_	_
97	18	are	be	VBP	19	auxpass	20063	20066	_	_	_	_	_
97	19	recommended	recommend	VBN	0	ROOT	20067	20078	B-event-211768	_	_	_	_
97	20	for	for	IN	22	case	20079	20082	_	_	_	_	_
97	21	all	all	DT	22	det	20083	20086	_	_	_	_	_
97	22	children	child	NNS	19	nmod	20087	20095	_	_	_	_	_
97	23	,	,	,	19	punct	20095	20096	_	_	_	_	_
97	24	at	at	IN	25	case	20097	20099	_	_	_	_	_
97	25	2	2	CD	19	nmod	20100	20101	_	_	_	_	_
97	26	,	,	,	19	punct	20101	20102	_	_	_	_	_
97	27	4	4	CD	30	compound	20103	20104	_	_	_	_	_
97	28	and	and	CC	27	cc	20105	20108	_	_	_	_	_
97	29	6	6	CD	27	conj	20109	20110	_	_	_	_	_
97	30	months	month	NNS	19	dobj	20111	20117	_	_	_	_	_
97	31	of	of	IN	32	case	20118	20120	_	_	_	_	_
97	32	age	age	NN	30	nmod	20121	20124	_	_	_	_	_
97	33	.	.	.	19	punct	20124	20125	_	_	_	_	_

98	1	Thus	thus	RB	13	advmod	20126	20130	_	_	_	_	_
98	2	,	,	,	13	punct	20130	20131	_	_	_	_	_
98	3	a	a	DT	4	det	20132	20133	_	_	_	_	_
98	4	total	total	NN	13	nsubjpass	20134	20139	_	_	_	_	_
98	5	of	of	IN	7	case	20140	20142	_	_	_	_	_
98	6	4	4	CD	7	nummod	20143	20144	_	_	_	_	_
98	7	doses	dose	NNS	4	nmod	20145	20150	_	_	_	_	_
98	8	of	of	IN	11	case	20151	20153	_	_	_	_	_
98	9	hepatitis	hepatitis	NN	11	compound	20154	20163	_	_	_	_	_
98	10	B	b	NN	11	compound	20164	20165	_	_	_	_	_
98	11	vaccine	vaccine	NN	7	nmod	20166	20173	B-event-211769	_	_	_	_
98	12	are	be	VBP	13	auxpass	20174	20177	_	_	_	_	_
98	13	provided	provide	VBN	0	ROOT	20178	20186	_	_	_	_	_
98	14	in	in	IN	17	case	20187	20189	_	_	_	_	_
98	15	the	the	DT	17	det	20190	20193	_	_	_	_	_
98	16	1st	1st	CD	17	nummod	20194	20197	_	_	_	_	_
98	17	year	year	NN	13	nmod	20198	20202	_	_	_	_	_
98	18	of	of	IN	19	case	20203	20205	_	_	_	_	_
98	19	life	life	NN	17	nmod	20206	20210	_	_	_	_	_
98	20	.	.	.	13	punct	20210	20211	_	_	_	_	_

99	1	The	the	DT	3	det	20212	20215	_	_	_	_	_
99	2	1st	1st	JJ	3	amod	20216	20219	_	_	_	_	_
99	3	dose	dose	NN	11	nsubjpass	20220	20224	_	_	_	_	_
99	4	of	of	IN	8	case	20225	20227	_	_	_	_	_
99	5	a	a	DT	8	det	20228	20229	_	_	_	_	_
99	6	hepatitis	hepatitis	NN	8	compound	20230	20239	_	_	_	_	_
99	7	B-containing	b-containing	JJ	8	amod	20240	20252	_	_	_	_	_
99	8	vaccine	vaccine	NN	3	nmod	20253	20260	B-event-211770	_	_	_	_
99	9	can	can	MD	11	aux	20261	20264	_	_	_	_	_
99	10	be	be	VB	11	auxpass	20265	20267	_	_	_	_	_
99	11	given	give	VBN	0	ROOT	20268	20273	_	_	_	_	_
99	12	as	as	RB	13	advmod	20274	20276	_	_	_	_	_
99	13	early	early	RB	11	advmod	20277	20282	_	_	_	_	_
99	14	as	as	IN	16	case	20283	20285	_	_	_	_	_
99	15	6	6	CD	16	nummod	20286	20287	_	_	_	_	_
99	16	weeks	week	NNS	11	nmod	20288	20293	_	_	_	_	_
99	17	of	of	IN	18	case	20294	20296	_	_	_	_	_
99	18	age	age	NN	16	nmod	20297	20300	_	_	_	_	_
99	19	.	.	.	11	punct	20300	20301	_	_	_	_	_

100	1	If	if	IN	6	mark	20302	20304	_	_	_	_	_
100	2	the	the	DT	4	det	20305	20308	_	_	_	_	_
100	3	1st	1st	JJ	4	amod	20309	20312	_	_	_	_	_
100	4	dose	dose	NN	6	nsubjpass	20313	20317	B-event-211771	_	_	_	_
100	5	is	be	VBZ	6	auxpass	20318	20320	_	_	_	_	_
100	6	given	give	VBN	20	advcl	20321	20326	_	_	_	_	_
100	7	at	at	IN	9	case	20327	20329	_	_	_	_	_
100	8	6	6	CD	9	nummod	20330	20331	_	_	_	_	_
100	9	weeks	week	NNS	6	nmod	20332	20337	_	_	_	_	_
100	10	of	of	IN	11	case	20338	20340	_	_	_	_	_
100	11	age	age	NN	9	nmod	20341	20344	_	_	_	_	_
100	12	,	,	,	20	punct	20344	20345	_	_	_	_	_
100	13	the	the	DT	16	det	20346	20349	_	_	_	_	_
100	14	next	next	JJ	16	amod	20350	20354	_	_	_	_	_
100	15	scheduled	scheduled	JJ	16	amod	20355	20364	_	_	_	_	_
100	16	doses	dose	NNS	20	nsubjpass	20365	20370	B-event-211772	_	_	_	_
100	17	should	should	MD	20	aux	20371	20377	_	_	_	_	_
100	18	still	still	RB	20	advmod	20378	20383	_	_	_	_	_
100	19	be	be	VB	20	auxpass	20384	20386	_	_	_	_	_
100	20	given	give	VBN	0	ROOT	20387	20392	_	_	_	_	_
100	21	at	at	IN	23	case	20393	20395	_	_	_	_	_
100	22	4	4	CD	23	nummod	20396	20397	_	_	_	_	_
100	23	months	month	NNS	20	nmod	20398	20404	_	_	_	_	_
100	24	and	and	CC	23	cc	20405	20408	_	_	_	_	_
100	25	6	6	CD	26	nummod	20409	20410	_	_	_	_	_
100	26	months	month	NNS	23	conj	20411	20417	_	_	_	_	_
100	27	of	of	IN	28	case	20418	20420	_	_	_	_	_
100	28	age	age	NN	26	nmod	20421	20424	_	_	_	_	_
100	29	.	.	.	20	punct	20424	20425	_	_	_	_	_

101	1	If	if	IN	6	mark	20427	20429	_	_	_	_	_
101	2	an	a	DT	3	det	20430	20432	_	_	_	_	_
101	3	infant	infant	NN	6	nsubj	20433	20439	_	_	_	_	_
101	4	has	have	VBZ	6	aux	20440	20443	_	_	_	_	_
101	5	not	not	RB	6	neg	20444	20447	_	_	_	_	_
101	6	received	receive	VBN	30	advcl	20448	20456	_	_	_	_	_
101	7	a	a	DT	9	det	20457	20458	_	_	_	_	_
101	8	birth	birth	NN	9	compound	20459	20464	_	_	_	_	_
101	9	dose	dose	NN	6	dobj	20465	20469	B-event-211773	_	_	_	_
101	10	within	within	IN	14	case	20470	20476	_	_	_	_	_
101	11	the	the	DT	14	det	20477	20480	_	_	_	_	_
101	12	1st	1st	JJ	14	amod	20481	20484	_	_	_	_	_
101	13	7	7	CD	14	nummod	20485	20486	_	_	_	_	_
101	14	days	day	NNS	6	nmod	20487	20491	_	_	_	_	_
101	15	of	of	IN	16	case	20492	20494	_	_	_	_	_
101	16	life	life	NN	14	nmod	20495	20499	_	_	_	_	_
101	17	,	,	,	30	punct	20499	20500	_	_	_	_	_
101	18	a	a	DT	21	det	20501	20502	_	_	_	_	_
101	19	primary	primary	JJ	21	amod	20503	20510	_	_	_	_	_
101	20	3-dose	3-dose	NN	21	compound	20511	20517	_	_	_	_	_
101	21	course	course	NN	30	nsubjpass	20518	20524	_	_	_	_	_
101	22	of	of	IN	27	case	20525	20527	_	_	_	_	_
101	23	a	a	DT	27	det	20528	20529	_	_	_	_	_
101	24	hepatitis	hepatitis	NN	27	compound	20530	20539	_	_	_	_	_
101	25	B-containing	b-containing	JJ	27	amod	20540	20552	_	_	_	_	_
101	26	combination	combination	NN	27	compound	20553	20564	_	_	_	_	_
101	27	vaccine	vaccine	NN	21	nmod	20565	20572	B-event-211774	_	_	_	_
101	28	should	should	MD	30	aux	20573	20579	_	_	_	_	_
101	29	be	be	VB	30	auxpass	20580	20582	_	_	_	_	_
101	30	given	give	VBN	0	ROOT	20583	20588	_	_	_	_	_
101	31	,	,	,	30	punct	20588	20589	_	_	_	_	_
101	32	at	at	IN	33	case	20590	20592	_	_	_	_	_
101	33	2	2	CD	30	nmod	20593	20594	_	_	_	_	_
101	34	,	,	,	30	punct	20594	20595	_	_	_	_	_
101	35	4	4	CD	38	compound	20596	20597	_	_	_	_	_
101	36	and	and	CC	35	cc	20598	20601	_	_	_	_	_
101	37	6	6	CD	35	conj	20602	20603	_	_	_	_	_
101	38	months	month	NNS	30	dobj	20604	20610	_	_	_	_	_
101	39	of	of	IN	40	case	20611	20613	_	_	_	_	_
101	40	age	age	NN	38	nmod	20614	20617	_	_	_	_	_
101	41	;	;	:	30	punct	20617	20618	_	_	_	_	_
101	42	catch-up	catch-up	NN	49	nsubj	20619	20627	B-event-211775	_	_	_	_
101	43	of	of	IN	46	case	20628	20630	_	_	_	_	_
101	44	the	the	DT	46	det	20631	20634	_	_	_	_	_
101	45	birth	birth	NN	46	compound	20635	20640	_	_	_	_	_
101	46	dose	dose	NN	42	nmod	20641	20645	_	_	_	_	_
101	47	is	be	VBZ	49	cop	20646	20648	_	_	_	_	_
101	48	not	not	RB	49	neg	20649	20652	_	_	_	_	_
101	49	necessary	necessary	JJ	30	parataxis	20653	20662	_	_	_	_	_
101	50	.	.	.	30	punct	20662	20663	_	_	_	_	_

102	1	The	the	DT	2	det	20664	20667	_	_	_	_	B-claim-10417
102	2	rationale	rationale	NN	12	nsubj	20668	20677	_	_	_	_	I-claim-10417
102	3	for	for	IN	4	mark	20678	20681	_	_	_	_	I-claim-10417
102	4	recommending	recommend	VBG	2	acl	20682	20694	_	_	_	B-cue-25312	I-claim-10417
102	5	the	the	DT	7	det	20695	20698	_	B-content-25313:25312-Cue	_	_	I-claim-10417
102	6	birth	birth	NN	7	compound	20699	20704	_	I-content-25313	_	_	I-claim-10417
102	7	dose	dose	NN	4	dobj	20705	20709	B-event-211776	I-content-25313	_	_	I-claim-10417
102	8	for	for	IN	11	case	20710	20713	_	I-content-25313	_	_	I-claim-10417
102	9	all	all	DT	11	det	20714	20717	_	I-content-25313	_	_	I-claim-10417
102	10	newborn	newborn	JJ	11	amod	20718	20725	_	I-content-25313	_	_	I-claim-10417
102	11	infants	infant	NNS	4	nmod	20726	20733	_	I-content-25313	_	_	I-claim-10417
102	12	is	be	VBZ	0	ROOT	20734	20736	_	_	_	_	I-claim-10417
102	13	not	not	RB	12	neg	20737	20740	_	_	_	_	I-claim-10417
102	14	only	only	RB	12	advmod	20741	20745	_	_	_	_	I-claim-10417
102	15	to	to	TO	16	mark	20746	20748	_	_	_	_	I-claim-10417
102	16	prevent	prevent	VB	12	ccomp	20749	20756	B-event-211777	_	_	_	I-claim-10417
102	17	vertical	vertical	JJ	18	amod	20757	20765	_	_	_	_	I-claim-10417
102	18	transmission	transmission	NN	16	dobj	20766	20778	B-event-211778	_	_	_	I-claim-10417
102	19	from	from	IN	28	mark	20779	20783	_	_	_	_	I-claim-10417
102	20	a	a	DT	21	det	20784	20785	_	_	_	_	I-claim-10417
102	21	mother	mother	NN	28	nsubj	20786	20792	_	_	_	_	I-claim-10417
102	22	with	with	IN	27	case	20793	20797	_	_	_	_	I-claim-10417
102	23	chronic	chronic	JJ	27	amod	20798	20805	_	_	_	_	I-claim-10417
102	24	hepatitis	hepatitis	NN	27	compound	20806	20815	B-event-211779	_	_	_	I-claim-10417
102	25	B	b	NN	27	compound	20816	20817	I-event-211779	_	_	_	I-claim-10417
102	26	infection	infection	NN	27	compound	20818	20827	B-event-211780	_	_	_	I-claim-10417
102	27	(	(	NN	21	nmod	20828	20829	_	_	_	_	I-claim-10417
102	28	recognising	recognise	VBG	16	advcl	20829	20840	_	_	_	_	I-claim-10417
102	29	that	that	IN	33	mark	20841	20845	_	_	_	_	I-claim-10417
102	30	there	there	EX	33	expl	20846	20851	_	_	_	_	I-claim-10417
102	31	may	may	MD	33	aux	20852	20855	_	_	_	_	I-claim-10417
102	32	be	be	VB	33	cop	20856	20858	_	_	_	_	I-claim-10417
102	33	errors	error	NNS	28	ccomp	20859	20865	_	_	_	_	I-claim-10417
102	34	or	or	CC	33	cc	20866	20868	_	_	_	_	I-claim-10417
102	35	delays	delay	NNS	33	conj	20869	20875	_	_	_	_	I-claim-10417
102	36	in	in	IN	38	case	20876	20878	_	_	_	_	I-claim-10417
102	37	maternal	maternal	JJ	38	amod	20879	20887	_	_	_	_	I-claim-10417
102	38	testing	testing	NN	33	nmod	20888	20895	B-event-211781	_	_	_	I-claim-10417
102	39	,	,	,	28	punct	20895	20896	_	_	_	_	I-claim-10417
102	40	reporting	report	VBG	28	dep	20897	20906	B-event-211782	_	_	_	I-claim-10417
102	41	,	,	,	28	punct	20906	20907	_	_	_	_	I-claim-10417
102	42	communication	communication	NN	28	dobj	20908	20921	B-event-211783	_	_	_	I-claim-10417
102	43	or	or	CC	42	cc	20922	20924	_	_	_	_	I-claim-10417
102	44	appropriate	appropriate	JJ	46	amod	20925	20936	_	_	_	_	I-claim-10417
102	45	response	response	NN	46	compound	20937	20945	B-event-211784	_	_	_	I-claim-10417
102	46	)	)	NN	42	conj	20945	20946	_	_	_	_	I-claim-10417
102	47	,	,	,	16	punct	20946	20947	_	_	_	_	I-claim-10417
102	48	but	but	CC	16	cc	20948	20951	_	_	_	_	I-claim-10417
102	49	also	also	RB	51	advmod	20952	20956	_	_	_	_	I-claim-10417
102	50	to	to	TO	51	mark	20957	20959	_	_	_	_	I-claim-10417
102	51	prevent	prevent	VB	16	conj	20960	20967	B-event-211785	_	_	_	I-claim-10417
102	52	horizontal	horizontal	JJ	53	amod	20968	20978	_	_	_	_	I-claim-10417
102	53	transmission	transmission	NN	51	dobj	20979	20991	B-event-211786	_	_	_	I-claim-10417
102	54	to	to	TO	56	case	20992	20994	_	_	_	_	I-claim-10417
102	55	the	the	DT	56	det	20995	20998	_	_	_	_	I-claim-10417
102	56	infant	infant	NN	51	nmod	20999	21005	_	_	_	_	I-claim-10417
102	57	in	in	IN	60	case	21006	21008	_	_	_	_	I-claim-10417
102	58	the	the	DT	60	det	21009	21012	_	_	_	_	I-claim-10417
102	59	first	first	JJ	60	amod	21013	21018	_	_	_	_	I-claim-10417
102	60	months	month	NNS	56	nmod	21019	21025	_	_	_	_	I-claim-10417
102	61	of	of	IN	62	case	21026	21028	_	_	_	_	I-claim-10417
102	62	life	life	NN	60	nmod	21029	21033	_	_	_	_	I-claim-10417
102	63	from	from	IN	64	case	21034	21038	_	_	_	_	I-claim-10417
102	64	persons	person	NNS	51	nmod	21039	21046	_	_	_	_	I-claim-10417
102	65	with	with	IN	69	case	21047	21051	_	_	_	_	I-claim-10417
102	66	chronic	chronic	JJ	69	amod	21052	21059	_	_	_	_	I-claim-10417
102	67	hepatitis	hepatitis	NN	69	compound	21060	21069	B-event-211787	_	_	_	I-claim-10417
102	68	B	b	NN	69	compound	21070	21071	I-event-211787	_	_	_	I-claim-10417
102	69	infection	infection	NN	64	nmod	21072	21081	B-event-211788	_	_	_	I-claim-10417
102	70	who	who	WP	72	nsubj	21082	21085	_	_	_	_	I-claim-10417
102	71	are	be	VBP	72	cop	21086	21089	_	_	_	_	I-claim-10417
102	72	household	household	NN	69	acl:relcl	21090	21099	_	_	_	_	I-claim-10417
102	73	or	or	CC	72	cc	21100	21102	_	_	_	_	I-claim-10417
102	74	other	other	JJ	76	amod	21103	21108	_	_	_	_	I-claim-10417
102	75	close	close	JJ	76	amod	21109	21114	_	_	_	_	I-claim-10417
102	76	contacts	contact	NNS	72	conj	21115	21123	_	_	_	_	I-claim-10417
102	77	.48	.48	CD	76	dep	21123	21126	_	_	_	_	_
102	78	The	the	DT	80	det	21127	21130	_	_	_	_	B-claim-10416
102	79	birth	birth	NN	80	compound	21131	21136	_	_	_	_	I-claim-10416
102	80	dose	dose	NN	83	nsubjpass	21137	21141	B-event-211789	_	_	_	I-claim-10416
102	81	should	should	MD	83	aux	21142	21148	_	_	_	_	I-claim-10416
102	82	be	be	VB	83	auxpass	21149	21151	_	_	_	_	I-claim-10416
102	83	given	give	VBN	77	acl:relcl	21152	21157	_	_	_	_	I-claim-10416
102	84	as	as	RB	85	advmod	21158	21160	_	_	_	_	I-claim-10416
102	85	soon	soon	RB	83	advmod	21161	21165	_	_	_	_	I-claim-10416
102	86	as	as	IN	91	mark	21166	21168	_	_	_	_	I-claim-10416
102	87	the	the	DT	88	det	21169	21172	_	_	_	_	I-claim-10416
102	88	baby	baby	NN	91	nsubj	21173	21177	_	_	_	_	I-claim-10416
102	89	is	be	VBZ	91	cop	21178	21180	_	_	_	_	I-claim-10416
102	90	medically	medically	RB	91	advmod	21181	21190	_	_	_	_	I-claim-10416
102	91	stable	stable	JJ	85	advcl	21191	21197	_	_	_	_	I-claim-10416
102	92	,	,	,	77	punct	21197	21198	_	_	_	_	I-claim-10416
102	93	and	and	CC	77	cc	21199	21202	_	_	_	_	I-claim-10416
102	94	preferably	preferably	RB	97	advmod	21203	21213	_	_	_	_	I-claim-10416
102	95	within	within	IN	97	case	21214	21220	_	_	_	_	I-claim-10416
102	96	24	24	CD	97	nummod	21221	21223	_	_	_	_	I-claim-10416
102	97	hours	hour	NNS	77	conj	21224	21229	_	_	_	_	I-claim-10416
102	98	of	of	IN	99	case	21230	21232	_	_	_	_	I-claim-10416
102	99	birth	birth	NN	97	nmod	21233	21238	_	_	_	_	I-claim-10416
102	100	.	.	.	12	punct	21238	21239	_	_	_	_	_

103	1	Every	every	DT	2	det	21240	21245	_	_	_	_	B-claim-10418
103	2	effort	effort	NN	5	nsubjpass	21246	21252	_	_	_	_	I-claim-10418
103	3	should	should	MD	5	aux	21253	21259	_	_	_	_	I-claim-10418
103	4	be	be	VB	5	auxpass	21260	21262	_	_	_	_	I-claim-10418
103	5	made	make	VBN	0	ROOT	21263	21267	_	_	_	_	I-claim-10418
103	6	to	to	TO	7	mark	21268	21270	_	_	_	_	I-claim-10418
103	7	administer	administer	VB	5	xcomp	21271	21281	B-event-211790	_	_	_	I-claim-10418
103	8	the	the	DT	9	det	21282	21285	_	_	_	_	I-claim-10418
103	9	vaccine	vaccine	NN	7	dobj	21286	21293	B-event-211791	_	_	_	I-claim-10418
103	10	before	before	IN	11	case	21294	21300	_	_	_	_	I-claim-10418
103	11	discharge	discharge	NN	7	nmod	21301	21310	B-event-211792	_	_	_	I-claim-10418
103	12	from	from	IN	15	case	21311	21315	_	_	_	_	I-claim-10418
103	13	the	the	DT	15	det	21316	21319	_	_	_	_	I-claim-10418
103	14	obstetric	obstetric	JJ	15	amod	21320	21329	_	_	_	_	I-claim-10418
103	15	hospital	hospital	NN	7	nmod	21330	21338	_	_	_	_	I-claim-10418
103	16	or	or	CC	15	cc	21339	21341	_	_	_	_	I-claim-10418
103	17	delivery	delivery	NN	18	compound	21342	21350	_	_	_	_	I-claim-10418
103	18	unit	unit	NN	15	conj	21351	21355	_	_	_	_	I-claim-10418
103	19	.	.	.	5	punct	21355	21356	_	_	_	_	_

104	1	All	all	DT	2	det	21357	21360	_	_	_	_	B-claim-10419
104	2	newborns	newborn	NNS	14	nsubjpass	21361	21369	_	_	_	_	I-claim-10419
104	3	of	of	IN	4	case	21370	21372	_	_	_	_	I-claim-10419
104	4	mothers	mother	NNS	2	nmod	21373	21380	_	_	_	_	I-claim-10419
104	5	known	know	VBN	4	acl	21381	21386	_	_	_	_	I-claim-10419
104	6	to	to	TO	7	mark	21387	21389	_	_	_	_	I-claim-10419
104	7	have	have	VB	5	xcomp	21390	21394	_	_	_	_	I-claim-10419
104	8	chronic	chronic	JJ	11	amod	21395	21402	_	_	_	_	I-claim-10419
104	9	hepatitis	hepatitis	NN	11	compound	21403	21412	B-event-211793	_	_	_	I-claim-10419
104	10	B	b	NN	11	compound	21413	21414	I-event-211793	_	_	_	I-claim-10419
104	11	infection	infection	NN	7	dobj	21415	21424	B-event-211794	_	_	_	I-claim-10419
104	12	must	must	MD	14	aux	21425	21429	_	_	_	_	I-claim-10419
104	13	be	be	VB	14	auxpass	21430	21432	_	_	_	_	I-claim-10419
104	14	given	give	VBN	0	ROOT	21433	21438	_	_	_	_	I-claim-10419
104	15	a	a	DT	17	det	21439	21440	_	_	_	_	I-claim-10419
104	16	birth	birth	NN	17	compound	21441	21446	_	_	_	_	I-claim-10419
104	17	dose	dose	NN	14	iobj	21447	21451	_	_	_	_	I-claim-10419
104	18	of	of	IN	21	case	21452	21454	_	_	_	_	I-claim-10419
104	19	hepatitis	hepatitis	NN	21	compound	21455	21464	_	_	_	_	I-claim-10419
104	20	B	b	NN	21	compound	21465	21466	_	_	_	_	I-claim-10419
104	21	vaccine	vaccine	NN	17	nmod	21467	21474	B-event-211795	_	_	_	I-claim-10419
104	22	and	and	CC	21	cc	21475	21478	_	_	_	_	I-claim-10419
104	23	hepatitis	hepatitis	NN	25	compound	21479	21488	_	_	_	_	I-claim-10419
104	24	B	b	NN	25	compound	21489	21490	_	_	_	_	I-claim-10419
104	25	immunoglobulin	immunoglobulin	NN	21	conj	21491	21505	B-event-211796	_	_	_	I-claim-10419
104	26	(	(	CD	27	nummod	21506	21507	_	_	_	_	I-claim-10419
104	27	HBIG	hbig	NN	14	dobj	21507	21511	_	_	_	_	I-claim-10419
104	28	)	)	CD	29	nummod	21511	21512	_	_	_	_	I-claim-10419
104	29	(	(	NN	30	nsubj	21513	21514	_	_	_	_	I-claim-10419
104	30	refer	refer	VBP	27	acl:relcl	21514	21519	_	_	_	_	I-claim-10419
104	31	to	to	TO	32	mark	21520	21522	_	_	_	_	I-claim-10419
104	32	‘	‘	VB	30	xcomp	21523	21524	_	_	_	_	I-claim-10419
104	33	Management	management	NN	32	dobj	21524	21534	_	_	_	_	I-claim-10419
104	34	of	of	IN	35	case	21535	21537	_	_	_	_	I-claim-10419
104	35	infants	infant	NNS	33	nmod	21538	21545	_	_	_	_	I-claim-10419
104	36	born	bear	VBN	35	acl	21546	21550	_	_	_	_	I-claim-10419
104	37	to	to	TO	38	case	21551	21553	_	_	_	_	I-claim-10419
104	38	mothers	mother	NNS	36	nmod	21554	21561	_	_	_	_	I-claim-10419
104	39	who	who	WP	42	nsubj	21562	21565	_	_	_	_	I-claim-10419
104	40	are	be	VBP	42	cop	21566	21569	_	_	_	_	I-claim-10419
104	41	HBsAg-positive	hbsag-positive	JJ	42	amod	21570	21584	_	_	_	_	I-claim-10419
104	42	’	’	NN	38	acl:relcl	21584	21585	_	_	_	_	I-claim-10419
104	43	below	below	IN	44	case	21586	21591	_	_	_	_	I-claim-10419
104	44	)	)	NN	42	nmod	21591	21592	_	_	_	_	I-claim-10419
104	45	.	.	.	14	punct	21592	21593	_	_	_	_	_

105	1	Although	although	IN	6	mark	21594	21602	_	_	_	_	_
105	2	it	it	PRP	6	nsubjpass	21603	21605	_	B-content-25314:25315-Cue	_	_	_
105	3	is	be	VBZ	6	auxpass	21606	21608	_	_	_	_	_
105	4	not	not	RB	6	neg	21609	21612	_	_	_	_	_
105	5	routinely	routinely	RB	6	advmod	21613	21622	_	_	_	_	_
105	6	recommended	recommend	VBN	48	advcl	21623	21634	_	_	_	B-cue-25315	_
105	7	in	in	IN	8	case	21635	21637	_	_	_	_	_
105	8	Australia	Australia	NNP	6	nmod	21638	21647	_	_	_	_	_
105	9	,	,	,	48	punct	21647	21648	_	_	_	_	_
105	10	infants	infant	NNS	48	nsubjpass	21649	21656	_	_	_	_	_
105	11	or	or	CC	10	cc	21657	21659	_	_	_	_	_
105	12	toddlers	toddler	NNS	10	conj	21660	21668	_	_	_	_	_
105	13	who	who	WP	15	nsubj	21669	21672	_	_	_	_	_
105	14	have	have	VBP	15	aux	21673	21677	_	_	_	_	_
105	15	received	receive	VBN	10	acl:relcl	21678	21686	_	_	_	_	_
105	16	a	a	DT	18	det	21687	21688	_	_	_	_	_
105	17	3-dose	3-dose	JJ	18	amod	21689	21695	_	_	_	_	_
105	18	schedule	schedule	NN	15	dobj	21696	21704	_	_	_	_	_
105	19	of	of	IN	23	case	21705	21707	_	_	_	_	_
105	20	hepatitis	hepatitis	NN	23	compound	21708	21717	_	_	_	_	_
105	21	B	b	NN	23	compound	21718	21719	_	_	_	_	_
105	22	vaccine	vaccine	NN	23	compound	21720	21727	B-event-211797	_	_	_	_
105	23	(	(	NN	18	nmod	21728	21729	_	_	_	_	_
105	24	often	often	RB	25	advmod	21729	21734	_	_	_	_	_
105	25	given	give	VBN	23	acl	21735	21740	_	_	_	_	_
105	26	overseas	overseas	JJ	27	amod	21741	21749	_	_	_	_	_
105	27	)	)	NN	25	iobj	21749	21750	_	_	_	_	_
105	28	with	with	IN	29	case	21751	21755	_	_	_	_	_
105	29	doses	dose	NNS	27	nmod	21756	21761	B-event-211798	_	_	_	_
105	30	at	at	IN	31	case	21762	21764	_	_	_	_	_
105	31	birth	birth	NN	29	nmod	21765	21770	_	_	_	_	_
105	32	,	,	,	31	punct	21770	21771	_	_	_	_	_
105	33	1	1	CD	34	nummod	21772	21773	_	_	_	_	_
105	34	–	–	NN	31	appos	21773	21774	_	_	_	_	_
105	35	2	2	CD	36	nummod	21774	21775	_	_	_	_	_
105	36	months	month	NNS	29	nmod:tmod	21776	21782	_	_	_	_	_
105	37	of	of	IN	38	case	21783	21785	_	_	_	_	_
105	38	age	age	NN	27	nmod	21786	21789	_	_	_	_	_
105	39	and	and	CC	38	cc	21790	21793	_	_	_	_	_
105	40	≥	≥	NN	38	conj	21794	21795	_	_	_	_	_
105	41	6	6	CD	42	nummod	21795	21796	_	_	_	_	_
105	42	months	month	NNS	25	dobj	21797	21803	_	_	_	_	_
105	43	of	of	IN	44	case	21804	21806	_	_	_	_	_
105	44	age	age	NN	42	nmod	21807	21810	_	_	_	_	_
105	45	can	can	MD	48	aux	21811	21814	_	_	_	_	_
105	46	also	also	RB	48	advmod	21815	21819	_	_	_	_	_
105	47	be	be	VB	48	auxpass	21820	21822	_	_	_	_	_
105	48	considered	consider	VBN	0	ROOT	21823	21833	B-event-211799	_	_	_	_
105	49	fully	fully	RB	50	advmod	21834	21839	_	_	_	_	_
105	50	vaccinated	vaccinate	VBN	48	ccomp	21840	21850	B-event-211800	_	_	_	_
105	51	(	(	NN	50	dobj	21851	21852	_	_	_	_	_
105	52	refer	refer	VBP	51	acl:relcl	21852	21857	_	_	_	_	_
105	53	to	to	TO	55	case	21858	21860	_	_	_	_	_
105	54	4.5.4	4.5.4	CD	55	nummod	21861	21866	_	_	_	_	_
105	55	Vaccines	vaccine	NNS	52	nmod	21868	21876	_	_	_	_	_
105	56	,	,	,	55	punct	21876	21877	_	_	_	_	_
105	57	‘	‘	CD	55	appos	21878	21879	_	_	_	_	_
105	58	The	the	DT	61	det	21879	21882	_	_	_	_	_
105	59	standard	standard	JJ	61	amod	21883	21891	_	_	_	_	_
105	60	3-dose	3-dose	JJ	61	amod	21892	21898	_	_	_	_	_
105	61	schedule	schedule	NN	57	dep	21899	21907	_	_	_	_	_
105	62	and	and	CC	61	cc	21908	21911	_	_	_	_	_
105	63	variations	variation	NNS	64	compound	21912	21922	_	_	_	_	_
105	64	’	’	NN	61	conj	21922	21923	_	_	_	_	_
105	65	above	above	IN	66	case	21924	21929	_	_	_	_	_
105	66	)	)	NN	50	nmod	21929	21930	_	_	_	_	_
105	67	.	.	.	48	punct	21930	21931	_	_	_	_	_

106	1	The	the	DT	3	det	21932	21935	_	_	_	_	_
106	2	final	final	JJ	3	amod	21936	21941	_	_	_	_	_
106	3	dose	dose	NN	16	nsubjpass	21942	21946	_	_	_	_	_
106	4	of	of	IN	10	case	21947	21949	_	_	_	_	_
106	5	the	the	DT	10	det	21950	21953	_	_	_	_	_
106	6	primary	primary	JJ	10	amod	21954	21961	_	_	_	_	_
106	7	hepatitis	hepatitis	NN	10	compound	21962	21971	_	_	_	_	_
106	8	B	b	NN	10	compound	21972	21973	_	_	_	_	_
106	9	vaccine	vaccine	NN	10	compound	21974	21981	B-event-211803	_	_	_	_
106	10	course	course	NN	3	nmod	21982	21988	_	_	_	_	_
106	11	in	in	IN	12	case	21989	21991	_	_	_	_	_
106	12	infants	infant	NNS	10	nmod	21992	21999	_	_	_	_	_
106	13	should	should	MD	16	aux	22000	22006	_	_	_	_	_
106	14	preferably	preferably	RB	16	advmod	22007	22017	_	_	_	_	_
106	15	be	be	VB	16	auxpass	22018	22020	_	_	_	_	_
106	16	administered	administer	VBN	0	ROOT	22022	22034	B-event-211804	_	_	_	_
106	17	at	at	IN	20	case	22035	22037	_	_	_	_	_
106	18	≥	≥	CD	19	compound	22038	22039	_	_	_	_	_
106	19	24	24	CD	20	nummod	22039	22041	_	_	_	_	_
106	20	weeks	week	NNS	16	nmod	22042	22047	_	_	_	_	_
106	21	of	of	IN	22	case	22048	22050	_	_	_	_	_
106	22	age	age	NN	20	nmod	22051	22054	_	_	_	_	_
106	23	.	.	.	16	punct	22054	22055	_	_	_	_	_

107	1	However	however	RB	29	advmod	22056	22063	_	_	_	_	_
107	2	,	,	,	29	punct	22063	22064	_	_	_	_	_
107	3	if	if	IN	8	mark	22065	22067	_	_	_	_	_
107	4	the	the	DT	6	det	22068	22071	_	_	_	_	_
107	5	final	final	JJ	6	amod	22072	22077	_	_	_	_	_
107	6	dose	dose	NN	8	nsubjpass	22078	22082	B-event-211805	_	_	_	_
107	7	is	be	VBZ	8	auxpass	22083	22085	_	_	_	_	_
107	8	given	give	VBN	29	dep	22086	22091	_	_	_	_	_
107	9	at	at	IN	10	case	22092	22094	_	_	_	_	_
107	10	<	<	JJR	8	nmod	22095	22096	_	_	_	_	_
107	11	24	24	CD	12	nummod	22096	22098	_	_	_	_	_
107	12	weeks	week	NNS	10	nmod:tmod	22099	22104	_	_	_	_	_
107	13	but	but	CC	8	cc	22105	22108	_	_	_	_	_
107	14	≥	≥	CD	15	compound	22109	22110	_	_	_	_	_
107	15	16	16	CD	16	nummod	22110	22112	_	_	_	_	_
107	16	weeks	week	NNS	23	nsubj	22113	22118	_	_	_	_	_
107	17	of	of	IN	18	case	22119	22121	_	_	_	_	_
107	18	age	age	NN	16	nmod	22122	22125	_	_	_	_	_
107	19	,	,	,	23	punct	22125	22126	_	_	_	_	_
107	20	it	it	PRP	23	nsubj	22127	22129	_	_	_	_	_
107	21	is	be	VBZ	23	cop	22130	22132	_	_	_	_	_
107	22	not	not	RB	23	neg	22133	22136	_	_	_	_	_
107	23	necessary	necessary	JJ	8	conj	22137	22146	_	_	_	_	_
107	24	to	to	TO	25	mark	22147	22149	_	_	_	_	_
107	25	repeat	repeat	VB	23	xcomp	22150	22156	B-event-211806	_	_	_	_
107	26	the	the	DT	27	det	22157	22160	_	_	_	_	_
107	27	dose	dose	NN	25	dobj	22161	22165	B-event-211807	_	_	_	_
107	28	,	,	,	29	punct	22165	22166	_	_	_	_	_
107	29	provided	provide	VBD	0	ROOT	22167	22175	_	_	_	_	_
107	30	the	the	DT	32	det	22176	22179	_	_	_	_	_
107	31	minimum	minimum	JJ	32	amod	22180	22187	_	_	_	_	_
107	32	intervals	interval	NNS	29	dobj	22188	22197	_	_	_	_	_
107	33	between	between	IN	34	case	22198	22205	_	_	_	_	_
107	34	doses	dose	NNS	32	nmod	22206	22211	_	_	_	_	_
107	35	in	in	IN	36	case	22212	22214	_	_	_	_	_
107	36	Table	Table	NNP	34	nmod	22215	22220	_	_	_	_	_
107	37	2.1.7	2.1.7	CD	38	compound	22221	22226	_	_	_	_	_
107	38	(	(	CD	42	dep	22227	22228	_	_	_	_	_
107	39	in	in	IN	41	case	22228	22230	_	_	_	_	_
107	40	2.1.5	2.1.5	CD	41	nummod	22231	22236	_	_	_	_	_
107	41	ï	ï	NN	38	nmod	22236	22237	_	_	_	_	_
107	42	¿	¿	CD	32	dep	22237	22238	_	_	_	_	_
107	43	½	½	CD	44	nummod	22238	22239	_	_	_	_	_
107	44	Catch-up	catch-up	NN	42	dep	22239	22247	_	_	_	_	_
107	45	.	.	.	42	punct	22247	22248	_	_	_	_	_
107	46	)	)	SYM	32	dep	22248	22249	_	_	_	_	_

108	1	have	have	VB	3	aux	22250	22254	_	_	_	_	_
108	2	been	be	VBN	3	auxpass	22255	22259	_	_	_	_	_
108	3	met	meet	VBN	0	ROOT	22260	22263	_	_	_	_	_
108	4	.	.	.	3	punct	22263	22264	_	_	_	_	_

109	1	Management	management	NN	32	nsubj	22265	22275	_	_	_	_	_
109	2	of	of	IN	3	case	22276	22278	_	_	_	_	_
109	3	infants	infant	NNS	1	nmod	22279	22286	_	_	_	_	_
109	4	born	bear	VBN	3	acl	22287	22291	_	_	_	_	_
109	5	to	to	TO	6	case	22292	22294	_	_	_	_	_
109	6	mothers	mother	NNS	4	nmod	22295	22302	_	_	_	_	_
109	7	who	who	WP	9	nsubj	22303	22306	_	_	_	_	_
109	8	are	be	VBP	9	cop	22307	22310	_	_	_	_	_
109	9	HBsAg-positive	hbsag-positive	JJ	6	acl:relcl	22311	22325	_	_	_	_	_
109	10	Routine	routine	JJ	12	amod	22326	22333	_	B-content-25316:25317-Cue	_	_	B-claim-10420
109	11	antenatal	antenatal	JJ	12	amod	22334	22343	_	I-content-25316	_	_	I-claim-10420
109	12	screening	screening	NN	19	nsubjpass	22344	22353	B-event-211808	I-content-25316	_	_	I-claim-10420
109	13	of	of	IN	15	case	22354	22356	_	I-content-25316	_	_	I-claim-10420
109	14	pregnant	pregnant	JJ	15	amod	22357	22365	B-event-211809	I-content-25316	_	_	I-claim-10420
109	15	women	woman	NNS	12	nmod	22366	22371	_	I-content-25316	_	_	I-claim-10420
109	16	for	for	IN	17	case	22372	22375	_	I-content-25316	_	_	I-claim-10420
109	17	HBsAg	hbsag	NN	15	nmod	22376	22381	_	I-content-25316	_	_	I-claim-10420
109	18	is	be	VBZ	19	auxpass	22382	22384	_	_	_	_	I-claim-10420
109	19	recommended	recommend	VBN	9	ccomp	22385	22396	_	_	_	B-cue-25317	I-claim-10420
109	20	to	to	TO	21	mark	22397	22399	_	_	_	_	I-claim-10420
109	21	enable	enable	VB	19	xcomp	22400	22406	_	_	_	_	I-claim-10420
109	22	appropriate	appropriate	JJ	23	amod	22407	22418	_	_	_	_	I-claim-10420
109	23	management	management	NN	21	dobj	22419	22429	_	_	_	_	I-claim-10420
109	24	to	to	TO	25	mark	22430	22432	_	_	_	_	I-claim-10420
109	25	prevent	prevent	VB	21	advcl	22433	22440	B-event-211810	_	_	_	I-claim-10420
109	26	newborn	newborn	JJ	27	amod	22441	22448	_	_	_	_	I-claim-10420
109	27	infants	infant	NNS	25	dobj	22449	22456	_	_	_	_	I-claim-10420
109	28	developing	develop	VBG	25	xcomp	22457	22467	B-event-211811	_	_	_	I-claim-10420
109	29	HBV	hbv	NN	30	compound	22468	22471	B-event-211812	_	_	_	I-claim-10420
109	30	infection	infection	NN	28	dobj	22472	22481	B-event-211813	_	_	_	I-claim-10420
109	31	(	(	CD	30	nummod	22482	22483	_	_	_	_	_
109	32	refer	refer	VBP	0	ROOT	22483	22488	_	_	_	_	_
109	33	to	to	TO	36	case	22489	22491	_	_	_	_	_
109	34	4.5.2	4.5.2	CD	36	nummod	22492	22497	_	_	_	_	_
109	35	Clinical	clinical	JJ	36	amod	22498	22506	_	_	_	_	_
109	36	features	feature	NNS	32	nmod	22507	22515	_	_	_	_	_
109	37	and	and	CC	36	cc	22516	22519	_	_	_	_	_
109	38	4.5.3	4.5.3	CD	39	nummod	22520	22525	_	_	_	_	_
109	39	Epidemiology	epidemiology	NN	36	conj	22526	22538	_	_	_	_	_
109	40	above	above	IN	42	case	22539	22544	_	_	_	_	_
109	41	)	)	CD	42	nummod	22544	22545	_	_	_	_	_
109	42	.52-54	.52-54	CD	39	nmod	22545	22551	_	_	_	_	_
109	43	It	it	PRP	45	nsubj	22552	22554	_	_	_	_	_
109	44	also	also	RB	45	advmod	22555	22559	_	_	_	_	_
109	45	enables	enable	VBZ	32	ccomp	22560	22567	_	_	_	_	_
109	46	appropriate	appropriate	JJ	47	amod	22568	22579	_	_	_	_	_
109	47	follow-up	follow-up	NN	45	dobj	22580	22589	B-event-211814	_	_	_	_
109	48	and	and	CC	47	cc	22590	22593	_	_	_	_	_
109	49	management	management	NN	47	conj	22594	22604	_	_	_	_	_
109	50	of	of	IN	51	case	22605	22607	_	_	_	_	_
109	51	mothers	mother	NNS	47	nmod	22608	22615	_	_	_	_	_
109	52	who	who	WP	53	nsubj	22616	22619	_	_	_	_	_
109	53	have	have	VBP	51	acl:relcl	22620	22624	_	_	_	_	_
109	54	chronic	chronic	JJ	56	amod	22625	22632	_	_	_	_	_
109	55	HBV	hbv	NN	56	compound	22633	22636	B-event-211815	_	_	_	_
109	56	infection	infection	NN	53	dobj	22637	22646	B-event-211816	_	_	_	_
109	57	,	,	,	56	punct	22646	22647	_	_	_	_	_
109	58	identification	identification	NN	56	conj	22648	22662	_	_	_	_	_
109	59	of	of	IN	63	case	22663	22665	_	_	_	_	_
109	60	the	the	DT	63	det	22666	22669	_	_	_	_	_
109	61	HBV	hbv	NN	63	compound	22670	22673	B-event-211817	_	_	_	_
109	62	immune	immune	JJ	63	amod	22674	22680	B-event-211818	_	_	_	_
109	63	status	status	NN	58	nmod	22681	22687	_	_	_	_	_
109	64	of	of	IN	67	case	22688	22690	_	_	_	_	_
109	65	other	other	JJ	67	amod	22691	22696	_	_	_	_	_
109	66	household	household	NN	67	compound	22697	22706	_	_	_	_	_
109	67	members	member	NNS	63	nmod	22707	22714	_	_	_	_	_
109	68	,	,	,	56	punct	22714	22715	_	_	_	_	_
109	69	and	and	CC	56	cc	22716	22719	_	_	_	_	_
109	70	protection	protection	NN	56	conj	22720	22730	B-event-211819	_	_	_	_
109	71	of	of	IN	72	case	22731	22733	_	_	_	_	_
109	72	those	those	DT	70	nmod	22734	22739	_	_	_	_	_
109	73	who	who	WP	75	nsubj	22740	22743	_	_	_	_	_
109	74	are	be	VBP	75	cop	22744	22747	_	_	_	_	_
109	75	susceptible	susceptible	JJ	72	acl:relcl	22748	22759	_	_	_	_	_
109	76	to	to	TO	78	case	22760	22762	_	_	_	_	_
109	77	HBV	hbv	NN	78	compound	22763	22766	B-event-211820	_	_	_	_
109	78	infection	infection	NN	75	nmod	22767	22776	B-event-211821	_	_	_	_
109	79	.	.	.	32	punct	22776	22777	_	_	_	_	_

110	1	Infants	infant	NNS	8	nsubjpass	22779	22786	_	_	_	_	B-claim-10421
110	2	born	bear	VBN	1	acl	22787	22791	_	_	_	_	I-claim-10421
110	3	to	to	TO	5	case	22792	22794	_	_	_	_	I-claim-10421
110	4	HBsAg-positive	hbsag-positive	JJ	5	amod	22795	22809	_	_	_	_	I-claim-10421
110	5	mothers	mother	NNS	2	nmod	22810	22817	_	_	_	_	I-claim-10421
110	6	should	should	MD	8	aux	22818	22824	_	_	_	_	I-claim-10421
110	7	be	be	VB	8	auxpass	22825	22827	_	_	_	_	I-claim-10421
110	8	given	give	VBN	0	ROOT	22828	22833	_	_	_	_	I-claim-10421
110	9	HBIG	hbig	NN	8	xcomp	22834	22838	B-event-211822	_	_	_	I-claim-10421
110	10	and	and	CC	9	cc	22839	22842	_	_	_	_	I-claim-10421
110	11	a	a	DT	12	det	22843	22844	_	_	_	_	I-claim-10421
110	12	dose	dose	NN	9	conj	22845	22849	_	_	_	_	I-claim-10421
110	13	of	of	IN	17	case	22850	22852	_	_	_	_	I-claim-10421
110	14	monovalent	monovalent	JJ	17	amod	22853	22863	_	_	_	_	I-claim-10421
110	15	hepatitis	hepatitis	NN	17	compound	22864	22873	_	_	_	_	I-claim-10421
110	16	B	b	NN	17	compound	22874	22875	_	_	_	_	I-claim-10421
110	17	vaccine	vaccine	NN	12	nmod	22876	22883	B-event-211823	_	_	_	I-claim-10421
110	18	on	on	IN	20	case	22884	22886	_	_	_	_	I-claim-10421
110	19	the	the	DT	20	det	22887	22890	_	_	_	_	I-claim-10421
110	20	day	day	NN	17	nmod	22891	22894	_	_	_	_	I-claim-10421
110	21	of	of	IN	22	case	22895	22897	_	_	_	_	I-claim-10421
110	22	birth	birth	NN	20	nmod	22898	22903	B-event-211824	_	_	_	I-claim-10421
110	23	,	,	,	8	punct	22903	22904	_	_	_	_	I-claim-10421
110	24	concurrently	concurrently	RB	25	advmod	22905	22917	_	_	_	_	I-claim-10421
110	25	but	but	CC	8	advmod	22918	22921	_	_	_	_	I-claim-10421
110	26	in	in	IN	28	case	22922	22924	_	_	_	_	I-claim-10421
110	27	separate	separate	JJ	28	amod	22925	22933	_	_	_	_	I-claim-10421
110	28	thighs	thigh	NNS	25	conj	22934	22940	_	_	_	_	I-claim-10421
110	29	.	.	.	8	punct	22940	22941	_	_	_	_	I-claim-10421

111	1	The	the	DT	2	det	22942	22945	_	_	_	_	I-claim-10421
111	2	dose	dose	NN	7	nsubj	22946	22950	_	_	_	_	I-claim-10421
111	3	of	of	IN	4	case	22951	22953	_	_	_	_	I-claim-10421
111	4	HBIG	hbig	NN	2	nmod	22954	22958	_	_	_	_	I-claim-10421
111	5	is	be	VBZ	7	cop	22959	22961	_	_	_	_	I-claim-10421
111	6	100	100	CD	7	nummod	22962	22965	_	_	_	_	I-claim-10421
111	7	IU	iu	NN	0	ROOT	22966	22968	_	_	_	_	I-claim-10421
111	8	,	,	,	7	punct	22968	22969	_	_	_	_	I-claim-10421
111	9	to	to	TO	11	mark	22970	22972	_	_	_	_	I-claim-10421
111	10	be	be	VB	11	auxpass	22973	22975	_	_	_	_	I-claim-10421
111	11	given	give	VBN	7	advcl	22976	22981	_	_	_	_	I-claim-10421
111	12	by	by	IN	14	case	22982	22984	_	_	_	_	I-claim-10421
111	13	IM	im	NN	14	compound	22985	22987	_	_	_	_	I-claim-10421
111	14	injection	injection	NN	11	nmod	22988	22997	B-event-211825	_	_	_	I-claim-10421
111	15	.	.	.	7	punct	22997	22998	_	_	_	_	_

112	1	It	it	PRP	3	nsubj	22999	23001	_	_	_	_	B-claim-10422
112	2	is	be	VBZ	3	cop	23002	23004	_	_	_	_	I-claim-10422
112	3	preferable	preferable	JJ	0	ROOT	23005	23015	_	_	_	B-cue-25318	I-claim-10422
112	4	to	to	TO	5	mark	23016	23018	_	B-content-25319:25318-Cue	_	_	I-claim-10422
112	5	administer	administer	VB	3	xcomp	23019	23029	B-event-211826	I-content-25319	_	_	I-claim-10422
112	6	HBIG	hbig	NN	5	dobj	23030	23034	_	I-content-25319	_	_	I-claim-10422
112	7	immediately	immediately	RB	9	advmod	23035	23046	_	I-content-25319	_	_	I-claim-10422
112	8	after	after	IN	9	case	23047	23052	_	I-content-25319	_	_	I-claim-10422
112	9	birth	birth	NN	5	nmod	23053	23058	B-event-211827	I-content-25319	_	_	I-claim-10422
112	10	(	(	CD	9	nummod	23059	23060	_	_	_	_	I-claim-10422
112	11	preferably	preferably	RB	14	advmod	23060	23070	_	_	_	_	I-claim-10422
112	12	within	within	IN	14	case	23071	23077	_	_	_	_	I-claim-10422
112	13	12	12	CD	14	nummod	23078	23080	_	_	_	_	I-claim-10422
112	14	hours	hour	NNS	22	nmod	23081	23086	_	_	_	_	I-claim-10422
112	15	of	of	IN	16	case	23087	23089	_	_	_	_	I-claim-10422
112	16	birth	birth	NN	14	nmod	23090	23095	B-event-212487	_	_	_	I-claim-10422
112	17	and	and	CC	22	cc	23096	23099	_	_	_	_	I-claim-10422
112	18	certainly	certainly	RB	21	advmod	23100	23109	_	_	_	_	I-claim-10422
112	19	within	within	IN	21	case	23110	23116	_	_	_	_	I-claim-10422
112	20	48	48	CD	21	nummod	23117	23119	_	_	_	_	I-claim-10422
112	21	hours	hour	NNS	22	conj	23120	23125	_	_	_	_	I-claim-10422
112	22	)	)	RB	9	acl	23125	23126	_	_	_	_	I-claim-10422
112	23	as	as	IN	26	mark	23127	23129	_	_	_	_	I-claim-10422
112	24	its	its	PRP$	25	nmod:poss	23130	23133	_	_	_	_	I-claim-10422
112	25	efficacy	efficacy	NN	26	nsubj	23134	23142	B-event-211828	_	_	_	I-claim-10422
112	26	decreases	decrease	VBZ	5	advcl	23143	23152	_	_	_	_	I-claim-10422
112	27	markedly	markedly	RB	26	advmod	23153	23161	_	_	_	_	I-claim-10422
112	28	if	if	IN	29	mark	23162	23164	_	_	_	_	I-claim-10422
112	29	given	give	VBN	27	dep	23165	23170	_	_	_	_	I-claim-10422
112	30	more	more	JJR	32	advmod	23171	23175	_	_	_	_	I-claim-10422
112	31	than	than	IN	30	mwe	23176	23180	_	_	_	_	I-claim-10422
112	32	48	48	CD	33	nummod	23181	23183	_	_	_	_	I-claim-10422
112	33	hours	hour	NNS	29	nmod	23184	23189	_	_	_	_	I-claim-10422
112	34	after	after	IN	33	case	23190	23195	_	_	_	_	I-claim-10422
112	35	birth	birth	NN	33	dep	23196	23201	B-event-211830	_	_	_	I-claim-10422
112	36	.	.	.	3	punct	23201	23202	_	_	_	_	_

113	1	The	the	DT	2	det	23203	23206	_	_	_	_	B-claim-10423
113	2	dose	dose	NN	10	nsubjpass	23207	23211	_	_	_	_	I-claim-10423
113	3	of	of	IN	7	case	23212	23214	_	_	_	_	I-claim-10423
113	4	monovalent	monovalent	JJ	7	amod	23215	23225	_	_	_	_	I-claim-10423
113	5	hepatitis	hepatitis	NN	7	compound	23226	23235	_	_	_	_	I-claim-10423
113	6	B	b	NN	7	compound	23236	23237	_	_	_	_	I-claim-10423
113	7	vaccine	vaccine	NN	2	nmod	23238	23245	B-event-211829	_	_	_	I-claim-10423
113	8	should	should	MD	10	aux	23246	23252	_	_	_	_	I-claim-10423
113	9	be	be	VB	10	auxpass	23253	23255	_	_	_	_	I-claim-10423
113	10	given	give	VBN	0	ROOT	23256	23261	_	_	_	_	I-claim-10423
113	11	to	to	TO	13	case	23262	23264	_	_	_	_	I-claim-10423
113	12	the	the	DT	13	det	23265	23268	_	_	_	_	I-claim-10423
113	13	infant	infant	NN	10	nmod	23269	23275	_	_	_	_	I-claim-10423
113	14	preferably	preferably	RB	17	advmod	23276	23286	_	_	_	_	I-claim-10423
113	15	within	within	IN	17	case	23287	23293	_	_	_	_	I-claim-10423
113	16	24	24	CD	17	nummod	23294	23296	_	_	_	_	I-claim-10423
113	17	hours	hour	NNS	10	nmod	23297	23302	_	_	_	_	I-claim-10423
113	18	of	of	IN	19	case	23303	23305	_	_	_	_	I-claim-10423
113	19	birth	birth	NN	17	nmod	23306	23311	B-event-211831	_	_	_	I-claim-10423
113	20	,	,	,	17	punct	23311	23312	_	_	_	_	I-claim-10423
113	21	and	and	CC	17	cc	23313	23316	_	_	_	_	I-claim-10423
113	22	definitely	definitely	RB	25	advmod	23317	23327	_	_	_	_	I-claim-10423
113	23	within	within	IN	25	case	23328	23334	_	_	_	_	I-claim-10423
113	24	7	7	CD	25	nummod	23335	23336	_	_	_	_	I-claim-10423
113	25	days	day	NNS	17	conj	23337	23341	_	_	_	_	I-claim-10423
113	26	.	.	.	10	punct	23341	23342	_	_	_	_	_

114	1	This	this	DT	2	det	23343	23347	_	_	_	_	_
114	2	regimen	regimen	NN	3	nsubj	23348	23355	_	_	_	_	_
114	3	results	result	VBZ	0	ROOT	23356	23363	_	_	_	_	_
114	4	in	in	IN	6	case	23364	23366	_	_	_	_	_
114	5	seroconversion	seroconversion	NN	6	compound	23367	23381	B-event-211832	_	_	_	_
114	6	rates	rate	NNS	3	nmod	23382	23387	_	_	_	_	_
114	7	of	of	IN	11	case	23388	23390	_	_	_	_	_
114	8	more	more	JJR	10	advmod	23391	23395	_	_	_	_	_
114	9	than	than	IN	8	mwe	23396	23400	_	_	_	_	_
114	10	90	90	CD	11	nummod	23401	23403	_	_	_	_	_
114	11	%	%	NN	6	nmod	23403	23404	_	_	_	_	_
114	12	in	in	IN	13	case	23405	23407	_	_	_	_	_
114	13	neonates	neonate	NNS	11	nmod	23408	23416	_	_	_	_	_
114	14	,	,	,	3	punct	23416	23417	_	_	_	_	_
114	15	even	even	RB	18	advmod	23418	23422	_	_	_	_	_
114	16	with	with	IN	18	case	23423	23427	_	_	_	_	_
114	17	concurrent	concurrent	JJ	18	amod	23428	23438	_	_	_	_	_
114	18	administration	administration	NN	3	nmod	23439	23453	B-event-211833	_	_	_	_
114	19	of	of	IN	20	case	23454	23456	_	_	_	_	_
114	20	HBIG	hbig	NN	18	nmod	23457	23461	_	_	_	_	_
114	21	.	.	.	3	punct	23461	23462	_	_	_	_	_

115	1	Vaccination	vaccination	NN	5	nsubjpass	23463	23474	B-event-211834	_	_	_	B-claim-10424
115	2	should	should	MD	5	aux	23475	23481	_	_	_	_	I-claim-10424
115	3	not	not	RB	5	neg	23482	23485	_	_	_	_	I-claim-10424
115	4	be	be	VB	5	auxpass	23486	23488	_	_	_	_	I-claim-10424
115	5	delayed	delay	VBN	0	ROOT	23489	23496	B-event-211835	_	_	_	I-claim-10424
115	6	beyond	beyond	IN	8	case	23497	23503	_	_	_	_	I-claim-10424
115	7	7	7	CD	8	nummod	23504	23505	_	_	_	_	I-claim-10424
115	8	days	day	NNS	5	nmod	23506	23510	_	_	_	_	I-claim-10424
115	9	after	after	IN	26	mark	23511	23516	_	_	_	_	I-claim-10424
115	10	birth	birth	NN	26	nsubj	23517	23522	B-event-211836	_	_	_	I-claim-10424
115	11	,	,	,	10	punct	23522	23523	_	_	_	_	I-claim-10424
115	12	as	as	IN	17	mark	23524	23526	_	_	_	_	I-claim-10424
115	13	vaccination	vaccination	NN	17	nsubjpass	23527	23538	B-event-211837	_	_	_	I-claim-10424
115	14	alone	alone	RB	17	advmod	23539	23544	_	_	_	_	I-claim-10424
115	15	has	have	VBZ	17	aux	23545	23548	_	_	_	_	I-claim-10424
115	16	been	be	VBN	17	auxpass	23549	23553	_	_	_	_	I-claim-10424
115	17	shown	show	VBN	10	dep	23554	23559	_	_	_	_	I-claim-10424
115	18	to	to	TO	21	mark	23560	23562	_	_	_	_	I-claim-10424
115	19	be	be	VB	21	cop	23563	23565	_	_	_	_	I-claim-10424
115	20	reasonably	reasonably	RB	21	advmod	23566	23576	_	_	_	_	I-claim-10424
115	21	effective	effective	JJ	17	xcomp	23577	23586	B-event-211838	_	_	_	I-claim-10424
115	22	in	in	IN	23	mark	23587	23589	_	_	_	_	I-claim-10424
115	23	preventing	prevent	VBG	21	advcl	23590	23600	B-event-211839	_	_	_	I-claim-10424
115	24	infection	infection	NN	23	dobj	23601	23610	B-event-211840	_	_	_	I-claim-10424
115	25	,	,	,	10	punct	23610	23611	_	_	_	_	I-claim-10424
115	26	provided	provide	VBD	5	advcl	23612	23620	_	_	_	_	I-claim-10424
115	27	it	it	PRP	29	nsubjpass	23621	23623	_	_	_	_	I-claim-10424
115	28	is	be	VBZ	29	auxpass	23624	23626	_	_	_	_	I-claim-10424
115	29	given	give	VBN	26	ccomp	23627	23632	B-event-211841	_	_	_	I-claim-10424
115	30	early	early	JJ	34	amod	23633	23638	_	_	_	_	I-claim-10424
115	31	.52	.52	CD	34	nummod	23638	23641	_	_	_	_	_
115	32	Three	three	CD	34	nummod	23642	23647	_	_	_	_	B-claim-10425
115	33	subsequent	subsequent	JJ	34	amod	23648	23658	_	_	_	_	I-claim-10425
115	34	doses	dose	NNS	29	iobj	23659	23664	_	_	_	_	I-claim-10425
115	35	of	of	IN	37	case	23665	23667	_	_	_	_	I-claim-10425
115	36	a	a	DT	37	det	23668	23669	_	_	_	_	I-claim-10425
115	37	hepatitis	hepatitis	NN	34	nmod	23670	23679	_	_	_	_	I-claim-10425
115	38	B-containing	b-containing	JJ	39	amod	23680	23692	_	_	_	_	I-claim-10425
115	39	vaccine	vaccine	NN	29	dobj	23693	23700	B-event-211842	_	_	_	I-claim-10425
115	40	should	should	MD	42	aux	23701	23707	_	_	_	_	I-claim-10425
115	41	be	be	VB	42	auxpass	23708	23710	_	_	_	_	I-claim-10425
115	42	given	give	VBN	39	acl:relcl	23711	23716	_	_	_	_	I-claim-10425
115	43	,	,	,	42	punct	23716	23717	_	_	_	_	I-claim-10425
115	44	at	at	IN	45	case	23718	23720	_	_	_	_	I-claim-10425
115	45	2	2	CD	42	nmod	23721	23722	_	_	_	_	I-claim-10425
115	46	,	,	,	45	punct	23722	23723	_	_	_	_	I-claim-10425
115	47	4	4	CD	50	compound	23724	23725	_	_	_	_	I-claim-10425
115	48	and	and	CC	47	cc	23726	23729	_	_	_	_	I-claim-10425
115	49	6	6	CD	47	conj	23730	23731	_	_	_	_	I-claim-10425
115	50	months	month	NNS	45	appos	23732	23738	_	_	_	_	I-claim-10425
115	51	of	of	IN	52	case	23739	23741	_	_	_	_	I-claim-10425
115	52	age	age	NN	50	nmod	23742	23745	_	_	_	_	I-claim-10425
115	53	,	,	,	42	punct	23745	23746	_	_	_	_	I-claim-10425
115	54	so	so	RB	58	mark	23747	23749	_	_	_	_	I-claim-10425
115	55	that	that	IN	54	mwe	23750	23754	_	_	_	_	I-claim-10425
115	56	the	the	DT	57	det	23755	23758	_	_	_	_	I-claim-10425
115	57	infant	infant	NN	58	nsubj	23759	23765	_	_	_	_	I-claim-10425
115	58	receives	receive	VBZ	42	advcl	23766	23774	_	_	_	_	I-claim-10425
115	59	a	a	DT	60	det	23775	23776	_	_	_	_	I-claim-10425
115	60	total	total	NN	58	dobj	23777	23782	_	_	_	_	I-claim-10425
115	61	of	of	IN	63	case	23783	23785	_	_	_	_	I-claim-10425
115	62	4	4	CD	63	nummod	23786	23787	_	_	_	_	I-claim-10425
115	63	doses	dose	NNS	60	nmod	23788	23793	_	_	_	_	I-claim-10425
115	64	of	of	IN	67	case	23794	23796	_	_	_	_	I-claim-10425
115	65	hepatitis	hepatitis	NN	67	compound	23797	23806	_	_	_	_	I-claim-10425
115	66	B-containing	b-containing	JJ	67	amod	23807	23819	_	_	_	_	I-claim-10425
115	67	vaccines	vaccine	NNS	63	nmod	23820	23828	B-event-211843	_	_	_	I-claim-10425
115	68	.	.	.	5	punct	23828	23829	_	_	_	_	_

116	1	Anti-HBs	anti-hbs	JJ	2	amod	23830	23838	_	_	_	_	B-claim-10426
116	2	antibody	antibody	NN	8	nsubjpass	23839	23847	_	_	_	_	I-claim-10426
116	3	and	and	CC	2	cc	23848	23851	_	_	_	_	I-claim-10426
116	4	HBsAg	hbsag	NN	5	compound	23852	23857	_	_	_	_	I-claim-10426
116	5	levels	level	NNS	2	conj	23858	23864	_	_	_	_	I-claim-10426
116	6	should	should	MD	8	aux	23865	23871	_	_	_	_	I-claim-10426
116	7	be	be	VB	8	auxpass	23872	23874	_	_	_	_	I-claim-10426
116	8	measured	measure	VBN	0	ROOT	23875	23883	B-event-211844	_	_	_	I-claim-10426
116	9	in	in	IN	10	case	23884	23886	_	_	_	_	I-claim-10426
116	10	infants	infant	NNS	8	nmod	23887	23894	_	_	_	_	I-claim-10426
116	11	born	bear	VBN	10	acl	23895	23899	_	_	_	_	I-claim-10426
116	12	to	to	TO	13	case	23900	23902	_	_	_	_	I-claim-10426
116	13	mothers	mother	NNS	11	nmod	23903	23910	_	_	_	_	I-claim-10426
116	14	with	with	IN	18	case	23911	23915	_	_	_	_	I-claim-10426
116	15	chronic	chronic	JJ	18	amod	23916	23923	_	_	_	_	I-claim-10426
116	16	hepatitis	hepatitis	NN	18	compound	23924	23933	B-event-211845	_	_	_	I-claim-10426
116	17	B	b	NN	18	compound	23934	23935	I-event-211845	_	_	_	I-claim-10426
116	18	infection	infection	NN	13	nmod	23936	23945	B-event-211846	_	_	_	I-claim-10426
116	19	3	3	CD	21	compound	23946	23947	_	_	_	_	I-claim-10426
116	20	to	to	TO	21	dep	23948	23950	_	_	_	_	I-claim-10426
116	21	12	12	CD	22	nummod	23951	23953	_	_	_	_	I-claim-10426
116	22	months	month	NNS	11	nmod:tmod	23954	23960	_	_	_	_	I-claim-10426
116	23	after	after	IN	24	mark	23961	23966	_	_	_	_	I-claim-10426
116	24	completing	complete	VBG	8	advcl	23967	23977	B-event-211847	_	_	_	I-claim-10426
116	25	the	the	DT	28	det	23978	23981	_	_	_	_	I-claim-10426
116	26	primary	primary	JJ	28	amod	23982	23989	_	_	_	_	I-claim-10426
116	27	vaccine	vaccine	NN	28	compound	23990	23997	B-event-211848	_	_	_	I-claim-10426
116	28	course	course	NN	24	dobj	23998	24004	_	_	_	_	I-claim-10426
116	29	.	.	.	8	punct	24004	24005	_	_	_	_	_

117	1	Testing	test	VBG	5	nsubjpass	24006	24013	B-event-211849	_	_	_	B-claim-10427
117	2	should	should	MD	5	aux	24014	24020	_	_	_	_	I-claim-10427
117	3	not	not	RB	5	neg	24021	24024	_	_	_	_	I-claim-10427
117	4	be	be	VB	5	auxpass	24025	24027	_	_	_	_	I-claim-10427
117	5	performed	perform	VBN	0	ROOT	24028	24037	_	_	_	_	I-claim-10427
117	6	before	before	IN	8	case	24038	24044	_	_	_	_	I-claim-10427
117	7	9	9	CD	8	nummod	24045	24046	_	_	_	_	I-claim-10427
117	8	months	month	NNS	5	nmod	24047	24053	_	_	_	_	I-claim-10427
117	9	of	of	IN	10	case	24054	24056	_	_	_	_	I-claim-10427
117	10	age	age	NN	8	nmod	24057	24060	_	_	_	_	I-claim-10427
117	11	to	to	TO	12	mark	24061	24063	_	_	_	_	I-claim-10427
117	12	avoid	avoid	VB	5	xcomp	24064	24069	_	_	_	_	I-claim-10427
117	13	detection	detection	NN	12	dobj	24070	24079	B-event-211850	_	_	_	I-claim-10427
117	14	of	of	IN	16	case	24080	24082	_	_	_	_	I-claim-10427
117	15	anti-HBs	anti-hbs	JJ	16	amod	24083	24091	_	_	_	_	I-claim-10427
117	16	antibodies	antibody	NNS	13	nmod	24092	24102	_	_	_	_	I-claim-10427
117	17	from	from	IN	18	case	24103	24107	_	_	_	_	I-claim-10427
117	18	HBIG	hbig	NN	12	nmod	24108	24112	B-event-211851	_	_	_	I-claim-10427
117	19	given	give	VBN	21	case	24113	24118	_	_	_	_	I-claim-10427
117	20	at	at	IN	21	case	24119	24121	_	_	_	_	I-claim-10427
117	21	birth	birth	NN	18	nmod	24122	24127	_	_	_	_	I-claim-10427
117	22	.	.	.	5	punct	24127	24128	_	_	_	_	_

118	1	If	if	IN	5	mark	24129	24131	_	_	_	_	_
118	2	anti-HBs	anti-hbs	JJ	4	amod	24132	24140	_	_	_	_	_
118	3	antibody	antibody	NN	4	compound	24141	24149	_	_	_	_	_
118	4	levels	level	NNS	5	nsubj	24150	24156	_	_	_	_	_
118	5	are	be	VBP	21	advcl	24157	24160	_	_	_	_	_
118	6	adequate	adequate	JJ	11	amod	24161	24169	_	_	_	_	_
118	7	(	(	NN	11	compound	24170	24171	_	_	_	_	_
118	8	≥	≥	CD	11	nummod	24171	24172	_	_	_	_	_
118	9	10	10	CD	11	nummod	24172	24174	_	_	_	_	_
118	10	mIU/mL	miu/ml	NN	11	compound	24175	24181	_	_	_	_	_
118	11	)	)	NN	15	nsubj	24181	24182	_	_	_	_	_
118	12	and	and	CC	11	cc	24183	24186	_	_	_	_	_
118	13	HBsAg	hbsag	NN	11	conj	24187	24192	_	_	_	_	_
118	14	is	be	VBZ	15	cop	24193	24195	_	_	_	_	_
118	15	negative	negative	JJ	5	ccomp	24196	24204	_	_	_	_	_
118	16	,	,	,	21	punct	24204	24205	_	_	_	_	_
118	17	then	then	RB	19	advmod	24206	24210	_	_	_	_	_
118	18	the	the	DT	19	det	24211	24214	_	_	_	_	_
118	19	infant	infant	NN	21	nsubjpass	24215	24221	_	_	_	_	_
118	20	is	be	VBZ	21	auxpass	24222	24224	_	_	_	_	_
118	21	considered	consider	VBN	26	dep	24225	24235	B-event-211852	_	_	_	_
118	22	to	to	TO	25	mark	24236	24238	_	_	_	_	_
118	23	be	be	VB	25	cop	24239	24241	_	_	_	_	_
118	24	protected35	protected35	NN	25	compound	24242	24253	B-event-211853	_	_	_	_
118	25	(	(	NN	21	xcomp	24254	24255	_	_	_	_	_
118	26	refer	refer	VBP	0	ROOT	24255	24260	_	_	_	_	_
118	27	to	to	TO	28	mark	24261	24263	_	_	_	_	_
118	28	‘	‘	VB	26	xcomp	24264	24265	_	_	_	_	_
118	29	Serological	serological	JJ	30	amod	24265	24276	_	_	_	_	_
118	30	testing	testing	NN	28	dobj	24277	24284	_	_	_	_	_
118	31	following	follow	VBG	33	case	24285	24294	_	_	_	_	_
118	32	hepatitis	hepatitis	NN	33	compound	24295	24304	_	_	_	_	_
118	33	B	b	NN	30	nmod	24305	24306	_	_	_	_	_
118	34	vaccination	vaccination	NN	35	compound	24307	24318	_	_	_	_	_
118	35	’	’	NN	26	nsubj	24318	24319	_	_	_	_	_
118	36	below	below	IN	37	case	24320	24325	_	_	_	_	_
118	37	)	)	NN	35	nmod	24325	24326	_	_	_	_	_
118	38	.	.	.	26	punct	24326	24327	_	_	_	_	_

119	1	If	if	IN	4	case	24328	24330	_	_	_	_	B-claim-10428
119	2	the	the	DT	4	det	24331	24334	_	_	_	_	I-claim-10428
119	3	anti-HBs	anti-hbs	JJ	4	amod	24335	24343	_	_	_	_	I-claim-10428
119	4	level	level	NN	6	nmod	24344	24349	_	_	_	_	I-claim-10428
119	5	is	be	VBZ	6	cop	24350	24352	_	_	_	_	I-claim-10428
119	6	<	<	JJR	0	ROOT	24353	24354	_	_	_	_	I-claim-10428
119	7	10	10	CD	8	nummod	24354	24356	_	_	_	_	I-claim-10428
119	8	mIU/mL	miu/ml	NN	6	nsubj	24357	24363	_	_	_	_	I-claim-10428
119	9	,	,	,	8	punct	24363	24364	_	_	_	_	I-claim-10428
119	10	expert	expert	NN	11	compound	24365	24371	_	_	_	_	I-claim-10428
119	11	advice	advice	NN	8	appos	24372	24378	B-event-211854	_	_	_	I-claim-10428
119	12	regarding	regard	VBG	11	dep	24379	24388	_	_	_	_	I-claim-10428
119	13	revaccination	revaccination	NN	12	dobj	24389	24402	B-event-211855	_	_	_	I-claim-10428
119	14	and/or	and/or	CC	12	cc	24403	24409	_	_	_	_	I-claim-10428
119	15	further	further	JJ	16	amod	24410	24417	_	_	_	_	I-claim-10428
119	16	testing	testing	NN	12	conj	24418	24425	B-event-211856	_	_	_	I-claim-10428
119	17	should	should	MD	19	aux	24426	24432	_	_	_	_	I-claim-10428
119	18	be	be	VB	19	auxpass	24433	24435	_	_	_	_	I-claim-10428
119	19	sought	seek	VBN	16	acl:relcl	24436	24442	B-event-211857	_	_	_	I-claim-10428
119	20	.	.	.	6	punct	24442	24443	_	_	_	_	_

120	1	Preterm	Preterm	NNP	26	nsubj	24444	24451	_	_	_	_	_
120	2	and	and	CC	1	cc	24452	24455	_	_	_	_	_
120	3	low-birth-weight	low-birth-weight	JJ	4	amod	24456	24472	_	_	_	_	_
120	4	infants	infant	NNS	1	conj	24473	24480	_	_	_	_	_
120	5	Low-birth-weight	low-birth-weight	JJ	8	amod	24481	24497	_	_	_	_	_
120	6	preterm	preterm	JJ	8	amod	24498	24505	_	_	_	_	_
120	7	newborn	newborn	JJ	8	amod	24506	24513	_	_	_	_	_
120	8	infants	infant	NNS	11	nsubj	24514	24521	_	_	_	_	_
120	9	do	do	VBP	11	aux	24522	24524	_	_	_	_	_
120	10	not	not	RB	11	neg	24525	24528	_	_	_	_	_
120	11	respond	respond	VB	4	acl:relcl	24529	24536	B-event-211858	_	_	_	_
120	12	as	as	RB	21	cc	24537	24539	_	_	_	_	_
120	13	well	well	RB	12	mwe	24540	24544	_	_	_	_	_
120	14	to	to	TO	17	case	24545	24547	_	_	_	_	_
120	15	hepatitis	hepatitis	NN	17	compound	24548	24557	_	_	_	_	_
120	16	B-containing	b-containing	JJ	17	amod	24558	24570	_	_	_	_	_
120	17	vaccines	vaccine	NNS	21	nmod	24571	24579	B-event-211859	_	_	_	_
120	18	as	as	IN	20	case	24580	24582	_	_	_	_	_
120	19	full-term	full-term	JJ	20	amod	24583	24592	_	_	_	_	_
120	20	infants.56-58	infants.56-58	NN	17	nmod	24593	24606	_	_	_	_	_
120	21	Thus	thus	RB	11	nmod	24607	24611	_	_	_	_	_
120	22	,	,	,	21	punct	24611	24612	_	_	_	_	_
120	23	for	for	IN	25	case	24613	24616	_	_	_	_	_
120	24	low-birth-weight	low-birth-weight	JJ	25	amod	24617	24633	_	_	_	_	_
120	25	infants	infant	NNS	21	nmod	24634	24641	_	_	_	_	_
120	26	(	(	VBP	47	ccomp	24642	24643	_	_	_	_	_
120	27	<	<	JJR	26	xcomp	24643	24644	_	_	_	_	_
120	28	2000	2000	CD	29	nummod	24644	24648	_	_	_	_	_
120	29	g	g	NN	27	dep	24649	24650	_	_	_	_	_
120	30	)	)	CD	29	dep	24650	24651	_	_	_	_	_
120	31	and/or	and/or	CC	26	cc	24652	24658	_	_	_	_	_
120	32	infants	infant	NNS	33	dobj	24659	24666	_	_	_	_	_
120	33	born	bear	VBN	26	conj	24667	24671	_	_	_	_	_
120	34	at	at	IN	35	case	24672	24674	_	_	_	_	_
120	35	<	<	JJR	33	nmod	24675	24676	_	_	_	_	_
120	36	32	32	CD	37	nummod	24676	24678	_	_	_	_	_
120	37	weeks	week	NNS	35	nmod:tmod	24679	24684	_	_	_	_	_
120	38	gestation	gestation	JJ	39	amod	24685	24694	_	_	_	_	_
120	39	(	(	NN	40	nmod:npmod	24695	24696	_	_	_	_	_
120	40	irrespective	irrespective	RB	43	advmod	24696	24708	_	_	_	_	_
120	41	of	of	IN	43	case	24709	24711	_	_	_	_	_
120	42	weight	weight	NN	43	compound	24712	24718	_	_	_	_	_
120	43	)	)	NN	35	nmod	24718	24719	_	_	_	_	_
120	44	,	,	,	47	punct	24719	24720	_	_	_	_	_
120	45	it	it	PRP	47	nsubjpass	24721	24723	_	_	_	_	_
120	46	is	be	VBZ	47	auxpass	24724	24726	_	_	_	_	_
120	47	recommended	recommend	VBN	0	ROOT	24727	24738	_	_	_	B-cue-25320	_
120	48	to	to	TO	49	mark	24739	24741	_	B-content-25321:25320-Cue	_	_	_
120	49	give	give	VB	47	xcomp	24742	24746	_	I-content-25321	_	_	_
120	50	the	the	DT	51	det	24747	24750	_	I-content-25321	_	_	_
120	51	vaccine	vaccine	NN	49	iobj	24751	24758	B-event-211860	I-content-25321	_	_	_
120	52	in	in	IN	55	case	24759	24761	_	I-content-25321	_	_	_
120	53	a	a	DT	55	det	24762	24763	_	I-content-25321	_	_	_
120	54	4-dose	4-dose	JJ	55	amod	24764	24770	_	I-content-25321	_	_	_
120	55	schedule	schedule	NN	51	nmod	24771	24779	_	I-content-25321	_	_	_
120	56	at	at	IN	58	case	24780	24782	_	I-content-25321	_	_	_
120	57	0	0	CD	58	nummod	24783	24784	_	I-content-25321	_	_	_
120	58	(	(	CD	55	nmod	24785	24786	_	I-content-25321	_	_	_
120	59	birth	birth	NN	60	compound	24786	24791	_	I-content-25321	_	_	_
120	60	)	)	NN	49	dobj	24791	24792	_	I-content-25321	_	_	_
120	61	,	,	,	60	punct	24792	24793	_	I-content-25321	_	_	_
120	62	2	2	CD	60	amod	24794	24795	_	I-content-25321	_	_	_
120	63	,	,	,	60	punct	24795	24796	_	I-content-25321	_	_	_
120	64	4	4	CD	67	compound	24797	24798	_	I-content-25321	_	_	_
120	65	and	and	CC	64	cc	24799	24802	_	I-content-25321	_	_	_
120	66	6	6	CD	64	conj	24803	24804	_	I-content-25321	_	_	_
120	67	months	month	NNS	60	appos	24805	24811	_	I-content-25321	_	_	_
120	68	of	of	IN	69	case	24812	24814	_	I-content-25321	_	_	_
120	69	age	age	NN	67	nmod	24815	24818	_	I-content-25321	_	_	_
120	70	,	,	,	67	punct	24818	24819	_	I-content-25321	_	_	_
120	71	followed	follow	VBN	67	acl	24820	24828	_	I-content-25321	_	_	_
120	72	by	by	IN	71	nmod	24829	24831	_	I-content-25321	_	_	_
120	73	either	either	CC	71	advmod	24832	24838	_	I-content-25321	_	_	_
120	74	:	:	:	60	punct	24838	24839	_	I-content-25321	_	_	_
120	75	HIV-positive	hiv-positive	JJ	78	amod	24840	24852	B-event-212488	_	_	_	_
120	76	and	and	CC	75	cc	24853	24856	_	_	_	_	_
120	77	immunocompromised	immunocompromised	JJ	75	conj	24857	24874	B-event-211861	_	_	_	_
120	78	children	child	NNS	60	dep	24875	24883	_	_	_	_	_
120	79	All	all	DT	83	det	24884	24887	_	_	_	_	_
120	80	HIV-positive	hiv-positive	JJ	83	amod	24888	24900	B-event-212489	_	_	_	_
120	81	and	and	CC	80	cc	24901	24904	_	_	_	_	_
120	82	immunocompromised	immunocompromised	JJ	80	conj	24905	24922	B-event-211862	_	_	_	_
120	83	children	child	NNS	86	nsubj	24923	24931	_	_	_	_	_
120	84	should	should	MD	86	aux	24932	24938	_	_	_	_	_
120	85	be	be	VB	86	cop	24939	24941	_	_	_	_	_
120	86	age-appropriately	age-appropriately	JJ	78	acl:relcl	24942	24959	_	_	_	_	_
120	87	vaccinated	vaccinate	VBN	114	csubj	24960	24970	B-event-211863	_	_	_	_
120	88	against	against	IN	90	case	24971	24978	_	_	_	_	_
120	89	hepatitis	hepatitis	NNP	90	compound	24979	24988	B-event-211864	_	_	_	_
120	90	B.	B.	NNP	87	nmod	24989	24991	I-event-211864	_	_	_	_
120	91	HIV-positive	hiv-positive	JJ	92	amod	24992	25004	B-event-212490	_	_	_	B-claim-10429
120	92	children	child	NNS	94	nsubj	25005	25013	_	_	_	_	I-claim-10429
120	93	should	should	MD	94	aux	25014	25020	_	_	_	_	I-claim-10429
120	94	receive	receive	VB	90	acl:relcl	25021	25028	_	_	_	_	I-claim-10429
120	95	3	3	CD	96	nummod	25029	25030	_	_	_	_	I-claim-10429
120	96	doses	dose	NNS	94	dobj	25031	25036	_	_	_	_	I-claim-10429
120	97	of	of	IN	100	case	25037	25039	_	_	_	_	I-claim-10429
120	98	hepatitis	hepatitis	NN	100	compound	25040	25049	_	_	_	_	I-claim-10429
120	99	B	b	NN	100	compound	25050	25051	_	_	_	_	I-claim-10429
120	100	vaccine	vaccine	NN	96	nmod	25052	25059	B-event-211865	_	_	_	I-claim-10429
120	101	using	use	VBG	100	acl	25060	25065	_	_	_	_	I-claim-10429
120	102	an	a	DT	105	det	25066	25068	_	_	_	_	I-claim-10429
120	103	adult	adult	JJ	105	amod	25069	25074	_	_	_	_	I-claim-10429
120	104	formulation	formulation	NN	105	compound	25075	25086	_	_	_	_	I-claim-10429
120	105	(	(	NN	101	dobj	25087	25088	_	_	_	_	_
120	106	i.e.	i.e.	FW	107	nsubj	25088	25092	_	_	_	_	_
120	107	double	double	JJ	105	acl:relcl	25093	25099	_	_	_	_	_
120	108	the	the	DT	111	det	25100	25103	_	_	_	_	_
120	109	standard	standard	JJ	111	amod	25104	25112	_	_	_	_	_
120	110	recommended	recommend	VBN	111	amod	25113	25124	B-event-211866	_	_	_	_
120	111	dose	dose	NN	107	dobj	25125	25129	_	_	_	_	_
120	112	for	for	IN	113	case	25130	25133	_	_	_	_	_
120	113	children	child	NNS	111	nmod	25134	25142	_	_	_	_	_
120	114	)	)	VBP	86	ccomp	25142	25143	_	_	_	_	_
120	115	.	.	.	47	punct	25143	25144	_	_	_	_	_

121	1	In	in	IN	4	case	25145	25147	_	_	_	_	_
121	2	a	a	DT	4	det	25148	25149	_	_	B-source-25322	_	_
121	3	limited	limited	JJ	4	amod	25150	25157	_	_	I-source-25322	_	_
121	4	number	number	NN	12	nmod	25158	25164	_	_	I-source-25322	_	_
121	5	of	of	IN	6	case	25165	25167	_	_	I-source-25322	_	_
121	6	studies	study	NNS	4	nmod	25168	25175	B-event-211867	_	I-source-25322	_	_
121	7	,	,	,	12	punct	25175	25176	_	_	_	_	_
121	8	paediatric	paediatric	JJ	10	amod	25177	25187	_	B-content-25324:25322-Source_25323-Cue	_	_	_
121	9	haemodialysis	haemodialysis	NN	10	compound	25188	25201	_	I-content-25324	_	_	_
121	10	patients	patient	NNS	12	nsubj	25202	25210	B-event-212491	I-content-25324	_	_	_
121	11	have	have	VBP	12	aux	25211	25215	_	_	_	_	_
121	12	demonstrated	demonstrate	VBN	0	ROOT	25216	25228	_	_	_	B-cue-25323	_
121	13	improved	improved	JJ	14	amod	25229	25237	B-event-211868	D-content-25324	_	_	_
121	14	response	response	NN	12	dobj	25238	25246	B-event-211869	I-content-25324	_	_	_
121	15	when	when	WRB	33	advmod	25247	25251	_	I-content-25324	_	_	_
121	16	given	give	VBN	33	dep	25252	25257	_	I-content-25324	_	_	_
121	17	higher	higher	JJR	18	amod	25258	25264	_	I-content-25324	_	_	_
121	18	doses	dose	NNS	16	xcomp	25265	25270	B-event-211870	I-content-25324	_	_	_
121	19	in	in	IN	23	case	25271	25273	_	I-content-25324	_	_	_
121	20	a	a	DT	23	det	25274	25275	_	I-content-25324	_	_	_
121	21	3-dose	3-dose	JJ	23	amod	25276	25282	_	I-content-25324	_	_	_
121	22	schedule	schedule	NN	23	compound	25283	25291	_	I-content-25324	_	_	_
121	23	.59,60	.59,60	NN	18	nmod	25291	25297	_	_	_	_	_
121	24	For	for	IN	28	case	25298	25301	_	_	_	_	_
121	25	specific	specific	JJ	28	amod	25302	25310	_	_	_	_	_
121	26	hepatitis	hepatitis	NN	28	compound	25311	25320	_	_	_	_	_
121	27	B	b	NN	28	compound	25321	25322	_	_	_	_	_
121	28	recommendations	recommendation	NNS	18	dep	25323	25338	B-event-211871	_	_	_	_
121	29	for	for	IN	31	case	25339	25342	_	_	_	_	_
121	30	immunocompromised	immunocompromised	JJ	31	amod	25343	25360	B-event-211872	_	_	_	_
121	31	children	child	NNS	18	dep	25361	25369	_	_	_	_	_
121	32	,	,	,	33	punct	25369	25370	_	_	_	_	_
121	33	refer	refer	VBP	12	advcl	25371	25376	_	_	_	_	_
121	34	to	to	TO	36	case	25377	25379	_	_	_	_	_
121	35	3.3.3	3.3.3	CD	36	nummod	25380	25385	_	_	_	_	_
121	36	Vaccination	vaccination	NN	33	nmod	25386	25397	_	_	_	_	_
121	37	of	of	IN	39	case	25398	25400	_	_	_	_	_
121	38	immunocompromised	immunocompromised	JJ	39	amod	25401	25418	_	_	_	_	_
121	39	persons	person	NNS	36	nmod	25419	25426	_	_	_	_	_
121	40	.	.	.	12	punct	25426	25427	_	_	_	_	_

122	1	Adolescents	adolescent	NNS	2	compound	25428	25439	_	_	_	_	_
122	2	Vaccination	vaccination	NN	12	nsubjpass	25440	25451	B-event-211873	B-content-25326:25325-Cue	_	_	_
122	3	of	of	IN	4	case	25452	25454	_	I-content-25326	_	_	_
122	4	adolescents	adolescent	NNS	2	nmod	25455	25466	_	I-content-25326	_	_	_
122	5	10	10	CD	6	compound	25467	25469	_	I-content-25326	_	_	_
122	6	–	–	CD	4	amod	25469	25470	_	I-content-25326	_	_	_
122	7	13	13	CD	8	nummod	25470	25472	_	I-content-25326	_	_	_
122	8	years	year	NNS	6	nmod:tmod	25473	25478	_	I-content-25326	_	_	_
122	9	of	of	IN	10	case	25479	25481	_	I-content-25326	_	_	_
122	10	age	age	NN	4	nmod	25482	25485	_	I-content-25326	_	_	_
122	11	is	be	VBZ	12	auxpass	25486	25488	_	_	_	_	_
122	12	recommended	recommend	VBN	0	ROOT	25489	25500	_	_	_	B-cue-25325	_
122	13	for	for	IN	15	case	25501	25504	_	_	_	_	_
122	14	all	all	PDT	15	det:predet	25505	25508	_	_	_	_	_
122	15	those	those	DT	12	nmod	25509	25514	_	_	_	_	_
122	16	in	in	IN	19	case	25515	25517	_	_	_	_	_
122	17	this	this	DT	19	det	25518	25522	_	_	_	_	_
122	18	age	age	NN	19	compound	25523	25526	_	_	_	_	_
122	19	group	group	NN	12	nmod	25527	25532	_	_	_	_	_
122	20	who	who	WP	24	nsubj	25533	25536	_	_	_	_	_
122	21	have	have	VBP	24	aux	25537	25541	_	_	_	_	_
122	22	not	not	RB	24	neg	25542	25545	_	_	_	_	_
122	23	already	already	RB	24	advmod	25546	25553	_	_	_	_	_
122	24	received	receive	VBD	19	acl:relcl	25554	25562	_	_	_	_	_
122	25	a	a	DT	27	det	25563	25564	_	_	_	_	_
122	26	primary	primary	JJ	27	amod	25565	25572	_	_	_	_	_
122	27	course	course	NN	24	dobj	25573	25579	_	_	_	_	_
122	28	of	of	IN	31	case	25580	25582	_	_	_	_	_
122	29	hepatitis	hepatitis	NN	31	compound	25583	25592	_	_	_	_	_
122	30	B	b	NN	31	compound	25593	25594	_	_	_	_	_
122	31	vaccine	vaccine	NN	27	nmod	25595	25602	B-event-211874	_	_	_	_
122	32	.	.	.	12	punct	25602	25603	_	_	_	_	_

123	1	Refer	refer	VB	19	dep	25604	25609	_	_	_	_	_
123	2	to	to	TO	6	case	25610	25612	_	_	_	_	_
123	3	your	you	PRP$	6	nmod:poss	25613	25617	_	_	_	_	_
123	4	state/territory	state/territory	JJ	6	amod	25618	25633	_	_	_	_	_
123	5	health	health	NN	6	compound	25634	25640	_	_	_	_	_
123	6	authority	authority	NN	1	nmod	25641	25650	_	_	_	_	_
123	7	for	for	IN	9	case	25651	25654	_	_	_	_	_
123	8	further	further	JJ	9	amod	25655	25662	_	_	_	_	_
123	9	information	information	NN	6	nmod	25663	25674	_	_	_	_	_
123	10	about	about	IN	13	case	25675	25680	_	_	_	_	_
123	11	hepatitis	hepatitis	NN	13	compound	25681	25690	_	_	_	_	_
123	12	B	b	NN	13	compound	25691	25692	_	_	_	_	_
123	13	vaccine	vaccine	NN	1	nmod	25693	25700	_	_	_	_	_
123	14	for	for	IN	17	case	25701	25704	_	_	_	_	_
123	15	this	this	DT	17	det	25705	25709	_	_	_	_	_
123	16	age	age	NN	17	compound	25710	25713	_	_	_	_	_
123	17	group	group	NN	13	nmod	25714	25719	_	_	_	_	_
123	18	(	(	CD	19	nsubj	25720	25721	_	_	_	_	_
123	19	refer	refer	VBP	0	ROOT	25721	25726	_	_	_	_	_
123	20	to	to	TO	24	case	25727	25729	_	_	_	_	_
123	21	Appendix	appendix	NN	24	compound	25730	25738	_	_	_	_	_
123	22	1	1	CD	24	nummod	25739	25740	_	_	_	_	_
123	23	Contact	contact	NN	24	compound	25741	25748	_	_	_	_	_
123	24	details	detail	NNS	19	nmod	25749	25756	_	_	_	_	_
123	25	for	for	IN	31	case	25757	25760	_	_	_	_	_
123	26	Australian	australian	JJ	31	compound	25761	25771	_	_	_	_	_
123	27	,	,	,	26	punct	25771	25772	_	_	_	_	_
123	28	state	state	NN	26	conj	25773	25778	_	_	_	_	_
123	29	and	and	CC	26	cc	25779	25782	_	_	_	_	_
123	30	territory	territory	NN	26	conj	25783	25792	_	_	_	_	_
123	31	government	government	NN	19	nmod	25793	25803	_	_	_	_	_
123	32	health	health	NN	33	compound	25804	25810	_	_	_	_	_
123	33	authorities	authority	NNS	31	dep	25811	25822	_	_	_	_	_
123	34	and	and	CC	31	cc	25823	25826	_	_	_	_	_
123	35	communicable	communicable	JJ	37	amod	25827	25839	_	_	_	_	_
123	36	disease	disease	NN	37	compound	25840	25847	_	_	_	_	_
123	37	control	control	NN	31	conj	25848	25855	_	_	_	_	_
123	38	)	)	CD	37	dep	25855	25856	_	_	_	_	_
123	39	.	.	.	19	punct	25856	25857	_	_	_	_	_

124	1	As	as	IN	9	mark	25858	25860	_	_	_	_	_
124	2	the	the	DT	3	det	25861	25864	_	_	_	_	_
124	3	risk	risk	NN	9	nsubj	25865	25869	B-event-211875	_	_	_	_
124	4	in	in	IN	6	case	25870	25872	_	_	_	_	_
124	5	Australian	australian	JJ	6	amod	25873	25883	_	_	_	_	_
124	6	schools	school	NNS	3	nmod	25884	25891	_	_	_	_	_
124	7	is	be	VBZ	9	cop	25892	25894	_	_	_	_	_
124	8	very	very	RB	9	advmod	25895	25899	_	_	_	_	_
124	9	low	low	JJ	21	advcl	25900	25903	_	_	_	_	_
124	10	,61	,61	CD	11	nummod	25903	25906	_	_	_	_	_
124	11	vaccination	vaccination	NN	21	nsubjpass	25907	25918	B-event-211876	_	_	_	_
124	12	of	of	IN	14	case	25919	25921	_	_	_	_	_
124	13	classroom	classroom	NN	14	compound	25922	25931	_	_	_	_	_
124	14	contacts	contact	NNS	11	nmod	25932	25940	_	_	_	_	_
124	15	of	of	IN	18	case	25941	25943	_	_	_	_	_
124	16	hepatitis	hepatitis	NN	18	compound	25944	25953	B-event-211877	_	_	_	_
124	17	B	b	NN	18	compound	25954	25955	I-event-211877	_	_	_	_
124	18	cases	case	NNS	14	nmod	25956	25961	_	_	_	_	_
124	19	is	be	VBZ	21	auxpass	25962	25964	_	_	_	_	_
124	20	seldom	seldom	RB	21	advmod	25965	25971	_	_	_	_	_
124	21	indicated	indicate	VBN	0	ROOT	25972	25981	B-event-211878	_	_	_	_
124	22	.	.	.	21	punct	25981	25982	_	_	_	_	_

125	1	Nevertheless	nevertheless	RB	11	advmod	25983	25995	_	_	_	_	_
125	2	,	,	,	11	punct	25995	25996	_	_	_	_	_
125	3	vaccination	vaccination	NN	11	nsubjpass	25997	26008	B-event-211879	_	_	_	B-claim-10430
125	4	of	of	IN	6	case	26009	26011	_	_	_	_	I-claim-10430
125	5	all	all	DT	6	det	26012	26015	_	_	_	_	I-claim-10430
125	6	children	child	NNS	3	nmod	26016	26024	_	_	_	_	I-claim-10430
125	7	and	and	CC	6	cc	26025	26028	_	_	_	_	I-claim-10430
125	8	adolescents	adolescent	NNS	6	conj	26029	26040	_	_	_	_	I-claim-10430
125	9	should	should	MD	11	aux	26041	26047	_	_	_	_	I-claim-10430
125	10	be	be	VB	11	auxpass	26048	26050	_	_	_	_	I-claim-10430
125	11	encouraged	encourage	VBN	0	ROOT	26051	26061	B-event-211880	_	_	_	I-claim-10430
125	12	.	.	.	11	punct	26061	26062	_	_	_	_	_

126	1	A	a	DT	3	det	26063	26064	_	_	_	_	_
126	2	2-dose	2-dose	JJ	3	amod	26065	26071	_	_	_	_	_
126	3	schedule	schedule	NN	21	nsubjpass	26072	26080	_	_	_	_	_
126	4	of	of	IN	7	case	26081	26083	_	_	_	_	_
126	5	hepatitis	hepatitis	NN	7	compound	26084	26093	_	_	_	_	_
126	6	B	b	NN	7	compound	26094	26095	_	_	_	_	_
126	7	vaccine	vaccine	NN	3	nmod	26096	26103	B-event-211881	_	_	_	_
126	8	using	use	VBG	7	acl	26104	26109	_	_	_	_	_
126	9	the	the	DT	11	det	26110	26113	_	_	_	_	_
126	10	adult	adult	JJ	11	amod	26114	26119	_	_	_	_	_
126	11	formulation	formulation	NN	8	dobj	26120	26131	_	_	_	_	_
126	12	of	of	IN	13	case	26132	26134	_	_	_	_	_
126	13	either	either	DT	11	nmod	26135	26141	_	_	_	_	_
126	14	of	of	IN	18	case	26142	26144	_	_	_	_	_
126	15	the	the	DT	18	det	26145	26148	_	_	_	_	_
126	16	available	available	JJ	17	amod	26149	26158	_	_	_	_	_
126	17	monovalent	monovalent	JJ	18	amod	26159	26169	_	_	_	_	_
126	18	vaccines	vaccine	NNS	13	nmod	26170	26178	_	_	_	_	_
126	19	should	should	MD	21	aux	26179	26185	_	_	_	_	_
126	20	be	be	VB	21	auxpass	26186	26188	_	_	_	_	_
126	21	considered	consider	VBN	0	ROOT	26189	26199	B-event-211882	_	_	_	_
126	22	for	for	IN	23	case	26200	26203	_	_	_	_	_
126	23	adolescents	adolescent	NNS	21	nmod	26204	26215	_	_	_	_	_
126	24	aged	aged	JJ	23	amod	26216	26220	_	_	_	_	_
126	25	11	11	CD	26	compound	26221	26223	_	_	_	_	_
126	26	–	–	CD	24	nmod	26223	26224	_	_	_	_	_
126	27	15	15	CD	28	nummod	26224	26226	_	_	_	_	_
126	28	years	year	NNS	26	dep	26227	26232	_	_	_	_	_
126	29	who	who	WP	30	nsubj	26233	26236	_	_	_	_	_
126	30	are	be	VBP	23	acl:relcl	26237	26240	_	_	_	_	_
126	31	to	to	TO	32	mark	26241	26243	_	_	_	_	_
126	32	receive	receive	VB	30	xcomp	26244	26251	_	_	_	_	_
126	33	hepatitis	hepatitis	NN	34	compound	26252	26261	_	_	_	_	_
126	34	B	b	NN	32	dobj	26262	26263	_	_	_	_	_
126	35	vaccination	vaccination	NN	37	nsubj	26264	26275	B-event-211883	_	_	_	_
126	36	(	(	CD	35	nummod	26276	26277	_	_	_	_	_
126	37	refer	refer	VBP	34	acl:relcl	26277	26282	_	_	_	_	_
126	38	to	to	TO	39	case	26283	26285	_	_	_	_	_
126	39	Table	Table	NNP	37	nmod	26286	26291	_	_	_	_	_
126	40	4.5.1	4.5.1	CD	39	nummod	26292	26297	_	_	_	_	_
126	41	and	and	CC	23	cc	26298	26301	_	_	_	_	_
126	42	4.5.4	4.5.4	CD	43	nummod	26302	26307	_	_	_	_	_
126	43	Vaccines	vaccine	NNS	23	conj	26308	26316	_	_	_	_	_
126	44	above	above	IN	45	case	26317	26322	_	_	_	_	_
126	45	)	)	NN	43	nmod	26322	26323	_	_	_	_	_
126	46	.	.	.	21	punct	26323	26324	_	_	_	_	_

127	1	A	a	DT	3	det	26325	26326	_	_	_	_	_
127	2	2-dose	2-dose	JJ	3	amod	26327	26333	_	_	_	_	_
127	3	schedule	schedule	NN	4	nsubj	26334	26342	_	_	_	_	_
127	4	increases	increase	VBZ	0	ROOT	26343	26352	B-event-211884	_	_	_	_
127	5	compliance	compliance	NN	4	dobj	26353	26363	B-event-211885	_	_	_	_
127	6	and	and	CC	5	cc	26364	26367	_	_	_	_	_
127	7	thus	thus	RB	5	advmod	26368	26372	_	_	_	_	_
127	8	protection	protection	NN	5	dep	26373	26383	B-event-211886	_	_	_	_
127	9	in	in	IN	12	case	26384	26386	_	_	_	_	_
127	10	this	this	DT	12	det	26387	26391	_	_	_	_	_
127	11	age	age	NN	12	compound	26392	26395	_	_	_	_	_
127	12	group	group	NN	8	nmod	26396	26401	_	_	_	_	_
127	13	.	.	.	4	punct	26401	26402	_	_	_	_	_

128	1	Adolescents	adolescent	NNS	14	nsubjpass	26403	26414	_	_	_	_	B-claim-10431
128	2	who	who	WP	5	nsubj	26415	26418	_	_	_	_	I-claim-10431
128	3	did	do	VBD	5	aux	26419	26422	_	_	_	_	I-claim-10431
128	4	not	not	RB	5	neg	26423	26426	_	_	_	_	I-claim-10431
128	5	receive	receive	VB	1	acl:relcl	26427	26434	_	_	_	_	I-claim-10431
128	6	an	a	DT	9	det	26435	26437	_	_	_	_	I-claim-10431
128	7	age-appropriate	age-appropriate	JJ	9	amod	26438	26453	_	_	_	_	I-claim-10431
128	8	completed	complete	VBN	9	amod	26454	26463	_	_	_	_	I-claim-10431
128	9	course	course	NN	5	dobj	26464	26470	_	_	_	_	I-claim-10431
128	10	of	of	IN	11	case	26471	26473	_	_	_	_	I-claim-10431
128	11	vaccination	vaccination	NN	9	nmod	26474	26485	B-event-211887	_	_	_	I-claim-10431
128	12	should	should	MD	14	aux	26486	26492	_	_	_	_	I-claim-10431
128	13	be	be	VB	14	auxpass	26493	26495	_	_	_	_	I-claim-10431
128	14	identified	identify	VBN	0	ROOT	26496	26506	B-event-211888	_	_	_	I-claim-10431
128	15	and	and	CC	14	cc	26507	26510	_	_	_	_	I-claim-10431
128	16	offered	offer	VBN	14	conj	26511	26518	_	_	_	_	I-claim-10431
128	17	catch-up	catch-up	NN	18	compound	26519	26527	B-event-211889	_	_	_	I-claim-10431
128	18	vaccination	vaccination	NN	14	dobj	26528	26539	B-event-211890	_	_	_	I-claim-10431
128	19	,	,	,	14	punct	26539	26540	_	_	_	_	I-claim-10431
128	20	particularly	particularly	RB	23	advmod	26541	26553	_	_	_	_	I-claim-10431
128	21	if	if	IN	23	mark	26554	26556	_	_	_	_	I-claim-10431
128	22	they	they	PRP	23	nsubj	26557	26561	_	_	_	_	I-claim-10431
128	23	fall	fall	VBP	14	advcl	26562	26566	_	_	_	_	I-claim-10431
128	24	into	into	IN	25	case	26567	26571	_	_	_	_	I-claim-10431
128	25	one	one	CD	23	nmod	26572	26575	_	_	_	_	I-claim-10431
128	26	of	of	IN	29	case	26576	26578	_	_	_	_	I-claim-10431
128	27	the	the	DT	29	det	26579	26582	_	_	_	_	I-claim-10431
128	28	risk	risk	NN	29	compound	26583	26587	B-event-211891	_	_	_	I-claim-10431
128	29	categories	category	NNS	25	nmod	26588	26598	_	_	_	_	I-claim-10431
128	30	for	for	IN	33	case	26599	26602	_	_	_	_	I-claim-10431
128	31	hepatitis	hepatitis	NN	33	compound	26603	26612	B-event-211892	_	_	_	I-claim-10431
128	32	B	b	NN	33	compound	26613	26614	I-event-211892	_	_	_	I-claim-10431
128	33	infection	infection	NN	23	nmod	26615	26624	B-event-211893	_	_	_	I-claim-10431
128	34	,	,	,	33	punct	26624	26625	_	_	_	_	I-claim-10431
128	35	discussed	discuss	VBN	33	acl	26626	26635	_	_	_	_	I-claim-10431
128	36	under	under	IN	38	case	26636	26641	_	_	_	_	I-claim-10431
128	37	‘	‘	CD	38	nummod	26642	26643	_	_	_	_	I-claim-10431
128	38	Adults	adult	NNS	35	nmod	26643	26649	_	_	_	_	I-claim-10431
128	39	’	’	RB	38	advmod	26649	26650	_	_	_	_	I-claim-10431
128	40	below	below	IN	38	case	26651	26656	_	_	_	_	I-claim-10431
128	41	.	.	.	14	punct	26656	26657	_	_	_	_	_

129	1	Adults	adult	NNS	6	nsubjpass	26658	26664	_	_	_	_	_
129	2	Hepatitis	Hepatitis	NNP	4	compound	26666	26675	_	B-content-25327:25328-Cue	_	_	_
129	3	B	B	NNP	4	compound	26676	26677	_	I-content-25327	_	_	_
129	4	vaccination	vaccination	NN	1	dep	26678	26689	B-event-211894	I-content-25327	_	_	_
129	5	is	be	VBZ	6	auxpass	26690	26692	_	_	_	_	_
129	6	recommended	recommend	VBN	0	ROOT	26693	26704	_	_	_	B-cue-25328	_
129	7	for	for	IN	10	case	26705	26708	_	_	_	_	_
129	8	the	the	DT	10	det	26709	26712	_	_	_	_	_
129	9	following	follow	VBG	10	amod	26713	26722	_	_	_	_	_
129	10	groups	group	NNS	6	nmod	26723	26729	_	_	_	_	_
129	11	of	of	IN	12	case	26730	26732	_	_	_	_	_
129	12	adults	adult	NNS	10	nmod	26733	26739	_	_	_	_	_
129	13	because	because	IN	20	mark	26740	26747	_	_	_	_	_
129	14	they	they	PRP	20	nsubj	26748	26752	_	_	_	_	_
129	15	are	be	VBP	20	cop	26753	26756	_	_	_	_	_
129	16	either	either	RB	20	advmod	26757	26763	_	_	_	_	_
129	17	at	at	IN	20	case	26764	26766	_	_	_	_	_
129	18	a	a	DT	20	det	26767	26768	_	_	_	_	_
129	19	higher	higher	JJR	20	amod	26769	26775	_	_	_	_	_
129	20	risk	risk	NN	6	advcl	26776	26780	B-event-211895	_	_	_	_
129	21	of	of	IN	22	mark	26781	26783	_	_	_	_	_
129	22	acquiring	acquire	VBG	20	acl	26784	26793	B-event-211896	_	_	_	_
129	23	hepatitis	hepatitis	NN	25	compound	26794	26803	B-event-211897	_	_	_	_
129	24	B	b	NN	25	compound	26804	26805	I-event-211897	_	_	_	_
129	25	infection	infection	NN	22	dobj	26806	26815	B-event-211898	_	_	_	_
129	26	and/or	and/or	CC	6	cc	26816	26822	_	_	_	_	_
129	27	at	at	IN	29	case	26823	26825	_	_	_	_	_
129	28	higher	higher	JJR	29	amod	26826	26832	_	_	_	_	_
129	29	risk	risk	NN	6	conj	26833	26837	B-event-211899	_	_	_	_
129	30	of	of	IN	32	case	26838	26840	_	_	_	_	_
129	31	severe	severe	JJ	32	amod	26841	26847	_	_	_	_	_
129	32	disease	disease	NN	29	nmod	26848	26855	B-event-211900	_	_	_	_
129	33	.	.	.	6	punct	26855	26856	_	_	_	_	_

130	1	Refer	refer	VB	0	ROOT	26857	26862	_	_	_	_	_
130	2	to	to	TO	3	case	26863	26865	_	_	_	_	_
130	3	Tables	Tables	NNP	1	nmod	26866	26872	_	_	_	_	_
130	4	4.5.1	4.5.1	CD	3	nummod	26873	26878	_	_	_	_	_
130	5	and	and	CC	3	cc	26879	26882	_	_	_	_	_
130	6	4.5.2	4.5.2	CD	7	nummod	26883	26888	_	_	_	_	_
130	7	Vaccines	vaccine	NNS	12	advmod	26890	26898	_	_	_	_	_
130	8	above	above	IN	7	case	26899	26904	_	_	_	_	_
130	9	for	for	IN	12	case	26905	26908	_	_	_	_	_
130	10	recommended	recommend	VBN	12	amod	26909	26920	B-event-211901	_	_	_	_
130	11	adult	adult	JJ	12	amod	26921	26926	_	_	_	_	_
130	12	vaccination	vaccination	NN	3	conj	26927	26938	B-event-211902	_	_	_	_
130	13	schedules	schedule	NNS	12	dep	26939	26948	_	_	_	_	_
130	14	.	.	.	1	punct	26948	26949	_	_	_	_	_

131	1	Serological	serological	JJ	2	amod	26950	26961	_	_	_	_	_
131	2	testing	testing	NN	16	nsubj	26962	26969	B-event-211903	_	_	_	_
131	3	for	for	IN	7	case	26970	26973	_	_	_	_	_
131	4	previous	previous	JJ	7	amod	26974	26982	_	_	_	_	_
131	5	or	or	CC	4	cc	26983	26985	_	_	_	_	_
131	6	chronic	chronic	JJ	4	conj	26986	26993	_	_	_	_	_
131	7	hepatitis	hepatitis	NN	2	nmod	26994	27003	B-event-211904	_	_	_	_
131	8	B	b	NN	9	compound	27004	27005	I-event-211904	_	_	_	_
131	9	infection	infection	NN	12	nsubjpass	27006	27015	B-event-211905	_	_	_	_
131	10	may	may	MD	12	aux	27016	27019	_	_	_	_	_
131	11	be	be	VB	12	auxpass	27020	27022	_	_	_	_	_
131	12	indicated	indicate	VBN	2	acl:relcl	27023	27032	B-event-211906	_	_	_	_
131	13	in	in	IN	15	case	27033	27035	_	_	_	_	_
131	14	many	many	JJ	15	amod	27036	27040	_	_	_	_	_
131	15	circumstances	circumstance	NNS	12	nmod	27041	27054	_	_	_	_	_
131	16	(	(	VBP	0	ROOT	27055	27056	_	_	_	_	_
131	17	refer	refer	VB	16	xcomp	27056	27061	_	_	_	_	_
131	18	to	to	TO	21	case	27062	27064	_	_	_	_	_
131	19	‘	‘	CD	21	nummod	27065	27066	_	_	_	_	_
131	20	Serological	serological	JJ	21	amod	27066	27077	_	_	_	_	_
131	21	testing	testing	NN	17	nmod	27078	27085	_	_	_	_	_
131	22	prior	prior	RB	21	advmod	27086	27091	_	_	_	_	_
131	23	to	to	TO	27	case	27092	27094	_	_	_	_	_
131	24	hepatitis	hepatitis	NN	27	compound	27095	27104	_	_	_	_	_
131	25	B	b	NN	27	compound	27105	27106	_	_	_	_	_
131	26	vaccination	vaccination	NN	27	compound	27107	27118	_	_	_	_	_
131	27	’	’	NN	22	nmod	27118	27119	_	_	_	_	_
131	28	below	below	IN	29	case	27120	27125	_	_	_	_	_
131	29	)	)	NN	17	nmod	27125	27126	_	_	_	_	_
131	30	.	.	.	16	punct	27126	27127	_	_	_	_	_

132	1	Refer	refer	NN	0	ROOT	27128	27133	_	_	_	_	_
132	2	also	also	RB	5	advmod	27134	27138	_	_	_	_	_
132	3	to	to	TO	5	case	27139	27141	_	_	_	_	_
132	4	3.3	3.3	CD	5	nummod	27142	27145	_	_	_	_	_
132	5	Groups	group	NNS	1	nmod	27146	27152	_	_	_	_	_
132	6	with	with	IN	9	case	27153	27157	_	_	_	_	_
132	7	special	special	JJ	9	amod	27158	27165	_	_	_	_	_
132	8	vaccination	vaccination	NN	9	compound	27166	27177	B-event-211907	_	_	_	_
132	9	requirements	requirement	NNS	5	nmod	27178	27190	B-event-211908	_	_	_	_
132	10	.	.	.	1	punct	27190	27191	_	_	_	_	_

133	1	When	when	WRB	11	advmod	27192	27196	_	_	_	_	_
133	2	vaccination	vaccination	NN	11	nsubjpass	27197	27208	B-event-211909	_	_	_	_
133	3	against	against	IN	6	case	27209	27216	_	_	_	_	_
133	4	both	both	DT	6	cc:preconj	27217	27221	_	_	_	_	_
133	5	hepatitis	hepatitis	NN	6	compound	27222	27231	B-event-211910	_	_	_	_
133	6	B	b	NN	2	nmod	27232	27233	I-event-211910	_	_	_	_
133	7	and	and	CC	6	cc	27234	27237	_	_	_	_	_
133	8	hepatitis	hepatitis	NN	9	compound	27238	27247	B-event-211911	_	_	_	_
133	9	A	a	NN	6	conj	27248	27249	I-event-211911	_	_	_	_
133	10	is	be	VBZ	11	auxpass	27250	27252	_	_	_	_	_
133	11	indicated	indicate	VBN	21	advcl	27253	27262	B-event-211912	_	_	_	_
133	12	,	,	,	21	punct	27262	27263	_	_	_	_	_
133	13	the	the	DT	18	det	27264	27267	_	_	_	_	_
133	14	combination	combination	NN	18	compound	27268	27279	_	_	_	_	_
133	15	hepatitis	hepatitis	NN	18	compound	27280	27289	_	_	_	_	_
133	16	A/hepatitis	a/hepatitis	NN	18	compound	27290	27301	_	_	_	_	_
133	17	B	b	NN	18	compound	27302	27303	_	_	_	_	_
133	18	vaccines	vaccine	NNS	21	nsubjpass	27304	27312	B-event-211913	_	_	_	_
133	19	may	may	MD	21	aux	27313	27316	_	_	_	_	_
133	20	be	be	VB	21	auxpass	27317	27319	_	_	_	_	_
133	21	used	use	VBN	0	ROOT	27320	27324	_	_	_	_	_
133	22	.	.	.	21	punct	27324	27325	_	_	_	_	_

134	1	Refer	refer	VB	0	ROOT	27326	27331	_	_	_	_	_
134	2	to	to	TO	3	case	27332	27334	_	_	_	_	_
134	3	Tables	Tables	NNP	1	nmod	27335	27341	_	_	_	_	_
134	4	4.5.1	4.5.1	CD	3	nummod	27342	27347	_	_	_	_	_
134	5	and	and	CC	3	cc	27348	27351	_	_	_	_	_
134	6	4.5.2	4.5.2	CD	3	conj	27352	27357	_	_	_	_	_
134	7	above	above	IN	10	case	27358	27363	_	_	_	_	_
134	8	and	and	CC	9	cc	27364	27367	_	_	_	_	_
134	9	‘	‘	CD	10	nummod	27368	27369	_	_	_	_	_
134	10	Recommendations	recommendation	NNS	1	nmod	27369	27384	_	_	_	_	_
134	11	for	for	IN	13	case	27385	27388	_	_	_	_	_
134	12	the	the	DT	13	det	27389	27392	_	_	_	_	_
134	13	use	use	NN	10	nmod	27393	27396	_	_	_	_	_
134	14	of	of	IN	19	case	27397	27399	_	_	_	_	_
134	15	combination	combination	NN	19	compound	27400	27411	_	_	_	_	_
134	16	hepatitis	hepatitis	NN	19	compound	27412	27421	_	_	_	_	_
134	17	A/hepatitis	a/hepatitis	NN	19	compound	27422	27433	_	_	_	_	_
134	18	B	b	NN	19	compound	27434	27435	_	_	_	_	_
134	19	vaccines	vaccine	NNS	13	nmod	27436	27444	_	_	_	_	_
134	20	’	’	RB	1	advmod	27444	27445	_	_	_	_	_
134	21	below	below	IN	3	case	27446	27451	_	_	_	_	_
134	22	.	.	.	1	punct	27451	27452	_	_	_	_	_

135	1	Household	Household	NNP	8	dep	27454	27463	_	_	_	_	_
135	2	or	or	CC	1	cc	27464	27466	_	_	_	_	_
135	3	other	other	JJ	5	amod	27467	27472	_	_	_	_	_
135	4	close	close	JJ	5	amod	27473	27478	_	_	_	_	_
135	5	(	(	NN	1	conj	27479	27480	_	_	_	_	_
135	6	household-like	household-like	JJ	7	amod	27480	27494	_	_	_	_	_
135	7	)	)	NN	8	dep	27494	27495	_	_	_	_	_
135	8	contacts	contact	NNS	15	dep	27496	27504	_	_	_	_	_
135	9	of	of	IN	10	case	27505	27507	_	_	_	_	_
135	10	persons	person	NNS	8	nmod	27508	27515	_	_	_	_	_
135	11	with	with	IN	13	case	27516	27520	_	_	_	_	_
135	12	hepatitis	hepatitis	NN	13	compound	27521	27530	B-event-211914	_	_	_	_
135	13	B	b	NN	10	nmod	27531	27532	I-event-211914	_	_	_	_
135	14	There	there	EX	15	expl	27534	27539	_	_	_	_	_
135	15	is	be	VBZ	41	advcl	27540	27542	_	_	_	_	_
135	16	a	a	DT	17	dep	27543	27544	_	_	_	_	_
135	17	low	low	JJ	15	xcomp	27545	27548	_	_	_	_	_
135	18	,	,	,	17	punct	27548	27549	_	_	_	_	_
135	19	but	but	CC	17	cc	27550	27553	_	_	_	_	_
135	20	definite	definite	JJ	17	conj	27554	27562	_	_	_	_	_
135	21	,	,	,	41	punct	27562	27563	_	_	_	_	_
135	22	risk	risk	NN	41	nsubj	27564	27568	B-event-211915	_	_	_	_
135	23	of	of	IN	24	case	27569	27571	_	_	_	_	_
135	24	transmission	transmission	NN	22	nmod	27572	27584	B-event-211916	_	_	_	_
135	25	from	from	IN	27	case	27585	27589	_	_	_	_	_
135	26	a	a	DT	27	det	27590	27591	_	_	_	_	_
135	27	person	person	NN	24	nmod	27592	27598	_	_	_	_	_
135	28	with	with	IN	29	case	27599	27603	_	_	_	_	_
135	29	acute	acute	JJ	27	acl	27604	27609	_	_	_	_	_
135	30	or	or	CC	27	cc	27610	27612	_	_	_	_	_
135	31	chronic	chronic	JJ	33	amod	27613	27620	_	_	_	_	_
135	32	hepatitis	hepatitis	NN	33	compound	27621	27630	B-event-211917	_	_	_	_
135	33	B	b	NN	27	conj	27631	27632	I-event-211917	_	_	_	_
135	34	to	to	TO	35	case	27633	27635	_	_	_	_	_
135	35	household	household	NN	33	nmod	27636	27645	_	_	_	_	_
135	36	or	or	CC	35	cc	27646	27648	_	_	_	_	_
135	37	other	other	JJ	40	amod	27649	27654	_	_	_	_	_
135	38	close	close	JJ	40	amod	27655	27660	_	_	_	_	_
135	39	residential	residential	JJ	40	amod	27661	27672	_	_	_	_	_
135	40	contacts	contact	NNS	35	conj	27673	27681	_	_	_	_	_
135	41	(	(	VBP	0	ROOT	27682	27683	_	_	_	_	_
135	42	e.g.	e.g.	FW	47	nsubj	27683	27687	_	_	_	_	_
135	43	students	student	NNS	47	dep	27688	27696	_	_	_	_	_
135	44	or	or	CC	43	cc	27697	27699	_	_	_	_	_
135	45	asylum	asylum	NN	46	compound	27700	27706	_	_	_	_	_
135	46	seekers	seeker	NNS	43	conj	27707	27714	_	_	_	_	_
135	47	sharing	share	VBG	41	xcomp	27715	27722	_	_	_	_	_
135	48	residential	residential	JJ	50	amod	27723	27734	_	_	_	_	_
135	49	facilities	facility	NNS	50	compound	27735	27745	_	_	_	_	_
135	50	)	)	NN	47	dobj	27745	27746	_	_	_	_	_
135	51	.	.	.	41	punct	27746	27747	_	_	_	_	_

136	1	This	this	DT	4	nsubjpass	27748	27752	_	_	_	_	_
136	2	can	can	MD	4	aux	27753	27756	_	_	_	_	_
136	3	be	be	VB	4	auxpass	27757	27759	_	_	_	_	_
136	4	reduced	reduce	VBN	0	ROOT	27760	27767	B-event-211918	_	_	_	_
136	5	by	by	IN	6	mark	27768	27770	_	_	_	_	_
136	6	avoiding	avoid	VBG	4	advcl	27771	27779	B-event-211919	_	_	_	_
136	7	contact	contact	NN	6	dobj	27780	27787	B-event-211920	_	_	_	_
136	8	with	with	IN	13	case	27788	27792	_	_	_	_	_
136	9	blood	blood	NN	13	compound	27793	27798	_	_	_	_	_
136	10	or	or	CC	9	cc	27799	27801	_	_	_	_	_
136	11	other	other	JJ	9	conj	27802	27807	_	_	_	_	_
136	12	body	body	NN	13	compound	27808	27812	_	_	_	_	_
136	13	fluids	fluid	NNS	6	nmod	27813	27819	_	_	_	_	_
136	14	and	and	CC	6	cc	27820	27823	_	_	_	_	_
136	15	not	not	RB	16	neg	27824	27827	_	_	_	_	_
136	16	sharing	share	VBG	6	conj	27828	27835	B-event-211921	_	_	_	_
136	17	items	item	NNS	16	dobj	27836	27841	_	_	_	_	_
136	18	that	that	WDT	20	nsubj	27842	27846	_	_	_	_	_
136	19	may	may	MD	20	aux	27847	27850	_	_	_	_	_
136	20	penetrate	penetrate	VB	17	acl:relcl	27851	27860	B-event-211922	_	_	_	_
136	21	the	the	DT	23	det	27861	27864	_	_	_	_	_
136	22	skin	skin	NN	23	compound	27865	27869	_	_	_	_	_
136	23	(	(	NN	20	dobj	27870	27871	_	_	_	_	_
136	24	such	such	JJ	26	case	27871	27875	_	_	_	_	_
136	25	as	as	IN	24	mwe	27876	27878	_	_	_	_	_
136	26	combs	comb	NNS	23	nmod	27879	27884	_	_	_	_	_
136	27	,	,	,	26	punct	27884	27885	_	_	_	_	_
136	28	nail	nail	NN	29	compound	27886	27890	_	_	_	_	_
136	29	brushes	brush	NNS	26	conj	27891	27898	_	_	_	_	_
136	30	,	,	,	26	punct	27898	27899	_	_	_	_	_
136	31	toothbrushes	toothbrush	NNS	26	conj	27900	27912	_	_	_	_	_
136	32	and	and	CC	26	cc	27913	27916	_	_	_	_	_
136	33	razors	razor	NNS	26	conj	27917	27923	_	_	_	_	_
136	34	)	)	CD	33	nummod	27923	27924	_	_	_	_	_
136	35	.	.	.	4	punct	27924	27925	_	_	_	_	_

137	1	Immunisation	immunisation	NN	8	nsubjpass	27926	27938	B-event-211923	_	_	_	_
137	2	of	of	IN	5	case	27939	27941	_	_	_	_	_
137	3	susceptible	susceptible	JJ	4	amod	27942	27953	_	_	_	_	_
137	4	household-like	household-like	JJ	5	amod	27954	27968	_	_	_	_	_
137	5	contacts	contact	NNS	1	nmod	27969	27977	_	_	_	_	_
137	6	is	be	VBZ	8	auxpass	27978	27980	_	_	_	_	_
137	7	strongly	strongly	RB	8	advmod	27981	27989	_	_	_	_	_
137	8	recommended	recommend	VBN	0	ROOT	27990	28001	B-event-211924	_	_	_	_
137	9	.	.	.	8	punct	28001	28002	_	_	_	_	_

138	1	This	this	DT	2	nsubj	28003	28007	_	_	_	_	_
138	2	includes	include	VBZ	0	ROOT	28008	28016	_	_	_	_	_
138	3	household	household	NN	4	compound	28017	28026	_	_	_	_	_
138	4	members	member	NNS	2	dobj	28027	28034	_	_	_	_	_
138	5	of	of	IN	8	case	28035	28037	_	_	_	_	_
138	6	the	the	DT	8	det	28038	28041	_	_	_	_	_
138	7	adoptive	adoptive	JJ	8	amod	28042	28050	B-event-211925	_	_	_	_
138	8	family	family	NN	4	nmod	28051	28057	_	_	_	_	_
138	9	if	if	IN	14	mark	28058	28060	_	_	_	_	_
138	10	the	the	DT	12	det	28061	28064	_	_	_	_	_
138	11	adopted	adopt	VBN	12	amod	28065	28072	B-event-211926	_	_	_	_
138	12	child	child	NN	14	nsubjpass	28073	28078	_	_	_	_	_
138	13	is	be	VBZ	14	auxpass	28079	28081	_	_	_	_	_
138	14	known	know	VBN	2	advcl	28082	28087	_	_	_	_	_
138	15	to	to	TO	16	mark	28088	28090	_	_	_	_	_
138	16	have	have	VB	14	xcomp	28091	28095	_	_	_	_	_
138	17	chronic	chronic	JJ	20	amod	28096	28103	_	_	_	_	_
138	18	hepatitis	hepatitis	NN	20	compound	28104	28113	B-event-211927	_	_	_	_
138	19	B	b	NN	20	compound	28114	28115	I-event-211927	_	_	_	_
138	20	infection	infection	NN	16	dobj	28116	28125	B-event-211928	_	_	_	_
138	21	.	.	.	2	punct	28125	28126	_	_	_	_	_

139	1	Sexual	sexual	JJ	2	amod	28128	28134	B-event-211929	_	_	_	_
139	2	contacts	contact	NNS	39	nsubj	28135	28143	_	_	_	_	_
139	3	of	of	IN	4	case	28144	28146	_	_	_	_	_
139	4	persons	person	NNS	2	nmod	28147	28154	_	_	_	_	_
139	5	with	with	IN	7	case	28155	28159	_	_	_	_	_
139	6	hepatitis	hepatitis	NN	7	compound	28160	28169	B-event-211930	_	_	_	_
139	7	B	b	NN	4	nmod	28170	28171	I-event-211930	_	_	_	_
139	8	Susceptible	susceptible	JJ	10	amod	28173	28184	_	_	_	_	B-claim-10432
139	9	sexual	sexual	JJ	10	amod	28185	28191	B-event-211931	_	_	_	I-claim-10432
139	10	partners	partner	NNS	18	nsubjpass	28192	28200	_	_	_	_	I-claim-10432
139	11	of	of	IN	12	case	28201	28203	_	_	_	_	I-claim-10432
139	12	persons	person	NNS	10	nmod	28204	28211	_	_	_	_	I-claim-10432
139	13	who	who	WP	15	nsubj	28212	28215	_	_	_	_	I-claim-10432
139	14	are	be	VBP	15	cop	28216	28219	_	_	_	_	I-claim-10432
139	15	HBsAg-positive	hbsag-positive	JJ	12	acl:relcl	28220	28234	_	_	_	_	I-claim-10432
139	16	should	should	MD	18	aux	28235	28241	_	_	_	_	I-claim-10432
139	17	be	be	VB	18	auxpass	28242	28244	_	_	_	_	I-claim-10432
139	18	offered	offer	VBN	7	acl:relcl	28245	28252	B-event-211932	_	_	_	I-claim-10432
139	19	post-exposure	post-exposure	JJ	20	amod	28253	28266	B-event-211933	_	_	_	I-claim-10432
139	20	HBIG	hbig	NN	18	dobj	28267	28271	_	_	_	_	I-claim-10432
139	21	and	and	CC	20	cc	28272	28275	_	_	_	_	I-claim-10432
139	22	hepatitis	hepatitis	NN	24	compound	28276	28285	_	_	_	_	I-claim-10432
139	23	B	b	NN	24	compound	28286	28287	_	_	_	_	I-claim-10432
139	24	vaccination	vaccination	NN	20	conj	28288	28299	B-event-211934	_	_	_	I-claim-10432
139	25	;	;	:	20	punct	28299	28300	_	_	_	_	I-claim-10432
139	26	both	both	CC	29	nsubjpass	28301	28305	_	_	_	_	I-claim-10432
139	27	should	should	MD	29	aux	28306	28312	_	_	_	_	I-claim-10432
139	28	be	be	VB	29	auxpass	28313	28315	_	_	_	_	I-claim-10432
139	29	initiated	initiate	VBN	20	dep	28316	28325	B-event-211935	_	_	_	I-claim-10432
139	30	within	within	IN	32	case	28326	28332	_	_	_	_	I-claim-10432
139	31	14	14	CD	32	nummod	28333	28335	_	_	_	_	I-claim-10432
139	32	days	day	NNS	29	nmod	28336	28340	_	_	_	_	I-claim-10432
139	33	of	of	IN	38	case	28341	28343	_	_	_	_	I-claim-10432
139	34	the	the	DT	38	det	28344	28347	_	_	_	_	I-claim-10432
139	35	last	last	JJ	38	amod	28348	28352	_	_	_	_	I-claim-10432
139	36	sexual	sexual	JJ	38	amod	28353	28359	B-event-211936	_	_	_	I-claim-10432
139	37	contact	contact	NN	38	compound	28360	28367	B-event-211937	_	_	_	I-claim-10432
139	38	(	(	NN	32	nmod	28368	28369	_	_	_	_	_
139	39	refer	refer	VBP	0	ROOT	28369	28374	_	_	_	_	_
139	40	to	to	TO	44	case	28375	28377	_	_	_	_	_
139	41	4.5.11	4.5.11	CD	44	nummod	28378	28384	_	_	_	_	_
139	42	Public	Public	NNP	44	compound	28385	28391	_	_	_	_	_
139	43	health	health	NN	44	compound	28392	28398	_	_	_	_	_
139	44	management	management	NN	39	nmod	28399	28409	_	_	_	_	_
139	45	of	of	IN	47	case	28410	28412	_	_	_	_	_
139	46	hepatitis	hepatitis	NN	47	compound	28413	28422	_	_	_	_	_
139	47	B	b	NN	44	nmod	28423	28424	_	_	_	_	_
139	48	below	below	IN	47	advmod	28425	28430	_	_	_	_	_
139	49	and	and	CC	44	cc	28431	28434	_	_	_	_	_
139	50	Table	Table	NNP	44	conj	28435	28440	_	_	_	_	_
139	51	4.5.3	4.5.3	CD	52	compound	28441	28446	_	_	_	_	_
139	52	)	)	CD	50	dep	28446	28447	_	_	_	_	_
139	53	.	.	.	39	punct	28447	28448	_	_	_	_	_

140	1	Hepatitis	Hepatitis	NNP	2	compound	28449	28458	B-event-211938	_	_	_	B-claim-10433
140	2	B	B	NNP	5	nsubj	28459	28460	I-event-211938	_	_	_	I-claim-10433
140	3	is	be	VBZ	5	cop	28461	28463	_	_	_	_	I-claim-10433
140	4	relatively	relatively	RB	5	advmod	28464	28474	_	_	_	_	I-claim-10433
140	5	common	common	JJ	0	ROOT	28475	28481	_	_	_	_	I-claim-10433
140	6	in	in	IN	7	case	28482	28484	_	_	_	_	I-claim-10433
140	7	clients	client	NNS	5	nmod	28485	28492	_	_	_	_	I-claim-10433
140	8	of	of	IN	11	case	28493	28495	_	_	_	_	I-claim-10433
140	9	sexual	sexual	JJ	11	amod	28496	28502	_	_	_	_	I-claim-10433
140	10	health	health	NN	11	compound	28503	28509	_	_	_	_	I-claim-10433
140	11	services	service	NNS	7	nmod	28510	28518	_	_	_	_	I-claim-10433
140	12	and	and	CC	5	cc	28519	28522	_	_	_	_	I-claim-10433
140	13	vaccination	vaccination	NN	16	nsubjpass	28523	28534	B-event-211939	_	_	_	I-claim-10433
140	14	should	should	MD	16	aux	28535	28541	_	_	_	_	I-claim-10433
140	15	be	be	VB	16	auxpass	28542	28544	_	_	_	_	I-claim-10433
140	16	offered	offer	VBN	5	conj	28545	28552	_	_	_	_	I-claim-10433
140	17	to	to	TO	19	case	28553	28555	_	_	_	_	I-claim-10433
140	18	susceptible	susceptible	JJ	19	amod	28556	28567	_	_	_	_	I-claim-10433
140	19	persons	person	NNS	16	nmod	28568	28575	_	_	_	_	I-claim-10433
140	20	at	at	IN	22	case	28576	28578	_	_	_	_	I-claim-10433
140	21	the	the	DT	22	det	28579	28582	_	_	_	_	I-claim-10433
140	22	time	time	NN	16	nmod	28583	28587	_	_	_	_	I-claim-10433
140	23	of	of	IN	25	case	28588	28590	_	_	_	_	I-claim-10433
140	24	first	first	JJ	25	amod	28591	28596	_	_	_	_	I-claim-10433
140	25	attendance	attendance	NN	22	nmod	28597	28607	B-event-211940	_	_	_	I-claim-10433
140	26	.	.	.	5	punct	28607	28608	_	_	_	_	_

141	1	Susceptible	susceptible	JJ	5	amod	28609	28620	_	_	_	_	B-claim-10434
141	2	,	,	,	5	punct	28620	28621	_	_	_	_	I-claim-10434
141	3	sexually	sexually	RB	5	advmod	28622	28630	B-event-211941	_	_	_	I-claim-10434
141	4	active	active	JJ	5	amod	28631	28637	_	_	_	_	I-claim-10434
141	5	men	man	NNS	13	nsubjpass	28638	28641	_	_	_	_	I-claim-10434
141	6	who	who	WP	7	nsubj	28642	28645	_	_	_	_	I-claim-10434
141	7	have	have	VBP	5	acl:relcl	28646	28650	_	_	_	_	I-claim-10434
141	8	sex	sex	NN	7	dobj	28651	28654	B-event-211942	_	_	_	I-claim-10434
141	9	with	with	IN	10	case	28655	28659	_	_	_	_	I-claim-10434
141	10	men	man	NNS	7	nmod	28660	28663	_	_	_	_	I-claim-10434
141	11	should	should	MD	13	aux	28664	28670	_	_	_	_	I-claim-10434
141	12	be	be	VB	13	auxpass	28671	28673	_	_	_	_	I-claim-10434
141	13	vaccinated	vaccinate	VBN	0	ROOT	28674	28684	B-event-211943	_	_	_	I-claim-10434
141	14	.	.	.	13	punct	28684	28685	_	_	_	_	_

142	1	The	the	DT	4	det	28686	28689	_	_	_	_	_
142	2	combination	combination	NN	4	compound	28690	28701	_	_	_	_	_
142	3	hepatitis	hepatitis	NN	4	compound	28702	28711	_	_	_	_	_
142	4	A/hepatitis	a/hepatitis	NN	36	nsubj	28712	28723	_	_	_	_	_
142	5	B	b	NN	6	compound	28724	28725	_	_	_	_	_
142	6	vaccine	vaccine	NN	9	nsubj	28726	28733	B-event-211944	_	_	_	_
142	7	may	may	MD	9	aux	28734	28737	_	_	_	_	_
142	8	be	be	VB	9	cop	28738	28740	_	_	_	_	_
142	9	appropriate	appropriate	JJ	4	acl:relcl	28741	28752	_	_	_	_	_
142	10	for	for	IN	11	case	28753	28756	_	_	_	_	_
142	11	men	man	NNS	9	nmod	28757	28760	_	_	_	_	_
142	12	who	who	WP	13	nsubj	28761	28764	_	_	_	_	_
142	13	have	have	VBP	11	acl:relcl	28765	28769	_	_	_	_	_
142	14	sex	sex	NN	13	dobj	28770	28773	B-event-211945	_	_	_	_
142	15	with	with	IN	16	case	28774	28778	_	_	_	_	_
142	16	men	man	NNS	14	nmod	28779	28782	_	_	_	_	_
142	17	,	,	,	13	punct	28782	28783	_	_	_	_	_
142	18	if	if	IN	22	mark	28784	28786	_	_	_	_	_
142	19	they	they	PRP	22	nsubj	28787	28791	_	_	_	_	_
142	20	are	be	VBP	22	cop	28792	28795	_	_	_	_	_
142	21	not	not	RB	22	neg	28796	28799	_	_	_	_	_
142	22	immune	immune	JJ	13	advcl	28800	28806	B-event-211946	_	_	_	_
142	23	to	to	TO	25	case	28807	28809	_	_	_	_	_
142	24	either	either	CC	25	dep	28810	28816	_	_	_	_	_
142	25	disease	disease	NN	22	nmod	28817	28824	B-event-211947	_	_	_	_
142	26	,	,	,	25	punct	28824	28825	_	_	_	_	_
142	27	as	as	IN	32	mark	28826	28828	_	_	_	_	_
142	28	they	they	PRP	32	nsubj	28829	28833	_	_	_	_	_
142	29	are	be	VBP	32	cop	28834	28837	_	_	_	_	_
142	30	at	at	IN	32	case	28838	28840	_	_	_	_	_
142	31	increased	increase	VBN	32	amod	28841	28850	B-event-211948	_	_	_	_
142	32	risk	risk	NN	25	dep	28851	28855	B-event-211949	_	_	_	_
142	33	of	of	IN	35	case	28856	28858	_	_	_	_	_
142	34	both	both	DT	35	det	28859	28863	_	_	_	_	_
142	35	conditions	condition	NNS	32	nmod	28864	28874	B-event-211950	_	_	_	_
142	36	(	(	VBP	0	ROOT	28875	28876	_	_	_	_	_
142	37	refer	refer	VB	36	xcomp	28876	28881	_	_	_	_	_
142	38	to	to	TO	40	case	28882	28884	_	_	_	_	_
142	39	‘	‘	CD	40	nummod	28885	28886	_	_	_	_	_
142	40	Recommendations	recommendation	NNS	37	nmod	28886	28901	_	_	_	_	_
142	41	for	for	IN	43	case	28902	28905	_	_	_	_	_
142	42	the	the	DT	43	det	28906	28909	_	_	_	_	_
142	43	use	use	NN	40	nmod	28910	28913	_	_	_	_	_
142	44	of	of	IN	49	case	28914	28916	_	_	_	_	_
142	45	combination	combination	NN	49	compound	28917	28928	_	_	_	_	_
142	46	hepatitis	hepatitis	NN	49	compound	28929	28938	_	_	_	_	_
142	47	A/hepatitis	a/hepatitis	NN	49	compound	28939	28950	_	_	_	_	_
142	48	B	b	NN	49	compound	28951	28952	_	_	_	_	_
142	49	vaccines	vaccine	NNS	43	nmod	28953	28961	_	_	_	_	_
142	50	’	’	RB	52	advmod	28961	28962	_	_	_	_	_
142	51	below	below	IN	52	case	28963	28968	_	_	_	_	_
142	52	)	)	NN	37	nmod	28968	28969	_	_	_	_	_
142	53	.	.	.	36	punct	28969	28970	_	_	_	_	_

143	1	Migrants	Migrants	NNPS	13	nsubj	28971	28979	B-event-211951	_	_	_	_
143	2	from	from	IN	7	case	28980	28984	_	_	_	_	_
143	3	hepatitis	hepatitis	NN	6	compound	28985	28994	B-event-211952	_	_	_	_
143	4	B	b	NN	6	compound	28995	28996	I-event-211952	_	_	_	_
143	5	endemic	endemic	JJ	6	amod	28997	29004	_	_	_	_	_
143	6	countries	country	NNS	7	compound	29005	29014	_	_	_	_	_
143	7	Migrants	Migrants	NNPS	1	nmod	29015	29023	B-event-211953	_	_	_	_
143	8	from	from	IN	12	case	29024	29028	_	_	_	_	_
143	9	hepatitis	hepatitis	NN	12	compound	29029	29038	B-event-211954	_	_	_	_
143	10	B	b	NN	12	compound	29039	29040	I-event-211954	_	_	_	_
143	11	endemic	endemic	JJ	12	amod	29041	29048	_	_	_	_	_
143	12	countries	country	NNS	7	nmod	29049	29058	_	_	_	_	_
143	13	have	have	VBP	0	ROOT	29059	29063	_	_	_	_	_
143	14	a	a	DT	16	det	29064	29065	_	_	_	_	_
143	15	higher	higher	JJR	16	amod	29066	29072	_	_	_	_	_
143	16	likelihood	likelihood	NN	13	dobj	29073	29083	_	_	_	_	_
143	17	of	of	IN	21	mark	29084	29086	_	_	_	_	_
143	18	having	have	VBG	21	aux	29087	29093	_	_	_	_	_
143	19	been	be	VBN	21	auxpass	29094	29098	_	_	_	_	_
143	20	previously	previously	RB	21	advmod	29099	29109	_	_	_	_	_
143	21	infected	infect	VBN	16	acl	29110	29118	B-event-211955	_	_	_	_
143	22	with	with	IN	24	case	29119	29123	_	_	_	_	_
143	23	hepatitis	hepatitis	NN	24	compound	29124	29133	B-event-211956	_	_	_	_
143	24	B	b	NN	21	nmod	29134	29135	I-event-211956	_	_	_	_
143	25	and	and	CC	24	cc	29136	29139	_	_	_	_	_
143	26	of	of	IN	27	mark	29140	29142	_	_	_	_	_
143	27	having	have	VBG	24	conj	29143	29149	_	_	_	_	_
143	28	a	a	DT	31	det	29150	29151	_	_	_	_	_
143	29	close	close	JJ	31	amod	29152	29157	_	_	_	_	_
143	30	household	household	NN	31	compound	29158	29167	_	_	_	_	_
143	31	contact	contact	NN	27	dobj	29168	29175	_	_	_	_	_
143	32	with	with	IN	36	case	29176	29180	_	_	_	_	_
143	33	chronic	chronic	JJ	36	amod	29181	29188	_	_	_	_	_
143	34	hepatitis	hepatitis	NN	36	compound	29189	29198	B-event-211957	_	_	_	_
143	35	B	b	NN	36	compound	29199	29200	I-event-211957	_	_	_	_
143	36	infection	infection	NN	27	nmod	29201	29210	B-event-211958	_	_	_	_
143	37	.	.	.	13	punct	29210	29211	_	_	_	_	_

144	1	Such	such	JJ	2	amod	29212	29216	_	_	_	_	B-claim-10435
144	2	persons	person	NNS	5	nsubjpass	29217	29224	_	_	_	_	I-claim-10435
144	3	should	should	MD	5	aux	29225	29231	_	_	_	_	I-claim-10435
144	4	be	be	VB	5	auxpass	29232	29234	_	_	_	_	I-claim-10435
144	5	offered	offer	VBN	0	ROOT	29235	29242	B-event-211959	_	_	_	I-claim-10435
144	6	testing	testing	NN	5	dobj	29243	29250	B-event-211960	_	_	_	I-claim-10435
144	7	for	for	IN	9	case	29251	29254	_	_	_	_	I-claim-10435
144	8	hepatitis	hepatitis	NN	9	compound	29255	29264	B-event-211961	_	_	_	I-claim-10435
144	9	B	b	NN	6	nmod	29265	29266	I-event-211961	_	_	_	I-claim-10435
144	10	,	,	,	6	punct	29266	29267	_	_	_	_	I-claim-10435
144	11	and	and	CC	6	cc	29268	29271	_	_	_	_	I-claim-10435
144	12	vaccination	vaccination	NN	6	conj	29272	29283	B-event-211962	_	_	_	I-claim-10435
144	13	if	if	IN	14	dep	29284	29286	_	_	_	_	I-claim-10435
144	14	appropriate	appropriate	JJ	12	amod	29287	29298	_	_	_	_	I-claim-10435
144	15	.	.	.	5	punct	29298	29299	_	_	_	_	_

145	1	(	(	NN	2	compound	29300	29301	_	_	_	_	_
145	2	Refer	refer	NN	0	ROOT	29301	29306	_	_	_	_	_
145	3	also	also	RB	2	advmod	29307	29311	_	_	_	_	_
145	4	to	to	TO	6	case	29312	29314	_	_	_	_	_
145	5	3.3.8	3.3.8	CD	6	nummod	29315	29320	_	_	_	_	_
145	6	Vaccination	vaccination	NN	2	nmod	29321	29332	_	_	_	_	_
145	7	of	of	IN	8	case	29333	29335	_	_	_	_	_
145	8	migrants	migrant	NNS	6	nmod	29336	29344	_	_	_	_	_
145	9	to	to	TO	10	case	29345	29347	_	_	_	_	_
145	10	Australia	Australia	NNP	8	nmod	29348	29357	_	_	_	_	_
145	11	.	.	.	10	punct	29357	29358	_	_	_	_	_
145	12	)	)	SYM	10	dep	29358	29359	_	_	_	_	_

146	1	Areas	area	NNS	13	nsubj	29360	29365	_	_	_	_	_
146	2	of	of	IN	4	case	29366	29368	_	_	_	_	_
146	3	high	high	JJ	4	amod	29369	29373	_	_	_	_	_
146	4	endemicity	endemicity	NN	1	nmod	29374	29384	B-event-211963	_	_	_	_
146	5	,	,	,	1	punct	29384	29385	_	_	_	_	_
146	6	indicated	indicate	VBN	1	acl	29386	29395	_	_	_	_	_
146	7	by	by	IN	9	case	29396	29398	_	_	_	_	_
146	8	high	high	JJ	9	amod	29399	29403	_	_	_	_	_
146	9	seroprevalence	seroprevalence	NN	6	nmod	29404	29418	_	_	_	_	_
146	10	of	of	IN	11	case	29419	29421	_	_	_	_	_
146	11	HBsAg	hbsag	NN	9	nmod	29422	29427	_	_	_	_	_
146	12	,	,	,	1	punct	29427	29428	_	_	_	_	_
146	13	include	include	VBP	0	ROOT	29429	29436	_	_	_	_	_
146	14	most	most	JJS	13	dobj	29437	29441	_	_	_	_	_
146	15	of	of	IN	19	case	29442	29444	_	_	_	_	_
146	16	East	East	NNP	19	compound	29445	29449	_	_	_	_	_
146	17	and	and	CC	16	cc	29450	29453	_	_	_	_	_
146	18	Southeast	Southeast	NNP	16	conj	29454	29463	_	_	_	_	_
146	19	Asia	Asia	NNP	14	nmod	29464	29468	_	_	_	_	_
146	20	(	(	CD	19	nummod	29469	29470	_	_	_	_	_
146	21	except	except	IN	22	case	29470	29476	_	_	_	_	_
146	22	Japan	Japan	NNP	19	nmod	29477	29482	_	_	_	_	_
146	23	)	)	CD	22	nummod	29482	29483	_	_	_	_	_
146	24	,	,	,	19	punct	29483	29484	_	_	_	_	_
146	25	Pacific	Pacific	NNP	27	compound	29485	29492	_	_	_	_	_
146	26	island	island	NN	27	compound	29493	29499	_	_	_	_	_
146	27	groups	group	NNS	19	conj	29500	29506	_	_	_	_	_
146	28	,	,	,	27	punct	29506	29507	_	_	_	_	_
146	29	parts	part	NNS	27	appos	29508	29513	_	_	_	_	_
146	30	of	of	IN	32	case	29514	29516	_	_	_	_	_
146	31	central	central	JJ	32	amod	29517	29524	_	_	_	_	_
146	32	Asia	Asia	NNP	29	nmod	29525	29529	_	_	_	_	_
146	33	and	and	CC	19	cc	29530	29533	_	_	_	_	_
146	34	the	the	DT	36	det	29534	29537	_	_	_	_	_
146	35	Middle	Middle	NNP	36	compound	29538	29544	_	_	_	_	_
146	36	East	East	NNP	19	conj	29545	29549	_	_	_	_	_
146	37	,	,	,	36	punct	29549	29550	_	_	_	_	_
146	38	the	the	DT	40	det	29551	29554	_	_	_	_	_
146	39	Amazon	Amazon	NNP	40	compound	29555	29561	_	_	_	_	_
146	40	Basin	Basin	NNP	36	conj	29562	29567	_	_	_	_	_
146	41	,	,	,	36	punct	29567	29568	_	_	_	_	_
146	42	and	and	CC	36	cc	29569	29572	_	_	_	_	_
146	43	sub-Saharan	sub-Saharan	NNP	46	compound	29573	29584	_	_	_	_	_
146	44	Africa	Africa	NNP	46	compound	29585	29591	_	_	_	_	_
146	45	.62	.62	CD	46	nummod	29591	29594	_	_	_	_	_
146	46	Aboriginal	Aboriginal	NNP	36	conj	29596	29606	_	_	_	_	_
146	47	and	and	CC	14	cc	29607	29610	_	_	_	_	_
146	48	Torres	Torres	NNP	51	compound	29611	29617	_	_	_	_	_
146	49	Strait	Strait	NNP	51	compound	29618	29624	_	_	_	_	_
146	50	Islander	Islander	NNP	51	compound	29625	29633	_	_	_	_	_
146	51	people	people	NNS	14	conj	29634	29640	_	_	_	_	_
146	52	There	there	EX	53	expl	29641	29646	_	_	_	_	_
146	53	is	be	VBZ	51	dep	29647	29649	_	_	_	_	_
146	54	an	a	DT	56	det	29650	29652	_	_	_	_	_
146	55	increased	increase	VBN	56	amod	29653	29662	_	_	_	_	_
146	56	risk	risk	NN	53	nsubj	29663	29667	B-event-211964	_	_	_	_
146	57	of	of	IN	58	mark	29668	29670	_	_	_	_	_
146	58	acquiring	acquire	VBG	56	acl	29671	29680	B-event-211965	_	_	_	_
146	59	new	new	JJ	61	amod	29681	29684	_	_	_	_	_
146	60	HBV	hbv	NN	61	compound	29685	29688	B-event-211966	_	_	_	_
146	61	infection	infection	NN	58	dobj	29689	29698	B-event-211967	_	_	_	_
146	62	among	among	IN	68	case	29699	29704	_	_	_	_	_
146	63	Aboriginal	Aboriginal	NNP	68	compound	29705	29715	_	_	_	_	_
146	64	and	and	CC	63	cc	29716	29719	_	_	_	_	_
146	65	Torres	Torres	NNP	63	conj	29720	29726	_	_	_	_	_
146	66	Strait	Strait	NNP	68	compound	29727	29733	_	_	_	_	_
146	67	Islander	Islander	NNP	68	compound	29734	29742	_	_	_	_	_
146	68	people	people	NNS	61	nmod	29743	29749	_	_	_	_	_
146	69	compared	compare	VBN	72	case	29750	29758	_	_	_	_	_
146	70	with	with	IN	72	case	29759	29763	_	_	_	_	_
146	71	other	other	JJ	72	amod	29764	29769	_	_	_	_	_
146	72	Australians	Australians	NNPS	58	advcl	29770	29781	_	_	_	_	_
146	73	.17,18	.17,18	CD	92	dep	29781	29787	_	_	_	_	_
146	74	Although	although	IN	92	mark	29788	29796	_	_	_	_	_
146	75	many	many	JJ	76	amod	29797	29801	_	_	_	_	_
146	76	younger	younger	JJR	92	nsubj	29802	29809	_	_	_	_	_
146	77	Aboriginal	Aboriginal	NNP	82	compound	29810	29820	_	_	_	_	_
146	78	and	and	CC	77	cc	29821	29824	_	_	_	_	_
146	79	Torres	Torres	NNP	77	conj	29825	29831	_	_	_	_	_
146	80	Strait	Strait	NNP	82	compound	29832	29838	_	_	_	_	_
146	81	Islander	Islander	NNP	82	compound	29839	29847	_	_	_	_	_
146	82	people	people	NNS	76	dep	29848	29854	_	_	_	_	_
146	83	,	,	,	76	punct	29854	29855	_	_	_	_	_
146	84	especially	especially	RB	85	advmod	29856	29866	_	_	_	_	_
146	85	children	child	NNS	76	appos	29867	29875	_	_	_	_	_
146	86	and	and	CC	85	cc	29876	29879	_	_	_	_	_
146	87	adolescents	adolescent	NNS	85	conj	29880	29891	_	_	_	_	_
146	88	,	,	,	76	punct	29891	29892	_	_	_	_	_
146	89	would	would	MD	92	aux	29893	29898	_	_	_	_	_
146	90	have	have	VB	92	aux	29899	29903	_	_	_	_	_
146	91	been	be	VBN	92	cop	29904	29908	_	_	_	_	_
146	92	eligible	eligible	JJ	53	dep	29909	29917	_	_	_	_	_
146	93	for	for	IN	92	nmod	29918	29921	_	_	_	_	_
146	94	,	,	,	92	punct	29921	29922	_	_	_	_	_
146	95	and	and	CC	92	cc	29923	29926	_	_	_	_	_
146	96	have	have	VBP	97	aux	29927	29931	_	_	_	_	_
146	97	received	receive	VBN	92	conj	29932	29940	_	_	_	_	_
146	98	,	,	,	97	punct	29940	29941	_	_	_	_	_
146	99	hepatitis	hepatitis	NN	101	compound	29942	29951	_	_	_	_	_
146	100	B	b	NN	101	compound	29952	29953	_	_	_	_	_
146	101	vaccination	vaccination	NN	97	dobj	29954	29965	B-event-211968	_	_	_	_
146	102	through	through	IN	105	case	29966	29973	_	_	_	_	_
146	103	population-wide	population-wide	JJ	105	amod	29974	29989	_	_	_	_	_
146	104	vaccination	vaccination	NN	105	compound	29990	30001	B-event-211969	_	_	_	_
146	105	programs	program	NNS	109	nmod	30002	30010	B-event-211970	_	_	_	_
146	106	,	,	,	109	punct	30010	30011	_	_	_	_	_
146	107	it	it	PRP	109	nsubjpass	30012	30014	_	_	_	_	_
146	108	is	be	VBZ	109	auxpass	30015	30017	_	_	_	_	_
146	109	recommended	recommend	VBN	101	acl:relcl	30018	30029	_	_	_	B-cue-25329	_
146	110	that	that	IN	117	mark	30030	30034	_	B-content-25330:25329-Cue	_	_	_
146	111	Aboriginal	Aboriginal	NNP	116	compound	30035	30045	_	I-content-25330	_	_	_
146	112	and	and	CC	111	cc	30046	30049	_	I-content-25330	_	_	_
146	113	Torres	Torres	NNP	111	conj	30050	30056	_	I-content-25330	_	_	_
146	114	Strait	Strait	NNP	116	compound	30057	30063	_	I-content-25330	_	_	_
146	115	Islander	Islander	NNP	116	compound	30064	30072	_	I-content-25330	_	_	_
146	116	people	people	NNS	117	nsubj	30073	30079	_	I-content-25330	_	_	_
146	117	have	have	VBP	109	ccomp	30080	30084	_	I-content-25330	_	_	_
146	118	their	they	PRP$	119	nmod:poss	30085	30090	_	I-content-25330	_	_	_
146	119	risks	risk	NNS	117	dobj	30091	30096	B-event-211971	I-content-25330	_	_	_
146	120	and	and	CC	109	cc	30097	30100	_	I-content-25330	_	_	_
146	121	vaccination	vaccination	NN	122	compound	30101	30112	B-event-211972	I-content-25330	_	_	_
146	122	status	status	NN	126	nsubj	30113	30119	_	I-content-25330	_	_	_
146	123	for	for	IN	125	case	30120	30123	_	I-content-25330	_	_	_
146	124	hepatitis	hepatitis	NN	125	compound	30124	30133	_	I-content-25330	_	_	_
146	125	B	b	NN	122	nmod	30134	30135	_	I-content-25330	_	_	_
146	126	reviewed	review	VBN	109	conj	30136	30144	B-event-211973	I-content-25330	_	_	_
146	127	,	,	,	92	punct	30144	30145	_	I-content-25330	_	_	_
146	128	be	be	VB	129	auxpass	30146	30148	_	I-content-25330	_	_	_
146	129	offered	offer	VBN	92	conj	30149	30156	B-event-211974	I-content-25330	_	_	_
146	130	testing	testing	NN	129	dobj	30157	30164	B-event-211975	I-content-25330	_	_	_
146	131	for	for	IN	135	case	30165	30168	_	I-content-25330	_	_	_
146	132	previous	previous	JJ	135	amod	30169	30177	_	I-content-25330	_	_	_
146	133	hepatitis	hepatitis	NN	135	compound	30178	30187	B-event-211976	I-content-25330	_	_	_
146	134	B	b	NN	135	compound	30188	30189	I-event-211976	I-content-25330	_	_	_
146	135	infection	infection	NN	130	nmod	30190	30199	B-event-211977	I-content-25330	_	_	_
146	136	,	,	,	92	punct	30199	30200	_	I-content-25330	_	_	_
146	137	and	and	CC	92	cc	30201	30204	_	I-content-25330	_	_	_
146	138	be	be	VB	139	auxpass	30205	30207	_	I-content-25330	_	_	_
146	139	offered	offer	VBN	92	conj	30208	30215	B-event-211978	I-content-25330	_	_	_
146	140	vaccination	vaccination	NN	139	dobj	30216	30227	B-event-211979	I-content-25330	_	_	_
146	141	if	if	IN	142	dep	30228	30230	_	I-content-25330	_	_	_
146	142	non-immune	non-immune	JJ	140	amod	30231	30241	_	I-content-25330	_	_	_
146	143	.	.	.	13	punct	30241	30242	_	_	_	_	_

147	1	(	(	NN	0	ROOT	30243	30244	_	_	_	_	_
147	2	Refer	refer	NN	1	dep	30244	30249	_	_	_	_	_
147	3	also	also	RB	2	advmod	30250	30254	_	_	_	_	_
147	4	to	to	TO	2	dep	30255	30257	_	_	_	_	_
147	5	3.1	3.1	CD	6	nummod	30258	30261	_	_	_	_	_
147	6	Vaccination	vaccination	NN	2	dep	30262	30273	_	_	_	_	_
147	7	for	for	IN	12	case	30274	30277	_	_	_	_	_
147	8	Aboriginal	Aboriginal	NNP	12	dep	30278	30288	_	_	_	_	_
147	9	and	and	CC	8	cc	30289	30292	_	_	_	_	_
147	10	Torres	Torres	NNP	8	conj	30293	30299	_	_	_	_	_
147	11	Strait	Strait	NNP	12	compound	30300	30306	_	_	_	_	_
147	12	Islander	Islander	NNP	6	acl	30307	30315	_	_	_	_	_
147	13	people	people	NNS	12	dep	30316	30322	_	_	_	_	_
147	14	.	.	.	12	punct	30322	30323	_	_	_	_	_
147	15	)	)	SYM	6	dep	30323	30324	_	_	_	_	_

148	1	Adult	adult	JJ	3	amod	30325	30330	_	_	_	_	_
148	2	haemodialysis	haemodialysis	NN	3	compound	30331	30344	_	_	_	_	_
148	3	patients	patient	NNS	36	nsubj	30345	30353	_	_	_	_	_
148	4	and	and	CC	3	cc	30354	30357	_	_	_	_	_
148	5	patients	patient	NNS	3	conj	30358	30366	_	_	_	_	_
148	6	with	with	IN	10	case	30367	30371	_	_	_	_	_
148	7	severely	severely	RB	8	advmod	30372	30380	_	_	_	_	_
148	8	impaired	impaired	JJ	10	amod	30381	30389	B-event-211980	_	_	_	_
148	9	renal	renal	JJ	10	amod	30390	30395	_	_	_	_	_
148	10	function	function	NN	3	nmod	30396	30404	_	_	_	_	_
148	11	in	in	IN	12	case	30405	30407	_	_	_	_	_
148	12	whom	whom	WP	15	nmod	30408	30412	_	_	_	_	_
148	13	dialysis	dialysis	NN	15	nsubjpass	30413	30421	B-event-211981	_	_	_	_
148	14	is	be	VBZ	15	auxpass	30422	30424	_	_	_	_	_
148	15	anticipated	anticipate	VBN	10	acl:relcl	30425	30436	_	_	_	_	_
148	16	Dialysis	dialysis	NN	17	compound	30437	30445	B-event-211982	_	_	_	_
148	17	patients	patient	NNS	15	dobj	30446	30454	B-event-211983	_	_	_	_
148	18	,	,	,	3	punct	30454	30455	_	_	_	_	_
148	19	and	and	CC	3	cc	30456	30459	_	_	_	_	_
148	20	patients	patient	NNS	3	conj	30460	30468	B-event-211984	_	_	_	_
148	21	with	with	IN	25	case	30469	30473	_	_	_	_	_
148	22	severely	severely	RB	23	advmod	30474	30482	_	_	_	_	_
148	23	impaired	impaired	JJ	25	amod	30483	30491	B-event-211985	_	_	_	_
148	24	renal	renal	JJ	25	amod	30492	30497	_	_	_	_	_
148	25	function	function	NN	20	nmod	30498	30506	_	_	_	_	_
148	26	in	in	IN	27	case	30507	30509	_	_	_	_	_
148	27	whom	whom	WP	30	nmod	30510	30514	_	_	_	_	_
148	28	dialysis	dialysis	NN	30	nsubjpass	30515	30523	B-event-211986	_	_	_	_
148	29	is	be	VBZ	30	auxpass	30524	30526	_	_	_	_	_
148	30	anticipated	anticipate	VBN	25	acl:relcl	30527	30538	_	_	_	_	_
148	31	,	,	,	3	punct	30538	30539	_	_	_	_	_
148	32	may	may	MD	36	aux	30540	30543	_	_	_	_	_
148	33	be	be	VB	36	cop	30544	30546	_	_	_	_	_
148	34	at	at	IN	36	case	30547	30549	_	_	_	_	_
148	35	increased	increase	VBN	36	amod	30550	30559	_	_	_	_	_
148	36	risk	risk	NN	0	ROOT	30560	30564	B-event-211987	_	_	_	_
148	37	of	of	IN	38	mark	30565	30567	_	_	_	_	_
148	38	acquiring	acquire	VBG	36	acl	30568	30577	B-event-211988	_	_	_	_
148	39	hepatitis	hepatitis	NN	41	compound	30578	30587	B-event-211989	_	_	_	_
148	40	B	b	NN	41	compound	30588	30589	I-event-211989	_	_	_	_
148	41	infection	infection	NN	38	dobj	30590	30599	B-event-211990	_	_	_	_
148	42	and	and	CC	36	cc	30600	30603	_	_	_	_	_
148	43	also	also	RB	44	advmod	30604	30608	_	_	_	_	_
148	44	respond	respond	VBP	36	conj	30609	30616	B-event-211991	_	_	_	_
148	45	less	less	RBR	46	advmod	30617	30621	_	_	_	_	_
148	46	well	well	RB	44	advmod	30622	30626	_	_	_	_	_
148	47	to	to	TO	48	case	30627	30629	_	_	_	_	_
148	48	vaccination	vaccination	NN	44	nmod	30630	30641	B-event-211992	_	_	_	_
148	49	.	.	.	36	punct	30641	30642	_	_	_	_	_

149	1	These	these	DT	2	det	30643	30648	_	_	_	_	B-claim-10436
149	2	patients	patient	NNS	5	nsubjpass	30649	30657	B-event-211993	_	_	_	I-claim-10436
149	3	should	should	MD	5	aux	30658	30664	_	_	_	_	I-claim-10436
149	4	be	be	VB	5	auxpass	30665	30667	_	_	_	_	I-claim-10436
149	5	given	give	VBN	0	ROOT	30668	30673	_	_	_	_	I-claim-10436
149	6	a	a	DT	10	det	30674	30675	_	_	_	_	I-claim-10436
149	7	larger	larger	JJR	9	dep	30676	30682	_	_	_	_	I-claim-10436
149	8	than	than	IN	9	dep	30683	30687	_	_	_	_	I-claim-10436
149	9	usual	usual	JJ	10	amod	30688	30693	_	_	_	_	I-claim-10436
149	10	dose	dose	NN	5	dobj	30694	30698	_	_	_	_	I-claim-10436
149	11	of	of	IN	14	case	30699	30701	_	_	_	_	I-claim-10436
149	12	hepatitis	hepatitis	NN	14	compound	30702	30711	_	_	_	_	I-claim-10436
149	13	B	b	NN	14	compound	30712	30713	_	_	_	_	I-claim-10436
149	14	vaccine	vaccine	NN	10	nmod	30714	30721	B-event-211994	_	_	_	I-claim-10436
149	15	.	.	.	5	punct	30721	30722	_	_	_	_	_

150	1	Adult	adult	JJ	2	amod	30724	30729	_	_	_	_	B-claim-10437
150	2	haemodialysis	haemodialysis	NN	8	nsubjpass	30730	30743	_	_	_	_	I-claim-10437
150	3	or	or	CC	2	cc	30744	30746	_	_	_	_	I-claim-10437
150	4	pre-dialysis	pre-dialysis	JJ	5	amod	30747	30759	_	_	_	_	I-claim-10437
150	5	patients	patient	NNS	2	conj	30760	30768	B-event-211995	_	_	_	I-claim-10437
150	6	should	should	MD	8	aux	30769	30775	_	_	_	_	I-claim-10437
150	7	be	be	VB	8	auxpass	30776	30778	_	_	_	_	I-claim-10437
150	8	given	give	VBN	0	ROOT	30779	30784	_	_	_	_	I-claim-10437
150	9	either	either	CC	8	advmod	30785	30791	_	_	_	_	I-claim-10437
150	10	:	:	:	8	punct	30791	30792	_	_	_	_	_
150	11	Solid	solid	JJ	12	amod	30794	30799	_	_	_	_	_
150	12	organ	organ	NN	55	nsubjpass	30800	30805	_	_	_	_	_
150	13	and	and	CC	12	cc	30806	30809	_	_	_	_	_
150	14	haematopoietic	haematopoietic	JJ	18	amod	30810	30824	_	_	_	_	_
150	15	stem	stem	NN	18	compound	30825	30829	_	_	_	_	_
150	16	cell	cell	NN	18	compound	30830	30834	_	_	_	_	_
150	17	transplant	transplant	NN	18	compound	30835	30845	B-event-211996	_	_	_	_
150	18	recipients	recipient	NNS	12	conj	30846	30856	B-event-211997	_	_	_	_
150	19	If	if	IN	20	mark	30858	30860	_	_	_	_	B-claim-10438
150	20	seronegative	seronegative	JJ	31	advcl	30861	30873	_	_	_	_	I-claim-10438
150	21	for	for	IN	23	case	30874	30877	_	_	_	_	I-claim-10438
150	22	hepatitis	hepatitis	NN	23	compound	30878	30887	B-event-212492	_	_	_	I-claim-10438
150	23	B	b	NN	20	dep	30888	30889	I-event-212492	_	_	_	I-claim-10438
150	24	,	,	,	31	punct	30889	30890	_	_	_	_	I-claim-10438
150	25	solid	solid	JJ	28	amod	30891	30896	_	_	_	_	I-claim-10438
150	26	organ	organ	NN	28	compound	30897	30902	_	_	_	_	I-claim-10438
150	27	transplant	transplant	NN	28	compound	30903	30913	B-event-211998	_	_	_	I-claim-10438
150	28	recipients	recipient	NNS	31	nsubjpass	30914	30924	B-event-211999	_	_	_	I-claim-10438
150	29	should	should	MD	31	aux	30925	30931	_	_	_	_	I-claim-10438
150	30	be	be	VB	31	auxpass	30932	30934	_	_	_	_	I-claim-10438
150	31	vaccinated	vaccinate	VBN	18	acl:relcl	30935	30945	B-event-212000	_	_	_	I-claim-10438
150	32	before	before	IN	33	case	30946	30952	_	_	_	_	I-claim-10438
150	33	transplantation	transplantation	NN	31	nmod	30953	30968	B-event-212001	_	_	_	I-claim-10438
150	34	as	as	IN	40	mark	30969	30971	_	_	_	_	I-claim-10438
150	35	they	they	PRP	40	nsubj	30972	30976	_	_	_	_	I-claim-10438
150	36	may	may	MD	40	aux	30977	30980	_	_	_	_	I-claim-10438
150	37	be	be	VB	40	cop	30981	30983	_	_	_	_	I-claim-10438
150	38	at	at	IN	40	case	30984	30986	_	_	_	_	I-claim-10438
150	39	increased	increase	VBN	40	amod	30987	30996	_	_	_	_	I-claim-10438
150	40	risk	risk	NN	31	advcl	30997	31001	B-event-212002	_	_	_	I-claim-10438
150	41	of	of	IN	42	case	31002	31004	_	_	_	_	I-claim-10438
150	42	infection	infection	NN	40	nmod	31005	31014	B-event-212003	_	_	_	I-claim-10438
150	43	from	from	IN	46	case	31015	31019	_	_	_	_	I-claim-10438
150	44	the	the	DT	46	det	31020	31023	_	_	_	_	I-claim-10438
150	45	transplanted	transplant	VBN	46	amod	31024	31036	B-event-212004	_	_	_	I-claim-10438
150	46	organ	organ	NN	40	nmod	31037	31042	_	_	_	_	I-claim-10438
150	47	.64	.64	CD	52	nummod	31042	31045	_	_	_	_	_
150	48	Haematopoietic	haematopoietic	JJ	52	amod	31046	31060	_	_	_	_	B-claim-10439
150	49	stem	stem	NN	52	compound	31061	31065	_	_	_	_	I-claim-10439
150	50	cell	cell	NN	52	compound	31066	31070	_	_	_	_	I-claim-10439
150	51	transplant	transplant	NN	52	compound	31071	31081	B-event-212005	_	_	_	I-claim-10439
150	52	recipients	recipient	NNS	46	dep	31082	31092	B-event-212006	_	_	_	I-claim-10439
150	53	should	should	MD	55	aux	31093	31099	_	_	_	_	I-claim-10439
150	54	be	be	VB	55	auxpass	31100	31102	_	_	_	_	I-claim-10439
150	55	revaccinated	revaccinate	VBN	8	parataxis	31103	31115	B-event-212007	_	_	_	I-claim-10439
150	56	following	follow	VBG	57	case	31116	31125	_	_	_	_	I-claim-10439
150	57	transplantation	transplantation	NN	55	nmod	31126	31141	B-event-212008	_	_	_	I-claim-10439
150	58	,	,	,	57	punct	31141	31142	_	_	_	_	I-claim-10439
150	59	due	due	JJ	57	amod	31143	31146	_	_	_	_	I-claim-10439
150	60	to	to	TO	62	case	31147	31149	_	_	_	_	I-claim-10439
150	61	the	the	DT	62	det	31150	31153	_	_	_	_	I-claim-10439
150	62	loss	loss	NN	59	nmod	31154	31158	B-event-212009	_	_	_	I-claim-10439
150	63	of	of	IN	65	case	31159	31161	_	_	_	_	I-claim-10439
150	64	immune	immune	JJ	65	amod	31162	31168	_	_	_	_	I-claim-10439
150	65	memory	memory	NN	62	nmod	31169	31175	_	_	_	_	I-claim-10439
150	66	that	that	WDT	68	nsubj	31176	31180	_	_	_	_	I-claim-10439
150	67	often	often	RB	68	advmod	31181	31186	_	_	_	_	I-claim-10439
150	68	follows	follow	VBZ	62	acl:relcl	31187	31194	_	_	_	_	I-claim-10439
150	69	the	the	DT	71	det	31195	31198	_	_	_	_	I-claim-10439
150	70	transplant	transplant	NN	71	compound	31199	31209	B-event-212010	_	_	_	I-claim-10439
150	71	procedure	procedure	NN	68	dobj	31210	31219	_	_	_	_	I-claim-10439
150	72	.	.	.	8	punct	31219	31220	_	_	_	_	_

151	1	(	(	NN	0	ROOT	31221	31222	_	_	_	_	_
151	2	Refer	refer	NN	1	dep	31222	31227	_	_	_	_	_
151	3	also	also	RB	2	advmod	31228	31232	_	_	_	_	_
151	4	to	to	TO	2	dep	31233	31235	_	_	_	_	_
151	5	3.3.3	3.3.3	CD	6	nummod	31236	31241	_	_	_	_	_
151	6	Vaccination	vaccination	NN	2	dep	31242	31253	_	_	_	_	_
151	7	of	of	IN	9	case	31254	31256	_	_	_	_	_
151	8	immunocompromised	immunocompromised	JJ	9	amod	31257	31274	_	_	_	_	_
151	9	persons	person	NNS	6	acl	31275	31282	_	_	_	_	_
151	10	.	.	.	9	punct	31282	31283	_	_	_	_	_
151	11	)	)	SYM	6	dep	31283	31284	_	_	_	_	_

152	1	HIV-positive	hiv-positive	JJ	2	amod	31285	31297	B-event-212012	_	_	_	_
152	2	adults	adult	NNS	19	nsubj	31298	31304	_	_	_	_	_
152	3	and	and	CC	2	cc	31305	31308	_	_	_	_	_
152	4	other	other	JJ	6	amod	31309	31314	_	_	_	_	_
152	5	immunocompromised	immunocompromised	JJ	6	amod	31315	31332	B-event-212011	_	_	_	_
152	6	adults	adult	NNS	2	conj	31333	31339	_	_	_	_	_
152	7	HIV-positive	hiv-positive	JJ	8	amod	31341	31353	B-event-212013	_	_	_	_
152	8	adults	adult	NNS	6	dep	31354	31360	_	_	_	_	_
152	9	,	,	,	8	punct	31360	31361	_	_	_	_	_
152	10	and	and	CC	8	cc	31362	31365	_	_	_	_	_
152	11	other	other	JJ	13	amod	31366	31371	_	_	_	_	_
152	12	immunocompromised	immunocompromised	JJ	13	amod	31372	31389	B-event-212014	_	_	_	_
152	13	adults	adult	NNS	8	conj	31390	31396	_	_	_	_	_
152	14	,	,	,	8	punct	31396	31397	_	_	_	_	_
152	15	may	may	MD	19	aux	31398	31401	_	_	_	_	_
152	16	be	be	VB	19	cop	31402	31404	_	_	_	_	_
152	17	at	at	IN	19	case	31405	31407	_	_	_	_	_
152	18	increased	increase	VBN	19	amod	31408	31417	_	_	_	_	_
152	19	risk	risk	NN	0	ROOT	31418	31422	B-event-212015	_	_	_	_
152	20	of	of	IN	21	mark	31423	31425	_	_	_	_	_
152	21	acquiring	acquire	VBG	19	acl	31426	31435	B-event-212016	_	_	_	_
152	22	hepatitis	hepatitis	NN	24	compound	31436	31445	B-event-212017	_	_	_	_
152	23	B	b	NN	24	compound	31446	31447	I-event-212017	_	_	_	_
152	24	infection	infection	NN	21	dobj	31448	31457	B-event-212018	_	_	_	_
152	25	and	and	CC	19	cc	31458	31461	_	_	_	_	_
152	26	also	also	RB	27	advmod	31462	31466	_	_	_	_	_
152	27	respond	respond	VBP	19	conj	31467	31474	B-event-212019	_	_	_	_
152	28	less	less	RBR	29	advmod	31475	31479	_	_	_	_	_
152	29	well	well	RB	27	advmod	31480	31484	_	_	_	_	_
152	30	to	to	TO	31	case	31485	31487	_	_	_	_	_
152	31	vaccination	vaccination	NN	27	nmod	31488	31499	B-event-212020	_	_	_	_
152	32	.	.	.	19	punct	31499	31500	_	_	_	_	_

153	1	Limited	limited	JJ	2	amod	31501	31508	_	_	_	_	_
153	2	studies	study	NNS	7	nsubj	31509	31516	B-event-212022	_	_	_	_
153	3	in	in	IN	5	case	31517	31519	_	_	_	_	_
153	4	HIV1-positive	hiv1-positive	JJ	5	amod	31520	31533	B-event-212021	_	_	_	_
153	5	adults	adult	NNS	2	nmod	31534	31540	_	_	_	_	_
153	6	have	have	VBP	7	aux	31541	31545	_	_	_	_	_
153	7	demonstrated	demonstrate	VBN	0	ROOT	31546	31558	_	_	_	_	_
153	8	an	a	DT	13	det	31559	31561	_	_	_	_	_
153	9	improved	improve	VBN	13	amod	31562	31570	B-event-212023	_	_	_	_
153	10	and	and	CC	9	cc	31571	31574	_	_	_	_	_
153	11	accelerated	accelerate	VBN	9	conj	31575	31586	B-event-212024	_	_	_	_
153	12	serological	serological	JJ	13	amod	31587	31598	_	_	_	_	_
153	13	response	response	NN	7	dobj	31599	31607	B-event-212493	_	_	_	_
153	14	to	to	TO	16	case	31608	31610	_	_	_	_	_
153	15	a	a	DT	16	det	31611	31612	_	_	_	_	_
153	16	schedule	schedule	NN	13	nmod	31613	31621	_	_	_	_	_
153	17	that	that	WDT	18	nsubj	31622	31626	_	_	_	_	_
153	18	consists	consist	VBZ	16	acl:relcl	31627	31635	_	_	_	_	_
153	19	of	of	IN	22	case	31636	31638	_	_	_	_	_
153	20	4	4	CD	22	nummod	31639	31640	_	_	_	_	_
153	21	double	double	JJ	22	amod	31641	31647	_	_	_	_	_
153	22	doses	dose	NNS	18	nmod	31648	31653	B-event-212025	_	_	_	_
153	23	,	,	,	7	punct	31653	31654	_	_	_	_	_
153	24	comprising	comprise	VBG	7	advcl	31655	31665	_	_	_	_	_
153	25	two	two	CD	26	nummod	31666	31669	_	_	_	_	_
153	26	injections	injection	NNS	24	dobj	31670	31680	B-event-212026	_	_	_	_
153	27	of	of	IN	32	case	31681	31683	_	_	_	_	_
153	28	the	the	DT	32	det	31684	31687	_	_	_	_	_
153	29	standard	standard	JJ	32	amod	31688	31696	_	_	_	_	_
153	30	adult	adult	JJ	32	amod	31697	31702	_	_	_	_	_
153	31	dose	dose	NN	32	compound	31703	31707	_	_	_	_	_
153	32	(	(	NN	26	nmod	31708	31709	_	_	_	_	_
153	33	using	use	VBG	32	dep	31709	31714	_	_	_	_	_
153	34	Engerix-B	engerix-b	NN	35	compound	31715	31724	_	_	_	_	_
153	35	)	)	NN	33	dobj	31724	31725	_	_	_	_	_
153	36	on	on	IN	38	case	31726	31728	_	_	_	_	_
153	37	each	each	DT	38	det	31729	31733	_	_	_	_	_
153	38	occasion	occasion	NN	35	nmod	31734	31742	_	_	_	_	_
153	39	,	,	,	33	punct	31742	31743	_	_	_	_	_
153	40	at	at	IN	41	case	31744	31746	_	_	_	_	_
153	41	times	time	NNS	33	nmod	31747	31752	_	_	_	_	_
153	42	0	0	CD	41	nummod	31753	31754	_	_	_	_	_
153	43	,	,	,	41	punct	31754	31755	_	_	_	_	_
153	44	1	1	CD	41	conj	31756	31757	_	_	_	_	_
153	45	,	,	,	41	punct	31757	31758	_	_	_	_	_
153	46	2	2	CD	41	conj	31759	31760	_	_	_	_	_
153	47	and	and	CC	41	cc	31761	31764	_	_	_	_	_
153	48	6	6	CD	49	nummod	31765	31766	_	_	_	_	_
153	49	months	month	NNS	41	conj	31767	31773	_	_	_	_	_
153	50	.65,66	.65,66	CD	51	nummod	31773	31779	_	_	_	_	_
153	51	Persons	person	NNS	33	nmod:tmod	31780	31787	_	_	_	_	_
153	52	with	with	IN	55	case	31788	31792	_	_	_	_	_
153	53	chronic	chronic	JJ	55	amod	31793	31800	_	_	_	_	_
153	54	liver	liver	NN	55	compound	31801	31806	_	_	_	_	_
153	55	disease	disease	NN	51	nmod	31807	31814	B-event-212027	_	_	_	_
153	56	and/or	and/or	CC	33	cc	31815	31821	_	_	_	_	_
153	57	hepatitis	hepatitis	NN	60	compound	31822	31831	B-event-212028	_	_	_	_
153	58	C	c	NN	60	compound	31832	31833	I-event-212028	_	_	_	_
153	59	Hepatitis	Hepatitis	NNP	60	compound	31834	31843	_	B-content-25331:25332-Cue	_	_	_
153	60	B	B	NNP	33	conj	31844	31845	_	I-content-25331	_	_	_
153	61	vaccination	vaccination	NN	63	nsubjpass	31846	31857	B-event-212029	I-content-25331	_	_	_
153	62	is	be	VBZ	63	auxpass	31858	31860	_	_	_	_	_
153	63	recommended	recommend	VBN	60	acl:relcl	31861	31872	_	_	_	B-cue-25332	_
153	64	for	for	IN	65	case	31873	31876	_	_	_	_	_
153	65	those	those	DT	63	nmod	31877	31882	_	_	_	_	_
153	66	in	in	IN	68	case	31883	31885	_	_	_	_	_
153	67	this	this	DT	68	det	31886	31890	_	_	_	_	_
153	68	category	category	NN	65	nmod	31891	31899	_	_	_	_	_
153	69	who	who	WP	71	nsubj	31900	31903	_	_	_	_	_
153	70	are	be	VBP	71	cop	31904	31907	_	_	_	_	_
153	71	seronegative	seronegative	JJ	68	acl:relcl	31908	31920	_	_	_	_	_
153	72	for	for	IN	74	case	31921	31924	_	_	_	_	_
153	73	hepatitis	hepatitis	NN	74	compound	31925	31934	B-event-212494	_	_	_	_
153	74	B	b	NN	71	nmod	31935	31936	I-event-212494	_	_	_	_
153	75	,	,	,	71	punct	31936	31937	_	_	_	_	_
153	76	because	because	IN	100	mark	31938	31945	_	_	_	_	_
153	77	of	of	IN	79	case	31946	31948	_	_	_	_	_
153	78	the	the	DT	79	det	31949	31952	_	_	_	_	_
153	79	risk	risk	NN	100	nmod	31953	31957	B-event-212030	_	_	_	_
153	80	of	of	IN	83	case	31958	31960	_	_	_	_	_
153	81	severe	severe	JJ	83	amod	31961	31967	_	_	_	_	_
153	82	liver	liver	NN	83	compound	31968	31973	_	_	_	_	_
153	83	disease	disease	NN	79	nmod	31974	31981	B-event-212031	_	_	_	_
153	84	following	follow	VBG	85	case	31982	31991	_	_	_	_	_
153	85	infection	infection	NN	83	nmod	31992	32001	B-event-212032	_	_	_	_
153	86	with	with	IN	88	case	32002	32006	_	_	_	_	_
153	87	hepatitis	hepatitis	NNP	88	compound	32007	32016	B-event-212033	_	_	_	_
153	88	B.	B.	NNP	85	nmod	32017	32019	I-event-212033	_	_	_	_
153	89	67	67	CD	90	nummod	32019	32021	_	_	_	_	_
153	90	Persons	person	NNS	100	nsubjpass	32022	32029	_	_	_	_	_
153	91	who	who	WP	92	nsubj	32030	32033	_	_	_	_	_
153	92	inject	inject	VBP	90	acl:relcl	32034	32040	B-event-212034	_	_	_	_
153	93	drugs	drug	NNS	94	compound	32041	32046	_	_	_	_	_
153	94	Persons	person	NNS	92	dobj	32047	32054	_	_	_	_	B-claim-10440
153	95	who	who	WP	96	nsubj	32055	32058	_	_	_	_	I-claim-10440
153	96	inject	inject	VBP	94	acl:relcl	32059	32065	B-event-212035	_	_	_	I-claim-10440
153	97	drugs	drug	NNS	96	dobj	32066	32071	_	_	_	_	I-claim-10440
153	98	should	should	MD	100	aux	32072	32078	_	_	_	_	I-claim-10440
153	99	be	be	VB	100	auxpass	32079	32081	_	_	_	_	I-claim-10440
153	100	tested	test	VBN	71	advcl	32082	32088	B-event-212036	_	_	_	I-claim-10440
153	101	,	,	,	100	punct	32088	32089	_	_	_	_	I-claim-10440
153	102	and	and	CC	100	cc	32090	32093	_	_	_	_	I-claim-10440
153	103	be	be	VB	104	auxpass	32094	32096	_	_	_	_	I-claim-10440
153	104	vaccinated	vaccinate	VBN	100	conj	32097	32107	B-event-212037	_	_	_	I-claim-10440
153	105	if	if	IN	111	mark	32108	32110	_	_	_	_	I-claim-10440
153	106	they	they	PRP	111	nsubjpass	32111	32115	_	_	_	_	I-claim-10440
153	107	have	have	VBP	111	aux	32116	32120	_	_	_	_	I-claim-10440
153	108	not	not	RB	111	neg	32121	32124	_	_	_	_	I-claim-10440
153	109	previously	previously	RB	111	advmod	32125	32135	_	_	_	_	I-claim-10440
153	110	been	be	VBN	111	auxpass	32136	32140	_	_	_	_	I-claim-10440
153	111	infected	infect	VBN	104	advcl	32141	32149	B-event-212038	_	_	_	I-claim-10440
153	112	with	with	IN	113	case	32150	32154	_	_	_	_	I-claim-10440
153	113	HBV	hbv	NN	111	nmod	32155	32158	B-event-212039	_	_	_	I-claim-10440
153	114	.	.	.	7	punct	32158	32159	_	_	_	_	_

154	1	Recipients	recipient	NNS	13	nsubj	32160	32170	B-event-212040	_	_	_	_
154	2	of	of	IN	6	case	32171	32173	_	_	_	_	_
154	3	certain	certain	JJ	6	amod	32174	32181	_	_	_	_	_
154	4	blood	blood	NN	6	compound	32182	32187	_	_	_	_	_
154	5	products	product	NNS	6	compound	32188	32196	_	_	_	_	_
154	6	Screening	screening	NN	1	nmod	32197	32206	B-event-212041	_	_	_	_
154	7	of	of	IN	10	case	32207	32209	_	_	_	_	_
154	8	all	all	DT	10	det	32210	32213	_	_	_	_	_
154	9	blood	blood	NN	10	compound	32214	32219	_	_	_	_	_
154	10	donors	donor	NNS	6	nmod	32220	32226	_	_	_	_	_
154	11	for	for	IN	12	case	32227	32230	_	_	_	_	_
154	12	HBV	hbv	NN	10	nmod	32231	32234	_	_	_	_	_
154	13	using	use	VBG	0	ROOT	32235	32240	_	_	_	_	_
154	14	HBsAg	hbsag	NN	13	dobj	32241	32246	_	_	_	_	_
154	15	and	and	CC	13	cc	32247	32250	_	_	_	_	_
154	16	nucleic	nucleic	JJ	19	amod	32251	32258	_	_	_	_	_
154	17	acid	acid	NN	19	compound	32259	32263	_	_	_	_	_
154	18	amplification	amplification	NN	19	compound	32264	32277	_	_	_	_	_
154	19	tests	test	NNS	22	nsubj	32278	32283	B-event-212042	_	_	_	_
154	20	has	have	VBZ	22	aux	32284	32287	_	_	_	_	_
154	21	greatly	greatly	RB	22	advmod	32288	32295	_	_	_	_	_
154	22	decreased	decrease	VBN	13	conj	32296	32305	B-event-212043	_	_	_	_
154	23	the	the	DT	24	det	32306	32309	_	_	_	_	_
154	24	incidence	incidence	NN	22	dobj	32310	32319	_	_	_	_	_
154	25	of	of	IN	30	case	32320	32322	_	_	_	_	_
154	26	transfusion-related	transfusion-related	JJ	30	amod	32323	32342	B-event-212044	_	_	_	_
154	27	hepatitis	hepatitis	NN	30	compound	32343	32352	B-event-212045	_	_	_	_
154	28	B	b	NN	30	compound	32353	32354	I-event-212045	_	_	_	_
154	29	virus	virus	NN	30	compound	32355	32360	B-event-212046	_	_	_	_
154	30	infection	infection	NN	24	nmod	32361	32370	B-event-212047	_	_	_	_
154	31	.	.	.	13	punct	32370	32371	_	_	_	_	_

155	1	Since	since	IN	2	case	32372	32377	_	_	_	_	_
155	2	2010	2010	CD	9	nmod	32378	32382	_	_	_	_	_
155	3	,	,	,	9	punct	32382	32383	_	_	_	_	_
155	4	nucleic	nucleic	JJ	6	amod	32384	32391	_	_	_	_	_
155	5	acid	acid	NN	6	compound	32392	32396	_	_	_	_	_
155	6	testing	testing	NN	9	nsubjpass	32397	32404	B-event-212048	_	_	_	_
155	7	has	have	VBZ	9	aux	32405	32408	_	_	_	_	_
155	8	been	be	VBN	9	auxpass	32409	32413	_	_	_	_	_
155	9	introduced	introduce	VBN	0	ROOT	32414	32424	B-event-212049	_	_	_	_
155	10	nationally	nationally	RB	9	advmod	32425	32435	_	_	_	_	_
155	11	to	to	TO	12	mark	32436	32438	_	_	_	_	_
155	12	improve	improve	VB	9	xcomp	32439	32446	_	_	_	_	_
155	13	detection	detection	NN	12	dobj	32447	32456	B-event-212050	_	_	_	_
155	14	of	of	IN	17	case	32457	32459	_	_	_	_	_
155	15	hepatitis	hepatitis	NN	17	compound	32460	32469	B-event-212051	_	_	_	_
155	16	B	b	NN	17	compound	32470	32471	I-event-212051	_	_	_	_
155	17	infection	infection	NN	13	nmod	32472	32481	B-event-212052	_	_	_	_
155	18	in	in	IN	20	case	32482	32484	_	_	_	_	_
155	19	donated	donate	VBN	20	amod	32485	32492	B-event-212053	_	_	_	_
155	20	blood	blood	NN	17	nmod	32493	32498	_	_	_	_	_
155	21	,	,	,	9	punct	32498	32499	_	_	_	_	_
155	22	mainly	mainly	RB	24	advmod	32500	32506	_	_	_	_	_
155	23	through	through	IN	24	case	32507	32514	_	_	_	_	_
155	24	reduction	reduction	NN	9	nmod	32515	32524	B-event-212054	_	_	_	_
155	25	of	of	IN	29	case	32525	32527	_	_	_	_	_
155	26	the	the	DT	29	det	32528	32531	_	_	_	_	_
155	27	infectious	infectious	JJ	29	amod	32532	32542	B-event-212055	_	_	_	_
155	28	window	window	NN	29	compound	32543	32549	_	_	_	_	_
155	29	period	period	NN	24	nmod	32550	32556	_	_	_	_	_
155	30	when	when	WRB	38	advmod	32557	32561	_	_	_	_	_
155	31	acute	acute	JJ	34	amod	32562	32567	_	_	_	_	_
155	32	hepatitis	hepatitis	NN	34	compound	32568	32577	B-event-212056	_	_	_	_
155	33	B	b	NN	34	compound	32578	32579	I-event-212056	_	_	_	_
155	34	infection	infection	NN	38	nsubjpass	32580	32589	B-event-212057	_	_	_	_
155	35	may	may	MD	38	aux	32590	32593	_	_	_	_	_
155	36	not	not	RB	38	neg	32594	32597	_	_	_	_	_
155	37	be	be	VB	38	auxpass	32598	32600	_	_	_	_	_
155	38	detected	detect	VBN	29	acl:relcl	32601	32609	B-event-212058	_	_	_	_
155	39	using	use	VBG	38	xcomp	32610	32615	_	_	_	_	_
155	40	HBsAg	hbsag	NN	39	dobj	32616	32621	_	_	_	_	_
155	41	,	,	,	24	punct	32621	32622	_	_	_	_	_
155	42	but	but	CC	24	cc	32623	32626	_	_	_	_	_
155	43	also	also	RB	45	advmod	32627	32631	_	_	_	_	_
155	44	through	through	IN	45	mark	32632	32639	_	_	_	_	_
155	45	detecting	detect	VBG	24	conj	32640	32649	B-event-212059	_	_	_	_
155	46	persons	person	NNS	45	dobj	32650	32657	_	_	_	_	_
155	47	with	with	IN	51	case	32658	32662	_	_	_	_	_
155	48	occult	occult	NN	51	compound	32663	32669	_	_	_	_	_
155	49	hepatitis	hepatitis	NN	51	compound	32670	32679	B-event-212060	_	_	_	_
155	50	B	b	NN	51	compound	32680	32681	I-event-212060	_	_	_	_
155	51	infection	infection	NN	45	nmod	32682	32691	B-event-212061	_	_	_	_
155	52	.	.	.	9	punct	32691	32692	_	_	_	_	_

156	1	This	this	DT	2	det	32693	32697	_	_	_	_	_
156	2	further	further	JJ	3	nsubj	32698	32705	_	_	_	_	_
156	3	reduces	reduce	VBZ	0	ROOT	32706	32713	_	_	_	_	_
156	4	the	the	DT	6	det	32714	32717	_	_	_	_	_
156	5	residual	residual	JJ	6	amod	32718	32726	_	_	_	_	_
156	6	risk	risk	NN	3	dobj	32727	32731	B-event-212062	_	_	_	_
156	7	of	of	IN	10	case	32732	32734	_	_	_	_	_
156	8	hepatitis	hepatitis	NN	10	compound	32735	32744	B-event-212063	_	_	_	_
156	9	B	b	NN	10	compound	32745	32746	I-event-212063	_	_	_	_
156	10	transmission	transmission	NN	6	nmod	32747	32759	B-event-212064	_	_	_	_
156	11	through	through	IN	12	case	32760	32767	_	_	_	_	_
156	12	transfusion	transfusion	NN	3	nmod	32768	32779	B-event-212065	_	_	_	_
156	13	in	in	IN	14	case	32780	32782	_	_	_	_	_
156	14	Australia	Australia	NNP	12	nmod	32783	32792	_	_	_	_	_
156	15	,	,	,	3	punct	32792	32793	_	_	_	_	_
156	16	to	to	TO	18	case	32794	32796	_	_	_	_	_
156	17	approximately	approximately	RB	18	advmod	32797	32810	_	_	_	_	_
156	18	1	1	CD	3	nmod	32811	32812	_	_	_	_	_
156	19	in	in	IN	21	case	32813	32815	_	_	_	_	_
156	20	982	982	CD	21	compound	32816	32819	_	_	_	_	_
156	21	000	000	CD	18	nmod	32820	32823	_	_	_	_	_
156	22	per	per	IN	23	case	32824	32827	_	_	_	_	_
156	23	unit	unit	NN	18	nmod	32828	32832	_	_	_	_	_
156	24	transfused	transfuse	VBD	18	acl	32833	32843	B-event-212066	_	_	_	_
156	25	.21	.21	CD	24	dobj	32843	32846	_	_	_	_	_
156	26	However	however	RB	24	advmod	32847	32854	_	_	_	_	_
156	27	,	,	,	18	punct	32854	32855	_	_	_	_	_
156	28	persons	person	NNS	18	conj	32856	32863	_	_	_	_	B-claim-10441
156	29	with	with	IN	31	case	32864	32868	_	_	_	_	I-claim-10441
156	30	clotting	clot	VBG	31	amod	32869	32877	_	_	_	_	I-claim-10441
156	31	disorders	disorder	NNS	28	nmod	32878	32887	B-event-212067	_	_	_	I-claim-10441
156	32	who	who	WP	33	nsubj	32888	32891	_	_	_	_	I-claim-10441
156	33	receive	receive	VBP	28	acl:relcl	32892	32899	B-event-212068	_	_	_	I-claim-10441
156	34	blood	blood	NN	35	compound	32900	32905	_	_	_	_	I-claim-10441
156	35	product	product	NN	36	nsubj	32906	32913	_	_	_	_	I-claim-10441
156	36	concentrates	concentrate	VBZ	33	ccomp	32914	32926	_	_	_	_	I-claim-10441
156	37	,	,	,	18	punct	32926	32927	_	_	_	_	I-claim-10441
156	38	persons	person	NNS	18	conj	32928	32935	_	_	_	_	I-claim-10441
156	39	with	with	IN	42	case	32936	32940	_	_	_	_	I-claim-10441
156	40	recurrent	recurrent	JJ	42	amod	32941	32950	_	_	_	_	I-claim-10441
156	41	transfusion	transfusion	NN	42	compound	32951	32962	B-event-212069	_	_	_	I-claim-10441
156	42	requirements	requirement	NNS	38	nmod	32963	32975	_	_	_	_	I-claim-10441
156	43	,	,	,	18	punct	32975	32976	_	_	_	_	I-claim-10441
156	44	and	and	CC	18	cc	32977	32980	_	_	_	_	I-claim-10441
156	45	persons	person	NNS	18	conj	32981	32988	_	_	_	_	I-claim-10441
156	46	with	with	IN	48	case	32989	32993	_	_	_	_	I-claim-10441
156	47	underlying	underlie	VBG	48	amod	32994	33004	_	_	_	_	I-claim-10441
156	48	immunocompromise68	immunocompromise68	NN	45	nmod	33005	33023	B-event-212070	_	_	_	I-claim-10441
156	49	have	have	VBP	48	ccomp	33024	33028	_	_	_	_	I-claim-10441
156	50	an	a	DT	52	det	33029	33031	_	_	_	_	I-claim-10441
156	51	elevated	elevated	JJ	52	amod	33032	33040	_	_	_	_	I-claim-10441
156	52	risk	risk	NN	49	dobj	33041	33045	B-event-212071	_	_	_	I-claim-10441
156	53	of	of	IN	57	case	33046	33048	_	_	_	_	I-claim-10441
156	54	hepatitis	hepatitis	NN	57	compound	33049	33058	B-event-212072	_	_	_	I-claim-10441
156	55	B	b	NN	57	compound	33059	33060	I-event-212072	_	_	_	I-claim-10441
156	56	virus	virus	NN	57	compound	33061	33066	B-event-212073	_	_	_	I-claim-10441
156	57	infection	infection	NN	52	nmod	33067	33076	B-event-212074	_	_	_	I-claim-10441
156	58	,	,	,	49	punct	33076	33077	_	_	_	_	I-claim-10441
156	59	and	and	CC	49	cc	33078	33081	_	_	_	_	I-claim-10441
156	60	should	should	MD	63	aux	33082	33088	_	_	_	_	I-claim-10441
156	61	therefore	therefore	RB	63	advmod	33089	33098	_	_	_	_	I-claim-10441
156	62	be	be	VB	63	auxpass	33099	33101	_	_	_	_	I-claim-10441
156	63	vaccinated	vaccinate	VBN	49	conj	33102	33112	B-event-212075	_	_	_	I-claim-10441
156	64	.	.	.	3	punct	33112	33113	_	_	_	_	_

157	1	Persons	person	NNS	7	nsubjpass	33114	33121	_	_	_	_	_
157	2	with	with	IN	5	case	33122	33126	_	_	_	_	_
157	3	developmental	developmental	JJ	5	amod	33127	33140	_	_	_	_	_
157	4	disabilities	disability	NNS	5	compound	33141	33153	B-event-212076	_	_	_	_
157	5	Vaccination	vaccination	NN	1	nmod	33155	33166	B-event-212077	_	_	B-cue-25333	_
157	6	is	be	VBZ	7	auxpass	33167	33169	_	_	_	_	_
157	7	recommended	recommend	VBN	0	ROOT	33170	33181	B-event-212078	B-content-25334:25333-Cue	_	_	_
157	8	for	for	IN	9	case	33182	33185	_	_	_	_	_
157	9	persons	person	NNS	7	nmod	33186	33193	_	_	_	_	_
157	10	who	who	WP	11	nsubj	33194	33197	_	_	_	_	_
157	11	attend	attend	VBP	9	acl:relcl	33198	33204	B-event-212079	_	_	_	_
157	12	either	either	CC	17	case	33205	33211	_	_	_	_	_
157	13	residential	residential	JJ	17	amod	33212	33223	_	_	_	_	_
157	14	or	or	CC	13	cc	33224	33226	_	_	_	_	_
157	15	non-residential	non-residential	JJ	13	conj	33227	33242	_	_	_	_	_
157	16	day-care	day-care	JJ	17	amod	33243	33251	_	_	_	_	_
157	17	facilities	facility	NNS	11	nmod	33252	33262	_	_	_	_	_
157	18	for	for	IN	19	case	33263	33266	_	_	_	_	_
157	19	persons	person	NNS	11	nmod	33267	33274	_	_	_	_	_
157	20	with	with	IN	22	case	33275	33279	_	_	_	_	_
157	21	developmental	developmental	JJ	22	amod	33280	33293	_	_	_	_	_
157	22	disabilities	disability	NNS	19	nmod	33294	33306	B-event-212080	_	_	_	_
157	23	.	.	.	7	punct	33306	33307	_	_	_	_	_

158	1	This	this	DT	3	nsubj	33308	33312	_	_	_	_	_
158	2	is	be	VBZ	3	cop	33313	33315	_	_	_	_	_
158	3	due	due	JJ	0	ROOT	33316	33319	_	_	_	_	_
158	4	to	to	TO	7	case	33320	33322	_	_	_	_	_
158	5	the	the	DT	7	det	33323	33326	_	_	_	_	_
158	6	high	high	JJ	7	amod	33327	33331	_	_	_	_	_
158	7	prevalence	prevalence	NN	3	nmod	33332	33342	_	_	_	_	_
158	8	of	of	IN	9	case	33343	33345	_	_	_	_	_
158	9	markers	marker	NNS	7	nmod	33346	33353	_	_	_	_	_
158	10	indicating	indicate	VBG	9	acl	33354	33364	_	_	_	_	_
158	11	past	past	IN	10	dep	33365	33369	_	_	_	_	_
158	12	or	or	CC	7	cc	33370	33372	_	_	_	_	_
158	13	current	current	JJ	14	amod	33373	33380	_	_	_	_	_
158	14	infection	infection	NN	7	conj	33381	33390	B-event-212081	_	_	_	_
158	15	in	in	IN	16	case	33391	33393	_	_	_	_	_
158	16	persons	person	NNS	14	nmod	33394	33401	_	_	_	_	_
158	17	in	in	IN	19	case	33402	33404	_	_	_	_	_
158	18	these	these	DT	19	det	33405	33410	_	_	_	_	_
158	19	settings	setting	NNS	16	nmod	33411	33419	_	_	_	_	_
158	20	,	,	,	16	punct	33419	33420	_	_	_	_	_
158	21	including	include	VBG	24	case	33421	33430	_	_	_	_	_
158	22	an	a	DT	24	det	33431	33433	_	_	_	_	_
158	23	HBsAg	hbsag	NN	24	compound	33434	33439	_	_	_	_	_
158	24	prevalence	prevalence	NN	16	nmod	33440	33450	_	_	_	_	_
158	25	of	of	IN	26	case	33451	33453	_	_	_	_	_
158	26	>	>	JJR	24	nmod	33454	33455	_	_	_	_	_
158	27	10	10	CD	28	compound	33455	33457	_	_	_	_	_
158	28	%	%	NN	26	amod	33457	33458	_	_	_	_	_
158	29	.69-71	.69-71	CD	30	nummod	33458	33464	_	_	_	_	_
158	30	Inmates	inmate	NNS	38	nsubj	33466	33473	_	_	_	_	_
158	31	of	of	IN	34	case	33474	33476	_	_	_	_	_
158	32	correctional	correctional	JJ	34	amod	33477	33489	_	_	_	_	_
158	33	facilities	facility	NNS	34	compound	33490	33500	_	_	_	_	_
158	34	Inmates	inmate	NNS	30	nmod	33501	33508	_	_	_	_	_
158	35	are	be	VBP	38	cop	33509	33512	_	_	_	_	_
158	36	at	at	IN	38	case	33513	33515	_	_	_	_	_
158	37	increased	increase	VBN	38	amod	33516	33525	_	_	_	_	_
158	38	risk	risk	NN	26	acl:relcl	33526	33530	B-event-212082	_	_	_	_
158	39	of	of	IN	42	case	33531	33533	_	_	_	_	_
158	40	hepatitis	hepatitis	NN	42	compound	33534	33543	B-event-212083	_	_	_	_
158	41	B	b	NN	42	compound	33544	33545	I-event-212083	_	_	_	_
158	42	infection	infection	NN	38	nmod	33546	33555	B-event-212084	_	_	_	_
158	43	because	because	IN	46	mark	33556	33563	_	_	_	_	_
158	44	of	of	IN	46	case	33564	33566	_	_	_	_	_
158	45	the	the	DT	46	det	33567	33570	_	_	_	_	_
158	46	prevalence	prevalence	NN	42	dep	33571	33581	_	_	_	_	_
158	47	of	of	IN	50	case	33582	33584	_	_	_	_	_
158	48	chronic	chronic	JJ	50	amod	33585	33592	_	_	_	_	_
158	49	hepatitis	hepatitis	NN	50	compound	33593	33602	B-event-212085	_	_	_	_
158	50	B	b	NN	38	nmod	33603	33604	I-event-212085	_	_	_	_
158	51	among	among	IN	52	case	33605	33610	_	_	_	_	_
158	52	inmates	inmate	NNS	38	nmod	33611	33618	_	_	_	_	_
158	53	,	,	,	38	punct	33618	33619	_	_	_	_	_
158	54	and	and	CC	38	cc	33620	33623	_	_	_	_	_
158	55	the	the	DT	56	det	33624	33627	_	_	_	_	_
158	56	potential	potential	NN	38	conj	33628	33637	_	_	_	_	_
158	57	for	for	IN	60	case	33638	33641	_	_	_	_	_
158	58	unprotected	unprotected	JJ	60	amod	33642	33653	B-event-212086	_	_	_	_
158	59	sexual	sexual	JJ	60	amod	33654	33660	B-event-212087	_	_	_	_
158	60	intercourse	intercourse	NN	56	nmod	33661	33672	B-event-212088	_	_	_	_
158	61	,	,	,	60	punct	33672	33673	_	_	_	_	_
158	62	injecting	inject	VBG	64	amod	33674	33683	B-event-212089	_	_	_	_
158	63	drug	drug	NN	64	compound	33684	33688	_	_	_	_	_
158	64	use	use	NN	60	conj	33689	33692	_	_	_	_	_
158	65	and	and	CC	60	cc	33693	33696	_	_	_	_	_
158	66	amateur	amateur	JJ	67	amod	33697	33704	_	_	_	_	_
158	67	tattooing	tattooing	NN	60	conj	33705	33714	B-event-212090	_	_	_	_
158	68	in	in	IN	70	case	33715	33717	_	_	_	_	_
158	69	correctional	correctional	JJ	70	amod	33718	33730	_	_	_	_	_
158	70	facilities	facility	NNS	67	nmod	33731	33741	_	_	_	_	_
158	71	.	.	.	3	punct	33741	33742	_	_	_	_	_

159	1	Therefore	therefore	RB	6	advmod	33743	33752	_	_	_	_	_
159	2	,	,	,	6	punct	33752	33753	_	_	_	_	_
159	3	they	they	PRP	6	nsubjpass	33754	33758	_	_	_	_	B-claim-10442
159	4	should	should	MD	6	aux	33759	33765	_	_	_	_	I-claim-10442
159	5	be	be	VB	6	auxpass	33766	33768	_	_	_	_	I-claim-10442
159	6	offered	offer	VBN	0	ROOT	33769	33776	B-event-212091	_	_	_	I-claim-10442
159	7	the	the	DT	8	det	33777	33780	_	_	_	_	I-claim-10442
159	8	opportunity	opportunity	NN	6	dobj	33781	33792	_	_	_	_	I-claim-10442
159	9	to	to	TO	11	mark	33793	33795	_	_	_	_	I-claim-10442
159	10	be	be	VB	11	auxpass	33796	33798	_	_	_	_	I-claim-10442
159	11	screened	screen	VBN	6	advcl	33799	33807	B-event-212092	_	_	_	I-claim-10442
159	12	for	for	IN	15	case	33808	33811	_	_	_	_	I-claim-10442
159	13	hepatitis	hepatitis	NN	15	compound	33812	33821	B-event-212093	_	_	_	I-claim-10442
159	14	Bupon	bupon	NN	15	compound	33822	33827	I-event-212093	_	_	_	I-claim-10442
159	15	incarceration	incarceration	NN	11	nmod	33828	33841	B-event-212094	_	_	_	I-claim-10442
159	16	,	,	,	6	punct	33841	33842	_	_	_	_	I-claim-10442
159	17	as	as	IN	18	case	33843	33845	_	_	_	_	I-claim-10442
159	18	part	part	NN	6	nmod	33846	33850	_	_	_	_	I-claim-10442
159	19	of	of	IN	23	case	33851	33853	_	_	_	_	I-claim-10442
159	20	the	the	DT	23	det	33854	33857	_	_	_	_	I-claim-10442
159	21	preventive	preventive	JJ	23	amod	33858	33868	B-event-212095	_	_	_	I-claim-10442
159	22	health	health	NN	23	compound	33869	33875	_	_	_	_	I-claim-10442
159	23	program	program	NN	18	nmod	33876	33883	B-event-212096	_	_	_	I-claim-10442
159	24	for	for	IN	26	case	33884	33887	_	_	_	_	I-claim-10442
159	25	blood-borne	blood-borne	JJ	26	amod	33888	33899	_	_	_	_	I-claim-10442
159	26	viruses	virus	NNS	23	nmod	33900	33907	B-event-212097	_	_	_	I-claim-10442
159	27	,	,	,	6	punct	33907	33908	_	_	_	_	I-claim-10442
159	28	and	and	CC	6	cc	33909	33912	_	_	_	_	I-claim-10442
159	29	vaccinated	vaccinate	VBN	6	conj	33913	33923	B-event-212098	_	_	_	I-claim-10442
159	30	if	if	IN	31	mark	33924	33926	_	_	_	_	I-claim-10442
159	31	susceptible	susceptible	JJ	29	advcl	33927	33938	_	_	_	_	I-claim-10442
159	32	.	.	.	6	punct	33938	33939	_	_	_	_	_

160	1	Sex	sex	NN	3	compound	33940	33943	_	_	_	_	_
160	2	industry	industry	NN	3	compound	33944	33952	_	_	_	_	_
160	3	workers	worker	NNS	8	nsubj	33953	33960	_	_	_	_	_
160	4	Sex	sex	NN	6	compound	33961	33964	_	_	_	_	_
160	5	industry	industry	NN	6	compound	33965	33973	_	_	_	_	_
160	6	workers	worker	NNS	3	dep	33974	33981	_	_	_	_	_
160	7	are	be	VBP	8	cop	33982	33985	_	_	_	_	_
160	8	one	one	CD	0	ROOT	33986	33989	_	_	_	_	_
160	9	of	of	IN	12	case	33990	33992	_	_	_	_	_
160	10	the	the	DT	12	det	33993	33996	_	_	_	_	_
160	11	population	population	NN	12	compound	33997	34007	_	_	_	_	_
160	12	groups	group	NNS	8	nmod	34008	34014	_	_	_	_	_
160	13	at	at	IN	15	case	34015	34017	_	_	_	_	_
160	14	higher	higher	JJR	15	amod	34018	34024	_	_	_	_	_
160	15	risk	risk	NN	12	nmod	34025	34029	B-event-212099	_	_	_	_
160	16	of	of	IN	18	case	34030	34032	_	_	_	_	_
160	17	HBV	hbv	NN	18	compound	34033	34036	B-event-212100	_	_	_	_
160	18	infection	infection	NN	15	nmod	34037	34046	B-event-212101	_	_	_	_
160	19	.	.	.	8	punct	34046	34047	_	_	_	_	_

161	1	They	they	PRP	5	nsubjpass	34048	34052	_	_	_	_	_
161	2	have	have	VBP	5	aux	34053	34057	_	_	_	_	_
161	3	been	be	VBN	5	auxpass	34058	34062	_	_	_	_	_
161	4	specifically	specifically	RB	5	advmod	34063	34075	_	_	_	_	_
161	5	identified	identify	VBN	0	ROOT	34076	34086	B-event-212102	_	_	_	_
161	6	as	as	IN	9	case	34087	34089	_	_	_	_	_
161	7	an	a	DT	9	det	34090	34092	_	_	_	_	_
161	8	important	important	JJ	9	amod	34093	34102	_	_	_	_	_
161	9	population	population	NN	5	nmod	34103	34113	_	_	_	_	_
161	10	on	on	IN	13	mark	34114	34116	_	_	_	_	_
161	11	which	which	WDT	13	nsubj	34117	34122	_	_	_	_	_
161	12	to	to	TO	13	mark	34123	34125	_	_	_	_	_
161	13	focus	focus	VB	9	acl	34126	34131	_	_	_	_	_
161	14	for	for	IN	16	case	34132	34135	_	_	_	_	_
161	15	the	the	DT	16	det	34136	34139	_	_	_	_	_
161	16	prevention	prevention	NN	13	nmod	34140	34150	B-event-212103	_	_	_	_
161	17	of	of	IN	20	case	34151	34153	_	_	_	_	_
161	18	hepatitis	hepatitis	NN	20	compound	34154	34163	B-event-212104	_	_	_	_
161	19	B	b	NN	20	compound	34164	34165	I-event-212104	_	_	_	_
161	20	transmission	transmission	NN	16	nmod	34166	34178	B-event-212105	_	_	_	_
161	21	.72	.72	CD	13	dobj	34178	34181	_	_	_	_	_
161	22	They	they	PRP	28	nsubj	34182	34186	_	_	_	_	_
161	23	are	be	VBP	28	cop	34187	34190	_	_	_	_	_
161	24	at	at	IN	28	case	34191	34193	_	_	_	_	_
161	25	a	a	DT	28	det	34194	34195	_	_	_	_	_
161	26	particularly	particularly	RB	27	advmod	34196	34208	_	_	_	_	_
161	27	high	high	JJ	28	amod	34209	34213	_	_	_	_	_
161	28	risk	risk	NN	21	acl:relcl	34214	34218	B-event-212106	_	_	_	_
161	29	if	if	IN	31	mark	34219	34221	_	_	_	_	_
161	30	they	they	PRP	31	nsubj	34222	34226	_	_	_	_	_
161	31	engage	engage	VBP	28	advcl	34227	34233	_	_	_	_	_
161	32	in	in	IN	34	case	34234	34236	_	_	_	_	_
161	33	unprotected	unprotected	JJ	34	amod	34237	34248	B-event-212107	_	_	_	_
161	34	sex	sex	NN	31	nmod	34249	34252	B-event-212108	_	_	_	_
161	35	.	.	.	5	punct	34252	34253	_	_	_	_	_

162	1	Persons	person	NNS	12	nsubj	34254	34261	_	_	_	_	_
162	2	at	at	IN	4	case	34262	34264	_	_	_	_	_
162	3	occupational	occupational	JJ	4	amod	34265	34277	_	_	_	_	_
162	4	risk	risk	NN	1	nmod	34278	34282	B-event-212109	_	_	_	_
162	5	The	the	DT	6	det	34283	34286	_	_	_	_	_
162	6	risk	risk	NN	4	dep	34287	34291	B-event-212110	_	_	_	_
162	7	to	to	TO	8	case	34292	34294	_	_	_	_	_
162	8	persons	person	NNS	6	nmod	34295	34302	_	_	_	_	_
162	9	in	in	IN	11	case	34303	34305	_	_	_	_	_
162	10	certain	certain	JJ	11	amod	34306	34313	_	_	_	_	_
162	11	occupations	occupation	NNS	8	nmod	34314	34325	_	_	_	_	_
162	12	differs	differ	VBZ	0	ROOT	34326	34333	_	_	_	_	_
162	13	considerably	considerably	RB	12	advmod	34334	34346	_	_	_	_	_
162	14	from	from	IN	15	mark	34347	34351	_	_	_	_	_
162	15	setting	set	VBG	12	advcl	34352	34359	_	_	_	_	_
162	16	to	to	TO	17	mark	34360	34362	_	_	_	_	_
162	17	setting	set	VBG	15	advcl	34363	34370	_	_	_	_	_
162	18	in	in	IN	20	case	34371	34373	_	_	_	_	_
162	19	different	different	JJ	20	amod	34374	34383	_	_	_	_	_
162	20	parts	part	NNS	17	nmod	34384	34389	_	_	_	_	_
162	21	of	of	IN	22	case	34390	34392	_	_	_	_	_
162	22	Australia	Australia	NNP	20	nmod	34393	34402	_	_	_	_	_
162	23	.	.	.	12	punct	34402	34403	_	_	_	_	_

163	1	However	however	RB	27	advmod	34404	34411	_	_	_	_	_
163	2	,	,	,	5	punct	34411	34412	_	_	_	_	_
163	3	it	it	PRP	5	nsubjpass	34413	34415	_	_	_	_	B-claim-10443
163	4	is	be	VBZ	5	auxpass	34416	34418	_	_	_	_	I-claim-10443
163	5	recommended	recommend	VBN	27	parataxis	34419	34430	_	_	_	B-cue-25335	I-claim-10443
163	6	that	that	IN	10	mark	34431	34435	_	B-content-25336:25335-Cue	_	_	I-claim-10443
163	7	all	all	DT	8	det	34436	34439	_	I-content-25336	_	_	I-claim-10443
163	8	staff	staff	NN	10	nsubj	34440	34445	_	I-content-25336	_	_	I-claim-10443
163	9	directly	directly	RB	10	advmod	34446	34454	_	I-content-25336	_	_	I-claim-10443
163	10	involved	involve	VBN	5	ccomp	34455	34463	_	I-content-25336	_	_	I-claim-10443
163	11	in	in	IN	13	case	34464	34466	_	I-content-25336	_	_	I-claim-10443
163	12	patient	patient	NN	13	compound	34467	34474	_	I-content-25336	_	_	I-claim-10443
163	13	care	care	NN	10	nmod	34475	34479	B-event-212111	I-content-25336	_	_	I-claim-10443
163	14	and/or	and/or	CC	5	cc	34480	34486	_	I-content-25336	_	_	I-claim-10443
163	15	the	the	DT	16	det	34487	34490	_	I-content-25336	_	_	I-claim-10443
163	16	handling	handling	NN	5	conj	34491	34499	B-event-212112	I-content-25336	_	_	I-claim-10443
163	17	of	of	IN	19	case	34500	34502	_	I-content-25336	_	_	I-claim-10443
163	18	human	human	JJ	19	amod	34503	34508	_	I-content-25336	_	_	I-claim-10443
163	19	tissue	tissue	NN	16	nmod	34509	34515	_	I-content-25336	_	_	I-claim-10443
163	20	,	,	,	5	punct	34515	34516	_	I-content-25336	_	_	I-claim-10443
163	21	blood	blood	NN	24	compound	34517	34522	_	I-content-25336	_	_	I-claim-10443
163	22	or	or	CC	21	cc	34523	34525	_	I-content-25336	_	_	I-claim-10443
163	23	body	body	NN	21	conj	34526	34530	_	I-content-25336	_	_	I-claim-10443
163	24	fluids	fluid	NNS	27	nsubjpass	34531	34537	_	I-content-25336	_	_	I-claim-10443
163	25	should	should	MD	27	aux	34538	34544	_	I-content-25336	_	_	I-claim-10443
163	26	be	be	VB	27	auxpass	34545	34547	_	I-content-25336	_	_	I-claim-10443
163	27	vaccinated	vaccinate	VBN	0	ROOT	34548	34558	B-event-212113	I-content-25336	_	_	I-claim-10443
163	28	.	.	.	27	punct	34558	34559	_	_	_	_	_

164	1	In	in	IN	2	case	34560	34562	_	_	_	_	_
164	2	addition	addition	NN	18	nmod	34563	34571	_	_	_	_	_
164	3	,	,	,	18	punct	34571	34572	_	_	_	_	_
164	4	standard	standard	JJ	5	amod	34573	34581	_	_	_	_	B-claim-10444
164	5	precautions	precaution	NNS	18	nsubjpass	34582	34593	B-event-212114	_	_	_	I-claim-10444
164	6	against	against	IN	7	case	34594	34601	_	_	_	_	I-claim-10444
164	7	exposure	exposure	NN	5	nmod	34602	34610	B-event-212115	_	_	_	I-claim-10444
164	8	to	to	TO	15	case	34611	34613	_	_	_	_	I-claim-10444
164	9	human	human	JJ	15	amod	34614	34619	_	_	_	_	I-claim-10444
164	10	tissue	tissue	NN	15	compound	34620	34626	_	_	_	_	I-claim-10444
164	11	,	,	,	10	punct	34626	34627	_	_	_	_	I-claim-10444
164	12	blood	blood	NN	10	conj	34628	34633	_	_	_	_	I-claim-10444
164	13	or	or	CC	10	cc	34634	34636	_	_	_	_	I-claim-10444
164	14	body	body	NN	10	conj	34637	34641	_	_	_	_	I-claim-10444
164	15	fluids	fluid	NNS	7	nmod	34642	34648	_	_	_	_	I-claim-10444
164	16	should	should	MD	18	aux	34649	34655	_	_	_	_	I-claim-10444
164	17	be	be	VB	18	auxpass	34656	34658	_	_	_	_	I-claim-10444
164	18	used	use	VBN	0	ROOT	34659	34663	_	_	_	_	I-claim-10444
164	19	as	as	IN	36	mark	34664	34666	_	_	_	_	I-claim-10444
164	20	a	a	DT	21	det	34667	34668	_	_	_	_	I-claim-10444
164	21	matter	matter	NN	36	nsubj	34669	34675	_	_	_	_	I-claim-10444
164	22	of	of	IN	26	case	34676	34678	_	_	_	_	I-claim-10444
164	23	routine	routine	JJ	26	amod	34679	34686	_	_	_	_	I-claim-10444
164	24	.73	.73	CD	26	nummod	34686	34689	_	_	_	_	_
164	25	Other	other	JJ	26	amod	34690	34695	_	_	_	_	_
164	26	occupations	occupation	NNS	21	nmod	34696	34707	_	_	_	_	_
164	27	where	where	WRB	35	advmod	34708	34713	_	_	_	_	_
164	28	the	the	DT	29	det	34714	34717	_	_	_	_	_
164	29	risk	risk	NN	35	nsubjpass	34718	34722	B-event-212116	_	_	_	_
164	30	of	of	IN	31	mark	34723	34725	_	_	_	_	_
164	31	acquiring	acquire	VBG	29	acl	34726	34735	B-event-212117	_	_	_	_
164	32	hepatitis	hepatitis	NN	33	compound	34736	34745	B-event-212118	_	_	_	_
164	33	B	b	NN	31	dobj	34746	34747	I-event-212118	_	_	_	_
164	34	is	be	VBZ	35	auxpass	34748	34750	_	_	_	_	_
164	35	increased	increase	VBN	26	acl:relcl	34751	34760	_	_	_	_	_
164	36	include	include	VBP	18	advcl	34761	34768	_	_	_	_	_
164	37	:	:	:	18	punct	34768	34769	_	_	_	_	_
164	38	Staff	staff	NN	48	nsubj	34770	34775	_	_	_	_	_
164	39	of	of	IN	42	case	34776	34778	_	_	_	_	_
164	40	child	child	NN	42	compound	34779	34784	_	_	_	_	_
164	41	day-care	day-care	JJ	42	amod	34785	34793	_	_	_	_	_
164	42	centres	centre	NNS	38	nmod	34794	34801	_	_	_	_	_
164	43	will	will	MD	48	aux	34802	34806	_	_	_	_	_
164	44	normally	normally	RB	48	advmod	34807	34815	_	_	_	_	_
164	45	be	be	VB	48	cop	34816	34818	_	_	_	_	_
164	46	at	at	IN	48	case	34819	34821	_	_	_	_	_
164	47	minimal	minimal	JJ	48	amod	34822	34829	_	_	_	_	_
164	48	risk	risk	NN	18	parataxis	34830	34834	B-event-212119	_	_	_	_
164	49	of	of	IN	51	case	34835	34837	_	_	_	_	_
164	50	hepatitis	hepatitis	NN	51	compound	34838	34847	B-event-212120	_	_	_	_
164	51	B	b	NN	48	nmod	34848	34849	I-event-212120	_	_	_	_
164	52	.	.	.	18	punct	34849	34850	_	_	_	_	_

165	1	If	if	IN	6	mark	34851	34853	_	_	_	_	B-claim-10445
165	2	advice	advice	NN	6	nsubjpass	34854	34860	B-event-212121	_	_	_	I-claim-10445
165	3	on	on	IN	4	case	34861	34863	_	_	_	_	I-claim-10445
165	4	risk	risk	NN	2	nmod	34864	34868	B-event-212122	_	_	_	I-claim-10445
165	5	is	be	VBZ	6	auxpass	34869	34871	_	_	_	_	I-claim-10445
165	6	sought	seek	VBN	12	advcl	34872	34878	B-event-212123	_	_	_	I-claim-10445
165	7	,	,	,	12	punct	34878	34879	_	_	_	_	I-claim-10445
165	8	the	the	DT	9	det	34880	34883	_	_	_	_	I-claim-10445
165	9	enquiry	enquiry	NN	12	nsubjpass	34884	34891	_	_	_	_	I-claim-10445
165	10	should	should	MD	12	aux	34892	34898	_	_	_	_	I-claim-10445
165	11	be	be	VB	12	auxpass	34899	34901	_	_	_	_	I-claim-10445
165	12	directed	direct	VBN	0	ROOT	34902	34910	_	_	_	_	I-claim-10445
165	13	to	to	TO	18	case	34911	34913	_	_	_	_	I-claim-10445
165	14	the	the	DT	18	det	34914	34917	_	_	_	_	I-claim-10445
165	15	local	local	JJ	18	amod	34918	34923	_	_	_	_	I-claim-10445
165	16	public	public	JJ	18	amod	34924	34930	_	_	_	_	I-claim-10445
165	17	health	health	NN	18	compound	34931	34937	_	_	_	_	I-claim-10445
165	18	authority	authority	NN	12	nmod	34938	34947	_	_	_	_	I-claim-10445
165	19	.	.	.	12	punct	34947	34948	_	_	_	_	_

166	1	Contact	contact	NN	2	compound	34949	34956	_	_	_	_	_
166	2	sports	sport	NNS	4	nsubj	34957	34963	_	_	_	_	_
166	3	generally	generally	RB	4	advmod	34964	34973	_	_	_	_	_
166	4	carry	carry	VBP	0	ROOT	34974	34979	_	_	_	_	_
166	5	a	a	DT	7	det	34980	34981	_	_	_	_	_
166	6	low	low	JJ	7	amod	34982	34985	_	_	_	_	_
166	7	risk	risk	NN	4	dobj	34986	34990	B-event-212124	_	_	_	_
166	8	of	of	IN	11	case	34991	34993	_	_	_	_	_
166	9	hepatitis	hepatitis	NN	11	compound	34994	35003	B-event-212125	_	_	_	_
166	10	B	b	NN	11	compound	35004	35005	I-event-212125	_	_	_	_
166	11	infection	infection	NN	7	nmod	35006	35015	B-event-212126	_	_	_	_
166	12	.	.	.	4	punct	35015	35016	_	_	_	_	_

167	1	However	however	RB	8	advmod	35017	35024	_	_	_	_	_
167	2	,	,	,	8	punct	35024	35025	_	_	_	_	_
167	3	age-appropriate	age-appropriate	JJ	6	amod	35026	35041	_	B-content-25337:25338-Cue	_	_	B-claim-10446
167	4	hepatitis	hepatitis	NN	6	compound	35042	35051	B-event-212127	I-content-25337	_	_	I-claim-10446
167	5	B	b	NN	6	compound	35052	35053	I-event-212127	I-content-25337	_	_	I-claim-10446
167	6	vaccination	vaccination	NN	8	nsubjpass	35054	35065	B-event-212128	I-content-25337	_	_	I-claim-10446
167	7	is	be	VBZ	8	auxpass	35066	35068	_	_	_	_	I-claim-10446
167	8	recommended	recommend	VBN	0	ROOT	35069	35080	_	_	_	B-cue-25338	I-claim-10446
167	9	.	.	.	8	punct	35080	35081	_	_	_	_	_

168	1	Travellers	traveller	NNS	45	nsubjpass	35082	35092	B-event-212129	_	_	_	_
168	2	to	to	TO	4	case	35093	35095	_	_	_	_	_
168	3	hepatitis	hepatitis	NN	4	compound	35096	35105	B-event-212130	_	_	_	_
168	4	B	b	NN	1	nmod	35106	35107	I-event-212130	_	_	_	_
168	5	endemic	endemic	JJ	6	amod	35108	35115	_	_	_	_	_
168	6	areas	area	NNS	7	nsubj	35116	35121	_	_	_	_	_
168	7	Persons	person	NNS	4	acl:relcl	35122	35129	_	_	_	_	B-claim-10447
168	8	travelling	travel	VBG	7	dep	35130	35140	B-event-212131	_	_	_	I-claim-10447
168	9	to	to	TO	10	case	35141	35143	_	_	_	_	I-claim-10447
168	10	regions	region	NNS	8	nmod	35144	35151	_	_	_	_	I-claim-10447
168	11	of	of	IN	15	case	35152	35154	_	_	_	_	I-claim-10447
168	12	intermediate	intermediate	JJ	15	amod	35155	35167	_	_	_	_	I-claim-10447
168	13	or	or	CC	12	cc	35168	35170	_	_	_	_	I-claim-10447
168	14	high	high	JJ	12	conj	35171	35175	_	_	_	_	I-claim-10447
168	15	endemicity	endemicity	NN	10	nmod	35176	35186	B-event-212132	_	_	_	I-claim-10447
168	16	,	,	,	8	punct	35186	35187	_	_	_	_	I-claim-10447
168	17	either	either	CC	8	dep	35188	35194	_	_	_	_	I-claim-10447
168	18	long-term	long-term	JJ	8	conj	35195	35204	_	_	_	_	I-claim-10447
168	19	or	or	CC	23	cc	35205	35207	_	_	_	_	I-claim-10447
168	20	for	for	IN	23	case	35208	35211	_	_	_	_	I-claim-10447
168	21	frequent	frequent	JJ	23	amod	35212	35220	_	_	_	_	I-claim-10447
168	22	short	short	JJ	23	amod	35221	35226	_	_	_	_	I-claim-10447
168	23	terms	term	NNS	7	dep	35227	35232	_	_	_	_	I-claim-10447
168	24	,	,	,	7	punct	35232	35233	_	_	_	_	I-claim-10447
168	25	or	or	CC	7	cc	35234	35236	_	_	_	_	I-claim-10447
168	26	who	who	WP	28	nsubj	35237	35240	_	_	_	_	I-claim-10447
168	27	are	be	VBP	28	cop	35241	35244	_	_	_	_	I-claim-10447
168	28	likely	likely	JJ	7	conj	35245	35251	_	_	_	_	I-claim-10447
168	29	to	to	TO	30	mark	35252	35254	_	_	_	_	I-claim-10447
168	30	undertake	undertake	VB	28	xcomp	35255	35264	_	_	_	_	I-claim-10447
168	31	activities	activity	NNS	30	dobj	35265	35275	B-event-212133	_	_	_	I-claim-10447
168	32	that	that	WDT	33	nsubj	35276	35280	_	_	_	_	I-claim-10447
168	33	increase	increase	VBP	31	acl:relcl	35281	35289	_	_	_	_	I-claim-10447
168	34	their	they	PRP$	35	nmod:poss	35290	35295	_	_	_	_	I-claim-10447
168	35	risks	risk	NNS	33	dobj	35296	35301	B-event-212134	_	_	_	I-claim-10447
168	36	of	of	IN	37	case	35302	35304	_	_	_	_	I-claim-10447
168	37	exposure	exposure	NN	35	nmod	35305	35313	B-event-212135	_	_	_	I-claim-10447
168	38	to	to	TO	39	case	35314	35316	_	_	_	_	I-claim-10447
168	39	HBV	hbv	NN	30	nmod	35317	35320	B-event-212136	_	_	_	I-claim-10447
168	40	during	during	IN	41	case	35321	35327	_	_	_	_	I-claim-10447
168	41	travel	travel	NN	30	nmod	35328	35334	B-event-212137	_	_	_	I-claim-10447
168	42	,	,	,	45	punct	35334	35335	_	_	_	_	I-claim-10447
168	43	should	should	MD	45	aux	35336	35342	_	_	_	_	I-claim-10447
168	44	be	be	VB	45	auxpass	35343	35345	_	_	_	_	I-claim-10447
168	45	vaccinated	vaccinate	VBN	0	ROOT	35346	35356	B-event-212138	_	_	_	I-claim-10447
168	46	.62	.62	CD	47	compound	35356	35359	_	_	_	_	_
168	47	(	(	CD	48	nummod	35360	35361	_	_	_	_	_
168	48	Refer	refer	NN	45	dobj	35361	35366	_	_	_	_	_
168	49	also	also	RB	52	advmod	35367	35371	_	_	_	_	_
168	50	to	to	TO	52	case	35372	35374	_	_	_	_	_
168	51	3.2	3.2	CD	52	nummod	35375	35378	_	_	_	_	_
168	52	Vaccination	vaccination	NN	48	nmod	35379	35390	_	_	_	_	_
168	53	for	for	IN	55	mark	35391	35394	_	_	_	_	_
168	54	international	international	JJ	55	amod	35395	35408	_	_	_	_	_
168	55	travel	travel	NN	52	dep	35409	35415	_	_	_	_	_
168	56	.	.	.	55	punct	35415	35416	_	_	_	_	_
168	57	)	)	SYM	48	dep	35416	35417	_	_	_	_	_

169	1	Recommendations	recommendation	NNS	65	nsubj	35419	35434	B-event-212139	_	_	_	_
169	2	for	for	IN	4	case	35435	35438	_	_	_	_	_
169	3	the	the	DT	4	det	35439	35442	_	_	_	_	_
169	4	use	use	NN	1	nmod	35443	35446	_	_	_	_	_
169	5	of	of	IN	12	case	35447	35449	_	_	_	_	_
169	6	combination	combination	NN	12	compound	35450	35461	_	_	_	_	_
169	7	hepatitis	hepatitis	NN	12	compound	35462	35471	_	_	_	_	_
169	8	A/hepatitis	a/hepatitis	NN	12	compound	35472	35483	_	_	_	_	_
169	9	B	b	NN	12	compound	35484	35485	_	_	_	_	_
169	10	vaccines	vaccine	NNS	12	compound	35486	35494	B-event-212140	_	_	_	_
169	11	Combination	combination	NN	12	compound	35496	35507	_	_	_	_	B-claim-10448
169	12	hepatitis	hepatitis	NN	4	nmod	35508	35517	_	_	_	_	I-claim-10448
169	13	A/hepatitis	a/hepatitis	NN	15	compound	35518	35529	_	_	_	_	I-claim-10448
169	14	B	b	NN	15	compound	35530	35531	_	_	_	_	I-claim-10448
169	15	vaccines	vaccine	NNS	18	nsubjpass	35532	35540	B-event-212141	_	_	_	I-claim-10448
169	16	should	should	MD	18	aux	35541	35547	_	_	_	_	I-claim-10448
169	17	be	be	VB	18	auxpass	35548	35550	_	_	_	_	I-claim-10448
169	18	considered	consider	VBN	12	acl:relcl	35551	35561	B-event-212142	_	_	_	I-claim-10448
169	19	for	for	IN	21	case	35562	35565	_	_	_	_	I-claim-10448
169	20	susceptible	susceptible	JJ	21	amod	35566	35577	_	_	_	_	I-claim-10448
169	21	persons	person	NNS	18	advcl	35578	35585	_	_	_	_	I-claim-10448
169	22	in	in	IN	23	case	35586	35588	_	_	_	_	I-claim-10448
169	23	whom	whom	WP	32	nmod	35589	35593	_	_	_	_	I-claim-10448
169	24	both	both	DT	26	det	35594	35598	_	B-content-25339:25340-Cue	_	_	I-claim-10448
169	25	hepatitis	hepatitis	NN	26	compound	35599	35608	_	I-content-25339	_	_	I-claim-10448
169	26	A	a	NN	32	nsubjpass	35609	35610	_	I-content-25339	_	_	I-claim-10448
169	27	and	and	CC	26	cc	35611	35614	_	I-content-25339	_	_	I-claim-10448
169	28	hepatitis	hepatitis	NN	30	compound	35615	35624	_	I-content-25339	_	_	I-claim-10448
169	29	B	b	NN	30	compound	35625	35626	_	I-content-25339	_	_	I-claim-10448
169	30	vaccines	vaccine	NNS	26	conj	35627	35635	B-event-212143	I-content-25339	_	_	I-claim-10448
169	31	are	be	VBP	32	auxpass	35636	35639	_	_	_	_	I-claim-10448
169	32	recommended	recommend	VBN	21	acl:relcl	35640	35651	_	_	_	B-cue-25340	I-claim-10448
169	33	,	,	,	21	punct	35651	35652	_	_	_	_	_
169	34	including	include	VBG	21	nmod	35653	35662	_	_	_	_	_
169	35	:	:	:	18	punct	35662	35663	_	_	_	_	_
169	36	If	if	IN	45	mark	35664	35666	_	_	_	_	_
169	37	a	a	DT	39	det	35667	35668	_	_	_	_	_
169	38	combination	combination	NN	39	compound	35669	35680	_	_	_	_	_
169	39	hepatitis	hepatitis	NN	45	nsubj	35681	35690	_	_	_	_	_
169	40	A/hepatitis	a/hepatitis	NN	42	compound	35691	35702	_	_	_	_	_
169	41	B	b	NN	42	compound	35703	35704	_	_	_	_	_
169	42	vaccine	vaccine	NN	39	dep	35705	35712	B-event-212144	_	_	_	_
169	43	is	be	VBZ	45	cop	35713	35715	_	_	_	_	_
169	44	not	not	RB	45	neg	35716	35719	_	_	_	_	_
169	45	available	available	JJ	56	advcl	35720	35729	_	_	_	_	_
169	46	,	,	,	56	punct	35729	35730	_	_	_	_	_
169	47	monovalent	monovalent	JJ	49	amod	35731	35741	_	_	_	_	_
169	48	hepatitis	hepatitis	NN	49	compound	35742	35751	_	_	_	_	_
169	49	A	a	NN	56	nsubjpass	35752	35753	_	_	_	_	_
169	50	and	and	CC	49	cc	35754	35757	_	_	_	_	_
169	51	hepatitis	hepatitis	NN	53	compound	35758	35767	_	_	_	_	_
169	52	B	b	NN	53	compound	35768	35769	_	_	_	_	_
169	53	vaccines	vaccine	NNS	49	conj	35770	35778	B-event-212145	_	_	_	_
169	54	can	can	MD	56	aux	35779	35782	_	_	_	_	_
169	55	be	be	VB	56	auxpass	35783	35785	_	_	_	_	_
169	56	administered	administer	VBN	18	parataxis	35786	35798	B-event-212146	_	_	_	_
169	57	simultaneously	simultaneously	RB	56	advmod	35799	35813	_	_	_	_	_
169	58	(	(	RB	61	advmod	35814	35815	_	_	_	_	_
169	59	in	in	IN	61	case	35815	35817	_	_	_	_	_
169	60	separate	separate	JJ	61	amod	35818	35826	_	_	_	_	_
169	61	syringes	syringe	NNS	56	nmod	35827	35835	_	_	_	_	_
169	62	at	at	IN	64	case	35836	35838	_	_	_	_	_
169	63	separate	separate	JJ	64	amod	35839	35847	_	_	_	_	_
169	64	sites	site	NNS	61	nmod	35848	35853	_	_	_	_	_
169	65	)	)	VBP	0	ROOT	35853	35854	_	_	_	_	_
169	66	(	(	CD	67	nsubj	35855	35856	_	_	_	_	_
169	67	refer	refer	VBP	65	ccomp	35856	35861	_	_	_	_	_
169	68	to	to	TO	69	mark	35862	35864	_	_	_	_	_
169	69	‘	‘	VB	67	xcomp	35865	35866	_	_	_	_	_
169	70	Interchangeability	interchangeability	NN	75	nsubj	35866	35884	_	_	_	_	_
169	71	of	of	IN	74	case	35885	35887	_	_	_	_	_
169	72	hepatitis	hepatitis	NN	74	compound	35888	35897	_	_	_	_	_
169	73	B	b	NN	74	compound	35898	35899	_	_	_	_	_
169	74	vaccines	vaccine	NNS	70	nmod	35900	35908	_	_	_	_	_
169	75	’	’	VBP	69	ccomp	35908	35909	_	_	_	_	_
169	76	above	above	IN	77	case	35910	35915	_	_	_	_	_
169	77	)	)	NN	75	nmod	35915	35916	_	_	_	_	_
169	78	.	.	.	65	punct	35916	35917	_	_	_	_	_

170	1	Refer	refer	VB	0	ROOT	35918	35923	_	_	_	_	_
170	2	to	to	TO	4	case	35924	35926	_	_	_	_	_
170	3	4.5.7	4.5.7	CD	4	nummod	35927	35932	_	_	_	_	_
170	4	Recommendations	recommendation	NNS	1	nmod	35934	35949	_	_	_	_	_
170	5	above	above	IN	9	case	35950	35955	_	_	_	_	_
170	6	and	and	CC	7	cc	35956	35959	_	_	_	_	_
170	7	4.4	4.4	CD	9	nummod	35960	35963	_	_	_	_	_
170	8	Hepatitis	Hepatitis	NNP	9	compound	35964	35973	_	_	_	_	_
170	9	A	A	NNP	4	nmod	35974	35975	_	_	_	_	_
170	10	for	for	IN	12	case	35976	35979	_	_	_	_	_
170	11	more	more	JJR	12	amod	35980	35984	_	_	_	_	_
170	12	details	detail	NNS	9	nmod	35985	35992	_	_	_	_	_
170	13	.	.	.	1	punct	35992	35993	_	_	_	_	_

171	1	Refer	refer	NN	0	ROOT	35994	35999	_	_	_	_	_
171	2	also	also	RB	5	advmod	36000	36004	_	_	_	_	_
171	3	to	to	TO	5	case	36005	36007	_	_	_	_	_
171	4	3.3	3.3	CD	5	nummod	36008	36011	_	_	_	_	_
171	5	Groups	group	NNS	1	nmod	36012	36018	_	_	_	_	_
171	6	with	with	IN	9	case	36019	36023	_	_	_	_	_
171	7	special	special	JJ	9	amod	36024	36031	_	_	_	_	_
171	8	vaccination	vaccination	NN	9	compound	36032	36043	_	_	_	_	_
171	9	requirements	requirement	NNS	5	nmod	36044	36056	_	_	_	_	_
171	10	.	.	.	1	punct	36056	36057	_	_	_	_	_

172	1	Booster	Booster	NNP	2	compound	36058	36065	_	_	_	_	_
172	2	doses	dose	NNS	23	nsubjpass	36066	36071	_	_	_	_	_
172	3	Booster	Booster	NNP	4	compound	36072	36079	_	B-content-25341:25342-Cue	_	_	_
172	4	doses	dose	NNS	2	dep	36080	36085	_	I-content-25341	_	_	_
172	5	of	of	IN	8	case	36086	36088	_	I-content-25341	_	_	_
172	6	hepatitis	hepatitis	NN	8	compound	36089	36098	_	I-content-25341	_	_	_
172	7	B	b	NN	8	compound	36099	36100	_	I-content-25341	_	_	_
172	8	vaccine	vaccine	NN	4	nmod	36101	36108	B-event-212149	I-content-25341	_	_	_
172	9	(	(	CD	2	dep	36109	36110	_	I-content-25341	_	_	_
172	10	after	after	IN	11	case	36110	36115	_	I-content-25341	_	_	_
172	11	completion	completion	NN	23	nmod	36116	36126	B-event-212147	I-content-25341	_	_	_
172	12	of	of	IN	15	case	36127	36129	_	I-content-25341	_	_	_
172	13	a	a	DT	15	det	36130	36131	_	I-content-25341	_	_	_
172	14	primary	primary	JJ	15	amod	36132	36139	_	I-content-25341	_	_	_
172	15	course	course	NN	11	nmod	36140	36146	_	I-content-25341	_	_	_
172	16	by	by	IN	17	mark	36147	36149	_	I-content-25341	_	_	_
172	17	using	use	VBG	15	acl	36150	36155	_	I-content-25341	_	_	_
172	18	recommended	recommend	VBN	20	amod	36156	36167	B-event-212148	I-content-25341	_	_	_
172	19	schedule	schedule	NN	20	compound	36168	36176	_	I-content-25341	_	_	_
172	20	)	)	NN	23	nsubjpass	36176	36177	_	I-content-25341	_	_	_
172	21	are	be	VBP	23	auxpass	36178	36181	_	_	_	_	_
172	22	not	not	RB	23	neg	36182	36185	_	_	_	_	_
172	23	recommended	recommend	VBN	0	ROOT	36186	36197	_	_	_	B-cue-25342	_
172	24	for	for	IN	26	case	36198	36201	_	_	_	_	_
172	25	immunocompetent	immunocompetent	JJ	26	amod	36202	36217	B-event-212150	_	_	_	_
172	26	persons	person	NNS	23	nmod	36218	36225	_	_	_	_	_
172	27	.	.	.	23	punct	36225	36226	_	_	_	_	_

173	1	This	this	DT	2	nsubj	36227	36231	_	_	_	_	_
173	2	applies	apply	VBZ	14	dep	36232	36239	_	_	_	_	_
173	3	to	to	TO	4	case	36240	36242	_	_	_	_	_
173	4	children	child	NNS	2	nmod	36243	36251	_	_	_	_	_
173	5	and	and	CC	4	cc	36252	36255	_	_	_	_	_
173	6	adults	adult	NNS	4	conj	36256	36262	_	_	_	_	_
173	7	,	,	,	2	punct	36262	36263	_	_	_	_	_
173	8	including	include	VBG	10	case	36264	36273	_	_	_	_	_
173	9	healthcare	healthcare	NN	10	compound	36274	36284	_	_	_	_	_
173	10	workers	worker	NNS	2	nmod	36285	36292	_	_	_	_	_
173	11	and	and	CC	10	cc	36293	36296	_	_	_	_	_
173	12	dentists.74-80	dentists.74-80	JJ	10	conj	36297	36311	_	_	_	_	_
173	13	This	this	DT	14	nsubj	36312	36316	_	_	_	_	_
173	14	is	be	VBZ	0	ROOT	36317	36319	_	_	_	_	_
173	15	because	because	IN	17	mark	36320	36327	_	_	_	_	_
173	16	there	there	EX	17	expl	36328	36333	_	_	_	_	_
173	17	is	be	VBZ	14	advcl	36334	36336	_	_	_	_	_
173	18	good	good	JJ	19	amod	36337	36341	_	_	_	_	_
173	19	evidence	evidence	NN	17	nsubj	36342	36350	_	_	_	_	_
173	20	that	that	IN	29	mark	36351	36355	_	_	_	_	_
173	21	a	a	DT	24	det	36356	36357	_	_	_	_	_
173	22	completed	complete	VBN	24	amod	36358	36367	B-event-212151	_	_	_	_
173	23	primary	primary	JJ	24	amod	36368	36375	_	_	_	_	_
173	24	course	course	NN	29	nsubj	36376	36382	_	_	_	_	_
173	25	of	of	IN	28	case	36383	36385	_	_	_	_	_
173	26	hepatitis	hepatitis	NN	28	compound	36386	36395	_	_	_	_	_
173	27	B	b	NN	28	compound	36396	36397	_	_	_	_	_
173	28	vaccination	vaccination	NN	24	nmod	36398	36409	B-event-212152	_	_	_	_
173	29	provides	provide	VBZ	17	ccomp	36410	36418	_	_	_	_	_
173	30	long-lasting	long-lasting	JJ	31	amod	36419	36431	_	_	_	_	_
173	31	protection	protection	NN	29	dobj	36432	36442	B-event-212153	_	_	_	_
173	32	.	.	.	14	punct	36442	36443	_	_	_	_	_

174	1	Even	even	RB	7	advmod	36444	36448	_	_	_	_	_
174	2	though	though	IN	7	mark	36449	36455	_	_	_	_	_
174	3	vaccine-induced	vaccine-induced	JJ	5	amod	36456	36471	B-event-212154	_	_	_	_
174	4	antibody	antibody	NN	5	compound	36472	36480	_	_	_	_	_
174	5	levels	level	NNS	7	nsubj	36481	36487	_	_	_	_	_
174	6	may	may	MD	7	aux	36488	36491	_	_	_	_	_
174	7	decline	decline	VB	17	advcl	36492	36499	B-event-212155	_	_	_	_
174	8	with	with	IN	9	case	36500	36504	_	_	_	_	_
174	9	time	time	NN	7	nmod	36505	36509	_	_	_	_	_
174	10	and	and	CC	7	cc	36510	36513	_	_	_	_	_
174	11	may	may	MD	12	aux	36514	36517	_	_	_	_	_
174	12	become	become	VB	7	conj	36518	36524	_	_	_	_	_
174	13	undetectable	undetectable	JJ	12	xcomp	36525	36537	B-event-212156	_	_	_	_
174	14	,	,	,	17	punct	36537	36538	_	_	_	_	_
174	15	immune	immune	JJ	16	amod	36539	36545	_	_	_	_	_
174	16	memory	memory	NN	17	nsubj	36546	36552	_	_	_	_	_
174	17	persists	persist	VBZ	35	ccomp	36553	36561	_	_	_	_	_
174	18	and	and	CC	17	cc	36562	36565	_	_	_	_	_
174	19	is	be	VBZ	20	auxpass	36566	36568	_	_	_	_	_
174	20	thought	think	VBN	17	conj	36569	36576	_	_	_	_	_
174	21	to	to	TO	22	mark	36577	36579	_	_	_	_	_
174	22	result	result	VB	20	xcomp	36580	36586	_	_	_	_	_
174	23	in	in	IN	27	case	36587	36589	_	_	_	_	_
174	24	a	a	DT	27	det	36590	36591	_	_	_	_	_
174	25	protective	protective	JJ	27	amod	36592	36602	B-event-212157	_	_	_	_
174	26	immune	immune	JJ	27	amod	36603	36609	_	_	_	_	_
174	27	response	response	NN	22	nmod	36610	36618	B-event-212158	_	_	_	_
174	28	on	on	IN	29	case	36619	36621	_	_	_	_	_
174	29	re-exposure.81	re-exposure.81	NN	27	nmod	36622	36636	B-event-212159	_	_	_	_
174	30	However	however	RB	22	advmod	36637	36644	_	_	_	_	_
174	31	,	,	,	35	punct	36644	36645	_	_	_	_	_
174	32	booster	booster	NN	33	compound	36646	36653	_	B-content-25343:25344-Cue	_	_	_
174	33	doses	dose	NNS	35	nsubjpass	36654	36659	B-event-212160	I-content-25343	_	_	_
174	34	are	be	VBP	35	auxpass	36660	36663	_	_	_	_	_
174	35	recommended	recommend	VBN	0	ROOT	36664	36675	_	_	_	B-cue-25344	_
174	36	for	for	IN	37	case	36676	36679	_	_	_	_	_
174	37	persons	person	NNS	35	nmod	36680	36687	_	_	_	_	_
174	38	who	who	WP	40	nsubj	36688	36691	_	_	_	_	_
174	39	are	be	VBP	40	cop	36692	36695	_	_	_	_	_
174	40	immunocompromised	immunocompromised	JJ	37	acl:relcl	36696	36713	B-event-212161	_	_	_	_
174	41	,	,	,	40	punct	36713	36714	_	_	_	_	_
174	42	in	in	IN	43	case	36715	36717	_	_	_	_	_
174	43	particular	particular	JJ	40	nmod	36718	36728	_	_	_	_	_
174	44	those	those	DT	43	dep	36729	36734	_	_	_	_	_
174	45	with	with	IN	48	case	36735	36739	_	_	_	_	_
174	46	either	either	CC	48	cc:preconj	36740	36746	_	_	_	_	_
174	47	HIV	hiv	NN	48	compound	36747	36750	B-event-212162	_	_	_	_
174	48	infection	infection	NN	43	nmod	36751	36760	B-event-212163	_	_	_	_
174	49	or	or	CC	48	cc	36761	36763	_	_	_	_	_
174	50	renal	renal	JJ	51	amod	36764	36769	_	_	_	_	_
174	51	failure	failure	NN	48	conj	36770	36777	B-event-212164	_	_	_	_
174	52	.	.	.	35	punct	36777	36778	_	_	_	_	_

175	1	The	the	DT	2	det	36779	36782	_	_	_	_	B-claim-10449
175	2	time	time	NN	10	nsubjpass	36783	36787	_	_	_	_	I-claim-10449
175	3	for	for	IN	4	mark	36788	36791	_	_	_	_	I-claim-10449
175	4	boosting	boost	VBG	2	acl	36792	36800	B-event-212165	_	_	_	I-claim-10449
175	5	in	in	IN	7	case	36801	36803	_	_	_	_	I-claim-10449
175	6	such	such	JJ	7	amod	36804	36808	_	_	_	_	I-claim-10449
175	7	persons	person	NNS	4	nmod	36809	36816	_	_	_	_	I-claim-10449
175	8	should	should	MD	10	aux	36817	36823	_	_	_	_	I-claim-10449
175	9	be	be	VB	10	auxpass	36824	36826	_	_	_	_	I-claim-10449
175	10	decided	decide	VBN	0	ROOT	36827	36834	B-event-212166	_	_	_	I-claim-10449
175	11	by	by	IN	13	case	36835	36837	_	_	_	_	I-claim-10449
175	12	regular	regular	JJ	13	amod	36838	36845	_	_	_	_	I-claim-10449
175	13	monitoring	monitoring	NN	10	nmod	36846	36856	B-event-212167	_	_	_	I-claim-10449
175	14	of	of	IN	16	case	36857	36859	_	_	_	_	I-claim-10449
175	15	anti-HBs	anti-hbs	JJ	16	amod	36860	36868	_	_	_	_	I-claim-10449
175	16	levels	level	NNS	13	nmod	36869	36875	_	_	_	_	I-claim-10449
175	17	at	at	IN	18	case	36876	36878	_	_	_	_	I-claim-10449
175	18	6	6	CD	10	advcl	36879	36880	_	_	_	_	I-claim-10449
175	19	-	-	:	18	punct	36880	36881	_	_	_	_	I-claim-10449
175	20	to	to	TO	22	case	36882	36884	_	_	_	_	I-claim-10449
175	21	12-monthly	12-monthly	JJ	22	amod	36885	36895	_	_	_	_	I-claim-10449
175	22	intervals	interval	NNS	18	nmod	36896	36905	_	_	_	_	I-claim-10449
175	23	.74	.74	CD	25	nummod	36905	36908	_	_	_	_	_
175	24	Serological	serological	JJ	25	amod	36909	36920	_	_	_	_	_
175	25	testing	testing	NN	26	nmod:npmod	36921	36928	B-event-212168	_	_	_	_
175	26	prior	prior	RB	30	advmod	36929	36934	_	_	_	_	_
175	27	to	to	TO	30	case	36935	36937	_	_	_	_	_
175	28	hepatitis	hepatitis	NN	30	compound	36938	36947	_	_	_	_	_
175	29	B	b	NN	30	compound	36948	36949	_	_	_	_	_
175	30	vaccination	vaccination	NN	22	nmod	36950	36961	B-event-212169	_	_	_	_
175	31	Routine	routine	JJ	33	amod	36962	36969	_	B-content-25345:25346-Cue	_	_	_
175	32	antenatal	antenatal	JJ	33	amod	36970	36979	_	I-content-25345	_	_	_
175	33	screening	screening	NN	41	nsubjpass	36980	36989	B-event-212244	I-content-25345	_	_	_
175	34	of	of	IN	37	case	36990	36992	_	I-content-25345	_	_	_
175	35	all	all	DT	37	det	36993	36996	_	I-content-25345	_	_	_
175	36	pregnant	pregnant	JJ	37	amod	36997	37005	B-event-212245	I-content-25345	_	_	_
175	37	women	woman	NNS	33	nmod	37006	37011	_	I-content-25345	_	_	_
175	38	for	for	IN	39	case	37012	37015	_	I-content-25345	_	_	_
175	39	HBsAg	hbsag	NN	37	nmod	37016	37021	_	I-content-25345	_	_	_
175	40	is	be	VBZ	41	auxpass	37022	37024	_	_	_	_	_
175	41	recommended	recommend	VBN	30	acl:relcl	37025	37036	_	_	_	B-cue-25346	_
175	42	to	to	TO	43	mark	37037	37039	_	_	_	_	_
175	43	allow	allow	VB	41	xcomp	37040	37045	_	_	_	_	_
175	44	appropriate	appropriate	JJ	45	amod	37046	37057	_	_	_	_	_
175	45	measures	measure	NNS	43	dobj	37058	37066	B-event-212246	_	_	_	_
175	46	to	to	TO	48	mark	37067	37069	_	_	_	_	_
175	47	be	be	VB	48	auxpass	37070	37072	_	_	_	_	_
175	48	implemented	implement	VBN	43	xcomp	37073	37084	B-event-212248	_	_	_	_
175	49	to	to	TO	50	mark	37085	37087	_	_	_	_	_
175	50	prevent	prevent	VB	48	xcomp	37088	37095	B-event-212247	_	_	_	_
175	51	newborn	newborn	JJ	52	amod	37096	37103	_	_	_	_	_
175	52	infants	infant	NNS	50	dobj	37104	37111	_	_	_	_	_
175	53	developing	develop	VBG	50	xcomp	37112	37122	B-event-212249	_	_	_	_
175	54	chronic	chronic	JJ	56	amod	37123	37130	_	_	_	_	_
175	55	HBV	hbv	NN	56	compound	37131	37134	B-event-212250	_	_	_	_
175	56	infection49-51	infection49-51	NN	53	dobj	37135	37149	B-event-212251	_	_	_	_
175	57	(	(	CD	58	nsubj	37150	37151	_	_	_	_	_
175	58	refer	refer	VBP	56	acl:relcl	37151	37156	_	_	_	_	_
175	59	to	to	TO	60	mark	37157	37159	_	_	_	_	_
175	60	‘	‘	VB	58	xcomp	37160	37161	_	_	_	_	_
175	61	Management	management	NN	60	dobj	37161	37171	_	_	_	_	_
175	62	of	of	IN	63	case	37172	37174	_	_	_	_	_
175	63	infants	infant	NNS	61	nmod	37175	37182	_	_	_	_	_
175	64	born	bear	VBN	63	acl	37183	37187	_	_	_	_	_
175	65	to	to	TO	66	case	37188	37190	_	_	_	_	_
175	66	mothers	mother	NNS	64	nmod	37191	37198	_	_	_	_	_
175	67	who	who	WP	70	nsubj	37199	37202	_	_	_	_	_
175	68	are	be	VBP	70	cop	37203	37206	_	_	_	_	_
175	69	HBsAg-positive	hbsag-positive	JJ	70	amod	37207	37221	_	_	_	_	_
175	70	’	’	NN	66	acl:relcl	37221	37222	_	_	_	_	_
175	71	above	above	IN	72	case	37223	37228	_	_	_	_	_
175	72	)	)	NN	70	nmod	37228	37229	_	_	_	_	_
175	73	.	.	.	10	punct	37229	37230	_	_	_	_	_

176	1	Serological	serological	JJ	2	amod	37231	37242	_	_	_	_	_
176	2	testing	testing	NN	19	nsubjpass	37243	37250	B-event-212252	_	_	_	_
176	3	for	for	IN	4	case	37251	37254	_	_	_	_	_
176	4	evidence	evidence	NN	2	nmod	37255	37263	_	_	_	_	_
176	5	of	of	IN	7	case	37264	37266	_	_	_	_	_
176	6	past	past	JJ	7	amod	37267	37271	_	_	_	_	_
176	7	(	(	CD	4	nmod	37272	37273	_	_	_	_	_
176	8	or	or	CC	4	cc	37273	37275	_	_	_	_	_
176	9	current	current	JJ	10	amod	37276	37283	_	_	_	_	_
176	10	)	)	CD	4	conj	37283	37284	_	_	_	_	_
176	11	hepatitis	hepatitis	NN	13	compound	37285	37294	B-event-212253	_	_	_	_
176	12	B	b	NN	13	compound	37295	37296	I-event-212253	_	_	_	_
176	13	infection	infection	NN	10	nmod:tmod	37297	37306	B-event-212254	_	_	_	_
176	14	prior	prior	RB	13	advmod	37307	37312	_	_	_	_	_
176	15	to	to	TO	16	case	37313	37315	_	_	_	_	_
176	16	vaccination	vaccination	NN	14	nmod	37316	37327	B-event-212255	_	_	_	_
176	17	may	may	MD	19	aux	37328	37331	_	_	_	_	_
176	18	be	be	VB	19	auxpass	37332	37334	_	_	_	_	_
176	19	warranted	warrant	VBN	0	ROOT	37335	37344	_	_	_	_	_
176	20	for	for	IN	23	case	37345	37348	_	_	_	_	_
176	21	certain	certain	JJ	23	amod	37349	37356	_	_	_	_	_
176	22	older	older	JJR	23	amod	37357	37362	_	_	_	_	_
176	23	children	child	NNS	19	nmod	37363	37371	_	_	_	_	_
176	24	,	,	,	23	punct	37371	37372	_	_	_	_	_
176	25	adolescents	adolescent	NNS	23	conj	37373	37384	_	_	_	_	_
176	26	and	and	CC	23	cc	37385	37388	_	_	_	_	_
176	27	adults	adult	NNS	23	conj	37389	37395	_	_	_	_	_
176	28	.	.	.	19	punct	37395	37396	_	_	_	_	_

177	1	This	this	DT	4	nsubj	37397	37401	_	_	_	_	_
177	2	is	be	VBZ	4	cop	37402	37404	_	_	_	_	_
177	3	particularly	particularly	RB	4	advmod	37405	37417	_	_	_	_	_
177	4	so	so	RB	0	ROOT	37418	37420	_	_	_	_	_
177	5	for	for	IN	6	case	37421	37424	_	_	_	_	_
177	6	those	those	DT	4	nmod	37425	37430	_	_	_	_	_
177	7	at	at	IN	9	case	37431	37433	_	_	_	_	_
177	8	increased	increase	VBN	9	amod	37434	37443	_	_	_	_	_
177	9	risk	risk	NN	4	nmod	37444	37448	B-event-212256	_	_	_	_
177	10	of	of	IN	11	mark	37449	37451	_	_	_	_	_
177	11	acquiring	acquire	VBG	9	acl	37452	37461	B-event-212257	_	_	_	_
177	12	hepatitis	hepatitis	NN	14	compound	37462	37471	B-event-212258	_	_	_	_
177	13	B	b	NN	14	compound	37472	37473	I-event-212258	_	_	_	_
177	14	infection	infection	NN	11	dobj	37474	37483	B-event-212259	_	_	_	_
177	15	,	,	,	14	punct	37483	37484	_	_	_	_	_
177	16	such	such	JJ	18	case	37485	37489	_	_	_	_	_
177	17	as	as	IN	16	mwe	37490	37492	_	_	_	_	_
177	18	persons	person	NNS	14	nmod	37493	37500	_	_	_	_	_
177	19	who	who	WP	20	nsubj	37501	37504	_	_	_	_	_
177	20	inject	inject	VBP	18	acl:relcl	37505	37511	B-event-212260	_	_	_	_
177	21	drugs	drug	NNS	20	dobj	37512	37517	_	_	_	_	_
177	22	,	,	,	21	punct	37517	37518	_	_	_	_	_
177	23	sex	sex	NN	25	compound	37519	37522	_	_	_	_	_
177	24	industry	industry	NN	25	compound	37523	37531	_	_	_	_	_
177	25	workers	worker	NNS	21	conj	37532	37539	_	_	_	_	_
177	26	,	,	,	21	punct	37539	37540	_	_	_	_	_
177	27	immunocompromised	immunocompromised	JJ	28	amod	37541	37558	B-event-212261	_	_	_	_
177	28	persons	person	NNS	21	conj	37559	37566	_	_	_	_	_
177	29	,	,	,	21	punct	37566	37567	_	_	_	_	_
177	30	and	and	CC	21	cc	37568	37571	_	_	_	_	_
177	31	those	those	DT	21	conj	37572	37577	_	_	_	_	_
177	32	living	live	VBG	31	acl	37578	37584	_	_	_	_	_
177	33	in	in	IN	34	case	37585	37587	_	_	_	_	_
177	34	communities	community	NNS	32	nmod	37588	37599	_	_	_	_	_
177	35	with	with	IN	37	case	37600	37604	_	_	_	_	_
177	36	higher	higher	JJR	37	amod	37605	37611	_	_	_	_	_
177	37	prevalence	prevalence	NN	34	nmod	37612	37622	_	_	_	_	_
177	38	of	of	IN	39	case	37623	37625	_	_	_	_	_
177	39	HBV	hbv	NN	37	nmod	37626	37629	B-event-212262	_	_	_	_
177	40	,	,	,	14	punct	37629	37630	_	_	_	_	_
177	41	including	include	VBG	43	case	37631	37640	_	_	_	_	_
177	42	migrant	migrant	JJ	43	amod	37641	37648	B-event-212263	_	_	_	_
177	43	communities	community	NNS	14	nmod	37649	37660	_	_	_	_	_
177	44	and	and	CC	43	cc	37661	37664	_	_	_	_	_
177	45	Aboriginal	aboriginal	JJ	50	amod	37665	37675	_	_	_	_	_
177	46	and	and	CC	45	cc	37676	37679	_	_	_	_	_
177	47	Torres	Torres	NNP	45	conj	37680	37686	_	_	_	_	_
177	48	Strait	Strait	NNP	50	compound	37687	37693	_	_	_	_	_
177	49	Islander	Islander	NNP	50	compound	37694	37702	_	_	_	_	_
177	50	people	people	NNS	43	conj	37703	37709	_	_	_	_	_
177	51	.	.	.	4	punct	37709	37710	_	_	_	_	_

178	1	Serological	serological	JJ	2	amod	37711	37722	_	_	_	_	_
178	2	testing	testing	NN	3	nsubj	37723	37730	B-event-212264	_	_	_	_
178	3	enables	enable	VBZ	0	ROOT	37731	37738	_	_	_	_	_
178	4	identification	identification	NN	3	dobj	37739	37753	B-event-212265	_	_	_	_
178	5	of	of	IN	6	case	37754	37756	_	_	_	_	_
178	6	persons	person	NNS	4	nmod	37757	37764	_	_	_	_	_
178	7	who	who	WP	9	nsubjpass	37765	37768	_	_	_	_	_
178	8	were	be	VBD	9	auxpass	37769	37773	_	_	_	_	_
178	9	infected	infect	VBN	6	acl:relcl	37774	37782	B-event-212266	_	_	_	_
178	10	by	by	IN	11	case	37783	37785	_	_	_	_	_
178	11	HBV	hbv	NN	9	nmod	37786	37789	B-event-212267	_	_	_	_
178	12	,	,	,	11	punct	37789	37790	_	_	_	_	_
178	13	to	to	TO	14	mark	37791	37793	_	_	_	_	_
178	14	facilitate	facilitate	VB	11	acl	37794	37804	_	_	_	_	_
178	15	timely	timely	JJ	16	amod	37805	37811	_	_	_	_	_
178	16	appropriate	appropriate	JJ	18	amod	37812	37823	_	_	_	_	_
178	17	clinical	clinical	JJ	18	amod	37824	37832	_	_	_	_	_
178	18	management	management	NN	14	dobj	37833	37843	_	_	_	_	_
178	19	and	and	CC	11	cc	37844	37847	_	_	_	_	_
178	20	prevention	prevention	NN	11	conj	37848	37858	B-event-212268	_	_	_	_
178	21	of	of	IN	23	case	37859	37861	_	_	_	_	_
178	22	onward	onward	RB	23	advmod	37862	37868	_	_	_	_	_
178	23	transmission	transmission	NN	20	nmod	37869	37881	B-event-212269	_	_	_	_
178	24	,	,	,	23	punct	37881	37882	_	_	_	_	_
178	25	hence	hence	RB	26	advmod	37883	37888	_	_	_	_	_
178	26	reducing	reduce	VBG	23	acl	37889	37897	B-event-212270	_	_	_	_
178	27	population	population	NN	28	compound	37898	37908	_	_	_	_	_
178	28	impact	impact	NN	26	dobj	37909	37915	B-event-212271	_	_	_	_
178	29	of	of	IN	31	case	37916	37918	_	_	_	_	_
178	30	HBV	hbv	NN	31	compound	37919	37922	B-event-212272	_	_	_	_
178	31	infection	infection	NN	28	nmod	37923	37932	B-event-212273	_	_	_	_
178	32	.	.	.	3	punct	37932	37933	_	_	_	_	_

179	1	Testing	test	VBG	3	csubj	37934	37941	B-event-212274	_	_	_	B-claim-10450
179	2	also	also	RB	1	advmod	37942	37946	_	_	_	_	I-claim-10450
179	3	identifies	identify	VBZ	74	dep	37947	37957	_	_	_	_	I-claim-10450
179	4	those	those	DT	61	nsubjpass	37958	37963	_	_	_	_	I-claim-10450
179	5	who	who	WP	7	nsubj	37964	37967	_	_	_	_	I-claim-10450
179	6	are	be	VBP	7	cop	37968	37971	_	_	_	_	I-claim-10450
179	7	susceptible	susceptible	JJ	4	acl:relcl	37972	37983	_	_	_	_	I-claim-10450
179	8	to	to	TO	10	case	37984	37986	_	_	_	_	I-claim-10450
179	9	HBV	hbv	NN	10	compound	37987	37990	B-event-212275	_	_	_	I-claim-10450
179	10	infection	infection	NN	7	nmod	37991	38000	B-event-212276	_	_	_	I-claim-10450
179	11	and	and	CC	7	cc	38001	38004	_	_	_	_	I-claim-10450
179	12	,	,	,	14	punct	38004	38005	_	_	_	_	I-claim-10450
179	13	as	as	IN	14	mark	38006	38008	_	_	_	_	I-claim-10450
179	14	such	such	JJ	18	parataxis	38009	38013	_	_	_	_	I-claim-10450
179	15	,	,	,	14	punct	38013	38014	_	_	_	_	I-claim-10450
179	16	should	should	MD	18	aux	38015	38021	_	_	_	_	I-claim-10450
179	17	be	be	VB	18	auxpass	38022	38024	_	_	_	_	I-claim-10450
179	18	offered	offer	VBN	7	conj	38025	38032	B-event-212277	_	_	_	I-claim-10450
179	19	vaccination	vaccination	NN	18	dobj	38033	38044	B-event-212278	_	_	_	I-claim-10450
179	20	if	if	IN	22	mark	38045	38047	_	_	_	_	I-claim-10450
179	21	they	they	PRP	22	nsubj	38048	38052	_	_	_	_	I-claim-10450
179	22	continue	continue	VBP	18	advcl	38053	38061	_	_	_	_	I-claim-10450
179	23	to	to	TO	24	mark	38062	38064	_	_	_	_	I-claim-10450
179	24	have	have	VB	22	xcomp	38065	38069	_	_	_	_	I-claim-10450
179	25	a	a	DT	29	det	38070	38071	_	_	_	_	I-claim-10450
179	26	high	high	JJ	29	amod	38072	38076	_	_	_	_	I-claim-10450
179	27	exposure	exposure	NN	29	compound	38077	38085	B-event-212279	_	_	_	I-claim-10450
179	28	risk	risk	NN	29	compound	38086	38090	B-event-212280	_	_	_	I-claim-10450
179	29	(	(	NN	30	nsubj	38091	38092	_	_	_	_	_
179	30	refer	refer	VBP	24	xcomp	38092	38097	_	_	_	_	_
179	31	to	to	TO	33	case	38098	38100	_	_	_	_	_
179	32	4.5.7	4.5.7	CD	33	nummod	38101	38106	_	_	_	_	_
179	33	Recommendations	recommendation	NNS	30	nmod	38107	38122	_	_	_	_	_
179	34	above	above	IN	36	case	38123	38128	_	_	_	_	_
179	35	)	)	CD	36	nummod	38128	38129	_	_	_	_	_
179	36	.72	.72	CD	33	nmod	38129	38132	_	_	_	_	_
179	37	Testing	test	VBG	30	xcomp	38133	38140	B-event-212281	_	_	_	_
179	38	for	for	IN	39	case	38141	38144	_	_	_	_	_
179	39	immunity	immunity	NN	37	nmod	38145	38153	B-event-212282	_	_	_	_
179	40	to	to	TO	44	case	38154	38156	_	_	_	_	_
179	41	hepatitis	hepatitis	NN	44	compound	38157	38166	B-event-212283	_	_	_	_
179	42	A	a	NN	44	compound	38167	38168	I-event-212283	_	_	_	_
179	43	infection	infection	NN	44	compound	38169	38178	B-event-212284	_	_	_	_
179	44	(	(	NN	37	nmod	38179	38180	_	_	_	_	_
179	45	and	and	CC	30	cc	38180	38183	_	_	_	_	_
179	46	vaccination	vaccination	NN	57	nsubj	38184	38195	B-event-212285	_	_	_	_
179	47	of	of	IN	50	case	38196	38198	_	_	_	_	_
179	48	susceptible	susceptible	JJ	49	amod	38199	38210	_	_	_	_	_
179	49	at-risk	at-risk	JJ	50	amod	38211	38218	B-event-212286	_	_	_	_
179	50	persons	person	NNS	46	nmod	38219	38226	_	_	_	_	_
179	51	with	with	IN	56	case	38227	38231	_	_	_	_	_
179	52	combination	combination	NN	56	compound	38232	38243	_	_	_	_	_
179	53	hepatitis	hepatitis	NN	56	compound	38244	38253	_	_	_	_	_
179	54	A/hepatitis	a/hepatitis	NN	56	compound	38254	38265	_	_	_	_	_
179	55	B	b	NN	56	compound	38266	38267	_	_	_	_	_
179	56	vaccines	vaccine	NNS	50	nmod	38268	38276	B-event-212287	_	_	_	_
179	57	)	)	VBP	30	conj	38276	38277	_	_	_	_	_
179	58	may	may	MD	61	aux	38278	38281	_	_	_	_	_
179	59	also	also	RB	61	advmod	38282	38286	_	_	_	_	_
179	60	be	be	VB	61	auxpass	38287	38289	_	_	_	_	_
179	61	indicated	indicate	VBN	3	ccomp	38290	38299	_	_	_	_	_
179	62	for	for	IN	65	case	38300	38303	_	_	_	_	_
179	63	some	some	DT	65	det	38304	38308	_	_	_	_	_
179	64	population	population	NN	65	compound	38309	38319	_	_	_	_	_
179	65	groups	group	NNS	61	nmod	38320	38326	_	_	_	_	_
179	66	at	at	IN	68	case	38327	38329	_	_	_	_	_
179	67	increased	increase	VBN	68	amod	38330	38339	_	_	_	_	_
179	68	risk	risk	NN	61	nmod	38340	38344	B-event-212288	_	_	_	_
179	69	of	of	IN	71	case	38345	38347	_	_	_	_	_
179	70	hepatitis	hepatitis	NN	71	compound	38348	38357	B-event-212289	_	_	_	_
179	71	A	a	NN	68	nmod	38358	38359	I-event-212289	_	_	_	_
179	72	exposure	exposure	NN	74	nsubj	38360	38368	B-event-212290	_	_	_	_
179	73	(	(	CD	72	nummod	38369	38370	_	_	_	_	_
179	74	refer	refer	VBP	0	ROOT	38370	38375	_	_	_	_	_
179	75	to	to	TO	79	case	38376	38378	_	_	_	_	_
179	76	4.4	4.4	CD	79	nummod	38379	38382	_	_	_	_	_
179	77	Hepatitis	Hepatitis	NNP	79	compound	38384	38393	_	_	_	_	_
179	78	A	A	NNP	79	compound	38394	38395	_	_	_	_	_
179	79	)	)	NN	74	nmod	38395	38396	_	_	_	_	_
179	80	.	.	.	74	punct	38396	38397	_	_	_	_	_

180	1	Interpretation	interpretation	NN	10	nsubjpass	38399	38413	B-event-212293	_	_	_	_
180	2	of	of	IN	4	case	38414	38416	_	_	_	_	_
180	3	the	the	DT	4	det	38417	38420	_	_	_	_	_
180	4	results	result	NNS	1	nmod	38421	38428	_	_	_	_	_
180	5	of	of	IN	7	case	38429	38431	_	_	_	_	_
180	6	serological	serological	JJ	7	amod	38432	38443	_	_	_	_	_
180	7	testing	testing	NN	4	nmod	38444	38451	B-event-212291	_	_	_	_
180	8	may	may	MD	10	aux	38452	38455	_	_	_	_	_
180	9	be	be	VB	10	auxpass	38456	38458	_	_	_	_	_
180	10	enhanced	enhance	VBN	0	ROOT	38459	38467	_	_	_	_	_
180	11	by	by	IN	12	case	38468	38470	_	_	_	_	_
180	12	discussion	discussion	NN	10	nmod	38471	38481	B-event-212292	_	_	_	_
180	13	with	with	IN	15	case	38482	38486	_	_	_	_	_
180	14	the	the	DT	15	det	38487	38490	_	_	_	_	_
180	15	laboratory	laboratory	NN	10	nmod	38491	38501	_	_	_	_	_
180	16	that	that	WDT	17	nsubj	38502	38506	_	_	_	_	_
180	17	performed	perform	VBD	15	acl:relcl	38507	38516	_	_	_	_	_
180	18	the	the	DT	19	det	38517	38520	_	_	_	_	_
180	19	test	test	NN	17	dobj	38521	38525	B-event-212294	_	_	_	_
180	20	,	,	,	17	punct	38525	38526	_	_	_	_	_
180	21	ensuring	ensure	VBG	17	advcl	38527	38535	_	_	_	_	_
180	22	that	that	IN	27	mark	38536	38540	_	_	_	_	_
180	23	relevant	relevant	JJ	25	amod	38541	38549	_	_	_	_	_
180	24	clinical	clinical	JJ	25	amod	38550	38558	_	_	_	_	_
180	25	information	information	NN	27	nsubjpass	38559	38570	_	_	_	_	_
180	26	is	be	VBZ	27	auxpass	38571	38573	_	_	_	_	_
180	27	provided	provide	VBN	21	ccomp	38574	38582	B-event-212295	_	_	_	_
180	28	.	.	.	10	punct	38582	38583	_	_	_	_	_

181	1	Serological	serological	JJ	2	amod	38584	38595	_	_	_	_	_
181	2	testing	testing	NN	39	nsubj	38596	38603	B-event-212296	_	_	_	_
181	3	following	follow	VBG	6	case	38604	38613	_	_	_	_	_
181	4	hepatitis	hepatitis	NN	6	compound	38614	38623	_	_	_	_	_
181	5	B	b	NN	6	compound	38624	38625	_	_	_	_	_
181	6	vaccination	vaccination	NN	2	nmod	38626	38637	B-event-212297	_	_	_	_
181	7	Anti-HBs	anti-hbs	JJ	8	amod	38639	38647	_	_	_	_	B-claim-10451
181	8	antibody	antibody	NN	14	nsubjpass	38648	38656	_	_	_	_	I-claim-10451
181	9	and	and	CC	8	cc	38657	38660	_	_	_	_	I-claim-10451
181	10	HBsAg	hbsag	NN	11	compound	38661	38666	_	_	_	_	I-claim-10451
181	11	levels	level	NNS	8	conj	38667	38673	_	_	_	_	I-claim-10451
181	12	should	should	MD	14	aux	38674	38680	_	_	_	_	I-claim-10451
181	13	be	be	VB	14	auxpass	38681	38683	_	_	_	_	I-claim-10451
181	14	measured	measure	VBN	6	acl:relcl	38684	38692	B-event-212298	_	_	_	I-claim-10451
181	15	in	in	IN	16	case	38693	38695	_	_	_	_	I-claim-10451
181	16	infants	infant	NNS	14	nmod	38696	38703	_	_	_	_	I-claim-10451
181	17	born	bear	VBN	16	acl	38704	38708	_	_	_	_	I-claim-10451
181	18	to	to	TO	19	case	38709	38711	_	_	_	_	I-claim-10451
181	19	mothers	mother	NNS	17	nmod	38712	38719	_	_	_	_	I-claim-10451
181	20	with	with	IN	24	case	38720	38724	_	_	_	_	I-claim-10451
181	21	chronic	chronic	JJ	24	amod	38725	38732	_	_	_	_	I-claim-10451
181	22	hepatitis	hepatitis	NN	24	compound	38733	38742	B-event-212299	_	_	_	I-claim-10451
181	23	B	b	NN	24	compound	38743	38744	I-event-212299	_	_	_	I-claim-10451
181	24	infection	infection	NN	19	nmod	38745	38754	B-event-212300	_	_	_	I-claim-10451
181	25	3	3	CD	27	compound	38755	38756	_	_	_	_	I-claim-10451
181	26	to	to	TO	27	dep	38757	38759	_	_	_	_	I-claim-10451
181	27	12	12	CD	28	nummod	38760	38762	_	_	_	_	I-claim-10451
181	28	months	month	NNS	17	nmod:tmod	38763	38769	_	_	_	_	I-claim-10451
181	29	after	after	IN	30	mark	38770	38775	_	_	_	_	I-claim-10451
181	30	completing	complete	VBG	14	advcl	38776	38786	B-event-212301	_	_	_	I-claim-10451
181	31	the	the	DT	35	det	38787	38790	_	_	_	_	I-claim-10451
181	32	primary	primary	JJ	35	amod	38791	38798	_	_	_	_	I-claim-10451
181	33	vaccine	vaccine	NN	35	compound	38799	38806	_	_	_	_	I-claim-10451
181	34	course	course	NN	35	compound	38807	38813	_	_	_	_	I-claim-10451
181	35	(	(	NN	30	dobj	38814	38815	_	_	_	_	_
181	36	for	for	IN	38	case	38815	38818	_	_	_	_	_
181	37	more	more	JJR	38	amod	38819	38823	_	_	_	_	_
181	38	information	information	NN	35	nmod	38824	38835	_	_	_	_	_
181	39	refer	refer	VBP	0	ROOT	38836	38841	_	_	_	_	_
181	40	to	to	TO	41	mark	38842	38844	_	_	_	_	_
181	41	‘	‘	VB	39	xcomp	38845	38846	_	_	_	_	_
181	42	Management	management	NN	41	dobj	38846	38856	_	_	_	_	_
181	43	of	of	IN	44	case	38857	38859	_	_	_	_	_
181	44	infants	infant	NNS	42	nmod	38860	38867	_	_	_	_	_
181	45	born	bear	VBN	44	acl	38868	38872	_	_	_	_	_
181	46	to	to	TO	47	case	38873	38875	_	_	_	_	_
181	47	mothers	mother	NNS	45	nmod	38876	38883	_	_	_	_	_
181	48	who	who	WP	51	nsubj	38884	38887	_	_	_	_	_
181	49	are	be	VBP	51	cop	38888	38891	_	_	_	_	_
181	50	HBsAg-positive	hbsag-positive	JJ	51	amod	38892	38906	_	_	_	_	_
181	51	’	’	NN	47	acl:relcl	38906	38907	_	_	_	_	_
181	52	above	above	IN	53	case	38908	38913	_	_	_	_	_
181	53	)	)	NN	51	nmod	38913	38914	_	_	_	_	_
181	54	.	.	.	39	punct	38914	38915	_	_	_	_	_

182	1	Other	other	JJ	18	nsubjpass	38916	38921	_	_	_	_	_
182	2	than	than	IN	5	advmod	38922	38926	_	_	_	_	_
182	3	for	for	IN	4	case	38927	38930	_	_	_	_	_
182	4	infants	infant	NNS	2	nmod	38931	38938	_	_	_	_	_
182	5	born	bear	VBN	1	acl	38939	38943	_	_	_	_	_
182	6	to	to	TO	7	case	38944	38946	_	_	_	_	_
182	7	mothers	mother	NNS	5	nmod	38947	38954	_	_	_	_	_
182	8	with	with	IN	12	case	38955	38959	_	_	_	_	_
182	9	chronic	chronic	JJ	12	amod	38960	38967	_	_	_	_	_
182	10	hepatitis	hepatitis	NN	12	compound	38968	38977	B-event-212302	_	_	_	_
182	11	B	b	NN	12	compound	38978	38979	I-event-212302	_	_	_	_
182	12	infection	infection	NN	7	nmod	38980	38989	B-event-212303	_	_	_	_
182	13	,	,	,	12	punct	38989	38990	_	_	_	_	_
182	14	post-vaccination	post-vaccination	JJ	16	amod	38991	39007	B-event-212304	B-content-25347:25348-Cue	_	_	_
182	15	serological	serological	JJ	16	amod	39008	39019	_	I-content-25347	_	_	_
182	16	testing	testing	NN	12	appos	39020	39027	B-event-212305	I-content-25347	_	_	_
182	17	is	be	VBZ	18	auxpass	39028	39030	_	_	_	_	_
182	18	recommended	recommend	VBN	0	ROOT	39031	39042	_	_	_	B-cue-25348	_
182	19	4	4	CD	21	compound	39043	39044	_	_	_	_	_
182	20	to	to	TO	21	dep	39045	39047	_	_	_	_	_
182	21	8	8	CD	22	nummod	39048	39049	_	_	_	_	_
182	22	weeks	week	NNS	18	nmod	39050	39055	_	_	_	_	_
182	23	after	after	IN	22	case	39056	39061	_	_	_	_	_
182	24	completion	completion	NN	22	dep	39062	39072	B-event-212306	_	_	_	_
182	25	of	of	IN	28	case	39073	39075	_	_	_	_	_
182	26	the	the	DT	28	det	39076	39079	_	_	_	_	_
182	27	primary	primary	JJ	28	amod	39080	39087	_	_	_	_	_
182	28	course	course	NN	24	nmod	39088	39094	_	_	_	_	_
182	29	for	for	IN	30	case	39095	39098	_	_	_	_	_
182	30	persons	person	NNS	28	nmod	39099	39106	_	_	_	_	_
182	31	in	in	IN	34	case	39107	39109	_	_	_	_	_
182	32	the	the	DT	34	det	39110	39113	_	_	_	_	_
182	33	following	follow	VBG	34	amod	39114	39123	_	_	_	_	_
182	34	categories	category	NNS	30	nmod	39124	39134	_	_	_	_	_
182	35	:	:	:	18	punct	39134	39135	_	_	_	_	_
182	36	For	for	IN	38	case	39136	39139	_	_	_	_	B-claim-10452
182	37	these	these	DT	38	det	39140	39145	_	_	_	_	I-claim-10452
182	38	individuals	individual	NNS	77	nmod	39146	39157	_	_	_	_	I-claim-10452
182	39	,	,	,	77	punct	39157	39158	_	_	_	_	I-claim-10452
182	40	if	if	IN	44	mark	39159	39161	_	_	_	_	I-claim-10452
182	41	adequate	adequate	JJ	43	amod	39162	39170	_	_	_	_	I-claim-10452
182	42	anti-HBs	anti-hbs	JJ	43	amod	39171	39179	_	_	_	_	I-claim-10452
182	43	levels	level	NNS	44	nsubj	39180	39186	_	_	_	_	I-claim-10452
182	44	(	(	VBP	77	advcl	39187	39188	_	_	_	_	I-claim-10452
182	45	≥	≥	CD	46	compound	39188	39189	_	_	_	_	I-claim-10452
182	46	10	10	CD	48	nummod	39189	39191	_	_	_	_	I-claim-10452
182	47	mIU/mL	miu/ml	NN	48	compound	39192	39198	_	_	_	_	I-claim-10452
182	48	)	)	NN	51	nsubjpass	39198	39199	_	_	_	_	I-claim-10452
182	49	are	be	VBP	51	auxpass	39200	39203	_	_	_	_	I-claim-10452
182	50	not	not	RB	51	neg	39204	39207	_	_	_	_	I-claim-10452
182	51	reached	reach	VBN	44	ccomp	39208	39215	B-event-212307	_	_	_	I-claim-10452
182	52	on	on	IN	54	case	39216	39218	_	_	_	_	I-claim-10452
182	53	serological	serological	JJ	54	amod	39219	39230	_	_	_	_	I-claim-10452
182	54	testing	testing	NN	51	nmod	39231	39238	B-event-212308	_	_	_	I-claim-10452
182	55	4	4	CD	57	compound	39239	39240	_	_	_	_	I-claim-10452
182	56	to	to	TO	57	dep	39241	39243	_	_	_	_	I-claim-10452
182	57	8	8	CD	58	nummod	39244	39245	_	_	_	_	I-claim-10452
182	58	weeks	week	NNS	51	nmod	39246	39251	_	_	_	_	I-claim-10452
182	59	after	after	IN	58	case	39252	39257	_	_	_	_	I-claim-10452
182	60	the	the	DT	62	det	39258	39261	_	_	_	_	I-claim-10452
182	61	3rd	3rd	JJ	62	amod	39262	39265	_	_	_	_	I-claim-10452
182	62	dose	dose	NN	58	dep	39266	39270	B-event-212309	_	_	_	I-claim-10452
182	63	,	,	,	77	punct	39270	39271	_	_	_	_	I-claim-10452
182	64	the	the	DT	65	det	39272	39275	_	_	_	_	I-claim-10452
182	65	possibility	possibility	NN	77	nsubjpass	39276	39287	_	_	_	_	I-claim-10452
182	66	of	of	IN	68	case	39288	39290	_	_	_	_	I-claim-10452
182	67	HBV	hbv	NN	68	compound	39291	39294	B-event-212310	_	_	_	I-claim-10452
182	68	infection	infection	NN	65	nmod	39295	39304	B-event-212311	_	_	_	I-claim-10452
182	69	,	,	,	65	punct	39304	39305	_	_	_	_	I-claim-10452
182	70	including	include	VBG	73	case	39306	39315	_	_	_	_	I-claim-10452
182	71	chronic	chronic	JJ	73	amod	39316	39323	_	_	_	_	I-claim-10452
182	72	HBV	hbv	NN	73	compound	39324	39327	B-event-212312	_	_	_	I-claim-10452
182	73	infection	infection	NN	65	nmod	39328	39337	B-event-212313	_	_	_	I-claim-10452
182	74	,	,	,	65	punct	39337	39338	_	_	_	_	I-claim-10452
182	75	should	should	MD	77	aux	39339	39345	_	_	_	_	I-claim-10452
182	76	be	be	VB	77	auxpass	39346	39348	_	_	_	_	I-claim-10452
182	77	investigated	investigate	VBN	18	parataxis	39349	39361	B-event-212314	_	_	_	I-claim-10452
182	78	by	by	IN	79	case	39362	39364	_	_	_	_	I-claim-10452
182	79	testing	testing	NN	77	nmod	39365	39372	B-event-212315	_	_	_	I-claim-10452
182	80	for	for	IN	82	case	39373	39376	_	_	_	_	I-claim-10452
182	81	serological	serological	JJ	82	amod	39377	39388	_	_	_	_	I-claim-10452
182	82	markers	marker	NNS	77	nmod	39389	39396	_	_	_	_	I-claim-10452
182	83	,	,	,	77	punct	39396	39397	_	_	_	_	I-claim-10452
182	84	including	include	VBG	85	case	39398	39407	_	_	_	_	I-claim-10452
182	85	HBsAg	hbsag	NN	77	nmod	39408	39413	_	_	_	_	I-claim-10452
182	86	and	and	CC	85	cc	39414	39417	_	_	_	_	I-claim-10452
182	87	anti-HBc	anti-hbc	JJ	88	amod	39418	39426	_	_	_	_	I-claim-10452
182	88	antibodies	antibody	NNS	85	conj	39427	39437	_	_	_	_	I-claim-10452
182	89	.	.	.	18	punct	39437	39438	_	_	_	_	_

183	1	In	in	IN	3	case	39439	39441	_	_	_	_	B-claim-10453
183	2	select	select	JJ	3	amod	39442	39448	_	_	_	_	I-claim-10453
183	3	cases	case	NNS	19	nmod	39449	39454	_	_	_	_	I-claim-10453
183	4	in	in	IN	5	case	39455	39457	_	_	_	_	I-claim-10453
183	5	which	which	WDT	10	nmod	39458	39463	_	_	_	_	I-claim-10453
183	6	hepatitis	hepatitis	NN	8	compound	39464	39473	B-event-212316	_	_	_	I-claim-10453
183	7	B	b	NN	8	compound	39474	39475	I-event-212316	_	_	_	I-claim-10453
183	8	infection	infection	NN	10	nsubjpass	39476	39485	B-event-212317	_	_	_	I-claim-10453
183	9	is	be	VBZ	10	auxpass	39486	39488	_	_	_	_	I-claim-10453
183	10	suspected	suspect	VBN	3	acl:relcl	39489	39498	B-event-212318	_	_	_	I-claim-10453
183	11	,	,	,	19	punct	39498	39499	_	_	_	_	I-claim-10453
183	12	HBV	hbv	NN	19	nsubjpass	39500	39503	_	_	_	_	I-claim-10453
183	13	nucleic	nucleic	JJ	15	amod	39504	39511	_	_	_	_	I-claim-10453
183	14	acid	acid	NN	15	compound	39512	39516	_	_	_	_	I-claim-10453
183	15	testing	testing	NN	12	dep	39517	39524	B-event-212319	_	_	_	I-claim-10453
183	16	may	may	MD	19	aux	39525	39528	_	_	_	_	I-claim-10453
183	17	also	also	RB	19	advmod	39529	39533	_	_	_	_	I-claim-10453
183	18	be	be	VB	19	auxpass	39534	39536	_	_	_	_	I-claim-10453
183	19	indicated	indicate	VBN	0	ROOT	39537	39546	_	_	_	_	I-claim-10453
183	20	,	,	,	19	punct	39546	39547	_	_	_	_	I-claim-10453
183	21	and	and	CC	19	cc	39548	39551	_	_	_	_	I-claim-10453
183	22	expert	expert	NN	23	compound	39552	39558	_	_	_	_	I-claim-10453
183	23	advice	advice	NN	29	nsubjpass	39559	39565	B-event-212320	_	_	_	I-claim-10453
183	24	regarding	regard	VBG	26	case	39566	39575	_	_	_	_	I-claim-10453
183	25	further	further	JJ	26	amod	39576	39583	_	_	_	_	I-claim-10453
183	26	management	management	NN	23	nmod	39584	39594	_	_	_	_	I-claim-10453
183	27	should	should	MD	29	aux	39595	39601	_	_	_	_	I-claim-10453
183	28	be	be	VB	29	auxpass	39602	39604	_	_	_	_	I-claim-10453
183	29	sought	seek	VBN	19	conj	39605	39611	B-event-212321	_	_	_	I-claim-10453
183	30	.	.	.	19	punct	39611	39612	_	_	_	_	_

184	1	If	if	IN	3	mark	39613	39615	_	_	_	_	B-claim-10454
184	2	there	there	EX	3	expl	39616	39621	_	_	_	_	I-claim-10454
184	3	are	be	VBP	14	advcl	39622	39625	_	_	_	_	I-claim-10454
184	4	no	no	DT	5	neg	39626	39628	_	_	_	_	I-claim-10454
184	5	markers	marker	NNS	3	nsubj	39629	39636	_	_	_	_	I-claim-10454
184	6	of	of	IN	8	case	39637	39639	_	_	_	_	I-claim-10454
184	7	HBV	hbv	NN	8	compound	39640	39643	B-event-212322	_	_	_	I-claim-10454
184	8	infection	infection	NN	5	nmod	39644	39653	B-event-212323	_	_	_	I-claim-10454
184	9	,	,	,	14	punct	39653	39654	_	_	_	_	I-claim-10454
184	10	the	the	DT	11	det	39655	39658	_	_	_	_	I-claim-10454
184	11	individual	individual	NN	14	nsubjpass	39659	39669	_	_	_	_	I-claim-10454
184	12	should	should	MD	14	aux	39670	39676	_	_	_	_	I-claim-10454
184	13	be	be	VB	14	auxpass	39677	39679	_	_	_	_	I-claim-10454
184	14	managed	manage	VBN	0	ROOT	39680	39687	_	_	_	_	I-claim-10454
184	15	as	as	IN	21	case	39688	39690	_	_	_	_	I-claim-10454
184	16	a	a	DT	21	det	39691	39692	_	_	_	_	I-claim-10454
184	17	non-responder	non-responder	JJ	21	amod	39693	39706	B-event-212324	_	_	_	I-claim-10454
184	18	to	to	TO	20	case	39707	39709	_	_	_	_	I-claim-10454
184	19	hepatitis	hepatitis	NN	20	compound	39710	39719	_	_	_	_	I-claim-10454
184	20	B	b	NN	17	nmod	39720	39721	_	_	_	_	I-claim-10454
184	21	vaccination	vaccination	NN	14	nmod	39722	39733	B-event-212325	_	_	_	I-claim-10454
184	22	(	(	CD	23	nsubj	39734	39735	_	_	_	_	_
184	23	refer	refer	VBP	21	acl:relcl	39735	39740	_	_	_	_	_
184	24	to	to	TO	25	mark	39741	39743	_	_	_	_	_
184	25	‘	‘	VB	23	xcomp	39744	39745	_	_	_	_	_
184	26	Non-responders	non-responder	NNS	25	dobj	39745	39759	_	_	_	_	_
184	27	to	to	TO	30	case	39760	39762	_	_	_	_	_
184	28	primary	primary	JJ	30	amod	39763	39770	_	_	_	_	_
184	29	vaccination	vaccination	NN	30	compound	39771	39782	_	_	_	_	_
184	30	’	’	NN	25	nmod	39782	39783	_	_	_	_	_
184	31	below	below	IN	32	case	39784	39789	_	_	_	_	_
184	32	)	)	NN	25	nmod	39789	39790	_	_	_	_	_
184	33	.	.	.	14	punct	39790	39791	_	_	_	_	_

185	1	If	if	IN	16	mark	39792	39794	_	_	_	_	B-claim-10455
185	2	persons	person	NNS	16	nsubj	39795	39802	_	_	_	_	I-claim-10455
185	3	who	who	WP	7	nsubj	39803	39806	_	_	_	_	I-claim-10455
185	4	are	be	VBP	7	cop	39807	39810	_	_	_	_	I-claim-10455
185	5	at	at	IN	7	case	39811	39813	_	_	_	_	I-claim-10455
185	6	significant	significant	JJ	7	amod	39814	39825	_	_	_	_	I-claim-10455
185	7	risk	risk	NN	2	acl:relcl	39826	39830	B-event-212326	_	_	_	I-claim-10455
185	8	of	of	IN	10	case	39831	39833	_	_	_	_	I-claim-10455
185	9	hepatitis	hepatitis	NN	10	compound	39834	39843	B-event-212327	_	_	_	I-claim-10455
185	10	B	b	NN	7	nmod	39844	39845	I-event-212327	_	_	_	I-claim-10455
185	11	(	(	CD	10	nummod	39846	39847	_	_	_	_	I-claim-10455
185	12	such	such	JJ	15	case	39847	39851	_	_	_	_	I-claim-10455
185	13	as	as	IN	12	mwe	39852	39854	_	_	_	_	I-claim-10455
185	14	healthcare	healthcare	NN	15	compound	39855	39865	_	_	_	_	I-claim-10455
185	15	workers	worker	NNS	7	nmod	39866	39873	_	_	_	_	I-claim-10455
185	16	)	)	VBP	38	advcl	39873	39874	_	_	_	_	I-claim-10455
185	17	were	be	VBD	19	auxpass	39875	39879	_	_	_	_	I-claim-10455
185	18	not	not	RB	19	neg	39880	39883	_	_	_	_	I-claim-10455
185	19	tested	test	VBN	16	ccomp	39884	39890	B-event-212328	_	_	_	I-claim-10455
185	20	for	for	IN	21	case	39891	39894	_	_	_	_	I-claim-10455
185	21	anti-HBs	anti-hb	NNS	19	nmod	39895	39903	_	_	_	_	I-claim-10455
185	22	within	within	IN	26	case	39904	39910	_	_	_	_	I-claim-10455
185	23	4	4	CD	25	compound	39911	39912	_	_	_	_	I-claim-10455
185	24	to	to	TO	25	dep	39913	39915	_	_	_	_	I-claim-10455
185	25	8	8	CD	26	nummod	39916	39917	_	_	_	_	I-claim-10455
185	26	weeks	week	NNS	21	nmod	39918	39923	_	_	_	_	I-claim-10455
185	27	after	after	IN	28	case	39924	39929	_	_	_	_	I-claim-10455
185	28	completion	completion	NN	19	nmod	39930	39940	B-event-212329	_	_	_	I-claim-10455
185	29	of	of	IN	33	case	39941	39943	_	_	_	_	I-claim-10455
185	30	the	the	DT	33	det	39944	39947	_	_	_	_	I-claim-10455
185	31	documented	document	VBN	33	amod	39948	39958	B-event-212330	_	_	_	I-claim-10455
185	32	primary	primary	JJ	33	amod	39959	39966	_	_	_	_	I-claim-10455
185	33	course	course	NN	28	nmod	39967	39973	_	_	_	_	I-claim-10455
185	34	,	,	,	38	punct	39973	39974	_	_	_	_	I-claim-10455
185	35	they	they	PRP	38	nsubj	39975	39979	_	_	_	_	I-claim-10455
185	36	should	should	MD	38	aux	39980	39986	_	_	_	_	I-claim-10455
185	37	still	still	RB	38	advmod	39987	39992	_	_	_	_	I-claim-10455
185	38	undergo	undergo	VB	0	ROOT	39993	40000	_	_	_	_	I-claim-10455
185	39	serological	serological	JJ	40	amod	40001	40012	_	_	_	_	I-claim-10455
185	40	testing	testing	NN	38	dobj	40013	40020	B-event-212331	_	_	_	I-claim-10455
185	41	to	to	TO	42	mark	40021	40023	_	_	_	_	I-claim-10455
185	42	ensure	ensure	VB	38	advcl	40024	40030	_	_	_	_	I-claim-10455
185	43	immunity	immunity	NN	42	dobj	40031	40039	B-event-212332	_	_	_	I-claim-10455
185	44	.	.	.	38	punct	40039	40040	_	_	_	_	_

186	1	If	if	IN	7	mark	40041	40043	_	_	_	_	_
186	2	,	,	,	7	punct	40043	40044	_	_	_	_	_
186	3	on	on	IN	4	case	40045	40047	_	_	_	_	_
186	4	testing	testing	NN	7	nmod	40048	40055	B-event-212333	_	_	_	_
186	5	,	,	,	7	punct	40055	40056	_	_	_	_	_
186	6	they	they	PRP	7	nsubj	40057	40061	_	_	_	_	_
186	7	have	have	VBP	19	advcl	40062	40066	_	_	_	_	_
186	8	an	a	DT	10	det	40067	40069	_	_	_	_	_
186	9	anti-HBs	anti-hbs	JJ	10	amod	40070	40078	_	_	_	_	_
186	10	level	level	NN	7	dobj	40079	40084	_	_	_	_	_
186	11	of	of	IN	12	case	40085	40087	_	_	_	_	_
186	12	<	<	JJR	10	nmod	40088	40089	_	_	_	_	_
186	13	10	10	CD	14	nummod	40089	40091	_	_	_	_	_
186	14	mIU/mL	miu/ml	NN	12	dep	40092	40098	_	_	_	_	_
186	15	,	,	,	19	punct	40098	40099	_	_	_	_	_
186	16	they	they	PRP	19	nsubjpass	40100	40104	_	_	_	_	_
186	17	should	should	MD	19	aux	40105	40111	_	_	_	_	_
186	18	be	be	VB	19	auxpass	40112	40114	_	_	_	_	_
186	19	given	give	VBN	0	ROOT	40115	40120	_	_	_	_	_
186	20	a	a	DT	24	det	40121	40122	_	_	_	_	_
186	21	single	single	JJ	24	amod	40123	40129	_	_	_	_	_
186	22	booster	booster	NN	24	compound	40130	40137	_	_	_	_	_
186	23	dose	dose	NN	24	compound	40138	40142	_	_	_	_	_
186	24	(	(	NN	19	iobj	40143	40144	_	_	_	_	_
186	25	4th	4th	JJ	27	amod	40144	40147	_	_	_	_	_
186	26	dose	dose	NN	27	compound	40148	40152	_	_	_	_	_
186	27	)	)	NN	19	dobj	40152	40153	_	_	_	_	_
186	28	of	of	IN	29	case	40154	40156	_	_	_	_	_
186	29	vaccine	vaccine	NN	27	nmod	40157	40164	B-event-212334	_	_	_	_
186	30	.	.	.	19	punct	40164	40165	_	_	_	_	_

187	1	Persons	person	NNS	11	nsubj	40166	40173	_	_	_	_	B-claim-10456
187	2	with	with	IN	4	case	40174	40178	_	_	_	_	I-claim-10456
187	3	immune	immune	JJ	4	amod	40179	40185	_	_	_	_	I-claim-10456
187	4	memory	memory	NN	1	nmod	40186	40192	_	_	_	_	I-claim-10456
187	5	established	establish	VBN	4	acl	40193	40204	_	_	_	_	I-claim-10456
187	6	from	from	IN	9	case	40205	40209	_	_	_	_	I-claim-10456
187	7	effective	effective	JJ	9	amod	40210	40219	_	_	_	_	I-claim-10456
187	8	prior	prior	JJ	9	amod	40220	40225	_	_	_	_	I-claim-10456
187	9	vaccination	vaccination	NN	5	nmod	40226	40237	B-event-212335	_	_	_	I-claim-10456
187	10	should	should	MD	11	aux	40238	40244	_	_	_	_	I-claim-10456
187	11	respond	respond	VB	0	ROOT	40245	40252	B-event-212336	_	_	_	I-claim-10456
187	12	to	to	TO	15	case	40253	40255	_	_	_	_	I-claim-10456
187	13	this	this	DT	15	det	40256	40260	_	_	_	_	I-claim-10456
187	14	booster	booster	NN	15	compound	40261	40268	_	_	_	_	I-claim-10456
187	15	dose	dose	NN	11	nmod	40269	40273	B-event-212337	_	_	_	I-claim-10456
187	16	.	.	.	11	punct	40273	40274	_	_	_	_	_

188	1	Anti-HBs	anti-hb	NNS	4	nsubjpass	40275	40283	_	_	_	_	B-claim-10457
188	2	should	should	MD	4	aux	40284	40290	_	_	_	_	I-claim-10457
188	3	be	be	VB	4	auxpass	40291	40293	_	_	_	_	I-claim-10457
188	4	checked	check	VBN	0	ROOT	40294	40301	B-event-212338	_	_	_	I-claim-10457
188	5	4	4	CD	6	nummod	40302	40303	_	_	_	_	I-claim-10457
188	6	weeks	week	NNS	4	nmod:tmod	40304	40309	_	_	_	_	I-claim-10457
188	7	later	later	RB	6	advmod	40310	40315	_	_	_	_	I-claim-10457
188	8	,	,	,	4	punct	40315	40316	_	_	_	_	I-claim-10457
188	9	and	and	CC	4	cc	40317	40320	_	_	_	_	I-claim-10457
188	10	if	if	IN	14	mark	40321	40323	_	_	_	_	I-claim-10457
188	11	the	the	DT	13	det	40324	40327	_	_	_	_	I-claim-10457
188	12	anti-HBs	anti-hbs	JJ	13	amod	40328	40336	_	_	_	_	I-claim-10457
188	13	level	level	NN	14	nsubj	40337	40342	_	_	_	_	I-claim-10457
188	14	remains	remain	VBZ	26	advcl	40343	40350	_	_	_	_	I-claim-10457
188	15	<	<	JJR	14	xcomp	40351	40352	_	_	_	_	I-claim-10457
188	16	10	10	CD	17	nummod	40352	40354	_	_	_	_	I-claim-10457
188	17	mIU/mL	miu/ml	NN	26	nsubjpass	40355	40361	_	_	_	_	I-claim-10457
188	18	,	,	,	17	punct	40361	40362	_	_	_	_	I-claim-10457
188	19	the	the	DT	20	det	40363	40366	_	_	_	_	I-claim-10457
188	20	possibility	possibility	NN	17	appos	40367	40378	_	_	_	_	I-claim-10457
188	21	of	of	IN	23	case	40379	40381	_	_	_	_	I-claim-10457
188	22	HBV	hbv	NN	23	compound	40382	40385	B-event-212339	_	_	_	I-claim-10457
188	23	infection	infection	NN	20	nmod	40386	40395	B-event-212340	_	_	_	I-claim-10457
188	24	should	should	MD	26	aux	40396	40402	_	_	_	_	I-claim-10457
188	25	be	be	VB	26	auxpass	40403	40405	_	_	_	_	I-claim-10457
188	26	investigated	investigate	VBN	4	conj	40406	40418	B-event-212341	_	_	_	I-claim-10457
188	27	(	(	NN	26	dobj	40419	40420	_	_	_	_	_
188	28	and	and	CC	26	cc	40420	40423	_	_	_	_	_
188	29	,	,	,	37	punct	40423	40424	_	_	_	_	_
188	30	if	if	IN	37	mark	40425	40427	_	_	_	_	B-claim-10458
188	31	excluded	exclude	VBN	37	advcl	40428	40436	B-event-212342	_	_	_	I-claim-10458
188	32	,	,	,	37	punct	40436	40437	_	_	_	_	I-claim-10458
188	33	the	the	DT	34	det	40438	40441	_	_	_	_	I-claim-10458
188	34	person	person	NN	37	nsubjpass	40442	40448	_	_	_	_	I-claim-10458
188	35	should	should	MD	37	aux	40449	40455	_	_	_	_	I-claim-10458
188	36	be	be	VB	37	auxpass	40456	40458	_	_	_	_	I-claim-10458
188	37	managed	manage	VBN	26	parataxis	40459	40466	_	_	_	_	I-claim-10458
188	38	as	as	IN	40	case	40467	40469	_	_	_	_	I-claim-10458
188	39	a	a	DT	40	det	40470	40471	_	_	_	_	I-claim-10458
188	40	non-responder	non-responder	JJ	37	nmod	40472	40485	B-event-212343	_	_	_	I-claim-10458
188	41	to	to	TO	42	case	40486	40488	_	_	_	_	I-claim-10458
188	42	vaccination	vaccination	NN	37	nmod	40489	40500	B-event-212344	_	_	_	I-claim-10458
188	43	,	,	,	37	punct	40500	40501	_	_	_	_	_
188	44	refer	refer	VBP	26	conj	40502	40507	_	_	_	_	_
188	45	to	to	TO	47	case	40508	40510	_	_	_	_	_
188	46	below	below	IN	47	amod	40511	40516	_	_	_	_	_
188	47	)	)	NN	44	nmod	40516	40517	_	_	_	_	_
188	48	.	.	.	4	punct	40517	40518	_	_	_	_	_

189	1	If	if	IN	8	mark	40519	40521	_	_	_	_	_
189	2	the	the	DT	4	det	40522	40525	_	_	_	_	_
189	3	anti-HBs	anti-hbs	JJ	4	amod	40526	40534	_	_	_	_	_
189	4	level	level	NN	8	nsubj	40535	40540	_	_	_	_	_
189	5	is	be	VBZ	8	cop	40541	40543	_	_	_	_	_
189	6	≥	≥	CD	7	compound	40544	40545	_	_	_	_	_
189	7	10	10	CD	8	nummod	40545	40547	_	_	_	_	_
189	8	mIU/mL	miu/ml	NN	14	advcl	40548	40554	_	_	_	_	_
189	9	,	,	,	14	punct	40554	40555	_	_	_	_	_
189	10	the	the	DT	11	det	40556	40559	_	_	_	_	_
189	11	person	person	NN	14	nsubjpass	40560	40566	_	_	_	_	_
189	12	can	can	MD	14	aux	40567	40570	_	_	_	_	_
189	13	be	be	VB	14	auxpass	40571	40573	_	_	_	_	_
189	14	regarded	regard	VBN	0	ROOT	40574	40582	_	_	_	_	_
189	15	as	as	IN	16	case	40583	40585	_	_	_	_	_
189	16	immune	immune	JJ	14	advcl	40586	40592	B-event-212345	_	_	_	_
189	17	.	.	.	14	punct	40592	40593	_	_	_	_	_

190	1	Non-responders	non-responder	NNS	9	nsubj	40594	40608	B-event-212346	_	_	_	_
190	2	to	to	TO	4	case	40609	40611	_	_	_	_	_
190	3	primary	primary	JJ	4	amod	40612	40619	_	_	_	_	_
190	4	vaccination	vaccination	NN	1	nmod	40620	40631	B-event-212347	_	_	_	_
190	5	A	a	DT	6	det	40632	40633	_	_	_	_	_
190	6	non-responder	non-responder	JJ	1	nmod:tmod	40634	40647	B-event-212348	_	_	_	_
190	7	is	be	VBZ	9	cop	40648	40650	_	_	_	_	_
190	8	a	a	DT	9	det	40651	40652	_	_	_	_	_
190	9	person	person	NN	0	ROOT	40653	40659	_	_	_	_	_
190	10	without	without	IN	12	case	40660	40667	_	_	_	_	_
190	11	HBV	hbv	NN	12	compound	40668	40671	B-event-212349	_	_	_	_
190	12	infection	infection	NN	9	nmod	40672	40681	B-event-212350	_	_	_	_
190	13	who	who	WP	14	nsubj	40682	40685	_	_	_	_	_
190	14	has	have	VBZ	12	acl:relcl	40686	40689	_	_	_	_	_
190	15	a	a	DT	17	det	40690	40691	_	_	_	_	_
190	16	documented	documented	JJ	17	amod	40692	40702	B-event-212351	_	_	_	_
190	17	history	history	NN	14	dobj	40703	40710	_	_	_	_	_
190	18	of	of	IN	22	case	40711	40713	_	_	_	_	_
190	19	an	a	DT	22	det	40714	40716	_	_	_	_	_
190	20	age-appropriate	age-appropriate	JJ	22	amod	40717	40732	_	_	_	_	_
190	21	primary	primary	JJ	22	amod	40733	40740	_	_	_	_	_
190	22	course	course	NN	17	nmod	40741	40747	_	_	_	_	_
190	23	of	of	IN	26	case	40748	40750	_	_	_	_	_
190	24	hepatitis	hepatitis	NN	26	compound	40751	40760	_	_	_	_	_
190	25	B	b	NN	26	compound	40761	40762	_	_	_	_	_
190	26	vaccine	vaccine	NN	22	nmod	40763	40770	B-event-212352	_	_	_	_
190	27	,	,	,	12	punct	40770	40771	_	_	_	_	_
190	28	but	but	CC	12	cc	40772	40775	_	_	_	_	_
190	29	with	with	IN	33	case	40776	40780	_	_	_	_	_
190	30	a	a	DT	33	det	40781	40782	_	_	_	_	_
190	31	current	current	JJ	33	amod	40783	40790	_	_	_	_	_
190	32	anti-HBs	anti-hbs	JJ	33	amod	40791	40799	_	_	_	_	_
190	33	level	level	NN	12	conj	40800	40805	_	_	_	_	_
190	34	<	<	JJR	33	dep	40806	40807	_	_	_	_	_
190	35	10	10	CD	36	nummod	40807	40809	_	_	_	_	_
190	36	mIU/mL	miu/ml	NN	34	dep	40810	40816	_	_	_	_	_
190	37	.	.	.	9	punct	40816	40817	_	_	_	_	_

191	1	There	there	EX	2	expl	40818	40823	_	_	_	_	_
191	2	are	be	VBP	0	ROOT	40824	40827	_	_	_	_	_
191	3	a	a	DT	4	det	40828	40829	_	_	_	_	_
191	4	number	number	NN	2	nsubj	40830	40836	_	_	_	_	_
191	5	of	of	IN	7	case	40837	40839	_	_	_	_	_
191	6	potential	potential	JJ	7	amod	40840	40849	_	_	_	_	_
191	7	options	option	NNS	4	nmod	40850	40857	_	_	_	_	_
191	8	for	for	IN	9	case	40858	40861	_	_	_	_	_
191	9	non-responders	non-responder	NNS	7	nmod	40862	40876	B-event-212353	_	_	_	_
191	10	.	.	.	2	punct	40876	40877	_	_	_	_	_

192	1	Persons	person	NNS	24	nsubjpass	40878	40885	_	_	_	_	_
192	2	who	who	WP	5	nsubj	40886	40889	_	_	_	_	_
192	3	do	do	VBP	5	aux	40890	40892	_	_	_	_	_
192	4	not	not	RB	5	neg	40893	40896	_	_	_	_	_
192	5	respond	respond	VB	1	acl:relcl	40897	40904	B-event-212354	_	_	_	_
192	6	to	to	TO	10	case	40905	40907	_	_	_	_	_
192	7	the	the	DT	10	det	40908	40911	_	_	_	_	_
192	8	primary	primary	JJ	10	amod	40912	40919	_	_	_	_	_
192	9	vaccination	vaccination	NN	10	compound	40920	40931	B-event-212355	_	_	_	_
192	10	course	course	NN	5	nmod	40932	40938	_	_	_	_	_
192	11	,	,	,	10	punct	40938	40939	_	_	_	_	_
192	12	and	and	CC	10	cc	40940	40943	_	_	_	_	_
192	13	in	in	IN	20	mark	40944	40946	_	_	_	_	_
192	14	whom	whom	WP	20	dobj	40947	40951	_	_	_	_	_
192	15	chronic	chronic	JJ	17	amod	40952	40959	_	_	_	_	_
192	16	HBV	hbv	NN	17	compound	40960	40963	B-event-212356	_	_	_	_
192	17	infection	infection	NN	20	nsubjpass	40964	40973	B-event-212357	_	_	_	_
192	18	has	have	VBZ	20	aux	40974	40977	_	_	_	_	_
192	19	been	be	VBN	20	auxpass	40978	40982	_	_	_	_	_
192	20	excluded	exclude	VBN	10	conj	40983	40991	B-event-212358	_	_	_	_
192	21	,	,	,	24	punct	40991	40992	_	_	_	_	_
192	22	should	should	MD	24	aux	40993	40999	_	_	_	_	_
192	23	be	be	VB	24	auxpass	41000	41002	_	_	_	_	_
192	24	offered	offer	VBN	0	ROOT	41003	41010	B-event-212359	_	_	_	_
192	25	further	further	JJ	26	amod	41011	41018	_	_	_	_	_
192	26	doses	dose	NNS	24	dobj	41019	41024	B-event-212360	_	_	_	_
192	27	.	.	.	24	punct	41024	41025	_	_	_	_	_

193	1	As	as	IN	2	mark	41027	41029	_	_	_	_	_
193	2	discussed	discuss	VBN	27	advcl	41030	41039	_	_	_	_	_
193	3	above	above	IN	2	nmod	41040	41045	_	_	_	_	_
193	4	,	,	,	2	punct	41045	41046	_	_	_	_	_
193	5	in	in	IN	8	case	41047	41049	_	_	_	_	_
193	6	‘	‘	CD	8	nummod	41050	41051	_	_	_	_	_
193	7	Serological	serological	JJ	8	amod	41051	41062	_	_	_	_	_
193	8	testing	testing	NN	2	nmod	41063	41070	_	_	_	_	_
193	9	following	follow	VBG	13	case	41071	41080	_	_	_	_	_
193	10	hepatitis	hepatitis	NN	13	compound	41081	41090	_	_	_	_	_
193	11	B	b	NN	13	compound	41091	41092	_	_	_	_	_
193	12	vaccination	vaccination	NN	13	compound	41093	41104	_	_	_	_	_
193	13	’	’	NN	8	nmod	41104	41105	_	_	_	_	_
193	14	,	,	,	27	punct	41105	41106	_	_	_	_	_
193	15	a	a	DT	22	det	41107	41108	_	_	_	_	_
193	16	single	single	JJ	22	amod	41109	41115	_	_	_	_	_
193	17	booster	booster	NN	22	compound	41116	41123	_	_	_	_	_
193	18	dose	dose	NN	22	compound	41124	41128	_	_	_	_	_
193	19	(	(	NN	22	compound	41129	41130	_	_	_	_	_
193	20	4th	4th	JJ	22	amod	41130	41133	_	_	_	_	_
193	21	dose	dose	NN	22	compound	41134	41138	_	_	_	_	_
193	22	)	)	NN	27	nsubjpass	41138	41139	_	_	_	_	_
193	23	of	of	IN	24	case	41140	41142	_	_	_	_	_
193	24	vaccine	vaccine	NN	22	nmod	41143	41150	B-event-212361	_	_	_	_
193	25	can	can	MD	27	aux	41151	41154	_	_	_	_	_
193	26	be	be	VB	27	auxpass	41155	41157	_	_	_	_	_
193	27	given	give	VBN	0	ROOT	41158	41163	_	_	_	_	_
193	28	to	to	TO	29	mark	41164	41166	_	_	_	_	_
193	29	confirm	confirm	VB	27	xcomp	41167	41174	B-event-212363	_	_	_	_
193	30	non-responder	non-responder	JJ	31	amod	41175	41188	B-event-212362	_	_	_	_
193	31	status	status	NN	29	dobj	41189	41195	_	_	_	_	_
193	32	.	.	.	27	punct	41195	41196	_	_	_	_	_

194	1	Persons	person	NNS	22	nsubj	41197	41204	_	_	_	_	_
194	2	who	who	WP	4	nsubj	41205	41208	_	_	_	_	_
194	3	are	be	VBP	4	cop	41209	41212	_	_	_	_	_
194	4	non-responders	non-responder	NNS	1	acl:relcl	41213	41227	B-event-212364	_	_	_	_
194	5	after	after	IN	7	mark	41228	41233	_	_	_	_	_
194	6	being	be	VBG	7	auxpass	41234	41239	_	_	_	_	_
194	7	given	give	VBN	4	dep	41240	41245	_	_	_	_	_
194	8	the	the	DT	11	det	41246	41249	_	_	_	_	_
194	9	booster/4th	booster/4th	NN	11	compound	41250	41261	_	_	_	_	_
194	10	dose	dose	NN	11	compound	41262	41266	B-event-212365	_	_	_	_
194	11	(	(	NN	7	dobj	41267	41268	_	_	_	_	_
194	12	and	and	CC	7	cc	41268	41271	_	_	_	_	_
194	13	in	in	IN	19	mark	41272	41274	_	_	_	_	_
194	14	whom	whom	WP	19	dobj	41275	41279	_	_	_	_	_
194	15	HBV	hbv	NN	16	compound	41280	41283	B-event-212366	_	_	_	_
194	16	infection	infection	NN	19	nsubjpass	41284	41293	B-event-212367	_	_	_	_
194	17	has	have	VBZ	19	aux	41294	41297	_	_	_	_	_
194	18	been	be	VBN	19	auxpass	41298	41302	_	_	_	_	_
194	19	excluded	exclude	VBN	7	conj	41303	41311	B-event-212368	_	_	_	_
194	20	)	)	NN	19	dobj	41311	41312	_	_	_	_	_
194	21	should	should	MD	22	aux	41313	41319	_	_	_	_	_
194	22	have	have	VB	0	ROOT	41320	41324	_	_	_	_	_
194	23	2	2	CD	25	nummod	41325	41326	_	_	_	_	_
194	24	further	further	JJ	25	amod	41327	41334	_	_	_	_	_
194	25	doses	dose	NNS	22	dobj	41335	41340	_	_	_	_	_
194	26	of	of	IN	29	case	41341	41343	_	_	_	_	_
194	27	hepatitis	hepatitis	NN	29	compound	41344	41353	_	_	_	_	_
194	28	B	b	NN	29	compound	41354	41355	_	_	_	_	_
194	29	vaccine	vaccine	NN	25	nmod	41356	41363	B-event-212369	_	_	_	_
194	30	at	at	IN	32	case	41364	41366	_	_	_	_	_
194	31	monthly	monthly	JJ	32	amod	41367	41374	_	_	_	_	_
194	32	intervals	interval	NNS	29	nmod	41375	41384	_	_	_	_	_
194	33	,	,	,	22	punct	41384	41385	_	_	_	_	_
194	34	and	and	CC	22	cc	41386	41389	_	_	_	_	_
194	35	be	be	VB	36	auxpass	41390	41392	_	_	_	_	_
194	36	re-tested	re-test	VBN	22	conj	41393	41402	B-event-212370	_	_	_	_
194	37	for	for	IN	39	case	41403	41406	_	_	_	_	_
194	38	anti-HBs	anti-hbs	JJ	39	amod	41407	41415	_	_	_	_	_
194	39	levels	level	NNS	36	nmod	41416	41422	_	_	_	_	_
194	40	at	at	IN	41	case	41423	41425	_	_	_	_	_
194	41	least	least	JJS	42	nmod:npmod	41426	41431	_	_	_	_	_
194	42	4	4	CD	43	nummod	41432	41433	_	_	_	_	_
194	43	weeks	week	NNS	36	nmod	41434	41439	_	_	_	_	_
194	44	after	after	IN	43	case	41440	41445	_	_	_	_	_
194	45	the	the	DT	47	det	41446	41449	_	_	_	_	_
194	46	last	last	JJ	47	amod	41450	41454	_	_	_	_	_
194	47	dose	dose	NN	43	dep	41455	41459	B-event-212371	_	_	_	_
194	48	.	.	.	22	punct	41459	41460	_	_	_	_	_

195	1	The	the	DT	3	det	41461	41464	_	_	_	_	_
195	2	booster/4th	booster/4th	NN	3	compound	41465	41476	_	_	_	_	_
195	3	dose	dose	NN	9	nsubjpass	41477	41481	B-event-212372	_	_	_	_
195	4	that	that	WDT	6	nsubjpass	41482	41486	_	_	_	_	_
195	5	was	be	VBD	6	auxpass	41487	41490	_	_	_	_	_
195	6	received	receive	VBN	3	acl:relcl	41491	41499	_	_	_	_	_
195	7	could	could	MD	9	aux	41500	41505	_	_	_	_	_
195	8	be	be	VB	9	auxpass	41506	41508	_	_	_	_	_
195	9	counted	count	VBN	0	ROOT	41509	41516	B-event-212373	_	_	_	_
195	10	as	as	IN	12	case	41517	41519	_	_	_	_	_
195	11	the	the	DT	12	det	41520	41523	_	_	_	_	_
195	12	1st	1st	CD	9	nmod	41524	41527	_	_	_	_	_
195	13	of	of	IN	17	case	41528	41530	_	_	_	_	_
195	14	the	the	DT	17	det	41531	41534	_	_	_	_	_
195	15	3	3	CD	17	nummod	41535	41536	_	_	_	_	_
195	16	repeat	repeat	NN	17	compound	41537	41543	_	_	_	_	_
195	17	doses	dose	NNS	12	nmod	41544	41549	B-event-212374	_	_	_	_
195	18	,	,	,	9	punct	41549	41550	_	_	_	_	_
195	19	as	as	IN	20	mark	41551	41553	_	_	_	_	_
195	20	recommended	recommend	VBN	9	advcl	41554	41565	B-event-212375	_	_	_	_
195	21	for	for	IN	22	case	41566	41569	_	_	_	_	_
195	22	non-responders	non-responder	NNS	20	nmod	41570	41584	B-event-212376	_	_	_	_
195	23	.	.	.	9	punct	41584	41585	_	_	_	_	_

196	1	A	a	DT	4	det	41586	41587	_	_	B-source-25349	_	_
196	2	few	few	JJ	4	amod	41588	41591	_	_	I-source-25349	_	_
196	3	small	small	JJ	4	amod	41592	41597	_	_	I-source-25349	_	_
196	4	studies	study	NNS	6	nsubj	41598	41605	B-event-212377	_	I-source-25349	_	_
196	5	have	have	VBP	6	aux	41606	41610	_	_	_	_	_
196	6	reported	report	VBN	0	ROOT	41611	41619	_	_	_	B-cue-25350	_
196	7	attainment	attainment	NN	6	dobj	41620	41630	_	B-content-25351:25349-Source_25350-Cue	_	_	_
196	8	of	of	IN	9	case	41631	41633	_	I-content-25351	_	_	_
196	9	seroprotection	seroprotection	NN	7	nmod	41634	41648	_	I-content-25351	_	_	_
196	10	in	in	IN	11	case	41649	41651	_	I-content-25351	_	_	_
196	11	non-responders	non-responder	NNS	6	nmod	41652	41666	B-event-212378	I-content-25351	_	_	_
196	12	with	with	IN	14	case	41667	41671	_	I-content-25351	_	_	_
196	13	high-dose	high-dose	JJ	14	amod	41672	41681	_	I-content-25351	_	_	_
196	14	formulations	formulation	NNS	11	nmod	41682	41694	_	I-content-25351	_	_	_
196	15	or	or	CC	11	cc	41695	41697	_	I-content-25351	_	_	_
196	16	double-dose	double-dose	JJ	17	amod	41698	41709	_	I-content-25351	_	_	_
196	17	administration	administration	NN	11	conj	41710	41724	B-event-212379	I-content-25351	_	_	_
196	18	for	for	IN	25	case	41725	41728	_	I-content-25351	_	_	_
196	19	a	a	DT	25	det	41729	41730	_	I-content-25351	_	_	_
196	20	4th	4th	JJ	25	amod	41731	41734	_	I-content-25351	_	_	_
196	21	,	,	,	20	punct	41734	41735	_	I-content-25351	_	_	_
196	22	or	or	CC	20	cc	41736	41738	_	I-content-25351	_	_	_
196	23	subsequent	subsequent	JJ	20	conj	41739	41749	_	I-content-25351	_	_	_
196	24	,	,	,	20	punct	41749	41750	_	I-content-25351	_	_	_
196	25	dose	dose	NN	17	nmod	41751	41755	_	I-content-25351	_	_	_
196	26	of	of	IN	29	case	41756	41758	_	I-content-25351	_	_	_
196	27	hepatitis	hepatitis	NN	29	compound	41759	41768	_	I-content-25351	_	_	_
196	28	B	b	NN	29	compound	41769	41770	_	I-content-25351	_	_	_
196	29	vaccination	vaccination	NN	25	nmod	41771	41782	B-event-212380	I-content-25351	_	_	_
196	30	,	,	,	6	punct	41782	41783	_	_	_	_	_
196	31	but	but	CC	6	cc	41784	41787	_	_	_	_	_
196	32	there	there	EX	33	expl	41788	41793	_	_	_	_	_
196	33	is	be	VBZ	6	conj	41794	41796	_	_	_	_	_
196	34	no	no	DT	36	neg	41797	41799	_	_	_	_	_
196	35	consistent	consistent	JJ	36	amod	41800	41810	_	_	_	_	_
196	36	evidence	evidence	NN	33	nsubj	41811	41819	_	_	_	_	_
196	37	to	to	TO	38	mark	41820	41822	_	_	_	_	_
196	38	suggest	suggest	VB	36	acl	41823	41830	_	_	_	_	_
196	39	that	that	IN	46	mark	41831	41835	_	_	_	_	_
196	40	a	a	DT	42	det	41836	41837	_	_	_	_	_
196	41	higher	higher	JJR	42	amod	41838	41844	_	_	_	_	_
196	42	proportion	proportion	NN	46	nsubj	41845	41855	_	_	_	_	_
196	43	of	of	IN	44	case	41856	41858	_	_	_	_	_
196	44	subjects	subject	NNS	42	nmod	41859	41867	_	_	_	_	_
196	45	would	would	MD	46	aux	41868	41873	_	_	_	_	_
196	46	respond	respond	VB	38	ccomp	41874	41881	B-event-212381	_	_	_	_
196	47	with	with	IN	50	case	41882	41886	_	_	_	_	_
196	48	these	these	DT	50	det	41887	41892	_	_	_	_	_
196	49	higher-dose	higher-dose	JJ	50	amod	41893	41904	_	_	_	_	_
196	50	regimens.82-84	regimens.82-84	NN	46	nmod	41905	41919	_	_	_	_	_
196	51	For	for	IN	33	dep	41920	41923	_	_	_	_	_
196	52	HBsAg-negative	hbsag-negative	JJ	54	amod	41924	41938	_	_	_	_	_
196	53	healthcare	healthcare	NN	54	compound	41939	41949	_	_	_	_	_
196	54	workers	worker	NNS	70	nsubj	41950	41957	_	_	_	_	_
196	55	who	who	WP	57	nsubj	41958	41961	_	_	_	_	_
196	56	are	be	VBP	57	cop	41962	41965	_	_	_	_	_
196	57	non-responders	non-responder	NNS	54	acl:relcl	41966	41980	B-event-212382	_	_	_	_
196	58	to	to	TO	61	case	41981	41983	_	_	_	_	_
196	59	a	a	DT	61	det	41984	41985	_	_	_	_	_
196	60	primary	primary	JJ	61	amod	41986	41993	_	_	_	_	_
196	61	course	course	NN	57	nmod	41994	42000	_	_	_	_	_
196	62	of	of	IN	63	case	42001	42003	_	_	_	_	_
196	63	vaccination	vaccination	NN	61	nmod	42004	42015	B-event-212383	_	_	_	_
196	64	and	and	CC	61	cc	42016	42019	_	_	_	_	_
196	65	to	to	TO	69	case	42020	42022	_	_	_	_	_
196	66	subsequent	subsequent	JJ	69	amod	42023	42033	_	_	_	_	_
196	67	additional	additional	JJ	69	amod	42034	42044	_	_	_	_	_
196	68	IM	im	NN	69	compound	42045	42047	_	_	_	_	_
196	69	doses	dose	NNS	61	conj	42048	42053	B-event-212384	_	_	_	_
196	70	(	(	VBP	33	parataxis	42054	42055	_	_	_	_	_
196	71	≥	≥	CD	72	compound	42055	42056	_	_	_	_	_
196	72	5	5	CD	73	nummod	42056	42057	_	_	_	_	_
196	73	doses	dose	NNS	70	dobj	42058	42063	_	_	_	_	_
196	74	in	in	IN	76	case	42064	42066	_	_	_	_	_
196	75	total	total	JJ	76	amod	42067	42072	_	_	_	_	_
196	76	)	)	NN	73	nmod	42072	42073	_	_	_	_	_
196	77	,	,	,	33	punct	42073	42074	_	_	_	_	_
196	78	some	some	DT	81	det	42075	42079	_	_	B-source-25352	_	_
196	79	small	small	JJ	81	amod	42080	42085	_	_	I-source-25352	_	_
196	80	observational	observational	JJ	81	amod	42086	42099	_	_	I-source-25352	_	_
196	81	studies	study	NNS	82	nsubj	42100	42107	B-event-212385	_	I-source-25352	_	_
196	82	report	report	VBP	33	parataxis	42108	42114	_	_	_	B-cue-25353	_
196	83	that	that	IN	87	mark	42115	42119	_	B-content-25354:25353-Cue_25352-Source	_	_	_
196	84	some	some	DT	85	det	42120	42124	_	I-content-25354	_	_	_
196	85	individuals	individual	NNS	87	nsubj	42125	42136	_	I-content-25354	_	_	_
196	86	may	may	MD	87	aux	42137	42140	_	I-content-25354	_	_	_
196	87	respond	respond	VB	82	ccomp	42141	42148	B-event-212386	I-content-25354	_	_	_
196	88	to	to	TO	90	case	42149	42151	_	I-content-25354	_	_	_
196	89	the	the	DT	90	det	42152	42155	_	I-content-25354	_	_	_
196	90	vaccine	vaccine	NN	87	nmod	42156	42163	B-event-212388	I-content-25354	_	_	_
196	91	administered	administer	VBN	90	acl	42164	42176	B-event-212387	I-content-25354	_	_	_
196	92	intradermally.85-87	intradermally.85-87	JJ	94	amod	42177	42196	_	I-content-25354	_	_	_
196	93	Engerix-B	engerix-b	NN	94	compound	42197	42206	_	_	_	_	_
196	94	(	(	NN	91	dobj	42207	42208	_	_	_	_	_
196	95	0.25	0.25	CD	96	nummod	42208	42212	_	_	_	_	_
196	96	mL	ml	NN	148	nsubjpass	42213	42215	_	_	_	_	_
196	97	[	[	CD	98	compound	42216	42217	_	_	_	_	_
196	98	5	5	CD	100	nummod	42217	42218	_	_	_	_	_
196	99	μg	μg	NN	100	compound	42219	42221	_	_	_	_	_
196	100	]	]	NN	105	nsubjpass	42221	42222	_	_	_	_	_
196	101	per	per	IN	103	case	42223	42226	_	_	_	_	_
196	102	dose	dose	NN	103	compound	42227	42231	_	_	_	_	_
196	103	)	)	NN	100	nmod	42231	42232	_	_	_	_	_
196	104	was	be	VBD	105	auxpass	42233	42236	_	_	_	_	_
196	105	used	use	VBN	96	acl:relcl	42237	42241	_	_	_	_	_
196	106	in	in	IN	108	case	42242	42244	_	_	_	_	_
196	107	these	these	DT	108	det	42245	42250	_	_	_	_	_
196	108	studies	study	NNS	105	nmod	42251	42258	B-event-212389	_	_	_	_
196	109	,	,	,	108	punct	42258	42259	_	_	_	_	_
196	110	giving	give	VBG	108	acl	42260	42266	_	_	_	_	_
196	111	up	up	RP	110	compound:prt	42267	42269	_	_	_	_	_
196	112	to	to	TO	114	case	42270	42272	_	_	_	_	_
196	113	4	4	CD	114	nummod	42273	42274	_	_	_	_	_
196	114	doses	dose	NNS	110	nmod	42275	42280	B-event-212390	_	_	_	_
196	115	.85	.85	CD	117	nummod	42280	42283	_	_	_	_	_
196	116	Younger	Younger	NNP	117	compound	42284	42291	_	_	_	_	_
196	117	age	age	NN	114	dep	42292	42295	_	_	_	_	_
196	118	and	and	CC	114	cc	42296	42299	_	_	_	_	_
196	119	longer	longer	JJR	120	amod	42300	42306	_	_	_	_	_
196	120	duration	duration	NN	114	conj	42307	42315	_	_	_	_	_
196	121	(	(	CD	122	compound	42316	42317	_	_	_	_	_
196	122	≥	≥	CD	120	dep	42317	42318	_	_	_	_	_
196	123	6	6	CD	124	nummod	42318	42319	_	_	_	_	_
196	124	months	month	NNS	110	nmod:tmod	42320	42326	_	_	_	_	_
196	125	)	)	RB	146	dep	42326	42327	_	_	_	_	_
196	126	since	since	IN	133	mark	42328	42333	_	_	_	_	_
196	127	the	the	DT	130	det	42334	42337	_	_	_	_	_
196	128	last	last	JJ	130	amod	42338	42342	_	_	_	_	_
196	129	IM	im	NN	130	compound	42343	42345	_	_	_	_	_
196	130	dose	dose	NN	133	nsubjpass	42346	42350	B-event-212391	_	_	_	_
196	131	may	may	MD	133	aux	42351	42354	_	_	_	_	_
196	132	be	be	VB	133	auxpass	42355	42357	_	_	_	_	_
196	133	associated	associate	VBN	125	ccomp	42358	42368	_	_	_	_	_
196	134	with	with	IN	136	case	42369	42373	_	_	_	_	_
196	135	greater	greater	JJR	136	amod	42374	42381	_	_	_	_	_
196	136	probability	probability	NN	133	nmod	42382	42393	_	_	_	_	_
196	137	of	of	IN	138	case	42394	42396	_	_	_	_	_
196	138	response	response	NN	136	nmod	42397	42405	B-event-212392	_	_	_	_
196	139	.86	.86	CD	138	nummod	42405	42408	_	_	_	_	_
196	140	If	if	IN	146	mark	42409	42411	_	_	_	_	_
196	141	an	a	DT	144	det	42412	42414	_	_	_	_	_
196	142	intradermal	intradermal	JJ	144	amod	42415	42426	_	_	_	_	_
196	143	dose	dose	NN	144	compound	42427	42431	B-event-212395	_	_	_	_
196	144	(	(	NN	146	nsubj	42431	42432	I-event-212395	_	_	_	_
196	145	s	be	VBZ	146	cop	42432	42433	I-event-212395	_	_	_	_
196	146	)	)	NN	110	xcomp	42433	42434	I-event-212395	_	_	_	_
196	147	is	be	VBZ	148	auxpass	42435	42437	_	_	_	_	_
196	148	given	give	VBN	94	acl:relcl	42438	42443	_	_	_	_	_
196	149	,	,	,	33	punct	42443	42444	_	_	_	_	_
196	150	it	it	PRP	152	nsubjpass	42445	42447	_	_	_	_	_
196	151	is	be	VBZ	152	auxpass	42448	42450	_	_	_	_	_
196	152	recommended	recommend	VBN	33	parataxis	42451	42462	B-event-212393	_	_	_	_
196	153	that	that	IN	158	mark	42463	42467	_	_	_	_	_
196	154	the	the	DT	156	det	42468	42471	_	_	_	_	_
196	155	anti-HBs	anti-hbs	JJ	156	amod	42472	42480	_	_	_	_	_
196	156	levels	level	NNS	158	nsubjpass	42481	42487	_	_	_	_	_
196	157	be	be	VB	158	auxpass	42488	42490	_	_	_	_	_
196	158	measured	measure	VBN	152	ccomp	42491	42499	B-event-212394	_	_	_	_
196	159	before	before	IN	162	case	42500	42506	_	_	_	_	_
196	160	each	each	DT	162	det	42507	42511	_	_	_	_	_
196	161	subsequent	subsequent	JJ	162	amod	42512	42522	_	_	_	_	_
196	162	dose	dose	NN	158	nmod	42523	42527	B-event-212396	_	_	_	_
196	163	to	to	TO	164	mark	42528	42530	_	_	_	_	_
196	164	assess	assess	VB	158	xcomp	42531	42537	B-event-212397	_	_	_	_
196	165	for	for	IN	166	case	42538	42541	_	_	_	_	_
196	166	seroconversion	seroconversion	NN	164	nmod	42542	42556	B-event-212398	_	_	_	_
196	167	.	.	.	6	punct	42556	42557	_	_	_	_	_

197	1	Persistent	persistent	JJ	2	amod	42559	42569	_	_	_	_	B-claim-10459
197	2	non-responders	non-responder	NNS	5	nsubjpass	42570	42584	B-event-212399	_	_	_	I-claim-10459
197	3	should	should	MD	5	aux	42585	42591	_	_	_	_	I-claim-10459
197	4	be	be	VB	5	auxpass	42592	42594	_	_	_	_	I-claim-10459
197	5	informed	inform	VBN	0	ROOT	42595	42603	_	_	_	B-cue-25355	I-claim-10459
197	6	that	that	IN	10	mark	42604	42608	_	B-content-25356:25355-Cue	_	_	I-claim-10459
197	7	they	they	PRP	10	nsubjpass	42609	42613	_	I-content-25356	_	_	I-claim-10459
197	8	should	should	MD	10	aux	42614	42620	_	I-content-25356	_	_	I-claim-10459
197	9	be	be	VB	10	auxpass	42621	42623	_	I-content-25356	_	_	I-claim-10459
197	10	considered	consider	VBN	5	ccomp	42624	42634	B-event-212400	I-content-25356	_	_	I-claim-10459
197	11	not	not	RB	12	neg	42635	42638	_	I-content-25356	_	_	I-claim-10459
197	12	protected	protect	VBN	10	ccomp	42639	42648	B-event-212401	I-content-25356	_	_	I-claim-10459
197	13	against	against	IN	15	case	42649	42656	_	I-content-25356	_	_	I-claim-10459
197	14	hepatitis	hepatitis	NN	15	compound	42657	42666	B-event-212402	I-content-25356	_	_	I-claim-10459
197	15	B	b	NN	12	nmod	42667	42668	I-event-212402	I-content-25356	_	_	I-claim-10459
197	16	and	and	CC	10	cc	42669	42672	_	I-content-25356	_	_	I-claim-10459
197	17	should	should	MD	18	aux	42673	42679	_	I-content-25356	_	_	I-claim-10459
197	18	minimise	minimise	VB	10	conj	42680	42688	_	I-content-25356	_	_	I-claim-10459
197	19	exposures	exposure	NNS	18	dobj	42689	42698	B-event-212403	I-content-25356	_	_	I-claim-10459
197	20	.	.	.	5	punct	42698	42699	_	_	_	_	_

198	1	They	they	PRP	5	nsubjpass	42700	42704	_	_	_	_	I-claim-10460
198	2	should	should	MD	5	aux	42705	42711	_	_	_	_	I-claim-10460
198	3	also	also	RB	5	advmod	42712	42716	_	_	_	_	I-claim-10460
198	4	be	be	VB	5	auxpass	42717	42719	_	_	_	_	I-claim-10460
198	5	informed	inform	VBN	22	dep	42720	42728	B-event-212404	_	_	_	I-claim-10460
198	6	about	about	IN	8	case	42729	42734	_	_	_	_	I-claim-10460
198	7	the	the	DT	8	det	42735	42738	_	_	_	_	I-claim-10460
198	8	need	need	NN	5	nmod	42739	42743	_	_	_	_	I-claim-10460
198	9	for	for	IN	10	case	42744	42747	_	_	_	_	I-claim-10460
198	10	HBIG	hbig	NN	8	nmod	42748	42752	_	_	_	_	I-claim-10460
198	11	within	within	IN	13	case	42753	42759	_	_	_	_	I-claim-10460
198	12	72	72	CD	13	nummod	42760	42762	_	_	_	_	I-claim-10460
198	13	hours	hour	NNS	5	nmod	42763	42768	_	_	_	_	I-claim-10460
198	14	of	of	IN	18	case	42769	42771	_	_	_	_	I-claim-10460
198	15	parenteral	parenteral	JJ	18	amod	42772	42782	_	_	_	_	I-claim-10460
198	16	or	or	CC	15	cc	42783	42785	_	_	_	_	I-claim-10460
198	17	mucosal	mucosal	JJ	15	conj	42786	42793	_	_	_	_	I-claim-10460
198	18	exposure	exposure	NN	13	nmod	42794	42802	B-event-212405	_	_	_	I-claim-10460
198	19	to	to	TO	21	case	42803	42805	_	_	_	_	I-claim-10460
198	20	HBV	hbv	NN	21	compound	42806	42809	B-event-212406	_	_	_	I-claim-10460
198	21	(	(	NN	5	nmod	42810	42811	_	_	_	_	_
198	22	refer	refer	VBP	0	ROOT	42811	42816	_	_	_	_	_
198	23	to	to	TO	24	case	42817	42819	_	_	_	_	_
198	24	Table	Table	NNP	22	nmod	42820	42825	_	_	_	_	_
198	25	4.5.3	4.5.3	CD	24	nummod	42826	42831	_	_	_	_	_
198	26	)	)	CD	22	nsubj	42831	42832	_	_	_	_	_
198	27	.	.	.	22	punct	42832	42833	_	_	_	_	_

199	1	4.5.8	4.5.8	CD	2	nummod	42835	42840	_	_	_	_	_
199	2	Pregnancy	pregnancy	NN	11	nsubjpass	42841	42850	B-event-212407	_	_	_	_
199	3	and	and	CC	2	cc	42851	42854	_	_	_	_	_
199	4	breastfeeding	breastfeeding	NN	6	compound	42855	42868	B-event-212408	_	_	_	_
199	5	Hepatitis	Hepatitis	NNP	6	compound	42869	42878	_	B-content-25357:25358-Cue	_	_	_
199	6	B	B	NNP	2	conj	42879	42880	_	I-content-25357	_	_	_
199	7	vaccine	vaccine	NN	6	dep	42881	42888	_	I-content-25357	_	_	_
199	8	is	be	VBZ	11	auxpass	42889	42891	_	_	_	_	_
199	9	not	not	RB	11	neg	42892	42895	_	_	_	_	_
199	10	routinely	routinely	RB	11	advmod	42896	42905	_	_	_	_	_
199	11	recommended	recommend	VBN	0	ROOT	42906	42917	_	_	_	B-cue-25358	_
199	12	for	for	IN	16	case	42918	42921	_	_	_	_	_
199	13	pregnant	pregnant	JJ	16	amod	42922	42930	B-event-212409	_	_	_	_
199	14	or	or	CC	13	cc	42931	42933	_	_	_	_	_
199	15	breastfeeding	breastfeeding	JJ	13	conj	42934	42947	B-event-212410	_	_	_	_
199	16	women	woman	NNS	11	nmod	42948	42953	_	_	_	_	_
199	17	.	.	.	11	punct	42953	42954	_	_	_	_	_

200	1	However	however	RB	13	advmod	42955	42962	_	_	_	_	_
200	2	,	,	,	13	punct	42962	42963	_	_	_	_	_
200	3	the	the	DT	13	nsubj	42964	42967	_	_	_	_	_
200	4	WHO	who	WP	5	nsubj	42968	42971	_	_	_	_	_
200	5	states	state	VBZ	3	acl:relcl	42972	42978	_	_	_	_	_
200	6	that	that	IN	5	xcomp	42979	42983	_	_	_	_	_
200	7	neither	neither	CC	8	cc:preconj	42984	42991	_	_	_	_	_
200	8	pregnancy	pregnancy	NN	6	dep	42992	43001	B-event-212411	_	_	_	_
200	9	nor	nor	CC	8	cc	43002	43005	_	_	_	_	_
200	10	breastfeeding	breastfeeding	NN	8	conj	43006	43019	B-event-212412	_	_	_	_
200	11	is	be	VBZ	13	cop	43020	43022	_	_	_	_	_
200	12	a	a	DT	13	det	43023	43024	_	_	_	_	_
200	13	contraindication	contraindication	NN	0	ROOT	43025	43041	B-event-212413	_	_	_	_
200	14	to	to	TO	16	case	43042	43044	_	_	_	_	_
200	15	the	the	DT	16	det	43045	43048	_	_	_	_	_
200	16	use	use	NN	13	nmod	43049	43052	_	_	_	_	_
200	17	of	of	IN	21	case	43053	43055	_	_	_	_	_
200	18	this	this	DT	21	det	43056	43060	_	_	_	_	_
200	19	vaccine	vaccine	NN	21	compound	43061	43068	B-event-212414	_	_	_	_
200	20	.88	.88	CD	21	nummod	43068	43071	_	_	_	_	_
200	21	Refer	refer	NN	16	nmod	43072	43077	_	_	_	_	_
200	22	to	to	TO	24	case	43078	43080	_	_	_	_	_
200	23	3.3	3.3	CD	24	nummod	43081	43084	_	_	_	_	_
200	24	Groups	group	NNS	21	nmod	43085	43091	_	_	_	_	_
200	25	with	with	IN	32	case	43092	43096	_	_	_	_	_
200	26	special	special	JJ	32	amod	43097	43104	_	_	_	_	_
200	27	vaccination	vaccination	NN	32	compound	43105	43116	_	_	_	_	_
200	28	requirements	requirement	NNS	32	compound	43117	43129	_	_	_	_	_
200	29	,	,	,	32	punct	43129	43130	_	_	_	_	_
200	30	Table	Table	NNP	32	dep	43131	43136	_	_	_	_	_
200	31	3.3.1	3.3.1	CD	32	nummod	43137	43142	_	_	_	_	_
200	32	Recommendations	recommendation	NNS	24	nmod	43143	43158	_	_	_	_	_
200	33	for	for	IN	34	case	43159	43162	_	_	_	_	_
200	34	vaccination	vaccination	NN	13	nmod	43163	43174	_	_	_	_	_
200	35	in	in	IN	36	case	43175	43177	_	_	_	_	_
200	36	pregnancy	pregnancy	NN	34	nmod	43178	43187	_	_	_	_	_
200	37	for	for	IN	39	case	43188	43191	_	_	_	_	_
200	38	more	more	JJR	39	amod	43192	43196	_	_	_	_	_
200	39	information	information	NN	36	nmod	43197	43208	_	_	_	_	_
200	40	.	.	.	13	punct	43208	43209	_	_	_	_	_

201	1	4.5.9	4.5.9	CD	2	nummod	43210	43215	_	_	_	_	_
201	2	Contraindications	contraindication	NNS	0	ROOT	43216	43233	B-event-212415	_	_	_	_
201	3	The	the	DT	6	det	43234	43237	_	_	_	_	_
201	4	only	only	JJ	6	amod	43238	43242	_	_	_	_	_
201	5	absolute	absolute	JJ	6	amod	43243	43251	_	_	_	_	_
201	6	contraindications	contraindication	NNS	11	nsubj	43252	43269	B-event-212416	_	_	_	_
201	7	to	to	TO	10	case	43270	43272	_	_	_	_	_
201	8	hepatitis	hepatitis	NN	10	compound	43273	43282	_	_	_	_	_
201	9	B	b	NN	10	compound	43283	43284	_	_	_	_	_
201	10	vaccines	vaccine	NNS	6	nmod	43285	43293	_	_	_	_	_
201	11	are	be	VBP	2	acl:relcl	43294	43297	_	_	_	_	_
201	12	:	:	:	2	punct	43297	43298	_	_	_	_	_
201	13	In	in	IN	14	case	43299	43301	_	_	_	_	_
201	14	particular	particular	JJ	20	advcl	43302	43312	_	_	_	_	_
201	15	,	,	,	20	punct	43312	43313	_	_	_	_	_
201	16	hepatitis	hepatitis	NN	18	compound	43314	43323	_	_	_	_	_
201	17	B	b	NN	18	compound	43324	43325	_	_	_	_	_
201	18	vaccines	vaccine	NNS	20	nsubjpass	43326	43334	B-event-212418	_	_	_	_
201	19	are	be	VBP	20	auxpass	43335	43338	_	_	_	_	_
201	20	contraindicated	contraindicate	VBN	2	parataxis	43339	43354	B-event-212417	_	_	_	_
201	21	in	in	IN	22	case	43355	43357	_	_	_	_	_
201	22	persons	person	NNS	20	nmod	43358	43365	_	_	_	_	_
201	23	with	with	IN	25	case	43366	43370	_	_	_	_	_
201	24	a	a	DT	25	det	43371	43372	_	_	_	_	_
201	25	history	history	NN	22	nmod	43373	43380	_	_	_	_	_
201	26	of	of	IN	27	case	43381	43383	_	_	_	_	_
201	27	anaphylaxis	anaphylaxis	NN	25	nmod	43384	43395	B-event-212419	_	_	_	_
201	28	to	to	TO	29	case	43396	43398	_	_	_	_	_
201	29	yeast	yeast	NN	20	nmod	43399	43404	_	_	_	_	_
201	30	.	.	.	2	punct	43404	43405	_	_	_	_	_

202	1	4.5.10	4.5.10	CD	3	nummod	43406	43412	_	_	_	_	_
202	2	Adverse	adverse	JJ	3	amod	43413	43420	_	_	_	_	_
202	3	events	event	NNS	6	nsubj	43421	43427	B-event-212420	_	_	_	_
202	4	Extensive	extensive	JJ	5	amod	43428	43437	_	_	_	_	_
202	5	experience	experience	NN	3	dep	43438	43448	_	_	_	_	_
202	6	indicates	indicate	VBZ	0	ROOT	43449	43458	_	_	_	_	_
202	7	that	that	IN	18	mark	43459	43463	_	_	_	_	_
202	8	the	the	DT	10	det	43464	43467	_	_	_	_	_
202	9	birth	birth	NN	10	compound	43468	43473	_	_	_	_	_
202	10	dose	dose	NN	18	nsubjpass	43474	43478	_	_	_	_	_
202	11	of	of	IN	14	case	43479	43481	_	_	_	_	_
202	12	hepatitis	hepatitis	NN	14	compound	43482	43491	_	_	_	_	_
202	13	B	b	NN	14	compound	43492	43493	_	_	_	_	_
202	14	vaccine	vaccine	NN	10	nmod	43494	43501	B-event-212495	_	_	_	_
202	15	is	be	VBZ	18	auxpass	43502	43504	_	_	_	_	_
202	16	very	very	RB	17	advmod	43505	43509	_	_	_	_	_
202	17	well	well	RB	18	advmod	43510	43514	_	_	_	_	_
202	18	tolerated	tolerate	VBN	6	ccomp	43515	43524	B-event-212421	_	_	_	_
202	19	by	by	IN	21	case	43525	43527	_	_	_	_	_
202	20	newborn	newborn	JJ	21	amod	43528	43535	_	_	_	_	_
202	21	infants	infant	NNS	18	nmod	43536	43543	_	_	_	_	_
202	22	.	.	.	6	punct	43543	43544	_	_	_	_	_

203	1	It	it	PRP	4	nsubj	43545	43547	_	_	_	_	_
203	2	does	do	VBZ	4	aux	43548	43552	_	_	_	_	_
203	3	not	not	RB	4	neg	43553	43556	_	_	_	_	_
203	4	interfere	interfere	VB	0	ROOT	43557	43566	B-event-212496	_	_	_	_
203	5	with	with	IN	8	case	43567	43571	_	_	_	_	_
203	6	either	either	CC	8	cc:preconj	43572	43578	_	_	_	_	_
203	7	the	the	DT	8	det	43579	43582	_	_	_	_	_
203	8	establishment	establishment	NN	4	nmod	43583	43596	_	_	_	_	_
203	9	or	or	CC	8	cc	43597	43599	_	_	_	_	_
203	10	maintenance	maintenance	NN	8	conj	43600	43611	_	_	_	_	_
203	11	of	of	IN	12	case	43612	43614	_	_	_	_	_
203	12	breastfeeding	breastfeeding	NN	8	nmod	43615	43628	B-event-212422	_	_	_	_
203	13	,	,	,	4	punct	43628	43629	_	_	_	_	_
203	14	and	and	CC	4	cc	43630	43633	_	_	_	_	_
203	15	it	it	PRP	18	nsubjpass	43634	43636	_	_	_	_	_
203	16	is	be	VBZ	18	auxpass	43637	43639	_	_	_	_	_
203	17	not	not	RB	18	neg	43640	43643	_	_	_	_	_
203	18	associated	associate	VBN	4	conj	43644	43654	_	_	_	_	_
203	19	with	with	IN	22	case	43655	43659	_	_	_	_	_
203	20	an	a	DT	22	det	43660	43662	_	_	_	_	_
203	21	increased	increase	VBN	22	amod	43663	43672	_	_	_	_	_
203	22	risk	risk	NN	18	nmod	43673	43677	B-event-212423	_	_	_	_
203	23	of	of	IN	25	case	43678	43680	_	_	_	_	_
203	24	either	either	CC	25	dep	43681	43687	_	_	_	_	_
203	25	fever	fever	NN	22	nmod	43688	43693	B-event-212424	_	_	_	_
203	26	,	,	,	25	punct	43693	43694	_	_	_	_	_
203	27	medical	medical	JJ	28	amod	43695	43702	_	_	_	_	_
203	28	investigation	investigation	NN	25	conj	43703	43716	B-event-212425	_	_	_	_
203	29	for	for	IN	30	case	43717	43720	_	_	_	_	_
203	30	sepsis	sepsis	NN	28	nmod	43721	43727	_	_	_	_	_
203	31	,	,	,	25	punct	43727	43728	_	_	_	_	_
203	32	or	or	CC	25	cc	43729	43731	_	_	_	_	_
203	33	serious	serious	JJ	34	amod	43732	43739	_	_	_	_	_
203	34	outcomes	outcome	NNS	25	conj	43740	43748	B-event-212426	_	_	_	_
203	35	in	in	IN	36	case	43749	43751	_	_	_	_	_
203	36	newborns	newborn	NNS	34	nmod	43752	43760	_	_	_	_	_
203	37	who	who	WP	39	nsubjpass	43761	43764	_	_	_	_	_
203	38	were	be	VBD	39	auxpass	43765	43769	_	_	_	_	_
203	39	vaccinated	vaccinate	VBN	36	acl:relcl	43770	43780	B-event-212427	_	_	_	_
203	40	compared	compare	VBN	45	case	43781	43789	_	_	_	_	_
203	41	with	with	IN	45	case	43790	43794	_	_	_	_	_
203	42	the	the	DT	45	det	43795	43798	_	_	_	_	_
203	43	unvaccinated.89-91	unvaccinated.89-91	JJ	45	amod	43799	43817	B-event-212428	_	_	_	_
203	44	Adverse	adverse	JJ	45	amod	43818	43825	_	_	_	_	_
203	45	events	event	NNS	39	advcl	43826	43832	B-event-212429	_	_	_	_
203	46	after	after	IN	51	mark	43833	43838	_	_	_	_	_
203	47	hepatitis	hepatitis	NN	49	compound	43839	43848	_	_	_	_	_
203	48	B	b	NN	49	compound	43849	43850	_	_	_	_	_
203	49	vaccination	vaccination	NN	51	nsubj	43851	43862	B-event-212430	_	_	_	_
203	50	are	be	VBP	51	cop	43863	43866	_	_	_	_	_
203	51	transient	transient	JJ	39	advcl	43867	43876	_	_	_	_	_
203	52	and	and	CC	51	cc	43877	43880	_	_	_	_	_
203	53	minor	minor	JJ	51	conj	43881	43886	_	_	_	_	_
203	54	,	,	,	4	punct	43886	43887	_	_	_	_	_
203	55	and	and	CC	4	cc	43888	43891	_	_	_	_	_
203	56	include	include	VBP	4	conj	43892	43899	_	_	_	_	_
203	57	soreness	soreness	NN	56	dobj	43900	43908	B-event-212431	_	_	_	_
203	58	at	at	IN	61	case	43909	43911	_	_	_	_	_
203	59	the	the	DT	61	det	43912	43915	_	_	_	_	_
203	60	injection	injection	NN	61	compound	43916	43925	B-event-212432	_	_	_	_
203	61	site	site	NN	56	nmod	43926	43930	_	_	_	_	_
203	62	(	(	CD	63	compound	43931	43932	_	_	_	_	_
203	63	5	5	CD	64	dep	43932	43933	_	_	_	_	_
203	64	%	%	NN	61	dep	43933	43934	_	_	_	_	_
203	65	)	)	CD	56	nsubj	43934	43935	_	_	_	_	_
203	66	,	,	,	65	punct	43935	43936	_	_	_	_	_
203	67	fever	fever	NN	68	compound	43937	43942	B-event-212433	_	_	_	_
203	68	(	(	NN	65	appos	43943	43944	_	_	_	_	_
203	69	usually	usually	RB	70	advmod	43944	43951	_	_	_	_	_
203	70	low	low	JJ	71	amod	43952	43955	_	_	_	_	_
203	71	grade	grade	NN	68	dep	43956	43961	_	_	_	_	_
203	72	;	;	:	68	punct	43961	43962	_	_	_	_	_
203	73	2	2	CD	74	compound	43963	43964	_	_	_	_	_
203	74	–	–	CD	68	dep	43964	43965	_	_	_	_	_
203	75	3	3	CD	76	nummod	43965	43966	_	_	_	_	_
203	76	%	%	NN	74	dep	43966	43967	_	_	_	_	_
203	77	)	)	CD	74	dep	43967	43968	_	_	_	_	_
203	78	,	,	,	77	punct	43968	43969	_	_	_	_	_
203	79	nausea	nausea	NN	77	appos	43970	43976	B-event-212434	_	_	_	_
203	80	,	,	,	79	punct	43976	43977	_	_	_	_	_
203	81	dizziness	dizziness	NN	79	conj	43978	43987	B-event-212435	_	_	_	_
203	82	,	,	,	79	punct	43987	43988	_	_	_	_	_
203	83	malaise	malaise	NN	79	conj	43989	43996	B-event-212436	_	_	_	_
203	84	,	,	,	79	punct	43996	43997	_	_	_	_	_
203	85	myalgia	myalgia	NN	79	conj	43998	44005	B-event-212437	_	_	_	_
203	86	and	and	CC	79	cc	44006	44009	_	_	_	_	_
203	87	arthralgia	arthralgia	NN	79	conj	44010	44020	B-event-212438	_	_	_	_
203	88	.	.	.	4	punct	44020	44021	_	_	_	_	_

204	1	Fever	fever	NN	4	nsubjpass	44022	44027	B-event-212439	_	_	_	_
204	2	can	can	MD	4	aux	44028	44031	_	_	_	_	_
204	3	be	be	VB	4	auxpass	44032	44034	_	_	_	_	_
204	4	expected	expect	VBN	0	ROOT	44035	44043	B-event-212440	_	_	_	_
204	5	in	in	IN	7	case	44044	44046	_	_	_	_	_
204	6	some	some	DT	7	det	44047	44051	_	_	_	_	_
204	7	neonates	neonate	NNS	4	nmod	44052	44060	_	_	_	_	_
204	8	following	follow	VBG	9	case	44061	44070	_	_	_	_	_
204	9	immunisation	immunisation	NN	7	nmod	44071	44083	B-event-212441	_	_	_	_
204	10	with	with	IN	13	case	44084	44088	_	_	_	_	_
204	11	hepatitis	hepatitis	NN	13	compound	44089	44098	_	_	_	_	_
204	12	B	b	NN	13	compound	44099	44100	_	_	_	_	_
204	13	vaccine	vaccine	NN	9	nmod	44101	44108	B-event-212442	_	_	_	_
204	14	(	(	CD	15	nummod	44109	44110	_	_	_	_	_
204	15	0.6	0.6	CD	13	dep	44110	44113	_	_	_	_	_
204	16	–	–	CD	17	compound	44113	44114	_	_	_	_	_
204	17	3.7	3.7	CD	18	nummod	44114	44117	_	_	_	_	_
204	18	%	%	NN	15	dep	44117	44118	_	_	_	_	_
204	19	)	)	CD	15	dep	44118	44119	_	_	_	_	_
204	20	.	.	.	4	punct	44119	44120	_	_	_	_	_

205	1	Anaphylaxis	Anaphylaxis	NNP	4	nsubjpass	44121	44132	B-event-212443	_	_	_	_
205	2	has	have	VBZ	4	aux	44133	44136	_	_	_	_	_
205	3	been	be	VBN	4	auxpass	44137	44141	_	_	_	_	_
205	4	reported	report	VBN	57	dep	44142	44150	B-event-212444	_	_	_	_
205	5	very	very	RB	6	advmod	44151	44155	_	_	_	_	_
205	6	rarely	rarely	RB	4	xcomp	44156	44162	_	_	_	_	_
205	7	in	in	IN	8	case	44163	44165	_	_	_	_	_
205	8	adults	adult	NNS	6	nmod	44166	44172	_	_	_	_	_
205	9	,	,	,	4	punct	44172	44173	_	_	_	_	_
205	10	notably	notably	RB	32	advmod	44174	44181	_	_	_	_	_
205	11	in	in	IN	13	case	44182	44184	_	_	_	_	_
205	12	yeast-sensitive	yeast-sensitive	JJ	13	amod	44185	44200	_	_	_	_	_
205	13	individuals	individual	NNS	10	nmod	44201	44212	_	_	_	_	_
205	14	.92	.92	CD	13	nmod:tmod	44212	44215	_	_	_	_	_
205	15	Although	although	IN	32	mark	44216	44224	_	_	_	_	B-claim-10461
205	16	various	various	JJ	18	amod	44225	44232	_	_	_	_	I-claim-10461
205	17	adverse	adverse	JJ	18	amod	44233	44240	_	_	_	_	I-claim-10461
205	18	events	event	NNS	32	nsubjpass	44241	44247	B-event-212445	_	_	_	I-claim-10461
205	19	such	such	JJ	22	case	44248	44252	_	_	_	_	I-claim-10461
205	20	as	as	IN	19	mwe	44253	44255	_	_	_	_	I-claim-10461
205	21	demyelinating	demyelinating	JJ	22	amod	44256	44269	B-event-212447	_	_	_	I-claim-10461
205	22	diseases	disease	NNS	18	nmod	44270	44278	B-event-212446	_	_	_	I-claim-10461
205	23	,	,	,	22	punct	44278	44279	_	_	_	_	I-claim-10461
205	24	Guillain-Barrï	Guillain-Barrï	NNP	22	appos	44280	44294	B-event-212448	_	_	_	I-claim-10461
205	25	¿	¿	CD	24	nummod	44294	44295	I-event-212448	_	_	_	I-claim-10461
205	26	½	½	NN	27	compound	44295	44296	I-event-212448	_	_	_	I-claim-10461
205	27	syndrome	syndrome	NN	24	dep	44297	44305	B-event-212449	_	_	_	I-claim-10461
205	28	and	and	CC	27	cc	44306	44309	_	_	_	_	I-claim-10461
205	29	arthritis	arthritis	NN	27	conj	44310	44319	B-event-212450	_	_	_	I-claim-10461
205	30	have	have	VBP	32	aux	44320	44324	_	_	_	_	I-claim-10461
205	31	been	be	VBN	32	auxpass	44325	44329	_	_	_	_	I-claim-10461
205	32	reported	report	VBN	35	advcl	44330	44338	B-event-212451	_	_	_	I-claim-10461
205	33	,	,	,	35	punct	44338	44339	_	_	_	_	I-claim-10461
205	34	there	there	EX	35	expl	44340	44345	_	_	_	_	I-claim-10461
205	35	is	be	VBZ	4	parataxis	44346	44348	_	_	_	_	I-claim-10461
205	36	no	no	DT	37	neg	44349	44351	_	_	_	_	I-claim-10461
205	37	evidence	evidence	NN	35	nsubj	44352	44360	_	_	_	_	I-claim-10461
205	38	of	of	IN	53	case	44361	44363	_	_	_	_	I-claim-10461
205	39	a	a	DT	41	det	44364	44365	_	_	_	_	I-claim-10461
205	40	causal	causal	JJ	41	amod	44366	44372	_	_	_	_	I-claim-10461
205	41	relationship	relationship	NN	53	dep	44373	44385	_	_	_	_	I-claim-10461
205	42	with	with	IN	44	case	44386	44390	_	_	_	_	I-claim-10461
205	43	hepatitis	hepatitis	NN	44	compound	44391	44400	_	_	_	_	I-claim-10461
205	44	B	b	NN	41	nmod	44401	44402	_	_	_	_	I-claim-10461
205	45	vaccination	vaccination	NN	53	dep	44403	44414	B-event-212452	_	_	_	I-claim-10461
205	46	.92,93	.92,93	CD	45	nummod	44414	44420	_	_	_	_	_
205	47	The	the	DT	53	det	44422	44425	_	_	B-source-25359	_	_
205	48	World	World	NNP	53	compound	44426	44431	_	_	I-source-25359	_	_
205	49	Health	Health	NNP	53	compound	44432	44438	_	_	I-source-25359	_	_
205	50	Organization	Organization	NNP	53	compound	44439	44451	_	_	I-source-25359	_	_
205	51	Global	Global	NNP	53	compound	44452	44458	_	_	I-source-25359	_	_
205	52	Advisory	Advisory	NNP	53	compound	44459	44467	_	_	I-source-25359	_	_
205	53	Committee	Committee	NNP	37	acl	44468	44477	_	_	I-source-25359	_	_
205	54	on	on	IN	56	case	44478	44480	_	_	I-source-25359	_	_
205	55	Vaccine	Vaccine	NNP	56	compound	44481	44488	_	_	I-source-25359	_	_
205	56	Safety	Safety	NNP	53	nmod	44489	44495	_	_	I-source-25359	_	_
205	57	states	state	VBZ	0	ROOT	44496	44502	_	_	_	B-cue-25360	_
205	58	that	that	IN	66	mark	44503	44507	_	B-content-25361:25359-Source_25360-Cue	_	_	_
205	59	‘	‘	CD	61	nummod	44508	44509	_	I-content-25361	_	_	_
205	60	multiple	multiple	JJ	61	amod	44509	44517	_	I-content-25361	_	_	_
205	61	studies	study	NNS	66	nsubj	44518	44525	B-event-212453	I-content-25361	_	_	_
205	62	and	and	CC	61	cc	44526	44529	_	I-content-25361	_	_	_
205	63	review	review	NN	64	compound	44530	44536	B-event-212454	I-content-25361	_	_	_
205	64	panels	panel	NNS	61	conj	44537	44543	_	I-content-25361	_	_	_
205	65	have	have	VBP	66	aux	44544	44548	_	I-content-25361	_	_	_
205	66	concluded	conclude	VBN	57	ccomp	44549	44558	_	I-content-25361	_	_	_
205	67	that	that	IN	69	mark	44559	44563	_	I-content-25361	_	_	_
205	68	there	there	EX	69	expl	44564	44569	_	I-content-25361	_	_	B-claim-10462
205	69	is	be	VBZ	66	ccomp	44570	44572	_	I-content-25361	_	_	I-claim-10462
205	70	no	no	DT	71	neg	44573	44575	_	I-content-25361	_	_	I-claim-10462
205	71	link	link	NN	69	nsubj	44576	44580	_	I-content-25361	_	_	I-claim-10462
205	72	between	between	IN	77	case	44581	44588	_	I-content-25361	_	_	I-claim-10462
205	73	MS	ms	NN	77	compound	44589	44591	B-event-212455	I-content-25361	_	_	I-claim-10462
205	74	[	[	CD	77	nummod	44592	44593	_	I-content-25361	_	_	I-claim-10462
205	75	multiple	multiple	JJ	77	amod	44593	44601	_	I-content-25361	_	_	I-claim-10462
205	76	sclerosis	sclerosis	NN	77	compound	44602	44611	_	I-content-25361	_	_	I-claim-10462
205	77	]	]	NN	71	nmod	44611	44612	_	I-content-25361	_	_	I-claim-10462
205	78	and	and	CC	77	cc	44613	44616	_	I-content-25361	_	_	I-claim-10462
205	79	hepatitis	hepatitis	NN	81	compound	44617	44626	_	I-content-25361	_	_	I-claim-10462
205	80	B	b	NN	81	compound	44627	44628	_	I-content-25361	_	_	I-claim-10462
205	81	vaccination	vaccination	NN	77	conj	44629	44640	B-event-212456	I-content-25361	_	_	I-claim-10462
205	82	’	’	CD	83	compound	44640	44641	_	I-content-25361	_	_	_
205	83	.94,95	.94,95	CD	57	nsubj	44641	44647	_	_	_	_	_
205	84	The	the	DT	85	det	44648	44651	_	_	_	_	_
205	85	vaccine	vaccine	NN	86	nsubj	44652	44659	B-event-212457	_	_	_	_
205	86	produces	produce	VBZ	83	acl:relcl	44660	44668	B-event-212458	_	_	_	_
205	87	neither	neither	CC	89	cc:preconj	44669	44676	_	_	_	_	_
205	88	therapeutic	therapeutic	JJ	89	amod	44677	44688	_	_	_	_	_
205	89	effects	effect	NNS	86	xcomp	44689	44696	B-event-212459	_	_	_	_
205	90	nor	nor	CC	89	cc	44697	44700	_	_	_	_	_
205	91	adverse	adverse	JJ	92	amod	44701	44708	_	_	_	_	_
205	92	events	event	NNS	89	conj	44709	44715	B-event-212460	_	_	_	_
205	93	in	in	IN	94	case	44716	44718	_	_	_	_	_
205	94	persons	person	NNS	86	nmod	44719	44726	_	_	_	_	_
205	95	with	with	IN	98	case	44727	44731	_	_	_	_	_
205	96	chronic	chronic	JJ	98	amod	44732	44739	_	_	_	_	_
205	97	HBV	hbv	NN	98	compound	44740	44743	B-event-212461	_	_	_	_
205	98	infection	infection	NN	94	nmod	44744	44753	B-event-212462	_	_	_	_
205	99	.	.	.	57	punct	44753	44754	_	_	_	_	_

206	1	It	it	PRP	4	nsubj	44755	44757	_	_	_	_	_
206	2	is	be	VBZ	4	cop	44758	44760	_	_	_	_	_
206	3	also	also	RB	4	advmod	44761	44765	_	_	_	_	_
206	4	safe	safe	JJ	0	ROOT	44766	44770	_	_	_	_	_
206	5	,	,	,	10	punct	44770	44771	_	_	_	_	_
206	6	though	though	IN	10	mark	44772	44778	_	_	_	_	_
206	7	of	of	IN	10	case	44779	44781	_	_	_	_	_
206	8	no	no	DT	10	neg	44782	44784	_	_	_	_	_
206	9	additional	additional	JJ	10	amod	44785	44795	_	_	_	_	_
206	10	benefit	benefit	NN	4	dep	44796	44803	B-event-212463	_	_	_	_
206	11	,	,	,	10	punct	44803	44804	_	_	_	_	_
206	12	in	in	IN	18	case	44805	44807	_	_	_	_	_
206	13	those	those	DT	18	det	44808	44813	_	_	_	_	_
206	14	already	already	RB	15	advmod	44814	44821	_	_	_	_	_
206	15	immune	immune	JJ	18	amod	44822	44828	B-event-212464	_	_	_	_
206	16	to	to	TO	17	case	44829	44831	_	_	_	_	_
206	17	hepatitis	hepatitis	NN	15	nmod	44832	44841	B-event-212465	_	_	_	_
206	18	B	b	NN	4	nmod	44842	44843	I-event-212465	_	_	_	_
206	19	through	through	IN	22	case	44844	44851	_	_	_	_	_
206	20	past	past	JJ	22	amod	44852	44856	_	_	_	_	_
206	21	natural	natural	JJ	22	amod	44857	44864	_	_	_	_	_
206	22	infection	infection	NN	18	nmod	44865	44874	B-event-212466	_	_	_	_
206	23	.	.	.	4	punct	44874	44875	_	_	_	_	_

207	1	4.5.11	4.5.11	CD	4	nummod	44876	44882	_	_	_	_	_
207	2	Public	Public	NNP	4	compound	44883	44889	_	_	_	_	_
207	3	health	health	NN	4	compound	44890	44896	_	_	_	_	_
207	4	management	management	NN	19	nsubj	44897	44907	_	_	_	_	_
207	5	of	of	IN	7	case	44908	44910	_	_	_	_	_
207	6	hepatitis	hepatitis	NN	7	compound	44911	44920	B-event-212204	_	_	_	_
207	7	B	b	NN	4	nmod	44921	44922	I-event-212204	_	_	_	_
207	8	Acute	acute	JJ	10	amod	44923	44928	_	_	_	_	_
207	9	hepatitis	hepatitis	NN	10	compound	44929	44938	B-event-212205	_	_	_	_
207	10	B	b	NN	7	dep	44939	44940	I-event-212205	_	_	_	_
207	11	and	and	CC	7	cc	44941	44944	_	_	_	_	_
207	12	newly	newly	RB	13	advmod	44945	44950	_	_	_	_	_
207	13	identified	identify	VBN	15	amod	44951	44961	B-event-212206	_	_	_	_
207	14	chronic	chronic	JJ	15	amod	44962	44969	_	_	_	_	_
207	15	hepatitis	hepatitis	NN	7	conj	44970	44979	B-event-212207	_	_	_	_
207	16	B	b	NN	15	dep	44980	44981	I-event-212207	_	_	_	_
207	17	are	be	VBP	19	cop	44982	44985	_	_	_	_	_
207	18	notifiable	notifiable	JJ	19	amod	44986	44996	_	_	_	_	_
207	19	diseases	disease	NNS	0	ROOT	44997	45005	B-event-212208	_	_	_	_
207	20	in	in	IN	22	case	45006	45008	_	_	_	_	_
207	21	all	all	DT	22	det	45009	45012	_	_	_	_	_
207	22	states	state	NNS	19	nmod	45013	45019	_	_	_	_	_
207	23	and	and	CC	22	cc	45020	45023	_	_	_	_	_
207	24	territories	territory	NNS	22	conj	45024	45035	_	_	_	_	_
207	25	in	in	IN	26	case	45036	45038	_	_	_	_	_
207	26	Australia	Australia	NNP	22	nmod	45039	45048	_	_	_	_	_
207	27	.	.	.	19	punct	45048	45049	_	_	_	_	_

208	1	Further	further	JJ	2	amod	45050	45057	_	_	_	_	B-claim-10463
208	2	instructions	instruction	NNS	33	nsubjpass	45058	45070	_	_	_	_	I-claim-10463
208	3	about	about	IN	7	case	45071	45076	_	_	_	_	I-claim-10463
208	4	the	the	DT	7	det	45077	45080	_	_	_	_	I-claim-10463
208	5	public	public	JJ	7	amod	45081	45087	_	_	_	_	I-claim-10463
208	6	health	health	NN	7	compound	45088	45094	_	_	_	_	I-claim-10463
208	7	management	management	NN	2	nmod	45095	45105	_	_	_	_	I-claim-10463
208	8	of	of	IN	10	case	45106	45108	_	_	_	_	I-claim-10463
208	9	hepatitis	hepatitis	NN	10	compound	45109	45118	B-event-212209	_	_	_	I-claim-10463
208	10	B	b	NN	7	nmod	45119	45120	I-event-212209	_	_	_	I-claim-10463
208	11	,	,	,	7	punct	45120	45121	_	_	_	_	I-claim-10463
208	12	including	include	VBG	13	case	45122	45131	_	_	_	_	I-claim-10463
208	13	management	management	NN	7	nmod	45132	45142	_	_	_	_	I-claim-10463
208	14	of	of	IN	15	case	45143	45145	_	_	_	_	I-claim-10463
208	15	cases	case	NNS	13	nmod	45146	45151	_	_	_	_	I-claim-10463
208	16	of	of	IN	19	case	45152	45154	_	_	_	_	I-claim-10463
208	17	acute	acute	JJ	19	amod	45155	45160	_	_	_	_	I-claim-10463
208	18	hepatitis	hepatitis	NN	19	compound	45161	45170	B-event-212210	_	_	_	I-claim-10463
208	19	B	b	NN	15	nmod	45171	45172	I-event-212210	_	_	_	I-claim-10463
208	20	and	and	CC	13	cc	45173	45176	_	_	_	_	I-claim-10463
208	21	newly	newly	RB	22	advmod	45177	45182	_	_	_	_	I-claim-10463
208	22	identified	identify	VBN	13	conj	45183	45193	B-event-212211	_	_	_	I-claim-10463
208	23	chronic	chronic	JJ	25	amod	45194	45201	_	_	_	_	I-claim-10463
208	24	hepatitis	hepatitis	NN	25	compound	45202	45211	B-event-212212	_	_	_	I-claim-10463
208	25	B	b	NN	22	dobj	45212	45213	I-event-212212	_	_	_	I-claim-10463
208	26	,	,	,	25	punct	45213	45214	_	_	_	_	I-claim-10463
208	27	and	and	CC	25	cc	45215	45218	_	_	_	_	I-claim-10463
208	28	their	they	PRP$	29	nmod:poss	45219	45224	_	_	_	_	I-claim-10463
208	29	contacts	contact	NNS	25	conj	45225	45233	_	_	_	_	I-claim-10463
208	30	,	,	,	25	punct	45233	45234	_	_	_	_	I-claim-10463
208	31	should	should	MD	33	aux	45235	45241	_	_	_	_	I-claim-10463
208	32	be	be	VB	33	auxpass	45242	45244	_	_	_	_	I-claim-10463
208	33	obtained	obtain	VBN	39	dep	45245	45253	B-event-212213	_	_	_	I-claim-10463
208	34	from	from	IN	38	case	45254	45258	_	_	_	_	I-claim-10463
208	35	state/territory	state/territory	JJ	38	amod	45259	45274	_	_	_	_	I-claim-10463
208	36	public	public	JJ	38	amod	45275	45281	_	_	_	_	I-claim-10463
208	37	health	health	NN	38	compound	45282	45288	_	_	_	_	I-claim-10463
208	38	authorities	authority	NNS	33	nmod	45289	45300	_	_	_	_	I-claim-10463
208	39	(	(	VBP	0	ROOT	45301	45302	_	_	_	_	_
208	40	refer	refer	VB	39	xcomp	45302	45307	_	_	_	_	_
208	41	to	to	TO	42	case	45308	45310	_	_	_	_	_
208	42	Appendix	appendix	NN	40	nmod	45311	45319	_	_	_	_	_
208	43	1	1	CD	45	nummod	45320	45321	_	_	_	_	_
208	44	Contact	contact	NN	45	compound	45322	45329	_	_	_	_	_
208	45	details	detail	NNS	39	nsubj	45330	45337	_	_	_	_	_
208	46	for	for	IN	54	case	45338	45341	_	_	_	_	_
208	47	Australian	australian	JJ	54	compound	45342	45352	_	_	_	_	_
208	48	,	,	,	47	punct	45352	45353	_	_	_	_	_
208	49	state	state	NN	47	conj	45354	45359	_	_	_	_	_
208	50	and	and	CC	47	cc	45360	45363	_	_	_	_	_
208	51	territory	territory	NN	47	conj	45364	45373	_	_	_	_	_
208	52	government	government	NN	54	compound	45374	45384	_	_	_	_	_
208	53	health	health	NN	54	compound	45385	45391	_	_	_	_	_
208	54	authorities	authority	NNS	45	nmod	45392	45403	_	_	_	_	_
208	55	and	and	CC	45	cc	45404	45407	_	_	_	_	_
208	56	communicable	communicable	JJ	58	amod	45408	45420	_	_	_	_	_
208	57	disease	disease	NN	58	compound	45421	45428	_	_	_	_	_
208	58	control	control	NN	45	conj	45429	45436	_	_	_	_	_
208	59	)	)	CD	58	dep	45436	45437	_	_	_	_	_
208	60	.	.	.	39	punct	45437	45438	_	_	_	_	_

209	1	Following	follow	VBG	4	case	45440	45449	_	_	_	_	B-claim-10464
209	2	significant	significant	JJ	4	amod	45450	45461	_	_	_	_	I-claim-10464
209	3	exposure	exposure	NN	4	compound	45462	45470	B-event-212214	_	_	_	I-claim-10464
209	4	(	(	NN	28	nmod	45471	45472	_	_	_	_	I-claim-10464
209	5	percutaneous	percutaneous	JJ	4	amod	45472	45484	_	_	_	_	I-claim-10464
209	6	,	,	,	5	punct	45484	45485	_	_	_	_	I-claim-10464
209	7	ocular	ocular	JJ	5	conj	45486	45492	_	_	_	_	I-claim-10464
209	8	or	or	CC	5	cc	45493	45495	_	_	_	_	I-claim-10464
209	9	mucous	mucous	JJ	5	conj	45496	45502	_	_	_	_	I-claim-10464
209	10	membrane	membrane	NN	28	nsubjpass	45503	45511	_	_	_	_	I-claim-10464
209	11	)	)	CD	10	nummod	45511	45512	_	_	_	_	I-claim-10464
209	12	to	to	TO	13	case	45513	45515	_	_	_	_	I-claim-10464
209	13	blood	blood	NN	25	nmod	45516	45521	_	_	_	_	I-claim-10464
209	14	or	or	CC	25	cc	45522	45524	_	_	_	_	I-claim-10464
209	15	to	to	TO	18	case	45525	45527	_	_	_	_	I-claim-10464
209	16	potentially	potentially	RB	17	advmod	45528	45539	_	_	_	_	I-claim-10464
209	17	blood-contaminated	blood-contaminated	JJ	18	amod	45540	45558	B-event-212215	_	_	_	I-claim-10464
209	18	secretions	secretion	NNS	25	conj	45559	45569	_	_	_	_	I-claim-10464
209	19	,	,	,	21	punct	45569	45570	_	_	_	_	I-claim-10464
209	20	where	where	WRB	21	dep	45571	45576	_	_	_	_	I-claim-10464
209	21	feasible	feasible	JJ	18	dep	45577	45585	_	_	_	_	I-claim-10464
209	22	,	,	,	21	punct	45585	45586	_	_	_	_	I-claim-10464
209	23	the	the	DT	25	det	45587	45590	_	_	_	_	I-claim-10464
209	24	source	source	NN	25	compound	45591	45597	_	_	_	_	I-claim-10464
209	25	individual	individual	NN	10	nmod	45598	45608	_	_	_	_	I-claim-10464
209	26	should	should	MD	28	aux	45609	45615	_	_	_	_	I-claim-10464
209	27	be	be	VB	28	auxpass	45616	45618	_	_	_	_	I-claim-10464
209	28	tested	test	VBN	0	ROOT	45619	45625	B-event-212216	_	_	_	I-claim-10464
209	29	for	for	IN	30	case	45626	45629	_	_	_	_	I-claim-10464
209	30	HBsAg	hbsag	NN	28	nmod	45630	45635	_	_	_	_	I-claim-10464
209	31	as	as	RB	32	advmod	45636	45638	_	_	_	_	I-claim-10464
209	32	soon	soon	RB	28	advmod	45639	45643	_	_	_	_	I-claim-10464
209	33	as	as	IN	34	case	45644	45646	_	_	_	_	I-claim-10464
209	34	possible	possible	JJ	32	advcl	45647	45655	_	_	_	_	I-claim-10464
209	35	.	.	.	28	punct	45655	45656	_	_	_	_	_

210	1	If	if	IN	9	mark	45657	45659	_	_	_	_	B-claim-10465
210	2	the	the	DT	3	det	45660	45663	_	_	_	_	I-claim-10465
210	3	person	person	NN	9	nsubjpass	45664	45670	_	_	_	_	I-claim-10465
210	4	exposed	expose	VBN	3	acl	45671	45678	B-event-212217	_	_	_	I-claim-10465
210	5	has	have	VBZ	9	aux	45679	45682	_	_	_	_	I-claim-10465
210	6	not	not	RB	9	neg	45683	45686	_	_	_	_	I-claim-10465
210	7	been	be	VBN	9	auxpass	45687	45691	_	_	_	_	I-claim-10465
210	8	previously	previously	RB	9	advmod	45692	45702	_	_	_	_	I-claim-10465
210	9	vaccinated	vaccinate	VBN	26	advcl	45703	45713	B-event-212218	_	_	_	I-claim-10465
210	10	against	against	IN	12	case	45714	45721	_	_	_	_	I-claim-10465
210	11	hepatitis	hepatitis	NN	12	compound	45722	45731	B-event-212219	_	_	_	I-claim-10465
210	12	B	b	NN	9	nmod	45732	45733	I-event-212219	_	_	_	I-claim-10465
210	13	,	,	,	26	punct	45733	45734	_	_	_	_	I-claim-10465
210	14	their	they	PRP$	16	nmod:poss	45735	45740	_	_	_	_	I-claim-10465
210	15	anti-HBs	anti-hbs	JJ	16	amod	45741	45749	_	_	_	_	I-claim-10465
210	16	level	level	NN	26	nsubjpass	45750	45755	_	_	_	_	I-claim-10465
210	17	,	,	,	16	punct	45755	45756	_	_	_	_	I-claim-10465
210	18	and	and	CC	16	cc	45757	45760	_	_	_	_	I-claim-10465
210	19	anti-HBc	anti-hbc	JJ	22	amod	45761	45769	_	_	_	_	I-claim-10465
210	20	and	and	CC	19	cc	45770	45773	_	_	_	_	I-claim-10465
210	21	HBsAg	hbsag	NN	19	conj	45774	45779	_	_	_	_	I-claim-10465
210	22	status	status	NN	16	conj	45780	45786	_	_	_	_	I-claim-10465
210	23	,	,	,	16	punct	45786	45787	_	_	_	_	I-claim-10465
210	24	should	should	MD	26	aux	45788	45794	_	_	_	_	I-claim-10465
210	25	be	be	VB	26	auxpass	45795	45797	_	_	_	_	I-claim-10465
210	26	determined	determine	VBN	0	ROOT	45798	45808	B-event-212220	_	_	_	I-claim-10465
210	27	immediately	immediately	RB	26	advmod	45809	45820	_	_	_	_	I-claim-10465
210	28	.	.	.	26	punct	45820	45821	_	_	_	_	_

211	1	If	if	IN	12	mark	45822	45824	_	_	_	_	B-claim-10466
211	2	the	the	DT	3	det	45825	45828	_	_	_	_	I-claim-10466
211	3	person	person	NN	12	nsubj	45829	45835	_	_	_	_	I-claim-10466
211	4	exposed	expose	VBN	3	acl	45836	45843	B-event-212221	_	_	_	I-claim-10466
211	5	is	be	VBZ	12	cop	45844	45846	_	_	_	_	I-claim-10466
211	6	anti-HBs	anti-hbs	JJ	12	amod	45847	45855	_	_	_	_	I-claim-10466
211	7	and	and	CC	6	cc	45856	45859	_	_	_	_	I-claim-10466
211	8	anti-HBc	anti-hbc	JJ	6	conj	45860	45868	_	_	_	_	I-claim-10466
211	9	negative	negative	JJ	12	amod	45869	45877	_	_	_	_	I-claim-10466
211	10	(	(	NN	12	compound	45878	45879	_	_	_	_	I-claim-10466
211	11	non-immune	non-immune	JJ	12	amod	45879	45889	_	_	_	_	I-claim-10466
211	12	)	)	NN	35	advcl	45889	45890	_	_	_	_	I-claim-10466
211	13	and	and	CC	12	cc	45891	45894	_	_	_	_	I-claim-10466
211	14	the	the	DT	15	det	45895	45898	_	_	_	_	I-claim-10466
211	15	source	source	NN	18	nsubj	45899	45905	_	_	_	_	I-claim-10466
211	16	is	be	VBZ	18	cop	45906	45908	_	_	_	_	I-claim-10466
211	17	either	either	CC	18	advmod	45909	45915	_	_	_	_	I-claim-10466
211	18	HBsAg-positive	hbsag-positive	JJ	12	conj	45916	45930	_	_	_	_	I-claim-10466
211	19	or	or	CC	18	cc	45931	45933	_	_	_	_	I-claim-10466
211	20	can	can	MD	23	aux	45934	45937	_	_	_	_	I-claim-10466
211	21	not	not	RB	23	neg	45937	45940	_	_	_	_	I-claim-10466
211	22	be	be	VB	23	auxpass	45941	45943	_	_	_	_	I-claim-10466
211	23	identified	identify	VBN	18	conj	45944	45954	B-event-212222	_	_	_	I-claim-10466
211	24	and	and	CC	23	cc	45955	45958	_	_	_	_	I-claim-10466
211	25	tested	test	VBN	23	conj	45959	45965	B-event-212223	_	_	_	I-claim-10466
211	26	rapidly	rapidly	RB	23	advmod	45966	45973	_	_	_	_	I-claim-10466
211	27	,	,	,	35	punct	45973	45974	_	_	_	_	I-claim-10466
211	28	a	a	DT	30	det	45975	45976	_	_	_	_	I-claim-10466
211	29	single	single	JJ	30	amod	45977	45983	_	_	_	_	I-claim-10466
211	30	dose	dose	NN	35	nsubjpass	45984	45988	_	_	_	_	I-claim-10466
211	31	of	of	IN	32	case	45989	45991	_	_	_	_	I-claim-10466
211	32	HBIG	hbig	NN	30	nmod	45992	45996	_	_	_	_	I-claim-10466
211	33	should	should	MD	35	aux	45997	46003	_	_	_	_	I-claim-10466
211	34	be	be	VB	35	auxpass	46004	46006	_	_	_	_	I-claim-10466
211	35	administered	administer	VBN	0	ROOT	46007	46019	B-event-212224	_	_	_	I-claim-10466
211	36	according	accord	VBG	39	case	46020	46029	_	_	_	_	_
211	37	to	to	TO	36	mwe	46030	46032	_	_	_	_	_
211	38	the	the	DT	39	det	46033	46036	_	_	_	_	_
211	39	recommendations	recommendation	NNS	35	nmod	46037	46052	B-event-212225	_	_	_	_
211	40	in	in	IN	41	case	46053	46055	_	_	_	_	_
211	41	Table	Table	NNP	39	nmod	46056	46061	_	_	_	_	_
211	42	4.5.3	4.5.3	CD	41	nummod	46062	46067	_	_	_	_	_
211	43	.	.	.	35	punct	46067	46068	_	_	_	_	_

212	1	below	below	IN	0	ROOT	46069	46074	_	_	_	_	_
212	2	.	.	.	1	punct	46074	46075	_	_	_	_	_

213	1	The	the	DT	2	det	46076	46079	_	_	_	_	_
213	2	dose	dose	NN	7	nsubj	46080	46084	_	_	_	_	_
213	3	of	of	IN	4	case	46085	46087	_	_	_	_	_
213	4	HBIG	hbig	NN	2	nmod	46088	46092	_	_	_	_	_
213	5	is	be	VBZ	7	cop	46093	46095	_	_	_	_	_
213	6	100	100	CD	7	nummod	46096	46099	_	_	_	_	_
213	7	IU	iu	NN	0	ROOT	46100	46102	_	_	_	_	_
213	8	for	for	IN	9	case	46103	46106	_	_	_	_	_
213	9	children	child	NNS	7	nmod	46107	46115	_	_	_	_	_
213	10	weighing	weigh	VBG	9	acl	46116	46124	_	_	_	_	_
213	11	up	up	RP	10	compound:prt	46125	46127	_	_	_	_	_
213	12	to	to	TO	15	case	46128	46130	_	_	_	_	_
213	13	30	30	CD	15	nummod	46131	46133	_	_	_	_	_
213	14	kg	kg	NN	15	compound	46134	46136	_	_	_	_	_
213	15	(	(	NN	10	nmod	46137	46138	_	_	_	_	_
213	16	about	about	IN	18	case	46138	46143	_	_	_	_	_
213	17	5	5	CD	18	nummod	46144	46145	_	_	_	_	_
213	18	years	year	NNS	15	nmod	46146	46151	_	_	_	_	_
213	19	of	of	IN	21	case	46152	46154	_	_	_	_	_
213	20	age	age	NN	21	compound	46155	46158	_	_	_	_	_
213	21	)	)	NN	18	nmod	46158	46159	_	_	_	_	_
213	22	and	and	CC	18	cc	46160	46163	_	_	_	_	_
213	23	400	400	CD	24	nummod	46164	46167	_	_	_	_	_
213	24	IU	iu	NN	18	conj	46168	46170	_	_	_	_	_
213	25	for	for	IN	27	case	46171	46174	_	_	_	_	_
213	26	all	all	DT	27	det	46175	46178	_	_	_	_	_
213	27	others	other	NNS	24	nmod	46179	46185	_	_	_	_	_
213	28	.	.	.	7	punct	46185	46186	_	_	_	_	_

214	1	Hepatitis	Hepatitis	NNP	2	compound	46187	46196	_	_	_	_	B-claim-10469
214	2	Bvaccine	Bvaccine	NNP	6	nsubjpass	46197	46205	B-event-212226	_	_	_	I-claim-10469
214	3	must	must	MD	6	aux	46206	46210	_	_	_	_	I-claim-10469
214	4	also	also	RB	6	advmod	46211	46215	_	_	_	_	I-claim-10469
214	5	be	be	VB	6	auxpass	46216	46218	_	_	_	_	I-claim-10469
214	6	given	give	VBN	0	ROOT	46219	46224	_	_	_	_	I-claim-10469
214	7	as	as	RB	8	advmod	46225	46227	_	_	_	_	I-claim-10469
214	8	soon	soon	RB	6	advmod	46228	46232	_	_	_	_	I-claim-10469
214	9	as	as	IN	10	case	46233	46235	_	_	_	_	I-claim-10469
214	10	possible	possible	JJ	6	advcl	46236	46244	_	_	_	_	I-claim-10469
214	11	,	,	,	6	punct	46244	46245	_	_	_	_	_
214	12	with	with	IN	14	case	46246	46250	_	_	_	_	_
214	13	further	further	JJ	14	amod	46251	46258	_	_	_	_	_
214	14	doses	dose	NNS	6	nmod	46259	46264	B-event-212227	_	_	_	_
214	15	as	as	IN	16	case	46265	46267	_	_	_	_	_
214	16	recommended	recommend	VBN	14	nmod	46268	46279	B-event-212228	_	_	_	_
214	17	in	in	IN	18	case	46280	46282	_	_	_	_	_
214	18	Table	Table	NNP	16	nmod	46283	46288	_	_	_	_	_
214	19	4.5.3	4.5.3	CD	18	nummod	46289	46294	_	_	_	_	_
214	20	.	.	.	6	punct	46294	46295	_	_	_	_	_

215	1	below	below	IN	0	ROOT	46296	46301	_	_	_	_	_
215	2	.	.	.	1	punct	46301	46302	_	_	_	_	_

216	1	For	for	IN	3	mark	46304	46307	_	_	_	_	_
216	2	previously	previously	RB	3	advmod	46308	46318	_	_	_	_	_
216	3	vaccinated	vaccinate	VBN	27	advcl	46319	46329	B-event-212229	_	_	_	_
216	4	persons	person	NNS	3	dobj	46330	46337	_	_	_	_	_
216	5	exposed	expose	VBN	4	acl	46338	46345	B-event-212230	_	_	_	_
216	6	to	to	TO	10	case	46346	46348	_	_	_	_	_
216	7	either	either	CC	10	cc:preconj	46349	46355	_	_	_	_	_
216	8	an	a	DT	10	det	46356	46358	_	_	_	_	_
216	9	HBsAg-positive	hbsag-positive	JJ	10	amod	46359	46373	_	_	_	_	_
216	10	source	source	NN	5	nmod	46374	46380	_	_	_	_	_
216	11	or	or	CC	10	cc	46381	46383	_	_	_	_	_
216	12	a	a	DT	13	det	46384	46385	_	_	_	_	_
216	13	source	source	NN	10	conj	46386	46392	_	_	_	_	_
216	14	whose	whose	WP$	21	dep	46393	46398	_	_	_	_	_
216	15	hepatitis	hepatitis	NN	17	compound	46399	46408	_	_	_	_	_
216	16	B	b	NN	17	compound	46409	46410	_	_	_	_	_
216	17	status	status	NN	21	nsubjpass	46411	46417	_	_	_	_	_
216	18	can	can	MD	21	aux	46418	46421	_	_	_	_	_
216	19	not	not	RB	21	neg	46421	46424	_	_	_	_	_
216	20	be	be	VB	21	auxpass	46425	46427	_	_	_	_	_
216	21	determined	determine	VBN	4	dep	46428	46438	B-event-212231	_	_	_	_
216	22	,	,	,	27	punct	46438	46439	_	_	_	_	_
216	23	post-exposure	post-exposure	JJ	24	amod	46440	46453	B-event-212232	_	_	_	_
216	24	prophylaxis	prophylaxis	NN	27	nsubj	46454	46465	_	_	_	_	_
216	25	is	be	VBZ	27	cop	46466	46468	_	_	_	_	_
216	26	not	not	RB	27	neg	46469	46472	_	_	_	_	_
216	27	necessary	necessary	JJ	0	ROOT	46473	46482	_	_	_	_	_
216	28	if	if	IN	30	mark	46483	46485	_	_	_	_	_
216	29	there	there	EX	30	expl	46486	46491	_	_	_	_	_
216	30	was	be	VBD	27	advcl	46492	46495	_	_	_	_	_
216	31	a	a	DT	34	det	46496	46497	_	_	_	_	_
216	32	documented	document	VBN	34	amod	46498	46508	B-event-212233	_	_	_	_
216	33	protective	protective	JJ	34	amod	46509	46519	B-event-212234	_	_	_	_
216	34	response	response	NN	30	nsubj	46520	46528	B-event-212235	_	_	_	_
216	35	(	(	CD	30	nmod	46529	46530	_	_	_	_	_
216	36	anti-HBs	anti-hbs	JJ	41	amod	46530	46538	_	_	_	_	_
216	37	level	level	NN	41	compound	46539	46544	_	_	_	_	_
216	38	≥	≥	NN	41	compound	46545	46546	_	_	_	_	_
216	39	10	10	CD	41	nummod	46546	46548	_	_	_	_	_
216	40	mIU/mL	miu/ml	NN	41	compound	46549	46555	_	_	_	_	_
216	41	)	)	NN	35	dep	46555	46556	_	_	_	_	_
216	42	at	at	IN	44	case	46557	46559	_	_	_	_	_
216	43	any	any	DT	44	det	46560	46563	_	_	_	_	_
216	44	time	time	NN	41	nmod	46564	46568	_	_	_	_	_
216	45	after	after	IN	46	case	46569	46574	_	_	_	_	_
216	46	vaccination	vaccination	NN	44	nmod	46575	46586	B-event-212236	_	_	_	_
216	47	.	.	.	27	punct	46586	46587	_	_	_	_	_

217	1	If	if	IN	8	mark	46588	46590	_	_	_	_	B-claim-10471
217	2	the	the	DT	3	det	46591	46594	_	_	_	_	I-claim-10471
217	3	response	response	NN	8	nsubj	46595	46603	B-event-212237	_	_	_	I-claim-10471
217	4	to	to	TO	6	case	46604	46606	_	_	_	_	I-claim-10471
217	5	previous	previous	JJ	6	amod	46607	46615	_	_	_	_	I-claim-10471
217	6	vaccination	vaccination	NN	3	nmod	46616	46627	B-event-212238	_	_	_	I-claim-10471
217	7	is	be	VBZ	8	cop	46628	46630	_	_	_	_	I-claim-10471
217	8	unknown	unknown	JJ	15	advcl	46631	46638	_	_	_	_	I-claim-10471
217	9	,	,	,	15	punct	46638	46639	_	_	_	_	I-claim-10471
217	10	the	the	DT	12	det	46640	46643	_	_	_	_	I-claim-10471
217	11	anti-HBs	anti-hbs	JJ	12	amod	46644	46652	_	_	_	_	I-claim-10471
217	12	level	level	NN	15	nsubjpass	46653	46658	_	_	_	_	I-claim-10471
217	13	should	should	MD	15	aux	46659	46665	_	_	_	_	I-claim-10471
217	14	be	be	VB	15	auxpass	46666	46668	_	_	_	_	I-claim-10471
217	15	determined	determine	VBN	0	ROOT	46669	46679	B-event-212239	_	_	_	I-claim-10471
217	16	as	as	RB	17	advmod	46680	46682	_	_	_	_	I-claim-10471
217	17	quickly	quickly	RB	15	advmod	46683	46690	_	_	_	_	I-claim-10471
217	18	as	as	IN	19	case	46691	46693	_	_	_	_	I-claim-10471
217	19	possible	possible	JJ	15	advcl	46694	46702	_	_	_	_	I-claim-10471
217	20	.	.	.	15	punct	46702	46703	_	_	_	_	_

218	1	If	if	IN	6	mark	46704	46706	_	_	_	_	B-claim-10472
218	2	the	the	DT	4	det	46707	46710	_	_	_	_	I-claim-10472
218	3	anti-HBs	anti-hbs	JJ	4	amod	46711	46719	_	_	_	_	I-claim-10472
218	4	level	level	NN	6	nsubj	46720	46725	_	_	_	_	I-claim-10472
218	5	is	be	VBZ	6	cop	46726	46728	_	_	_	_	I-claim-10472
218	6	<	<	JJR	24	advcl	46729	46730	_	_	_	_	I-claim-10472
218	7	10	10	CD	8	nummod	46730	46732	_	_	_	_	I-claim-10472
218	8	mIU/mL	miu/ml	NN	6	dep	46733	46739	_	_	_	_	I-claim-10472
218	9	and	and	CC	6	cc	46740	46743	_	_	_	_	I-claim-10472
218	10	there	there	EX	11	expl	46744	46749	_	_	_	_	I-claim-10472
218	11	is	be	VBZ	6	conj	46750	46752	_	_	_	_	I-claim-10472
218	12	no	no	DT	13	neg	46753	46755	_	_	_	_	I-claim-10472
218	13	evidence	evidence	NN	11	nsubj	46756	46764	_	_	_	_	I-claim-10472
218	14	of	of	IN	16	case	46765	46767	_	_	_	_	I-claim-10472
218	15	HBV	hbv	NN	16	compound	46768	46771	B-event-212240	_	_	_	I-claim-10472
218	16	infection	infection	NN	13	nmod	46772	46781	B-event-212241	_	_	_	I-claim-10472
218	17	,	,	,	24	punct	46781	46782	_	_	_	_	I-claim-10472
218	18	HBIG	hbig	NN	21	compound	46783	46787	_	_	_	_	I-claim-10472
218	19	and	and	CC	18	cc	46788	46791	_	_	_	_	I-claim-10472
218	20	HBV	hbv	NN	18	conj	46792	46795	_	_	_	_	I-claim-10472
218	21	vaccine	vaccine	NN	24	nsubjpass	46796	46803	B-event-212242	_	_	_	I-claim-10472
218	22	should	should	MD	24	aux	46804	46810	_	_	_	_	I-claim-10472
218	23	be	be	VB	24	auxpass	46811	46813	_	_	_	_	I-claim-10472
218	24	administered	administer	VBN	0	ROOT	46814	46826	B-event-212243	_	_	_	I-claim-10472
218	25	as	as	IN	27	case	46827	46829	_	_	_	_	_
218	26	per	per	IN	27	case	46830	46833	_	_	_	_	_
218	27	Table	Table	NNP	24	nmod	46834	46839	_	_	_	_	_
218	28	4.5.3	4.5.3	CD	27	nummod	46840	46845	_	_	_	_	_
218	29	.	.	.	24	punct	46845	46846	_	_	_	_	_

219	1	below	below	IN	0	ROOT	46847	46852	_	_	_	_	_
219	2	.	.	.	1	punct	46852	46853	_	_	_	_	_

220	1	All	all	DT	2	det	46854	46857	_	_	_	_	B-claim-10474
220	2	healthcare	healthcare	NN	21	nsubjpass	46858	46868	_	_	_	_	I-claim-10474
220	3	workers	worker	NNS	6	nsubjpass	46869	46876	_	_	_	_	I-claim-10474
220	4	should	should	MD	6	aux	46877	46883	_	_	_	_	I-claim-10474
220	5	be	be	VB	6	auxpass	46884	46886	_	_	_	_	I-claim-10474
220	6	immunised	immunise	VBN	2	acl:relcl	46887	46896	B-event-212170	_	_	_	I-claim-10474
220	7	against	against	IN	10	case	46897	46904	_	_	_	_	I-claim-10474
220	8	hepatitis	hepatitis	NNP	10	compound	46905	46914	B-event-212171	_	_	_	I-claim-10474
220	9	B.	B.	NNP	10	compound	46915	46917	I-event-212171	_	_	_	I-claim-10474
220	10	Completion	Completion	NNP	6	nmod	46918	46928	B-event-212172	B-content-25362:25363-Cue	_	_	_
220	11	of	of	IN	14	case	46929	46931	_	I-content-25362	_	_	_
220	12	a	a	DT	14	det	46932	46933	_	I-content-25362	_	_	_
220	13	full	full	JJ	14	amod	46934	46938	_	I-content-25362	_	_	_
220	14	course	course	NN	10	nmod	46939	46945	_	I-content-25362	_	_	_
220	15	of	of	IN	18	case	46946	46948	_	I-content-25362	_	_	_
220	16	hepatitis	hepatitis	NN	18	compound	46949	46958	_	I-content-25362	_	_	_
220	17	B	b	NN	18	compound	46959	46960	_	I-content-25362	_	_	_
220	18	vaccination	vaccination	NN	14	nmod	46961	46972	B-event-212173	I-content-25362	_	_	_
220	19	is	be	VBZ	21	auxpass	46973	46975	_	_	_	_	_
220	20	strongly	strongly	RB	21	advmod	46976	46984	_	_	_	_	_
220	21	recommended	recommend	VBN	0	ROOT	46985	46996	_	_	_	B-cue-25363	_
220	22	for	for	IN	26	case	46997	47000	_	_	_	_	_
220	23	any	any	DT	26	det	47001	47004	_	_	_	_	_
220	24	non-immune	non-immune	JJ	26	amod	47005	47015	_	_	_	_	_
220	25	healthcare	healthcare	NN	26	compound	47016	47026	_	_	_	_	_
220	26	worker	worker	NN	21	nmod	47027	47033	_	_	_	_	_
220	27	who	who	WP	29	nsubj	47034	47037	_	_	_	_	_
220	28	has	have	VBZ	29	aux	47038	47041	_	_	_	_	_
220	29	sustained	sustain	VBN	26	acl:relcl	47042	47051	_	_	_	_	_
220	30	a	a	DT	32	det	47052	47053	_	_	_	_	_
220	31	needle-stick	needle-stick	JJ	32	amod	47054	47066	_	_	_	_	_
220	32	injury	injury	NN	29	dobj	47067	47073	B-event-212174	_	_	_	_
220	33	or	or	CC	32	cc	47074	47076	_	_	_	_	_
220	34	other	other	JJ	36	amod	47077	47082	_	_	_	_	_
220	35	potential	potential	JJ	36	amod	47083	47092	_	_	_	_	_
220	36	hepatitis	hepatitis	NN	32	conj	47093	47102	B-event-212175	_	_	_	_
220	37	B	b	NN	38	compound	47103	47104	I-event-212175	_	_	_	_
220	38	exposure	exposure	NN	36	dep	47105	47113	B-event-212176	_	_	_	_
220	39	.	.	.	21	punct	47113	47114	_	_	_	_	_

221	1	*	*	SYM	9	dep	47115	47116	_	_	_	_	_
221	2	Refer	refer	NN	9	nsubj	47117	47122	_	_	_	_	_
221	3	also	also	RB	6	advmod	47123	47127	_	_	_	_	_
221	4	to	to	TO	6	case	47128	47130	_	_	_	_	_
221	5	‘	‘	CD	6	nummod	47131	47132	_	_	_	_	_
221	6	Management	management	NN	2	nmod	47132	47142	_	_	_	_	_
221	7	of	of	IN	8	case	47143	47145	_	_	_	_	_
221	8	infants	infant	NNS	6	nmod	47146	47153	_	_	_	_	_
221	9	born	bear	VBN	0	ROOT	47154	47158	_	_	_	_	_
221	10	to	to	TO	11	case	47159	47161	_	_	_	_	_
221	11	mothers	mother	NNS	9	nmod	47162	47169	_	_	_	_	_
221	12	who	who	WP	15	nsubj	47170	47173	_	_	_	_	_
221	13	are	be	VBP	15	cop	47174	47177	_	_	_	_	_
221	14	HBsAg-positive	hbsag-positive	JJ	15	amod	47178	47192	_	_	_	_	_
221	15	’	’	NN	11	acl:relcl	47192	47193	_	_	_	_	_
221	16	above	above	IN	15	advmod	47194	47199	_	_	_	_	_
221	17	.	.	.	9	punct	47199	47200	_	_	_	_	_

222	1	†	†	NN	7	nsubjpass	47202	47203	_	_	_	_	_
222	2	The	the	DT	4	det	47204	47207	_	_	_	_	_
222	3	1st	1st	JJ	4	amod	47208	47211	_	_	_	_	_
222	4	dose	dose	NN	1	dep	47212	47216	B-event-212177	_	_	_	_
222	5	can	can	MD	7	aux	47217	47220	_	_	_	_	_
222	6	be	be	VB	7	auxpass	47221	47223	_	_	_	_	_
222	7	given	give	VBN	0	ROOT	47224	47229	_	_	_	_	_
222	8	at	at	IN	11	case	47230	47232	_	_	_	_	_
222	9	the	the	DT	11	det	47233	47236	_	_	_	_	_
222	10	same	same	JJ	11	amod	47237	47241	_	_	_	_	_
222	11	time	time	NN	7	nmod	47242	47246	_	_	_	_	_
222	12	as	as	IN	13	case	47247	47249	_	_	_	_	_
222	13	HBIG	hbig	NN	11	nmod	47250	47254	_	_	_	_	_
222	14	,	,	,	7	punct	47254	47255	_	_	_	_	_
222	15	but	but	CC	7	cc	47256	47259	_	_	_	_	_
222	16	should	should	MD	18	aux	47260	47266	_	_	_	_	_
222	17	be	be	VB	18	auxpass	47267	47269	_	_	_	_	_
222	18	administered	administer	VBN	7	conj	47270	47282	B-event-212178	_	_	_	_
222	19	at	at	IN	22	case	47283	47285	_	_	_	_	_
222	20	a	a	DT	22	det	47286	47287	_	_	_	_	_
222	21	separate	separate	JJ	22	amod	47288	47296	_	_	_	_	_
222	22	site	site	NN	18	nmod	47297	47301	_	_	_	_	_
222	23	.	.	.	7	punct	47301	47302	_	_	_	_	_

223	1	Administration	administration	NN	9	nsubjpass	47303	47317	B-event-212179	_	_	_	_
223	2	as	as	RB	3	advmod	47318	47320	_	_	_	_	_
223	3	soon	soon	RB	1	advmod	47321	47325	_	_	_	_	_
223	4	as	as	IN	5	case	47326	47328	_	_	_	_	_
223	5	possible	possible	JJ	3	advcl	47329	47337	_	_	_	_	_
223	6	after	after	IN	7	case	47338	47343	_	_	_	_	_
223	7	exposure	exposure	NN	5	nmod	47344	47352	B-event-212180	_	_	_	_
223	8	is	be	VBZ	9	auxpass	47353	47355	_	_	_	_	_
223	9	preferred	prefer	VBN	0	ROOT	47356	47365	_	_	_	_	_
223	10	.	.	.	9	punct	47365	47366	_	_	_	_	_

224	1	‡	‡	NN	26	nsubjpass	47368	47369	_	_	_	_	_
224	2	There	there	EX	3	expl	47370	47375	_	_	_	_	_
224	3	is	be	VBZ	1	acl:relcl	47376	47378	_	_	_	_	_
224	4	limited	limited	JJ	5	amod	47379	47386	_	_	_	_	_
224	5	evidence	evidence	NN	3	nsubj	47387	47395	_	_	_	_	_
224	6	for	for	IN	7	case	47396	47399	_	_	_	_	_
224	7	efficacy	efficacy	NN	5	nmod	47400	47408	B-event-212181	_	_	_	_
224	8	if	if	IN	9	mark	47409	47411	_	_	_	_	_
224	9	given	give	VBN	3	advcl	47412	47417	_	_	_	_	_
224	10	within	within	IN	12	case	47418	47424	_	_	_	_	_
224	11	14	14	CD	12	nummod	47425	47427	_	_	_	_	_
224	12	days	day	NNS	9	nmod	47428	47432	_	_	_	_	_
224	13	of	of	IN	14	case	47433	47435	_	_	_	_	_
224	14	contact	contact	NN	12	nmod	47436	47443	_	_	_	_	_
224	15	;	;	:	12	punct	47443	47444	_	_	_	_	_
224	16	however	however	RB	12	advmod	47445	47452	_	_	_	_	_
224	17	,	,	,	12	punct	47452	47453	_	_	_	_	_
224	18	administration	administration	NN	12	dep	47454	47468	B-event-212182	_	_	_	_
224	19	as	as	RB	20	advmod	47469	47471	_	_	_	_	_
224	20	soon	soon	RB	18	advmod	47472	47476	_	_	_	_	_
224	21	as	as	IN	22	case	47477	47479	_	_	_	_	_
224	22	possible	possible	JJ	20	advcl	47480	47488	_	_	_	_	_
224	23	after	after	IN	24	case	47489	47494	_	_	_	_	_
224	24	exposure	exposure	NN	9	nmod	47495	47503	B-event-212183	_	_	_	_
224	25	is	be	VBZ	26	auxpass	47504	47506	_	_	_	_	_
224	26	preferred	prefer	VBN	0	ROOT	47507	47516	_	_	_	_	_
224	27	.	.	.	26	punct	47516	47517	_	_	_	_	_

225	1	Hepatitis	Hepatitis	NNP	6	compound	47518	47527	_	_	_	_	_
225	2	B	B	NNP	6	compound	47528	47529	_	_	_	_	_
225	3	immunoglobulin	immunoglobulin	NN	6	compound	47530	47544	_	_	_	_	_
225	4	(	(	CD	6	nummod	47545	47546	_	_	_	_	_
225	5	HBIG	hbig	NN	6	compound	47546	47550	_	_	_	_	_
225	6	)	)	NN	8	nsubjpass	47550	47551	_	_	_	_	_
225	7	is	be	VBZ	8	auxpass	47552	47554	_	_	_	_	_
225	8	prepared	prepare	VBN	0	ROOT	47555	47563	B-event-212184	_	_	_	_
225	9	from	from	IN	10	case	47564	47568	_	_	_	_	_
225	10	plasma	plasma	NN	8	nmod	47569	47575	_	_	_	_	_
225	11	donated	donate	VBN	10	acl	47576	47583	_	_	_	_	_
225	12	through	through	IN	16	case	47584	47591	_	_	_	_	_
225	13	routine	routine	JJ	16	amod	47592	47599	_	_	_	_	_
225	14	blood	blood	NN	16	compound	47600	47605	_	_	_	_	_
225	15	bank	bank	NN	16	compound	47606	47610	_	_	_	_	_
225	16	collection	collection	NN	11	nmod	47611	47621	B-event-212185	_	_	_	_
225	17	.	.	.	8	punct	47621	47622	_	_	_	_	_

226	1	Samples	sample	NNS	3	nsubjpass	47623	47630	_	_	_	_	_
226	2	are	be	VBP	3	auxpass	47631	47634	_	_	_	_	_
226	3	selected	select	VBN	0	ROOT	47635	47643	B-event-212186	_	_	_	_
226	4	on	on	IN	6	case	47644	47646	_	_	_	_	_
226	5	the	the	DT	6	det	47647	47650	_	_	_	_	_
226	6	basis	basis	NN	3	nmod	47651	47656	_	_	_	_	_
226	7	that	that	IN	9	mark	47657	47661	_	_	_	_	_
226	8	they	they	PRP	9	nsubj	47662	47666	_	_	_	_	_
226	9	contain	contain	VBP	3	ccomp	47667	47674	_	_	_	_	_
226	10	high	high	JJ	11	amod	47675	47679	_	_	_	_	_
226	11	levels	level	NNS	9	dobj	47680	47686	_	_	_	_	_
226	12	of	of	IN	14	case	47687	47689	_	_	_	_	_
226	13	anti-HBs	anti-hbs	JJ	14	amod	47690	47698	_	_	_	_	_
226	14	antibodies	antibody	NNS	11	nmod	47699	47709	_	_	_	_	_
226	15	.	.	.	3	punct	47709	47710	_	_	_	_	_

227	1	As	as	IN	7	mark	47711	47713	_	_	_	_	B-claim-10475
227	2	stocks	stock	NNS	7	nsubj	47714	47720	_	_	_	_	I-claim-10475
227	3	of	of	IN	4	case	47721	47723	_	_	_	_	I-claim-10475
227	4	HBIG	hbig	NN	2	nmod	47724	47728	_	_	_	_	I-claim-10475
227	5	are	be	VBP	7	cop	47729	47732	_	_	_	_	I-claim-10475
227	6	very	very	RB	7	advmod	47733	47737	_	_	_	_	I-claim-10475
227	7	limited	limited	JJ	13	advcl	47738	47745	_	_	_	_	I-claim-10475
227	8	,	,	,	13	punct	47745	47746	_	_	_	_	I-claim-10475
227	9	use	use	NN	13	nsubjpass	47747	47750	_	_	_	_	I-claim-10475
227	10	should	should	MD	13	aux	47751	47757	_	_	_	_	I-claim-10475
227	11	be	be	VB	13	auxpass	47758	47760	_	_	_	_	I-claim-10475
227	12	strictly	strictly	RB	13	advmod	47761	47769	_	_	_	_	I-claim-10475
227	13	reserved	reserve	VBN	71	dep	47770	47778	_	_	_	_	I-claim-10475
227	14	for	for	IN	15	case	47779	47782	_	_	_	_	I-claim-10475
227	15	those	those	DT	13	nmod	47783	47788	_	_	_	_	I-claim-10475
227	16	who	who	WP	20	nsubj	47789	47792	_	_	_	_	I-claim-10475
227	17	are	be	VBP	20	cop	47793	47796	_	_	_	_	I-claim-10475
227	18	at	at	IN	20	case	47797	47799	_	_	_	_	I-claim-10475
227	19	high	high	JJ	20	amod	47800	47804	_	_	_	_	I-claim-10475
227	20	risk	risk	NN	15	acl:relcl	47805	47809	B-event-212187	_	_	_	I-claim-10475
227	21	,	,	,	20	punct	47809	47810	_	_	_	_	_
227	22	such	such	JJ	24	case	47811	47815	_	_	_	_	_
227	23	as	as	IN	22	mwe	47816	47818	_	_	_	_	_
227	24	babies	baby	NNS	20	nmod	47819	47825	_	_	_	_	_
227	25	born	bear	VBN	24	acl	47826	47830	_	_	_	_	_
227	26	to	to	TO	27	case	47831	47833	_	_	_	_	_
227	27	mothers	mother	NNS	25	nmod	47834	47841	_	_	_	_	_
227	28	with	with	IN	31	case	47842	47846	_	_	_	_	_
227	29	chronic	chronic	JJ	31	amod	47847	47854	_	_	_	_	_
227	30	HBV	hbv	NN	31	compound	47855	47858	B-event-212188	_	_	_	_
227	31	infection	infection	NN	27	nmod	47859	47868	B-event-212189	_	_	_	_
227	32	and	and	CC	27	cc	47869	47872	_	_	_	_	_
227	33	non-immune	non-immune	JJ	34	amod	47873	47883	_	_	_	_	_
227	34	persons	person	NNS	27	conj	47884	47891	_	_	_	_	_
227	35	who	who	WP	37	nsubjpass	47892	47895	_	_	_	_	_
227	36	are	be	VBP	37	auxpass	47896	47899	_	_	_	_	_
227	37	exposed	expose	VBN	34	acl:relcl	47900	47907	B-event-212190	_	_	_	_
227	38	through	through	IN	40	case	47908	47915	_	_	_	_	_
227	39	occupational	occupational	JJ	40	amod	47916	47928	_	_	_	_	_
227	40	exposure	exposure	NN	37	nmod	47929	47937	B-event-212191	_	_	_	_
227	41	to	to	TO	43	case	47938	47940	_	_	_	_	_
227	42	the	the	DT	43	det	47941	47944	_	_	_	_	_
227	43	blood	blood	NN	37	nmod	47945	47950	_	_	_	_	_
227	44	of	of	IN	46	case	47951	47953	_	_	_	_	_
227	45	unidentified	unidentified	JJ	46	amod	47954	47966	_	_	_	_	_
227	46	persons	person	NNS	43	nmod	47967	47974	_	_	_	_	_
227	47	or	or	CC	27	cc	47975	47977	_	_	_	_	_
227	48	to	to	TO	49	case	47978	47980	_	_	_	_	_
227	49	persons	person	NNS	27	conj	47981	47988	_	_	_	_	_
227	50	who	who	WP	53	nsubjpass	47989	47992	_	_	_	_	_
227	51	are	be	VBP	53	auxpass	47993	47996	_	_	_	_	_
227	52	chronically	chronically	RB	53	advmod	47997	48008	_	_	_	_	_
227	53	infected	infect	VBN	49	acl:relcl	48009	48017	B-event-212192	_	_	_	_
227	54	with	with	IN	56	case	48018	48022	_	_	_	_	_
227	55	hepatitis	hepatitis	NN	56	compound	48023	48032	B-event-212193	_	_	_	_
227	56	B	b	NN	53	nmod	48033	48034	I-event-212193	_	_	_	_
227	57	or	or	CC	20	cc	48035	48037	_	_	_	_	_
227	58	whose	whose	WP$	59	nmod:poss	48038	48043	_	_	_	_	_
227	59	hepatitis	hepatitis	NN	64	dobj	48044	48053	_	_	_	_	_
227	60	status	status	NN	64	nsubjpass	48054	48060	_	_	_	_	_
227	61	can	can	MD	64	aux	48061	48064	_	_	_	_	_
227	62	not	not	RB	64	neg	48064	48067	_	_	_	_	_
227	63	be	be	VB	64	auxpass	48068	48070	_	_	_	_	_
227	64	ascertained	ascertain	VBN	20	conj	48071	48082	B-event-212194	_	_	_	_
227	65	in	in	IN	68	case	48083	48085	_	_	_	_	_
227	66	time	time	NN	68	compound	48086	48090	_	_	_	_	_
227	67	.88	.88	CD	68	nummod	48090	48093	_	_	_	_	_
227	68	Requests	request	NNS	64	nmod	48094	48102	_	_	_	_	B-claim-10476
227	69	should	should	MD	71	aux	48103	48109	_	_	_	_	I-claim-10476
227	70	be	be	VB	71	auxpass	48110	48112	_	_	_	_	I-claim-10476
227	71	directed	direct	VBN	0	ROOT	48113	48121	_	_	_	_	I-claim-10476
227	72	to	to	TO	78	case	48122	48124	_	_	_	_	I-claim-10476
227	73	the	the	DT	78	det	48125	48128	_	_	_	_	I-claim-10476
227	74	Australian	australian	JJ	78	amod	48129	48139	_	_	_	_	I-claim-10476
227	75	Red	Red	NNP	78	compound	48140	48143	_	_	_	_	I-claim-10476
227	76	Cross	Cross	NNP	78	compound	48144	48149	_	_	_	_	I-claim-10476
227	77	Blood	Blood	NNP	78	compound	48150	48155	_	_	_	_	I-claim-10476
227	78	Service	Service	NNP	71	nmod	48156	48163	_	_	_	_	I-claim-10476
227	79	in	in	IN	82	case	48164	48166	_	_	_	_	I-claim-10476
227	80	your	you	PRP$	82	nmod:poss	48167	48171	_	_	_	_	I-claim-10476
227	81	state/territory	state/territory	JJ	82	amod	48172	48187	_	_	_	_	I-claim-10476
227	82	(	(	NN	78	nmod	48188	48189	_	_	_	_	_
227	83	refer	refer	VB	71	ccomp	48189	48194	_	_	_	_	_
227	84	to	to	TO	86	case	48195	48197	_	_	_	_	_
227	85	5.1.1	5.1.1	CD	86	nummod	48198	48203	_	_	_	_	_
227	86	Availability	availability	NN	83	nmod	48204	48216	_	_	_	_	_
227	87	of	of	IN	88	case	48217	48219	_	_	_	_	_
227	88	immunoglobulins	immunoglobulin	NNS	86	nmod	48220	48235	_	_	_	_	_
227	89	in	in	IN	90	case	48236	48238	_	_	_	_	_
227	90	Part	Part	NNP	88	nmod	48239	48243	_	_	_	_	_
227	91	5	5	CD	94	nummod	48244	48245	_	_	_	_	_
227	92	Passive	passive	JJ	94	amod	48246	48253	_	_	_	_	_
227	93	immunisation	immunisation	NN	94	compound	48254	48266	_	_	_	_	_
227	94	)	)	NN	71	nsubjpass	48266	48267	_	_	_	_	_
227	95	.	.	.	71	punct	48267	48268	_	_	_	_	_

228	1	4.5.12	4.5.12	CD	2	nummod	48269	48275	_	_	_	_	_
228	2	Variations	variation	NNS	43	nsubjpass	48276	48286	_	_	_	_	_
228	3	from	from	IN	5	case	48287	48291	_	_	_	_	_
228	4	product	product	NN	5	compound	48292	48299	_	_	_	_	_
228	5	information	information	NN	2	nmod	48300	48311	_	_	_	_	_
228	6	The	the	DT	8	det	48312	48315	_	_	B-source-25364	_	_
228	7	product	product	NN	8	compound	48316	48323	_	_	I-source-25364	_	_
228	8	information	information	NN	5	dep	48324	48335	_	_	I-source-25364	_	_
228	9	for	for	IN	12	case	48336	48339	_	_	I-source-25364	_	_
228	10	Infanrix	Infanrix	NNP	12	compound	48340	48348	_	_	I-source-25364	_	_
228	11	hexa	hexa	JJ	12	amod	48349	48353	_	_	I-source-25364	_	_
228	12	states	state	NNS	8	nmod	48354	48360	_	_	_	B-cue-25365	_
228	13	that	that	IN	17	mark	48361	48365	_	B-content-25366:25364-Source_25365-Cue	_	_	_
228	14	this	this	DT	15	det	48366	48370	_	I-content-25366	_	_	_
228	15	vaccine	vaccine	NN	17	nsubjpass	48371	48378	_	I-content-25366	_	_	_
228	16	is	be	VBZ	17	auxpass	48379	48381	_	I-content-25366	_	_	_
228	17	indicated	indicate	VBN	8	dep	48382	48391	_	I-content-25366	_	_	_
228	18	for	for	IN	20	case	48392	48395	_	I-content-25366	_	_	_
228	19	primary	primary	JJ	20	amod	48396	48403	_	I-content-25366	_	_	_
228	20	immunisation	immunisation	NN	17	nmod	48404	48416	B-event-212195	I-content-25366	_	_	_
228	21	of	of	IN	22	case	48417	48419	_	I-content-25366	_	_	_
228	22	infants	infant	NNS	20	nmod	48420	48427	_	I-content-25366	_	_	_
228	23	from	from	IN	25	case	48428	48432	_	I-content-25366	_	_	_
228	24	the	the	DT	25	det	48433	48436	_	I-content-25366	_	_	_
228	25	age	age	NN	17	nmod	48437	48440	_	I-content-25366	_	_	_
228	26	of	of	IN	28	case	48441	48443	_	I-content-25366	_	_	_
228	27	6	6	CD	28	nummod	48444	48445	_	I-content-25366	_	_	_
228	28	weeks	week	NNS	25	nmod	48446	48451	_	I-content-25366	_	_	_
228	29	and	and	CC	25	cc	48452	48455	_	I-content-25366	_	_	_
228	30	as	as	IN	33	case	48456	48458	_	I-content-25366	_	_	_
228	31	a	a	DT	33	det	48459	48460	_	I-content-25366	_	_	_
228	32	booster	booster	NN	33	compound	48461	48468	_	I-content-25366	_	_	_
228	33	dose	dose	NN	25	conj	48469	48473	B-event-212197	I-content-25366	_	_	_
228	34	for	for	IN	35	case	48474	48477	_	I-content-25366	_	_	_
228	35	children	child	NNS	33	nmod	48478	48486	_	I-content-25366	_	_	_
228	36	18	18	CD	37	nummod	48487	48489	_	I-content-25366	_	_	_
228	37	months	month	NNS	35	nmod:tmod	48490	48496	_	I-content-25366	_	_	_
228	38	of	of	IN	39	case	48497	48499	_	I-content-25366	_	_	_
228	39	age	age	NN	35	nmod	48500	48503	_	I-content-25366	_	_	_
228	40	if	if	IN	41	mark	48504	48506	_	I-content-25366	_	_	_
228	41	boosting	boost	VBG	17	advcl	48507	48515	B-event-212196	I-content-25366	_	_	_
228	42	is	be	VBZ	43	auxpass	48516	48518	_	I-content-25366	_	_	_
228	43	required	require	VBN	0	ROOT	48519	48527	_	I-content-25366	_	_	_
228	44	for	for	IN	46	case	48528	48531	_	I-content-25366	_	_	_
228	45	all	all	DT	46	det	48532	48535	_	I-content-25366	_	_	_
228	46	antigens	antigen	NNS	43	nmod	48536	48544	_	I-content-25366	_	_	_
228	47	.	.	.	43	punct	48544	48545	_	_	_	_	_

229	1	The	the	DT	2	det	48546	48549	_	_	B-source-25367	_	_
229	2	ATAGI	ATAGI	NNP	3	nsubj	48550	48555	_	_	I-source-25367	_	_
229	3	recommends	recommend	VBZ	0	ROOT	48556	48566	_	_	_	B-cue-25368	_
229	4	that	that	IN	10	mark	48567	48571	_	B-content-25369:25367-Source_25368-Cue	_	_	_
229	5	this	this	DT	6	det	48572	48576	_	I-content-25369	_	_	_
229	6	vaccine	vaccine	NN	10	nsubjpass	48577	48584	_	I-content-25369	_	_	_
229	7	may	may	MD	10	aux	48585	48588	_	I-content-25369	_	_	_
229	8	also	also	RB	10	advmod	48589	48593	_	I-content-25369	_	_	_
229	9	be	be	VB	10	auxpass	48594	48596	_	I-content-25369	_	_	_
229	10	used	use	VBN	3	ccomp	48597	48601	_	I-content-25369	_	_	_
229	11	for	for	IN	12	case	48602	48605	_	I-content-25369	_	_	_
229	12	catch-up	catch-up	NN	10	nmod	48606	48614	B-event-212198	I-content-25369	_	_	_
229	13	of	of	IN	16	case	48615	48617	_	I-content-25369	_	_	_
229	14	the	the	DT	16	det	48618	48621	_	I-content-25369	_	_	_
229	15	primary	primary	JJ	16	amod	48622	48629	_	I-content-25369	_	_	_
229	16	schedule	schedule	NN	12	nmod	48630	48638	_	I-content-25369	_	_	_
229	17	in	in	IN	18	case	48639	48641	_	I-content-25369	_	_	_
229	18	children	child	NNS	16	nmod	48642	48650	_	I-content-25369	_	_	_
229	19	<	<	JJR	18	amod	48651	48652	_	I-content-25369	_	_	_
229	20	10	10	CD	21	nummod	48652	48654	_	I-content-25369	_	_	_
229	21	years	year	NNS	19	nmod:tmod	48655	48660	_	I-content-25369	_	_	_
229	22	of	of	IN	23	case	48661	48663	_	I-content-25369	_	_	_
229	23	age	age	NN	18	nmod	48664	48667	_	I-content-25369	_	_	_
229	24	.	.	.	3	punct	48667	48668	_	_	_	_	_

230	1	The	the	DT	3	det	48669	48672	_	_	B-source-25370	_	_
230	2	product	product	NN	3	compound	48673	48680	_	_	I-source-25370	_	_
230	3	information	information	NN	0	ROOT	48681	48692	_	_	I-source-25370	_	_
230	4	for	for	IN	7	case	48693	48696	_	_	I-source-25370	_	_
230	5	Infanrix	Infanrix	NNP	7	compound	48697	48705	_	_	I-source-25370	_	_
230	6	hexa	hexa	JJ	7	amod	48706	48710	_	_	I-source-25370	_	_
230	7	states	state	NNS	3	nmod	48711	48717	_	_	_	B-cue-25371	_
230	8	that	that	IN	12	mark	48718	48722	_	B-content-25372:25370-Source_25371-Cue	_	_	_
230	9	this	this	DT	10	det	48723	48727	_	I-content-25372	_	_	B-claim-10477
230	10	vaccine	vaccine	NN	12	nsubjpass	48728	48735	_	I-content-25372	_	_	I-claim-10477
230	11	is	be	VBZ	12	auxpass	48736	48738	_	I-content-25372	_	_	I-claim-10477
230	12	contraindicated	contraindicate	VBN	7	dep	48739	48754	B-event-212199	I-content-25372	_	_	I-claim-10477
230	13	in	in	IN	14	case	48755	48757	_	I-content-25372	_	_	I-claim-10477
230	14	children	child	NNS	12	nmod	48758	48766	_	I-content-25372	_	_	I-claim-10477
230	15	with	with	IN	16	case	48767	48771	_	I-content-25372	_	_	I-claim-10477
230	16	encephalopathy	encephalopathy	NN	14	nmod	48772	48786	B-event-212200	I-content-25372	_	_	I-claim-10477
230	17	of	of	IN	19	case	48787	48789	_	I-content-25372	_	_	I-claim-10477
230	18	unknown	unknown	JJ	19	amod	48790	48797	_	I-content-25372	_	_	I-claim-10477
230	19	aetiology	aetiology	NN	16	nmod	48798	48807	_	I-content-25372	_	_	I-claim-10477
230	20	or	or	CC	14	cc	48808	48810	_	I-content-25372	_	_	I-claim-10477
230	21	with	with	IN	23	case	48811	48815	_	I-content-25372	_	_	I-claim-10477
230	22	neurologic	neurologic	JJ	23	amod	48816	48826	_	I-content-25372	_	_	I-claim-10477
230	23	complications	complication	NNS	14	conj	48827	48840	B-event-212201	I-content-25372	_	_	I-claim-10477
230	24	occurring	occur	VBG	23	acl	48841	48850	_	I-content-25372	_	_	I-claim-10477
230	25	within	within	IN	27	case	48851	48857	_	I-content-25372	_	_	I-claim-10477
230	26	7	7	CD	27	nummod	48858	48859	_	I-content-25372	_	_	I-claim-10477
230	27	days	day	NNS	24	nmod	48860	48864	_	I-content-25372	_	_	I-claim-10477
230	28	following	follow	VBG	31	case	48865	48874	_	I-content-25372	_	_	I-claim-10477
230	29	a	a	DT	31	det	48875	48876	_	I-content-25372	_	_	I-claim-10477
230	30	vaccine	vaccine	NN	31	compound	48877	48884	B-event-212202	I-content-25372	_	_	I-claim-10477
230	31	dose	dose	NN	27	nmod	48885	48889	_	I-content-25372	_	_	I-claim-10477
230	32	.	.	.	3	punct	48889	48890	_	_	_	_	_

231	1	The	the	DT	2	det	48891	48894	_	_	B-source-25373	_	_
231	2	ATAGI	ATAGI	NNP	3	nsubj	48895	48900	_	_	I-source-25373	_	_
231	3	recommends	recommend	VBZ	0	ROOT	48901	48911	_	_	_	B-cue-25374	_
231	4	instead	instead	RB	3	advmod	48912	48919	_	_	_	_	_
231	5	that	that	IN	11	mark	48920	48924	_	B-content-25375:25374-Cue_25373-Source	_	_	_
231	6	the	the	DT	8	det	48925	48928	_	I-content-25375	_	_	B-claim-10480
231	7	only	only	JJ	8	amod	48929	48933	_	I-content-25375	_	_	I-claim-10480
231	8	contraindication	contraindication	NN	11	nsubj	48934	48950	B-event-212203	I-content-25375	_	_	I-claim-10480
231	9	is	be	VBZ	11	cop	48951	48953	_	I-content-25375	_	_	I-claim-10480
231	10	a	a	DT	11	det	48954	48955	_	I-content-25375	_	_	I-claim-10480
231	11	history	history	NN	3	ccomp	48956	48963	_	I-content-25375	_	_	I-claim-10480
231	12	of	of	IN	13	case	48964	48966	_	I-content-25375	_	_	I-claim-10480
231	13	anaphylaxis	anaphylaxis	NN	11	nmod	48967	48978	B-event-211801	I-content-25375	_	_	I-claim-10480
231	14	to	to	TO	17	case	48979	48981	_	I-content-25375	_	_	I-claim-10480
231	15	a	a	DT	17	det	48982	48983	_	I-content-25375	_	_	I-claim-10480
231	16	previous	previous	JJ	17	amod	48984	48992	_	I-content-25375	_	_	I-claim-10480
231	17	dose	dose	NN	13	nmod	48993	48997	B-event-211802	I-content-25375	_	_	I-claim-10480
231	18	or	or	CC	17	cc	48998	49000	_	I-content-25375	_	_	I-claim-10480
231	19	to	to	TO	20	case	49001	49003	_	I-content-25375	_	_	I-claim-10480
231	20	any	any	DT	17	conj	49004	49007	_	I-content-25375	_	_	I-claim-10480
231	21	of	of	IN	24	case	49008	49010	_	I-content-25375	_	_	I-claim-10480
231	22	the	the	DT	24	det	49011	49014	_	I-content-25375	_	_	I-claim-10480
231	23	vaccine	vaccine	NN	24	compound	49015	49022	_	I-content-25375	_	_	I-claim-10480
231	24	components	component	NNS	20	nmod	49023	49033	_	I-content-25375	_	_	I-claim-10480
231	25	.	.	.	3	punct	49033	49034	_	_	_	_	_

232	1	Dandri	Dandri	NNP	2	compound	49035	49041	_	_	_	_	_
232	2	M	M	NNP	0	ROOT	49042	49043	_	_	_	_	_
232	3	,	,	,	2	punct	49043	49044	_	_	_	_	_
232	4	Locarnini	Locarnini	NNP	7	compound	49045	49054	_	_	_	_	_
232	5	S.	S.	NNP	7	compound	49055	49057	_	_	_	_	_
232	6	New	New	NNP	7	compound	49058	49061	_	_	_	_	_
232	7	insight	insight	NN	2	appos	49062	49069	_	_	_	_	_
232	8	in	in	IN	10	case	49070	49072	_	_	_	_	_
232	9	the	the	DT	10	det	49073	49076	_	_	_	_	_
232	10	pathobiology	pathobiology	NN	7	nmod	49077	49089	_	_	_	_	_
232	11	of	of	IN	15	case	49090	49092	_	_	_	_	_
232	12	hepatitis	hepatitis	NN	15	compound	49093	49102	_	_	_	_	_
232	13	B	b	NN	15	compound	49103	49104	_	_	_	_	_
232	14	virus	virus	NN	15	compound	49105	49110	_	_	_	_	_
232	15	infection	infection	NN	10	nmod	49111	49120	_	_	_	_	_
232	16	.	.	.	2	punct	49120	49121	_	_	_	_	_

233	1	Gut	gut	NN	0	ROOT	49122	49125	_	_	_	_	_
233	2	2012	2012	CD	1	nummod	49126	49130	_	_	_	_	_
233	3	;	;	:	1	punct	49130	49131	_	_	_	_	_
233	4	61	61	CD	5	nummod	49131	49133	_	_	_	_	_
233	5	Suppl	suppl	NN	1	dep	49134	49139	_	_	_	_	_
233	6	1	1	CD	5	dep	49140	49141	_	_	_	_	_
233	7	:	:	:	5	punct	49141	49142	_	_	_	_	_
233	8	i6-17	i6-17	NN	5	dep	49142	49147	_	_	_	_	_
233	9	.	.	.	1	punct	49147	49148	_	_	_	_	_

234	1	Shepard	Shepard	NNP	2	compound	49149	49156	_	_	_	_	_
234	2	CW	CW	NNP	0	ROOT	49157	49159	_	_	_	_	_
234	3	,	,	,	2	punct	49159	49160	_	_	_	_	_
234	4	Simard	Simard	NNP	5	compound	49161	49167	_	_	_	_	_
234	5	EP	EP	NNP	2	appos	49168	49170	_	_	_	_	_
234	6	,	,	,	2	punct	49170	49171	_	_	_	_	_
234	7	Finelli	Finelli	NNP	8	compound	49172	49179	_	_	_	_	_
234	8	L	L	NNP	2	appos	49180	49181	_	_	_	_	_
234	9	,	,	,	2	punct	49181	49182	_	_	_	_	_
234	10	Fiore	Fiore	NNP	11	compound	49183	49188	_	_	_	_	_
234	11	AE	AE	NNP	2	appos	49189	49191	_	_	_	_	_
234	12	,	,	,	2	punct	49191	49192	_	_	_	_	_
234	13	Bell	Bell	NNP	14	compound	49193	49197	_	_	_	_	_
234	14	BP	BP	NNP	2	appos	49198	49200	_	_	_	_	_
234	15	.	.	.	2	punct	49200	49201	_	_	_	_	_

235	1	Hepatitis	Hepatitis	NNP	4	compound	49202	49211	_	_	_	_	_
235	2	B	b	NN	4	compound	49212	49213	_	_	_	_	_
235	3	virus	virus	NN	4	compound	49214	49219	_	_	_	_	_
235	4	infection	infection	NN	0	ROOT	49220	49229	_	_	_	_	_
235	5	:	:	:	4	punct	49229	49230	_	_	_	_	_
235	6	epidemiology	epidemiology	NN	4	dep	49231	49243	_	_	_	_	_
235	7	and	and	CC	6	cc	49244	49247	_	_	_	_	_
235	8	vaccination	vaccination	NN	6	conj	49248	49259	_	_	_	_	_
235	9	.	.	.	4	punct	49259	49260	_	_	_	_	_

236	1	Epidemiologic	epidemiologic	JJ	2	amod	49261	49274	_	_	_	_	_
236	2	Reviews	review	NNS	0	ROOT	49275	49282	_	_	_	_	_
236	3	2006	2006	CD	5	nummod	49283	49287	_	_	_	_	_
236	4	;	;	:	5	punct	49287	49288	_	_	_	_	_
236	5	28:112-25	28:112-25	CD	2	dep	49288	49297	_	_	_	_	_
236	6	.	.	.	2	punct	49297	49298	_	_	_	_	_

237	1	McMahon	McMahon	NNP	2	compound	49299	49306	_	_	_	_	_
237	2	BJ	BJ	NNP	0	ROOT	49307	49309	_	_	_	_	_
237	3	,	,	,	2	punct	49309	49310	_	_	_	_	_
237	4	Alward	Alward	NNP	5	compound	49311	49317	_	_	_	_	_
237	5	WL	WL	NNP	2	appos	49318	49320	_	_	_	_	_
237	6	,	,	,	2	punct	49320	49321	_	_	_	_	_
237	7	Hall	Hall	NNP	8	compound	49322	49326	_	_	_	_	_
237	8	DB	DB	NNP	2	appos	49327	49329	_	_	_	_	_
237	9	,	,	,	2	punct	49329	49330	_	_	_	_	_
237	10	et	et	FW	11	compound	49331	49333	_	_	_	_	_
237	11	al.	al.	FW	2	appos	49334	49337	_	_	_	_	_
237	12	.	.	.	2	punct	_	_	_	_	_	_	_

238	1	Acute	acute	JJ	5	amod	49338	49343	_	_	_	_	_
238	2	hepatitis	hepatitis	NN	5	compound	49344	49353	_	_	_	_	_
238	3	B	b	NN	5	compound	49354	49355	_	_	_	_	_
238	4	virus	virus	NN	5	compound	49356	49361	_	_	_	_	_
238	5	infection	infection	NN	0	ROOT	49362	49371	_	_	_	_	_
238	6	:	:	:	5	punct	49371	49372	_	_	_	_	_
238	7	relation	relation	NN	5	dep	49373	49381	_	_	_	_	_
238	8	of	of	IN	9	case	49382	49384	_	_	_	_	_
238	9	age	age	NN	7	nmod	49385	49388	_	_	_	_	_
238	10	to	to	TO	13	case	49389	49391	_	_	_	_	_
238	11	the	the	DT	13	det	49392	49395	_	_	_	_	_
238	12	clinical	clinical	JJ	13	amod	49396	49404	_	_	_	_	_
238	13	expression	expression	NN	9	nmod	49405	49415	_	_	_	_	_
238	14	of	of	IN	15	case	49416	49418	_	_	_	_	_
238	15	disease	disease	NN	13	nmod	49419	49426	_	_	_	_	_
238	16	and	and	CC	13	cc	49427	49430	_	_	_	_	_
238	17	subsequent	subsequent	JJ	18	amod	49431	49441	_	_	_	_	_
238	18	development	development	NN	13	conj	49442	49453	_	_	_	_	_
238	19	of	of	IN	22	case	49454	49456	_	_	_	_	_
238	20	the	the	DT	22	det	49457	49460	_	_	_	_	_
238	21	carrier	carrier	NN	22	compound	49461	49468	_	_	_	_	_
238	22	state	state	NN	18	nmod	49469	49474	_	_	_	_	_
238	23	.	.	.	5	punct	49474	49475	_	_	_	_	_

239	1	Journal	Journal	NNP	0	ROOT	49476	49483	_	_	_	_	_
239	2	of	of	IN	4	case	49484	49486	_	_	_	_	_
239	3	Infectious	infectious	JJ	4	amod	49487	49497	_	_	_	_	_
239	4	Diseases	disease	NNS	1	nmod	49498	49506	_	_	_	_	_
239	5	1985	1985	CD	1	dep	49507	49511	_	_	_	_	_
239	6	;	;	:	1	punct	49511	49512	_	_	_	_	_
239	7	151:599-603	151:599-603	CD	1	dep	49512	49523	_	_	_	_	_
239	8	.	.	.	1	punct	49523	49524	_	_	_	_	_

240	1	Koziel	Koziel	NNP	2	compound	49525	49531	_	_	_	_	_
240	2	MJ	MJ	NNP	0	ROOT	49532	49534	_	_	_	_	_
240	3	,	,	,	2	punct	49534	49535	_	_	_	_	_
240	4	Thio	Thio	NNP	5	compound	49536	49540	_	_	_	_	_
240	5	CL	cl	NN	2	appos	49541	49543	_	_	_	_	_
240	6	.	.	.	2	punct	49543	49544	_	_	_	_	_

241	1	Hepatitis	Hepatitis	NNP	0	ROOT	49545	49554	_	_	_	_	_
241	2	B	b	NN	3	compound	49555	49556	_	_	_	_	_
241	3	virus	virus	NN	1	dep	49557	49562	_	_	_	_	_
241	4	and	and	CC	3	cc	49563	49566	_	_	_	_	_
241	5	hepatitis	hepatitis	NN	7	compound	49567	49576	_	_	_	_	_
241	6	delta	delta	NN	7	compound	49577	49582	_	_	_	_	_
241	7	virus	virus	NN	3	conj	49583	49588	_	_	_	_	_
241	8	.	.	.	1	punct	49588	49589	_	_	_	_	_

242	1	In	in	IN	4	dep	49590	49592	_	_	_	_	_
242	2	:	:	:	4	punct	49592	49593	_	_	_	_	_
242	3	Mandell	Mandell	NNP	4	compound	49594	49601	_	_	_	_	_
242	4	GL	GL	NNP	0	ROOT	49602	49604	_	_	_	_	_
242	5	,	,	,	4	punct	49604	49605	_	_	_	_	_
242	6	Bennett	Bennett	NNP	7	compound	49606	49613	_	_	_	_	_
242	7	JE	JE	NNP	4	appos	49614	49616	_	_	_	_	_
242	8	,	,	,	4	punct	49616	49617	_	_	_	_	_
242	9	Dolin	Dolin	NNP	10	compound	49618	49623	_	_	_	_	_
242	10	R	R	NNP	4	appos	49624	49625	_	_	_	_	_
242	11	,	,	,	4	punct	49625	49626	_	_	_	_	_
242	12	eds	ed	NNS	4	appos	49627	49630	_	_	_	_	_
242	13	.	.	.	4	punct	49630	49631	_	_	_	_	_

243	1	Mandell	Mandell	NNP	0	ROOT	49632	49639	_	_	_	_	_
243	2	,	,	,	1	punct	49639	49640	_	_	_	_	_
243	3	Douglas	Douglas	NNP	1	conj	49641	49648	_	_	_	_	_
243	4	,	,	,	1	punct	49648	49649	_	_	_	_	_
243	5	and	and	CC	1	cc	49650	49653	_	_	_	_	_
243	6	Bennett	Bennett	NNP	8	nmod:poss	49654	49661	_	_	_	_	_
243	7	’s	’s	POS	6	case	49661	49663	_	_	_	_	_
243	8	principles	principle	NNS	1	conj	49664	49674	_	_	_	_	_
243	9	and	and	CC	8	cc	49675	49678	_	_	_	_	_
243	10	practice	practice	NN	8	conj	49679	49687	_	_	_	_	_
243	11	of	of	IN	13	case	49688	49690	_	_	_	_	_
243	12	infectious	infectious	JJ	13	amod	49691	49701	_	_	_	_	_
243	13	diseases	disease	NNS	8	nmod	49702	49710	_	_	_	_	_
243	14	.	.	.	1	punct	49710	49711	_	_	_	_	_

244	1	7th	7th	JJ	2	nsubj	49712	49715	_	_	_	_	_
244	2	ed	ed	VBN	0	ROOT	49716	49718	_	_	_	_	_
244	3	.	.	.	2	punct	49718	49719	_	_	_	_	_

245	1	Philadelphia	Philadelphia	NNP	0	ROOT	49720	49732	_	_	_	_	_
245	2	:	:	:	1	punct	49732	49733	_	_	_	_	_
245	3	Churchill	Churchill	NNP	4	compound	49734	49743	_	_	_	_	_
245	4	Livingstone	Livingstone	NNP	1	dep	49744	49755	_	_	_	_	_
245	5	,	,	,	4	punct	49755	49756	_	_	_	_	_
245	6	2010	2010	CD	4	amod	49757	49761	_	_	_	_	_
245	7	.	.	.	1	punct	49761	49762	_	_	_	_	_

246	1	Edmunds	Edmunds	NNP	2	compound	49763	49770	_	_	_	_	_
246	2	WJ	WJ	NNP	0	ROOT	49771	49773	_	_	_	_	_
246	3	,	,	,	2	punct	49773	49774	_	_	_	_	_
246	4	Medley	Medley	NNP	5	compound	49775	49781	_	_	_	_	_
246	5	GF	gf	NN	2	appos	49782	49784	_	_	_	_	_
246	6	,	,	,	2	punct	49784	49785	_	_	_	_	_
246	7	Nokes	Nokes	NNP	8	compound	49786	49791	_	_	_	_	_
246	8	DJ	DJ	NNP	2	appos	49792	49794	_	_	_	_	_
246	9	,	,	,	2	punct	49794	49795	_	_	_	_	_
246	10	Hall	Hall	NNP	11	compound	49796	49800	_	_	_	_	_
246	11	AJ	AJ	NNP	2	appos	49801	49803	_	_	_	_	_
246	12	,	,	,	2	punct	49803	49804	_	_	_	_	_
246	13	Whittle	Whittle	NNP	14	compound	49805	49812	_	_	_	_	_
246	14	HC	HC	NNP	2	appos	49813	49815	_	_	_	_	_
246	15	.	.	.	2	punct	49815	49816	_	_	_	_	_

247	1	The	the	DT	2	det	49817	49820	_	_	_	_	_
247	2	influence	influence	NN	0	ROOT	49821	49830	_	_	_	_	_
247	3	of	of	IN	4	case	49831	49833	_	_	_	_	_
247	4	age	age	NN	2	nmod	49834	49837	_	_	_	_	_
247	5	on	on	IN	7	case	49838	49840	_	_	_	_	_
247	6	the	the	DT	7	det	49841	49844	_	_	_	_	_
247	7	development	development	NN	2	nmod	49845	49856	_	_	_	_	_
247	8	of	of	IN	13	case	49857	49859	_	_	_	_	_
247	9	the	the	DT	13	det	49860	49863	_	_	_	_	_
247	10	hepatitis	hepatitis	NN	13	compound	49864	49873	_	_	_	_	_
247	11	B	b	NN	13	compound	49874	49875	_	_	_	_	_
247	12	carrier	carrier	NN	13	compound	49876	49883	_	_	_	_	_
247	13	state	state	NN	7	nmod	49884	49889	_	_	_	_	_
247	14	.	.	.	2	punct	49889	49890	_	_	_	_	_

248	1	Proceedings	Proceedings	NNP	0	ROOT	49891	49902	_	_	_	_	_
248	2	of	of	IN	5	case	49903	49905	_	_	_	_	_
248	3	the	the	DT	5	det	49906	49909	_	_	_	_	_
248	4	Royal	Royal	NNP	5	compound	49910	49915	_	_	_	_	_
248	5	Society	Society	NNP	1	nmod	49916	49923	_	_	_	_	_
248	6	of	of	IN	9	case	49924	49926	_	_	_	_	_
248	7	London	London	NNP	9	compound	49927	49933	_	_	_	_	_
248	8	Series	Series	NNP	9	compound	49934	49940	_	_	_	_	_
248	9	B	B	NNP	5	nmod	49941	49942	_	_	_	_	_
248	10	:	:	:	1	punct	49942	49943	_	_	_	_	_
248	11	Biological	Biological	NNP	12	compound	49944	49954	_	_	_	_	_
248	12	Sciences	Sciences	NNPS	1	dep	49955	49963	_	_	_	_	_
248	13	1993	1993	CD	15	nummod	49964	49968	_	_	_	_	_
248	14	;	;	:	15	punct	49968	49969	_	_	_	_	_
248	15	253:197-201	253:197-201	CD	12	dep	49969	49980	_	_	_	_	_
248	16	.	.	.	1	punct	49980	49981	_	_	_	_	_

249	1	Wood	Wood	NNP	2	compound	49982	49986	_	_	_	_	_
249	2	N	N	NNP	0	ROOT	49987	49988	_	_	_	_	_
249	3	,	,	,	2	punct	49988	49989	_	_	_	_	_
249	4	Backhouse	Backhouse	NNP	5	compound	49990	49999	_	_	_	_	_
249	5	J	J	NNP	2	appos	50000	50001	_	_	_	_	_
249	6	,	,	,	2	punct	50001	50002	_	_	_	_	_
249	7	Gidding	Gidding	NNP	8	compound	50003	50010	_	_	_	_	_
249	8	HF	hf	NN	2	appos	50011	50013	_	_	_	_	_
249	9	,	,	,	2	punct	50013	50014	_	_	_	_	_
249	10	et	et	FW	11	compound	50015	50017	_	_	_	_	_
249	11	al.	al.	FW	2	appos	50018	50021	_	_	_	_	_
249	12	.	.	.	2	punct	_	_	_	_	_	_	_

250	1	Estimates	estimate	NNS	0	ROOT	50022	50031	_	_	_	_	_
250	2	of	of	IN	7	case	50032	50034	_	_	_	_	_
250	3	chronic	chronic	JJ	7	amod	50035	50042	_	_	_	_	_
250	4	hepatitis	hepatitis	NN	7	compound	50043	50052	_	_	_	_	_
250	5	B	b	NN	7	compound	50053	50054	_	_	_	_	_
250	6	virus	virus	NN	7	compound	50055	50060	_	_	_	_	_
250	7	infection	infection	NN	1	nmod	50061	50070	_	_	_	_	_
250	8	in	in	IN	11	case	50071	50073	_	_	_	_	_
250	9	the	the	DT	11	det	50074	50077	_	_	_	_	_
250	10	Northern	northern	JJ	11	amod	50078	50086	_	_	_	_	_
250	11	Territory	territory	NN	1	nmod	50087	50096	_	_	_	_	_
250	12	.	.	.	1	punct	50096	50097	_	_	_	_	_

251	1	Communicable	communicable	JJ	2	amod	50098	50110	_	_	_	_	_
251	2	Diseases	disease	NNS	0	ROOT	50111	50119	_	_	_	_	_
251	3	Intelligence	Intelligence	NNP	2	dep	50120	50132	_	_	_	_	_
251	4	2005	2005	CD	3	nummod	50133	50137	_	_	_	_	_
251	5	;	;	:	2	punct	50137	50138	_	_	_	_	_
251	6	29:289-90	29:289-90	CD	2	dep	50138	50147	_	_	_	_	_
251	7	.	.	.	2	punct	50147	50148	_	_	_	_	_

252	1	Clements	Clements	NNP	2	compound	50149	50157	_	_	_	_	_
252	2	CJ	CJ	NNP	0	ROOT	50158	50160	_	_	_	_	_
252	3	,	,	,	2	punct	50160	50161	_	_	_	_	_
252	4	Baoping	Baoping	NNP	5	compound	50162	50169	_	_	_	_	_
252	5	Y	y	NN	2	appos	50170	50171	_	_	_	_	_
252	6	,	,	,	2	punct	50171	50172	_	_	_	_	_
252	7	Crouch	Crouch	NNP	8	compound	50173	50179	_	_	_	_	_
252	8	A	A	NNP	2	appos	50180	50181	_	_	_	_	_
252	9	,	,	,	2	punct	50181	50182	_	_	_	_	_
252	10	et	et	FW	11	compound	50183	50185	_	_	_	_	_
252	11	al.	al.	FW	2	appos	50186	50189	_	_	_	_	_
252	12	.	.	.	2	punct	_	_	_	_	_	_	_

253	1	Progress	Progress	NNP	0	ROOT	50190	50198	_	_	_	_	_
253	2	in	in	IN	4	case	50199	50201	_	_	_	_	_
253	3	the	the	DT	4	det	50202	50205	_	_	_	_	_
253	4	control	control	NN	1	nmod	50206	50213	_	_	_	_	_
253	5	of	of	IN	8	case	50214	50216	_	_	_	_	_
253	6	hepatitis	hepatitis	NN	8	compound	50217	50226	_	_	_	_	_
253	7	B	b	NN	8	compound	50227	50228	_	_	_	_	_
253	8	infection	infection	NN	1	nmod	50229	50238	_	_	_	_	_
253	9	in	in	IN	13	case	50239	50241	_	_	_	_	_
253	10	the	the	DT	13	det	50242	50245	_	_	_	_	_
253	11	Western	Western	NNP	13	compound	50246	50253	_	_	_	_	_
253	12	Pacific	Pacific	NNP	13	compound	50254	50261	_	_	_	_	_
253	13	Region	Region	NNP	8	nmod	50262	50268	_	_	_	_	_
253	14	.	.	.	1	punct	50268	50269	_	_	_	_	_

254	1	Vaccine	vaccine	NN	0	ROOT	50270	50277	_	_	_	_	_
254	2	2006	2006	CD	1	nummod	50278	50282	_	_	_	_	_
254	3	;	;	:	1	punct	50282	50283	_	_	_	_	_
254	4	24:1975-82	24:1975-82	CD	1	dep	50283	50293	_	_	_	_	_
254	5	.	.	.	1	punct	50293	50294	_	_	_	_	_

255	1	Wasley	Wasley	NNP	2	compound	50295	50301	_	_	_	_	_
255	2	A	A	NNP	0	ROOT	50302	50303	_	_	_	_	_
255	3	,	,	,	2	punct	50303	50304	_	_	_	_	_
255	4	Kruszon-Moran	Kruszon-Moran	NNP	5	compound	50305	50318	_	_	_	_	_
255	5	D	D	NNP	2	appos	50319	50320	_	_	_	_	_
255	6	,	,	,	2	punct	50320	50321	_	_	_	_	_
255	7	Kuhnert	Kuhnert	NNP	8	compound	50322	50329	_	_	_	_	_
255	8	W	W	NNP	2	appos	50330	50331	_	_	_	_	_
255	9	,	,	,	2	punct	50331	50332	_	_	_	_	_
255	10	et	et	FW	11	compound	50333	50335	_	_	_	_	_
255	11	al.	al.	FW	2	appos	50336	50339	_	_	_	_	_
255	12	.	.	.	2	punct	_	_	_	_	_	_	_

256	1	The	the	DT	2	det	50340	50343	_	_	_	_	_
256	2	prevalence	prevalence	NN	0	ROOT	50344	50354	_	_	_	_	_
256	3	of	of	IN	7	case	50355	50357	_	_	_	_	_
256	4	hepatitis	hepatitis	NN	7	compound	50358	50367	_	_	_	_	_
256	5	B	b	NN	7	compound	50368	50369	_	_	_	_	_
256	6	virus	virus	NN	7	compound	50370	50375	_	_	_	_	_
256	7	infection	infection	NN	2	nmod	50376	50385	_	_	_	_	_
256	8	in	in	IN	11	case	50386	50388	_	_	_	_	_
256	9	the	the	DT	11	det	50389	50392	_	_	_	_	_
256	10	United	United	NNP	11	compound	50393	50399	_	_	_	_	_
256	11	States	States	NNPS	2	nmod	50400	50406	_	_	_	_	_
256	12	in	in	IN	14	case	50407	50409	_	_	_	_	_
256	13	the	the	DT	14	det	50410	50413	_	_	_	_	_
256	14	era	era	NN	2	nmod	50414	50417	_	_	_	_	_
256	15	of	of	IN	16	case	50418	50420	_	_	_	_	_
256	16	vaccination	vaccination	NN	14	nmod	50421	50432	_	_	_	_	_
256	17	.	.	.	2	punct	50432	50433	_	_	_	_	_

257	1	Journal	Journal	NNP	0	ROOT	50434	50441	_	_	_	_	_
257	2	of	of	IN	4	case	50442	50444	_	_	_	_	_
257	3	Infectious	infectious	JJ	4	amod	50445	50455	_	_	_	_	_
257	4	Diseases	disease	NNS	1	nmod	50456	50464	_	_	_	_	_
257	5	2010	2010	CD	1	dep	50465	50469	_	_	_	_	_
257	6	;	;	:	1	punct	50469	50470	_	_	_	_	_
257	7	202:192-201	202:192-201	CD	1	dep	50470	50481	_	_	_	_	_
257	8	.	.	.	1	punct	50481	50482	_	_	_	_	_

258	1	Gidding	gidd	VBG	0	ROOT	50483	50490	_	_	_	_	_
258	2	HF	hf	NN	1	dobj	50491	50493	_	_	_	_	_
258	3	,	,	,	2	punct	50493	50494	_	_	_	_	_
258	4	Warlow	Warlow	NNP	5	compound	50495	50501	_	_	_	_	_
258	5	M	M	NNP	2	appos	50502	50503	_	_	_	_	_
258	6	,	,	,	2	punct	50503	50504	_	_	_	_	_
258	7	MacIntyre	MacIntyre	NNP	8	compound	50505	50514	_	_	_	_	_
258	8	CR	cr	NN	2	appos	50515	50517	_	_	_	_	_
258	9	,	,	,	2	punct	50517	50518	_	_	_	_	_
258	10	et	et	FW	11	compound	50519	50521	_	_	_	_	_
258	11	al.	al.	FW	2	appos	50522	50525	_	_	_	_	_
258	12	.	.	.	1	punct	_	_	_	_	_	_	_

259	1	The	the	DT	2	det	50526	50529	_	_	_	_	_
259	2	impact	impact	NN	0	ROOT	50530	50536	_	_	_	_	_
259	3	of	of	IN	7	case	50537	50539	_	_	_	_	_
259	4	a	a	DT	7	det	50540	50541	_	_	_	_	_
259	5	new	new	JJ	7	amod	50542	50545	_	_	_	_	_
259	6	universal	universal	JJ	7	amod	50546	50555	_	_	_	_	_
259	7	infant	infant	NN	2	nmod	50556	50562	_	_	_	_	_
259	8	and	and	CC	7	cc	50563	50566	_	_	_	_	_
259	9	school-based	school-based	JJ	11	amod	50567	50579	_	_	_	_	_
259	10	adolescent	adolescent	JJ	11	amod	50580	50590	_	_	_	_	_
259	11	hepatitis	hepatitis	NN	7	conj	50591	50600	_	_	_	_	_
259	12	B	b	NN	14	compound	50601	50602	_	_	_	_	_
259	13	vaccination	vaccination	NN	14	compound	50603	50614	_	_	_	_	_
259	14	program	program	NN	2	dep	50615	50622	_	_	_	_	_
259	15	in	in	IN	16	case	50623	50625	_	_	_	_	_
259	16	Australia	Australia	NNP	14	nmod	50626	50635	_	_	_	_	_
259	17	.	.	.	2	punct	50635	50636	_	_	_	_	_

260	1	Vaccine	vaccine	NN	0	ROOT	50637	50644	_	_	_	_	_
260	2	2007	2007	CD	1	nummod	50645	50649	_	_	_	_	_
260	3	;	;	:	1	punct	50649	50650	_	_	_	_	_
260	4	25:8637-41	25:8637-41	CD	1	dep	50650	50660	_	_	_	_	_
260	5	.	.	.	1	punct	50660	50661	_	_	_	_	_

261	1	Nguyen	Nguyen	NNP	2	compound	50662	50668	_	_	_	_	_
261	2	VT	VT	NNP	0	ROOT	50669	50671	_	_	_	_	_
261	3	,	,	,	2	punct	50671	50672	_	_	_	_	_
261	4	Razali	Razali	NNP	5	compound	50673	50679	_	_	_	_	_
261	5	K	K	NNP	2	appos	50680	50681	_	_	_	_	_
261	6	,	,	,	2	punct	50681	50682	_	_	_	_	_
261	7	Amin	Amin	NNP	8	compound	50683	50687	_	_	_	_	_
261	8	J	J	NNP	2	appos	50688	50689	_	_	_	_	_
261	9	,	,	,	2	punct	50689	50690	_	_	_	_	_
261	10	Law	Law	NNP	11	compound	50691	50694	_	_	_	_	_
261	11	MG	mg	NN	2	appos	50695	50697	_	_	_	_	_
261	12	,	,	,	2	punct	50697	50698	_	_	_	_	_
261	13	Dore	Dore	NNP	14	compound	50699	50703	_	_	_	_	_
261	14	GJ	GJ	NNP	2	appos	50704	50706	_	_	_	_	_
261	15	.	.	.	2	punct	50706	50707	_	_	_	_	_

262	1	Estimates	estimate	NNS	0	ROOT	50708	50717	_	_	_	_	_
262	2	and	and	CC	1	cc	50718	50721	_	_	_	_	_
262	3	projections	projection	NNS	1	conj	50722	50733	_	_	_	_	_
262	4	of	of	IN	8	case	50734	50736	_	_	_	_	_
262	5	hepatitis	hepatitis	NN	8	compound	50737	50746	_	_	_	_	_
262	6	B-related	b-related	JJ	8	amod	50747	50756	_	_	_	_	_
262	7	hepatocellular	hepatocellular	JJ	8	amod	50757	50771	_	_	_	_	_
262	8	carcinoma	carcinoma	NN	1	nmod	50772	50781	_	_	_	_	_
262	9	in	in	IN	10	case	50782	50784	_	_	_	_	_
262	10	Australia	Australia	NNP	1	nmod	50785	50794	_	_	_	_	_
262	11	among	among	IN	12	case	50795	50800	_	_	_	_	_
262	12	people	people	NNS	1	nmod	50801	50807	_	_	_	_	_
262	13	born	bear	VBN	1	acl	50808	50812	_	_	_	_	_
262	14	in	in	IN	16	case	50813	50815	_	_	_	_	_
262	15	Asia-Pacific	asia-pacific	JJ	16	amod	50816	50828	_	_	_	_	_
262	16	countries	country	NNS	13	nmod	50829	50838	_	_	_	_	_
262	17	.	.	.	1	punct	50838	50839	_	_	_	_	_

263	1	Journal	Journal	NNP	0	ROOT	50840	50847	_	_	_	_	_
263	2	of	of	IN	3	case	50848	50850	_	_	_	_	_
263	3	Gastroenterology	Gastroenterology	NNP	1	nmod	50851	50867	_	_	_	_	_
263	4	and	and	CC	3	cc	50868	50871	_	_	_	_	_
263	5	Hepatology	Hepatology	NNP	3	conj	50872	50882	_	_	_	_	_
263	6	2008	2008	CD	5	nummod	50883	50887	_	_	_	_	_
263	7	;	;	:	1	punct	50887	50888	_	_	_	_	_
263	8	23:922-9	23:922-9	CD	1	dep	50888	50896	_	_	_	_	_
263	9	.	.	.	1	punct	50896	50897	_	_	_	_	_

264	1	O’Sullivan	O’Sullivan	NNP	2	compound	50898	50908	_	_	_	_	_
264	2	BG	BG	NNP	0	ROOT	50909	50911	_	_	_	_	_
264	3	,	,	,	2	punct	50911	50912	_	_	_	_	_
264	4	Gidding	Gidding	NNP	5	compound	50913	50920	_	_	_	_	_
264	5	HF	hf	NN	2	appos	50921	50923	_	_	_	_	_
264	6	,	,	,	2	punct	50923	50924	_	_	_	_	_
264	7	Law	Law	NNP	8	compound	50925	50928	_	_	_	_	_
264	8	M	m	NN	2	appos	50929	50930	_	_	_	_	_
264	9	,	,	,	2	punct	50930	50931	_	_	_	_	_
264	10	et	et	FW	11	compound	50932	50934	_	_	_	_	_
264	11	al.	al.	FW	2	appos	50935	50938	_	_	_	_	_
264	12	.	.	.	2	punct	_	_	_	_	_	_	_

265	1	Estimates	estimate	NNS	0	ROOT	50939	50948	_	_	_	_	_
265	2	of	of	IN	7	case	50949	50951	_	_	_	_	_
265	3	chronic	chronic	JJ	7	amod	50952	50959	_	_	_	_	_
265	4	hepatitis	hepatitis	NN	7	compound	50960	50969	_	_	_	_	_
265	5	B	b	NN	7	compound	50970	50971	_	_	_	_	_
265	6	virus	virus	NN	7	compound	50972	50977	_	_	_	_	_
265	7	infection	infection	NN	1	nmod	50978	50987	_	_	_	_	_
265	8	in	in	IN	9	case	50988	50990	_	_	_	_	_
265	9	Australia	Australia	NNP	1	nmod	50991	51000	_	_	_	_	_
265	10	,	,	,	9	punct	51000	51001	_	_	_	_	_
265	11	2000	2000	CD	9	amod	51002	51006	_	_	_	_	_
265	12	.	.	.	1	punct	51006	51007	_	_	_	_	_

266	1	Australian	australian	JJ	0	ROOT	51008	51018	_	_	_	_	_
266	2	and	and	CC	1	cc	51019	51022	_	_	_	_	_
266	3	New	New	NNP	5	compound	51023	51026	_	_	_	_	_
266	4	Zealand	Zealand	NNP	5	compound	51027	51034	_	_	_	_	_
266	5	Journal	Journal	NNP	1	conj	51035	51042	_	_	_	_	_
266	6	of	of	IN	8	case	51043	51045	_	_	_	_	_
266	7	Public	Public	NNP	8	compound	51046	51052	_	_	_	_	_
266	8	Health	Health	NNP	5	nmod	51053	51059	_	_	_	_	_
266	9	2004	2004	CD	8	nummod	51060	51064	_	_	_	_	_
266	10	;	;	:	1	punct	51064	51065	_	_	_	_	_
266	11	28:212-6	28:212-6	CD	1	dep	51065	51073	_	_	_	_	_
266	12	.	.	.	1	punct	51073	51074	_	_	_	_	_

267	1	Tawk	Tawk	NNP	2	compound	51075	51079	_	_	_	_	_
267	2	HM	hm	NNS	0	ROOT	51080	51082	_	_	_	_	_
267	3	,	,	,	2	punct	51082	51083	_	_	_	_	_
267	4	Vickery	Vickery	NNP	5	compound	51084	51091	_	_	_	_	_
267	5	K	K	NNP	2	appos	51092	51093	_	_	_	_	_
267	6	,	,	,	2	punct	51093	51094	_	_	_	_	_
267	7	Bisset	Bisset	NNP	8	compound	51095	51101	_	_	_	_	_
267	8	L	L	NNP	2	appos	51102	51103	_	_	_	_	_
267	9	,	,	,	2	punct	51103	51104	_	_	_	_	_
267	10	et	et	FW	11	compound	51105	51107	_	_	_	_	_
267	11	al.	al.	FW	2	appos	51108	51111	_	_	_	_	_
267	12	.	.	.	2	punct	_	_	_	_	_	_	_

268	1	The	the	DT	3	det	51112	51115	_	_	_	_	_
268	2	current	current	JJ	3	amod	51116	51123	_	_	_	_	_
268	3	pattern	pattern	NN	0	ROOT	51124	51131	_	_	_	_	_
268	4	of	of	IN	8	case	51132	51134	_	_	_	_	_
268	5	hepatitis	hepatitis	NN	8	compound	51135	51144	_	_	_	_	_
268	6	B	b	NN	8	compound	51145	51146	_	_	_	_	_
268	7	virus	virus	NN	8	compound	51147	51152	_	_	_	_	_
268	8	infection	infection	NN	3	nmod	51153	51162	_	_	_	_	_
268	9	in	in	IN	10	case	51163	51165	_	_	_	_	_
268	10	Australia	Australia	NNP	3	nmod	51166	51175	_	_	_	_	_
268	11	.	.	.	3	punct	51175	51176	_	_	_	_	_

269	1	Journal	Journal	NNP	0	ROOT	51177	51184	_	_	_	_	_
269	2	of	of	IN	4	case	51185	51187	_	_	_	_	_
269	3	Viral	viral	JJ	4	amod	51188	51193	_	_	_	_	_
269	4	Hepatitis	Hepatitis	NNP	1	nmod	51194	51203	_	_	_	_	_
269	5	2006	2006	CD	4	nummod	51204	51208	_	_	_	_	_
269	6	;	;	:	1	punct	51208	51209	_	_	_	_	_
269	7	13:206-15	13:206-15	CD	1	dep	51209	51218	_	_	_	_	_
269	8	.	.	.	1	punct	51218	51219	_	_	_	_	_

270	1	NNDSS	NNDSS	NNP	2	nsubj	51220	51225	_	_	_	_	_
270	2	Annual	annual	JJ	0	ROOT	51226	51232	_	_	_	_	_
270	3	Report	Report	NNP	4	nsubj	51233	51239	_	_	_	_	_
270	4	Writing	write	VBG	2	dep	51240	51247	_	_	_	_	_
270	5	Group	Group	NNP	4	dobj	51248	51253	_	_	_	_	_
270	6	.	.	.	2	punct	51253	51254	_	_	_	_	_

271	1	Australia	Australia	NNP	5	nmod:poss	51255	51264	_	_	_	_	_
271	2	’s	’s	POS	1	case	51264	51266	_	_	_	_	_
271	3	notifiable	notifiable	JJ	5	amod	51267	51277	_	_	_	_	_
271	4	disease	disease	NN	5	compound	51278	51285	_	_	_	_	_
271	5	status	status	NN	0	ROOT	51286	51292	_	_	_	_	_
271	6	,	,	,	5	punct	51292	51293	_	_	_	_	_
271	7	2010	2010	CD	5	amod	51294	51298	_	_	_	_	_
271	8	:	:	:	5	punct	51298	51299	_	_	_	_	_
271	9	annual	annual	JJ	10	amod	51300	51306	_	_	_	_	_
271	10	report	report	NN	5	dep	51307	51313	_	_	_	_	_
271	11	of	of	IN	15	case	51314	51316	_	_	_	_	_
271	12	the	the	DT	15	det	51317	51320	_	_	_	_	_
271	13	National	National	NNP	15	compound	51321	51329	_	_	_	_	_
271	14	Notifiable	notifiable	JJ	15	amod	51330	51340	_	_	_	_	_
271	15	Diseases	disease	NNS	10	nmod	51341	51349	_	_	_	_	_
271	16	Surveillance	Surveillance	NNP	17	compound	51350	51362	_	_	_	_	_
271	17	System	System	NNP	15	dep	51363	51369	_	_	_	_	_
271	18	.	.	.	5	punct	51369	51370	_	_	_	_	_

272	1	Communicable	communicable	JJ	2	amod	51371	51383	_	_	_	_	_
272	2	Diseases	disease	NNS	0	ROOT	51384	51392	_	_	_	_	_
272	3	Intelligence	Intelligence	NNP	2	dep	51393	51405	_	_	_	_	_
272	4	2012	2012	CD	3	nummod	51406	51410	_	_	_	_	_
272	5	;	;	:	2	punct	51410	51411	_	_	_	_	_
272	6	36:1-69	36:1-69	CD	2	dep	51411	51418	_	_	_	_	_
272	7	.	.	.	2	punct	51418	51419	_	_	_	_	_

273	1	Chiu	Chiu	NNP	2	compound	51420	51424	_	_	_	_	_
273	2	C	C	NNP	0	ROOT	51425	51426	_	_	_	_	_
273	3	,	,	,	2	punct	51426	51427	_	_	_	_	_
273	4	Dey	Dey	NNP	5	compound	51428	51431	_	_	_	_	_
273	5	A	A	NNP	2	appos	51432	51433	_	_	_	_	_
273	6	,	,	,	2	punct	51433	51434	_	_	_	_	_
273	7	Wang	Wang	NNP	8	compound	51435	51439	_	_	_	_	_
273	8	H	H	NNP	2	appos	51440	51441	_	_	_	_	_
273	9	,	,	,	2	punct	51441	51442	_	_	_	_	_
273	10	et	et	FW	11	compound	51443	51445	_	_	_	_	_
273	11	al.	al.	FW	2	appos	51446	51449	_	_	_	_	_
273	12	.	.	.	2	punct	_	_	_	_	_	_	_

274	1	Vaccine	vaccine	NN	0	ROOT	51450	51457	_	_	_	_	_
274	2	preventable	preventable	JJ	3	amod	51458	51469	_	_	_	_	_
274	3	diseases	disease	NNS	1	dep	51470	51478	_	_	_	_	_
274	4	in	in	IN	5	case	51479	51481	_	_	_	_	_
274	5	Australia	Australia	NNP	3	nmod	51482	51491	_	_	_	_	_
274	6	,	,	,	5	punct	51491	51492	_	_	_	_	_
274	7	2005	2005	CD	9	nummod	51493	51497	_	_	_	_	_
274	8	to	to	TO	9	dep	51498	51500	_	_	_	_	_
274	9	2007	2007	CD	5	appos	51501	51505	_	_	_	_	_
274	10	.	.	.	1	punct	51505	51506	_	_	_	_	_

275	1	Communicable	communicable	JJ	2	amod	51507	51519	_	_	_	_	_
275	2	Diseases	disease	NNS	0	ROOT	51520	51528	_	_	_	_	_
275	3	Intelligence	Intelligence	NNP	2	dep	51529	51541	_	_	_	_	_
275	4	2010	2010	CD	3	nummod	51542	51546	_	_	_	_	_
275	5	;	;	:	2	punct	51546	51547	_	_	_	_	_
275	6	34	34	CD	7	nummod	51547	51549	_	_	_	_	_
275	7	Suppl	Suppl	NNP	2	dep	51550	51555	_	_	_	_	_
275	8	:	:	:	7	punct	51555	51556	_	_	_	_	_
275	9	ix-S167	ix-s167	NN	7	dep	51556	51563	_	_	_	_	_
275	10	.	.	.	2	punct	51563	51564	_	_	_	_	_

276	1	Menzies	menzy	NNS	2	compound	51565	51572	_	_	_	_	_
276	2	R	r	NN	0	ROOT	51573	51574	_	_	_	_	_
276	3	,	,	,	2	punct	51574	51575	_	_	_	_	_
276	4	Turnour	turnour	NN	5	compound	51576	51583	_	_	_	_	_
276	5	C	c	NN	2	appos	51584	51585	_	_	_	_	_
276	6	,	,	,	2	punct	51585	51586	_	_	_	_	_
276	7	Chiu	Chiu	NNP	8	compound	51587	51591	_	_	_	_	_
276	8	C	C	NNP	2	appos	51592	51593	_	_	_	_	_
276	9	,	,	,	2	punct	51593	51594	_	_	_	_	_
276	10	McIntyre	McIntyre	NNP	12	compound	51595	51603	_	_	_	_	_
276	11	P.	P.	NNP	12	compound	51604	51606	_	_	_	_	_
276	12	Vaccine	Vaccine	NNP	2	appos	51607	51614	_	_	_	_	_
276	13	preventable	preventable	JJ	14	amod	51615	51626	_	_	_	_	_
276	14	diseases	disease	NNS	12	dep	51627	51635	_	_	_	_	_
276	15	and	and	CC	12	cc	51636	51639	_	_	_	_	_
276	16	vaccination	vaccination	NN	17	compound	51640	51651	_	_	_	_	_
276	17	coverage	coverage	NN	12	conj	51652	51660	_	_	_	_	_
276	18	in	in	IN	24	case	51661	51663	_	_	_	_	_
276	19	Aboriginal	Aboriginal	NNP	24	compound	51664	51674	_	_	_	_	_
276	20	and	and	CC	19	cc	51675	51678	_	_	_	_	_
276	21	Torres	Torres	NNP	19	conj	51679	51685	_	_	_	_	_
276	22	Strait	Strait	NNP	24	compound	51686	51692	_	_	_	_	_
276	23	Islander	Islander	NNP	24	compound	51693	51701	_	_	_	_	_
276	24	people	people	NNS	17	nmod	51702	51708	_	_	_	_	_
276	25	,	,	,	2	punct	51708	51709	_	_	_	_	_
276	26	Australia	Australia	NNP	2	appos	51710	51719	_	_	_	_	_
276	27	,	,	,	2	punct	51719	51720	_	_	_	_	_
276	28	2003	2003	CD	2	appos	51721	51725	_	_	_	_	_
276	29	to	to	TO	30	case	51726	51728	_	_	_	_	_
276	30	2006	2006	CD	28	nmod	51729	51733	_	_	_	_	_
276	31	.	.	.	2	punct	51733	51734	_	_	_	_	_

277	1	Communicable	communicable	JJ	2	amod	51735	51747	_	_	_	_	_
277	2	Diseases	disease	NNS	0	ROOT	51748	51756	_	_	_	_	_
277	3	Intelligence	Intelligence	NNP	2	dep	51757	51769	_	_	_	_	_
277	4	2008	2008	CD	3	nummod	51770	51774	_	_	_	_	_
277	5	;	;	:	2	punct	51774	51775	_	_	_	_	_
277	6	32	32	CD	7	nummod	51775	51777	_	_	_	_	_
277	7	Suppl	Suppl	NNP	2	dep	51778	51783	_	_	_	_	_
277	8	:	:	:	7	punct	51783	51784	_	_	_	_	_
277	9	S2-67	s2-67	NN	7	dep	51784	51789	_	_	_	_	_
277	10	.	.	.	2	punct	51789	51790	_	_	_	_	_

278	1	Reilly	Reilly	NNP	2	compound	51791	51797	_	_	_	_	_
278	2	ML	ML	NNP	0	ROOT	51798	51800	_	_	_	_	_
278	3	,	,	,	2	punct	51800	51801	_	_	_	_	_
278	4	Schillie	Schillie	NNP	5	compound	51802	51810	_	_	_	_	_
278	5	SF	SF	NNP	2	appos	51811	51813	_	_	_	_	_
278	6	,	,	,	2	punct	51813	51814	_	_	_	_	_
278	7	Smith	Smith	NNP	8	compound	51815	51820	_	_	_	_	_
278	8	E	E	NNP	2	appos	51821	51822	_	_	_	_	_
278	9	,	,	,	2	punct	51822	51823	_	_	_	_	_
278	10	et	et	FW	11	compound	51824	51826	_	_	_	_	_
278	11	al.	al.	FW	2	appos	51827	51830	_	_	_	_	_
278	12	.	.	.	2	punct	_	_	_	_	_	_	_

279	1	Increased	increase	VBN	2	amod	51831	51840	_	_	_	_	_
279	2	risk	risk	NN	0	ROOT	51841	51845	_	_	_	_	_
279	3	of	of	IN	6	case	51846	51848	_	_	_	_	_
279	4	acute	acute	JJ	6	amod	51849	51854	_	_	_	_	_
279	5	hepatitis	hepatitis	NN	6	compound	51855	51864	_	_	_	_	_
279	6	B	b	NN	2	nmod	51865	51866	_	_	_	_	_
279	7	among	among	IN	8	case	51867	51872	_	_	_	_	_
279	8	adults	adult	NNS	2	nmod	51873	51879	_	_	_	_	_
279	9	with	with	IN	12	case	51880	51884	_	_	_	_	_
279	10	diagnosed	diagnose	VBN	12	amod	51885	51894	_	_	_	_	_
279	11	diabetes	diabetes	NN	12	compound	51895	51903	_	_	_	_	_
279	12	mellitus	mellitus	NN	8	nmod	51904	51912	_	_	_	_	_
279	13	.	.	.	2	punct	51912	51913	_	_	_	_	_

280	1	Journal	Journal	NNP	0	ROOT	51914	51921	_	_	_	_	_
280	2	of	of	IN	4	case	51922	51924	_	_	_	_	_
280	3	Diabetes	Diabetes	NNP	4	compound	51925	51933	_	_	_	_	_
280	4	Science	Science	NNP	1	nmod	51934	51941	_	_	_	_	_
280	5	and	and	CC	4	cc	51942	51945	_	_	_	_	_
280	6	Technology	Technology	NNP	4	conj	51946	51956	_	_	_	_	_
280	7	2012	2012	CD	6	nummod	51957	51961	_	_	_	_	_
280	8	;	;	:	1	punct	51961	51962	_	_	_	_	_
280	9	6:858-66	6:858-66	CD	1	dep	51962	51970	_	_	_	_	_
280	10	.	.	.	1	punct	51970	51971	_	_	_	_	_

281	1	Seed	seed	NN	2	compound	51972	51976	_	_	_	_	_
281	2	CR	cr	NN	0	ROOT	51977	51979	_	_	_	_	_
281	3	,	,	,	2	punct	51979	51980	_	_	_	_	_
281	4	Kiely	Kiely	NNP	5	compound	51981	51986	_	_	_	_	_
281	5	P	p	NN	2	appos	51987	51988	_	_	_	_	_
281	6	,	,	,	5	punct	51988	51989	_	_	_	_	_
281	7	Keller	Keller	NNP	8	compound	51990	51996	_	_	_	_	_
281	8	AJ	AJ	NNP	5	appos	51997	51999	_	_	_	_	_
281	9	.	.	.	2	punct	51999	52000	_	_	_	_	_

282	1	Residual	residual	JJ	2	amod	52001	52009	_	_	_	_	_
282	2	risk	risk	NN	5	nsubj	52010	52014	_	_	_	_	_
282	3	of	of	IN	4	case	52016	52018	_	_	_	_	_
282	4	transfusion	transfusion	NN	2	nmod	52019	52030	_	_	_	_	_
282	5	transmitted	transmit	VBD	0	ROOT	52031	52042	_	_	_	_	_
282	6	human	human	JJ	8	amod	52043	52048	_	_	_	_	_
282	7	immunodeficiency	immunodeficiency	NN	8	compound	52049	52065	_	_	_	_	_
282	8	virus	virus	NN	5	dobj	52066	52071	_	_	_	_	_
282	9	,	,	,	8	punct	52071	52072	_	_	_	_	_
282	10	hepatitis	hepatitis	NN	12	compound	52073	52082	_	_	_	_	_
282	11	B	b	NN	12	compound	52083	52084	_	_	_	_	_
282	12	virus	virus	NN	8	conj	52085	52090	_	_	_	_	_
282	13	,	,	,	8	punct	52090	52091	_	_	_	_	_
282	14	hepatitis	hepatitis	NN	16	compound	52092	52101	_	_	_	_	_
282	15	C	c	NN	16	compound	52102	52103	_	_	_	_	_
282	16	virus	virus	NN	8	conj	52104	52109	_	_	_	_	_
282	17	and	and	CC	8	cc	52110	52113	_	_	_	_	_
282	18	human	human	JJ	21	amod	52115	52120	_	_	_	_	_
282	19	T	t	NN	21	compound	52121	52122	_	_	_	_	_
282	20	lymphotrophic	lymphotrophic	JJ	21	amod	52123	52136	_	_	_	_	_
282	21	virus	virus	NN	8	conj	52137	52142	_	_	_	_	_
282	22	.	.	.	5	punct	52142	52143	_	_	_	_	_

283	1	Internal	internal	JJ	3	amod	52144	52152	_	_	_	_	_
283	2	Medicine	Medicine	NNP	3	compound	52153	52161	_	_	_	_	_
283	3	Journal	Journal	NNP	0	ROOT	52162	52169	_	_	_	_	_
283	4	2005	2005	CD	6	nummod	52170	52174	_	_	_	_	_
283	5	;	;	:	6	punct	52174	52175	_	_	_	_	_
283	6	35:592-8	35:592-8	CD	3	dep	52175	52183	_	_	_	_	_
283	7	.	.	.	3	punct	52183	52184	_	_	_	_	_

284	1	Seed	seed	NN	2	compound	52185	52189	_	_	_	_	_
284	2	CR	cr	NN	0	ROOT	52190	52192	_	_	_	_	_
284	3	,	,	,	2	punct	52192	52193	_	_	_	_	_
284	4	Kiely	Kiely	NNP	5	compound	52194	52199	_	_	_	_	_
284	5	P	p	NN	2	appos	52200	52201	_	_	_	_	_
284	6	.	.	.	2	punct	52201	52202	_	_	_	_	_

285	1	A	a	DT	2	det	52203	52204	_	_	_	_	_
285	2	method	method	NN	0	ROOT	52205	52211	_	_	_	_	_
285	3	for	for	IN	4	mark	52212	52215	_	_	_	_	_
285	4	estimating	estimate	VBG	2	acl	52216	52226	_	_	_	_	_
285	5	the	the	DT	7	det	52227	52230	_	_	_	_	_
285	6	residual	residual	JJ	7	amod	52231	52239	_	_	_	_	_
285	7	risk	risk	NN	4	dobj	52240	52244	_	_	_	_	_
285	8	of	of	IN	11	case	52245	52247	_	_	_	_	_
285	9	transfusion-transmitted	transfusion-transmitted	JJ	11	amod	52248	52271	_	_	_	_	_
285	10	HBV	hbv	NN	11	compound	52272	52275	_	_	_	_	_
285	11	infection	infection	NN	2	nmod	52276	52285	_	_	_	_	_
285	12	associated	associate	VBN	2	acl	52286	52296	_	_	_	_	_
285	13	with	with	IN	18	case	52297	52301	_	_	_	_	_
285	14	occult	occult	NN	18	compound	52302	52308	_	_	_	_	_
285	15	hepatitis	hepatitis	NN	18	compound	52309	52318	_	_	_	_	_
285	16	B	b	NN	18	compound	52319	52320	_	_	_	_	_
285	17	virus	virus	NN	18	compound	52321	52326	_	_	_	_	_
285	18	infection	infection	NN	12	nmod	52327	52336	_	_	_	_	_
285	19	in	in	IN	22	case	52337	52339	_	_	_	_	_
285	20	a	a	DT	22	det	52340	52341	_	_	_	_	_
285	21	donor	donor	NN	22	compound	52342	52347	_	_	_	_	_
285	22	population	population	NN	18	nmod	52348	52358	_	_	_	_	_
285	23	without	without	IN	26	case	52359	52366	_	_	_	_	_
285	24	universal	universal	JJ	26	amod	52367	52376	_	_	_	_	_
285	25	anti-HBc	anti-hbc	JJ	26	amod	52377	52385	_	_	_	_	_
285	26	screening	screening	NN	12	nmod	52386	52395	_	_	_	_	_
285	27	.	.	.	2	punct	52395	52396	_	_	_	_	_

286	1	Vox	Vox	NNP	2	compound	52397	52400	_	_	_	_	_
286	2	Sanguinis	Sanguinis	NNP	0	ROOT	52401	52410	_	_	_	_	_
286	3	2013	2013	CD	2	nummod	52411	52415	_	_	_	_	_
286	4	;	;	:	2	punct	52415	52416	_	_	_	_	_
286	5	105:290-8	105:290-8	CD	2	dep	52416	52425	_	_	_	_	_
286	6	.	.	.	2	punct	52425	52426	_	_	_	_	_

287	1	van	van	NN	0	ROOT	52427	52430	_	_	_	_	_
287	2	der	der	SYM	4	dep	52431	52434	_	_	_	_	_
287	3	Eijk	Eijk	NNP	4	compound	52435	52439	_	_	_	_	_
287	4	AA	AA	NNP	1	acl:relcl	52440	52442	_	_	_	_	_
287	5	,	,	,	1	punct	52442	52443	_	_	_	_	_
287	6	Niesters	Niesters	NNP	7	compound	52444	52452	_	_	_	_	_
287	7	HG	HG	NNP	1	appos	52453	52455	_	_	_	_	_
287	8	,	,	,	7	punct	52455	52456	_	_	_	_	_
287	9	Hansen	Hansen	NNP	7	appos	52457	52463	_	_	_	_	_
287	10	BE	be	VB	9	acl:relcl	52464	52466	_	_	_	_	_
287	11	,	,	,	9	punct	52466	52467	_	_	_	_	_
287	12	et	et	FW	13	compound	52468	52470	_	_	_	_	_
287	13	al.	al.	FW	9	appos	52471	52474	_	_	_	_	_
287	14	.	.	.	1	punct	_	_	_	_	_	_	_

288	1	Paired	paired	JJ	4	amod	52475	52481	_	_	_	_	_
288	2	,	,	,	4	punct	52481	52482	_	_	_	_	_
288	3	quantitative	quantitative	JJ	4	amod	52483	52495	_	_	_	_	_
288	4	measurements	measurement	NNS	0	ROOT	52496	52508	_	_	_	_	_
288	5	of	of	IN	9	case	52509	52511	_	_	_	_	_
288	6	hepatitis	hepatitis	NN	9	compound	52512	52521	_	_	_	_	_
288	7	B	b	NN	9	compound	52522	52523	_	_	_	_	_
288	8	virus	virus	NN	9	compound	52524	52529	_	_	_	_	_
288	9	DNA	dna	NN	4	nmod	52530	52533	_	_	_	_	_
288	10	in	in	IN	11	case	52534	52536	_	_	_	_	_
288	11	saliva	saliva	NN	4	nmod	52537	52543	_	_	_	_	_
288	12	,	,	,	11	punct	52543	52544	_	_	_	_	_
288	13	urine	urine	NN	11	conj	52545	52550	_	_	_	_	_
288	14	and	and	CC	11	cc	52551	52554	_	_	_	_	_
288	15	serum	serum	NN	11	conj	52555	52560	_	_	_	_	_
288	16	of	of	IN	20	case	52561	52563	_	_	_	_	_
288	17	chronic	chronic	JJ	20	amod	52564	52571	_	_	_	_	_
288	18	hepatitis	hepatitis	NN	20	compound	52572	52581	_	_	_	_	_
288	19	B	b	NN	20	compound	52582	52583	_	_	_	_	_
288	20	patients	patient	NNS	4	nmod	52584	52592	_	_	_	_	_
288	21	.	.	.	4	punct	52592	52593	_	_	_	_	_

289	1	European	european	JJ	2	amod	52594	52602	_	_	_	_	_
289	2	Journal	Journal	NNP	0	ROOT	52603	52610	_	_	_	_	_
289	3	of	of	IN	4	case	52611	52613	_	_	_	_	_
289	4	Gastroenterology	Gastroenterology	NNP	2	nmod	52614	52630	_	_	_	_	_
289	5	and	and	CC	4	cc	52631	52634	_	_	_	_	_
289	6	Hepatology	Hepatology	NNP	4	conj	52635	52645	_	_	_	_	_
289	7	2005	2005	CD	6	nummod	52646	52650	_	_	_	_	_
289	8	;	;	:	2	punct	52650	52651	_	_	_	_	_
289	9	17:1173-9	17:1173-9	CD	2	dep	52651	52660	_	_	_	_	_
289	10	.	.	.	2	punct	52660	52661	_	_	_	_	_

290	1	Scott	Scott	NNP	2	compound	52662	52667	_	_	_	_	_
290	2	RM	rm	NN	0	ROOT	52668	52670	_	_	_	_	_
290	3	,	,	,	2	punct	52670	52671	_	_	_	_	_
290	4	Snitbhan	snitbhan	JJ	5	amod	52672	52680	_	_	_	_	_
290	5	R	r	NN	2	appos	52681	52682	_	_	_	_	_
290	6	,	,	,	2	punct	52682	52683	_	_	_	_	_
290	7	Bancroft	Bancroft	NNP	8	compound	52684	52692	_	_	_	_	_
290	8	WH	WH	NNP	2	appos	52693	52695	_	_	_	_	_
290	9	,	,	,	2	punct	52695	52696	_	_	_	_	_
290	10	Alter	Alter	NNP	11	compound	52697	52702	_	_	_	_	_
290	11	HJ	HJ	NNP	2	appos	52703	52705	_	_	_	_	_
290	12	,	,	,	2	punct	52705	52706	_	_	_	_	_
290	13	Tingpalapong	Tingpalapong	NNP	16	compound	52707	52719	_	_	_	_	_
290	14	M.	M.	NNP	16	compound	52720	52722	_	_	_	_	_
290	15	Experimental	experimental	JJ	16	amod	52723	52735	_	_	_	_	_
290	16	transmission	transmission	NN	2	appos	52736	52748	_	_	_	_	_
290	17	of	of	IN	20	case	52749	52751	_	_	_	_	_
290	18	hepatitis	hepatitis	NN	20	compound	52752	52761	_	_	_	_	_
290	19	B	b	NN	20	compound	52762	52763	_	_	_	_	_
290	20	virus	virus	NN	16	nmod	52764	52769	_	_	_	_	_
290	21	by	by	IN	22	case	52770	52772	_	_	_	_	_
290	22	semen	semen	NN	20	nmod	52773	52778	_	_	_	_	_
290	23	and	and	CC	22	cc	52779	52782	_	_	_	_	_
290	24	saliva	saliva	NN	22	conj	52783	52789	_	_	_	_	_
290	25	.	.	.	2	punct	52789	52790	_	_	_	_	_

291	1	Journal	Journal	NNP	0	ROOT	52791	52798	_	_	_	_	_
291	2	of	of	IN	4	case	52799	52801	_	_	_	_	_
291	3	Infectious	infectious	JJ	4	amod	52802	52812	_	_	_	_	_
291	4	Diseases	disease	NNS	1	nmod	52813	52821	_	_	_	_	_
291	5	1980	1980	CD	1	dep	52822	52826	_	_	_	_	_
291	6	;	;	:	1	punct	52826	52827	_	_	_	_	_
291	7	142:67-71	142:67-71	CD	1	dep	52827	52836	_	_	_	_	_
291	8	.	.	.	1	punct	52836	52837	_	_	_	_	_

292	1	Marie-Cardine	Marie-Cardine	NNP	2	compound	52838	52851	_	_	_	_	_
292	2	A	A	NNP	0	ROOT	52852	52853	_	_	_	_	_
292	3	,	,	,	2	punct	52853	52854	_	_	_	_	_
292	4	Mouterde	Mouterde	NNP	5	compound	52855	52863	_	_	_	_	_
292	5	O	O	NNP	2	conj	52864	52865	_	_	_	_	_
292	6	,	,	,	2	punct	52865	52866	_	_	_	_	_
292	7	Dubuisson	Dubuisson	NNP	8	compound	52867	52876	_	_	_	_	_
292	8	S	s	NN	2	conj	52877	52878	_	_	_	_	_
292	9	,	,	,	2	punct	52878	52879	_	_	_	_	_
292	10	Buffet-Janvresse	buffet-janvresse	NN	11	compound	52880	52896	_	_	_	_	_
292	11	C	c	NN	2	conj	52897	52898	_	_	_	_	_
292	12	,	,	,	2	punct	52898	52899	_	_	_	_	_
292	13	Mallet	Mallet	NNP	16	compound	52900	52906	_	_	_	_	_
292	14	E.	E.	NNP	16	compound	52907	52909	_	_	_	_	_
292	15	Salivary	salivary	JJ	16	amod	52910	52918	_	_	_	_	_
292	16	transmission	transmission	NN	2	conj	52919	52931	_	_	_	_	_
292	17	in	in	IN	20	case	52932	52934	_	_	_	_	_
292	18	an	a	DT	20	det	52935	52937	_	_	_	_	_
292	19	intrafamilial	intrafamilial	JJ	20	amod	52938	52951	_	_	_	_	_
292	20	cluster	cluster	NN	16	nmod	52952	52959	_	_	_	_	_
292	21	of	of	IN	24	case	52960	52962	_	_	_	_	_
292	22	hepatitis	hepatitis	NNP	24	compound	52963	52972	_	_	_	_	_
292	23	B.	B.	NNP	24	compound	52973	52975	_	_	_	_	_
292	24	Journal	Journal	NNP	20	nmod	52976	52983	_	_	_	_	_
292	25	of	of	IN	27	case	52984	52986	_	_	_	_	_
292	26	Pediatric	Pediatric	NNP	27	compound	52987	52996	_	_	_	_	_
292	27	Gastroenterology	Gastroenterology	NNP	24	nmod	52997	53013	_	_	_	_	_
292	28	and	and	CC	2	cc	53014	53017	_	_	_	_	_
292	29	Nutrition	Nutrition	NNP	2	conj	53018	53027	_	_	_	_	_
292	30	2002	2002	CD	29	nummod	53028	53032	_	_	_	_	_
292	31	;	;	:	2	punct	53032	53033	_	_	_	_	_
292	32	34:227-30	34:227-30	CD	2	dep	53033	53042	_	_	_	_	_
292	33	.	.	.	2	punct	53042	53043	_	_	_	_	_

293	1	Alter	alter	VB	0	ROOT	53044	53049	_	_	_	_	_
293	2	HJ	HJ	NNP	1	dobj	53050	53052	_	_	_	_	_
293	3	,	,	,	2	punct	53052	53053	_	_	_	_	_
293	4	Purcell	Purcell	NNP	5	compound	53054	53061	_	_	_	_	_
293	5	RH	RH	NNP	2	appos	53062	53064	_	_	_	_	_
293	6	,	,	,	2	punct	53064	53065	_	_	_	_	_
293	7	Gerin	Gerin	NNP	8	compound	53066	53071	_	_	_	_	_
293	8	JL	JL	NNP	2	appos	53072	53074	_	_	_	_	_
293	9	,	,	,	2	punct	53074	53075	_	_	_	_	_
293	10	et	et	FW	11	compound	53076	53078	_	_	_	_	_
293	11	al.	al.	FW	2	appos	53079	53082	_	_	_	_	_
293	12	.	.	.	1	punct	_	_	_	_	_	_	_

294	1	Transmission	Transmission	NNP	0	ROOT	53083	53095	_	_	_	_	_
294	2	of	of	IN	4	case	53096	53098	_	_	_	_	_
294	3	hepatitis	hepatitis	NN	4	compound	53099	53108	_	_	_	_	_
294	4	B	b	NN	1	nmod	53109	53110	_	_	_	_	_
294	5	to	to	TO	6	case	53111	53113	_	_	_	_	_
294	6	chimpanzees	chimpanzee	NNS	1	nmod	53114	53125	_	_	_	_	_
294	7	by	by	IN	12	case	53126	53128	_	_	_	_	_
294	8	hepatitis	hepatitis	NN	12	compound	53129	53138	_	_	_	_	_
294	9	B	b	NN	12	compound	53139	53140	_	_	_	_	_
294	10	surface	surface	NN	12	compound	53141	53148	_	_	_	_	_
294	11	antigen-positive	antigen-positive	JJ	12	amod	53149	53165	_	_	_	_	_
294	12	saliva	saliva	NN	6	nmod	53166	53172	_	_	_	_	_
294	13	and	and	CC	12	cc	53173	53176	_	_	_	_	_
294	14	semen	semen	NN	12	conj	53177	53182	_	_	_	_	_
294	15	.	.	.	1	punct	53182	53183	_	_	_	_	_

295	1	Infection	infection	NN	0	ROOT	53184	53193	_	_	_	_	_
295	2	and	and	CC	1	cc	53194	53197	_	_	_	_	_
295	3	Immunity	immunity	NN	1	conj	53198	53206	_	_	_	_	_
295	4	1977	1977	CD	6	nummod	53207	53211	_	_	_	_	_
295	5	;	;	:	6	punct	53211	53212	_	_	_	_	_
295	6	16:928-33	16:928-33	CD	1	dep	53212	53221	_	_	_	_	_
295	7	.	.	.	1	punct	53221	53222	_	_	_	_	_

296	1	Villarejos	Villarejos	NNP	13	compound	53223	53233	_	_	_	_	_
296	2	VM	VM	NNP	13	compound	53234	53236	_	_	_	_	_
296	3	,	,	,	13	punct	53236	53237	_	_	_	_	_
296	4	Visonï	Visonï	NNP	13	appos	53238	53244	_	_	_	_	_
296	5	¿	¿	CD	13	nummod	53244	53245	_	_	_	_	_
296	6	½	½	CD	13	nummod	53245	53246	_	_	_	_	_
296	7	KA	ka	NN	13	compound	53247	53249	_	_	_	_	_
296	8	,	,	,	13	punct	53249	53250	_	_	_	_	_
296	9	Gutiï	Gutiï	NNP	13	dep	53251	53256	_	_	_	_	_
296	10	¿	¿	CD	13	nummod	53256	53257	_	_	_	_	_
296	11	½	½	CD	13	nummod	53257	53258	_	_	_	_	_
296	12	rrez	rrez	NN	13	compound	53258	53262	_	_	_	_	_
296	13	A	a	NN	15	nsubj	53263	53264	_	_	_	_	_
296	14	,	,	,	13	punct	53264	53265	_	_	_	_	_
296	15	Rodrï	Rodrï	NNP	0	ROOT	53266	53271	_	_	_	_	_
296	16	¿	¿	CD	15	nummod	53271	53272	_	_	_	_	_
296	17	½	½	CD	20	nummod	53272	53273	_	_	_	_	_
296	18	guez	guez	NN	20	compound	53273	53277	_	_	_	_	_
296	19	A.	a.	NN	20	compound	53278	53280	_	_	_	_	_
296	20	Role	role	NN	15	dobj	53281	53285	_	_	_	_	_
296	21	of	of	IN	22	case	53286	53288	_	_	_	_	_
296	22	saliva	saliva	NN	20	nmod	53289	53295	_	_	_	_	_
296	23	,	,	,	22	punct	53295	53296	_	_	_	_	_
296	24	urine	urine	NN	22	conj	53297	53302	_	_	_	_	_
296	25	and	and	CC	22	cc	53303	53306	_	_	_	_	_
296	26	feces	fece	NNS	22	conj	53307	53312	_	_	_	_	_
296	27	in	in	IN	29	case	53313	53315	_	_	_	_	_
296	28	the	the	DT	29	det	53316	53319	_	_	_	_	_
296	29	transmission	transmission	NN	15	nmod	53320	53332	_	_	_	_	_
296	30	of	of	IN	33	case	53333	53335	_	_	_	_	_
296	31	type	type	NN	33	compound	53336	53340	_	_	_	_	_
296	32	B	b	NN	33	compound	53341	53342	_	_	_	_	_
296	33	hepatitis	hepatitis	NN	29	nmod	53343	53352	_	_	_	_	_
296	34	.	.	.	15	punct	53352	53353	_	_	_	_	_

297	1	New	New	NNP	3	compound	53354	53357	_	_	_	_	_
297	2	England	England	NNP	3	compound	53358	53365	_	_	_	_	_
297	3	Journal	Journal	NNP	0	ROOT	53366	53373	_	_	_	_	_
297	4	of	of	IN	5	case	53374	53376	_	_	_	_	_
297	5	Medicine	Medicine	NNP	3	nmod	53377	53385	_	_	_	_	_
297	6	1974	1974	CD	5	nummod	53386	53390	_	_	_	_	_
297	7	;	;	:	5	punct	53390	53391	_	_	_	_	_
297	8	291:1375-8	291:1375-8	CD	5	nummod	53391	53401	_	_	_	_	_
297	9	.	.	.	3	punct	53401	53402	_	_	_	_	_

298	1	Powell	Powell	NNP	2	compound	53403	53409	_	_	_	_	_
298	2	E	E	NNP	0	ROOT	53410	53411	_	_	_	_	_
298	3	,	,	,	2	punct	53411	53412	_	_	_	_	_
298	4	Duke	Duke	NNP	5	compound	53413	53417	_	_	_	_	_
298	5	M	M	NNP	2	appos	53418	53419	_	_	_	_	_
298	6	,	,	,	5	punct	53419	53420	_	_	_	_	_
298	7	Cooksley	Cooksley	NNP	8	compound	53421	53429	_	_	_	_	_
298	8	WG	WG	NNP	5	appos	53430	53432	_	_	_	_	_
298	9	.	.	.	2	punct	53432	53433	_	_	_	_	_

299	1	Hepatitis	Hepatitis	NNP	3	compound	53434	53443	_	_	_	_	_
299	2	B	B	NNP	3	compound	53444	53445	_	_	_	_	_
299	3	transmission	transmission	NN	0	ROOT	53446	53458	_	_	_	_	_
299	4	within	within	IN	5	case	53459	53465	_	_	_	_	_
299	5	families	family	NNS	3	nmod	53466	53474	_	_	_	_	_
299	6	:	:	:	3	punct	53474	53475	_	_	_	_	_
299	7	potential	potential	JJ	8	amod	53476	53485	_	_	_	_	_
299	8	importance	importance	NN	3	dep	53486	53496	_	_	_	_	_
299	9	of	of	IN	10	case	53497	53499	_	_	_	_	_
299	10	saliva	saliva	NN	8	nmod	53500	53506	_	_	_	_	_
299	11	as	as	IN	13	case	53507	53509	_	_	_	_	_
299	12	a	a	DT	13	det	53510	53511	_	_	_	_	_
299	13	vehicle	vehicle	NN	10	nmod	53512	53519	_	_	_	_	_
299	14	of	of	IN	15	case	53520	53522	_	_	_	_	_
299	15	spread	spread	NN	13	nmod	53523	53529	_	_	_	_	_
299	16	.	.	.	3	punct	53529	53530	_	_	_	_	_

300	1	Australian	australian	JJ	0	ROOT	53531	53541	_	_	_	_	_
300	2	and	and	CC	1	cc	53542	53545	_	_	_	_	_
300	3	New	New	NNP	5	compound	53546	53549	_	_	_	_	_
300	4	Zealand	Zealand	NNP	5	compound	53550	53557	_	_	_	_	_
300	5	Journal	Journal	NNP	1	conj	53558	53565	_	_	_	_	_
300	6	of	of	IN	7	case	53566	53568	_	_	_	_	_
300	7	Medicine	Medicine	NNP	5	nmod	53569	53577	_	_	_	_	_
300	8	1985	1985	CD	7	nummod	53578	53582	_	_	_	_	_
300	9	;	;	:	1	punct	53582	53583	_	_	_	_	_
300	10	15:717-20	15:717-20	CD	1	dep	53583	53592	_	_	_	_	_
300	11	.	.	.	1	punct	53592	53593	_	_	_	_	_

301	1	Hui	Hui	NNP	2	compound	53594	53597	_	_	_	_	_
301	2	AY	AY	NNP	0	ROOT	53598	53600	_	_	_	_	_
301	3	,	,	,	2	punct	53600	53601	_	_	_	_	_
301	4	Hung	Hung	NNP	5	compound	53602	53606	_	_	_	_	_
301	5	LC	LC	NNP	2	appos	53607	53609	_	_	_	_	_
301	6	,	,	,	2	punct	53609	53610	_	_	_	_	_
301	7	Tse	Tse	NNP	8	compound	53611	53614	_	_	_	_	_
301	8	PC	PC	NNP	2	appos	53615	53617	_	_	_	_	_
301	9	,	,	,	2	punct	53617	53618	_	_	_	_	_
301	10	et	et	FW	11	compound	53619	53621	_	_	_	_	_
301	11	al.	al.	FW	2	appos	53622	53625	_	_	_	_	_
301	12	.	.	.	2	punct	_	_	_	_	_	_	_

302	1	Transmission	Transmission	NNP	0	ROOT	53626	53638	_	_	_	_	_
302	2	of	of	IN	4	case	53639	53641	_	_	_	_	_
302	3	hepatitis	hepatitis	NN	4	compound	53642	53651	_	_	_	_	_
302	4	B	b	NN	1	nmod	53652	53653	_	_	_	_	_
302	5	by	by	IN	9	case	53654	53656	_	_	_	_	_
302	6	human	human	JJ	9	amod	53657	53662	_	_	_	_	_
302	7	bite	bite	NN	9	compound	53663	53667	_	_	_	_	_
302	8	—	—	NN	9	compound	53667	53668	_	_	_	_	_
302	9	confirmation	confirmation	NN	4	nmod	53668	53680	_	_	_	_	_
302	10	by	by	IN	11	case	53681	53683	_	_	_	_	_
302	11	detection	detection	NN	9	nmod	53684	53693	_	_	_	_	_
302	12	of	of	IN	13	case	53694	53696	_	_	_	_	_
302	13	virus	virus	NN	1	nmod	53697	53702	_	_	_	_	_
302	14	in	in	IN	19	case	53703	53705	_	_	_	_	_
302	15	saliva	saliva	NN	19	compound	53706	53712	_	_	_	_	_
302	16	and	and	CC	15	cc	53713	53716	_	_	_	_	_
302	17	full	full	JJ	15	conj	53717	53721	_	_	_	_	_
302	18	genome	genome	NN	19	compound	53722	53728	_	_	_	_	_
302	19	sequencing	sequencing	NN	1	nmod	53729	53739	_	_	_	_	_
302	20	.	.	.	1	punct	53739	53740	_	_	_	_	_

303	1	Journal	Journal	NNP	0	ROOT	53741	53748	_	_	_	_	_
303	2	of	of	IN	4	case	53749	53751	_	_	_	_	_
303	3	Clinical	clinical	JJ	4	amod	53752	53760	_	_	_	_	_
303	4	Virology	Virology	NNP	1	nmod	53761	53769	_	_	_	_	_
303	5	2005	2005	CD	4	nummod	53770	53774	_	_	_	_	_
303	6	;	;	:	1	punct	53774	53775	_	_	_	_	_
303	7	33:254-6	33:254-6	CD	1	dep	53775	53783	_	_	_	_	_
303	8	.	.	.	1	punct	53783	53784	_	_	_	_	_

304	1	Bancroft	Bancroft	NNP	2	compound	53785	53793	_	_	_	_	_
304	2	WH	WH	NNP	0	ROOT	53794	53796	_	_	_	_	_
304	3	,	,	,	2	punct	53796	53797	_	_	_	_	_
304	4	Snitbhan	Snitbhan	NNP	5	compound	53798	53806	_	_	_	_	_
304	5	R	R	NNP	2	appos	53807	53808	_	_	_	_	_
304	6	,	,	,	2	punct	53808	53809	_	_	_	_	_
304	7	Scott	Scott	NNP	8	compound	53810	53815	_	_	_	_	_
304	8	RM	rm	NN	2	appos	53816	53818	_	_	_	_	_
304	9	,	,	,	2	punct	53818	53819	_	_	_	_	_
304	10	et	et	FW	11	compound	53820	53822	_	_	_	_	_
304	11	al.	al.	FW	2	appos	53823	53826	_	_	_	_	_
304	12	.	.	.	2	punct	_	_	_	_	_	_	_

305	1	Transmission	Transmission	NNP	0	ROOT	53827	53839	_	_	_	_	_
305	2	of	of	IN	5	case	53840	53842	_	_	_	_	_
305	3	hepatitis	hepatitis	NN	5	compound	53843	53852	_	_	_	_	_
305	4	B	b	NN	5	compound	53853	53854	_	_	_	_	_
305	5	virus	virus	NN	1	nmod	53855	53860	_	_	_	_	_
305	6	to	to	TO	7	case	53861	53863	_	_	_	_	_
305	7	gibbons	gibbon	NNS	5	nmod	53864	53871	_	_	_	_	_
305	8	by	by	IN	9	case	53872	53874	_	_	_	_	_
305	9	exposure	exposure	NN	7	nmod	53875	53883	_	_	_	_	_
305	10	to	to	TO	12	case	53884	53886	_	_	_	_	_
305	11	human	human	JJ	12	amod	53887	53892	_	_	_	_	_
305	12	saliva	saliva	NN	7	nmod	53893	53899	_	_	_	_	_
305	13	containing	contain	VBG	1	acl	53900	53910	_	_	_	_	_
305	14	hepatitis	hepatitis	NN	17	compound	53911	53920	_	_	_	_	_
305	15	B	b	NN	17	compound	53921	53922	_	_	_	_	_
305	16	surface	surface	NN	17	compound	53923	53930	_	_	_	_	_
305	17	antigen	antigen	NN	13	dobj	53931	53938	_	_	_	_	_
305	18	.	.	.	1	punct	53938	53939	_	_	_	_	_

306	1	Journal	Journal	NNP	0	ROOT	53940	53947	_	_	_	_	_
306	2	of	of	IN	4	case	53948	53950	_	_	_	_	_
306	3	Infectious	infectious	JJ	4	amod	53951	53961	_	_	_	_	_
306	4	Diseases	disease	NNS	1	nmod	53962	53970	_	_	_	_	_
306	5	1977	1977	CD	1	dep	53971	53975	_	_	_	_	_
306	6	;	;	:	1	punct	53975	53976	_	_	_	_	_
306	7	135:79-85	135:79-85	CD	1	dep	53976	53985	_	_	_	_	_
306	8	.	.	.	1	punct	53985	53986	_	_	_	_	_

307	1	Greenberg	Greenberg	NNP	2	compound	53987	53996	_	_	_	_	_
307	2	DP	dp	NN	0	ROOT	53997	53999	_	_	_	_	_
307	3	,	,	,	2	punct	53999	54000	_	_	_	_	_
307	4	Vadheim	Vadheim	NNP	5	compound	54001	54008	_	_	_	_	_
307	5	CM	cm	NN	2	appos	54009	54011	_	_	_	_	_
307	6	,	,	,	2	punct	54011	54012	_	_	_	_	_
307	7	Marcy	Marcy	NNP	8	compound	54013	54018	_	_	_	_	_
307	8	SM	SM	NNP	2	appos	54019	54021	_	_	_	_	_
307	9	,	,	,	2	punct	54021	54022	_	_	_	_	_
307	10	et	et	FW	11	compound	54023	54025	_	_	_	_	_
307	11	al.	al.	FW	2	appos	54026	54029	_	_	_	_	_
307	12	.	.	.	2	punct	_	_	_	_	_	_	_

308	1	Safety	safety	NN	10	nsubj	54030	54036	_	_	_	_	_
308	2	and	and	CC	1	cc	54037	54040	_	_	_	_	_
308	3	immunogenicity	immunogenicity	NN	1	conj	54041	54055	_	_	_	_	_
308	4	of	of	IN	9	case	54056	54058	_	_	_	_	_
308	5	a	a	DT	9	det	54059	54060	_	_	_	_	_
308	6	recombinant	recombinant	JJ	9	amod	54061	54072	_	_	_	_	_
308	7	hepatitis	hepatitis	NN	9	compound	54073	54082	_	_	_	_	_
308	8	B	b	NN	9	compound	54083	54084	_	_	_	_	_
308	9	vaccine	vaccine	NN	1	nmod	54085	54092	_	_	_	_	_
308	10	administered	administer	VBN	0	ROOT	54093	54105	_	_	_	_	_
308	11	to	to	TO	12	case	54106	54108	_	_	_	_	_
308	12	infants	infant	NNS	10	nmod	54109	54116	_	_	_	_	_
308	13	at	at	IN	14	case	54117	54119	_	_	_	_	_
308	14	2	2	CD	12	nmod	54120	54121	_	_	_	_	_
308	15	,	,	,	14	punct	54121	54122	_	_	_	_	_
308	16	4	4	CD	14	nummod	54123	54124	_	_	_	_	_
308	17	and	and	CC	14	cc	54125	54128	_	_	_	_	_
308	18	6	6	CD	14	conj	54129	54130	_	_	_	_	_
308	19	months	month	NNS	10	dobj	54131	54137	_	_	_	_	_
308	20	of	of	IN	21	case	54138	54140	_	_	_	_	_
308	21	age	age	NN	19	nmod	54141	54144	_	_	_	_	_
308	22	.	.	.	10	punct	54144	54145	_	_	_	_	_

309	1	Vaccine	vaccine	NN	0	ROOT	54146	54153	_	_	_	_	_
309	2	1996	1996	CD	1	nummod	54154	54158	_	_	_	_	_
309	3	;	;	:	1	punct	54158	54159	_	_	_	_	_
309	4	14:811-6	14:811-6	CD	1	dep	54159	54167	_	_	_	_	_
309	5	.	.	.	1	punct	54167	54168	_	_	_	_	_

310	1	Greenberg	Greenberg	NNP	2	compound	54169	54178	_	_	_	_	_
310	2	DP	dp	NN	0	ROOT	54179	54181	_	_	_	_	_
310	3	,	,	,	2	punct	54181	54182	_	_	_	_	_
310	4	Vadheim	Vadheim	NNP	5	compound	54183	54190	_	_	_	_	_
310	5	CM	cm	NN	2	appos	54191	54193	_	_	_	_	_
310	6	,	,	,	2	punct	54193	54194	_	_	_	_	_
310	7	Wong	Wong	NNP	8	compound	54195	54199	_	_	_	_	_
310	8	VK	VK	NNP	2	appos	54200	54202	_	_	_	_	_
310	9	,	,	,	2	punct	54202	54203	_	_	_	_	_
310	10	et	et	FW	11	compound	54204	54206	_	_	_	_	_
310	11	al.	al.	FW	2	appos	54207	54210	_	_	_	_	_
310	12	.	.	.	2	punct	_	_	_	_	_	_	_

311	1	Comparative	comparative	JJ	2	amod	54211	54222	_	_	_	_	_
311	2	safety	safety	NN	11	nsubj	54223	54229	_	_	_	_	_
311	3	and	and	CC	2	cc	54230	54233	_	_	_	_	_
311	4	immunogenicity	immunogenicity	NN	2	conj	54234	54248	_	_	_	_	_
311	5	of	of	IN	10	case	54249	54251	_	_	_	_	_
311	6	two	two	CD	10	nummod	54252	54255	_	_	_	_	_
311	7	recombinant	recombinant	JJ	10	amod	54256	54267	_	_	_	_	_
311	8	hepatitis	hepatitis	NN	10	compound	54268	54277	_	_	_	_	_
311	9	B	b	NN	10	compound	54278	54279	_	_	_	_	_
311	10	vaccines	vaccine	NNS	2	nmod	54280	54288	_	_	_	_	_
311	11	given	give	VBN	0	ROOT	54289	54294	_	_	_	_	_
311	12	to	to	TO	13	case	54295	54297	_	_	_	_	_
311	13	infants	infant	NNS	11	nmod	54298	54305	_	_	_	_	_
311	14	at	at	IN	15	case	54306	54308	_	_	_	_	_
311	15	two	two	CD	13	nmod	54309	54312	_	_	_	_	_
311	16	,	,	,	15	punct	54312	54313	_	_	_	_	_
311	17	four	four	CD	15	nummod	54314	54318	_	_	_	_	_
311	18	and	and	CC	15	cc	54319	54322	_	_	_	_	_
311	19	six	six	CD	15	conj	54323	54326	_	_	_	_	_
311	20	months	month	NNS	11	dobj	54327	54333	_	_	_	_	_
311	21	of	of	IN	22	case	54334	54336	_	_	_	_	_
311	22	age	age	NN	20	nmod	54337	54340	_	_	_	_	_
311	23	.	.	.	11	punct	54340	54341	_	_	_	_	_

312	1	Pediatric	Pediatric	NNP	2	nsubj	54342	54351	_	_	_	_	_
312	2	Infectious	infectious	JJ	0	ROOT	54352	54362	_	_	_	_	_
312	3	Disease	disease	NN	4	dep	54363	54370	_	_	_	_	_
312	4	Journal	Journal	NNP	2	nmod	54371	54378	_	_	_	_	_
312	5	1996	1996	CD	4	nummod	54379	54383	_	_	_	_	_
312	6	;	;	:	4	punct	54383	54384	_	_	_	_	_
312	7	15:590-6	15:590-6	CD	4	nummod	54384	54392	_	_	_	_	_
312	8	.	.	.	2	punct	54392	54393	_	_	_	_	_

313	1	Greenberg	Greenberg	NNP	2	compound	54394	54403	_	_	_	_	_
313	2	DP	dp	NN	0	ROOT	54404	54406	_	_	_	_	_
313	3	,	,	,	2	punct	54406	54407	_	_	_	_	_
313	4	Wong	Wong	NNP	5	compound	54408	54412	_	_	_	_	_
313	5	VK	VK	NNP	2	appos	54413	54415	_	_	_	_	_
313	6	,	,	,	2	punct	54415	54416	_	_	_	_	_
313	7	Partridge	Partridge	NNP	8	compound	54417	54426	_	_	_	_	_
313	8	S	s	NN	2	appos	54427	54428	_	_	_	_	_
313	9	,	,	,	2	punct	54428	54429	_	_	_	_	_
313	10	Howe	Howe	NNP	11	compound	54430	54434	_	_	_	_	_
313	11	BJ	BJ	NNP	2	appos	54435	54437	_	_	_	_	_
313	12	,	,	,	2	punct	54437	54438	_	_	_	_	_
313	13	Ward	Ward	NNP	14	compound	54439	54443	_	_	_	_	_
313	14	JI	JI	NNP	2	appos	54444	54446	_	_	_	_	_
313	15	.	.	.	2	punct	54446	54447	_	_	_	_	_

314	1	Safety	safety	NN	12	nsubj	54448	54454	_	_	_	_	_
314	2	and	and	CC	1	cc	54455	54458	_	_	_	_	_
314	3	immunogenicity	immunogenicity	NN	1	conj	54459	54473	_	_	_	_	_
314	4	of	of	IN	7	case	54474	54476	_	_	_	_	_
314	5	a	a	DT	7	det	54477	54478	_	_	_	_	_
314	6	combination	combination	NN	7	compound	54479	54490	_	_	_	_	_
314	7	diphtheria-tetanus	diphtheria-tetanus	NN	1	nmod	54491	54509	_	_	_	_	_
314	8	toxoids-acellular	toxoids-acellular	JJ	11	amod	54510	54527	_	_	_	_	_
314	9	pertussis-hepatitis	pertussis-hepatitis	NN	11	compound	54528	54547	_	_	_	_	_
314	10	B	b	NN	11	compound	54548	54549	_	_	_	_	_
314	11	vaccine	vaccine	NN	7	dep	54550	54557	_	_	_	_	_
314	12	administered	administer	VBN	0	ROOT	54558	54570	_	_	_	_	_
314	13	at	at	IN	14	case	54571	54573	_	_	_	_	_
314	14	two	two	CD	12	nmod	54574	54577	_	_	_	_	_
314	15	,	,	,	14	punct	54577	54578	_	_	_	_	_
314	16	four	four	CD	14	nummod	54579	54583	_	_	_	_	_
314	17	and	and	CC	14	cc	54584	54587	_	_	_	_	_
314	18	six	six	CD	14	conj	54588	54591	_	_	_	_	_
314	19	months	month	NNS	12	dobj	54592	54598	_	_	_	_	_
314	20	of	of	IN	21	case	54599	54601	_	_	_	_	_
314	21	age	age	NN	19	nmod	54602	54605	_	_	_	_	_
314	22	compared	compare	VBN	27	case	54606	54614	_	_	_	_	_
314	23	with	with	IN	27	case	54615	54619	_	_	_	_	_
314	24	monovalent	monovalent	JJ	27	amod	54620	54630	_	_	_	_	_
314	25	hepatitis	hepatitis	NN	27	compound	54631	54640	_	_	_	_	_
314	26	B	b	NN	27	compound	54641	54642	_	_	_	_	_
314	27	vaccine	vaccine	NN	12	advcl	54643	54650	_	_	_	_	_
314	28	administered	administer	VBN	27	acl	54651	54663	_	_	_	_	_
314	29	at	at	IN	30	case	54664	54666	_	_	_	_	_
314	30	birth	birth	NN	28	nmod	54667	54672	_	_	_	_	_
314	31	,	,	,	30	punct	54672	54673	_	_	_	_	_
314	32	one	one	CD	33	nummod	54674	54677	_	_	_	_	_
314	33	month	month	NN	30	conj	54678	54683	_	_	_	_	_
314	34	and	and	CC	30	cc	54684	54687	_	_	_	_	_
314	35	six	six	CD	36	nummod	54688	54691	_	_	_	_	_
314	36	months	month	NNS	30	conj	54692	54698	_	_	_	_	_
314	37	of	of	IN	38	case	54699	54701	_	_	_	_	_
314	38	age	age	NN	36	nmod	54702	54705	_	_	_	_	_
314	39	.	.	.	12	punct	54705	54706	_	_	_	_	_

315	1	Pediatric	Pediatric	NNP	2	nsubj	54707	54716	_	_	_	_	_
315	2	Infectious	infectious	JJ	0	ROOT	54717	54727	_	_	_	_	_
315	3	Disease	disease	NN	4	dep	54728	54735	_	_	_	_	_
315	4	Journal	Journal	NNP	2	nmod	54736	54743	_	_	_	_	_
315	5	2002	2002	CD	4	nummod	54744	54748	_	_	_	_	_
315	6	;	;	:	4	punct	54748	54749	_	_	_	_	_
315	7	21:769-76	21:769-76	CD	4	nummod	54749	54758	_	_	_	_	_
315	8	.	.	.	2	punct	54758	54759	_	_	_	_	_

316	1	Andrï	Andrï	NNP	0	ROOT	54760	54765	_	_	_	_	_
316	2	¿	¿	CD	3	compound	54765	54766	_	_	_	_	_
316	3	½	½	CD	1	dep	54766	54767	_	_	_	_	_
316	4	FE	FE	NNP	7	compound	54768	54770	_	_	_	_	_
316	5	,	,	,	7	punct	54770	54771	_	_	_	_	_
316	6	Zuckerman	Zuckerman	NNP	7	appos	54772	54781	_	_	_	_	_
316	7	AJ	AJ	NNP	3	dep	54782	54784	_	_	_	_	_
316	8	.	.	.	1	punct	54784	54785	_	_	_	_	_

317	1	Review	review	NN	0	ROOT	54786	54792	_	_	_	_	_
317	2	:	:	:	1	punct	54792	54793	_	_	_	_	_
317	3	protective	protective	JJ	4	amod	54794	54804	_	_	_	_	_
317	4	efficacy	efficacy	NN	1	dep	54805	54813	_	_	_	_	_
317	5	of	of	IN	8	case	54814	54816	_	_	_	_	_
317	6	hepatitis	hepatitis	NN	8	compound	54817	54826	_	_	_	_	_
317	7	B	b	NN	8	compound	54827	54828	_	_	_	_	_
317	8	vaccines	vaccine	NNS	4	nmod	54829	54837	_	_	_	_	_
317	9	in	in	IN	10	case	54838	54840	_	_	_	_	_
317	10	neonates	neonate	NNS	8	nmod	54841	54849	_	_	_	_	_
317	11	.	.	.	1	punct	54849	54850	_	_	_	_	_

318	1	Journal	Journal	NNP	0	ROOT	54851	54858	_	_	_	_	_
318	2	of	of	IN	4	case	54859	54861	_	_	_	_	_
318	3	Medical	Medical	NNP	4	compound	54862	54869	_	_	_	_	_
318	4	Virology	Virology	NNP	1	nmod	54870	54878	_	_	_	_	_
318	5	1994	1994	CD	4	nummod	54879	54883	_	_	_	_	_
318	6	;	;	:	1	punct	54883	54884	_	_	_	_	_
318	7	44:144-51	44:144-51	CD	1	dep	54884	54893	_	_	_	_	_
318	8	.	.	.	1	punct	54893	54894	_	_	_	_	_

319	1	Wistrï	Wistrï	NNP	0	ROOT	54895	54901	_	_	_	_	_
319	2	¿	¿	CD	1	nummod	54901	54902	_	_	_	_	_
319	3	½	½	CD	5	nummod	54902	54903	_	_	_	_	_
319	4	m	m	NN	5	compound	54903	54904	_	_	_	_	_
319	5	J	j	NN	1	dep	54905	54906	_	_	_	_	_
319	6	,	,	,	5	punct	54906	54907	_	_	_	_	_
319	7	Ahlm	ahlm	NN	8	compound	54908	54912	_	_	_	_	_
319	8	C	c	NN	5	appos	54913	54914	_	_	_	_	_
319	9	,	,	,	5	punct	54914	54915	_	_	_	_	_
319	10	Lundberg	Lundberg	NNP	11	compound	54916	54924	_	_	_	_	_
319	11	S	s	NN	5	appos	54925	54926	_	_	_	_	_
319	12	,	,	,	5	punct	54926	54927	_	_	_	_	_
319	13	Settergren	settergren	NN	14	compound	54928	54938	_	_	_	_	_
319	14	B	b	NN	5	appos	54939	54940	_	_	_	_	_
319	15	,	,	,	5	punct	54940	54941	_	_	_	_	_
319	16	Tï	tï	NN	19	compound	54942	54944	_	_	_	_	_
319	17	¿	¿	CD	19	nummod	54944	54945	_	_	_	_	_
319	18	½	½	NN	19	compound	54945	54946	_	_	_	_	_
319	19	rnvik	rnvik	NN	5	appos	54946	54951	_	_	_	_	_
319	20	A.	a.	NN	22	compound	54952	54954	_	_	_	_	_
319	21	Booster	Booster	NNP	22	compound	54955	54962	_	_	_	_	_
319	22	vaccination	vaccination	NN	1	dep	54963	54974	_	_	_	_	_
319	23	with	with	IN	27	case	54975	54979	_	_	_	_	_
319	24	recombinant	recombinant	JJ	27	amod	54980	54991	_	_	_	_	_
319	25	hepatitis	hepatitis	NN	27	compound	54992	55001	_	_	_	_	_
319	26	B	b	NN	27	compound	55002	55003	_	_	_	_	_
319	27	vaccine	vaccine	NN	22	nmod	55004	55011	_	_	_	_	_
319	28	four	four	CD	29	nummod	55012	55016	_	_	_	_	_
319	29	years	year	NNS	1	dep	55017	55022	_	_	_	_	_
319	30	after	after	IN	31	case	55023	55028	_	_	_	_	_
319	31	priming	priming	NN	29	nmod	55029	55036	_	_	_	_	_
319	32	with	with	IN	35	case	55037	55041	_	_	_	_	_
319	33	one	one	CD	35	nummod	55042	55045	_	_	_	_	_
319	34	single	single	JJ	35	amod	55046	55052	_	_	_	_	_
319	35	dose	dose	NN	31	nmod	55053	55057	_	_	_	_	_
319	36	.	.	.	1	punct	55057	55058	_	_	_	_	_

320	1	Vaccine	vaccine	NN	0	ROOT	55059	55066	_	_	_	_	_
320	2	1999	1999	CD	1	nummod	55067	55071	_	_	_	_	_
320	3	;	;	:	1	punct	55071	55072	_	_	_	_	_
320	4	17:2162-5	17:2162-5	CD	1	dep	55072	55081	_	_	_	_	_
320	5	.	.	.	1	punct	55081	55082	_	_	_	_	_

321	1	Centers	Centers	NNPS	8	dep	55083	55090	_	_	_	_	_
321	2	for	for	IN	4	case	55091	55094	_	_	_	_	_
321	3	Disease	Disease	NNP	4	compound	55095	55102	_	_	_	_	_
321	4	Control	Control	NNP	1	nmod	55103	55110	_	_	_	_	_
321	5	and	and	CC	4	cc	55111	55114	_	_	_	_	_
321	6	Prevention	Prevention	NNP	4	conj	55115	55125	_	_	_	_	_
321	7	(	(	CD	8	nummod	55126	55127	_	_	_	_	_
321	8	CDC	CDC	NNP	0	ROOT	55127	55130	_	_	_	_	_
321	9	)	)	CD	8	nummod	55130	55131	_	_	_	_	_
321	10	,	,	,	8	punct	55131	55132	_	_	_	_	_
321	11	Mast	mast	NN	12	compound	55133	55137	_	_	_	_	_
321	12	EE	ee	NN	8	appos	55138	55140	_	_	_	_	_
321	13	,	,	,	8	punct	55140	55141	_	_	_	_	_
321	14	Margolis	Margolis	NNP	15	compound	55142	55150	_	_	_	_	_
321	15	HS	hs	NN	8	appos	55151	55153	_	_	_	_	_
321	16	,	,	,	8	punct	55153	55154	_	_	_	_	_
321	17	et	et	FW	18	compound	55155	55157	_	_	_	_	_
321	18	al.	al.	FW	8	appos	55158	55161	_	_	_	_	_
321	19	.	.	.	8	punct	_	_	_	_	_	_	_

322	1	A	a	DT	4	det	55162	55163	_	_	_	_	_
322	2	comprehensive	comprehensive	JJ	4	amod	55164	55177	_	_	_	_	_
322	3	immunization	immunization	NN	4	compound	55178	55190	_	_	_	_	_
322	4	strategy	strategy	NN	0	ROOT	55191	55199	_	_	_	_	_
322	5	to	to	TO	6	mark	55200	55202	_	_	_	_	_
322	6	eliminate	eliminate	VB	4	acl	55203	55212	_	_	_	_	_
322	7	transmission	transmission	NN	6	dobj	55213	55225	_	_	_	_	_
322	8	of	of	IN	10	case	55226	55228	_	_	_	_	_
322	9	hepatitis	hepatitis	NN	10	compound	55229	55238	_	_	_	_	_
322	10	B	b	NN	7	nmod	55239	55240	_	_	_	_	_
322	11	virus	virus	NN	12	compound	55241	55246	_	_	_	_	_
322	12	infection	infection	NN	4	dep	55247	55256	_	_	_	_	_
322	13	in	in	IN	16	case	55257	55259	_	_	_	_	_
322	14	the	the	DT	16	det	55260	55263	_	_	_	_	_
322	15	United	United	NNP	16	compound	55264	55270	_	_	_	_	_
322	16	States	States	NNPS	12	nmod	55271	55277	_	_	_	_	_
322	17	:	:	:	4	punct	55277	55278	_	_	_	_	_
322	18	recommendations	recommendation	NNS	4	dep	55279	55294	_	_	_	_	_
322	19	of	of	IN	22	case	55295	55297	_	_	_	_	_
322	20	the	the	DT	22	det	55298	55301	_	_	_	_	_
322	21	Advisory	Advisory	NNP	22	compound	55302	55310	_	_	_	_	_
322	22	Committee	Committee	NNP	18	nmod	55311	55320	_	_	_	_	_
322	23	on	on	IN	25	case	55321	55323	_	_	_	_	_
322	24	Immunization	Immunization	NNP	25	compound	55324	55336	_	_	_	_	_
322	25	Practices	Practices	NNPS	22	nmod	55337	55346	_	_	_	_	_
322	26	(	(	FW	28	compound	55347	55348	_	_	_	_	_
322	27	ACIP	acip	FW	28	compound	55348	55352	_	_	_	_	_
322	28	)	)	FW	18	dep	55352	55353	_	_	_	_	_
322	29	.	.	.	4	punct	55353	55354	_	_	_	_	_

323	1	Part	Part	NNP	0	ROOT	55355	55359	_	_	_	_	_
323	2	1	1	CD	1	nummod	55360	55361	_	_	_	_	_
323	3	:	:	:	1	punct	55361	55362	_	_	_	_	_
323	4	immunization	immunization	NN	1	dep	55363	55375	_	_	_	_	_
323	5	of	of	IN	6	case	55376	55378	_	_	_	_	_
323	6	infants	infant	NNS	4	nmod	55379	55386	_	_	_	_	_
323	7	,	,	,	6	punct	55386	55387	_	_	_	_	_
323	8	children	child	NNS	6	conj	55388	55396	_	_	_	_	_
323	9	,	,	,	6	punct	55396	55397	_	_	_	_	_
323	10	and	and	CC	6	cc	55398	55401	_	_	_	_	_
323	11	adolescents	adolescent	NNS	6	conj	55402	55413	_	_	_	_	_
323	12	.	.	.	1	punct	55413	55414	_	_	_	_	_

324	1	[	[	NN	2	compound	55415	55416	_	_	_	_	_
324	2	errata	erratum	NNS	3	nsubj	55416	55422	_	_	_	_	_
324	3	appear	appear	VBP	0	ROOT	55423	55429	_	_	_	_	_
324	4	in	in	IN	9	case	55430	55432	_	_	_	_	_
324	5	MMWR	MMWR	NNP	9	compound	55433	55437	_	_	_	_	_
324	6	Morb	Morb	NNP	9	compound	55438	55442	_	_	_	_	_
324	7	Mortal	Mortal	NNP	9	compound	55443	55449	_	_	_	_	_
324	8	Wkly	Wkly	NNP	9	compound	55450	55454	_	_	_	_	_
324	9	Rep.	Rep.	NNP	3	nmod	55455	55459	_	_	_	_	_
324	10	2006	2006	CD	11	nummod	55460	55464	_	_	_	_	_
324	11	Feb	Feb	NNP	9	dep	55465	55468	_	_	_	_	_
324	12	17	17	CD	11	nummod	55469	55471	_	_	_	_	_
324	13	;	;	:	9	punct	55471	55472	_	_	_	_	_
324	14	55	55	CD	15	compound	55472	55474	_	_	_	_	_
324	15	(	(	CD	9	dep	55474	55475	_	_	_	_	_
324	16	6	6	CD	17	nummod	55475	55476	_	_	_	_	_
324	17	)	)	NN	15	dep	55476	55477	_	_	_	_	_
324	18	:	:	:	9	punct	55477	55478	_	_	_	_	_
324	19	158-9	158-9	CD	9	dep	55478	55483	_	_	_	_	_
324	20	and	and	CC	19	cc	55484	55487	_	_	_	_	_
324	21	MMWR	MMWR	NNP	25	compound	55488	55492	_	_	_	_	_
324	22	Morb	Morb	NNP	25	compound	55493	55497	_	_	_	_	_
324	23	Mortal	Mortal	NNP	25	compound	55498	55504	_	_	_	_	_
324	24	Wkly	Wkly	NNP	25	compound	55505	55509	_	_	_	_	_
324	25	Rep.	Rep.	NNP	19	conj	55510	55514	_	_	_	_	_
324	26	2007	2007	CD	25	nummod	55515	55519	_	_	_	_	_
324	27	Dec	Dec	NNP	19	nmod:tmod	55520	55523	_	_	_	_	_
324	28	7	7	CD	27	nummod	55524	55525	_	_	_	_	_
324	29	;	;	:	9	punct	55525	55526	_	_	_	_	_
324	30	56	56	CD	31	compound	55526	55528	_	_	_	_	_
324	31	(	(	CD	9	dep	55528	55529	_	_	_	_	_
324	32	48	48	CD	33	nummod	55529	55531	_	_	_	_	_
324	33	)	)	NN	31	dep	55531	55532	_	_	_	_	_
324	34	:	:	:	9	punct	55532	55533	_	_	_	_	_
324	35	1267	1267	CD	36	nummod	55533	55537	_	_	_	_	_
324	36	]	]	CD	9	dep	55537	55538	_	_	_	_	_
324	37	.	.	.	3	punct	55538	55539	_	_	_	_	_

325	1	MMWR	mmwr	NN	2	compound	55540	55544	_	_	_	_	_
325	2	Recommendations	recommendation	NNS	0	ROOT	55545	55560	_	_	_	_	_
325	3	and	and	CC	2	cc	55561	55564	_	_	_	_	_
325	4	Reports	report	NNS	2	conj	55565	55572	_	_	_	_	_
325	5	2005	2005	CD	2	dep	55573	55577	_	_	_	_	_
325	6	;	;	:	2	punct	55577	55578	_	_	_	_	_
325	7	54	54	CD	8	compound	55578	55580	_	_	_	_	_
325	8	(	(	CD	9	nummod	55580	55581	_	_	_	_	_
325	9	RR-16	rr-16	NN	2	dep	55581	55586	_	_	_	_	_
325	10	)	)	CD	12	nummod	55586	55587	_	_	_	_	_
325	11	:	:	:	12	punct	55587	55588	_	_	_	_	_
325	12	1-32	1-32	CD	9	dep	55588	55592	_	_	_	_	_
325	13	.	.	.	2	punct	55592	55593	_	_	_	_	_

326	1	Mintai	Mintai	NNP	2	compound	55594	55600	_	_	_	_	_
326	2	Z	Z	NNP	0	ROOT	55601	55602	_	_	_	_	_
326	3	,	,	,	2	punct	55602	55603	_	_	_	_	_
326	4	Kezhou	Kezhou	NNP	5	compound	55604	55610	_	_	_	_	_
326	5	L	L	NNP	2	appos	55611	55612	_	_	_	_	_
326	6	,	,	,	2	punct	55612	55613	_	_	_	_	_
326	7	Lieming	lieming	NN	8	compound	55614	55621	_	_	_	_	_
326	8	D	d	NN	2	appos	55622	55623	_	_	_	_	_
326	9	,	,	,	2	punct	55623	55624	_	_	_	_	_
326	10	Smego	Smego	NNP	11	compound	55625	55630	_	_	_	_	_
326	11	RA	ra	NN	2	appos	55631	55633	_	_	_	_	_
326	12	,	,	,	2	punct	55633	55634	_	_	_	_	_
326	13	Jr.	Jr.	NNP	2	appos	55635	55638	_	_	_	_	_
326	14	.	.	.	2	punct	_	_	_	_	_	_	_

327	1	Duration	duration	NN	0	ROOT	55639	55647	_	_	_	_	_
327	2	and	and	CC	1	cc	55648	55651	_	_	_	_	_
327	3	efficacy	efficacy	NN	1	conj	55652	55660	_	_	_	_	_
327	4	of	of	IN	6	case	55661	55663	_	_	_	_	_
327	5	immune	immune	JJ	6	amod	55664	55670	_	_	_	_	_
327	6	response	response	NN	1	nmod	55671	55679	_	_	_	_	_
327	7	to	to	TO	10	case	55680	55682	_	_	_	_	_
327	8	hepatitis	hepatitis	NN	10	compound	55683	55692	_	_	_	_	_
327	9	B	b	NN	10	compound	55693	55694	_	_	_	_	_
327	10	vaccine	vaccine	NN	1	nmod	55695	55702	_	_	_	_	_
327	11	in	in	IN	14	case	55703	55705	_	_	_	_	_
327	12	high-risk	high-risk	JJ	14	amod	55706	55715	_	_	_	_	_
327	13	Chinese	chinese	JJ	14	amod	55716	55723	_	_	_	_	_
327	14	adolescents	adolescent	NNS	10	nmod	55724	55735	_	_	_	_	_
327	15	.	.	.	1	punct	55735	55736	_	_	_	_	_

328	1	Clinical	clinical	JJ	3	amod	55737	55745	_	_	_	_	_
328	2	Infectious	infectious	JJ	3	amod	55746	55756	_	_	_	_	_
328	3	Diseases	disease	NNS	0	ROOT	55757	55765	_	_	_	_	_
328	4	1993	1993	CD	6	nummod	55766	55770	_	_	_	_	_
328	5	;	;	:	6	punct	55770	55771	_	_	_	_	_
328	6	16:165-7	16:165-7	CD	3	dep	55771	55779	_	_	_	_	_
328	7	.	.	.	3	punct	55779	55780	_	_	_	_	_

329	1	Hadler	Hadler	NNP	2	compound	55781	55787	_	_	_	_	_
329	2	SC	SC	NNP	0	ROOT	55788	55790	_	_	_	_	_
329	3	,	,	,	2	punct	55790	55791	_	_	_	_	_
329	4	de	de	FW	2	appos	55792	55794	_	_	_	_	_
329	5	Monzon	Monzon	NNP	6	compound	55795	55801	_	_	_	_	_
329	6	MA	MA	NNP	4	dep	55802	55804	_	_	_	_	_
329	7	,	,	,	2	punct	55804	55805	_	_	_	_	_
329	8	Lugo	Lugo	NNP	9	compound	55806	55810	_	_	_	_	_
329	9	DR	dr	NN	2	appos	55811	55813	_	_	_	_	_
329	10	,	,	,	2	punct	55813	55814	_	_	_	_	_
329	11	Perez	Perez	NNP	13	compound	55815	55820	_	_	_	_	_
329	12	M.	M.	NNP	13	compound	55821	55823	_	_	_	_	_
329	13	Effect	effect	NN	2	appos	55824	55830	_	_	_	_	_
329	14	of	of	IN	15	case	55831	55833	_	_	_	_	_
329	15	timing	timing	NN	13	nmod	55834	55840	_	_	_	_	_
329	16	of	of	IN	18	case	55841	55843	_	_	_	_	_
329	17	hepatitis	hepatitis	NN	18	compound	55844	55853	_	_	_	_	_
329	18	B	b	NN	15	nmod	55854	55855	_	_	_	_	_
329	19	vaccine	vaccine	NN	20	compound	55856	55863	_	_	_	_	_
329	20	doses	dose	NNS	2	dep	55864	55869	_	_	_	_	_
329	21	on	on	IN	22	case	55870	55872	_	_	_	_	_
329	22	response	response	NN	20	nmod	55873	55881	_	_	_	_	_
329	23	to	to	TO	24	case	55882	55884	_	_	_	_	_
329	24	vaccine	vaccine	NN	22	nmod	55885	55892	_	_	_	_	_
329	25	in	in	IN	27	case	55893	55895	_	_	_	_	_
329	26	Yucpa	Yucpa	NNP	27	compound	55896	55901	_	_	_	_	_
329	27	Indians	Indians	NNPS	24	nmod	55902	55909	_	_	_	_	_
329	28	.	.	.	2	punct	55909	55910	_	_	_	_	_

330	1	Vaccine	vaccine	NN	0	ROOT	55911	55918	_	_	_	_	_
330	2	1989	1989	CD	1	nummod	55919	55923	_	_	_	_	_
330	3	;	;	:	1	punct	55923	55924	_	_	_	_	_
330	4	7:106-10	7:106-10	CD	1	dep	55924	55932	_	_	_	_	_
330	5	.	.	.	1	punct	55932	55933	_	_	_	_	_

331	1	Floreani	Floreani	NNP	2	compound	55934	55942	_	_	_	_	_
331	2	A	A	NNP	0	ROOT	55943	55944	_	_	_	_	_
331	3	,	,	,	2	punct	55944	55945	_	_	_	_	_
331	4	Baldo	Baldo	NNP	5	compound	55946	55951	_	_	_	_	_
331	5	V	V	NNP	2	appos	55952	55953	_	_	_	_	_
331	6	,	,	,	2	punct	55953	55954	_	_	_	_	_
331	7	Cristofoletti	Cristofoletti	NNP	8	compound	55955	55968	_	_	_	_	_
331	8	M	M	NNP	2	appos	55969	55970	_	_	_	_	_
331	9	,	,	,	2	punct	55970	55971	_	_	_	_	_
331	10	et	et	FW	11	compound	55972	55974	_	_	_	_	_
331	11	al.	al.	FW	2	appos	55975	55978	_	_	_	_	_
331	12	.	.	.	2	punct	_	_	_	_	_	_	_

332	1	Long-term	long-term	JJ	2	amod	55979	55988	_	_	_	_	_
332	2	persistence	persistence	NN	0	ROOT	55989	56000	_	_	_	_	_
332	3	of	of	IN	4	case	56001	56003	_	_	_	_	_
332	4	anti-HBs	anti-hb	NNS	2	nmod	56004	56012	_	_	_	_	_
332	5	after	after	IN	6	case	56013	56018	_	_	_	_	_
332	6	vaccination	vaccination	NN	4	nmod	56020	56031	_	_	_	_	_
332	7	against	against	IN	8	case	56032	56039	_	_	_	_	_
332	8	HBV	hbv	NN	6	nmod	56040	56043	_	_	_	_	_
332	9	:	:	:	2	punct	56043	56044	_	_	_	_	_
332	10	an	a	DT	13	det	56045	56047	_	_	_	_	_
332	11	18	18	CD	13	nummod	56048	56050	_	_	_	_	_
332	12	year	year	NN	13	compound	56051	56055	_	_	_	_	_
332	13	experience	experience	NN	2	dep	56056	56066	_	_	_	_	_
332	14	in	in	IN	17	case	56067	56069	_	_	_	_	_
332	15	health	health	NN	17	compound	56070	56076	_	_	_	_	_
332	16	care	care	NN	17	compound	56077	56081	_	_	_	_	_
332	17	workers	worker	NNS	13	nmod	56082	56089	_	_	_	_	_
332	18	.	.	.	2	punct	56089	56090	_	_	_	_	_

333	1	Vaccine	vaccine	NN	0	ROOT	56091	56098	_	_	_	_	_
333	2	2004	2004	CD	1	nummod	56099	56103	_	_	_	_	_
333	3	;	;	:	1	punct	56103	56104	_	_	_	_	_
333	4	22:607-10	22:607-10	CD	1	dep	56104	56113	_	_	_	_	_
333	5	.	.	.	1	punct	56113	56114	_	_	_	_	_

334	1	Schï	Schï	NNP	0	ROOT	56115	56119	_	_	_	_	_
334	2	¿	¿	CD	1	nummod	56119	56120	_	_	_	_	_
334	3	½	½	CD	5	nummod	56120	56121	_	_	_	_	_
334	4	nberger	nberger	NN	5	compound	56121	56128	_	_	_	_	_
334	5	K	k	NN	1	dep	56129	56130	_	_	_	_	_
334	6	,	,	,	5	punct	56130	56131	_	_	_	_	_
334	7	Riedel	Riedel	NNP	8	compound	56132	56138	_	_	_	_	_
334	8	C	C	NNP	5	appos	56139	56140	_	_	_	_	_
334	9	,	,	,	5	punct	56140	56141	_	_	_	_	_
334	10	Rï	Rï	NNP	5	appos	56142	56144	_	_	_	_	_
334	11	¿	¿	CD	12	compound	56144	56145	_	_	_	_	_
334	12	½	½	CD	14	nummod	56145	56146	_	_	_	_	_
334	13	ckinger	ckinger	NN	14	compound	56146	56153	_	_	_	_	_
334	14	S	s	NN	10	dep	56154	56155	_	_	_	_	_
334	15	,	,	,	5	punct	56155	56156	_	_	_	_	_
334	16	et	et	FW	17	compound	56157	56159	_	_	_	_	_
334	17	al.	al.	FW	5	appos	56160	56163	_	_	_	_	_
334	18	.	.	.	1	punct	_	_	_	_	_	_	_

335	1	Determinants	determinant	NNS	0	ROOT	56164	56176	_	_	_	_	_
335	2	of	of	IN	4	case	56177	56179	_	_	_	_	_
335	3	long-term	long-term	JJ	4	amod	56180	56189	_	_	_	_	_
335	4	protection	protection	NN	1	nmod	56190	56200	_	_	_	_	_
335	5	after	after	IN	8	case	56201	56206	_	_	_	_	_
335	6	hepatitis	hepatitis	NN	8	compound	56207	56216	_	_	_	_	_
335	7	B	b	NN	8	compound	56217	56218	_	_	_	_	_
335	8	vaccination	vaccination	NN	4	nmod	56219	56230	_	_	_	_	_
335	9	in	in	IN	10	case	56231	56233	_	_	_	_	_
335	10	infancy	infancy	NN	8	nmod	56234	56241	_	_	_	_	_
335	11	:	:	:	1	punct	56241	56242	_	_	_	_	_
335	12	a	a	DT	13	det	56243	56244	_	_	_	_	_
335	13	meta-analysis	meta-analysis	NN	1	dep	56245	56258	_	_	_	_	_
335	14	.	.	.	1	punct	56258	56259	_	_	_	_	_

336	1	Pediatric	Pediatric	NNP	2	nsubj	56260	56269	_	_	_	_	_
336	2	Infectious	infectious	JJ	0	ROOT	56270	56280	_	_	_	_	_
336	3	Disease	disease	NN	4	dep	56281	56288	_	_	_	_	_
336	4	Journal	Journal	NNP	2	nmod	56289	56296	_	_	_	_	_
336	5	2013	2013	CD	4	nummod	56297	56301	_	_	_	_	_
336	6	;	;	:	4	punct	56301	56302	_	_	_	_	_
336	7	32:307-13	32:307-13	CD	4	nummod	56302	56311	_	_	_	_	_
336	8	.	.	.	2	punct	56311	56312	_	_	_	_	_

337	1	Wouters	Wouters	NNP	2	compound	56313	56320	_	_	_	_	_
337	2	K	K	NNP	0	ROOT	56321	56322	_	_	_	_	_
337	3	,	,	,	2	punct	56322	56323	_	_	_	_	_
337	4	Leuridan	Leuridan	NNP	5	compound	56324	56332	_	_	_	_	_
337	5	E	E	NNP	2	appos	56333	56334	_	_	_	_	_
337	6	,	,	,	2	punct	56334	56335	_	_	_	_	_
337	7	Van	Van	NNP	9	compound	56336	56339	_	_	_	_	_
337	8	Herck	Herck	NNP	9	compound	56340	56345	_	_	_	_	_
337	9	K	K	NNP	2	appos	56346	56347	_	_	_	_	_
337	10	,	,	,	2	punct	56347	56348	_	_	_	_	_
337	11	et	et	FW	12	compound	56349	56351	_	_	_	_	_
337	12	al.	al.	FW	2	appos	56352	56355	_	_	_	_	_
337	13	.	.	.	2	punct	_	_	_	_	_	_	_

338	1	Compliance	compliance	NN	0	ROOT	56356	56366	_	_	_	_	_
338	2	and	and	CC	1	cc	56367	56370	_	_	_	_	_
338	3	immunogenicity	immunogenicity	NN	1	conj	56371	56385	_	_	_	_	_
338	4	of	of	IN	9	case	56386	56388	_	_	_	_	_
338	5	two	two	CD	9	nummod	56389	56392	_	_	_	_	_
338	6	hepatitis	hepatitis	NN	9	compound	56393	56402	_	_	_	_	_
338	7	B	b	NN	9	compound	56403	56404	_	_	_	_	_
338	8	vaccination	vaccination	NN	9	compound	56405	56416	_	_	_	_	_
338	9	schedules	schedule	NNS	1	nmod	56417	56426	_	_	_	_	_
338	10	in	in	IN	12	case	56427	56429	_	_	_	_	_
338	11	sex	sex	NN	12	compound	56430	56433	_	_	_	_	_
338	12	workers	worker	NNS	9	nmod	56434	56441	_	_	_	_	_
338	13	in	in	IN	14	case	56442	56444	_	_	_	_	_
338	14	Belgium	Belgium	NNP	1	nmod	56445	56452	_	_	_	_	_
338	15	.	.	.	1	punct	56452	56453	_	_	_	_	_

339	1	Vaccine	vaccine	NN	0	ROOT	56454	56461	_	_	_	_	_
339	2	2007	2007	CD	1	nummod	56462	56466	_	_	_	_	_
339	3	;	;	:	1	punct	56466	56467	_	_	_	_	_
339	4	25:1893-900	25:1893-900	CD	1	dep	56467	56478	_	_	_	_	_
339	5	.	.	.	1	punct	56478	56479	_	_	_	_	_

340	1	Jilg	Jilg	NNP	2	compound	56480	56484	_	_	_	_	_
340	2	W	W	NNP	0	ROOT	56485	56486	_	_	_	_	_
340	3	,	,	,	2	punct	56486	56487	_	_	_	_	_
340	4	Schmidt	Schmidt	NNP	5	compound	56488	56495	_	_	_	_	_
340	5	M	M	NNP	2	appos	56496	56497	_	_	_	_	_
340	6	,	,	,	2	punct	56497	56498	_	_	_	_	_
340	7	Deinhardt	Deinhardt	NNP	9	compound	56499	56508	_	_	_	_	_
340	8	F.	F.	NNP	9	compound	56509	56511	_	_	_	_	_
340	9	Vaccination	vaccination	NN	2	appos	56512	56523	_	_	_	_	_
340	10	against	against	IN	12	case	56524	56531	_	_	_	_	_
340	11	hepatitis	hepatitis	NN	12	compound	56532	56541	_	_	_	_	_
340	12	B	b	NN	9	nmod	56542	56543	_	_	_	_	_
340	13	:	:	:	2	punct	56543	56544	_	_	_	_	_
340	14	comparison	comparison	NN	2	dep	56545	56555	_	_	_	_	_
340	15	of	of	IN	19	case	56556	56558	_	_	_	_	_
340	16	three	three	CD	19	nummod	56559	56564	_	_	_	_	_
340	17	different	different	JJ	19	amod	56565	56574	_	_	_	_	_
340	18	vaccination	vaccination	NN	19	compound	56575	56586	_	_	_	_	_
340	19	schedules	schedule	NNS	14	nmod	56587	56596	_	_	_	_	_
340	20	.	.	.	2	punct	56596	56597	_	_	_	_	_

341	1	Journal	Journal	NNP	0	ROOT	56598	56605	_	_	_	_	_
341	2	of	of	IN	4	case	56606	56608	_	_	_	_	_
341	3	Infectious	infectious	JJ	4	amod	56609	56619	_	_	_	_	_
341	4	Diseases	disease	NNS	1	nmod	56620	56628	_	_	_	_	_
341	5	1989	1989	CD	1	dep	56629	56633	_	_	_	_	_
341	6	;	;	:	1	punct	56633	56634	_	_	_	_	_
341	7	160:766-9	160:766-9	CD	1	dep	56634	56643	_	_	_	_	_
341	8	.	.	.	1	punct	56643	56644	_	_	_	_	_

342	1	Van	Van	NNP	3	compound	56645	56648	_	_	_	_	_
342	2	Herck	Herck	NNP	3	compound	56649	56654	_	_	_	_	_
342	3	K	K	NNP	0	ROOT	56655	56656	_	_	_	_	_
342	4	,	,	,	3	punct	56656	56657	_	_	_	_	_
342	5	Leuridan	Leuridan	NNP	6	compound	56658	56666	_	_	_	_	_
342	6	E	E	NNP	3	appos	56667	56668	_	_	_	_	_
342	7	,	,	,	3	punct	56668	56669	_	_	_	_	_
342	8	Van	Van	NNP	11	compound	56670	56673	_	_	_	_	_
342	9	Damme	Damme	NNP	11	compound	56674	56679	_	_	_	_	_
342	10	P.	P.	NNP	11	compound	56680	56682	_	_	_	_	_
342	11	Schedules	Schedules	NNP	3	appos	56683	56692	_	_	_	_	_
342	12	for	for	IN	15	case	56693	56696	_	_	_	_	_
342	13	hepatitis	hepatitis	NN	15	compound	56697	56706	_	_	_	_	_
342	14	B	b	NN	15	compound	56707	56708	_	_	_	_	_
342	15	vaccination	vaccination	NN	11	nmod	56709	56720	_	_	_	_	_
342	16	of	of	IN	18	case	56721	56723	_	_	_	_	_
342	17	risk	risk	NN	18	compound	56724	56728	_	_	_	_	_
342	18	groups	group	NNS	15	nmod	56729	56735	_	_	_	_	_
342	19	:	:	:	3	punct	56735	56736	_	_	_	_	_
342	20	balancing	balance	VBG	21	amod	56737	56746	_	_	_	_	_
342	21	immunogenicity	immunogenicity	NN	3	dep	56747	56761	_	_	_	_	_
342	22	and	and	CC	21	cc	56762	56765	_	_	_	_	_
342	23	compliance	compliance	NN	21	conj	56766	56776	_	_	_	_	_
342	24	.	.	.	3	punct	56776	56777	_	_	_	_	_

343	1	Sexually	sexually	RB	2	advmod	56778	56786	_	_	_	_	_
343	2	Transmitted	transmit	VBN	0	ROOT	56787	56798	_	_	_	_	_
343	3	Infections	infection	NNS	2	nsubj	56799	56809	_	_	_	_	_
343	4	2007	2007	CD	6	nummod	56810	56814	_	_	_	_	_
343	5	;	;	:	6	punct	56814	56815	_	_	_	_	_
343	6	83:426-32	83:426-32	CD	3	dep	56815	56824	_	_	_	_	_
343	7	.	.	.	2	punct	56824	56825	_	_	_	_	_

344	1	Centers	Centers	NNPS	8	dep	56826	56833	_	_	_	_	_
344	2	for	for	IN	4	case	56834	56837	_	_	_	_	_
344	3	Disease	Disease	NNP	4	compound	56838	56845	_	_	_	_	_
344	4	Control	Control	NNP	1	nmod	56846	56853	_	_	_	_	_
344	5	and	and	CC	4	cc	56854	56857	_	_	_	_	_
344	6	Prevention	Prevention	NNP	4	conj	56858	56868	_	_	_	_	_
344	7	(	(	CD	8	nummod	56869	56870	_	_	_	_	_
344	8	CDC	CDC	NNP	0	ROOT	56870	56873	_	_	_	_	_
344	9	)	)	CD	8	nummod	56873	56874	_	_	_	_	_
344	10	,	,	,	8	punct	56874	56875	_	_	_	_	_
344	11	Mast	mast	NN	12	compound	56876	56880	_	_	_	_	_
344	12	EE	ee	NN	8	appos	56881	56883	_	_	_	_	_
344	13	,	,	,	8	punct	56883	56884	_	_	_	_	_
344	14	Weinbaum	Weinbaum	NNP	15	compound	56885	56893	_	_	_	_	_
344	15	CM	cm	NN	8	appos	56894	56896	_	_	_	_	_
344	16	,	,	,	8	punct	56896	56897	_	_	_	_	_
344	17	et	et	FW	18	compound	56898	56900	_	_	_	_	_
344	18	al.	al.	FW	8	appos	56901	56904	_	_	_	_	_
344	19	.	.	.	8	punct	_	_	_	_	_	_	_

345	1	A	a	DT	4	det	56905	56906	_	_	_	_	_
345	2	comprehensive	comprehensive	JJ	4	amod	56907	56920	_	_	_	_	_
345	3	immunization	immunization	NN	4	compound	56921	56933	_	_	_	_	_
345	4	strategy	strategy	NN	0	ROOT	56934	56942	_	_	_	_	_
345	5	to	to	TO	6	mark	56943	56945	_	_	_	_	_
345	6	eliminate	eliminate	VB	4	acl	56946	56955	_	_	_	_	_
345	7	transmission	transmission	NN	6	dobj	56956	56968	_	_	_	_	_
345	8	of	of	IN	10	case	56969	56971	_	_	_	_	_
345	9	hepatitis	hepatitis	NN	10	compound	56972	56981	_	_	_	_	_
345	10	B	b	NN	7	nmod	56982	56983	_	_	_	_	_
345	11	virus	virus	NN	12	compound	56984	56989	_	_	_	_	_
345	12	infection	infection	NN	4	dep	56990	56999	_	_	_	_	_
345	13	in	in	IN	16	case	57000	57002	_	_	_	_	_
345	14	the	the	DT	16	det	57003	57006	_	_	_	_	_
345	15	United	United	NNP	16	compound	57007	57013	_	_	_	_	_
345	16	States	States	NNPS	12	nmod	57014	57020	_	_	_	_	_
345	17	:	:	:	4	punct	57020	57021	_	_	_	_	_
345	18	recommendations	recommendation	NNS	4	dep	57022	57037	_	_	_	_	_
345	19	of	of	IN	22	case	57038	57040	_	_	_	_	_
345	20	the	the	DT	22	det	57041	57044	_	_	_	_	_
345	21	Advisory	Advisory	NNP	22	compound	57045	57053	_	_	_	_	_
345	22	Committee	Committee	NNP	18	nmod	57054	57063	_	_	_	_	_
345	23	on	on	IN	25	case	57064	57066	_	_	_	_	_
345	24	Immunization	Immunization	NNP	25	compound	57067	57079	_	_	_	_	_
345	25	Practices	Practices	NNPS	22	nmod	57080	57089	_	_	_	_	_
345	26	(	(	FW	28	compound	57090	57091	_	_	_	_	_
345	27	ACIP	acip	FW	28	compound	57091	57095	_	_	_	_	_
345	28	)	)	FW	18	dep	57095	57096	_	_	_	_	_
345	29	.	.	.	4	punct	57096	57097	_	_	_	_	_

346	1	Part	Part	NNP	2	compound	57098	57102	_	_	_	_	_
346	2	II	II	NNP	0	ROOT	57103	57105	_	_	_	_	_
346	3	:	:	:	2	punct	57105	57106	_	_	_	_	_
346	4	immunization	immunization	NN	2	dep	57107	57119	_	_	_	_	_
346	5	of	of	IN	6	case	57120	57122	_	_	_	_	_
346	6	adults	adult	NNS	4	nmod	57123	57129	_	_	_	_	_
346	7	.	.	.	2	punct	57129	57130	_	_	_	_	_

347	1	[	[	NN	2	compound	57131	57132	_	_	_	_	_
347	2	erratum	erratum	NN	3	nsubj	57132	57139	_	_	_	_	_
347	3	appears	appear	VBZ	0	ROOT	57140	57147	_	_	_	_	_
347	4	in	in	IN	9	case	57148	57150	_	_	_	_	_
347	5	MMWR	MMWR	NNP	9	compound	57151	57155	_	_	_	_	_
347	6	Morb	Morb	NNP	9	compound	57156	57160	_	_	_	_	_
347	7	Mortal	Mortal	NNP	9	compound	57161	57167	_	_	_	_	_
347	8	Wkly	Wkly	NNP	9	compound	57168	57172	_	_	_	_	_
347	9	Rep.	Rep.	NNP	3	nmod	57173	57177	_	_	_	_	_
347	10	2007	2007	CD	9	dep	57178	57182	_	_	_	_	_
347	11	Oct	Oct	NNP	10	nmod:tmod	57183	57186	_	_	_	_	_
347	12	26	26	CD	11	nummod	57187	57189	_	_	_	_	_
347	13	;	;	:	10	punct	57189	57190	_	_	_	_	_
347	14	56	56	CD	15	compound	57190	57192	_	_	_	_	_
347	15	(	(	CD	10	dep	57192	57193	_	_	_	_	_
347	16	42	42	CD	17	nummod	57193	57195	_	_	_	_	_
347	17	)	)	NN	15	dep	57195	57196	_	_	_	_	_
347	18	:	:	:	10	punct	57196	57197	_	_	_	_	_
347	19	1114	1114	CD	10	dep	57197	57201	_	_	_	_	_
347	20	]	]	CD	19	dep	57201	57202	_	_	_	_	_
347	21	.	.	.	3	punct	57202	57203	_	_	_	_	_

348	1	MMWR	mmwr	NN	2	compound	57204	57208	_	_	_	_	_
348	2	Recommendations	recommendation	NNS	0	ROOT	57209	57224	_	_	_	_	_
348	3	and	and	CC	2	cc	57225	57228	_	_	_	_	_
348	4	Reports	report	NNS	2	conj	57229	57236	_	_	_	_	_
348	5	2006	2006	CD	2	dep	57237	57241	_	_	_	_	_
348	6	;	;	:	2	punct	57241	57242	_	_	_	_	_
348	7	55	55	CD	8	compound	57242	57244	_	_	_	_	_
348	8	(	(	CD	9	nummod	57244	57245	_	_	_	_	_
348	9	RR-16	rr-16	NN	2	dep	57245	57250	_	_	_	_	_
348	10	)	)	CD	12	nummod	57250	57251	_	_	_	_	_
348	11	:	:	:	12	punct	57251	57252	_	_	_	_	_
348	12	1-33	1-33	CD	9	dep	57252	57256	_	_	_	_	_
348	13	.	.	.	2	punct	57256	57257	_	_	_	_	_

349	1	Cassidy	Cassidy	NNP	2	compound	57258	57265	_	_	_	_	_
349	2	WM	WM	NNP	0	ROOT	57266	57268	_	_	_	_	_
349	3	,	,	,	2	punct	57268	57269	_	_	_	_	_
349	4	Watson	Watson	NNP	5	compound	57270	57276	_	_	_	_	_
349	5	B	B	NNP	2	appos	57277	57278	_	_	_	_	_
349	6	,	,	,	2	punct	57278	57279	_	_	_	_	_
349	7	Ioli	Ioli	NNP	8	compound	57280	57284	_	_	_	_	_
349	8	VA	VA	NNP	2	appos	57285	57287	_	_	_	_	_
349	9	,	,	,	2	punct	57287	57288	_	_	_	_	_
349	10	et	et	FW	11	compound	57289	57291	_	_	_	_	_
349	11	al.	al.	FW	2	appos	57292	57295	_	_	_	_	_
349	12	.	.	.	2	punct	_	_	_	_	_	_	_

350	1	A	a	DT	3	det	57296	57297	_	_	_	_	_
350	2	randomized	randomized	JJ	3	amod	57298	57308	_	_	_	_	_
350	3	trial	trial	NN	0	ROOT	57309	57314	_	_	_	_	_
350	4	of	of	IN	6	case	57315	57317	_	_	_	_	_
350	5	alternative	alternative	JJ	6	amod	57318	57329	_	_	_	_	_
350	6	two	two	CD	3	nmod	57330	57333	_	_	_	_	_
350	7	-	-	:	6	punct	57333	57334	_	_	_	_	_
350	8	and	and	CC	3	cc	57335	57338	_	_	_	_	_
350	9	three-dose	three-dose	JJ	13	amod	57339	57349	_	_	_	_	_
350	10	hepatitis	hepatitis	NN	13	compound	57350	57359	_	_	_	_	_
350	11	B	b	NN	13	compound	57360	57361	_	_	_	_	_
350	12	vaccination	vaccination	NN	13	compound	57362	57373	_	_	_	_	_
350	13	regimens	regimen	NNS	3	conj	57374	57382	_	_	_	_	_
350	14	in	in	IN	15	case	57383	57385	_	_	_	_	_
350	15	adolescents	adolescent	NNS	13	nmod	57386	57397	_	_	_	_	_
350	16	:	:	:	3	punct	57397	57398	_	_	_	_	_
350	17	antibody	antibody	NN	18	compound	57399	57407	_	_	_	_	_
350	18	responses	response	NNS	3	dep	57408	57417	_	_	_	_	_
350	19	,	,	,	18	punct	57417	57418	_	_	_	_	_
350	20	safety	safety	NN	18	conj	57419	57425	_	_	_	_	_
350	21	,	,	,	18	punct	57425	57426	_	_	_	_	_
350	22	and	and	CC	18	cc	57427	57430	_	_	_	_	_
350	23	immunologic	immunologic	JJ	24	amod	57431	57442	_	_	_	_	_
350	24	memory	memory	NN	18	conj	57443	57449	_	_	_	_	_
350	25	.	.	.	3	punct	57449	57450	_	_	_	_	_

351	1	Pediatrics	pediatrics	NNS	0	ROOT	57451	57461	_	_	_	_	_
351	2	2001	2001	CD	1	nummod	57462	57466	_	_	_	_	_
351	3	;	;	:	1	punct	57466	57467	_	_	_	_	_
351	4	107:626-31	107:626-31	CD	1	dep	57467	57477	_	_	_	_	_
351	5	.	.	.	1	punct	57477	57478	_	_	_	_	_

352	1	Heron	Heron	NNP	2	compound	57479	57484	_	_	_	_	_
352	2	L	L	NNP	0	ROOT	57485	57486	_	_	_	_	_
352	3	,	,	,	2	punct	57486	57487	_	_	_	_	_
352	4	Selnikova	Selnikova	NNP	5	compound	57488	57497	_	_	_	_	_
352	5	O	O	NNP	2	appos	57498	57499	_	_	_	_	_
352	6	,	,	,	2	punct	57499	57500	_	_	_	_	_
352	7	Moiseieva	Moiseieva	NNP	8	compound	57501	57510	_	_	_	_	_
352	8	A	A	NNP	2	appos	57511	57512	_	_	_	_	_
352	9	,	,	,	2	punct	57512	57513	_	_	_	_	_
352	10	et	et	FW	11	compound	57514	57516	_	_	_	_	_
352	11	al.	al.	FW	2	appos	57517	57520	_	_	_	_	_
352	12	.	.	.	2	punct	_	_	_	_	_	_	_

353	1	Immunogenicity	immunogenicity	NN	0	ROOT	57521	57535	_	_	_	_	_
353	2	,	,	,	1	punct	57535	57536	_	_	_	_	_
353	3	reactogenicity	reactogenicity	NN	1	conj	57537	57551	_	_	_	_	_
353	4	and	and	CC	1	cc	57552	57555	_	_	_	_	_
353	5	safety	safety	NN	1	conj	57556	57562	_	_	_	_	_
353	6	of	of	IN	7	case	57563	57565	_	_	_	_	_
353	7	two-dose	two-dose	JJ	1	nmod	57566	57574	_	_	_	_	_
353	8	versus	versus	CC	16	case	57575	57581	_	_	_	_	_
353	9	three-dose	three-dose	JJ	16	amod	57582	57592	_	_	_	_	_
353	10	(	(	JJ	16	amod	57593	57594	_	_	_	_	_
353	11	standard	standard	JJ	16	amod	57594	57602	_	_	_	_	_
353	12	care	care	NN	16	compound	57603	57607	_	_	_	_	_
353	13	)	)	NN	16	compound	57607	57608	_	_	_	_	_
353	14	hepatitis	hepatitis	NN	16	compound	57609	57618	_	_	_	_	_
353	15	B	b	NN	16	compound	57619	57620	_	_	_	_	_
353	16	immunisation	immunisation	NN	7	nmod	57621	57633	_	_	_	_	_
353	17	of	of	IN	19	case	57634	57636	_	_	_	_	_
353	18	healthy	healthy	JJ	19	amod	57637	57644	_	_	_	_	_
353	19	adolescents	adolescent	NNS	16	nmod	57645	57656	_	_	_	_	_
353	20	aged	aged	JJ	19	amod	57657	57661	_	_	_	_	_
353	21	11	11	CD	22	compound	57662	57664	_	_	_	_	_
353	22	–	–	CD	20	nmod	57664	57665	_	_	_	_	_
353	23	15	15	CD	24	nummod	57665	57667	_	_	_	_	_
353	24	years	year	NNS	22	dep	57668	57673	_	_	_	_	_
353	25	:	:	:	1	punct	57673	57674	_	_	_	_	_
353	26	a	a	DT	29	det	57675	57676	_	_	_	_	_
353	27	randomised	randomised	JJ	29	amod	57677	57687	_	_	_	_	_
353	28	controlled	controlled	JJ	29	amod	57688	57698	_	_	_	_	_
353	29	trial	trial	NN	1	dep	57699	57704	_	_	_	_	_
353	30	.	.	.	1	punct	57704	57705	_	_	_	_	_

354	1	Vaccine	vaccine	NN	0	ROOT	57706	57713	_	_	_	_	_
354	2	2007	2007	CD	1	nummod	57714	57718	_	_	_	_	_
354	3	;	;	:	1	punct	57718	57719	_	_	_	_	_
354	4	25:2817-22	25:2817-22	CD	1	dep	57719	57729	_	_	_	_	_
354	5	.	.	.	1	punct	57729	57730	_	_	_	_	_

355	1	Van	Van	NNP	3	compound	57731	57734	_	_	_	_	_
355	2	Damme	Damme	NNP	3	compound	57735	57740	_	_	_	_	_
355	3	P	p	NN	0	ROOT	57741	57742	_	_	_	_	_
355	4	,	,	,	3	punct	57742	57743	_	_	_	_	_
355	5	Moiseeva	moiseeva	NN	6	compound	57744	57752	_	_	_	_	_
355	6	A	a	NN	3	appos	57753	57754	_	_	_	_	_
355	7	,	,	,	3	punct	57754	57755	_	_	_	_	_
355	8	Marichev	Marichev	NNP	3	appos	57756	57764	_	_	_	_	_
355	9	I	I	PRP	8	dep	57765	57766	_	_	_	_	_
355	10	,	,	,	3	punct	57766	57767	_	_	_	_	_
355	11	et	et	FW	12	compound	57768	57770	_	_	_	_	_
355	12	al.	al.	FW	3	appos	57771	57774	_	_	_	_	_
355	13	.	.	.	3	punct	_	_	_	_	_	_	_

356	1	Five	five	CD	2	nummod	57775	57779	_	_	_	_	_
356	2	years	year	NNS	0	ROOT	57780	57785	_	_	_	_	_
356	3	follow-up	follow-up	JJ	2	amod	57786	57795	_	_	_	_	_
356	4	following	follow	VBG	5	case	57796	57805	_	_	_	_	_
356	5	two	two	CD	2	nmod	57806	57809	_	_	_	_	_
356	6	or	or	CC	5	cc	57810	57812	_	_	_	_	_
356	7	three	three	CD	8	nummod	57813	57818	_	_	_	_	_
356	8	doses	dose	NNS	5	conj	57819	57824	_	_	_	_	_
356	9	of	of	IN	13	case	57825	57827	_	_	_	_	_
356	10	a	a	DT	13	det	57828	57829	_	_	_	_	_
356	11	hepatitis	hepatitis	NN	13	compound	57830	57839	_	_	_	_	_
356	12	B	b	NN	13	compound	57840	57841	_	_	_	_	_
356	13	vaccine	vaccine	NN	8	nmod	57842	57849	_	_	_	_	_
356	14	in	in	IN	15	case	57850	57852	_	_	_	_	_
356	15	adolescents	adolescent	NNS	13	nmod	57853	57864	_	_	_	_	_
356	16	aged	aged	JJ	15	amod	57865	57869	_	_	_	_	_
356	17	11	11	CD	18	compound	57870	57872	_	_	_	_	_
356	18	–	–	CD	16	nmod	57872	57873	_	_	_	_	_
356	19	15	15	CD	20	nummod	57873	57875	_	_	_	_	_
356	20	years	year	NNS	18	dep	57876	57881	_	_	_	_	_
356	21	:	:	:	8	punct	57881	57882	_	_	_	_	_
356	22	a	a	DT	25	det	57883	57884	_	_	_	_	_
356	23	randomised	randomised	JJ	24	amod	57885	57895	_	_	_	_	_
356	24	controlled	controlled	JJ	25	amod	57896	57906	_	_	_	_	_
356	25	study	study	NN	8	dep	57907	57912	_	_	_	_	_
356	26	.	.	.	2	punct	57912	57913	_	_	_	_	_

357	1	BMC	BMC	NNP	3	compound	57914	57917	_	_	_	_	_
357	2	Infectious	infectious	JJ	3	amod	57918	57928	_	_	_	_	_
357	3	Diseases	disease	NNS	0	ROOT	57929	57937	_	_	_	_	_
357	4	2010	2010	CD	6	nummod	57938	57942	_	_	_	_	_
357	5	;	;	:	6	punct	57942	57943	_	_	_	_	_
357	6	10:357	10:357	CD	3	dep	57943	57949	_	_	_	_	_
357	7	.	.	.	3	punct	57949	57950	_	_	_	_	_

358	1	Quaglio	Quaglio	NNP	2	compound	57951	57958	_	_	_	_	_
358	2	G	G	NNP	0	ROOT	57959	57960	_	_	_	_	_
358	3	,	,	,	2	punct	57960	57961	_	_	_	_	_
358	4	Talamini	Talamini	NNP	5	compound	57962	57970	_	_	_	_	_
358	5	G	G	NNP	2	appos	57971	57972	_	_	_	_	_
358	6	,	,	,	2	punct	57972	57973	_	_	_	_	_
358	7	Lugoboni	Lugoboni	NNP	8	compound	57974	57982	_	_	_	_	_
358	8	F	f	NN	2	appos	57983	57984	_	_	_	_	_
358	9	,	,	,	2	punct	57984	57985	_	_	_	_	_
358	10	et	et	FW	11	compound	57986	57988	_	_	_	_	_
358	11	al.	al.	FW	2	appos	57989	57992	_	_	_	_	_
358	12	.	.	.	2	punct	_	_	_	_	_	_	_

359	1	Compliance	compliance	NN	13	nsubj	57993	58003	_	_	_	_	_
359	2	with	with	IN	5	case	58004	58008	_	_	_	_	_
359	3	hepatitis	hepatitis	NN	5	compound	58009	58018	_	_	_	_	_
359	4	B	b	NN	5	compound	58019	58020	_	_	_	_	_
359	5	vaccination	vaccination	NN	1	nmod	58021	58032	_	_	_	_	_
359	6	in	in	IN	9	case	58033	58035	_	_	_	_	_
359	7	1175	1175	CD	9	nummod	58036	58040	_	_	_	_	_
359	8	heroin	heroin	NN	9	compound	58041	58047	_	_	_	_	_
359	9	users	user	NNS	5	nmod	58048	58053	_	_	_	_	_
359	10	and	and	CC	9	cc	58054	58057	_	_	_	_	_
359	11	risk	risk	NN	12	compound	58058	58062	_	_	_	_	_
359	12	factors	factor	NNS	9	conj	58063	58070	_	_	_	_	_
359	13	associated	associate	VBN	0	ROOT	58071	58081	_	_	_	_	_
359	14	with	with	IN	15	case	58082	58086	_	_	_	_	_
359	15	lack	lack	NN	13	nmod	58087	58091	_	_	_	_	_
359	16	of	of	IN	18	case	58092	58094	_	_	_	_	_
359	17	vaccine	vaccine	NN	18	compound	58095	58102	_	_	_	_	_
359	18	response	response	NN	15	nmod	58103	58111	_	_	_	_	_
359	19	.	.	.	13	punct	58111	58112	_	_	_	_	_

360	1	Addiction	addiction	NN	0	ROOT	58113	58122	_	_	_	_	_
360	2	2002	2002	CD	1	nummod	58123	58127	_	_	_	_	_
360	3	;	;	:	1	punct	58127	58128	_	_	_	_	_
360	4	97:985-92	97:985-92	CD	1	dep	58128	58137	_	_	_	_	_
360	5	.	.	.	1	punct	58137	58138	_	_	_	_	_

361	1	Christensen	Christensen	NNP	2	compound	58139	58150	_	_	_	_	_
361	2	PB	pb	NN	0	ROOT	58151	58153	_	_	_	_	_
361	3	,	,	,	2	punct	58153	58154	_	_	_	_	_
361	4	Fisker	Fisker	NNP	5	compound	58155	58161	_	_	_	_	_
361	5	N	N	NNP	2	appos	58162	58163	_	_	_	_	_
361	6	,	,	,	2	punct	58163	58164	_	_	_	_	_
361	7	Krarup	Krarup	NNP	8	compound	58165	58171	_	_	_	_	_
361	8	HB	HB	NNP	2	appos	58172	58174	_	_	_	_	_
361	9	,	,	,	2	punct	58174	58175	_	_	_	_	_
361	10	et	et	FW	11	compound	58176	58178	_	_	_	_	_
361	11	al.	al.	FW	2	appos	58179	58182	_	_	_	_	_
361	12	.	.	.	2	punct	_	_	_	_	_	_	_

362	1	Hepatitis	Hepatitis	NNP	3	compound	58183	58192	_	_	_	_	_
362	2	B	B	NNP	3	compound	58193	58194	_	_	_	_	_
362	3	vaccination	vaccination	NN	12	nsubj	58195	58206	_	_	_	_	_
362	4	in	in	IN	5	case	58207	58209	_	_	_	_	_
362	5	prison	prison	NN	3	nmod	58210	58216	_	_	_	_	_
362	6	with	with	IN	9	case	58217	58221	_	_	_	_	_
362	7	a	a	DT	9	det	58222	58223	_	_	_	_	_
362	8	3-week	3-week	JJ	9	amod	58224	58230	_	_	_	_	_
362	9	schedule	schedule	NN	5	nmod	58231	58239	_	_	_	_	_
362	10	is	be	VBZ	12	cop	58240	58242	_	_	_	_	_
362	11	more	more	RBR	12	advmod	58243	58247	_	_	_	_	_
362	12	efficient	efficient	JJ	0	ROOT	58248	58257	_	_	_	_	_
362	13	than	than	IN	17	case	58258	58262	_	_	_	_	_
362	14	the	the	DT	17	det	58263	58266	_	_	_	_	_
362	15	standard	standard	JJ	17	amod	58267	58275	_	_	_	_	_
362	16	6-month	6-month	JJ	17	amod	58276	58283	_	_	_	_	_
362	17	schedule	schedule	NN	12	nmod	58284	58292	_	_	_	_	_
362	18	.	.	.	12	punct	58292	58293	_	_	_	_	_

363	1	Vaccine	vaccine	NN	0	ROOT	58294	58301	_	_	_	_	_
363	2	2004	2004	CD	1	nummod	58302	58306	_	_	_	_	_
363	3	;	;	:	1	punct	58306	58307	_	_	_	_	_
363	4	22:3897-901	22:3897-901	CD	1	dep	58307	58318	_	_	_	_	_
363	5	.	.	.	1	punct	58318	58319	_	_	_	_	_

364	1	Seto	seto	NN	2	compound	58320	58324	_	_	_	_	_
364	2	D	d	NN	0	ROOT	58325	58326	_	_	_	_	_
364	3	,	,	,	2	punct	58326	58327	_	_	_	_	_
364	4	West	West	NNP	5	compound	58328	58332	_	_	_	_	_
364	5	DJ	DJ	NNP	2	appos	58333	58335	_	_	_	_	_
364	6	,	,	,	2	punct	58335	58336	_	_	_	_	_
364	7	Gilliam	Gilliam	NNP	8	compound	58337	58344	_	_	_	_	_
364	8	RR	RR	NNP	2	appos	58345	58347	_	_	_	_	_
364	9	,	,	,	2	punct	58347	58348	_	_	_	_	_
364	10	et	et	FW	11	compound	58349	58351	_	_	_	_	_
364	11	al.	al.	FW	2	appos	58352	58355	_	_	_	_	_
364	12	.	.	.	2	punct	_	_	_	_	_	_	_

365	1	Antibody	antibody	NN	2	compound	58356	58364	_	_	_	_	_
365	2	responses	response	NNS	0	ROOT	58365	58374	_	_	_	_	_
365	3	of	of	IN	5	case	58375	58377	_	_	_	_	_
365	4	healthy	healthy	JJ	5	amod	58378	58385	_	_	_	_	_
365	5	neonates	neonate	NNS	2	nmod	58386	58394	_	_	_	_	_
365	6	to	to	TO	9	case	58395	58397	_	_	_	_	_
365	7	two	two	CD	9	nummod	58398	58401	_	_	_	_	_
365	8	mixed	mixed	JJ	9	amod	58402	58407	_	_	_	_	_
365	9	regimens	regimen	NNS	2	nmod	58408	58416	_	_	_	_	_
365	10	of	of	IN	13	case	58417	58419	_	_	_	_	_
365	11	hepatitis	hepatitis	NN	13	compound	58420	58429	_	_	_	_	_
365	12	B	b	NN	13	compound	58430	58431	_	_	_	_	_
365	13	vaccine	vaccine	NN	9	nmod	58432	58439	_	_	_	_	_
365	14	.	.	.	2	punct	58439	58440	_	_	_	_	_

366	1	Pediatric	Pediatric	NNP	2	nsubj	58441	58450	_	_	_	_	_
366	2	Infectious	infectious	JJ	0	ROOT	58451	58461	_	_	_	_	_
366	3	Disease	disease	NN	4	dep	58462	58469	_	_	_	_	_
366	4	Journal	Journal	NNP	2	nmod	58470	58477	_	_	_	_	_
366	5	1999	1999	CD	4	nummod	58478	58482	_	_	_	_	_
366	6	;	;	:	4	punct	58482	58483	_	_	_	_	_
366	7	18:840-2	18:840-2	CD	4	nummod	58483	58491	_	_	_	_	_
366	8	.	.	.	2	punct	58491	58492	_	_	_	_	_

367	1	Palasanthiran	palasanthiran	NN	2	compound	58493	58506	_	_	_	_	_
367	2	P	p	NN	0	ROOT	58507	58508	_	_	_	_	_
367	3	,	,	,	2	punct	58508	58509	_	_	_	_	_
367	4	Starr	Starr	NNP	5	compound	58510	58515	_	_	_	_	_
367	5	M	M	NNP	2	appos	58516	58517	_	_	_	_	_
367	6	,	,	,	2	punct	58517	58518	_	_	_	_	_
367	7	Jones	Jones	NNP	8	compound	58519	58524	_	_	_	_	_
367	8	C	C	NNP	2	appos	58525	58526	_	_	_	_	_
367	9	,	,	,	2	punct	58526	58527	_	_	_	_	_
367	10	Giles	Giles	NNP	11	compound	58528	58533	_	_	_	_	_
367	11	M	M	NNP	2	appos	58534	58535	_	_	_	_	_
367	12	,	,	,	2	punct	58535	58536	_	_	_	_	_
367	13	eds	ed	NNS	2	appos	58537	58540	_	_	_	_	_
367	14	.	.	.	2	punct	58540	58541	_	_	_	_	_

368	1	Management	management	NN	0	ROOT	58542	58552	_	_	_	_	_
368	2	of	of	IN	4	case	58553	58555	_	_	_	_	_
368	3	perinatal	perinatal	JJ	4	amod	58556	58565	_	_	_	_	_
368	4	infections	infection	NNS	1	nmod	58566	58576	_	_	_	_	_
368	5	.	.	.	1	punct	58576	58577	_	_	_	_	_

369	1	Sydney	Sydney	NNP	0	ROOT	58578	58584	_	_	_	_	_
369	2	:	:	:	1	punct	58584	58585	_	_	_	_	_
369	3	Australasian	australasian	JJ	4	amod	58586	58598	_	_	_	_	_
369	4	Society	Society	NNP	1	dep	58599	58606	_	_	_	_	_
369	5	for	for	IN	7	case	58607	58610	_	_	_	_	_
369	6	Infectious	infectious	JJ	7	amod	58611	58621	_	_	_	_	_
369	7	Diseases	disease	NNS	4	nmod	58622	58630	_	_	_	_	_
369	8	,	,	,	7	punct	58630	58631	_	_	_	_	_
369	9	2014	2014	CD	7	amod	58632	58636	_	_	_	_	_
369	10	.	.	.	1	punct	58636	58637	_	_	_	_	_

370	1	Lee	Lee	NNP	2	compound	58638	58641	_	_	_	_	_
370	2	C	C	NNP	0	ROOT	58642	58643	_	_	_	_	_
370	3	,	,	,	2	punct	58643	58644	_	_	_	_	_
370	4	Gong	Gong	NNP	5	compound	58645	58649	_	_	_	_	_
370	5	Y	y	NN	2	appos	58650	58651	_	_	_	_	_
370	6	,	,	,	2	punct	58651	58652	_	_	_	_	_
370	7	Brok	Brok	NNP	8	compound	58653	58657	_	_	_	_	_
370	8	J	J	NNP	2	appos	58658	58659	_	_	_	_	_
370	9	,	,	,	2	punct	58659	58660	_	_	_	_	_
370	10	Boxall	Boxall	NNP	11	compound	58661	58667	_	_	_	_	_
370	11	EH	EH	NNP	2	appos	58668	58670	_	_	_	_	_
370	12	,	,	,	2	punct	58670	58671	_	_	_	_	_
370	13	Gluud	Gluud	NNP	15	compound	58672	58677	_	_	_	_	_
370	14	C.	C.	NNP	15	compound	58678	58680	_	_	_	_	_
370	15	Effect	effect	NN	2	appos	58681	58687	_	_	_	_	_
370	16	of	of	IN	19	case	58688	58690	_	_	_	_	_
370	17	hepatitis	hepatitis	NN	19	compound	58691	58700	_	_	_	_	_
370	18	B	b	NN	19	compound	58701	58702	_	_	_	_	_
370	19	immunisation	immunisation	NN	15	nmod	58703	58715	_	_	_	_	_
370	20	in	in	IN	22	case	58716	58718	_	_	_	_	_
370	21	newborn	newborn	JJ	22	amod	58719	58726	_	_	_	_	_
370	22	infants	infant	NNS	19	nmod	58727	58734	_	_	_	_	_
370	23	of	of	IN	30	case	58735	58737	_	_	_	_	_
370	24	mothers	mother	NNS	30	compound	58738	58745	_	_	_	_	_
370	25	positive	positive	JJ	30	amod	58746	58754	_	_	_	_	_
370	26	for	for	IN	28	case	58755	58758	_	_	_	_	_
370	27	hepatitis	hepatitis	NN	28	compound	58759	58768	_	_	_	_	_
370	28	B	b	NN	25	nmod	58769	58770	_	_	_	_	_
370	29	surface	surface	NN	30	compound	58771	58778	_	_	_	_	_
370	30	antigen	antigen	NN	2	nmod	58779	58786	_	_	_	_	_
370	31	:	:	:	2	punct	58786	58787	_	_	_	_	_
370	32	systematic	systematic	JJ	33	amod	58788	58798	_	_	_	_	_
370	33	review	review	NN	2	dep	58799	58805	_	_	_	_	_
370	34	and	and	CC	33	cc	58806	58809	_	_	_	_	_
370	35	meta-analysis	meta-analysis	NN	33	conj	58810	58823	_	_	_	_	_
370	36	.	.	.	2	punct	58823	58824	_	_	_	_	_

371	1	BMJ	BMJ	NNP	0	ROOT	58825	58828	_	_	_	_	_
371	2	2006	2006	CD	1	nummod	58829	58833	_	_	_	_	_
371	3	;	;	:	1	punct	58833	58834	_	_	_	_	_
371	4	332:328-36	332:328-36	CD	1	dep	58834	58844	_	_	_	_	_
371	5	.	.	.	1	punct	58844	58845	_	_	_	_	_

372	1	Blondheim	Blondheim	NNP	2	compound	58846	58855	_	_	_	_	_
372	2	O	O	NNP	0	ROOT	58856	58857	_	_	_	_	_
372	3	,	,	,	2	punct	58857	58858	_	_	_	_	_
372	4	Bader	Bader	NNP	5	compound	58859	58864	_	_	_	_	_
372	5	D	D	NNP	2	appos	58865	58866	_	_	_	_	_
372	6	,	,	,	2	punct	58866	58867	_	_	_	_	_
372	7	Abend	Abend	NNP	8	compound	58868	58873	_	_	_	_	_
372	8	M	M	NNP	2	appos	58874	58875	_	_	_	_	_
372	9	,	,	,	2	punct	58875	58876	_	_	_	_	_
372	10	et	et	FW	11	compound	58877	58879	_	_	_	_	_
372	11	al.	al.	FW	2	appos	58880	58883	_	_	_	_	_
372	12	.	.	.	2	punct	_	_	_	_	_	_	_

373	1	Immunogenicity	immunogenicity	NN	0	ROOT	58884	58898	_	_	_	_	_
373	2	of	of	IN	5	case	58899	58901	_	_	_	_	_
373	3	hepatitis	hepatitis	NN	5	compound	58902	58911	_	_	_	_	_
373	4	B	b	NN	5	compound	58912	58913	_	_	_	_	_
373	5	vaccine	vaccine	NN	1	nmod	58914	58921	_	_	_	_	_
373	6	in	in	IN	8	case	58922	58924	_	_	_	_	_
373	7	preterm	preterm	JJ	8	amod	58925	58932	_	_	_	_	_
373	8	infants	infant	NNS	1	nmod	58933	58940	_	_	_	_	_
373	9	.	.	.	1	punct	58940	58941	_	_	_	_	_

374	1	Archives	archive	NNS	0	ROOT	58942	58950	_	_	_	_	_
374	2	of	of	IN	3	case	58951	58953	_	_	_	_	_
374	3	Disease	disease	NN	1	nmod	58954	58961	_	_	_	_	_
374	4	in	in	IN	5	case	58962	58964	_	_	_	_	_
374	5	Childhood	Childhood	NNP	3	nmod	58965	58974	_	_	_	_	_
374	6	Fetal	fetal	JJ	5	amod	58975	58980	_	_	_	_	_
374	7	and	and	CC	3	cc	58981	58984	_	_	_	_	_
374	8	Neonatal	neonatal	JJ	9	amod	58985	58993	_	_	_	_	_
374	9	Edition	edition	NN	3	conj	58994	59001	_	_	_	_	_
374	10	1998	1998	CD	9	dep	59002	59006	_	_	_	_	_
374	11	;	;	:	1	punct	59006	59007	_	_	_	_	_
374	12	79	79	CD	14	nummod	59007	59009	_	_	_	_	_
374	13	:	:	:	14	punct	59009	59010	_	_	_	_	_
374	14	F206-8	f206-8	CD	1	dep	59010	59016	_	_	_	_	_
374	15	.	.	.	1	punct	59016	59017	_	_	_	_	_

375	1	Golbiowska	golbiowska	FW	0	ROOT	59018	59028	_	_	_	_	_
375	2	M	m	NN	1	dep	59029	59030	_	_	_	_	_
375	3	,	,	,	2	punct	59030	59031	_	_	_	_	_
375	4	Kardas-Sobantka	kardas-sobantka	NN	5	compound	59032	59047	_	_	_	_	_
375	5	D	d	NN	2	appos	59048	59049	_	_	_	_	_
375	6	,	,	,	2	punct	59049	59050	_	_	_	_	_
375	7	Chlebna-Sokï	Chlebna-Sokï	NNP	2	appos	59051	59063	_	_	_	_	_
375	8	¿	¿	CD	10	nummod	59063	59064	_	_	_	_	_
375	9	½	½	CD	10	nummod	59064	59065	_	_	_	_	_
375	10	l	l	NN	1	dep	59065	59066	_	_	_	_	_
375	11	D	d	NN	10	dep	59067	59068	_	_	_	_	_
375	12	,	,	,	1	punct	59068	59069	_	_	_	_	_
375	13	Sabanty	Sabanty	NNP	17	compound	59070	59077	_	_	_	_	_
375	14	W.	W.	NNP	17	compound	59078	59080	_	_	_	_	_
375	15	Hepatitis	Hepatitis	NNP	17	compound	59081	59090	_	_	_	_	_
375	16	B	B	NNP	17	compound	59091	59092	_	_	_	_	_
375	17	vaccination	vaccination	NN	1	appos	59093	59104	_	_	_	_	_
375	18	in	in	IN	20	case	59105	59107	_	_	_	_	_
375	19	preterm	preterm	JJ	20	amod	59108	59115	_	_	_	_	_
375	20	infants	infant	NNS	17	nmod	59116	59123	_	_	_	_	_
375	21	.	.	.	1	punct	59123	59124	_	_	_	_	_

376	1	European	european	JJ	2	amod	59125	59133	_	_	_	_	_
376	2	Journal	Journal	NNP	0	ROOT	59134	59141	_	_	_	_	_
376	3	of	of	IN	4	case	59142	59144	_	_	_	_	_
376	4	Pediatrics	Pediatrics	NNP	2	nmod	59145	59155	_	_	_	_	_
376	5	1999	1999	CD	4	nummod	59156	59160	_	_	_	_	_
376	6	;	;	:	4	punct	59160	59161	_	_	_	_	_
376	7	158:293-7	158:293-7	CD	4	nummod	59161	59170	_	_	_	_	_
376	8	.	.	.	2	punct	59170	59171	_	_	_	_	_

377	1	Saari	Saari	NNP	2	compound	59172	59177	_	_	_	_	_
377	2	TN	tn	NN	0	ROOT	59178	59180	_	_	_	_	_
377	3	,	,	,	2	punct	59180	59181	_	_	_	_	_
377	4	American	American	NNP	5	compound	59182	59190	_	_	_	_	_
377	5	Academy	Academy	NNP	2	appos	59191	59198	_	_	_	_	_
377	6	of	of	IN	8	case	59199	59201	_	_	_	_	_
377	7	Pediatrics	Pediatrics	NNP	8	compound	59202	59212	_	_	_	_	_
377	8	Committee	Committee	NNP	5	nmod	59213	59222	_	_	_	_	_
377	9	on	on	IN	11	case	59223	59225	_	_	_	_	_
377	10	Infectious	infectious	JJ	11	amod	59226	59236	_	_	_	_	_
377	11	Diseases	disease	NNS	8	nmod	59237	59245	_	_	_	_	_
377	12	.	.	.	2	punct	59245	59246	_	_	_	_	_

378	1	Immunization	immunization	NN	0	ROOT	59247	59259	_	_	_	_	_
378	2	of	of	IN	8	case	59260	59262	_	_	_	_	_
378	3	preterm	preterm	NN	8	compound	59263	59270	_	_	_	_	_
378	4	and	and	CC	3	cc	59271	59274	_	_	_	_	_
378	5	low	low	JJ	3	conj	59275	59278	_	_	_	_	_
378	6	birth	birth	NN	8	compound	59279	59284	_	_	_	_	_
378	7	weight	weight	NN	8	compound	59285	59291	_	_	_	_	_
378	8	infants	infant	NNS	1	nmod	59292	59299	_	_	_	_	_
378	9	.	.	.	1	punct	59299	59300	_	_	_	_	_

379	1	Pediatrics	pediatrics	NNS	0	ROOT	59301	59311	_	_	_	_	_
379	2	2003	2003	CD	1	nummod	59312	59316	_	_	_	_	_
379	3	;	;	:	1	punct	59316	59317	_	_	_	_	_
379	4	112:193-8	112:193-8	CD	1	dep	59317	59326	_	_	_	_	_
379	5	.	.	.	1	punct	59326	59327	_	_	_	_	_

380	1	Drachman	Drachman	NNP	2	compound	59328	59336	_	_	_	_	_
380	2	R	R	NNP	0	ROOT	59337	59338	_	_	_	_	_
380	3	,	,	,	2	punct	59338	59339	_	_	_	_	_
380	4	Isacsohn	Isacsohn	NNP	5	compound	59340	59348	_	_	_	_	_
380	5	M	M	NNP	2	appos	59349	59350	_	_	_	_	_
380	6	,	,	,	2	punct	59350	59351	_	_	_	_	_
380	7	Rudensky	Rudensky	NNP	8	compound	59352	59360	_	_	_	_	_
380	8	B	B	NNP	2	appos	59361	59362	_	_	_	_	_
380	9	,	,	,	2	punct	59362	59363	_	_	_	_	_
380	10	Drukker	Drukker	NNP	12	compound	59364	59371	_	_	_	_	_
380	11	A.	A.	NNP	12	compound	59372	59374	_	_	_	_	_
380	12	Vaccination	vaccination	NN	2	appos	59375	59386	_	_	_	_	_
380	13	against	against	IN	15	case	59387	59394	_	_	_	_	_
380	14	hepatitis	hepatitis	NN	15	compound	59395	59404	_	_	_	_	_
380	15	B	b	NN	12	nmod	59405	59406	_	_	_	_	_
380	16	in	in	IN	17	case	59407	59409	_	_	_	_	_
380	17	children	child	NNS	15	nmod	59410	59418	_	_	_	_	_
380	18	and	and	CC	15	cc	59419	59422	_	_	_	_	_
380	19	adolescent	adolescent	JJ	20	amod	59423	59433	_	_	_	_	_
380	20	patients	patient	NNS	15	conj	59434	59442	_	_	_	_	_
380	21	on	on	IN	22	case	59443	59445	_	_	_	_	_
380	22	dialysis	dialysis	NN	20	nmod	59446	59454	_	_	_	_	_
380	23	.	.	.	2	punct	59454	59455	_	_	_	_	_

381	1	Nephrology	Nephrology	NNP	3	compound	59456	59466	_	_	_	_	_
381	2	Dialysis	Dialysis	NNP	3	compound	59467	59475	_	_	_	_	_
381	3	Transplantation	transplantation	NN	0	ROOT	59476	59491	_	_	_	_	_
381	4	1989	1989	CD	3	nummod	59492	59496	_	_	_	_	_
381	5	;	;	:	3	punct	59496	59497	_	_	_	_	_
381	6	4:372-4	4:372-4	CD	3	dep	59497	59504	_	_	_	_	_
381	7	.	.	.	3	punct	59504	59505	_	_	_	_	_

382	1	Watkins	Watkins	NNP	2	compound	59506	59513	_	_	_	_	_
382	2	SL	SL	NNP	0	ROOT	59514	59516	_	_	_	_	_
382	3	,	,	,	2	punct	59516	59517	_	_	_	_	_
382	4	Alexander	Alexander	NNP	5	compound	59518	59527	_	_	_	_	_
382	5	SR	sr	NN	2	appos	59528	59530	_	_	_	_	_
382	6	,	,	,	2	punct	59530	59531	_	_	_	_	_
382	7	Brewer	Brewer	NNP	8	compound	59532	59538	_	_	_	_	_
382	8	ED	ED	NNP	2	appos	59539	59541	_	_	_	_	_
382	9	,	,	,	2	punct	59541	59542	_	_	_	_	_
382	10	et	et	FW	11	compound	59543	59545	_	_	_	_	_
382	11	al.	al.	FW	2	appos	59546	59549	_	_	_	_	_
382	12	.	.	.	2	punct	_	_	_	_	_	_	_

383	1	Response	response	NN	0	ROOT	59550	59558	_	_	_	_	_
383	2	to	to	TO	6	case	59559	59561	_	_	_	_	_
383	3	recombinant	recombinant	JJ	6	amod	59562	59573	_	_	_	_	_
383	4	hepatitis	hepatitis	NN	6	compound	59574	59583	_	_	_	_	_
383	5	B	b	NN	6	compound	59584	59585	_	_	_	_	_
383	6	vaccine	vaccine	NN	1	nmod	59586	59593	_	_	_	_	_
383	7	in	in	IN	8	case	59594	59596	_	_	_	_	_
383	8	children	child	NNS	1	nmod	59597	59605	_	_	_	_	_
383	9	and	and	CC	8	cc	59606	59609	_	_	_	_	_
383	10	adolescents	adolescent	NNS	8	conj	59610	59621	_	_	_	_	_
383	11	with	with	IN	14	case	59622	59626	_	_	_	_	_
383	12	chronic	chronic	JJ	14	amod	59627	59634	_	_	_	_	_
383	13	renal	renal	JJ	14	amod	59635	59640	_	_	_	_	_
383	14	failure	failure	NN	1	nmod	59641	59648	_	_	_	_	_
383	15	.	.	.	1	punct	59648	59649	_	_	_	_	_

384	1	American	American	NNP	2	compound	59650	59658	_	_	_	_	_
384	2	Journal	Journal	NNP	0	ROOT	59659	59666	_	_	_	_	_
384	3	of	of	IN	5	case	59667	59669	_	_	_	_	_
384	4	Kidney	kidney	NN	5	compound	59670	59676	_	_	_	_	_
384	5	Diseases	disease	NNS	2	nmod	59677	59685	_	_	_	_	_
384	6	2002	2002	CD	2	dep	59686	59690	_	_	_	_	_
384	7	;	;	:	2	punct	59690	59691	_	_	_	_	_
384	8	40:365-72	40:365-72	CD	2	dep	59691	59700	_	_	_	_	_
384	9	.	.	.	2	punct	59700	59701	_	_	_	_	_

385	1	Gill	Gill	NNP	2	compound	59702	59706	_	_	_	_	_
385	2	JS	JS	NNP	0	ROOT	59707	59709	_	_	_	_	_
385	3	,	,	,	2	punct	59709	59710	_	_	_	_	_
385	4	Bucens	Bucens	NNP	5	compound	59711	59717	_	_	_	_	_
385	5	M	M	NNP	2	appos	59718	59719	_	_	_	_	_
385	6	,	,	,	2	punct	59719	59720	_	_	_	_	_
385	7	Hatton	Hatton	NNP	8	compound	59721	59727	_	_	_	_	_
385	8	M	M	NNP	2	appos	59728	59729	_	_	_	_	_
385	9	,	,	,	2	punct	59729	59730	_	_	_	_	_
385	10	Carey	Carey	NNP	11	compound	59731	59736	_	_	_	_	_
385	11	M	M	NNP	2	appos	59737	59738	_	_	_	_	_
385	12	,	,	,	2	punct	59738	59739	_	_	_	_	_
385	13	Quadros	Quadros	NNP	15	compound	59740	59747	_	_	_	_	_
385	14	CF.	CF.	NNP	15	compound	59748	59751	_	_	_	_	_
385	15	Markers	Markers	NNPS	2	appos	59752	59759	_	_	_	_	_
385	16	of	of	IN	18	case	59760	59762	_	_	_	_	_
385	17	hepatitis	hepatitis	NN	18	compound	59763	59772	_	_	_	_	_
385	18	B	b	NN	15	nmod	59773	59774	_	_	_	_	_
385	19	virus	virus	NN	20	compound	59775	59780	_	_	_	_	_
385	20	infection	infection	NN	2	dep	59781	59790	_	_	_	_	_
385	21	in	in	IN	22	case	59791	59793	_	_	_	_	_
385	22	schoolchildren	schoolchildren	NNS	20	nmod	59794	59808	_	_	_	_	_
385	23	in	in	IN	25	case	59809	59811	_	_	_	_	_
385	24	the	the	DT	25	det	59812	59815	_	_	_	_	_
385	25	Kimberley	Kimberley	NNP	22	nmod	59816	59825	_	_	_	_	_
385	26	,	,	,	2	punct	59825	59826	_	_	_	_	_
385	27	Western	Western	NNP	28	compound	59827	59834	_	_	_	_	_
385	28	Australia	Australia	NNP	2	appos	59835	59844	_	_	_	_	_
385	29	.	.	.	2	punct	59844	59845	_	_	_	_	_

386	1	Medical	Medical	NNP	2	compound	59846	59853	_	_	_	_	_
386	2	Journal	Journal	NNP	0	ROOT	59854	59861	_	_	_	_	_
386	3	of	of	IN	4	case	59862	59864	_	_	_	_	_
386	4	Australia	Australia	NNP	2	nmod	59865	59874	_	_	_	_	_
386	5	1990	1990	CD	4	nummod	59875	59879	_	_	_	_	_
386	6	;	;	:	4	punct	59879	59880	_	_	_	_	_
386	7	153:34-7	153:34-7	CD	4	nummod	59880	59888	_	_	_	_	_
386	8	.	.	.	2	punct	59888	59889	_	_	_	_	_

387	1	Averhoff	Averhoff	NNP	4	compound	59890	59898	_	_	_	_	_
387	2	F.	F.	NNP	4	compound	59899	59901	_	_	_	_	_
387	3	Infectious	infectious	JJ	4	amod	59902	59912	_	_	_	_	_
387	4	diseases	disease	NNS	5	nsubj	59913	59921	_	_	_	_	_
387	5	related	relate	VBN	0	ROOT	59922	59929	_	_	_	_	_
387	6	to	to	TO	7	mark	59930	59932	_	_	_	_	_
387	7	travel	travel	VB	5	xcomp	59933	59939	_	_	_	_	_
387	8	.	.	.	5	punct	59939	59940	_	_	_	_	_

388	1	Hepatitis	Hepatitis	NNP	3	compound	59941	59950	_	_	_	_	_
388	2	B.	B.	NNP	3	compound	59951	59953	_	_	_	_	_
388	3	In	In	NNP	0	ROOT	59954	59956	_	_	_	_	_
388	4	:	:	:	3	punct	59956	59957	_	_	_	_	_
388	5	CDC	CDC	NNP	7	compound	59958	59961	_	_	_	_	_
388	6	Health	Health	NNP	7	compound	59962	59968	_	_	_	_	_
388	7	information	information	NN	3	dep	59969	59980	_	_	_	_	_
388	8	for	for	IN	10	case	59981	59984	_	_	_	_	_
388	9	international	international	JJ	10	amod	59985	59998	_	_	_	_	_
388	10	travel	travel	NN	7	nmod	59999	60005	_	_	_	_	_
388	11	2014	2014	CD	10	nummod	60006	60010	_	_	_	_	_
388	12	:	:	:	10	punct	60010	60011	_	_	_	_	_
388	13	the	the	DT	15	det	60012	60015	_	_	_	_	_
388	14	Yellow	Yellow	NNP	15	compound	60016	60022	_	_	_	_	_
388	15	Book	Book	NNP	10	dep	60023	60027	_	_	_	_	_
388	16	.	.	.	3	punct	60027	60028	_	_	_	_	_

389	1	New	New	NNP	2	compound	60029	60032	_	_	_	_	_
389	2	York	York	NNP	0	ROOT	60033	60037	_	_	_	_	_
389	3	:	:	:	2	punct	60037	60038	_	_	_	_	_
389	4	Oxford	Oxford	NNP	6	compound	60039	60045	_	_	_	_	_
389	5	University	University	NNP	6	compound	60046	60056	_	_	_	_	_
389	6	Press	Press	NNP	2	dep	60057	60062	_	_	_	_	_
389	7	,	,	,	6	punct	60062	60063	_	_	_	_	_
389	8	2014	2014	CD	6	amod	60064	60068	_	_	_	_	_
389	9	.	.	.	2	punct	60068	60069	_	_	_	_	_

390	1	Available	available	JJ	8	nsubj	60070	60079	_	_	_	_	_
390	2	at	at	IN	6	case	60080	60082	_	_	_	_	_
390	3	:	:	:	4	punct	60082	60083	_	_	_	_	_
390	4	wwwnc.cdc.gov	wwwnc.cdc.gov	NN	6	dep	60084	60097	_	_	_	_	_
390	5	/	/	:	4	punct	60097	60098	_	_	_	_	_
390	6	travel	travel	NN	1	nmod	60098	60104	_	_	_	_	_
390	7	(	(	CD	6	nummod	60105	60106	_	_	_	_	_
390	8	accessed	access	VBD	0	ROOT	60106	60114	_	_	_	_	_
390	9	Mar	Mar	NNP	11	dep	60115	60118	_	_	_	_	_
390	10	2015	2015	CD	11	nummod	60119	60123	_	_	_	_	_
390	11	)	)	CD	8	ccomp	60123	60124	_	_	_	_	_
390	12	.	.	.	8	punct	60124	60125	_	_	_	_	_

391	1	El-Reshaid	el-reshaid	NN	2	compound	60126	60136	_	_	_	_	_
391	2	K	k	NN	0	ROOT	60137	60138	_	_	_	_	_
391	3	,	,	,	2	punct	60138	60139	_	_	_	_	_
391	4	Al-Mufti	Al-Mufti	NNP	5	compound	60140	60148	_	_	_	_	_
391	5	S	s	NN	2	appos	60149	60150	_	_	_	_	_
391	6	,	,	,	2	punct	60150	60151	_	_	_	_	_
391	7	Johny	Johny	NNP	8	compound	60152	60157	_	_	_	_	_
391	8	KV	kv	NN	2	appos	60158	60160	_	_	_	_	_
391	9	,	,	,	2	punct	60160	60161	_	_	_	_	_
391	10	Sugathan	Sugathan	NNP	11	compound	60162	60170	_	_	_	_	_
391	11	TN	tn	NN	2	appos	60171	60173	_	_	_	_	_
391	12	.	.	.	2	punct	60173	60174	_	_	_	_	_

392	1	Comparison	comparison	NN	14	nsubj	60175	60185	_	_	_	_	_
392	2	of	of	IN	5	case	60186	60188	_	_	_	_	_
392	3	two	two	CD	5	nummod	60189	60192	_	_	_	_	_
392	4	immunization	immunization	NN	5	compound	60193	60205	_	_	_	_	_
392	5	schedules	schedule	NNS	1	nmod	60206	60215	_	_	_	_	_
392	6	with	with	IN	10	case	60216	60220	_	_	_	_	_
392	7	recombinant	recombinant	JJ	10	amod	60221	60232	_	_	_	_	_
392	8	hepatitis	hepatitis	NN	10	compound	60233	60242	_	_	_	_	_
392	9	B	b	NN	10	compound	60243	60244	_	_	_	_	_
392	10	vaccine	vaccine	NN	5	nmod	60245	60252	_	_	_	_	_
392	11	and	and	CC	10	cc	60253	60256	_	_	_	_	_
392	12	natural	natural	JJ	13	amod	60257	60264	_	_	_	_	_
392	13	immunity	immunity	NN	10	conj	60265	60273	_	_	_	_	_
392	14	acquired	acquire	VBN	0	ROOT	60274	60282	_	_	_	_	_
392	15	by	by	IN	18	case	60283	60285	_	_	_	_	_
392	16	hepatitis	hepatitis	NN	18	compound	60286	60295	_	_	_	_	_
392	17	B	b	NN	18	compound	60296	60297	_	_	_	_	_
392	18	infection	infection	NN	14	nmod	60298	60307	_	_	_	_	_
392	19	in	in	IN	21	case	60308	60310	_	_	_	_	_
392	20	dialysis	dialysis	NN	21	compound	60311	60319	_	_	_	_	_
392	21	patients	patient	NNS	18	nmod	60320	60328	_	_	_	_	_
392	22	.	.	.	14	punct	60328	60329	_	_	_	_	_

393	1	Vaccine	vaccine	NN	0	ROOT	60330	60337	_	_	_	_	_
393	2	1994	1994	CD	1	nummod	60338	60342	_	_	_	_	_
393	3	;	;	:	1	punct	60342	60343	_	_	_	_	_
393	4	12:223-34	12:223-34	CD	1	dep	60343	60352	_	_	_	_	_
393	5	.	.	.	1	punct	60352	60353	_	_	_	_	_

394	1	Danzinger-Isakov	Danzinger-Isakov	NNP	2	compound	60354	60370	_	_	_	_	_
394	2	L	L	NNP	0	ROOT	60371	60372	_	_	_	_	_
394	3	,	,	,	2	punct	60372	60373	_	_	_	_	_
394	4	Kumar	Kumar	NNP	10	compound	60374	60379	_	_	_	_	_
394	5	D	D	NNP	10	compound	60380	60381	_	_	_	_	_
394	6	,	,	,	10	punct	60381	60382	_	_	_	_	_
394	7	AST	AST	NNP	10	appos	60383	60386	_	_	_	_	_
394	8	Infectious	infectious	JJ	10	amod	60387	60397	_	_	_	_	_
394	9	Diseases	Diseases	NNP	10	compound	60398	60406	_	_	_	_	_
394	10	Community	Community	NNP	2	appos	60407	60416	_	_	_	_	_
394	11	of	of	IN	12	case	60417	60419	_	_	_	_	_
394	12	Practice	Practice	NNP	10	nmod	60420	60428	_	_	_	_	_
394	13	.	.	.	2	punct	60428	60429	_	_	_	_	_

395	1	Guidelines	guideline	NNS	0	ROOT	60430	60440	_	_	_	_	_
395	2	for	for	IN	3	case	60441	60444	_	_	_	_	_
395	3	vaccination	vaccination	NN	1	nmod	60445	60456	_	_	_	_	_
395	4	of	of	IN	8	case	60457	60459	_	_	_	_	_
395	5	solid	solid	JJ	8	amod	60460	60465	_	_	_	_	_
395	6	organ	organ	NN	8	compound	60466	60471	_	_	_	_	_
395	7	transplant	transplant	NN	8	compound	60472	60482	_	_	_	_	_
395	8	candidates	candidate	NNS	1	nmod	60483	60493	_	_	_	_	_
395	9	and	and	CC	8	cc	60494	60497	_	_	_	_	_
395	10	recipients	recipient	NNS	8	conj	60498	60508	_	_	_	_	_
395	11	.	.	.	1	punct	60508	60509	_	_	_	_	_

396	1	American	American	NNP	2	compound	60510	60518	_	_	_	_	_
396	2	Journal	Journal	NNP	0	ROOT	60519	60526	_	_	_	_	_
396	3	of	of	IN	4	case	60527	60529	_	_	_	_	_
396	4	Transplantation	Transplantation	NNP	2	nmod	60530	60545	_	_	_	_	_
396	5	2009	2009	CD	4	nummod	60546	60550	_	_	_	_	_
396	6	;	;	:	2	punct	60550	60551	_	_	_	_	_
396	7	9	9	CD	8	nummod	60551	60552	_	_	_	_	_
396	8	Suppl	suppl	NN	2	dep	60553	60558	_	_	_	_	_
396	9	4	4	CD	8	dep	60559	60560	_	_	_	_	_
396	10	:	:	:	8	punct	60560	60561	_	_	_	_	_
396	11	S258-62	s258-62	NN	8	dep	60561	60568	_	_	_	_	_
396	12	.	.	.	2	punct	60568	60569	_	_	_	_	_

397	1	Potsch	Potsch	NNP	2	compound	60570	60576	_	_	_	_	_
397	2	DV	DV	NNP	0	ROOT	60577	60579	_	_	_	_	_
397	3	,	,	,	2	punct	60579	60580	_	_	_	_	_
397	4	Oliveira	Oliveira	NNP	5	compound	60581	60589	_	_	_	_	_
397	5	ML	ML	NNP	2	appos	60590	60592	_	_	_	_	_
397	6	,	,	,	2	punct	60592	60593	_	_	_	_	_
397	7	Ginuï	Ginuï	NNP	2	appos	60594	60599	_	_	_	_	_
397	8	¿	¿	CD	9	compound	60599	60600	_	_	_	_	_
397	9	½	½	CD	11	nummod	60600	60601	_	_	_	_	_
397	10	no	no	DT	11	neg	60601	60603	_	_	_	_	_
397	11	C	c	NN	7	dep	60604	60605	_	_	_	_	_
397	12	,	,	,	2	punct	60605	60606	_	_	_	_	_
397	13	et	et	FW	14	compound	60607	60609	_	_	_	_	_
397	14	al.	al.	FW	2	appos	60610	60613	_	_	_	_	_
397	15	.	.	.	2	punct	_	_	_	_	_	_	_

398	1	High	high	JJ	2	amod	60614	60618	_	_	_	_	_
398	2	rates	rate	NNS	0	ROOT	60619	60624	_	_	_	_	_
398	3	of	of	IN	5	case	60625	60627	_	_	_	_	_
398	4	serological	serological	JJ	5	amod	60628	60639	_	_	_	_	_
398	5	response	response	NN	2	nmod	60640	60648	_	_	_	_	_
398	6	to	to	TO	12	case	60649	60651	_	_	_	_	_
398	7	a	a	DT	12	det	60652	60653	_	_	_	_	_
398	8	modified	modify	VBN	12	amod	60654	60662	_	_	_	_	_
398	9	hepatitis	hepatitis	NN	12	compound	60663	60672	_	_	_	_	_
398	10	B	b	NN	12	compound	60673	60674	_	_	_	_	_
398	11	vaccination	vaccination	NN	12	compound	60675	60686	_	_	_	_	_
398	12	schedule	schedule	NN	5	nmod	60687	60695	_	_	_	_	_
398	13	in	in	IN	16	case	60696	60698	_	_	_	_	_
398	14	HIV-infected	hiv-infected	JJ	16	amod	60699	60711	_	_	_	_	_
398	15	adults	adult	NNS	16	compound	60712	60718	_	_	_	_	_
398	16	subjects	subject	NNS	12	nmod	60719	60727	_	_	_	_	_
398	17	.	.	.	2	punct	60727	60728	_	_	_	_	_

399	1	Vaccine	vaccine	NN	0	ROOT	60729	60736	_	_	_	_	_
399	2	2010	2010	CD	1	nummod	60737	60741	_	_	_	_	_
399	3	;	;	:	1	punct	60741	60742	_	_	_	_	_
399	4	28:1447-50	28:1447-50	CD	1	dep	60742	60752	_	_	_	_	_
399	5	.	.	.	1	punct	60752	60753	_	_	_	_	_

400	1	Launay	Launay	NNP	2	compound	60754	60760	_	_	_	_	_
400	2	O	O	NNP	0	ROOT	60761	60762	_	_	_	_	_
400	3	,	,	,	2	punct	60762	60763	_	_	_	_	_
400	4	van	van	NNP	7	compound	60764	60767	_	_	_	_	_
400	5	der	der	NNP	7	compound	60768	60771	_	_	_	_	_
400	6	Vliet	Vliet	NNP	7	compound	60772	60777	_	_	_	_	_
400	7	D	D	NNP	2	appos	60778	60779	_	_	_	_	_
400	8	,	,	,	2	punct	60779	60780	_	_	_	_	_
400	9	Rosenberg	Rosenberg	NNP	10	compound	60781	60790	_	_	_	_	_
400	10	AR	ar	NNS	2	appos	60791	60793	_	_	_	_	_
400	11	,	,	,	2	punct	60793	60794	_	_	_	_	_
400	12	et	et	FW	13	compound	60795	60797	_	_	_	_	_
400	13	al.	al.	FW	2	appos	60798	60801	_	_	_	_	_
400	14	.	.	.	2	punct	_	_	_	_	_	_	_

401	1	Safety	safety	NN	0	ROOT	60802	60808	_	_	_	_	_
401	2	and	and	CC	1	cc	60809	60812	_	_	_	_	_
401	3	immunogenicity	immunogenicity	NN	1	conj	60813	60827	_	_	_	_	_
401	4	of	of	IN	8	case	60828	60830	_	_	_	_	_
401	5	4	4	CD	8	nummod	60831	60832	_	_	_	_	_
401	6	intramuscular	intramuscular	JJ	8	amod	60833	60846	_	_	_	_	_
401	7	double	double	JJ	8	amod	60847	60853	_	_	_	_	_
401	8	doses	dose	NNS	1	nmod	60854	60859	_	_	_	_	_
401	9	and	and	CC	8	cc	60860	60863	_	_	_	_	_
401	10	4	4	CD	13	nummod	60864	60865	_	_	_	_	_
401	11	intradermal	intradermal	JJ	13	amod	60866	60877	_	_	_	_	_
401	12	low	low	JJ	13	amod	60878	60881	_	_	_	_	_
401	13	doses	dose	NNS	8	conj	60882	60887	_	_	_	_	_
401	14	vs	vs	CC	1	cc	60888	60890	_	_	_	_	_
401	15	standard	standard	JJ	19	amod	60891	60899	_	_	_	_	_
401	16	hepatitis	hepatitis	NN	19	compound	60900	60909	_	_	_	_	_
401	17	B	b	NN	19	compound	60910	60911	_	_	_	_	_
401	18	vaccine	vaccine	NN	19	compound	60912	60919	_	_	_	_	_
401	19	regimen	regimen	NN	1	conj	60920	60927	_	_	_	_	_
401	20	in	in	IN	21	case	60928	60930	_	_	_	_	_
401	21	adults	adult	NNS	19	nmod	60931	60937	_	_	_	_	_
401	22	with	with	IN	23	case	60938	60942	_	_	_	_	_
401	23	HIV-1	hiv-1	NN	21	nmod	60943	60948	_	_	_	_	_
401	24	:	:	:	1	punct	60948	60949	_	_	_	_	_
401	25	a	a	DT	1	dep	60950	60951	_	_	_	_	_
401	26	randomized	randomize	VBN	25	acl	60952	60962	_	_	_	_	_
401	27	controlled	controlled	JJ	28	amod	60963	60973	_	_	_	_	_
401	28	trial	trial	NN	26	dobj	60974	60979	_	_	_	_	_
401	29	.	.	.	1	punct	60979	60980	_	_	_	_	_

402	1	JAMA	JAMA	NNP	0	ROOT	60981	60985	_	_	_	_	_
402	2	2011	2011	CD	1	nummod	60986	60990	_	_	_	_	_
402	3	;	;	:	1	punct	60990	60991	_	_	_	_	_
402	4	305:1432-40	305:1432-40	CD	1	dep	60991	61002	_	_	_	_	_
402	5	.	.	.	1	punct	61002	61003	_	_	_	_	_

403	1	Chlabicz	Chlabicz	NNP	2	compound	61004	61012	_	_	_	_	_
403	2	S	s	NN	0	ROOT	61013	61014	_	_	_	_	_
403	3	,	,	,	2	punct	61014	61015	_	_	_	_	_
403	4	Grzeszczuk	Grzeszczuk	NNP	9	compound	61016	61026	_	_	_	_	_
403	5	A.	A.	NNP	9	compound	61027	61029	_	_	_	_	_
403	6	Hepatitis	Hepatitis	NNP	9	compound	61030	61039	_	_	_	_	_
403	7	B	b	NN	9	compound	61040	61041	_	_	_	_	_
403	8	virus	virus	NN	9	compound	61042	61047	_	_	_	_	_
403	9	vaccine	vaccine	NN	2	appos	61048	61055	_	_	_	_	_
403	10	for	for	IN	11	case	61056	61059	_	_	_	_	_
403	11	patients	patient	NNS	9	nmod	61060	61068	_	_	_	_	_
403	12	with	with	IN	16	case	61069	61073	_	_	_	_	_
403	13	hepatitis	hepatitis	NN	16	compound	61074	61083	_	_	_	_	_
403	14	C	c	NN	16	compound	61084	61085	_	_	_	_	_
403	15	virus	virus	NN	16	compound	61086	61091	_	_	_	_	_
403	16	infection	infection	NN	11	nmod	61092	61101	_	_	_	_	_
403	17	.	.	.	2	punct	61101	61102	_	_	_	_	_

404	1	Infection	infection	NN	0	ROOT	61103	61112	_	_	_	_	_
404	2	2000	2000	CD	1	nummod	61113	61117	_	_	_	_	_
404	3	;	;	:	1	punct	61117	61118	_	_	_	_	_
404	4	28:341-5	28:341-5	CD	1	dep	61118	61126	_	_	_	_	_
404	5	.	.	.	1	punct	61126	61127	_	_	_	_	_

405	1	Candotti	candotti	NN	2	compound	61128	61136	_	_	_	_	_
405	2	D	d	NN	0	ROOT	61137	61138	_	_	_	_	_
405	3	,	,	,	2	punct	61138	61139	_	_	_	_	_
405	4	Allain	Allain	NNP	5	compound	61140	61146	_	_	_	_	_
405	5	JP	JP	NNP	2	appos	61147	61149	_	_	_	_	_
405	6	.	.	.	2	punct	61149	61150	_	_	_	_	_

406	1	Transfusion-transmitted	transfusion-transmitted	JJ	3	amod	61151	61174	_	_	_	_	_
406	2	hepatitis	hepatitis	NN	3	compound	61175	61184	_	_	_	_	_
406	3	B	b	NN	0	ROOT	61185	61186	_	_	_	_	_
406	4	virus	virus	NN	5	compound	61187	61192	_	_	_	_	_
406	5	infection	infection	NN	3	dep	61193	61202	_	_	_	_	_
406	6	.	.	.	3	punct	61202	61203	_	_	_	_	_

407	1	Journal	Journal	NNP	0	ROOT	61204	61211	_	_	_	_	_
407	2	of	of	IN	3	case	61212	61214	_	_	_	_	_
407	3	Hepatology	Hepatology	NNP	1	nmod	61215	61225	_	_	_	_	_
407	4	2009	2009	CD	3	nummod	61226	61230	_	_	_	_	_
407	5	;	;	:	3	punct	61230	61231	_	_	_	_	_
407	6	51:798-809	51:798-809	CD	3	nummod	61231	61241	_	_	_	_	_
407	7	.	.	.	1	punct	61241	61242	_	_	_	_	_

408	1	Perrillo	Perrillo	NNP	2	compound	61243	61251	_	_	_	_	_
408	2	RP	RP	NNP	0	ROOT	61252	61254	_	_	_	_	_
408	3	,	,	,	2	punct	61254	61255	_	_	_	_	_
408	4	Storch	Storch	NNP	5	compound	61256	61262	_	_	_	_	_
408	5	GA	GA	NNP	2	appos	61263	61265	_	_	_	_	_
408	6	,	,	,	2	punct	61265	61266	_	_	_	_	_
408	7	Bodicky	Bodicky	NNP	8	compound	61267	61274	_	_	_	_	_
408	8	CJ	CJ	NNP	2	appos	61275	61277	_	_	_	_	_
408	9	,	,	,	2	punct	61277	61278	_	_	_	_	_
408	10	Campbell	Campbell	NNP	11	compound	61279	61287	_	_	_	_	_
408	11	CR	cr	NN	2	appos	61288	61290	_	_	_	_	_
408	12	,	,	,	2	punct	61290	61291	_	_	_	_	_
408	13	Sanders	Sanders	NNP	14	compound	61292	61299	_	_	_	_	_
408	14	GE	GE	NNP	2	appos	61300	61302	_	_	_	_	_
408	15	.	.	.	2	punct	61302	61303	_	_	_	_	_

409	1	Survey	survey	NN	0	ROOT	61304	61310	_	_	_	_	_
409	2	of	of	IN	6	case	61311	61313	_	_	_	_	_
409	3	hepatitis	hepatitis	NN	6	compound	61314	61323	_	_	_	_	_
409	4	B	b	NN	6	compound	61324	61325	_	_	_	_	_
409	5	viral	viral	JJ	6	amod	61326	61331	_	_	_	_	_
409	6	markers	marker	NNS	1	nmod	61332	61339	_	_	_	_	_
409	7	at	at	IN	11	case	61340	61342	_	_	_	_	_
409	8	a	a	DT	11	det	61343	61344	_	_	_	_	_
409	9	public	public	JJ	11	amod	61345	61351	_	_	_	_	_
409	10	day	day	NN	11	compound	61352	61355	_	_	_	_	_
409	11	school	school	NN	1	nmod	61356	61362	_	_	_	_	_
409	12	and	and	CC	11	cc	61363	61366	_	_	_	_	_
409	13	a	a	DT	15	det	61367	61368	_	_	_	_	_
409	14	residential	residential	JJ	15	amod	61369	61380	_	_	_	_	_
409	15	institution	institution	NN	11	conj	61381	61392	_	_	_	_	_
409	16	sharing	share	VBG	1	acl	61393	61400	_	_	_	_	_
409	17	mentally	mentally	RB	19	advmod	61401	61409	_	_	_	_	_
409	18	handicapped	handicapped	JJ	19	amod	61410	61421	_	_	_	_	_
409	19	students	student	NNS	16	dobj	61422	61430	_	_	_	_	_
409	20	.	.	.	1	punct	61430	61431	_	_	_	_	_

410	1	Journal	Journal	NNP	0	ROOT	61432	61439	_	_	_	_	_
410	2	of	of	IN	4	case	61440	61442	_	_	_	_	_
410	3	Infectious	infectious	JJ	4	amod	61443	61453	_	_	_	_	_
410	4	Diseases	disease	NNS	1	nmod	61454	61462	_	_	_	_	_
410	5	1984	1984	CD	1	dep	61463	61467	_	_	_	_	_
410	6	;	;	:	1	punct	61467	61468	_	_	_	_	_
410	7	149:796-800	149:796-800	CD	1	dep	61468	61479	_	_	_	_	_
410	8	.	.	.	1	punct	61479	61480	_	_	_	_	_

411	1	Perrillo	Perrillo	NNP	2	compound	61481	61489	_	_	_	_	_
411	2	RP	RP	NNP	0	ROOT	61490	61492	_	_	_	_	_
411	3	,	,	,	2	punct	61492	61493	_	_	_	_	_
411	4	Strang	Strang	NNP	5	compound	61494	61500	_	_	_	_	_
411	5	S	s	NN	2	appos	61501	61502	_	_	_	_	_
411	6	,	,	,	5	punct	61502	61503	_	_	_	_	_
411	7	Lowry	Lowry	NNP	8	compound	61504	61509	_	_	_	_	_
411	8	OH	oh	NN	5	appos	61510	61512	_	_	_	_	_
411	9	.	.	.	2	punct	61512	61513	_	_	_	_	_

412	1	Different	different	JJ	3	amod	61514	61523	_	_	_	_	_
412	2	operating	operating	NN	3	compound	61524	61533	_	_	_	_	_
412	3	conditions	condition	NNS	4	nsubj	61534	61544	_	_	_	_	_
412	4	affect	affect	VBP	0	ROOT	61545	61551	_	_	_	_	_
412	5	risk	risk	NN	4	dobj	61552	61556	_	_	_	_	_
412	6	of	of	IN	10	case	61557	61559	_	_	_	_	_
412	7	hepatitis	hepatitis	NN	10	compound	61560	61569	_	_	_	_	_
412	8	B	b	NN	10	compound	61570	61571	_	_	_	_	_
412	9	virus	virus	NN	10	compound	61572	61577	_	_	_	_	_
412	10	infection	infection	NN	5	nmod	61578	61587	_	_	_	_	_
412	11	at	at	IN	14	case	61588	61590	_	_	_	_	_
412	12	two	two	CD	14	nummod	61591	61594	_	_	_	_	_
412	13	residential	residential	JJ	14	amod	61595	61606	_	_	_	_	_
412	14	institutions	institution	NNS	4	nmod	61607	61619	_	_	_	_	_
412	15	for	for	IN	18	case	61620	61623	_	_	_	_	_
412	16	the	the	DT	18	det	61624	61627	_	_	_	_	_
412	17	mentally	mentally	RB	18	advmod	61628	61636	_	_	_	_	_
412	18	disabled	disabled	JJ	14	nmod	61637	61645	_	_	_	_	_
412	19	.	.	.	4	punct	61645	61646	_	_	_	_	_

413	1	American	American	NNP	2	compound	61647	61655	_	_	_	_	_
413	2	Journal	Journal	NNP	0	ROOT	61656	61663	_	_	_	_	_
413	3	of	of	IN	4	case	61664	61666	_	_	_	_	_
413	4	Epidemiology	Epidemiology	NNP	2	nmod	61667	61679	_	_	_	_	_
413	5	1986	1986	CD	4	nummod	61680	61684	_	_	_	_	_
413	6	;	;	:	4	punct	61684	61685	_	_	_	_	_
413	7	123:690-8	123:690-8	CD	4	nummod	61685	61694	_	_	_	_	_
413	8	.	.	.	2	punct	61694	61695	_	_	_	_	_

414	1	Woodruff	Woodruff	NNP	2	compound	61696	61704	_	_	_	_	_
414	2	BA	ba	NN	0	ROOT	61705	61707	_	_	_	_	_
414	3	,	,	,	2	punct	61707	61708	_	_	_	_	_
414	4	Vazquez	Vazquez	NNP	6	compound	61709	61716	_	_	_	_	_
414	5	E.	E.	NNP	6	compound	61717	61719	_	_	_	_	_
414	6	Prevalence	prevalence	NN	2	appos	61720	61730	_	_	_	_	_
414	7	of	of	IN	10	case	61731	61733	_	_	_	_	_
414	8	hepatitis	hepatitis	NN	10	compound	61734	61743	_	_	_	_	_
414	9	virus	virus	NN	10	compound	61744	61749	_	_	_	_	_
414	10	infections	infection	NNS	6	nmod	61750	61760	_	_	_	_	_
414	11	in	in	IN	13	case	61761	61763	_	_	_	_	_
414	12	an	a	DT	13	det	61764	61766	_	_	_	_	_
414	13	institution	institution	NN	10	nmod	61767	61778	_	_	_	_	_
414	14	for	for	IN	15	case	61779	61782	_	_	_	_	_
414	15	persons	person	NNS	13	nmod	61783	61790	_	_	_	_	_
414	16	with	with	IN	18	case	61791	61795	_	_	_	_	_
414	17	developmental	developmental	JJ	18	amod	61796	61809	_	_	_	_	_
414	18	disabilities	disability	NNS	15	nmod	61810	61822	_	_	_	_	_
414	19	.	.	.	2	punct	61822	61823	_	_	_	_	_

415	1	American	American	NNP	2	compound	61824	61832	_	_	_	_	_
415	2	Journal	Journal	NNP	0	ROOT	61833	61840	_	_	_	_	_
415	3	of	of	IN	5	case	61841	61843	_	_	_	_	_
415	4	Mental	Mental	NNP	5	compound	61844	61850	_	_	_	_	_
415	5	Retardation	Retardation	NNP	2	nmod	61851	61862	_	_	_	_	_
415	6	2002	2002	CD	5	nummod	61863	61867	_	_	_	_	_
415	7	;	;	:	2	punct	61867	61868	_	_	_	_	_
415	8	107:278-92	107:278-92	CD	2	dep	61868	61878	_	_	_	_	_
415	9	.	.	.	2	punct	61878	61879	_	_	_	_	_

416	1	Australian	australian	JJ	3	amod	61880	61890	_	_	_	_	_
416	2	Government	Government	NNP	3	compound	61891	61901	_	_	_	_	_
416	3	Department	Department	NNP	0	ROOT	61902	61912	_	_	_	_	_
416	4	of	of	IN	5	case	61913	61915	_	_	_	_	_
416	5	Health	Health	NNP	3	nmod	61916	61922	_	_	_	_	_
416	6	and	and	CC	5	cc	61923	61926	_	_	_	_	_
416	7	Ageing	Ageing	NNP	5	conj	61927	61933	_	_	_	_	_
416	8	.	.	.	3	punct	61933	61934	_	_	_	_	_

417	1	National	National	NNP	4	compound	61935	61943	_	_	_	_	_
417	2	hepatitis	hepatitis	NNP	4	compound	61944	61953	_	_	_	_	_
417	3	B	B	NNP	4	compound	61954	61955	_	_	_	_	_
417	4	strategy	strategy	NN	0	ROOT	61956	61964	_	_	_	_	_
417	5	2010	2010	CD	4	nummod	61965	61969	_	_	_	_	_
417	6	–	–	CD	7	compound	61969	61970	_	_	_	_	_
417	7	2013	2013	CD	4	nummod	61970	61974	_	_	_	_	_
417	8	.	.	.	4	punct	61974	61975	_	_	_	_	_

418	1	Canberra	Canberra	NNP	0	ROOT	61976	61984	_	_	_	_	_
418	2	:	:	:	1	punct	61984	61985	_	_	_	_	_
418	3	Australian	australian	JJ	5	amod	61986	61996	_	_	_	_	_
418	4	Government	Government	NNP	5	compound	61997	62007	_	_	_	_	_
418	5	Department	Department	NNP	1	dep	62008	62018	_	_	_	_	_
418	6	of	of	IN	7	case	62019	62021	_	_	_	_	_
418	7	Health	Health	NNP	5	nmod	62022	62028	_	_	_	_	_
418	8	and	and	CC	7	cc	62029	62032	_	_	_	_	_
418	9	Ageing	Ageing	NNP	7	conj	62033	62039	_	_	_	_	_
418	10	,	,	,	1	punct	62039	62040	_	_	_	_	_
418	11	2010	2010	CD	1	amod	62041	62045	_	_	_	_	_
418	12	.	.	.	1	punct	62045	62046	_	_	_	_	_

419	1	Williams	Williams	NNP	2	compound	62051	62059	_	_	_	_	_
419	2	JL	JL	NNP	0	ROOT	62060	62062	_	_	_	_	_
419	3	,	,	,	2	punct	62062	62063	_	_	_	_	_
419	4	Christensen	Christensen	NNP	5	compound	62064	62075	_	_	_	_	_
419	5	CJ	CJ	NNP	2	appos	62076	62078	_	_	_	_	_
419	6	,	,	,	2	punct	62078	62079	_	_	_	_	_
419	7	McMahon	McMahon	NNP	8	compound	62080	62087	_	_	_	_	_
419	8	BJ	BJ	NNP	2	appos	62088	62090	_	_	_	_	_
419	9	,	,	,	2	punct	62090	62091	_	_	_	_	_
419	10	et	et	FW	11	compound	62092	62094	_	_	_	_	_
419	11	al.	al.	FW	2	appos	62095	62098	_	_	_	_	_
419	12	.	.	.	2	punct	_	_	_	_	_	_	_

420	1	Evaluation	evaluation	NN	0	ROOT	62099	62109	_	_	_	_	_
420	2	of	of	IN	4	case	62110	62112	_	_	_	_	_
420	3	the	the	DT	4	det	62113	62116	_	_	_	_	_
420	4	response	response	NN	1	nmod	62117	62125	_	_	_	_	_
420	5	to	to	TO	8	case	62126	62128	_	_	_	_	_
420	6	a	a	DT	8	det	62129	62130	_	_	_	_	_
420	7	booster	booster	NN	8	compound	62131	62138	_	_	_	_	_
420	8	dose	dose	NN	1	nmod	62139	62143	_	_	_	_	_
420	9	of	of	IN	12	case	62144	62146	_	_	_	_	_
420	10	hepatitis	hepatitis	NN	12	compound	62147	62156	_	_	_	_	_
420	11	B	b	NN	12	compound	62157	62158	_	_	_	_	_
420	12	vaccine	vaccine	NN	1	nmod	62159	62166	_	_	_	_	_
420	13	in	in	IN	14	case	62167	62169	_	_	_	_	_
420	14	previously	previously	RB	1	acl	62170	62180	_	_	_	_	_
420	15	immunized	immunize	VBN	1	acl	62181	62190	_	_	_	_	_
420	16	healthcare	healthcare	NN	17	compound	62191	62201	_	_	_	_	_
420	17	workers	worker	NNS	15	dobj	62202	62209	_	_	_	_	_
420	18	.	.	.	1	punct	62209	62210	_	_	_	_	_

421	1	Vaccine	vaccine	NN	0	ROOT	62211	62218	_	_	_	_	_
421	2	2001	2001	CD	1	nummod	62219	62223	_	_	_	_	_
421	3	;	;	:	1	punct	62223	62224	_	_	_	_	_
421	4	19:4081-5	19:4081-5	CD	1	dep	62224	62233	_	_	_	_	_
421	5	.	.	.	1	punct	62233	62234	_	_	_	_	_

422	1	Watson	Watson	NNP	2	compound	62235	62241	_	_	_	_	_
422	2	B	B	NNP	0	ROOT	62242	62243	_	_	_	_	_
422	3	,	,	,	2	punct	62243	62244	_	_	_	_	_
422	4	West	West	NNP	5	compound	62245	62249	_	_	_	_	_
422	5	DJ	DJ	NNP	2	appos	62250	62252	_	_	_	_	_
422	6	,	,	,	2	punct	62252	62253	_	_	_	_	_
422	7	Chilkatowsky	Chilkatowsky	NNP	8	compound	62254	62266	_	_	_	_	_
422	8	A	A	NNP	2	appos	62267	62268	_	_	_	_	_
422	9	,	,	,	2	punct	62268	62269	_	_	_	_	_
422	10	Piercy	Piercy	NNP	11	compound	62270	62276	_	_	_	_	_
422	11	S	S	NNP	2	appos	62277	62278	_	_	_	_	_
422	12	,	,	,	2	punct	62278	62279	_	_	_	_	_
422	13	Ioli	Ioli	NNP	14	compound	62280	62284	_	_	_	_	_
422	14	VA.	VA.	NNP	2	appos	62285	62288	_	_	_	_	_
422	15	.	.	.	2	punct	_	_	_	_	_	_	_

423	1	Persistence	persistence	NN	0	ROOT	62289	62300	_	_	_	_	_
423	2	of	of	IN	4	case	62301	62303	_	_	_	_	_
423	3	immunologic	immunologic	JJ	4	amod	62304	62315	_	_	_	_	_
423	4	memory	memory	NN	1	nmod	62316	62322	_	_	_	_	_
423	5	for	for	IN	7	case	62323	62326	_	_	_	_	_
423	6	13	13	CD	7	nummod	62327	62329	_	_	_	_	_
423	7	years	year	NNS	1	nmod	62330	62335	_	_	_	_	_
423	8	in	in	IN	9	case	62336	62338	_	_	_	_	_
423	9	recipients	recipient	NNS	7	nmod	62339	62349	_	_	_	_	_
423	10	of	of	IN	15	case	62350	62352	_	_	_	_	_
423	11	a	a	DT	15	det	62353	62354	_	_	_	_	_
423	12	recombinant	recombinant	JJ	15	amod	62355	62366	_	_	_	_	_
423	13	hepatitis	hepatitis	NN	15	compound	62367	62376	_	_	_	_	_
423	14	B	b	NN	15	compound	62377	62378	_	_	_	_	_
423	15	vaccine	vaccine	NN	9	nmod	62379	62386	_	_	_	_	_
423	16	.	.	.	1	punct	62386	62387	_	_	_	_	_

424	1	Vaccine	vaccine	NN	0	ROOT	62388	62395	_	_	_	_	_
424	2	2001	2001	CD	1	nummod	62396	62400	_	_	_	_	_
424	3	;	;	:	1	punct	62400	62401	_	_	_	_	_
424	4	19:3164-8	19:3164-8	CD	1	dep	62401	62410	_	_	_	_	_
424	5	.	.	.	1	punct	62410	62411	_	_	_	_	_

425	1	Greub	Greub	NNP	2	compound	62412	62417	_	_	_	_	_
425	2	G	G	NNP	0	ROOT	62418	62419	_	_	_	_	_
425	3	,	,	,	2	punct	62419	62420	_	_	_	_	_
425	4	Zysset	Zysset	NNP	5	compound	62421	62427	_	_	_	_	_
425	5	F	f	NN	2	appos	62428	62429	_	_	_	_	_
425	6	,	,	,	2	punct	62429	62430	_	_	_	_	_
425	7	Genton	genton	NN	8	compound	62431	62437	_	_	_	_	_
425	8	B	b	NN	2	appos	62438	62439	_	_	_	_	_
425	9	,	,	,	2	punct	62439	62440	_	_	_	_	_
425	10	Spertini	Spertini	NNP	11	compound	62441	62449	_	_	_	_	_
425	11	F	f	NN	2	appos	62450	62451	_	_	_	_	_
425	12	,	,	,	2	punct	62451	62452	_	_	_	_	_
425	13	Frei	Frei	NNP	14	compound	62453	62457	_	_	_	_	_
425	14	PC	PC	NNP	2	appos	62458	62460	_	_	_	_	_
425	15	.	.	.	2	punct	62460	62461	_	_	_	_	_

426	1	Absence	absence	NN	12	nsubj	62462	62469	_	_	_	_	_
426	2	of	of	IN	6	case	62470	62472	_	_	_	_	_
426	3	anti-hepatitis	anti-hepatitis	JJ	6	amod	62473	62487	_	_	_	_	_
426	4	B	b	NN	6	compound	62488	62489	_	_	_	_	_
426	5	surface	surface	NN	6	compound	62490	62497	_	_	_	_	_
426	6	antibody	antibody	NN	1	nmod	62498	62506	_	_	_	_	_
426	7	after	after	IN	8	case	62507	62512	_	_	_	_	_
426	8	vaccination	vaccination	NN	6	nmod	62513	62524	_	_	_	_	_
426	9	does	do	VBZ	12	aux	62525	62529	_	_	_	_	_
426	10	not	not	RB	12	neg	62530	62533	_	_	_	_	_
426	11	necessarily	necessarily	RB	12	advmod	62534	62545	_	_	_	_	_
426	12	mean	mean	VB	0	ROOT	62546	62550	_	_	_	_	_
426	13	absence	absence	NN	12	dobj	62551	62558	_	_	_	_	_
426	14	of	of	IN	16	case	62559	62561	_	_	_	_	_
426	15	immune	immune	JJ	16	amod	62562	62568	_	_	_	_	_
426	16	response	response	NN	13	nmod	62569	62577	_	_	_	_	_
426	17	.	.	.	12	punct	62577	62578	_	_	_	_	_

427	1	Medical	medical	JJ	2	amod	62579	62586	_	_	_	_	_
427	2	Microbiology	Microbiology	NNP	0	ROOT	62587	62599	_	_	_	_	_
427	3	and	and	CC	2	cc	62600	62603	_	_	_	_	_
427	4	Immunology	Immunology	NNP	2	conj	62604	62614	_	_	_	_	_
427	5	2001	2001	CD	4	nummod	62615	62619	_	_	_	_	_
427	6	;	;	:	2	punct	62619	62620	_	_	_	_	_
427	7	189:165-8	189:165-8	CD	2	dep	62620	62629	_	_	_	_	_
427	8	.	.	.	2	punct	62629	62630	_	_	_	_	_

428	1	Zanetti	Zanetti	NNP	2	compound	62631	62638	_	_	_	_	_
428	2	AR	ar	NNS	0	ROOT	62639	62641	_	_	_	_	_
428	3	,	,	,	2	punct	62641	62642	_	_	_	_	_
428	4	Mariano	Mariano	NNP	5	compound	62643	62650	_	_	_	_	_
428	5	A	A	NNP	2	appos	62651	62652	_	_	_	_	_
428	6	,	,	,	2	punct	62652	62653	_	_	_	_	_
428	7	Romanï	Romanï	NNP	2	appos	62654	62660	_	_	_	_	_
428	8	¿	¿	CD	9	compound	62660	62661	_	_	_	_	_
428	9	½	½	CD	10	nummod	62661	62662	_	_	_	_	_
428	10	L	l	NN	7	dep	62663	62664	_	_	_	_	_
428	11	,	,	,	2	punct	62664	62665	_	_	_	_	_
428	12	et	et	FW	13	compound	62666	62668	_	_	_	_	_
428	13	al.	al.	FW	2	appos	62669	62672	_	_	_	_	_
428	14	.	.	.	2	punct	_	_	_	_	_	_	_

429	1	Long-term	long-term	JJ	2	amod	62673	62682	_	_	_	_	_
429	2	immunogenicity	immunogenicity	NN	0	ROOT	62683	62697	_	_	_	_	_
429	3	of	of	IN	6	case	62698	62700	_	_	_	_	_
429	4	hepatitis	hepatitis	NN	6	compound	62701	62710	_	_	_	_	_
429	5	B	b	NN	6	compound	62711	62712	_	_	_	_	_
429	6	vaccination	vaccination	NN	2	nmod	62713	62724	_	_	_	_	_
429	7	and	and	CC	6	cc	62725	62728	_	_	_	_	_
429	8	policy	policy	NN	6	conj	62729	62735	_	_	_	_	_
429	9	for	for	IN	10	case	62736	62739	_	_	_	_	_
429	10	booster	booster	NN	8	nmod	62740	62747	_	_	_	_	_
429	11	:	:	:	2	punct	62747	62748	_	_	_	_	_
429	12	an	a	DT	15	det	62749	62751	_	_	_	_	_
429	13	Italian	italian	JJ	15	amod	62752	62759	_	_	_	_	_
429	14	multicentre	multicentre	JJ	15	amod	62760	62771	_	_	_	_	_
429	15	study	study	NN	2	dep	62772	62777	_	_	_	_	_
429	16	.	.	.	2	punct	62777	62778	_	_	_	_	_

430	1	The	the	DT	2	det	62779	62782	_	_	_	_	_
430	2	Lancet	Lancet	NNP	0	ROOT	62783	62789	_	_	_	_	_
430	3	2005	2005	CD	2	nummod	62790	62794	_	_	_	_	_
430	4	;	;	:	2	punct	62794	62795	_	_	_	_	_
430	5	366:1379-84	366:1379-84	CD	2	dep	62795	62806	_	_	_	_	_
430	6	.	.	.	2	punct	62806	62807	_	_	_	_	_

431	1	FitzSimons	FitzSimons	NNP	2	compound	62808	62818	_	_	_	_	_
431	2	D	D	NNP	0	ROOT	62819	62820	_	_	_	_	_
431	3	,	,	,	2	punct	62820	62821	_	_	_	_	_
431	4	Franï	Franï	NNP	2	appos	62822	62827	_	_	_	_	_
431	5	¿	¿	CD	6	compound	62827	62828	_	_	_	_	_
431	6	½	½	CD	8	nummod	62828	62829	_	_	_	_	_
431	7	ois	ois	NN	8	compound	62829	62832	_	_	_	_	_
431	8	G	g	NN	4	dep	62833	62834	_	_	_	_	_
431	9	,	,	,	2	punct	62834	62835	_	_	_	_	_
431	10	Hall	Hall	NNP	11	compound	62836	62840	_	_	_	_	_
431	11	A	A	NNP	2	appos	62841	62842	_	_	_	_	_
431	12	,	,	,	2	punct	62842	62843	_	_	_	_	_
431	13	et	et	FW	14	compound	62844	62846	_	_	_	_	_
431	14	al.	al.	FW	2	appos	62847	62850	_	_	_	_	_
431	15	.	.	.	2	punct	_	_	_	_	_	_	_

432	1	Long-term	long-term	JJ	2	amod	62851	62860	_	_	_	_	_
432	2	efficacy	efficacy	NN	0	ROOT	62861	62869	_	_	_	_	_
432	3	of	of	IN	6	case	62870	62872	_	_	_	_	_
432	4	hepatitis	hepatitis	NN	6	compound	62873	62882	_	_	_	_	_
432	5	B	b	NN	6	compound	62883	62884	_	_	_	_	_
432	6	vaccine	vaccine	NN	2	nmod	62885	62892	_	_	_	_	_
432	7	,	,	,	6	punct	62892	62893	_	_	_	_	_
432	8	booster	booster	NN	9	compound	62894	62901	_	_	_	_	_
432	9	policy	policy	NN	6	conj	62902	62908	_	_	_	_	_
432	10	,	,	,	6	punct	62908	62909	_	_	_	_	_
432	11	and	and	CC	6	cc	62910	62913	_	_	_	_	_
432	12	impact	impact	NN	6	conj	62914	62920	_	_	_	_	_
432	13	of	of	IN	17	case	62921	62923	_	_	_	_	_
432	14	hepatitis	hepatitis	NN	17	compound	62924	62933	_	_	_	_	_
432	15	B	b	NN	17	compound	62934	62935	_	_	_	_	_
432	16	virus	virus	NN	17	compound	62936	62941	_	_	_	_	_
432	17	mutants	mutant	NNS	2	nmod	62942	62949	_	_	_	_	_
432	18	.	.	.	2	punct	62949	62950	_	_	_	_	_

433	1	Vaccine	vaccine	NN	0	ROOT	62951	62958	_	_	_	_	_
433	2	2005	2005	CD	1	nummod	62959	62963	_	_	_	_	_
433	3	;	;	:	1	punct	62963	62964	_	_	_	_	_
433	4	23:4158-66	23:4158-66	CD	1	dep	62964	62974	_	_	_	_	_
433	5	.	.	.	1	punct	62974	62975	_	_	_	_	_

434	1	Petersen	Petersen	NNP	2	compound	62976	62984	_	_	_	_	_
434	2	KM	KM	NNP	0	ROOT	62985	62987	_	_	_	_	_
434	3	,	,	,	2	punct	62987	62988	_	_	_	_	_
434	4	Bulkow	Bulkow	NNP	5	compound	62989	62995	_	_	_	_	_
434	5	LR	LR	NNP	2	appos	62996	62998	_	_	_	_	_
434	6	,	,	,	2	punct	62998	62999	_	_	_	_	_
434	7	McMahon	McMahon	NNP	8	compound	63000	63007	_	_	_	_	_
434	8	BJ	BJ	NNP	2	appos	63008	63010	_	_	_	_	_
434	9	,	,	,	2	punct	63010	63011	_	_	_	_	_
434	10	et	et	FW	11	compound	63012	63014	_	_	_	_	_
434	11	al.	al.	FW	2	appos	63015	63018	_	_	_	_	_
434	12	.	.	.	2	punct	_	_	_	_	_	_	_

435	1	Duration	duration	NN	0	ROOT	63019	63027	_	_	_	_	_
435	2	of	of	IN	5	case	63028	63030	_	_	_	_	_
435	3	hepatitis	hepatitis	NN	5	compound	63031	63040	_	_	_	_	_
435	4	B	b	NN	5	compound	63041	63042	_	_	_	_	_
435	5	immunity	immunity	NN	1	nmod	63043	63051	_	_	_	_	_
435	6	in	in	IN	9	case	63052	63054	_	_	_	_	_
435	7	low	low	JJ	9	amod	63055	63058	_	_	_	_	_
435	8	risk	risk	NN	9	compound	63059	63063	_	_	_	_	_
435	9	children	child	NNS	5	nmod	63064	63072	_	_	_	_	_
435	10	receiving	receive	VBG	1	acl	63073	63082	_	_	_	_	_
435	11	hepatitis	hepatitis	NN	13	compound	63083	63092	_	_	_	_	_
435	12	B	b	NN	13	compound	63093	63094	_	_	_	_	_
435	13	vaccinations	vaccination	NNS	10	dobj	63095	63107	_	_	_	_	_
435	14	from	from	IN	15	case	63108	63112	_	_	_	_	_
435	15	birth	birth	NN	10	nmod	63113	63118	_	_	_	_	_
435	16	.	.	.	1	punct	63118	63119	_	_	_	_	_

436	1	Pediatric	Pediatric	NNP	2	nsubj	63120	63129	_	_	_	_	_
436	2	Infectious	infectious	JJ	0	ROOT	63130	63140	_	_	_	_	_
436	3	Disease	disease	NN	4	dep	63141	63148	_	_	_	_	_
436	4	Journal	Journal	NNP	2	nmod	63149	63156	_	_	_	_	_
436	5	2004	2004	CD	4	nummod	63157	63161	_	_	_	_	_
436	6	;	;	:	4	punct	63161	63162	_	_	_	_	_
436	7	23:650-5	23:650-5	CD	4	nummod	63162	63170	_	_	_	_	_
436	8	.	.	.	2	punct	63170	63171	_	_	_	_	_

437	1	But	but	CC	2	cc	63172	63175	_	_	_	_	_
437	2	DY	DY	NNP	0	ROOT	63176	63178	_	_	_	_	_
437	3	,	,	,	2	punct	63178	63179	_	_	_	_	_
437	4	Lai	Lai	NNP	5	compound	63180	63183	_	_	_	_	_
437	5	CL	cl	NN	2	appos	63184	63186	_	_	_	_	_
437	6	,	,	,	2	punct	63186	63187	_	_	_	_	_
437	7	Lim	Lim	NNP	8	compound	63188	63191	_	_	_	_	_
437	8	WL	WL	NNP	2	appos	63192	63194	_	_	_	_	_
437	9	,	,	,	2	punct	63194	63195	_	_	_	_	_
437	10	et	et	FW	11	compound	63196	63198	_	_	_	_	_
437	11	al.	al.	FW	2	appos	63199	63202	_	_	_	_	_
437	12	.	.	.	2	punct	_	_	_	_	_	_	_

438	1	Twenty-two	twenty-two	CD	2	nummod	63203	63213	_	_	_	_	_
438	2	years	year	NNS	3	compound	63214	63219	_	_	_	_	_
438	3	follow-up	follow-up	NN	0	ROOT	63220	63229	_	_	_	_	_
438	4	of	of	IN	8	case	63230	63232	_	_	_	_	_
438	5	a	a	DT	8	det	63233	63234	_	_	_	_	_
438	6	prospective	prospective	JJ	8	amod	63235	63246	_	_	_	_	_
438	7	randomized	randomized	JJ	8	amod	63247	63257	_	_	_	_	_
438	8	trial	trial	NN	3	nmod	63258	63263	_	_	_	_	_
438	9	of	of	IN	12	case	63264	63266	_	_	_	_	_
438	10	hepatitis	hepatitis	NN	12	compound	63267	63276	_	_	_	_	_
438	11	B	b	NN	12	compound	63277	63278	_	_	_	_	_
438	12	vaccines	vaccine	NNS	8	nmod	63279	63287	_	_	_	_	_
438	13	without	without	IN	15	case	63288	63295	_	_	_	_	_
438	14	booster	booster	NN	15	compound	63296	63303	_	_	_	_	_
438	15	dose	dose	NN	12	nmod	63304	63308	_	_	_	_	_
438	16	in	in	IN	17	case	63309	63311	_	_	_	_	_
438	17	children	child	NNS	15	nmod	63312	63320	_	_	_	_	_
438	18	:	:	:	3	punct	63320	63321	_	_	_	_	_
438	19	final	final	JJ	20	amod	63322	63327	_	_	_	_	_
438	20	report	report	NN	3	dep	63328	63334	_	_	_	_	_
438	21	.	.	.	3	punct	63334	63335	_	_	_	_	_

439	1	Vaccine	vaccine	NN	0	ROOT	63336	63343	_	_	_	_	_
439	2	2008	2008	CD	1	nummod	63344	63348	_	_	_	_	_
439	3	;	;	:	1	punct	63348	63349	_	_	_	_	_
439	4	26:6587-91	26:6587-91	CD	1	dep	63349	63359	_	_	_	_	_
439	5	.	.	.	1	punct	63359	63360	_	_	_	_	_

440	1	Goldwater	Goldwater	NNP	2	compound	63361	63370	_	_	_	_	_
440	2	PN	PN	NNP	0	ROOT	63371	63373	_	_	_	_	_
440	3	.	.	.	2	punct	63373	63374	_	_	_	_	_

441	1	Randomized	Randomized	NNP	0	ROOT	63375	63385	_	_	_	_	_
441	2	,	,	,	4	punct	63385	63386	_	_	_	_	_
441	3	comparative	comparative	JJ	4	amod	63387	63398	_	_	_	_	_
441	4	trial	trial	NN	1	dep	63399	63404	_	_	_	_	_
441	5	of	of	IN	7	case	63405	63407	_	_	_	_	_
441	6	20	20	CD	7	nummod	63408	63410	_	_	_	_	_
441	7	ï	ï	NN	4	nmod	63411	63412	_	_	_	_	_
441	8	¿	¿	CD	9	compound	63412	63413	_	_	_	_	_
441	9	½	½	CD	10	nummod	63413	63414	_	_	_	_	_
441	10	g	g	NN	1	dep	63414	63415	_	_	_	_	_
441	11	vs	vs	CC	10	cc	63416	63418	_	_	_	_	_
441	12	40	40	CD	13	nummod	63419	63421	_	_	_	_	_
441	13	ï	ï	NN	10	conj	63422	63423	_	_	_	_	_
441	14	¿	¿	CD	15	compound	63423	63424	_	_	_	_	_
441	15	½	½	CD	16	nummod	63424	63425	_	_	_	_	_
441	16	g	g	NN	1	dep	63425	63426	_	_	_	_	_
441	17	Engerix	Engerix	NNP	18	compound	63427	63434	_	_	_	_	_
441	18	B	B	NNP	16	dep	63435	63436	_	_	_	_	_
441	19	vaccine	vaccine	NN	1	dep	63437	63444	_	_	_	_	_
441	20	in	in	IN	24	case	63445	63447	_	_	_	_	_
441	21	hepatitis	hepatitis	NN	24	compound	63448	63457	_	_	_	_	_
441	22	B	b	NN	24	compound	63458	63459	_	_	_	_	_
441	23	vaccine	vaccine	NN	24	compound	63460	63467	_	_	_	_	_
441	24	non-responders	non-responder	NNS	19	nmod	63468	63482	_	_	_	_	_
441	25	.	.	.	1	punct	63482	63483	_	_	_	_	_

442	1	Vaccine	vaccine	NN	0	ROOT	63484	63491	_	_	_	_	_
442	2	1997	1997	CD	1	nummod	63492	63496	_	_	_	_	_
442	3	;	;	:	1	punct	63496	63497	_	_	_	_	_
442	4	15:353-6	15:353-6	CD	1	dep	63497	63505	_	_	_	_	_
442	5	.	.	.	1	punct	63505	63506	_	_	_	_	_

443	1	Bertino	Bertino	NNP	2	compound	63507	63514	_	_	_	_	_
443	2	JS	JS	NNP	0	ROOT	63515	63517	_	_	_	_	_
443	3	,	,	,	2	punct	63517	63518	_	_	_	_	_
443	4	Jr.	Jr.	NNP	2	appos	63519	63522	_	_	_	_	_
443	5	,	,	,	2	punct	63522	63523	_	_	_	_	_
443	6	Tirrell	Tirrell	NNP	7	compound	63524	63531	_	_	_	_	_
443	7	P	p	NN	2	appos	63532	63533	_	_	_	_	_
443	8	,	,	,	2	punct	63533	63534	_	_	_	_	_
443	9	Greenberg	Greenberg	NNP	10	compound	63535	63544	_	_	_	_	_
443	10	RN	RN	NNP	2	appos	63545	63547	_	_	_	_	_
443	11	,	,	,	2	punct	63547	63548	_	_	_	_	_
443	12	et	et	FW	13	compound	63549	63551	_	_	_	_	_
443	13	al.	al.	FW	2	appos	63552	63555	_	_	_	_	_
443	14	.	.	.	2	punct	_	_	_	_	_	_	_

444	1	A	a	DT	3	det	63556	63557	_	_	_	_	_
444	2	comparative	comparative	JJ	3	amod	63558	63569	_	_	_	_	_
444	3	trial	trial	NN	10	nsubj	63570	63575	_	_	_	_	_
444	4	of	of	IN	5	case	63576	63578	_	_	_	_	_
444	5	standard	standard	JJ	3	nmod	63579	63587	_	_	_	_	_
444	6	or	or	CC	5	cc	63588	63590	_	_	_	_	_
444	7	high-dose	high-dose	JJ	9	amod	63591	63600	_	_	_	_	_
444	8	S	s	NN	9	compound	63601	63602	_	_	_	_	_
444	9	subunit	subunit	NN	5	conj	63603	63610	_	_	_	_	_
444	10	recombinant	recombinant	JJ	0	ROOT	63611	63622	_	_	_	_	_
444	11	hepatitis	hepatitis	NN	13	compound	63623	63632	_	_	_	_	_
444	12	B	b	NN	13	compound	63633	63634	_	_	_	_	_
444	13	vaccine	vaccine	NN	10	dobj	63635	63642	_	_	_	_	_
444	14	versus	versus	CC	16	case	63643	63649	_	_	_	_	_
444	15	a	a	DT	16	det	63650	63651	_	_	_	_	_
444	16	vaccine	vaccine	NN	13	nmod	63652	63659	_	_	_	_	_
444	17	containing	contain	VBG	16	acl	63660	63670	_	_	_	_	_
444	18	S	s	NN	19	compound	63671	63672	_	_	_	_	_
444	19	subunit	subunit	NN	17	dobj	63673	63680	_	_	_	_	_
444	20	,	,	,	19	punct	63680	63681	_	_	_	_	_
444	21	pre-S1	pre-s1	NN	19	conj	63682	63688	_	_	_	_	_
444	22	,	,	,	19	punct	63688	63689	_	_	_	_	_
444	23	and	and	CC	19	cc	63690	63693	_	_	_	_	_
444	24	pre-S2	pre-s2	JJ	25	amod	63694	63700	_	_	_	_	_
444	25	particles	particle	NNS	19	conj	63701	63710	_	_	_	_	_
444	26	for	for	IN	27	case	63711	63714	_	_	_	_	_
444	27	revaccination	revaccination	NN	10	nmod	63715	63728	_	_	_	_	_
444	28	of	of	IN	31	case	63729	63731	_	_	_	_	_
444	29	healthy	healthy	JJ	31	amod	63732	63739	_	_	_	_	_
444	30	adult	adult	JJ	31	amod	63740	63745	_	_	_	_	_
444	31	nonresponders	nonresponder	NNS	27	nmod	63746	63759	_	_	_	_	_
444	32	.	.	.	10	punct	63759	63760	_	_	_	_	_

445	1	Journal	Journal	NNP	0	ROOT	63761	63768	_	_	_	_	_
445	2	of	of	IN	4	case	63769	63771	_	_	_	_	_
445	3	Infectious	infectious	JJ	4	amod	63772	63782	_	_	_	_	_
445	4	Diseases	disease	NNS	1	nmod	63783	63791	_	_	_	_	_
445	5	1997	1997	CD	1	dep	63792	63796	_	_	_	_	_
445	6	;	;	:	1	punct	63796	63797	_	_	_	_	_
445	7	175:678-81	175:678-81	CD	1	dep	63797	63807	_	_	_	_	_
445	8	.	.	.	1	punct	63807	63808	_	_	_	_	_

446	1	Kim	Kim	NNP	2	compound	63809	63812	_	_	_	_	_
446	2	MJ	MJ	NNP	0	ROOT	63813	63815	_	_	_	_	_
446	3	,	,	,	2	punct	63815	63816	_	_	_	_	_
446	4	Nafziger	Nafziger	NNP	2	appos	63817	63825	_	_	_	_	_
446	5	AN	a	DT	4	dep	63826	63828	_	_	_	_	_
446	6	,	,	,	2	punct	63828	63829	_	_	_	_	_
446	7	Harro	Harro	NNP	8	compound	63830	63835	_	_	_	_	_
446	8	CD	CD	NNP	2	appos	63836	63838	_	_	_	_	_
446	9	,	,	,	2	punct	63838	63839	_	_	_	_	_
446	10	et	et	FW	11	compound	63840	63842	_	_	_	_	_
446	11	al.	al.	FW	2	appos	63843	63846	_	_	_	_	_
446	12	.	.	.	2	punct	_	_	_	_	_	_	_

447	1	Revaccination	revaccination	NN	0	ROOT	63847	63860	_	_	_	_	_
447	2	of	of	IN	4	case	63861	63863	_	_	_	_	_
447	3	healthy	healthy	JJ	4	amod	63864	63871	_	_	_	_	_
447	4	nonresponders	nonresponder	NNS	1	nmod	63872	63885	_	_	_	_	_
447	5	with	with	IN	8	case	63886	63890	_	_	_	_	_
447	6	hepatitis	hepatitis	NN	8	compound	63891	63900	_	_	_	_	_
447	7	B	b	NN	8	compound	63901	63902	_	_	_	_	_
447	8	vaccine	vaccine	NN	1	nmod	63903	63910	_	_	_	_	_
447	9	and	and	CC	8	cc	63911	63914	_	_	_	_	_
447	10	prediction	prediction	NN	8	conj	63915	63925	_	_	_	_	_
447	11	of	of	IN	13	case	63926	63928	_	_	_	_	_
447	12	seroprotection	seroprotection	NN	13	compound	63929	63943	_	_	_	_	_
447	13	response	response	NN	1	nmod	63944	63952	_	_	_	_	_
447	14	.	.	.	1	punct	63952	63953	_	_	_	_	_

448	1	Vaccine	vaccine	NN	0	ROOT	63954	63961	_	_	_	_	_
448	2	2003	2003	CD	1	nummod	63962	63966	_	_	_	_	_
448	3	;	;	:	1	punct	63966	63967	_	_	_	_	_
448	4	21:1174-9	21:1174-9	CD	1	dep	63967	63976	_	_	_	_	_
448	5	.	.	.	1	punct	63976	63977	_	_	_	_	_

449	1	Playford	Playford	NNP	2	compound	63978	63986	_	_	_	_	_
449	2	EG	EG	NNP	0	ROOT	63987	63989	_	_	_	_	_
449	3	,	,	,	2	punct	63989	63990	_	_	_	_	_
449	4	Hogan	Hogan	NNP	5	compound	63991	63996	_	_	_	_	_
449	5	PG	PG	NNP	2	appos	63997	63999	_	_	_	_	_
449	6	,	,	,	2	punct	63999	64000	_	_	_	_	_
449	7	Bansal	Bansal	NNP	8	compound	64001	64007	_	_	_	_	_
449	8	AS	AS	NNP	2	appos	64008	64010	_	_	_	_	_
449	9	,	,	,	2	punct	64010	64011	_	_	_	_	_
449	10	et	et	FW	11	compound	64012	64014	_	_	_	_	_
449	11	al.	al.	FW	2	appos	64015	64018	_	_	_	_	_
449	12	.	.	.	2	punct	_	_	_	_	_	_	_

450	1	Intradermal	intradermal	JJ	3	amod	64019	64030	_	_	_	_	_
450	2	recombinant	recombinant	JJ	3	amod	64031	64042	_	_	_	_	_
450	3	hepatitis	hepatitis	NN	4	nsubj	64043	64052	_	_	_	_	_
450	4	B	b	NN	0	ROOT	64053	64054	_	_	_	_	_
450	5	vaccine	vaccine	NN	4	dobj	64055	64062	_	_	_	_	_
450	6	for	for	IN	8	case	64063	64066	_	_	_	_	_
450	7	healthcare	healthcare	NN	8	compound	64067	64077	_	_	_	_	_
450	8	workers	worker	NNS	5	nmod	64078	64085	_	_	_	_	_
450	9	who	who	WP	10	nsubj	64086	64089	_	_	_	_	_
450	10	fail	fail	VBP	5	acl:relcl	64090	64094	_	_	_	_	_
450	11	to	to	TO	12	mark	64095	64097	_	_	_	_	_
450	12	respond	respond	VB	10	xcomp	64098	64105	_	_	_	_	_
450	13	to	to	TO	15	case	64106	64108	_	_	_	_	_
450	14	intramuscular	intramuscular	JJ	15	amod	64109	64122	_	_	_	_	_
450	15	vaccine	vaccine	NN	12	nmod	64123	64130	_	_	_	_	_
450	16	.	.	.	4	punct	64130	64131	_	_	_	_	_

451	1	Infection	infection	NN	2	compound	64132	64141	_	_	_	_	_
451	2	Control	control	NN	0	ROOT	64142	64149	_	_	_	_	_
451	3	and	and	CC	2	cc	64150	64153	_	_	_	_	_
451	4	Hospital	hospital	NN	2	conj	64154	64162	_	_	_	_	_
451	5	Epidemiology	Epidemiology	NNP	2	dep	64163	64175	_	_	_	_	_
451	6	2002	2002	CD	5	nummod	64176	64180	_	_	_	_	_
451	7	;	;	:	2	punct	64180	64181	_	_	_	_	_
451	8	23:87-90	23:87-90	CD	2	dep	64181	64189	_	_	_	_	_
451	9	.	.	.	2	punct	64189	64190	_	_	_	_	_

452	1	Ghebrehewet	Ghebrehewet	NNP	2	compound	64191	64202	_	_	_	_	_
452	2	S	s	NN	24	nsubj	64203	64204	_	_	_	_	_
452	3	,	,	,	2	punct	64204	64205	_	_	_	_	_
452	4	Baxter	Baxter	NNP	5	compound	64206	64212	_	_	_	_	_
452	5	D	D	NNP	2	appos	64213	64214	_	_	_	_	_
452	6	,	,	,	2	punct	64214	64215	_	_	_	_	_
452	7	Falconer	Falconer	NNP	8	compound	64216	64224	_	_	_	_	_
452	8	M	M	NNP	2	appos	64225	64226	_	_	_	_	_
452	9	,	,	,	2	punct	64226	64227	_	_	_	_	_
452	10	Paver	Paver	NNP	12	compound	64228	64233	_	_	_	_	_
452	11	K.	K.	NNP	12	compound	64234	64236	_	_	_	_	_
452	12	Intradermal	Intradermal	NNP	2	appos	64237	64248	_	_	_	_	_
452	13	recombinant	recombinant	JJ	19	amod	64249	64260	_	_	_	_	_
452	14	hepatitis	hepatitis	NN	19	compound	64261	64270	_	_	_	_	_
452	15	B	b	NN	19	compound	64271	64272	_	_	_	_	_
452	16	vaccination	vaccination	NN	19	compound	64273	64284	_	_	_	_	_
452	17	(	(	CD	19	nummod	64285	64286	_	_	_	_	_
452	18	IDRV	idrv	NN	19	compound	64286	64290	_	_	_	_	_
452	19	)	)	NN	12	dep	64290	64291	_	_	_	_	_
452	20	for	for	IN	23	case	64292	64295	_	_	_	_	_
452	21	non-responsive	non-responsive	JJ	23	amod	64296	64310	_	_	_	_	_
452	22	healthcare	healthcare	NN	23	compound	64311	64321	_	_	_	_	_
452	23	workers	worker	NNS	19	nmod	64322	64329	_	_	_	_	_
452	24	(	(	VBP	0	ROOT	64330	64331	_	_	_	_	_
452	25	HCWs	hcw	NNS	24	dobj	64331	64335	_	_	_	_	_
452	26	)	)	CD	24	nmod:tmod	64335	64336	_	_	_	_	_
452	27	.	.	.	24	punct	64336	64337	_	_	_	_	_

453	1	Human	human	JJ	2	amod	64338	64343	_	_	_	_	_
453	2	Vaccines	vaccine	NNS	0	ROOT	64344	64352	_	_	_	_	_
453	3	2008	2008	CD	5	nummod	64353	64357	_	_	_	_	_
453	4	;	;	:	5	punct	64357	64358	_	_	_	_	_
453	5	4:280-5	4:280-5	CD	2	dep	64358	64365	_	_	_	_	_
453	6	.	.	.	2	punct	64365	64366	_	_	_	_	_

454	1	Roukens	Roukens	NNP	2	compound	64367	64374	_	_	_	_	_
454	2	AH	AH	NNP	0	ROOT	64375	64377	_	_	_	_	_
454	3	,	,	,	2	punct	64377	64378	_	_	_	_	_
454	4	Vossen	Vossen	NNP	5	compound	64379	64385	_	_	_	_	_
454	5	AC	ac	NN	2	appos	64386	64388	_	_	_	_	_
454	6	,	,	,	2	punct	64388	64389	_	_	_	_	_
454	7	Boland	Boland	NNP	8	compound	64390	64396	_	_	_	_	_
454	8	GJ	GJ	NNP	2	appos	64397	64399	_	_	_	_	_
454	9	,	,	,	2	punct	64399	64400	_	_	_	_	_
454	10	et	et	FW	11	compound	64401	64403	_	_	_	_	_
454	11	al.	al.	FW	2	appos	64404	64407	_	_	_	_	_
454	12	.	.	.	2	punct	_	_	_	_	_	_	_

455	1	Intradermal	intradermal	JJ	4	amod	64408	64419	_	_	_	_	_
455	2	hepatitis	hepatitis	NN	4	compound	64420	64429	_	_	_	_	_
455	3	B	b	NN	4	compound	64430	64431	_	_	_	_	_
455	4	vaccination	vaccination	NN	0	ROOT	64432	64443	_	_	_	_	_
455	5	in	in	IN	6	case	64444	64446	_	_	_	_	_
455	6	non-responders	non-responder	NNS	4	nmod	64447	64461	_	_	_	_	_
455	7	after	after	IN	9	case	64462	64467	_	_	_	_	_
455	8	topical	topical	JJ	9	amod	64468	64475	_	_	_	_	_
455	9	application	application	NN	6	nmod	64476	64487	_	_	_	_	_
455	10	of	of	IN	11	case	64488	64490	_	_	_	_	_
455	11	imiquimod	imiquimod	NN	9	nmod	64491	64500	_	_	_	_	_
455	12	(	(	CD	11	nummod	64501	64502	_	_	_	_	_
455	13	Aldaraï	Aldaraï	NNP	4	dep	64502	64509	_	_	_	_	_
455	14	¿	¿	CD	15	compound	64509	64510	_	_	_	_	_
455	15	½	½	CD	16	nummod	64510	64511	_	_	_	_	_
455	16	)	)	NN	13	dep	64511	64512	_	_	_	_	_
455	17	.	.	.	4	punct	64512	64513	_	_	_	_	_

456	1	Vaccine	vaccine	NN	0	ROOT	64514	64521	_	_	_	_	_
456	2	2010	2010	CD	1	nummod	64522	64526	_	_	_	_	_
456	3	;	;	:	1	punct	64526	64527	_	_	_	_	_
456	4	28:4288-93	28:4288-93	CD	1	dep	64527	64537	_	_	_	_	_
456	5	.	.	.	1	punct	64537	64538	_	_	_	_	_

457	1	Lewis	Lewis	NNP	2	compound	64539	64544	_	_	_	_	_
457	2	E	E	NNP	0	ROOT	64545	64546	_	_	_	_	_
457	3	,	,	,	2	punct	64546	64547	_	_	_	_	_
457	4	Shinefield	Shinefield	NNP	5	compound	64548	64558	_	_	_	_	_
457	5	HR	hr	NN	2	appos	64559	64561	_	_	_	_	_
457	6	,	,	,	2	punct	64561	64562	_	_	_	_	_
457	7	Woodruff	Woodruff	NNP	8	compound	64563	64571	_	_	_	_	_
457	8	BA	ba	NN	2	appos	64572	64574	_	_	_	_	_
457	9	,	,	,	2	punct	64574	64575	_	_	_	_	_
457	10	et	et	FW	11	compound	64576	64578	_	_	_	_	_
457	11	al.	al.	FW	2	appos	64579	64582	_	_	_	_	_
457	12	.	.	.	2	punct	_	_	_	_	_	_	_

458	1	Safety	safety	NN	0	ROOT	64583	64589	_	_	_	_	_
458	2	of	of	IN	7	case	64590	64592	_	_	_	_	_
458	3	neonatal	neonatal	JJ	7	amod	64593	64601	_	_	_	_	_
458	4	hepatitis	hepatitis	NN	7	compound	64602	64611	_	_	_	_	_
458	5	B	b	NN	7	compound	64612	64613	_	_	_	_	_
458	6	vaccine	vaccine	NN	7	compound	64614	64621	_	_	_	_	_
458	7	administration	administration	NN	1	nmod	64622	64636	_	_	_	_	_
458	8	.	.	.	1	punct	64636	64637	_	_	_	_	_

459	1	Pediatric	Pediatric	NNP	2	nsubj	64638	64647	_	_	_	_	_
459	2	Infectious	infectious	JJ	0	ROOT	64648	64658	_	_	_	_	_
459	3	Disease	disease	NN	4	dep	64659	64666	_	_	_	_	_
459	4	Journal	Journal	NNP	2	nmod	64667	64674	_	_	_	_	_
459	5	2001	2001	CD	4	nummod	64675	64679	_	_	_	_	_
459	6	;	;	:	4	punct	64679	64680	_	_	_	_	_
459	7	20:1049-54	20:1049-54	CD	4	nummod	64680	64690	_	_	_	_	_
459	8	.	.	.	2	punct	64690	64691	_	_	_	_	_

460	1	Niu	Niu	NNP	2	compound	64692	64695	_	_	_	_	_
460	2	MT	MT	NNP	0	ROOT	64696	64698	_	_	_	_	_
460	3	,	,	,	2	punct	64698	64699	_	_	_	_	_
460	4	Salive	Salive	NNP	5	compound	64700	64706	_	_	_	_	_
460	5	ME	ME	NNP	2	appos	64707	64709	_	_	_	_	_
460	6	,	,	,	5	punct	64709	64710	_	_	_	_	_
460	7	Ellenberg	Ellenberg	NNP	8	compound	64711	64720	_	_	_	_	_
460	8	SS	SS	NNP	5	appos	64721	64723	_	_	_	_	_
460	9	.	.	.	2	punct	64723	64724	_	_	_	_	_

461	1	Neonatal	neonatal	JJ	2	amod	64725	64733	_	_	_	_	_
461	2	deaths	death	NNS	0	ROOT	64734	64740	_	_	_	_	_
461	3	after	after	IN	6	case	64741	64746	_	_	_	_	_
461	4	hepatitis	hepatitis	NN	6	compound	64747	64756	_	_	_	_	_
461	5	B	b	NN	6	compound	64757	64758	_	_	_	_	_
461	6	vaccine	vaccine	NN	2	nmod	64759	64766	_	_	_	_	_
461	7	:	:	:	2	punct	64766	64767	_	_	_	_	_
461	8	the	the	DT	13	det	64768	64771	_	_	_	_	_
461	9	Vaccine	Vaccine	NNP	13	compound	64772	64779	_	_	_	_	_
461	10	Adverse	adverse	JJ	13	amod	64780	64787	_	_	_	_	_
461	11	Event	event	NN	13	compound	64788	64793	_	_	_	_	_
461	12	Reporting	Reporting	NNP	13	compound	64794	64803	_	_	_	_	_
461	13	System	System	NNP	2	dep	64804	64810	_	_	_	_	_
461	14	,	,	,	13	punct	64810	64811	_	_	_	_	_
461	15	1991	1991	CD	13	appos	64812	64816	_	_	_	_	_
461	16	–	–	CD	17	nummod	64816	64817	_	_	_	_	_
461	17	1998	1998	CD	15	dep	64817	64821	_	_	_	_	_
461	18	.	.	.	2	punct	64821	64822	_	_	_	_	_

462	1	Archives	archive	NNS	0	ROOT	64823	64831	_	_	_	_	_
462	2	of	of	IN	3	case	64832	64834	_	_	_	_	_
462	3	Pediatrics	pediatrics	NNS	1	nmod	64835	64845	_	_	_	_	_
462	4	and	and	CC	3	cc	64846	64849	_	_	_	_	_
462	5	Adolescent	adolescent	JJ	6	amod	64850	64860	_	_	_	_	_
462	6	Medicine	medicine	NN	3	conj	64861	64869	_	_	_	_	_
462	7	1999	1999	CD	6	nummod	64870	64874	_	_	_	_	_
462	8	;	;	:	1	punct	64874	64875	_	_	_	_	_
462	9	153:1279-82	153:1279-82	CD	1	dep	64875	64886	_	_	_	_	_
462	10	.	.	.	1	punct	64886	64887	_	_	_	_	_

463	1	Eriksen	Eriksen	NNP	2	compound	64888	64895	_	_	_	_	_
463	2	EM	EM	NNP	0	ROOT	64896	64898	_	_	_	_	_
463	3	,	,	,	2	punct	64898	64899	_	_	_	_	_
463	4	Perlman	Perlman	NNP	5	compound	64900	64907	_	_	_	_	_
463	5	JA	JA	NNP	2	appos	64908	64910	_	_	_	_	_
463	6	,	,	,	2	punct	64910	64911	_	_	_	_	_
463	7	Miller	Miller	NNP	8	compound	64912	64918	_	_	_	_	_
463	8	A	A	NNP	2	appos	64919	64920	_	_	_	_	_
463	9	,	,	,	2	punct	64920	64921	_	_	_	_	_
463	10	et	et	FW	11	compound	64922	64924	_	_	_	_	_
463	11	al.	al.	FW	2	appos	64925	64928	_	_	_	_	_
463	12	.	.	.	2	punct	_	_	_	_	_	_	_

464	1	Lack	lack	NN	0	ROOT	64929	64933	_	_	_	_	_
464	2	of	of	IN	3	case	64934	64936	_	_	_	_	_
464	3	association	association	NN	1	nmod	64937	64948	_	_	_	_	_
464	4	between	between	IN	8	case	64949	64956	_	_	_	_	_
464	5	hepatitis	hepatitis	NN	8	compound	64957	64966	_	_	_	_	_
464	6	B	b	NN	8	compound	64967	64968	_	_	_	_	_
464	7	birth	birth	NN	8	compound	64969	64974	_	_	_	_	_
464	8	immunization	immunization	NN	3	nmod	64975	64987	_	_	_	_	_
464	9	and	and	CC	8	cc	64988	64991	_	_	_	_	_
464	10	neonatal	neonatal	JJ	11	amod	64992	65000	_	_	_	_	_
464	11	death	death	NN	8	conj	65001	65006	_	_	_	_	_
464	12	:	:	:	1	punct	65006	65007	_	_	_	_	_
464	13	a	a	DT	15	det	65008	65009	_	_	_	_	_
464	14	population-based	population-based	JJ	15	amod	65010	65026	_	_	_	_	_
464	15	study	study	NN	1	dep	65027	65032	_	_	_	_	_
464	16	from	from	IN	21	case	65033	65037	_	_	_	_	_
464	17	the	the	DT	21	det	65038	65041	_	_	_	_	_
464	18	Vaccine	Vaccine	NNP	21	compound	65042	65049	_	_	_	_	_
464	19	Safety	Safety	NNP	21	compound	65050	65056	_	_	_	_	_
464	20	Datalink	Datalink	NNP	21	compound	65057	65065	_	_	_	_	_
464	21	Project	Project	NNP	15	nmod	65066	65073	_	_	_	_	_
464	22	.	.	.	1	punct	65073	65074	_	_	_	_	_

465	1	Pediatric	Pediatric	NNP	2	nsubj	65075	65084	_	_	_	_	_
465	2	Infectious	infectious	JJ	0	ROOT	65085	65095	_	_	_	_	_
465	3	Disease	disease	NN	4	dep	65096	65103	_	_	_	_	_
465	4	Journal	Journal	NNP	2	nmod	65104	65111	_	_	_	_	_
465	5	2004	2004	CD	4	nummod	65112	65116	_	_	_	_	_
465	6	;	;	:	4	punct	65116	65117	_	_	_	_	_
465	7	23:656-61	23:656-61	CD	4	nummod	65117	65126	_	_	_	_	_
465	8	.	.	.	2	punct	65126	65127	_	_	_	_	_

466	1	Institute	Institute	NNP	0	ROOT	65128	65137	_	_	_	_	_
466	2	of	of	IN	3	case	65138	65140	_	_	_	_	_
466	3	Medicine	Medicine	NNP	1	nmod	65141	65149	_	_	_	_	_
466	4	.	.	.	1	punct	65149	65150	_	_	_	_	_

467	1	Stratton	Stratton	NNP	2	compound	65151	65159	_	_	_	_	_
467	2	K	K	NNP	0	ROOT	65160	65161	_	_	_	_	_
467	3	,	,	,	2	punct	65161	65162	_	_	_	_	_
467	4	Ford	Ford	NNP	5	compound	65163	65167	_	_	_	_	_
467	5	A	A	NNP	2	appos	65168	65169	_	_	_	_	_
467	6	,	,	,	2	punct	65169	65170	_	_	_	_	_
467	7	Rusch	Rusch	NNP	8	compound	65171	65176	_	_	_	_	_
467	8	E	E	NNP	2	appos	65177	65178	_	_	_	_	_
467	9	,	,	,	2	punct	65178	65179	_	_	_	_	_
467	10	Wright	Wright	NNP	12	compound	65180	65186	_	_	_	_	_
467	11	Clayton	Clayton	NNP	12	compound	65187	65194	_	_	_	_	_
467	12	E	E	NNP	2	appos	65195	65196	_	_	_	_	_
467	13	,	,	,	2	punct	65196	65197	_	_	_	_	_
467	14	eds	ed	NNS	2	appos	65198	65201	_	_	_	_	_
467	15	.	.	.	2	punct	65201	65202	_	_	_	_	_

468	1	Adverse	adverse	JJ	2	amod	65203	65210	_	_	_	_	_
468	2	effects	effect	NNS	0	ROOT	65211	65218	_	_	_	_	_
468	3	of	of	IN	4	case	65219	65221	_	_	_	_	_
468	4	vaccines	vaccine	NNS	2	nmod	65222	65230	_	_	_	_	_
468	5	:	:	:	2	punct	65230	65231	_	_	_	_	_
468	6	evidence	evidence	NN	2	dep	65232	65240	_	_	_	_	_
468	7	and	and	CC	6	cc	65241	65244	_	_	_	_	_
468	8	causality	causality	NN	6	conj	65245	65254	_	_	_	_	_
468	9	.	.	.	2	punct	65254	65255	_	_	_	_	_

469	1	Washington	Washington	NNP	3	compound	65256	65266	_	_	_	_	_
469	2	,	,	,	3	punct	65266	65267	_	_	_	_	_
469	3	D.C.	D.C.	NNP	0	ROOT	65268	65272	_	_	_	_	_
469	4	:	:	:	3	punct	65272	65273	_	_	_	_	_
469	5	The	The	NNP	8	compound	65274	65277	_	_	_	_	_
469	6	National	National	NNP	8	compound	65278	65286	_	_	_	_	_
469	7	Academies	Academies	NNP	8	compound	65287	65296	_	_	_	_	_
469	8	Press	Press	NNP	3	dep	65297	65302	_	_	_	_	_
469	9	,	,	,	8	punct	65302	65303	_	_	_	_	_
469	10	2012	2012	CD	8	amod	65304	65308	_	_	_	_	_
469	11	.	.	.	3	punct	65308	65309	_	_	_	_	_
